data_2ltb_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2ltb _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.619 0 N-CA-C 112.132 -0.387 . . . . 0.0 112.132 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 504' ' ' THR . . . . . 0.55 ' HA ' HG22 ' A' ' 621' ' ' THR . 33.7 p -78.85 172.35 13.88 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.539 0.209 . . . . 0.0 110.582 179.29 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 505' ' ' VAL . . . . . 0.704 ' O ' ' HG ' ' A' ' 509' ' ' LEU . 13.0 m -57.85 -34.96 49.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.696 -0.229 . . . . 0.0 110.929 176.125 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 506' ' ' MET . . . . . 0.499 ' HE1' HG21 ' A' ' 528' ' ' THR . 95.0 mmm -61.5 -35.93 79.07 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-O 120.77 0.319 . . . . 0.0 110.928 178.687 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 507' ' ' ASP . . . . . 0.737 ' HA ' ' HE3' ' A' ' 510' ' ' LYS . 23.0 t70 -67.49 -35.85 79.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.279 -178.686 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 508' ' ' VAL . . . . . . . . . . . . . 45.8 t -71.92 -41.37 69.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 115.63 -0.713 . . . . 0.0 110.58 178.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 509' ' ' LEU . . . . . 0.704 ' HG ' ' O ' ' A' ' 505' ' ' VAL . 77.4 mt -62.73 -31.74 72.73 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.745 -176.672 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 510' ' ' LYS . . . . . 0.737 ' HE3' ' HA ' ' A' ' 507' ' ' ASP . 22.8 pttp -88.62 -13.71 39.25 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.061 0.458 . . . . 0.0 110.618 -177.741 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 511' ' ' GLY . . . . . . . . . . . . . . . -85.21 -11.57 75.48 Favored Glycine 0 N--CA 1.442 -0.947 0 C-N-CA 120.463 -0.875 . . . . 0.0 110.976 175.34 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 512' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -108.84 134.58 51.34 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.894 0.378 . . . . 0.0 110.194 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -72.88 -22.52 60.75 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.537 -176.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 514' ' ' ARG . . . . . 0.532 ' HG2' HD22 ' A' ' 544' ' ' ASN . 63.9 mtm180 -84.16 -33.85 24.14 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 120.987 0.422 . . . . 0.0 110.352 -176.799 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 515' ' ' PHE . . . . . 0.983 ' HZ ' HG22 ' A' ' 627' ' ' VAL . 11.5 m-30 -81.1 -7.73 59.62 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.408 -179.788 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 23.2 t -58.93 -43.32 91.14 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.872 -174.186 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 517' ' ' MET . . . . . . . . . . . . . 4.3 mpp? -67.18 -30.35 70.28 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-O 120.879 0.371 . . . . 0.0 110.504 179.346 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 518' ' ' LEU . . . . . 0.474 HD22 ' HA ' ' A' ' 541' ' ' ALA . 61.8 tp -68.68 -41.28 79.44 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.66 -0.416 . . . . 0.0 109.903 177.1 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 519' ' ' VAL . . . . . 0.432 ' O ' ' HG3' ' A' ' 523' ' ' GLN . 61.3 t -56.94 -36.42 50.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.086 0.47 . . . . 0.0 109.955 175.067 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 520' ' ' ALA . . . . . . . . . . . . . . . -69.67 -39.46 77.01 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.436 -179.451 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 521' ' ' ALA . . . . . . . . . . . . . . . -67.26 -46.65 73.07 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.299 176.091 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 522' ' ' ILE . . . . . 0.416 HG13 ' O ' ' A' ' 518' ' ' LEU . 71.5 mt -55.07 -45.46 76.98 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.072 177.248 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 523' ' ' GLN . . . . . 0.432 ' HG3' ' O ' ' A' ' 519' ' ' VAL . 26.3 mt-30 -65.46 -44.73 86.28 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.314 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 24.2 t -69.71 -32.46 71.04 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.567 -176.648 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 525' ' ' ALA . . . . . 0.48 ' HB3' ' HB2' ' A' ' 566' ' ' ALA . . . -86.32 -25.48 25.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.725 0.298 . . . . 0.0 111.265 -179.37 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 526' ' ' GLY . . . . . . . . . . . . . . . 90.76 31.71 9.87 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 121.009 -0.615 . . . . 0.0 112.564 177.424 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 527' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -92.16 -4.7 53.86 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.549 0.214 . . . . 0.0 111.303 -179.114 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 528' ' ' THR . . . . . 0.499 HG21 ' HE1' ' A' ' 506' ' ' MET . 8.1 m -54.24 -37.85 65.12 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.824 -176.428 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 529' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -62.84 -19.51 64.18 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 112.219 0.452 . . . . 0.0 112.219 -176.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 530' ' ' THR . . . . . 0.421 ' HB ' HD21 ' A' ' 531' ' ' LEU . 84.8 m -75.06 -54.7 6.71 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.94 0.4 . . . . 0.0 110.18 177.266 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 531' ' ' LEU . . . . . 0.426 ' HB3' HG22 ' A' ' 505' ' ' VAL . 1.4 mm? -75.53 -5.33 44.69 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.26 179.457 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 532' ' ' ASN . . . . . . . . . . . . . 61.3 t30 -81.44 -5.8 58.28 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.196 178.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 533' ' ' ARG . . . . . . . . . . . . . 29.6 mmm180 -110.12 146.9 34.67 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.283 178.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 534' ' ' GLU . . . . . 0.658 ' HA ' ' CB ' ' A' ' 622' ' ' ASN . 35.7 mt-10 -90.74 155.25 18.94 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.893 0.378 . . . . 0.0 110.253 177.572 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 535' ' ' GLY . . . . . . . . . . . . . . . 151.83 -132.74 3.9 Favored Glycine 0 N--CA 1.447 -0.62 0 N-CA-C 110.834 -0.907 . . . . 0.0 110.834 -174.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 536' ' ' VAL . . . . . 0.441 ' HA ' HD12 ' A' ' 577' ' ' ILE . 33.8 m -123.17 128.41 74.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 120.965 0.412 . . . . 0.0 110.851 177.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 537' ' ' TYR . . . . . . . . . . . . . 82.2 m-85 -155.16 152.94 30.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.057 179.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 538' ' ' THR . . . . . 0.647 ' OG1' ' HA ' ' A' ' 577' ' ' ILE . 94.6 m -130.42 102.8 6.33 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.213 -0.449 . . . . 0.0 109.994 174.825 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 539' ' ' VAL . . . . . . . . . . . . . 26.6 t -100.89 125.75 54.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 120.937 0.399 . . . . 0.0 111.411 -172.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 540' ' ' PHE . . . . . 0.535 ' HB3' HD13 ' A' ' 628' ' ' ILE . 97.3 m-85 -98.47 111.57 23.88 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 173.362 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 541' ' ' ALA . . . . . 0.474 ' HA ' HD22 ' A' ' 518' ' ' LEU . . . -102.08 115.41 64.69 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 116.651 -0.25 . . . . 0.0 111.263 -176.799 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 542' ' ' PRO . . . . . 0.495 ' HA ' HG13 ' A' ' 628' ' ' ILE . 13.4 Cg_exo -71.02 141.02 39.17 Favored 'Trans proline' 0 N--CA 1.463 -0.279 0 C-N-CA 123.146 2.564 . . . . 0.0 112.195 177.376 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 41.7 p -85.85 -177.03 6.25 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.058 178.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 544' ' ' ASN . . . . . 0.532 HD22 ' HG2' ' A' ' 514' ' ' ARG . 0.5 OUTLIER -59.72 -40.36 87.71 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 121.387 0.613 . . . . 0.0 109.958 -179.057 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 545' ' ' GLU . . . . . 0.438 ' CD ' ' H ' ' A' ' 545' ' ' GLU . 3.3 mp0 -58.15 -39.11 77.97 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 114.736 -1.12 . . . . 0.0 110.812 -178.148 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 546' ' ' ALA . . . . . 0.563 ' HB3' HG13 ' A' ' 631' ' ' VAL . . . -63.96 -43.51 95.59 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.027 0.441 . . . . 0.0 111.232 -178.4 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 547' ' ' PHE . . . . . . . . . . . . . 75.1 m-85 -72.87 -27.75 62.1 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.151 -179.007 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 548' ' ' ARG . . . . . 0.439 ' O ' ' HD2' ' A' ' 548' ' ' ARG . 5.5 tmm_? -80.33 -29.07 38.04 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.219 0.533 . . . . 0.0 109.912 179.161 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 549' ' ' ALA . . . . . . . . . . . . . . . -76.09 -17.68 59.51 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.232 179.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 550' ' ' LEU . . . . . 0.691 ' HB3' ' HB3' ' A' ' 555' ' ' ARG . 20.0 mt -58.31 134.3 84.94 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.089 178.116 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 551' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 550' ' ' LEU . 28.0 Cg_exo -62.84 143.9 92.55 Favored 'Trans proline' 0 C--O 1.234 0.308 0 C-N-CA 122.909 2.406 . . . . 0.0 111.766 -179.582 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 552' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -53.67 -38.0 84.16 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 123.261 2.64 . . . . 0.0 112.249 -177.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 553' ' ' ARG . . . . . . . . . . . . . 22.4 mmm180 -69.05 -52.92 23.56 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.851 -178.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 18.2 mt-10 -66.69 -51.22 58.53 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.712 -0.676 . . . . 0.0 112.42 -175.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 555' ' ' ARG . . . . . 0.691 ' HB3' ' HB3' ' A' ' 550' ' ' LEU . 18.6 ptt180 -67.4 -27.64 67.26 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 120.445 -0.502 . . . . 0.0 111.396 -175.063 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 47.1 t -71.21 -31.55 67.75 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.733 0.301 . . . . 0.0 110.701 177.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 557' ' ' ARG . . . . . 0.414 HH11 ' HD3' ' A' ' 557' ' ' ARG . 8.7 tpt180 -83.28 -53.03 6.06 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.487 -179.411 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 558' ' ' LEU . . . . . 0.521 HD21 ' HB3' ' A' ' 564' ' ' GLU . 0.3 OUTLIER -57.48 -47.36 82.11 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.23 -0.896 . . . . 0.0 111.429 -174.602 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 559' ' ' LEU . . . . . 0.663 HD23 HD23 ' A' ' 565' ' ' LEU . 93.5 mt -77.81 0.7 22.78 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.563 -175.161 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 560' ' ' GLY . . . . . . . . . . . . . . . -97.2 -11.51 52.05 Favored Glycine 0 N--CA 1.445 -0.746 0 C-N-CA 120.444 -0.884 . . . . 0.0 112.585 -178.287 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 561' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -132.23 127.91 36.78 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.923 0.392 . . . . 0.0 111.205 -177.282 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 562' ' ' ALA . . . . . . . . . . . . . . . -64.31 -29.24 70.33 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.909 -0.587 . . . . 0.0 112.227 -176.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 563' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -78.71 -39.85 35.34 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 -177.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 564' ' ' GLU . . . . . 0.521 ' HB3' HD21 ' A' ' 558' ' ' LEU . 44.5 mt-10 -64.25 -34.52 78.3 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.164 -0.471 . . . . 0.0 109.937 175.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 565' ' ' LEU . . . . . 0.663 HD23 HD23 ' A' ' 559' ' ' LEU . 58.1 mt -64.34 -52.42 58.49 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.986 175.031 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 566' ' ' ALA . . . . . 0.48 ' HB2' ' HB3' ' A' ' 525' ' ' ALA . . . -56.4 -40.71 75.09 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.821 -176.548 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 567' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -60.97 -47.91 84.27 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.757 -177.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 568' ' ' ILE . . . . . . . . . . . . . 50.6 mm -69.87 -33.42 55.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.389 -177.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 569' ' ' LEU . . . . . 0.426 ' HG ' ' O ' ' A' ' 565' ' ' LEU . 78.7 mt -65.98 -33.47 75.89 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.541 -0.3 . . . . 0.0 111.517 -179.15 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 570' ' ' LYS . . . . . 0.509 ' HE3' ' HA ' ' A' ' 593' ' ' GLN . 28.0 mtpp -66.94 -18.7 65.5 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.135 179.807 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 571' ' ' TYR . . . . . . . . . . . . . 20.5 t80 -87.12 -18.26 30.88 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.223 178.366 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 572' ' ' HIS . . . . . . . . . . . . . 62.5 m80 -89.09 -12.14 42.02 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.883 0.373 . . . . 0.0 111.403 -178.487 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 573' ' ' ILE . . . . . 0.408 ' O ' HD23 ' A' ' 592' ' ' LEU . 38.5 mt -108.64 119.69 58.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.359 179.105 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 574' ' ' GLY . . . . . 0.555 ' HA2' ' HA ' ' A' ' 591' ' ' SER . . . -91.97 151.24 20.68 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.99 -0.624 . . . . 0.0 111.941 177.179 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 575' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -93.99 9.3 38.11 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.087 0.47 . . . . 0.0 110.703 -173.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 576' ' ' GLU . . . . . 0.559 ' OE1' ' HG2' ' A' ' 590' ' ' LYS . 42.8 mt-10 -142.08 126.12 17.3 Favored 'General case' 0 CA--C 1.511 -0.521 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.951 -176.063 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 577' ' ' ILE . . . . . 0.647 ' HA ' ' OG1' ' A' ' 538' ' ' THR . 58.5 mt -76.06 105.11 4.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 121.218 0.532 . . . . 0.0 111.235 -177.861 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 578' ' ' LEU . . . . . 0.446 ' HG ' HG11 ' A' ' 587' ' ' VAL . 3.9 mm? -119.7 100.79 7.47 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.153 176.644 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 579' ' ' VAL . . . . . 0.536 ' O ' HG13 ' A' ' 583' ' ' ILE . 34.0 m -86.82 166.89 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 109.614 -0.514 . . . . 0.0 109.614 175.079 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 580' ' ' SER . . . . . . . . . . . . . 20.8 m -57.12 -40.13 76.5 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.893 0.377 . . . . 0.0 111.226 -176.084 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 581' ' ' GLY . . . . . . . . . . . . . . . -76.26 -8.7 85.61 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.783 -179.412 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . -103.24 -27.12 6.65 Favored Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.918 -177.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 583' ' ' ILE . . . . . 0.536 HG13 ' O ' ' A' ' 579' ' ' VAL . 77.1 mt -60.27 -59.02 4.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 120.893 0.377 . . . . 0.0 111.548 -178.158 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 584' ' ' GLY . . . . . . . . . . . . . . . 94.23 -81.29 0.96 Allowed Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.236 -178.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 585' ' ' ALA . . . . . . . . . . . . . . . -128.07 -62.26 1.06 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.753 0.311 . . . . 0.0 110.929 179.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 586' ' ' LEU . . . . . 0.947 ' HG ' ' HB3' ' A' ' 600' ' ' SER . 3.9 tt -155.3 140.2 17.25 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 178.344 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 587' ' ' VAL . . . . . 0.523 ' N ' HD23 ' A' ' 586' ' ' LEU . 9.3 p -142.18 136.92 29.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-O 121.102 0.477 . . . . 0.0 111.086 -178.515 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 588' ' ' ARG . . . . . . . . . . . . . 8.2 ttt180 -85.03 101.49 12.44 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.625 174.182 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 589' ' ' LEU . . . . . . . . . . . . . 2.7 tt -97.53 128.77 44.54 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.45 -0.796 . . . . 0.0 109.456 -175.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 590' ' ' LYS . . . . . 0.559 ' HG2' ' OE1' ' A' ' 576' ' ' GLU . 27.8 pttt -82.03 143.65 31.41 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 120.691 -0.404 . . . . 0.0 110.795 178.706 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 591' ' ' SER . . . . . 0.555 ' HA ' ' HA2' ' A' ' 574' ' ' GLY . 80.3 p -105.1 165.15 11.29 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.597 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 592' ' ' LEU . . . . . 0.408 HD23 ' O ' ' A' ' 573' ' ' ILE . 3.5 mm? -66.88 -9.17 35.08 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 178.572 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 593' ' ' GLN . . . . . 0.509 ' HA ' ' HE3' ' A' ' 570' ' ' LYS . 7.9 tt0 -86.01 -29.46 23.46 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.103 0.477 . . . . 0.0 110.359 176.283 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 594' ' ' GLY . . . . . . . . . . . . . . . 117.94 -21.21 10.42 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.559 -0.829 . . . . 0.0 111.784 -176.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 595' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -78.37 179.28 7.08 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 109.271 -0.641 . . . . 0.0 109.271 177.271 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 596' ' ' LYS . . . . . 0.713 ' H ' ' HD3' ' A' ' 596' ' ' LYS . 0.0 OUTLIER -115.8 140.29 49.36 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-O 121.027 0.442 . . . . 0.0 110.316 -175.741 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 597' ' ' LEU . . . . . . . . . . . . . 71.0 mt -101.39 117.17 34.41 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.934 -0.575 . . . . 0.0 109.601 173.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 598' ' ' GLU . . . . . 0.482 ' OE1' ' HG2' ' A' ' 596' ' ' LYS . 1.6 mp0 -80.89 84.86 6.3 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.204 0.525 . . . . 0.0 110.006 178.225 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 599' ' ' VAL . . . . . . . . . . . . . 26.1 t -93.29 126.53 45.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.586 -0.733 . . . . 0.0 109.738 -179.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 600' ' ' SER . . . . . 0.947 ' HB3' ' HG ' ' A' ' 586' ' ' LEU . 23.9 p -135.01 159.33 41.84 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.251 0.548 . . . . 0.0 111.692 -178.32 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 601' ' ' LEU . . . . . . . . . . . . . 27.5 tp -130.45 108.77 10.21 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.014 -0.994 . . . . 0.0 109.0 179.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 602' ' ' LYS . . . . . . . . . . . . . 8.6 ptpp? -137.07 131.68 33.09 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 110.113 -0.329 . . . . 0.0 110.113 -179.037 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 603' ' ' ASN . . . . . . . . . . . . . 14.1 m120 65.06 25.54 12.58 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.743 -176.466 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 604' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 71.59 10.3 6.43 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 114.952 -1.022 . . . . 0.0 110.164 -177.286 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 605' ' ' VAL . . . . . . . . . . . . . 62.1 t -101.11 119.23 48.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.936 177.004 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 606' ' ' VAL . . . . . 0.691 HG12 ' HB ' ' A' ' 613' ' ' VAL . 5.6 p -91.11 137.31 22.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 121.104 0.478 . . . . 0.0 110.635 178.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 607' ' ' SER . . . . . . . . . . . . . 18.5 m -143.34 140.02 30.35 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.862 -179.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 608' ' ' VAL . . . . . . . . . . . . . 3.8 p -113.63 114.3 46.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.637 176.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 609' ' ' ASN . . . . . . . . . . . . . 84.4 m-20 57.04 44.55 22.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.244 -175.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 610' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 76.9 -19.67 0.41 Allowed 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.141 0.977 . . . . 0.0 112.443 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 611' ' ' GLU . . . . . 0.469 ' HA ' ' HD3' ' A' ' 612' ' ' PRO . 46.7 mm-40 -79.28 121.27 82.79 Favored Pre-proline 0 C--N 1.332 -0.172 0 CA-C-O 120.831 0.348 . . . . 0.0 110.386 179.085 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 612' ' ' PRO . . . . . 0.469 ' HD3' ' HA ' ' A' ' 611' ' ' GLU . 11.7 Cg_exo -70.39 146.56 56.67 Favored 'Trans proline' 0 CA--C 1.529 0.255 0 C-N-CA 123.038 2.492 . . . . 0.0 112.935 -178.422 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 613' ' ' VAL . . . . . 0.691 ' HB ' HG12 ' A' ' 606' ' ' VAL . 85.4 t -87.85 135.63 25.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.979 177.604 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 614' ' ' ALA . . . . . . . . . . . . . . . -84.5 -31.91 24.22 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.553 -175.349 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 615' ' ' GLU . . . . . 0.489 ' HB3' ' CG2' ' A' ' 627' ' ' VAL . 8.7 tp10 -161.92 92.32 1.37 Allowed Pre-proline 0 C--N 1.327 -0.407 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 -177.597 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 616' ' ' PRO . . . . . 0.452 ' HB3' HG13 ' A' ' 613' ' ' VAL . 60.8 Cg_endo -89.77 165.67 5.02 Favored 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 123.078 2.519 . . . . 0.0 114.035 -176.315 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 617' ' ' ASP . . . . . 0.436 ' OD2' ' HB ' ' A' ' 579' ' ' VAL . 0.9 OUTLIER 76.81 34.54 0.43 Allowed 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 122.33 1.062 . . . . 0.0 110.514 165.78 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 618' ' ' ILE . . . . . 0.531 ' HB ' ' O ' ' A' ' 625' ' ' VAL . 13.6 mt -78.02 109.59 12.8 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.969 0 CA-C-N 113.92 -1.491 . . . . 0.0 109.327 172.254 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 619' ' ' MET . . . . . 0.462 ' HA ' ' HE1' ' A' ' 619' ' ' MET . 8.0 mmt -80.08 131.34 35.74 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.87 -0.604 . . . . 0.0 112.034 -174.13 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 620' ' ' ALA . . . . . . . . . . . . . . . -130.6 173.07 11.24 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.262 173.358 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 621' ' ' THR . . . . . 0.55 HG22 ' HA ' ' A' ' 504' ' ' THR . 6.3 t -72.14 -29.4 64.01 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.887 0.375 . . . . 0.0 111.239 -176.857 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 622' ' ' ASN . . . . . 0.658 ' CB ' ' HA ' ' A' ' 534' ' ' GLU . 28.7 p-10 -117.34 22.7 12.29 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 112.168 0.433 . . . . 0.0 112.168 -173.745 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 623' ' ' GLY . . . . . . . . . . . . . . . 151.05 -154.85 25.82 Favored Glycine 0 N--CA 1.442 -0.919 0 C-N-CA 119.631 -1.271 . . . . 0.0 113.056 176.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 624' ' ' VAL . . . . . 0.474 HG22 HG11 ' A' ' 579' ' ' VAL . 9.7 p -129.65 159.0 42.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 N-CA-C 109.932 -0.395 . . . . 0.0 109.932 -179.707 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 625' ' ' VAL . . . . . 0.531 ' O ' ' HB ' ' A' ' 618' ' ' ILE . 67.9 t -128.04 132.3 68.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.819 178.606 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 626' ' ' HIS . . . . . . . . . . . . . 69.6 m-70 -118.46 112.3 19.77 Favored 'General case' 0 N--CA 1.445 -0.68 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 177.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 627' ' ' VAL . . . . . 0.983 HG22 ' HZ ' ' A' ' 515' ' ' PHE . 38.5 t -64.38 126.11 22.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.146 178.757 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 628' ' ' ILE . . . . . 0.535 HD13 ' HB3' ' A' ' 540' ' ' PHE . 5.4 pt -121.06 142.52 36.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.064 0.459 . . . . 0.0 110.701 176.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 629' ' ' THR . . . . . . . . . . . . . 9.5 t -97.31 2.87 51.2 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.778 0.799 . . . . 0.0 109.851 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 630' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -132.77 157.56 44.64 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.086 -0.961 . . . . 0.0 108.833 178.1 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 631' ' ' VAL . . . . . 0.563 HG13 ' HB3' ' A' ' 546' ' ' ALA . 23.8 m -92.79 156.28 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.015 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 176.363 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 632' ' ' LEU . . . . . . . . . . . . . 92.2 mt -106.1 110.89 23.3 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-O 121.281 0.562 . . . . 0.0 110.521 -178.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 633' ' ' GLN . . . . . 0.471 ' HA ' ' HD3' ' A' ' 634' ' ' PRO . 53.8 mt-30 -117.44 130.76 24.44 Favored Pre-proline 0 C--N 1.319 -0.735 0 CA-C-N 115.122 -0.944 . . . . 0.0 109.936 -177.675 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 634' ' ' PRO . . . . . 0.471 ' HD3' ' HA ' ' A' ' 633' ' ' GLN . 14.2 Cg_exo . . . . . 0 C--O 1.25 1.113 0 C-N-CA 122.814 2.343 . . . . 0.0 111.722 177.528 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.545 0 N-CA-C 111.77 -0.532 . . . . 0.0 111.77 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 31.5 p -90.01 -179.28 5.66 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.366 0.127 . . . . 0.0 110.875 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 505' ' ' VAL . . . . . 0.661 ' O ' ' HG ' ' A' ' 509' ' ' LEU . 22.2 t -50.43 -47.61 26.49 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.275 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.223 179.826 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 506' ' ' MET . . . . . 0.578 ' HE1' HG21 ' A' ' 528' ' ' THR . 90.8 mmm -57.37 -34.81 69.22 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.993 -176.135 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 507' ' ' ASP . . . . . 0.576 ' HA ' ' HZ1' ' A' ' 510' ' ' LYS . 12.1 t70 -76.13 -35.64 59.16 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.799 0.333 . . . . 0.0 110.133 -178.675 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 508' ' ' VAL . . . . . . . . . . . . . 64.3 t -66.0 -39.61 85.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.473 178.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 509' ' ' LEU . . . . . 0.661 ' HG ' ' O ' ' A' ' 505' ' ' VAL . 22.8 mt -65.61 -19.92 66.11 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.048 -178.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 510' ' ' LYS . . . . . 0.576 ' HZ1' ' HA ' ' A' ' 507' ' ' ASP . 30.2 mtmm -81.62 -24.96 36.08 Favored 'General case' 0 CA--C 1.514 -0.432 0 CA-C-O 121.223 0.535 . . . . 0.0 110.024 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 511' ' ' GLY . . . . . . . . . . . . . . . -80.38 -8.17 87.83 Favored Glycine 0 N--CA 1.443 -0.872 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.806 179.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 512' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -118.9 152.99 35.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.341 0.591 . . . . 0.0 111.769 -178.423 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 43.2 t-20 -76.82 -39.41 51.41 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.408 -0.815 . . . . 0.0 111.095 -178.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 514' ' ' ARG . . . . . . . . . . . . . 3.0 mpp_? -80.58 -34.31 35.39 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.105 0.479 . . . . 0.0 110.808 -171.565 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 515' ' ' PHE . . . . . 0.534 ' CZ ' HG23 ' A' ' 627' ' ' VAL . 14.5 m-30 -75.99 -8.25 56.51 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.827 178.798 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 16.8 t -59.05 -38.55 79.62 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.673 -176.071 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 517' ' ' MET . . . . . 0.519 ' HE1' ' HA ' ' A' ' 544' ' ' ASN . 3.4 mpp? -68.61 -26.56 65.42 Favored 'General case' 0 CA--C 1.519 -0.219 0 C-N-CA 120.787 -0.365 . . . . 0.0 111.025 -179.821 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 518' ' ' LEU . . . . . 0.575 HD23 HD11 ' A' ' 522' ' ' ILE . 3.3 mt -65.49 -43.29 90.64 Favored 'General case' 0 CA--C 1.517 -0.312 0 C-N-CA 120.261 -0.575 . . . . 0.0 109.554 174.201 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 519' ' ' VAL . . . . . 0.673 ' O ' ' HB2' ' A' ' 523' ' ' GLN . 30.1 t -55.09 -31.68 26.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.129 0.49 . . . . 0.0 110.41 178.455 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 520' ' ' ALA . . . . . . . . . . . . . . . -84.29 -46.71 11.51 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.46 178.497 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 521' ' ' ALA . . . . . . . . . . . . . . . -64.73 -52.52 56.64 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.872 0.368 . . . . 0.0 110.934 -178.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 522' ' ' ILE . . . . . 0.575 HD11 HD23 ' A' ' 518' ' ' LEU . 41.2 mt -59.67 -26.93 36.45 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.306 177.75 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 523' ' ' GLN . . . . . 0.673 ' HB2' ' O ' ' A' ' 519' ' ' VAL . 7.5 tp-100 -69.49 -51.98 30.8 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.398 179.297 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 38.7 t -71.53 -23.37 61.76 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.587 -176.03 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 525' ' ' ALA . . . . . . . . . . . . . . . -81.87 -17.81 46.03 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 120.972 -0.291 . . . . 0.0 111.266 178.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 526' ' ' GLY . . . . . . . . . . . . . . . 82.86 22.68 57.42 Favored Glycine 0 N--CA 1.453 -0.193 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.852 179.276 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 527' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -98.01 4.74 49.3 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.873 0.368 . . . . 0.0 110.776 -179.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 528' ' ' THR . . . . . 0.578 HG21 ' HE1' ' A' ' 506' ' ' MET . 15.5 m -59.99 -37.0 78.38 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.422 -177.109 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 529' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -64.79 -28.73 69.77 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.732 -178.068 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 530' ' ' THR . . . . . 0.542 ' HB ' HD23 ' A' ' 531' ' ' LEU . 26.4 m -64.29 -59.27 4.59 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.98 -179.415 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 531' ' ' LEU . . . . . 0.542 HD23 ' HB ' ' A' ' 530' ' ' THR . 1.7 mm? -76.57 5.83 6.8 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-O 120.869 0.366 . . . . 0.0 111.524 -179.189 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 532' ' ' ASN . . . . . . . . . . . . . 64.7 t30 -86.26 -27.14 24.61 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.37 0.605 . . . . 0.0 109.716 177.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 533' ' ' ARG . . . . . . . . . . . . . 12.7 mmm180 -92.13 160.34 15.24 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.672 178.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 534' ' ' GLU . . . . . 0.767 ' HA ' ' HB3' ' A' ' 622' ' ' ASN . 40.9 mt-10 -87.71 179.35 6.52 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 120.76 -0.376 . . . . 0.0 110.25 177.232 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 535' ' ' GLY . . . . . . . . . . . . . . . 134.86 -145.3 17.41 Favored Glycine 0 N--CA 1.445 -0.764 0 N-CA-C 110.675 -0.97 . . . . 0.0 110.675 -175.108 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 536' ' ' VAL . . . . . . . . . . . . . 34.5 m -123.07 130.37 74.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-O 121.07 0.462 . . . . 0.0 110.057 176.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 537' ' ' TYR . . . . . . . . . . . . . 71.2 m-85 -152.46 153.73 34.11 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.057 -178.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 538' ' ' THR . . . . . 0.755 ' OG1' ' HA ' ' A' ' 577' ' ' ILE . 50.4 m -132.1 103.71 6.41 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 174.673 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 539' ' ' VAL . . . . . . . . . . . . . 47.9 t -105.71 124.65 60.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.926 -173.228 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 540' ' ' PHE . . . . . 0.575 ' HB3' HD12 ' A' ' 628' ' ' ILE . 99.0 m-85 -95.85 111.08 23.15 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 173.328 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -97.82 112.97 62.98 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.712 -176.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 542' ' ' PRO . . . . . 0.491 ' HA ' HG13 ' A' ' 628' ' ' ILE . 7.9 Cg_exo -73.12 135.75 23.46 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 122.702 2.268 . . . . 0.0 110.708 174.302 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 40.4 p -76.96 179.31 6.28 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.529 -177.216 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 544' ' ' ASN . . . . . 0.519 ' HA ' ' HE1' ' A' ' 517' ' ' MET . 25.0 t-20 -62.41 -33.73 75.37 Favored 'General case' 0 CA--C 1.52 -0.185 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 178.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 545' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -54.28 -45.09 72.41 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.19 -0.913 . . . . 0.0 110.759 178.152 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 546' ' ' ALA . . . . . 0.489 ' O ' HD21 ' A' ' 550' ' ' LEU . . . -67.06 -49.12 66.17 Favored 'General case' 0 CA--C 1.514 -0.431 0 CA-C-O 121.018 0.437 . . . . 0.0 111.283 -179.18 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 547' ' ' PHE . . . . . . . . . . . . . 29.9 m-85 -64.24 -25.61 68.14 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.705 -0.68 . . . . 0.0 111.315 -177.32 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 548' ' ' ARG . . . . . . . . . . . . . 23.8 ttm180 -86.7 -28.02 23.36 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.273 0.559 . . . . 0.0 110.179 178.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 549' ' ' ALA . . . . . . . . . . . . . . . -79.63 -10.51 59.8 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.242 -0.89 . . . . 0.0 112.103 -176.235 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 550' ' ' LEU . . . . . 0.519 ' HB2' ' HG3' ' A' ' 555' ' ' ARG . 0.1 OUTLIER -54.23 143.47 44.55 Favored Pre-proline 0 N--CA 1.454 -0.23 0 CA-C-O 120.759 0.314 . . . . 0.0 110.671 174.503 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 551' ' ' PRO . . . . . 0.627 ' HD2' ' HB2' ' A' ' 554' ' ' GLU . 2.6 Cg_endo -80.02 142.04 15.24 Favored 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 123.125 2.55 . . . . 0.0 110.547 -172.567 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 552' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_exo -43.47 -39.87 9.73 Favored 'Trans proline' 0 CA--C 1.533 0.458 0 C-N-CA 123.139 2.56 . . . . 0.0 113.348 -176.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 553' ' ' ARG . . . . . . . . . . . . . 44.7 mtp180 -68.3 -52.14 37.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.862 0.363 . . . . 0.0 111.721 177.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 554' ' ' GLU . . . . . 0.627 ' HB2' ' HD2' ' A' ' 551' ' ' PRO . 5.1 mm-40 -83.15 -42.72 17.0 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.911 -171.843 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 555' ' ' ARG . . . . . 0.519 ' HG3' ' HB2' ' A' ' 550' ' ' LEU . 26.1 ttt180 -46.87 -55.76 7.45 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 122.697 0.399 . . . . 0.0 111.429 173.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 14.8 m -62.45 -31.98 72.78 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.123 -178.159 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 557' ' ' ARG . . . . . . . . . . . . . 24.4 ttt180 -69.42 -59.24 3.12 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.587 176.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 558' ' ' LEU . . . . . 0.837 HD23 ' HB3' ' A' ' 564' ' ' GLU . 0.7 OUTLIER -60.2 -50.47 73.54 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.507 -175.406 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 559' ' ' LEU . . . . . . . . . . . . . 74.6 mt -87.95 19.53 3.53 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.632 -177.368 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 560' ' ' GLY . . . . . . . . . . . . . . . -125.4 4.11 8.21 Favored Glycine 0 N--CA 1.445 -0.706 0 CA-C-N 115.949 -0.568 . . . . 0.0 111.928 179.459 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 561' ' ' ASP . . . . . 0.481 ' OD2' ' HB3' ' A' ' 563' ' ' LYS . 18.0 t70 -142.59 142.24 32.11 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.653 0.264 . . . . 0.0 110.666 179.443 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 562' ' ' ALA . . . . . . . . . . . . . . . -76.51 -32.26 58.19 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.856 -177.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 563' ' ' LYS . . . . . 0.481 ' HB3' ' OD2' ' A' ' 561' ' ' ASP . 13.1 ttpt -69.0 -49.51 57.16 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.136 179.772 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 564' ' ' GLU . . . . . 0.837 ' HB3' HD23 ' A' ' 558' ' ' LEU . 59.7 mm-40 -52.07 -48.83 64.47 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.729 176.387 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 565' ' ' LEU . . . . . . . . . . . . . 39.5 mt -56.02 -55.2 35.71 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.416 177.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 566' ' ' ALA . . . . . . . . . . . . . . . -57.13 -48.06 79.6 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.55 -175.38 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 567' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -61.25 -45.62 93.78 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.637 -176.205 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 568' ' ' ILE . . . . . 0.692 HG13 HD22 ' A' ' 558' ' ' LEU . 47.7 mm -74.17 -34.9 39.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.828 -176.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 569' ' ' LEU . . . . . . . . . . . . . 66.4 mt -68.04 -33.31 74.33 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.962 -0.295 . . . . 0.0 111.01 179.632 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 570' ' ' LYS . . . . . 0.733 ' HE3' ' HA ' ' A' ' 593' ' ' GLN . 26.9 mtpp -62.97 -18.5 63.29 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.939 0.4 . . . . 0.0 111.012 175.61 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 571' ' ' TYR . . . . . 0.489 ' O ' HD21 ' A' ' 597' ' ' LEU . 25.9 t80 -91.75 -17.85 24.78 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.895 -177.136 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 572' ' ' HIS . . . . . . . . . . . . . 61.5 m80 -90.72 -14.72 31.59 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.866 0.365 . . . . 0.0 111.053 -179.287 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 573' ' ' ILE . . . . . . . . . . . . . 42.9 mt -103.83 116.4 47.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.318 178.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 574' ' ' GLY . . . . . 0.533 ' HA2' ' HA ' ' A' ' 591' ' ' SER . . . -97.95 153.86 20.14 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 121.013 -0.613 . . . . 0.0 111.723 176.043 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 575' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -90.96 -6.46 54.03 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.252 0.549 . . . . 0.0 111.062 -176.196 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 576' ' ' GLU . . . . . 0.455 ' HB2' HD23 ' A' ' 589' ' ' LEU . 24.9 mt-10 -129.11 122.75 30.54 Favored 'General case' 0 CA--C 1.508 -0.663 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 -170.245 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 577' ' ' ILE . . . . . 0.755 ' HA ' ' OG1' ' A' ' 538' ' ' THR . 61.5 mt -73.05 116.55 15.42 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.943 -175.233 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 578' ' ' LEU . . . . . 0.551 HD13 ' HA ' ' A' ' 583' ' ' ILE . 23.5 tp -127.03 113.41 16.43 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.442 179.057 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 579' ' ' VAL . . . . . 0.467 ' O ' HG13 ' A' ' 583' ' ' ILE . 35.8 m -104.96 163.1 4.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.177 178.086 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 580' ' ' SER . . . . . . . . . . . . . 32.8 t -56.48 -47.74 78.6 Favored 'General case' 0 C--N 1.331 -0.228 0 O-C-N 123.32 0.388 . . . . 0.0 110.887 -176.282 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 581' ' ' GLY . . . . . . . . . . . . . . . -74.73 8.27 15.76 Favored Glycine 0 CA--C 1.521 0.411 0 C-N-CA 120.941 -0.647 . . . . 0.0 113.327 -178.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . -131.77 9.87 5.48 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.511 -0.852 . . . . 0.0 113.109 179.245 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 583' ' ' ILE . . . . . 0.551 ' HA ' HD13 ' A' ' 578' ' ' LEU . 47.0 mt -78.02 -77.54 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.956 0.378 . . . . 0.0 110.877 178.779 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 584' ' ' GLY . . . . . . . . . . . . . . . 84.72 81.69 1.05 Allowed Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.495 -0.859 . . . . 0.0 112.069 -175.314 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 585' ' ' ALA . . . . . . . . . . . . . . . 71.73 -74.69 0.08 Allowed 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 123.578 0.751 . . . . 0.0 112.084 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 586' ' ' LEU . . . . . 0.642 ' HG ' ' HB2' ' A' ' 600' ' ' SER . 2.3 tt -164.71 142.2 6.37 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.571 0.225 . . . . 0.0 110.422 -176.755 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 587' ' ' VAL . . . . . 0.539 ' N ' HD23 ' A' ' 586' ' ' LEU . 91.2 t -140.14 139.75 36.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.23 -178.697 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 588' ' ' ARG . . . . . 0.4 ' HA ' ' HD3' ' A' ' 588' ' ' ARG . 34.0 mmt180 -85.57 105.51 16.21 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.927 0.394 . . . . 0.0 110.138 177.122 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 589' ' ' LEU . . . . . 0.455 HD23 ' HB2' ' A' ' 576' ' ' GLU . 0.3 OUTLIER -99.86 124.62 45.36 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.374 -177.189 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 590' ' ' LYS . . . . . . . . . . . . . 47.4 mtpt -90.48 140.1 30.06 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.466 0.65 . . . . 0.0 111.563 -177.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 591' ' ' SER . . . . . 0.533 ' HA ' ' HA2' ' A' ' 574' ' ' GLY . 78.0 p -102.15 166.47 10.58 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.367 -177.542 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 592' ' ' LEU . . . . . . . . . . . . . 9.9 mp -67.44 -7.21 23.56 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 112.527 0.566 . . . . 0.0 112.527 178.235 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 593' ' ' GLN . . . . . 0.733 ' HA ' ' HE3' ' A' ' 570' ' ' LYS . 4.6 tt0 -76.74 -29.2 56.05 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 171.708 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 594' ' ' GLY . . . . . . . . . . . . . . . 113.41 -20.36 18.61 Favored Glycine 0 N--CA 1.444 -0.791 0 CA-C-N 115.203 -0.908 . . . . 0.0 111.62 -177.15 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 595' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -84.08 -178.57 7.0 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 120.984 0.421 . . . . 0.0 109.867 -179.594 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 596' ' ' LYS . . . . . 0.723 ' H ' ' HD3' ' A' ' 596' ' ' LYS . 0.0 OUTLIER -118.72 136.96 53.66 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.796 -172.272 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 597' ' ' LEU . . . . . 0.489 HD21 ' O ' ' A' ' 571' ' ' TYR . 56.6 mt -90.51 142.55 27.63 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.648 179.609 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 598' ' ' GLU . . . . . 0.558 ' O ' ' HA ' ' A' ' 608' ' ' VAL . 13.7 tp10 -86.01 82.2 8.2 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 178.497 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 599' ' ' VAL . . . . . 0.449 HG13 HD21 ' A' ' 578' ' ' LEU . 25.8 t -104.58 121.88 56.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 121.128 0.489 . . . . 0.0 110.081 -176.879 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 600' ' ' SER . . . . . 0.642 ' HB2' ' HG ' ' A' ' 586' ' ' LEU . 37.4 t -141.23 168.39 19.89 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.499 0.666 . . . . 0.0 110.96 -172.626 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 601' ' ' LEU . . . . . 0.493 ' HB2' HD11 ' A' ' 583' ' ' ILE . 52.7 tp -140.45 108.27 5.67 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 114.535 -1.211 . . . . 0.0 108.955 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 602' ' ' LYS . . . . . . . . . . . . . 65.1 mttp -120.79 107.12 12.35 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.903 -177.239 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 603' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 63.42 42.86 6.41 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.613 177.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 604' ' ' ASN . . . . . . . . . . . . . 66.6 t30 72.95 14.65 4.75 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.608 178.067 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 605' ' ' VAL . . . . . . . . . . . . . 56.6 t -110.51 114.01 45.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.997 175.495 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 606' ' ' VAL . . . . . 0.723 HG11 ' HB ' ' A' ' 613' ' ' VAL . 6.6 p -84.97 140.16 16.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.2 0.524 . . . . 0.0 110.935 -179.01 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 607' ' ' SER . . . . . . . . . . . . . 7.4 p -142.19 154.58 44.94 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.835 -178.197 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 608' ' ' VAL . . . . . 0.558 ' HA ' ' O ' ' A' ' 598' ' ' GLU . 7.5 p -142.65 119.89 6.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.147 178.006 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 609' ' ' ASN . . . . . 0.824 ' HB2' HD21 ' A' ' 632' ' ' LEU . 4.0 m-20 59.88 50.04 7.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.131 173.715 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 610' ' ' LYS . . . . . 0.496 ' HE3' ' HB2' ' A' ' 610' ' ' LYS . 35.6 mtmt 77.15 -21.91 0.31 Allowed 'General case' 0 N--CA 1.476 0.826 0 O-C-N 123.66 0.6 . . . . 0.0 111.378 179.819 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 611' ' ' GLU . . . . . 0.402 ' H ' ' C ' ' A' ' 609' ' ' ASN . 48.6 mm-40 -90.96 140.91 26.19 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.732 -176.879 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 612' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -81.26 141.58 12.89 Favored 'Trans proline' 0 N--CA 1.458 -0.603 0 C-N-CA 122.134 1.889 . . . . 0.0 111.459 173.589 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 613' ' ' VAL . . . . . 0.723 ' HB ' HG11 ' A' ' 606' ' ' VAL . 99.5 t -74.34 120.59 23.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 176.76 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 614' ' ' ALA . . . . . 0.498 ' HB1' HG21 ' A' ' 629' ' ' THR . . . -76.5 -26.22 55.05 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.868 -172.815 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 615' ' ' GLU . . . . . 0.591 ' HB3' ' HB ' ' A' ' 627' ' ' VAL . 17.4 tt0 -165.49 89.25 0.94 Allowed Pre-proline 0 C--N 1.325 -0.49 0 CA-C-O 121.189 0.519 . . . . 0.0 109.832 -174.417 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 616' ' ' PRO . . . . . 0.432 ' HB3' HG13 ' A' ' 613' ' ' VAL . 72.0 Cg_endo -88.82 163.57 6.14 Favored 'Trans proline' 0 N--CA 1.456 -0.732 0 C-N-CA 123.059 2.506 . . . . 0.0 113.708 -175.669 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 26.6 t0 78.43 64.61 0.03 OUTLIER 'General case' 0 CA--C 1.51 -0.567 0 CA-C-O 123.024 1.392 . . . . 0.0 110.594 169.38 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 618' ' ' ILE . . . . . 0.511 ' HB ' ' O ' ' A' ' 625' ' ' VAL . 24.4 mt -115.86 102.21 13.38 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.278 0 CA-C-N 112.795 -2.002 . . . . 0.0 108.573 176.058 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 619' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.73 135.7 37.21 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.707 -0.679 . . . . 0.0 112.812 -169.313 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 620' ' ' ALA . . . . . . . . . . . . . . . -129.1 176.72 7.68 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.329 -0.851 . . . . 0.0 108.795 171.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 621' ' ' THR . . . . . . . . . . . . . 4.5 t -82.75 -21.71 34.6 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.603 -0.439 . . . . 0.0 110.874 -179.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 622' ' ' ASN . . . . . 0.767 ' HB3' ' HA ' ' A' ' 534' ' ' GLU . 27.4 p-10 -116.24 22.11 13.13 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.719 0.295 . . . . 0.0 111.441 -176.692 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 623' ' ' GLY . . . . . . . . . . . . . . . 147.47 -150.88 23.18 Favored Glycine 0 N--CA 1.443 -0.859 0 C-N-CA 120.332 -0.937 . . . . 0.0 112.626 177.229 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 624' ' ' VAL . . . . . . . . . . . . . 6.3 p -135.79 158.46 39.41 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 -179.164 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 625' ' ' VAL . . . . . 0.511 ' O ' ' HB ' ' A' ' 618' ' ' ILE . 46.8 t -123.93 136.87 58.87 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.675 178.764 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 626' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 -122.79 121.13 35.55 Favored 'General case' 0 N--CA 1.445 -0.681 0 N-CA-C 109.908 -0.405 . . . . 0.0 109.908 175.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 627' ' ' VAL . . . . . 0.591 ' HB ' ' HB3' ' A' ' 615' ' ' GLU . 60.8 t -70.21 130.67 34.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.56 179.025 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 628' ' ' ILE . . . . . 0.575 HD12 ' HB3' ' A' ' 540' ' ' PHE . 7.2 pt -127.34 150.19 33.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.819 176.199 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 629' ' ' THR . . . . . 0.498 HG21 ' HB1' ' A' ' 614' ' ' ALA . 16.6 p -94.91 2.83 55.45 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.91 -176.283 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 630' ' ' ASN . . . . . . . . . . . . . 66.1 m-20 -144.08 168.76 19.24 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.409 -177.39 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 631' ' ' VAL . . . . . . . . . . . . . 97.2 t -95.91 125.74 48.65 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 115.426 -0.807 . . . . 0.0 109.206 176.518 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 632' ' ' LEU . . . . . 0.824 HD21 ' HB2' ' A' ' 609' ' ' ASN . 89.6 mt -70.87 114.41 8.91 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-O 121.33 0.586 . . . . 0.0 110.893 -174.602 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 633' ' ' GLN . . . . . 0.491 ' HA ' ' HD3' ' A' ' 634' ' ' PRO . 85.7 mm-40 -102.47 131.17 22.74 Favored Pre-proline 0 C--N 1.317 -0.835 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.947 -177.095 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 634' ' ' PRO . . . . . 0.491 ' HD3' ' HA ' ' A' ' 633' ' ' GLN . 4.9 Cg_exo . . . . . 0 C--O 1.253 1.25 0 C-N-CA 123.051 2.501 . . . . 0.0 111.569 176.25 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.57 0 N-CA-C 111.311 -0.715 . . . . 0.0 111.311 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 504' ' ' THR . . . . . 0.452 ' O ' HG22 ' A' ' 508' ' ' VAL . 38.8 p -81.47 156.95 25.07 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 120.83 -0.348 . . . . 0.0 110.307 179.118 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 7.1 p -49.55 -39.2 13.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.892 -0.595 . . . . 0.0 112.359 -176.099 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 506' ' ' MET . . . . . 0.487 ' HG2' ' HB2' ' A' ' 531' ' ' LEU . 2.9 ppp? -83.82 -21.86 31.96 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.806 0.336 . . . . 0.0 111.524 -177.109 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 507' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -86.22 -28.89 23.58 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.042 0.448 . . . . 0.0 110.645 -178.238 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 508' ' ' VAL . . . . . 0.452 HG22 ' O ' ' A' ' 504' ' ' THR . 87.5 t -61.89 -27.58 42.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.297 175.394 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 509' ' ' LEU . . . . . . . . . . . . . 25.3 mt -65.05 -19.54 66.04 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.536 -179.099 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 5.3 mptt -76.25 -24.15 54.53 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.022 0.439 . . . . 0.0 110.481 -179.068 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 511' ' ' GLY . . . . . . . . . . . . . . . -80.56 -10.11 85.63 Favored Glycine 0 N--CA 1.444 -0.773 0 C-N-CA 120.407 -0.902 . . . . 0.0 111.179 177.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 512' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -114.86 137.62 51.75 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.26 0.552 . . . . 0.0 111.714 -176.253 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 9.9 p30 -77.34 -19.76 55.85 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 115.526 -0.761 . . . . 0.0 112.459 -177.214 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 514' ' ' ARG . . . . . . . . . . . . . 5.3 tpp180 -89.04 -28.54 20.08 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 120.687 0.279 . . . . 0.0 110.988 -170.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 515' ' ' PHE . . . . . 0.609 ' CZ ' HG23 ' A' ' 627' ' ' VAL . 9.5 m-85 -92.83 8.62 38.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.682 178.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 13.0 p -55.37 -44.8 76.36 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.066 -0.515 . . . . 0.0 112.376 -176.145 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 517' ' ' MET . . . . . 0.445 ' HE1' ' HB2' ' A' ' 517' ' ' MET . 2.8 mpp? -63.36 -31.29 72.4 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.502 0.191 . . . . 0.0 111.09 179.642 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 518' ' ' LEU . . . . . . . . . . . . . 44.2 tp -70.63 -36.38 73.41 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 120.502 -0.479 . . . . 0.0 110.207 -179.408 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 519' ' ' VAL . . . . . . . . . . . . . 59.1 t -58.94 -37.7 68.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.257 0.551 . . . . 0.0 109.559 174.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 520' ' ' ALA . . . . . . . . . . . . . . . -71.61 -40.98 69.46 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.644 -178.225 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 521' ' ' ALA . . . . . . . . . . . . . . . -63.96 -50.41 68.72 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.927 178.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 522' ' ' ILE . . . . . . . . . . . . . 72.9 mt -60.88 -40.43 85.25 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.894 179.115 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 523' ' ' GLN . . . . . . . . . . . . . 59.2 tt0 -61.78 -46.28 90.22 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.864 178.543 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 27.5 m -67.68 -47.52 69.22 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.495 -177.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 525' ' ' ALA . . . . . . . . . . . . . . . -70.77 -28.46 64.69 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.642 0.258 . . . . 0.0 111.504 -179.044 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 526' ' ' GLY . . . . . . . . . . . . . . . 85.54 41.49 7.31 Favored Glycine 0 C--O 1.227 -0.323 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.61 178.119 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 527' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -102.06 13.0 35.95 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.909 0.385 . . . . 0.0 110.863 -178.548 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 528' ' ' THR . . . . . . . . . . . . . 18.7 m -65.17 -33.99 77.31 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.117 -178.163 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 529' ' ' GLU . . . . . . . . . . . . . 28.9 mm-40 -55.44 -43.69 75.64 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.814 -176.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 530' ' ' THR . . . . . . . . . . . . . 22.1 m -66.27 -43.08 87.45 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.293 -176.124 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 531' ' ' LEU . . . . . 0.487 ' HB2' ' HG2' ' A' ' 506' ' ' MET . 68.8 mt -87.67 14.09 9.16 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.027 0.441 . . . . 0.0 111.314 -174.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 532' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -89.56 -29.5 18.86 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.756 178.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 533' ' ' ARG . . . . . 0.432 HH11 ' HD2' ' A' ' 533' ' ' ARG . 4.2 tpp180 -86.09 143.84 27.85 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.415 -0.812 . . . . 0.0 110.245 179.069 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 534' ' ' GLU . . . . . 0.657 ' HA ' ' CB ' ' A' ' 622' ' ' ASN . 42.8 tt0 -79.93 147.66 31.55 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.078 0.466 . . . . 0.0 110.515 176.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 535' ' ' GLY . . . . . . . . . . . . . . . 169.0 -136.33 4.01 Favored Glycine 0 N--CA 1.445 -0.75 0 N-CA-C 110.4 -1.08 . . . . 0.0 110.4 -177.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 536' ' ' VAL . . . . . 0.53 ' HB ' HG13 ' A' ' 577' ' ' ILE . 34.0 m -124.22 129.79 73.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 117.297 0.549 . . . . 0.0 110.411 177.518 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 537' ' ' TYR . . . . . . . . . . . . . 82.4 m-85 -154.19 146.55 23.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.934 -0.575 . . . . 0.0 109.926 -179.033 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 538' ' ' THR . . . . . 0.748 ' OG1' ' HA ' ' A' ' 577' ' ' ILE . 55.7 m -136.76 100.36 4.3 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 120.813 0.339 . . . . 0.0 110.117 175.235 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 539' ' ' VAL . . . . . 0.619 ' HA ' ' O ' ' A' ' 572' ' ' HIS . 1.3 p -115.17 132.09 65.48 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-O 121.392 0.615 . . . . 0.0 111.242 -177.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 540' ' ' PHE . . . . . . . . . . . . . 68.4 m-85 -89.1 117.16 27.9 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.003 -0.999 . . . . 0.0 109.693 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 541' ' ' ALA . . . . . 0.411 ' HA ' ' HD3' ' A' ' 542' ' ' PRO . . . -93.67 114.42 62.96 Favored Pre-proline 0 C--N 1.326 -0.435 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.575 -179.34 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 542' ' ' PRO . . . . . 0.619 ' HA ' HG13 ' A' ' 628' ' ' ILE . 7.9 Cg_exo -72.88 131.47 17.03 Favored 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 122.88 2.387 . . . . 0.0 111.516 177.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 75.2 p -71.87 175.48 5.77 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.574 179.364 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 544' ' ' ASN . . . . . . . . . . . . . 10.7 p30 -72.67 -21.21 61.11 Favored 'General case' 0 CA--C 1.519 -0.221 0 C-N-CA 120.094 -0.643 . . . . 0.0 109.449 179.05 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 545' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -62.18 -35.7 79.63 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.74 174.319 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 546' ' ' ALA . . . . . 0.565 ' HB3' HG22 ' A' ' 631' ' ' VAL . . . -70.13 -48.31 58.03 Favored 'General case' 0 CA--C 1.513 -0.474 0 CA-C-O 121.19 0.519 . . . . 0.0 110.772 178.838 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 547' ' ' PHE . . . . . . . . . . . . . 64.2 m-85 -68.14 -23.72 64.91 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.331 -177.575 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 548' ' ' ARG . . . . . . . . . . . . . 43.7 mtm180 -86.78 -21.9 26.23 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-O 120.706 0.289 . . . . 0.0 110.863 175.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 549' ' ' ALA . . . . . . . . . . . . . . . -85.66 -5.59 59.25 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.969 0.414 . . . . 0.0 110.682 177.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 550' ' ' LEU . . . . . 0.523 HD13 HG23 ' A' ' 631' ' ' VAL . 93.5 mt -75.74 134.27 72.43 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.264 176.172 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 551' ' ' PRO . . . . . 0.492 ' HD3' ' HA ' ' A' ' 550' ' ' LEU . 12.4 Cg_exo -69.99 148.02 62.68 Favored 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 122.7 2.267 . . . . 0.0 110.568 179.034 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 552' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_exo -50.83 -41.73 53.98 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.576 2.184 . . . . 0.0 112.072 -178.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 553' ' ' ARG . . . . . . . . . . . . . 22.8 tpt180 -57.25 -52.16 66.46 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.287 178.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -65.88 -55.29 17.73 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 111.824 0.305 . . . . 0.0 111.824 -176.328 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 555' ' ' ARG . . . . . 0.446 ' HG2' ' O ' ' A' ' 551' ' ' PRO . 30.8 ptt180 -63.96 -32.65 74.26 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 -175.699 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 32.1 m -74.94 -31.69 61.57 Favored 'General case' 0 N--CA 1.464 0.262 0 O-C-N 122.083 -0.385 . . . . 0.0 110.936 179.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 557' ' ' ARG . . . . . . . . . . . . . 73.7 ttt180 -69.65 -47.79 62.14 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.976 0.417 . . . . 0.0 109.964 176.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 558' ' ' LEU . . . . . 0.551 ' HG ' HD22 ' A' ' 565' ' ' LEU . 40.1 tp -60.56 -44.83 95.72 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.493 -178.131 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 559' ' ' LEU . . . . . 0.609 HD23 HD23 ' A' ' 565' ' ' LEU . 96.7 mt -81.98 4.55 22.29 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.065 0.459 . . . . 0.0 110.898 -179.452 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 560' ' ' GLY . . . . . . . . . . . . . . . -85.0 -22.61 52.14 Favored Glycine 0 N--CA 1.439 -1.114 0 C-N-CA 120.663 -0.78 . . . . 0.0 112.012 179.158 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 561' ' ' ASP . . . . . 0.672 ' HB3' ' HG2' ' A' ' 564' ' ' GLU . 11.9 t70 -139.38 142.7 37.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.939 0.399 . . . . 0.0 110.691 -178.037 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 562' ' ' ALA . . . . . . . . . . . . . . . -77.58 -29.04 51.86 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.821 -175.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 563' ' ' LYS . . . . . . . . . . . . . 27.2 ttpp -73.16 -39.03 65.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.815 0.341 . . . . 0.0 110.203 -178.231 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 564' ' ' GLU . . . . . 0.672 ' HG2' ' HB3' ' A' ' 561' ' ' ASP . 3.3 mm-40 -62.89 -42.5 99.8 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.436 178.728 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 565' ' ' LEU . . . . . 0.609 HD23 HD23 ' A' ' 559' ' ' LEU . 69.3 mt -55.81 -51.35 67.77 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.489 174.5 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 566' ' ' ALA . . . . . . . . . . . . . . . -58.07 -44.01 87.28 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.535 -178.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 567' ' ' ASN . . . . . . . . . . . . . 4.9 t30 -67.65 -32.86 73.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.189 -177.294 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 568' ' ' ILE . . . . . 0.501 HG12 ' O ' ' A' ' 564' ' ' GLU . 47.9 mm -72.94 -40.25 59.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 120.86 0.362 . . . . 0.0 110.386 176.73 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 569' ' ' LEU . . . . . 0.502 ' HG ' ' O ' ' A' ' 565' ' ' LEU . 96.0 mt -63.01 -42.92 99.96 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.301 179.673 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 570' ' ' LYS . . . . . 0.659 ' HE2' ' HA ' ' A' ' 593' ' ' GLN . 17.5 ptmt -70.86 -8.05 49.94 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.113 -178.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 571' ' ' TYR . . . . . 0.457 ' HB2' HE21 ' A' ' 593' ' ' GLN . 62.3 t80 -93.81 -18.76 21.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.962 0.41 . . . . 0.0 110.392 174.609 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 572' ' ' HIS . . . . . 0.619 ' O ' ' HA ' ' A' ' 539' ' ' VAL . 47.4 m80 -91.07 -20.18 22.34 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.748 179.643 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 573' ' ' ILE . . . . . 0.425 HG13 ' O ' ' A' ' 569' ' ' LEU . 27.2 mt -96.07 116.62 38.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.526 177.469 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 574' ' ' GLY . . . . . 0.583 ' HA2' ' HA ' ' A' ' 591' ' ' SER . . . -88.61 156.01 26.32 Favored Glycine 0 N--CA 1.449 -0.473 0 N-CA-C 111.78 -0.528 . . . . 0.0 111.78 176.297 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 575' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -82.75 -3.19 56.2 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 112.219 0.451 . . . . 0.0 112.219 -172.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 576' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -152.7 157.72 41.31 Favored 'General case' 0 N--CA 1.44 -0.967 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 -174.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 577' ' ' ILE . . . . . 0.748 ' HA ' ' OG1' ' A' ' 538' ' ' THR . 68.7 mt -92.56 117.59 36.27 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-N 115.76 -0.655 . . . . 0.0 112.055 -172.709 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 578' ' ' LEU . . . . . 0.549 HD22 HD12 ' A' ' 589' ' ' LEU . 3.4 mm? -123.99 102.3 7.69 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.389 175.544 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 579' ' ' VAL . . . . . 0.509 ' O ' HG13 ' A' ' 583' ' ' ILE . 30.9 m -97.28 172.11 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.07 179.36 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 580' ' ' SER . . . . . 0.505 ' HA ' HD13 ' A' ' 601' ' ' LEU . 27.6 m -54.72 -36.49 64.78 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.5 179.549 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 581' ' ' GLY . . . . . . . . . . . . . . . -80.81 -1.02 89.23 Favored Glycine 0 CA--C 1.521 0.425 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.982 -179.13 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . -114.4 -38.92 1.06 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.526 -0.845 . . . . 0.0 113.001 -177.554 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 583' ' ' ILE . . . . . 0.509 HG13 ' O ' ' A' ' 579' ' ' VAL . 63.8 mt -60.03 -57.69 10.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 120.692 0.282 . . . . 0.0 111.555 -176.292 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 584' ' ' GLY . . . . . . . . . . . . . . . 78.9 -66.47 3.37 Favored Glycine 0 CA--C 1.52 0.356 0 C-N-CA 120.924 -0.655 . . . . 0.0 113.327 176.523 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 585' ' ' ALA . . . . . . . . . . . . . . . -130.02 -68.61 0.7 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.532 0.206 . . . . 0.0 111.549 -176.382 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 586' ' ' LEU . . . . . 0.538 HD13 ' HB3' ' A' ' 600' ' ' SER . 41.2 tp -153.57 128.62 9.64 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.773 0.32 . . . . 0.0 110.569 -179.85 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 587' ' ' VAL . . . . . . . . . . . . . 57.9 t -137.03 127.47 39.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.627 178.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 588' ' ' ARG . . . . . 0.423 ' HG2' ' HG2' ' A' ' 598' ' ' GLU . 72.8 mtt180 -85.54 109.02 18.22 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.485 0.659 . . . . 0.0 109.909 176.662 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 589' ' ' LEU . . . . . 0.549 HD12 HD22 ' A' ' 578' ' ' LEU . 34.7 tp -91.22 113.78 26.13 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 114.806 -1.088 . . . . 0.0 110.214 -175.53 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 590' ' ' LYS . . . . . . . . . . . . . 25.6 pttm -76.46 134.82 39.43 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.635 -0.505 . . . . 0.0 109.635 177.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 591' ' ' SER . . . . . 0.583 ' HA ' ' HA2' ' A' ' 574' ' ' GLY . 79.7 p -99.08 166.88 11.04 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.128 -177.442 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 592' ' ' LEU . . . . . . . . . . . . . 10.3 mp -63.86 -12.9 40.5 Favored 'General case' 0 C--N 1.333 -0.123 0 N-CA-C 112.211 0.449 . . . . 0.0 112.211 178.244 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 593' ' ' GLN . . . . . 0.659 ' HA ' ' HE2' ' A' ' 570' ' ' LYS . 5.0 tt0 -77.55 -29.32 52.2 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.391 0.615 . . . . 0.0 109.854 174.825 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 594' ' ' GLY . . . . . . . . . . . . . . . 111.48 -16.53 26.61 Favored Glycine 0 N--CA 1.447 -0.588 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.423 -174.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 595' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -79.0 178.6 7.9 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 179.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 596' ' ' LYS . . . . . . . . . . . . . 56.6 mttp -124.43 121.4 34.8 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.281 0.562 . . . . 0.0 111.983 -169.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 597' ' ' LEU . . . . . . . . . . . . . 67.5 mt -90.38 116.54 28.4 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.235 -0.893 . . . . 0.0 109.306 173.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 598' ' ' GLU . . . . . 0.423 ' HG2' ' HG2' ' A' ' 588' ' ' ARG . 46.9 mt-10 -89.13 92.75 9.32 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 121.456 0.646 . . . . 0.0 110.092 -177.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 599' ' ' VAL . . . . . . . . . . . . . 23.4 t -96.53 125.64 49.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.051 -0.977 . . . . 0.0 110.146 -176.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 600' ' ' SER . . . . . 0.538 ' HB3' HD13 ' A' ' 586' ' ' LEU . 18.2 p -125.78 156.87 38.79 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.445 -179.383 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 601' ' ' LEU . . . . . 0.505 HD13 ' HA ' ' A' ' 580' ' ' SER . 0.3 OUTLIER -127.75 109.9 12.1 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.261 -179.626 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 602' ' ' LYS . . . . . 0.42 ' HE2' ' HB2' ' A' ' 602' ' ' LYS . 25.8 mtmm -128.87 123.0 31.58 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.25 -0.887 . . . . 0.0 109.806 -171.73 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 603' ' ' ASN . . . . . 0.449 ' O ' ' HB2' ' A' ' 604' ' ' ASN . 13.3 m120 64.38 25.93 13.49 Favored 'General case' 0 N--CA 1.466 0.34 0 O-C-N 123.571 0.544 . . . . 0.0 109.778 178.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 604' ' ' ASN . . . . . 0.449 ' HB2' ' O ' ' A' ' 603' ' ' ASN . 88.5 m-20 71.84 14.26 5.97 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.324 -175.633 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 605' ' ' VAL . . . . . . . . . . . . . 44.8 t -107.98 119.84 58.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.129 -0.487 . . . . 0.0 109.809 173.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 606' ' ' VAL . . . . . 0.806 HG12 ' HB ' ' A' ' 613' ' ' VAL . 5.2 p -86.67 139.8 16.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 121.026 0.441 . . . . 0.0 110.887 -178.6 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 607' ' ' SER . . . . . . . . . . . . . 2.9 m -140.71 135.19 31.33 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.474 -178.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 608' ' ' VAL . . . . . . . . . . . . . 3.7 p -111.48 119.95 60.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 177.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 609' ' ' ASN . . . . . 0.529 ' O ' ' HB2' ' A' ' 610' ' ' LYS . 5.3 m-20 59.22 37.18 23.9 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.485 177.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 610' ' ' LYS . . . . . 0.529 ' HB2' ' O ' ' A' ' 609' ' ' ASN . 34.4 mmtp 81.34 -15.44 0.72 Allowed 'General case' 0 N--CA 1.475 0.797 0 O-C-N 124.171 0.919 . . . . 0.0 112.326 -178.716 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 611' ' ' GLU . . . . . 0.413 ' HA ' ' HD3' ' A' ' 612' ' ' PRO . 18.1 mm-40 -84.8 138.55 37.63 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 120.8 0.333 . . . . 0.0 111.072 -178.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 612' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 611' ' ' GLU . 1.9 Cg_endo -82.02 134.02 8.03 Favored 'Trans proline' 0 N--CA 1.46 -0.468 0 C-N-CA 123.387 2.724 . . . . 0.0 113.274 -176.471 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 613' ' ' VAL . . . . . 0.806 ' HB ' HG12 ' A' ' 606' ' ' VAL . 50.3 t -81.57 130.89 35.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.053 175.773 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 614' ' ' ALA . . . . . . . . . . . . . . . -71.21 -42.72 68.58 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.173 -176.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 615' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -162.82 103.82 1.04 Allowed Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.27 0.557 . . . . 0.0 110.576 -178.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 616' ' ' PRO . . . . . 0.402 ' O ' ' HB2' ' A' ' 617' ' ' ASP . 65.0 Cg_endo -89.85 171.2 4.13 Favored 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 123.539 2.826 . . . . 0.0 113.411 -177.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 617' ' ' ASP . . . . . 0.402 ' HB2' ' O ' ' A' ' 616' ' ' PRO . 1.1 m-20 79.0 28.28 0.4 Allowed 'General case' 0 CA--C 1.508 -0.664 0 CA-C-N 115.123 -0.944 . . . . 0.0 111.373 164.721 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 618' ' ' ILE . . . . . 0.498 ' HB ' ' O ' ' A' ' 625' ' ' VAL . 18.5 mt -74.87 103.42 2.73 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 CA-C-N 114.591 -1.186 . . . . 0.0 109.085 171.505 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 619' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.77 132.96 38.32 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.841 -0.618 . . . . 0.0 112.391 -171.094 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 620' ' ' ALA . . . . . . . . . . . . . . . -127.92 173.61 9.87 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 170.408 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 621' ' ' THR . . . . . . . . . . . . . 4.7 t -75.56 -31.72 60.13 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 120.385 -0.526 . . . . 0.0 111.217 -174.374 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 622' ' ' ASN . . . . . 0.657 ' CB ' ' HA ' ' A' ' 534' ' ' GLU . 31.8 p-10 -117.39 21.76 12.87 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 111.946 0.35 . . . . 0.0 111.946 -176.325 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 623' ' ' GLY . . . . . . . . . . . . . . . 165.36 -167.71 39.03 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.159 -1.019 . . . . 0.0 112.87 178.526 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 624' ' ' VAL . . . . . 0.426 HG22 HG13 ' A' ' 579' ' ' VAL . 5.8 p -133.09 155.43 41.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 178.671 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 625' ' ' VAL . . . . . 0.498 ' O ' ' HB ' ' A' ' 618' ' ' ILE . 49.6 t -120.2 127.84 75.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.188 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 626' ' ' HIS . . . . . . . . . . . . . 46.9 m-70 -113.76 110.27 19.89 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.155 -0.475 . . . . 0.0 109.774 175.409 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 627' ' ' VAL . . . . . 0.609 HG23 ' CZ ' ' A' ' 515' ' ' PHE . 22.9 t -65.56 124.85 21.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.044 -179.741 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 628' ' ' ILE . . . . . 0.619 HG13 ' HA ' ' A' ' 542' ' ' PRO . 8.2 pt -116.86 143.77 26.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-O 121.353 0.596 . . . . 0.0 110.732 175.276 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 629' ' ' THR . . . . . . . . . . . . . 10.3 t -95.59 12.33 30.01 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-O 122.216 1.008 . . . . 0.0 109.318 -179.322 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 630' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 -139.19 176.66 8.51 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 114.381 -1.281 . . . . 0.0 109.359 -176.32 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 631' ' ' VAL . . . . . 0.565 HG22 ' HB3' ' A' ' 546' ' ' ALA . 61.6 t -116.64 144.26 24.78 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 172.366 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 632' ' ' LEU . . . . . . . . . . . . . 87.8 mt -96.58 118.26 32.69 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.018 0.437 . . . . 0.0 110.735 -177.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 633' ' ' GLN . . . . . . . . . . . . . 27.0 mp0 -96.64 116.79 66.27 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.089 -177.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 634' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo . . . . . 0 N--CA 1.452 -0.951 0 C-N-CA 122.902 2.401 . . . . 0.0 111.113 173.403 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.728 0 N-CA-C 110.987 -0.845 . . . . 0.0 110.987 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 504' ' ' THR . . . . . 0.459 ' O ' HG22 ' A' ' 508' ' ' VAL . 46.7 p -75.88 165.75 24.54 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 117.165 0.483 . . . . 0.0 110.118 178.495 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 505' ' ' VAL . . . . . 0.652 ' O ' ' HG ' ' A' ' 509' ' ' LEU . 14.7 p -60.0 -31.66 48.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 120.991 0.424 . . . . 0.0 110.307 179.809 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 506' ' ' MET . . . . . 0.48 ' O ' ' HG2' ' A' ' 510' ' ' LYS . 5.7 tpp -69.31 -43.17 74.31 Favored 'General case' 0 N--CA 1.437 -1.112 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.688 178.198 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 507' ' ' ASP . . . . . 0.567 ' HA ' ' CG ' ' A' ' 510' ' ' LYS . 31.5 t70 -67.29 -32.5 73.53 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.882 0.373 . . . . 0.0 110.557 -178.435 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 508' ' ' VAL . . . . . 0.459 HG22 ' O ' ' A' ' 504' ' ' THR . 90.0 t -62.27 -35.72 70.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.519 176.087 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 509' ' ' LEU . . . . . 0.652 ' HG ' ' O ' ' A' ' 505' ' ' VAL . 61.3 mt -74.44 -37.44 63.28 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.164 -178.602 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 510' ' ' LYS . . . . . 0.567 ' CG ' ' HA ' ' A' ' 507' ' ' ASP . 10.8 ptmm? -84.27 -13.13 53.38 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.284 -178.303 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 511' ' ' GLY . . . . . . . . . . . . . . . -85.7 -11.92 73.16 Favored Glycine 0 N--CA 1.441 -0.987 0 N-CA-C 111.169 -0.772 . . . . 0.0 111.169 173.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 512' ' ' ASP . . . . . 0.559 ' O ' ' HB2' ' A' ' 516' ' ' SER . 26.6 t70 -104.22 152.54 22.05 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.826 0.346 . . . . 0.0 111.122 179.825 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 42.4 m-80 -76.28 -33.32 59.1 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.864 -176.243 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 514' ' ' ARG . . . . . . . . . . . . . 26.2 mmt180 -82.88 -49.95 9.13 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.908 0.385 . . . . 0.0 110.086 -176.039 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 515' ' ' PHE . . . . . 0.982 ' HZ ' HG23 ' A' ' 627' ' ' VAL . 4.2 m-30 -66.97 -17.83 65.1 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.505 -177.458 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 516' ' ' SER . . . . . 0.559 ' HB2' ' O ' ' A' ' 512' ' ' ASP . 16.3 t -57.54 -41.9 81.84 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.665 -176.476 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 517' ' ' MET . . . . . 0.415 ' HE3' ' HB2' ' A' ' 517' ' ' MET . 3.4 ppp? -76.49 -24.96 53.8 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.881 0.372 . . . . 0.0 110.643 -178.426 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 518' ' ' LEU . . . . . 0.581 HD22 ' HD2' ' A' ' 542' ' ' PRO . 39.4 tp -66.8 -37.86 85.37 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 170.01 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 519' ' ' VAL . . . . . 0.454 ' O ' ' HG2' ' A' ' 523' ' ' GLN . 85.4 t -58.21 -34.46 49.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 174.498 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 520' ' ' ALA . . . . . . . . . . . . . . . -63.76 -38.26 90.43 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.937 0.399 . . . . 0.0 110.17 177.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 521' ' ' ALA . . . . . 0.402 ' HA ' HD22 ' A' ' 565' ' ' LEU . . . -66.61 -43.11 85.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.267 174.392 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 522' ' ' ILE . . . . . 0.548 HG21 ' HB2' ' A' ' 527' ' ' LEU . 76.6 mt -59.73 -39.49 79.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.269 177.381 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 523' ' ' GLN . . . . . 0.454 ' HG2' ' O ' ' A' ' 519' ' ' VAL . 16.1 mm100 -62.82 -33.93 76.25 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-O 121.087 0.47 . . . . 0.0 111.152 177.727 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 8.3 t -81.67 -36.2 29.05 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.321 -179.399 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 525' ' ' ALA . . . . . 0.468 ' HB3' ' HA ' ' A' ' 566' ' ' ALA . . . -78.18 -29.84 48.73 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.922 -178.859 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 526' ' ' GLY . . . . . . . . . . . . . . . 85.14 50.53 4.06 Favored Glycine 0 CA--C 1.52 0.355 0 C-N-CA 121.025 -0.607 . . . . 0.0 112.801 179.319 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 527' ' ' LEU . . . . . 0.548 ' HB2' HG21 ' A' ' 522' ' ' ILE . 4.0 mm? -113.12 5.91 17.31 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.875 0.369 . . . . 0.0 110.518 177.825 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 528' ' ' THR . . . . . 0.477 HG23 ' HE3' ' A' ' 506' ' ' MET . 4.4 m -62.29 -48.1 81.37 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.528 -175.404 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 529' ' ' GLU . . . . . 0.521 ' O ' ' HG3' ' A' ' 533' ' ' ARG . 29.9 mp0 -57.95 -40.89 81.64 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.883 0.373 . . . . 0.0 110.581 178.553 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 530' ' ' THR . . . . . . . . . . . . . 40.4 m -62.14 -45.98 91.02 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.558 -177.316 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 531' ' ' LEU . . . . . 0.48 HD22 HD13 ' A' ' 573' ' ' ILE . 61.5 mt -82.59 -4.91 58.39 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -175.378 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 532' ' ' ASN . . . . . . . . . . . . . 67.1 t30 -89.09 -18.24 27.65 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.273 0.558 . . . . 0.0 110.043 178.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 533' ' ' ARG . . . . . 0.521 ' HG3' ' O ' ' A' ' 529' ' ' GLU . 32.9 mtp85 -83.08 136.69 34.39 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.205 -179.215 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 534' ' ' GLU . . . . . 0.547 ' HA ' ' HB3' ' A' ' 622' ' ' ASN . 11.5 pt-20 -71.56 156.13 39.76 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.868 178.257 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 535' ' ' GLY . . . . . . . . . . . . . . . 147.05 -136.59 6.21 Favored Glycine 0 N--CA 1.445 -0.759 0 N-CA-C 110.43 -1.068 . . . . 0.0 110.43 -176.064 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 536' ' ' VAL . . . . . 0.453 ' HB ' HG13 ' A' ' 577' ' ' ILE . 34.3 m -124.08 130.08 73.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-O 121.142 0.496 . . . . 0.0 110.813 179.005 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 537' ' ' TYR . . . . . . . . . . . . . 84.4 m-85 -152.87 146.98 25.47 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.385 178.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 538' ' ' THR . . . . . 0.675 ' OG1' ' HA ' ' A' ' 577' ' ' ILE . 67.2 m -132.98 102.6 5.68 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 175.413 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 539' ' ' VAL . . . . . 0.42 HG22 HG22 ' A' ' 573' ' ' ILE . 48.5 t -107.31 122.88 62.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.085 0.469 . . . . 0.0 111.44 -172.788 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 540' ' ' PHE . . . . . 0.458 ' HB3' HD12 ' A' ' 628' ' ' ILE . 84.8 m-85 -91.77 107.15 19.0 Favored 'General case' 0 N--CA 1.447 -0.613 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 172.759 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -97.2 113.71 63.59 Favored Pre-proline 0 C--N 1.323 -0.577 0 CA-C-O 120.713 0.292 . . . . 0.0 110.924 -176.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 542' ' ' PRO . . . . . 0.61 ' HA ' HG13 ' A' ' 628' ' ' ILE . 7.9 Cg_exo -72.44 138.16 29.36 Favored 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 123.04 2.494 . . . . 0.0 111.427 177.886 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 60.8 p -74.22 -179.11 3.7 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.526 178.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 544' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -62.35 -33.64 75.1 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.172 0.511 . . . . 0.0 109.742 179.603 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 545' ' ' GLU . . . . . . . . . . . . . 14.1 mp0 -63.85 -27.44 69.17 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 114.798 -1.092 . . . . 0.0 111.499 -178.004 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 546' ' ' ALA . . . . . 0.591 ' HB3' HG22 ' A' ' 631' ' ' VAL . . . -64.24 -55.61 20.32 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.354 0.597 . . . . 0.0 110.514 179.142 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 547' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -70.63 -21.48 62.63 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.644 179.127 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 548' ' ' ARG . . . . . . . . . . . . . 75.2 ttt180 -74.81 -36.82 62.45 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.117 177.611 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 549' ' ' ALA . . . . . . . . . . . . . . . -62.03 -34.38 76.11 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.456 176.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 550' ' ' LEU . . . . . 0.503 ' HA ' ' HD3' ' A' ' 551' ' ' PRO . 81.2 mt -65.53 132.24 95.01 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.392 175.82 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 551' ' ' PRO . . . . . 0.503 ' HD3' ' HA ' ' A' ' 550' ' ' LEU . 21.3 Cg_exo -64.58 147.9 90.3 Favored 'Trans proline' 0 N--CA 1.463 -0.29 0 C-N-CA 122.98 2.453 . . . . 0.0 111.856 -173.723 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 552' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -48.89 -35.51 31.54 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 123.177 2.584 . . . . 0.0 113.351 -177.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 553' ' ' ARG . . . . . . . . . . . . . 56.2 ttp180 -73.57 -45.52 52.81 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.771 0.32 . . . . 0.0 110.842 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 554' ' ' GLU . . . . . 0.474 ' HB2' ' HD2' ' A' ' 551' ' ' PRO . 20.5 mm-40 -74.09 -41.66 61.34 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.454 -175.061 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 555' ' ' ARG . . . . . . . . . . . . . 5.5 ptp180 -61.75 -33.6 74.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.877 0.37 . . . . 0.0 110.024 177.451 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 7.9 t -71.5 -36.94 71.27 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.2 -0.455 . . . . 0.0 109.808 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 557' ' ' ARG . . . . . . . . . . . . . 79.8 mtt180 -61.22 -49.5 76.91 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.378 176.236 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 558' ' ' LEU . . . . . 0.489 HD23 HG13 ' A' ' 568' ' ' ILE . 2.1 tm? -57.95 -52.33 65.94 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.057 -0.974 . . . . 0.0 110.457 -178.54 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 559' ' ' LEU . . . . . 0.718 ' HA ' HD13 ' A' ' 565' ' ' LEU . 86.4 mt -76.78 -3.75 39.9 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.378 -175.352 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 560' ' ' GLY . . . . . . . . . . . . . . . -72.57 -22.54 78.93 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 121.168 -0.539 . . . . 0.0 112.534 -179.316 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 561' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -141.63 126.17 17.82 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 122.53 -0.394 . . . . 0.0 110.674 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 562' ' ' ALA . . . . . 0.416 ' HA ' HD12 ' A' ' 565' ' ' LEU . . . -59.46 -22.81 62.07 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.764 -0.653 . . . . 0.0 112.384 -176.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 563' ' ' LYS . . . . . . . . . . . . . 57.9 tttp -63.69 -40.3 96.47 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.358 0.599 . . . . 0.0 110.395 179.275 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 564' ' ' GLU . . . . . 0.435 ' HB3' HD21 ' A' ' 558' ' ' LEU . 7.7 mm-40 -68.55 -40.47 80.64 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.987 -178.011 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 565' ' ' LEU . . . . . 0.718 HD13 ' HA ' ' A' ' 559' ' ' LEU . 8.2 mp -57.19 -47.29 81.62 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.115 174.6 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 566' ' ' ALA . . . . . 0.621 ' O ' ' HB2' ' A' ' 570' ' ' LYS . . . -60.2 -40.18 89.17 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.245 -0.889 . . . . 0.0 111.666 -177.744 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 567' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -75.53 -47.12 28.27 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 120.916 -0.314 . . . . 0.0 111.318 -176.013 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 568' ' ' ILE . . . . . 0.489 HG13 HD23 ' A' ' 558' ' ' LEU . 28.5 mm -65.29 -48.85 81.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 112.465 0.543 . . . . 0.0 112.465 -177.728 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 569' ' ' LEU . . . . . 0.41 ' O ' HD11 ' A' ' 569' ' ' LEU . 0.6 OUTLIER -71.33 -21.84 61.99 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.736 -0.385 . . . . 0.0 110.433 -175.879 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 570' ' ' LYS . . . . . 0.621 ' HB2' ' O ' ' A' ' 566' ' ' ALA . 78.3 tttt -67.56 -22.17 65.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.214 0.531 . . . . 0.0 110.434 178.846 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 571' ' ' TYR . . . . . 0.457 ' CE1' ' HB3' ' A' ' 595' ' ' ASP . 15.3 t80 -77.89 -18.05 56.62 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.711 177.268 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 572' ' ' HIS . . . . . . . . . . . . . 74.4 m80 -88.56 -12.44 42.74 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.658 -176.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 573' ' ' ILE . . . . . 0.48 HD13 HD22 ' A' ' 531' ' ' LEU . 47.7 mt -104.42 114.28 43.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.627 179.615 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 574' ' ' GLY . . . . . 0.659 ' HA2' ' HA ' ' A' ' 591' ' ' SER . . . -99.4 152.99 19.61 Favored Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 121.06 -0.59 . . . . 0.0 111.777 176.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 575' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -96.79 16.13 20.04 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.064 0.459 . . . . 0.0 111.31 -175.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 576' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -139.27 122.17 16.62 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.139 -177.409 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 577' ' ' ILE . . . . . 0.675 ' HA ' ' OG1' ' A' ' 538' ' ' THR . 63.3 mt -79.95 101.27 4.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.272 0.558 . . . . 0.0 110.681 -179.024 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 578' ' ' LEU . . . . . . . . . . . . . 96.7 mt -118.91 102.48 8.82 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.393 -0.821 . . . . 0.0 109.879 178.045 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 579' ' ' VAL . . . . . . . . . . . . . 27.1 m -90.82 178.43 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.361 178.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 580' ' ' SER . . . . . . . . . . . . . 13.0 m -53.57 -38.77 64.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.26 -179.039 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 581' ' ' GLY . . . . . . . . . . . . . . . -86.53 23.66 9.77 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 121.13 -0.557 . . . . 0.0 112.824 -178.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . -138.63 6.82 3.28 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.595 177.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 583' ' ' ILE . . . . . . . . . . . . . 37.4 mt -83.95 -47.75 17.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.968 0.414 . . . . 0.0 110.977 -178.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 584' ' ' GLY . . . . . . . . . . . . . . . 79.39 -69.18 3.03 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.929 -0.653 . . . . 0.0 112.07 -178.024 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 585' ' ' ALA . . . . . . . . . . . . . . . -143.18 -69.87 0.33 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.862 0.363 . . . . 0.0 110.321 179.53 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 586' ' ' LEU . . . . . 0.803 ' HG ' ' HB2' ' A' ' 600' ' ' SER . 3.9 tt -151.33 131.15 13.24 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 176.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 587' ' ' VAL . . . . . 0.418 ' N ' HD22 ' A' ' 586' ' ' LEU . 7.8 p -143.99 137.23 23.93 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.173 -175.137 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 588' ' ' ARG . . . . . . . . . . . . . 35.0 ptt180 -88.04 108.52 19.27 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.414 0.626 . . . . 0.0 110.561 178.278 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 589' ' ' LEU . . . . . . . . . . . . . 3.8 tt -91.04 114.47 27.0 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 -178.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 590' ' ' LYS . . . . . 0.606 ' HB2' ' NZ ' ' A' ' 590' ' ' LYS . 9.6 mtmp? -72.43 148.69 44.93 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 121.273 0.559 . . . . 0.0 111.411 -174.062 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 591' ' ' SER . . . . . 0.659 ' HA ' ' HA2' ' A' ' 574' ' ' GLY . 68.7 p -112.09 158.63 19.37 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.823 -179.104 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 592' ' ' LEU . . . . . 0.482 ' O ' ' HE2' ' A' ' 570' ' ' LYS . 10.0 mp -62.26 -19.82 63.62 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.933 178.355 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 593' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -69.5 -29.69 67.38 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.806 -0.358 . . . . 0.0 110.537 176.477 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 594' ' ' GLY . . . . . . . . . . . . . . . 115.97 -4.85 20.46 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.674 -0.775 . . . . 0.0 112.745 -178.324 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 595' ' ' ASP . . . . . 0.474 ' CG ' ' H ' ' A' ' 596' ' ' LYS . 11.2 t70 -101.29 -168.94 1.62 Allowed 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 175.768 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 596' ' ' LYS . . . . . 0.547 ' N ' ' HD3' ' A' ' 596' ' ' LYS . 0.0 OUTLIER -135.05 131.83 37.48 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.007 0.432 . . . . 0.0 111.3 -172.881 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 597' ' ' LEU . . . . . 0.655 ' HB3' HG21 ' A' ' 608' ' ' VAL . 2.7 mm? -82.32 115.89 21.58 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 169.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 598' ' ' GLU . . . . . . . . . . . . . 57.8 mt-10 -84.42 92.43 8.05 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-O 121.626 0.727 . . . . 0.0 109.775 179.039 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 599' ' ' VAL . . . . . 0.456 ' HA ' ' O ' ' A' ' 607' ' ' SER . 61.1 t -93.64 132.41 37.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 114.619 -1.173 . . . . 0.0 110.118 -176.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 600' ' ' SER . . . . . 0.803 ' HB2' ' HG ' ' A' ' 586' ' ' LEU . 29.6 t -131.95 165.43 23.95 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-O 121.215 0.531 . . . . 0.0 110.286 179.69 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 601' ' ' LEU . . . . . . . . . . . . . 33.3 tp -136.89 108.07 6.79 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 114.929 -1.032 . . . . 0.0 109.609 -177.055 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 602' ' ' LYS . . . . . . . . . . . . . 11.3 ptmm? -134.77 118.19 16.78 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.899 -178.31 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 603' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 63.0 28.87 16.39 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 121.542 0.686 . . . . 0.0 109.539 -174.492 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 604' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 69.16 5.98 5.4 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 115.053 -0.976 . . . . 0.0 111.903 -177.368 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 605' ' ' VAL . . . . . . . . . . . . . 46.3 t -86.86 108.13 17.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 109.419 -0.585 . . . . 0.0 109.419 175.278 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 606' ' ' VAL . . . . . 0.712 HG11 ' HB ' ' A' ' 613' ' ' VAL . 6.1 p -84.33 134.41 27.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.934 -178.21 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 607' ' ' SER . . . . . 0.456 ' O ' ' HA ' ' A' ' 599' ' ' VAL . 3.3 p -139.03 142.58 38.25 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.72 -178.709 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 608' ' ' VAL . . . . . 0.655 HG21 ' HB3' ' A' ' 597' ' ' LEU . 3.0 p -122.07 112.78 36.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 116.238 -0.437 . . . . 0.0 109.962 179.159 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 609' ' ' ASN . . . . . 0.416 ' O ' ' HB3' ' A' ' 610' ' ' LYS . 87.7 m-20 56.57 44.76 23.48 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.763 -178.82 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 610' ' ' LYS . . . . . 0.416 ' HB3' ' O ' ' A' ' 609' ' ' ASN . 48.8 tttp 81.19 -26.19 0.15 Allowed 'General case' 0 N--CA 1.472 0.642 0 O-C-N 124.097 0.873 . . . . 0.0 111.701 179.096 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 611' ' ' GLU . . . . . 0.477 ' HA ' ' HD3' ' A' ' 612' ' ' PRO . 5.6 mm-40 -78.6 135.09 60.67 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 120.647 0.26 . . . . 0.0 110.393 -177.22 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 612' ' ' PRO . . . . . 0.477 ' HD3' ' HA ' ' A' ' 611' ' ' GLU . 4.9 Cg_exo -79.38 138.86 14.22 Favored 'Trans proline' 0 N--CA 1.462 -0.381 0 C-N-CA 123.038 2.492 . . . . 0.0 112.988 -176.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 613' ' ' VAL . . . . . 0.712 ' HB ' HG11 ' A' ' 606' ' ' VAL . 94.7 t -84.34 124.39 39.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.581 175.177 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 614' ' ' ALA . . . . . 0.493 ' HB1' HG23 ' A' ' 629' ' ' THR . . . -76.14 -31.41 58.58 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.573 -174.816 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 615' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -162.61 93.85 1.22 Allowed Pre-proline 0 C--N 1.325 -0.485 0 CA-C-O 121.184 0.516 . . . . 0.0 110.275 -176.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 616' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -89.32 165.24 5.5 Favored 'Trans proline' 0 N--CA 1.456 -0.708 0 C-N-CA 123.113 2.542 . . . . 0.0 113.422 -178.206 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 26.4 t0 77.36 40.63 0.16 Allowed 'General case' 0 CA--C 1.516 -0.345 0 CA-C-O 122.708 1.242 . . . . 0.0 110.092 165.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 618' ' ' ILE . . . . . 0.444 ' HB ' ' O ' ' A' ' 625' ' ' VAL . 17.8 mt -89.04 109.29 20.04 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.999 0 CA-C-N 113.776 -1.556 . . . . 0.0 109.266 173.226 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 619' ' ' MET . . . . . 0.46 ' HA ' ' HE1' ' A' ' 619' ' ' MET . 6.8 mmt -73.41 133.12 43.66 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.686 -0.688 . . . . 0.0 112.355 -173.086 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 620' ' ' ALA . . . . . . . . . . . . . . . -131.06 166.33 21.27 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 108.96 -0.755 . . . . 0.0 108.96 172.051 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 621' ' ' THR . . . . . 0.447 HG22 ' HA ' ' A' ' 504' ' ' THR . 1.2 t -72.82 -33.45 66.21 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.455 -0.498 . . . . 0.0 111.361 -174.167 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 622' ' ' ASN . . . . . 0.547 ' HB3' ' HA ' ' A' ' 534' ' ' GLU . 28.5 p-10 -117.83 24.02 11.31 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.656 0.265 . . . . 0.0 111.556 -176.016 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 623' ' ' GLY . . . . . 0.411 ' HA2' ' CD1' ' A' ' 577' ' ' ILE . . . 162.55 -160.13 32.42 Favored Glycine 0 N--CA 1.442 -0.922 0 C-N-CA 120.187 -1.006 . . . . 0.0 112.816 178.386 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 624' ' ' VAL . . . . . . . . . . . . . 8.5 p -134.83 157.29 40.9 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 179.448 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 625' ' ' VAL . . . . . 0.444 ' O ' ' HB ' ' A' ' 618' ' ' ILE . 59.4 t -122.77 134.13 66.87 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.163 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 626' ' ' HIS . . . . . . . . . . . . . 95.7 m-70 -121.47 112.95 19.16 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 175.033 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 627' ' ' VAL . . . . . 0.982 HG23 ' HZ ' ' A' ' 515' ' ' PHE . 37.1 t -68.22 128.89 32.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.844 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 628' ' ' ILE . . . . . 0.61 HG13 ' HA ' ' A' ' 542' ' ' PRO . 6.4 pt -126.71 147.35 31.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 121.22 0.533 . . . . 0.0 111.043 175.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 629' ' ' THR . . . . . 0.493 HG23 ' HB1' ' A' ' 614' ' ' ALA . 30.1 p -96.43 -1.47 47.42 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.401 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 630' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -126.17 158.95 34.27 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.64 -174.273 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 631' ' ' VAL . . . . . 0.591 HG22 ' HB3' ' A' ' 546' ' ' ALA . 2.3 t -96.06 122.42 47.54 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.7 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 177.116 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 632' ' ' LEU . . . . . 0.406 HD23 HG11 ' A' ' 608' ' ' VAL . 96.2 mt -71.83 110.67 6.51 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.485 0.66 . . . . 0.0 110.401 -177.362 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 633' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -120.92 120.76 29.2 Favored Pre-proline 0 C--N 1.318 -0.802 0 CA-C-N 114.907 -1.042 . . . . 0.0 109.649 -175.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 634' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_exo . . . . . 0 C--O 1.249 1.07 0 C-N-CA 122.752 2.301 . . . . 0.0 111.754 -179.867 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.714 0 N-CA-C 111.252 -0.739 . . . . 0.0 111.252 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 39.1 p -71.9 175.63 5.66 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 177.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 505' ' ' VAL . . . . . 0.641 ' O ' ' HG ' ' A' ' 509' ' ' LEU . 8.5 t -54.63 -38.71 43.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 121.146 0.498 . . . . 0.0 110.261 178.07 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 506' ' ' MET . . . . . . . . . . . . . 16.5 mmt -63.55 -35.1 79.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.787 -178.628 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 507' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -62.91 -28.84 70.33 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.267 0.556 . . . . 0.0 110.27 -178.091 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 508' ' ' VAL . . . . . . . . . . . . . 47.3 t -87.41 -43.11 15.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.797 179.147 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 509' ' ' LEU . . . . . 0.641 ' HG ' ' O ' ' A' ' 505' ' ' VAL . 69.7 mt -64.73 -24.22 67.5 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 121.097 0.475 . . . . 0.0 111.907 -176.01 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -85.71 -21.57 28.24 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.402 -176.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 511' ' ' GLY . . . . . . . . . . . . . . . -81.27 -9.54 85.86 Favored Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 120.665 -0.778 . . . . 0.0 111.53 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 512' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -109.84 148.18 31.99 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.16 0.505 . . . . 0.0 111.607 -178.406 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -76.51 -21.4 55.81 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.757 -0.656 . . . . 0.0 112.521 -176.488 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 514' ' ' ARG . . . . . 0.668 ' HB3' ' HA ' ' A' ' 543' ' ' THR . 9.8 mmt180 -89.97 -51.38 5.51 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.495 0.664 . . . . 0.0 109.496 -177.716 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 515' ' ' PHE . . . . . 0.972 ' HZ ' HG23 ' A' ' 627' ' ' VAL . 9.1 m-30 -62.31 -29.38 70.4 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 114.664 -1.153 . . . . 0.0 111.25 -175.583 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 2.7 p -62.82 -25.7 68.39 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 -175.055 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 517' ' ' MET . . . . . . . . . . . . . 48.4 ttp -80.91 -37.78 29.07 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 175.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 518' ' ' LEU . . . . . 0.42 HD23 ' HD2' ' A' ' 542' ' ' PRO . 66.5 tp -57.81 -39.11 76.81 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.234 171.39 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 519' ' ' VAL . . . . . 0.497 HG21 ' O ' ' A' ' 515' ' ' PHE . 86.6 t -53.76 -37.52 32.62 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 CA-C-O 121.058 0.456 . . . . 0.0 110.582 175.111 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 520' ' ' ALA . . . . . . . . . . . . . . . -71.64 -35.24 70.32 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.441 -178.132 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 521' ' ' ALA . . . . . . . . . . . . . . . -68.59 -48.14 64.93 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.491 176.439 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 522' ' ' ILE . . . . . 0.411 HG22 ' HB2' ' A' ' 527' ' ' LEU . 69.2 mt -59.55 -37.01 68.13 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.886 177.402 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 523' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -61.98 -52.93 62.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.015 177.837 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 40.8 m -62.0 -34.25 75.83 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.735 -178.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 525' ' ' ALA . . . . . . . . . . . . . . . -77.69 -12.01 59.93 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.479 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 526' ' ' GLY . . . . . . . . . . . . . . . 72.73 34.6 59.41 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 121.061 -0.59 . . . . 0.0 112.958 178.093 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 527' ' ' LEU . . . . . 0.411 ' HB2' HG22 ' A' ' 522' ' ' ILE . 95.2 mt -109.13 10.31 26.0 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.901 0.381 . . . . 0.0 110.49 -179.834 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 528' ' ' THR . . . . . . . . . . . . . 8.1 m -57.08 -43.18 81.92 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 -173.003 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 529' ' ' GLU . . . . . 0.494 ' O ' ' HG2' ' A' ' 533' ' ' ARG . 11.5 pt-20 -70.34 -17.01 63.05 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 111.826 0.306 . . . . 0.0 111.826 -174.091 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 530' ' ' THR . . . . . . . . . . . . . 78.0 m -62.77 -49.17 76.05 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.83 0.348 . . . . 0.0 110.613 178.531 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 531' ' ' LEU . . . . . 0.415 ' HB3' ' HB ' ' A' ' 505' ' ' VAL . 1.9 mm? -75.49 -14.51 60.43 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.19 178.25 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 532' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -78.47 -32.94 48.57 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.603 179.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 533' ' ' ARG . . . . . 0.494 ' HG2' ' O ' ' A' ' 529' ' ' GLU . 30.7 mmm180 -66.91 123.18 19.45 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.334 178.128 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 534' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -71.69 94.79 1.39 Allowed 'General case' 0 N--CA 1.443 -0.82 0 CA-C-O 122.627 1.203 . . . . 0.0 110.697 176.129 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 535' ' ' GLY . . . . . . . . . . . . . . . -161.85 175.06 38.41 Favored Glycine 0 N--CA 1.441 -1.001 0 N-CA-C 108.092 -2.003 . . . . 0.0 108.092 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 536' ' ' VAL . . . . . 0.641 ' HB ' HG13 ' A' ' 577' ' ' ILE . 33.9 m -87.32 131.42 35.2 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 118.405 1.103 . . . . 0.0 111.87 -167.489 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 537' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -150.48 144.31 25.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.051 -0.977 . . . . 0.0 109.964 179.406 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 538' ' ' THR . . . . . . . . . . . . . 22.6 m -108.32 102.91 11.99 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 173.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 539' ' ' VAL . . . . . 0.54 HG23 HG11 ' A' ' 505' ' ' VAL . 47.2 t -100.88 123.24 53.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 120.864 0.364 . . . . 0.0 111.641 -173.231 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 540' ' ' PHE . . . . . 0.498 ' HB3' HD12 ' A' ' 628' ' ' ILE . 97.6 m-85 -102.34 110.0 21.83 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 173.835 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -103.21 112.61 65.85 Favored Pre-proline 0 C--N 1.324 -0.537 0 CA-C-O 120.748 0.308 . . . . 0.0 110.863 -175.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 542' ' ' PRO . . . . . 0.572 ' HA ' HG13 ' A' ' 628' ' ' ILE . 11.8 Cg_exo -71.5 142.26 40.13 Favored 'Trans proline' 0 N--CA 1.461 -0.4 0 C-N-CA 123.028 2.485 . . . . 0.0 112.146 178.554 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 543' ' ' THR . . . . . 0.668 ' HA ' ' HB3' ' A' ' 514' ' ' ARG . 44.9 p -78.13 175.42 10.16 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.736 178.241 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 544' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -73.72 -24.17 59.87 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.821 -0.352 . . . . 0.0 110.478 -176.56 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 545' ' ' GLU . . . . . 0.431 ' OE2' ' HB ' ' A' ' 543' ' ' THR . 1.9 mp0 -64.35 -33.17 75.22 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 110.043 -0.355 . . . . 0.0 110.043 177.492 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 546' ' ' ALA . . . . . 0.622 ' HB3' HG21 ' A' ' 631' ' ' VAL . . . -59.76 -49.62 77.02 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.592 177.848 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 547' ' ' PHE . . . . . 0.4 ' HA ' ' HG ' ' A' ' 550' ' ' LEU . 88.9 m-85 -68.98 -21.81 64.13 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.79 -179.634 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 548' ' ' ARG . . . . . . . . . . . . . 30.5 ttm180 -79.12 -28.17 42.92 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.868 179.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 549' ' ' ALA . . . . . . . . . . . . . . . -96.41 1.07 51.37 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.452 -176.379 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 550' ' ' LEU . . . . . 0.429 ' HG ' ' O ' ' A' ' 546' ' ' ALA . 75.0 mt -67.35 137.72 93.88 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.564 179.71 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 551' ' ' PRO . . . . . 0.541 ' HD2' ' HB2' ' A' ' 554' ' ' GLU . 16.0 Cg_exo -68.1 155.81 68.13 Favored 'Trans proline' 0 C--O 1.235 0.368 0 C-N-CA 123.036 2.491 . . . . 0.0 111.437 179.593 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 552' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -43.93 -55.29 3.17 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 123.861 3.041 . . . . 0.0 113.598 -176.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 553' ' ' ARG . . . . . 0.401 ' O ' ' HG3' ' A' ' 557' ' ' ARG . 8.6 ptm180 -63.5 -38.76 92.35 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 -177.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 554' ' ' GLU . . . . . 0.541 ' HB2' ' HD2' ' A' ' 551' ' ' PRO . 4.5 mm-40 -73.22 -49.48 27.67 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.827 0.346 . . . . 0.0 111.04 -174.301 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 555' ' ' ARG . . . . . 0.409 ' HB3' ' HB2' ' A' ' 550' ' ' LEU . 20.6 ptt180 -66.53 -28.39 68.51 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.11 -179.285 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 47.6 t -73.37 -29.99 63.0 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.712 0.291 . . . . 0.0 110.757 179.522 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 557' ' ' ARG . . . . . 0.401 ' HG3' ' O ' ' A' ' 553' ' ' ARG . 22.2 mtp180 -83.04 -53.63 5.67 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.023 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 558' ' ' LEU . . . . . 0.59 ' O ' ' HG ' ' A' ' 565' ' ' LEU . 47.2 tp -63.91 -40.43 96.49 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.655 0.264 . . . . 0.0 111.564 -174.297 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 559' ' ' LEU . . . . . . . . . . . . . 63.7 mt -94.11 13.23 23.77 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.052 0.453 . . . . 0.0 110.98 -178.144 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 560' ' ' GLY . . . . . . . . . . . . . . . -126.12 -48.66 0.19 Allowed Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.609 -0.805 . . . . 0.0 112.469 -178.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 561' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -86.24 116.15 24.24 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.97 0.414 . . . . 0.0 110.548 -176.44 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 562' ' ' ALA . . . . . . . . . . . . . . . -68.71 -21.9 64.37 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.537 -176.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 563' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -81.33 -45.74 15.73 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 -178.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 564' ' ' GLU . . . . . 0.425 ' O ' HG12 ' A' ' 568' ' ' ILE . 29.2 mt-10 -69.69 -25.18 63.76 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.481 177.8 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 565' ' ' LEU . . . . . 0.59 ' HG ' ' O ' ' A' ' 558' ' ' LEU . 4.0 mt -58.77 -55.85 29.72 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.957 0.408 . . . . 0.0 109.946 170.797 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 566' ' ' ALA . . . . . 0.566 ' O ' ' HG3' ' A' ' 570' ' ' LYS . . . -62.51 -26.97 68.82 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.843 178.444 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 567' ' ' ASN . . . . . 0.451 ' C ' HD21 ' A' ' 567' ' ' ASN . 0.2 OUTLIER -73.18 -55.24 6.73 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.985 179.362 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 568' ' ' ILE . . . . . 0.425 HG12 ' O ' ' A' ' 564' ' ' GLU . 50.8 mm -68.81 -34.65 65.7 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 CA-C-O 120.701 0.286 . . . . 0.0 111.738 -175.113 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 569' ' ' LEU . . . . . 0.431 ' HG ' ' O ' ' A' ' 565' ' ' LEU . 87.1 mt -63.12 -25.63 68.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.799 0.333 . . . . 0.0 111.227 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 570' ' ' LYS . . . . . 0.566 ' HG3' ' O ' ' A' ' 566' ' ' ALA . 62.5 mttp -69.5 -13.93 62.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.893 0.378 . . . . 0.0 111.099 178.018 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 571' ' ' TYR . . . . . . . . . . . . . 15.6 t80 -94.72 -7.86 39.38 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.149 0.5 . . . . 0.0 110.506 -177.21 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 572' ' ' HIS . . . . . . . . . . . . . 75.8 m80 -101.03 -9.21 21.64 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.71 -179.227 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 573' ' ' ILE . . . . . 0.413 ' O ' HD23 ' A' ' 592' ' ' LEU . 29.3 mt -111.9 123.13 67.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.418 178.233 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 574' ' ' GLY . . . . . 0.493 ' HA2' ' HA ' ' A' ' 591' ' ' SER . . . -98.87 167.39 21.85 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.21 176.388 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 575' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -92.24 -4.8 53.56 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 113.112 0.782 . . . . 0.0 113.112 -168.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 576' ' ' GLU . . . . . 0.72 ' HB2' HD21 ' A' ' 589' ' ' LEU . 70.0 mm-40 -128.77 -167.08 1.72 Allowed 'General case' 0 CA--C 1.504 -0.812 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 179.783 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 577' ' ' ILE . . . . . 0.641 HG13 ' HB ' ' A' ' 536' ' ' VAL . 82.0 mt -112.42 105.32 18.56 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 N-CA-C 110.051 -0.352 . . . . 0.0 110.051 167.773 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 578' ' ' LEU . . . . . 0.639 HD23 HG12 ' A' ' 587' ' ' VAL . 0.3 OUTLIER -100.86 115.27 29.97 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 178.644 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 579' ' ' VAL . . . . . . . . . . . . . 30.6 m -113.69 163.73 10.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.496 179.384 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 580' ' ' SER . . . . . 0.414 ' C ' ' H ' ' A' ' 582' ' ' GLY . 49.6 p -62.33 -33.8 75.39 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-O 120.868 0.366 . . . . 0.0 111.03 -178.67 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 581' ' ' GLY . . . . . . . . . . . . . . . -77.32 22.9 2.41 Favored Glycine 0 CA--C 1.519 0.287 0 C-N-CA 121.207 -0.52 . . . . 0.0 112.543 179.529 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 582' ' ' GLY . . . . . 0.414 ' H ' ' C ' ' A' ' 580' ' ' SER . . . -140.58 23.64 2.66 Favored Glycine 0 N--CA 1.445 -0.757 0 N-CA-C 111.543 -0.623 . . . . 0.0 111.543 176.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 583' ' ' ILE . . . . . . . . . . . . . 2.5 mt -122.3 98.94 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 CA-C-O 121.152 0.501 . . . . 0.0 110.38 179.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 584' ' ' GLY . . . . . . . . . . . . . . . -82.15 -20.59 62.48 Favored Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 120.63 -0.795 . . . . 0.0 111.781 176.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 585' ' ' ALA . . . . . . . . . . . . . . . -163.19 -79.77 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.921 0.391 . . . . 0.0 110.328 178.028 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 586' ' ' LEU . . . . . 0.774 HD12 ' HB3' ' A' ' 598' ' ' GLU . 53.4 tp -135.92 132.6 36.68 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.173 179.681 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 587' ' ' VAL . . . . . 0.639 HG12 HD23 ' A' ' 578' ' ' LEU . 42.8 t -127.21 116.52 44.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.185 177.343 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 588' ' ' ARG . . . . . 0.855 ' HG2' ' HG2' ' A' ' 598' ' ' GLU . 96.7 mtt180 -85.43 103.59 14.46 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.142 0.496 . . . . 0.0 109.966 176.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 589' ' ' LEU . . . . . 0.72 HD21 ' HB2' ' A' ' 576' ' ' GLU . 0.7 OUTLIER -101.18 125.15 47.78 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.312 -0.858 . . . . 0.0 108.772 -177.309 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 590' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -65.05 149.97 48.92 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.088 0.47 . . . . 0.0 111.552 -177.751 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 591' ' ' SER . . . . . 0.493 ' HA ' ' HA2' ' A' ' 574' ' ' GLY . 54.4 p -111.17 158.3 19.07 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.493 174.414 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 592' ' ' LEU . . . . . 0.413 HD23 ' O ' ' A' ' 573' ' ' ILE . 3.3 mm? -60.74 -18.23 53.37 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 112.068 0.395 . . . . 0.0 112.068 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 593' ' ' GLN . . . . . 0.449 ' N ' ' HB3' ' A' ' 570' ' ' LYS . 4.8 tt0 -71.51 -29.04 64.34 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.027 0.441 . . . . 0.0 110.352 176.649 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 594' ' ' GLY . . . . . . . . . . . . . . . 109.3 -6.72 32.18 Favored Glycine 0 N--CA 1.443 -0.891 0 C-N-CA 120.72 -0.753 . . . . 0.0 111.683 -173.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 595' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -89.93 -174.59 4.31 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 176.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 596' ' ' LYS . . . . . 0.549 ' H ' ' HD3' ' A' ' 596' ' ' LYS . 0.0 OUTLIER -121.66 132.76 54.83 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.206 0.527 . . . . 0.0 111.287 -172.509 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 597' ' ' LEU . . . . . 0.617 ' HA ' HD22 ' A' ' 609' ' ' ASN . 42.6 mt -101.17 115.28 30.12 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 172.17 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 598' ' ' GLU . . . . . 0.855 ' HG2' ' HG2' ' A' ' 588' ' ' ARG . 46.3 mt-10 -89.42 91.78 8.86 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-O 121.203 0.525 . . . . 0.0 109.863 -179.135 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 599' ' ' VAL . . . . . . . . . . . . . 20.3 t -86.6 121.2 37.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 115.267 -0.879 . . . . 0.0 108.871 179.506 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 600' ' ' SER . . . . . . . . . . . . . 3.5 p -130.59 156.32 45.05 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.56 -174.008 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 601' ' ' LEU . . . . . . . . . . . . . 21.3 tp -126.35 107.3 10.17 Favored 'General case' 0 N--CA 1.445 -0.724 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 175.368 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 602' ' ' LYS . . . . . 0.529 ' HG2' ' OD1' ' A' ' 603' ' ' ASN . 36.1 ttpt -127.7 118.91 24.7 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.965 -175.71 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 603' ' ' ASN . . . . . 0.529 ' OD1' ' HG2' ' A' ' 602' ' ' LYS . 18.1 m120 61.47 35.93 17.38 Favored 'General case' 0 C--N 1.331 -0.217 0 O-C-N 123.346 0.404 . . . . 0.0 109.946 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 604' ' ' ASN . . . . . . . . . . . . . 14.2 m120 72.45 4.77 5.1 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 115.144 -0.935 . . . . 0.0 111.669 179.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 605' ' ' VAL . . . . . . . . . . . . . 58.6 t -103.56 123.54 57.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 110.273 -0.269 . . . . 0.0 110.273 178.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 606' ' ' VAL . . . . . 0.596 HG11 ' HB ' ' A' ' 613' ' ' VAL . 7.1 p -88.41 129.33 39.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 121.175 0.512 . . . . 0.0 110.8 -179.352 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 607' ' ' SER . . . . . 0.411 ' HA ' ' HA ' ' A' ' 612' ' ' PRO . 2.8 p -133.16 152.49 51.94 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.984 -179.76 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 608' ' ' VAL . . . . . 0.407 ' O ' HG13 ' A' ' 608' ' ' VAL . 2.6 p -133.91 104.73 6.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.863 179.676 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 609' ' ' ASN . . . . . 0.617 HD22 ' HA ' ' A' ' 597' ' ' LEU . 89.2 m-20 55.8 66.43 1.21 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.84 -178.43 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 610' ' ' LYS . . . . . 0.52 ' HB3' ' O ' ' A' ' 609' ' ' ASN . 58.9 tptt 78.56 -42.81 0.34 Allowed 'General case' 0 N--CA 1.47 0.575 0 CA-C-N 115.724 -0.671 . . . . 0.0 112.715 178.365 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 611' ' ' GLU . . . . . 0.457 ' HA ' ' HD3' ' A' ' 612' ' ' PRO . 4.5 mm-40 -88.99 137.66 29.57 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-O 120.79 0.329 . . . . 0.0 111.463 -172.599 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 612' ' ' PRO . . . . . 0.457 ' HD3' ' HA ' ' A' ' 611' ' ' GLU . 5.8 Cg_exo -77.65 153.91 30.46 Favored 'Trans proline' 0 N--CA 1.459 -0.501 0 C-N-CA 122.917 2.412 . . . . 0.0 112.445 179.236 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 613' ' ' VAL . . . . . 0.596 ' HB ' HG11 ' A' ' 606' ' ' VAL . 24.7 t -94.52 134.11 33.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.341 177.319 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 614' ' ' ALA . . . . . 0.462 ' HB2' HG21 ' A' ' 629' ' ' THR . . . -74.18 -47.1 37.88 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.533 -175.746 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 615' ' ' GLU . . . . . 0.445 ' HB3' ' CG2' ' A' ' 627' ' ' VAL . 36.7 tt0 -147.76 101.64 3.69 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-O 120.969 0.414 . . . . 0.0 110.332 -177.423 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 616' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -90.01 162.57 4.9 Favored 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 123.228 2.619 . . . . 0.0 113.866 -178.414 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 26.8 m-20 77.64 28.79 0.55 Allowed 'General case' 0 CA--C 1.508 -0.635 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.77 163.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 618' ' ' ILE . . . . . 0.574 ' HB ' ' O ' ' A' ' 625' ' ' VAL . 20.2 mt -71.92 108.73 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.081 0 CA-C-N 114.505 -1.225 . . . . 0.0 109.03 173.38 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 619' ' ' MET . . . . . 0.448 ' HA ' ' HE1' ' A' ' 619' ' ' MET . 5.7 mmt -79.04 129.29 34.29 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.769 -0.65 . . . . 0.0 112.547 -171.422 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 620' ' ' ALA . . . . . . . . . . . . . . . -118.71 174.91 6.0 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 169.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 621' ' ' THR . . . . . . . . . . . . . 6.0 t -75.19 -25.46 58.27 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.319 -0.552 . . . . 0.0 110.939 -178.115 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 622' ' ' ASN . . . . . 0.452 ' O ' ' HA ' ' A' ' 536' ' ' VAL . 22.9 p-10 -116.88 -9.2 11.22 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 112.481 0.548 . . . . 0.0 112.481 -175.359 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 623' ' ' GLY . . . . . . . . . . . . . . . -169.66 -160.7 18.55 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 119.369 -1.396 . . . . 0.0 113.202 -175.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 624' ' ' VAL . . . . . . . . . . . . . 5.6 p -130.13 155.27 41.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 -178.541 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 625' ' ' VAL . . . . . 0.574 ' O ' ' HB ' ' A' ' 618' ' ' ILE . 61.5 t -126.05 135.39 64.0 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.935 179.199 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 626' ' ' HIS . . . . . . . . . . . . . 82.4 m-70 -120.92 114.43 21.54 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.687 177.081 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 627' ' ' VAL . . . . . 0.972 HG23 ' HZ ' ' A' ' 515' ' ' PHE . 29.9 t -67.09 124.11 21.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.418 177.544 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 628' ' ' ILE . . . . . 0.572 HG13 ' HA ' ' A' ' 542' ' ' PRO . 4.4 pt -121.43 142.36 37.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-O 121.124 0.488 . . . . 0.0 110.565 175.273 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 629' ' ' THR . . . . . 0.462 HG21 ' HB2' ' A' ' 614' ' ' ALA . 37.8 p -89.12 -7.44 55.74 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.194 -178.151 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 630' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -129.05 160.43 32.8 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.649 -175.316 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 631' ' ' VAL . . . . . 0.622 HG21 ' HB3' ' A' ' 546' ' ' ALA . 81.1 t -95.11 128.98 45.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 179.479 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 632' ' ' LEU . . . . . . . . . . . . . 96.3 mt -80.92 111.51 17.46 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.313 0.578 . . . . 0.0 110.619 -178.403 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 633' ' ' GLN . . . . . 0.449 ' HA ' ' HD3' ' A' ' 634' ' ' PRO . 51.3 mt-30 -110.84 131.48 22.1 Favored Pre-proline 0 C--N 1.318 -0.761 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.619 -179.397 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 634' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 633' ' ' GLN . 5.6 Cg_exo . . . . . 0 C--O 1.248 0.998 0 C-N-CA 122.971 2.447 . . . . 0.0 111.179 175.307 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.904 0 N-CA-C 111.574 -0.61 . . . . 0.0 111.574 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 26.5 p -69.7 176.23 3.72 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 177.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 505' ' ' VAL . . . . . 0.702 ' O ' ' HG ' ' A' ' 509' ' ' LEU . 15.8 m -58.0 -32.04 42.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 C-N-CA 120.775 -0.37 . . . . 0.0 110.387 175.512 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 506' ' ' MET . . . . . . . . . . . . . 11.0 mmt -62.41 -43.74 98.1 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.271 176.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 507' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -61.39 -44.75 96.62 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 120.869 0.366 . . . . 0.0 110.84 179.454 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 508' ' ' VAL . . . . . . . . . . . . . 60.9 t -60.92 -45.51 98.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.745 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 509' ' ' LEU . . . . . 0.702 ' HG ' ' O ' ' A' ' 505' ' ' VAL . 77.5 mt -68.48 -36.23 78.65 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.218 -177.752 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 510' ' ' LYS . . . . . 0.448 ' HE2' HG11 ' A' ' 519' ' ' VAL . 54.4 mttm -77.28 -26.73 52.64 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.272 0.558 . . . . 0.0 110.011 -178.341 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 511' ' ' GLY . . . . . . . . . . . . . . . -71.48 -15.21 75.12 Favored Glycine 0 N--CA 1.445 -0.758 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.678 176.593 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 512' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -106.64 145.77 31.55 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.983 0.42 . . . . 0.0 111.04 179.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 -75.55 -25.23 56.97 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.207 -175.002 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 514' ' ' ARG . . . . . 0.413 ' HB3' ' HA ' ' A' ' 543' ' ' THR . 3.0 mpt_? -86.32 -50.0 7.25 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.305 0.574 . . . . 0.0 109.833 -178.189 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 515' ' ' PHE . . . . . 0.535 ' CZ ' HG21 ' A' ' 627' ' ' VAL . 11.5 m-30 -66.49 -27.0 67.44 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.635 -175.461 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 5.1 p -63.38 -30.21 71.38 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.657 0.265 . . . . 0.0 111.71 -178.52 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 517' ' ' MET . . . . . 0.498 ' HE1' ' HA ' ' A' ' 544' ' ' ASN . 54.7 mtm -69.78 -34.37 73.66 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 176.474 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 518' ' ' LEU . . . . . 0.5 HD21 ' HD2' ' A' ' 542' ' ' PRO . 51.9 tp -67.58 -40.04 84.84 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.372 173.362 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 519' ' ' VAL . . . . . 0.448 HG11 ' HE2' ' A' ' 510' ' ' LYS . 86.7 t -55.74 -37.09 45.44 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.371 0 CA-C-N 116.223 -0.444 . . . . 0.0 109.925 174.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 520' ' ' ALA . . . . . . . . . . . . . . . -63.74 -38.61 91.77 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.402 -179.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 521' ' ' ALA . . . . . . . . . . . . . . . -67.86 -51.39 48.78 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.825 0.345 . . . . 0.0 110.327 176.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 522' ' ' ILE . . . . . 0.474 ' HA ' ' HG ' ' A' ' 569' ' ' LEU . 62.1 mt -57.74 -40.83 77.71 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 CA-C-O 121.216 0.531 . . . . 0.0 111.164 178.136 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 523' ' ' GLN . . . . . 0.464 ' HA ' ' OG1' ' A' ' 528' ' ' THR . 21.5 tt0 -70.06 -39.21 75.79 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.408 -0.815 . . . . 0.0 110.762 -175.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 43.6 m -72.83 -31.16 64.6 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.93 0.395 . . . . 0.0 110.715 178.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 525' ' ' ALA . . . . . 0.629 ' HB3' ' HA ' ' A' ' 566' ' ' ALA . . . -74.86 -19.92 59.96 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.226 0.536 . . . . 0.0 110.524 176.817 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 526' ' ' GLY . . . . . . . . . . . . . . . 84.46 37.52 10.73 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.774 -0.726 . . . . 0.0 113.153 176.119 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 527' ' ' LEU . . . . . . . . . . . . . 9.1 mp -112.35 15.24 20.38 Favored 'General case' 0 C--N 1.326 -0.416 0 O-C-N 122.599 -0.353 . . . . 0.0 110.957 177.117 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 528' ' ' THR . . . . . 0.464 ' OG1' ' HA ' ' A' ' 523' ' ' GLN . 14.6 m -62.08 -33.74 74.99 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.579 -178.233 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 529' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -69.4 -24.85 63.91 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.551 -177.39 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 530' ' ' THR . . . . . 0.642 ' HB ' HD23 ' A' ' 531' ' ' LEU . 11.0 m -63.14 -53.36 54.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.062 0.458 . . . . 0.0 110.58 179.524 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 531' ' ' LEU . . . . . 0.642 HD23 ' HB ' ' A' ' 530' ' ' THR . 1.8 mm? -79.43 6.11 11.04 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.907 -178.808 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 532' ' ' ASN . . . . . . . . . . . . . 37.5 t-20 -87.83 -28.06 21.87 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.35 0.595 . . . . 0.0 109.428 179.441 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 533' ' ' ARG . . . . . . . . . . . . . 9.5 ttp180 -79.22 137.17 37.3 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.608 -0.723 . . . . 0.0 110.492 178.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 534' ' ' GLU . . . . . 0.615 ' HA ' ' HB3' ' A' ' 622' ' ' ASN . 48.5 mt-10 -77.04 133.91 38.95 Favored 'General case' 0 C--O 1.233 0.191 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 175.188 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 535' ' ' GLY . . . . . . . . . . . . . . . 173.7 -137.64 4.16 Favored Glycine 0 CA--C 1.501 -0.826 0 N-CA-C 110.675 -0.97 . . . . 0.0 110.675 -178.579 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 536' ' ' VAL . . . . . 0.45 ' HB ' HG13 ' A' ' 577' ' ' ILE . 33.8 m -119.52 130.27 74.27 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-O 121.077 0.465 . . . . 0.0 110.963 178.555 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 537' ' ' TYR . . . . . . . . . . . . . 75.8 m-85 -151.25 146.42 26.05 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.636 178.22 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 538' ' ' THR . . . . . 0.717 ' OG1' ' HA ' ' A' ' 577' ' ' ILE . 30.9 m -120.02 101.56 7.93 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 171.3 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 539' ' ' VAL . . . . . . . . . . . . . 51.8 t -103.46 127.34 57.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.115 -174.276 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 540' ' ' PHE . . . . . 0.542 ' HB3' HD12 ' A' ' 628' ' ' ILE . 94.8 m-85 -100.09 112.67 24.97 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 175.675 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 541' ' ' ALA . . . . . 0.456 ' HA ' HD21 ' A' ' 518' ' ' LEU . . . -105.93 113.0 64.2 Favored Pre-proline 0 C--N 1.325 -0.487 0 CA-C-O 120.705 0.288 . . . . 0.0 111.423 -176.788 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 542' ' ' PRO . . . . . 0.5 ' HD2' HD21 ' A' ' 518' ' ' LEU . 13.2 Cg_exo -71.02 142.24 41.94 Favored 'Trans proline' 0 N--CA 1.463 -0.29 0 C-N-CA 123.068 2.512 . . . . 0.0 112.079 176.693 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 543' ' ' THR . . . . . 0.413 ' HA ' ' HB3' ' A' ' 514' ' ' ARG . 40.9 p -80.4 179.56 7.64 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.017 178.732 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 544' ' ' ASN . . . . . 0.498 ' HA ' ' HE1' ' A' ' 517' ' ' MET . 7.9 t30 -61.78 -34.37 75.74 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.639 -179.168 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 545' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -62.82 -30.11 71.23 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.107 -176.131 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 546' ' ' ALA . . . . . 0.565 ' HB3' HG22 ' A' ' 631' ' ' VAL . . . -64.95 -49.73 69.2 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.301 0.572 . . . . 0.0 110.634 179.145 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 547' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -69.76 -22.04 63.39 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.784 -178.342 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 548' ' ' ARG . . . . . 0.512 ' O ' ' HD2' ' A' ' 548' ' ' ARG . 5.0 tmm_? -84.48 -35.71 22.78 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.859 -179.107 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 549' ' ' ALA . . . . . . . . . . . . . . . -69.36 -29.97 67.88 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.335 176.42 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 550' ' ' LEU . . . . . 0.469 ' HA ' ' HD3' ' A' ' 551' ' ' PRO . 70.8 mt -64.6 131.49 95.13 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.546 175.877 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 551' ' ' PRO . . . . . 0.472 ' HD2' ' HB2' ' A' ' 554' ' ' GLU . 6.9 Cg_exo -72.56 145.71 42.59 Favored 'Trans proline' 0 N--CA 1.459 -0.548 0 C-N-CA 122.828 2.352 . . . . 0.0 111.609 -177.309 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 552' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -53.86 -30.45 57.84 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 123.074 2.516 . . . . 0.0 112.082 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 553' ' ' ARG . . . . . . . . . . . . . 58.7 ttp180 -66.68 -54.71 20.2 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.806 177.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 554' ' ' GLU . . . . . 0.472 ' HB2' ' HD2' ' A' ' 551' ' ' PRO . 0.9 OUTLIER -65.15 -48.9 71.9 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.909 -175.939 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 555' ' ' ARG . . . . . . . . . . . . . 14.3 ptm180 -60.18 -39.23 85.73 Favored 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 121.12 -0.232 . . . . 0.0 111.464 -176.101 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 50.0 m -71.52 -27.5 63.24 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 111.683 0.253 . . . . 0.0 111.683 -175.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 557' ' ' ARG . . . . . . . . . . . . . 33.0 ttm180 -75.96 -43.28 45.39 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.053 0.454 . . . . 0.0 109.781 177.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 558' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -66.71 -42.88 85.67 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.218 -179.383 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 559' ' ' LEU . . . . . 0.725 HD22 HD22 ' A' ' 565' ' ' LEU . 63.7 mt -83.13 0.13 46.6 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.047 -178.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 560' ' ' GLY . . . . . . . . . . . . . . . -88.13 -9.63 70.12 Favored Glycine 0 N--CA 1.453 -0.196 0 CA-C-N 116.039 -0.528 . . . . 0.0 112.612 -178.25 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 561' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -127.86 129.92 47.73 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 178.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 562' ' ' ALA . . . . . . . . . . . . . . . -76.9 -28.23 55.26 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 111.927 0.343 . . . . 0.0 111.927 -175.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 563' ' ' LYS . . . . . 0.468 ' HD2' ' N ' ' A' ' 563' ' ' LYS . 0.5 OUTLIER -80.36 -35.28 35.68 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 -177.125 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 564' ' ' GLU . . . . . . . . . . . . . 21.4 mm-40 -61.14 -43.96 98.06 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 171.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 565' ' ' LEU . . . . . 0.725 HD22 HD22 ' A' ' 559' ' ' LEU . 60.3 mt -57.5 -53.36 59.03 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.74 175.261 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 566' ' ' ALA . . . . . 0.629 ' HA ' ' HB3' ' A' ' 525' ' ' ALA . . . -55.75 -26.18 44.38 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.218 -178.825 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 567' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -86.59 -35.12 19.64 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.808 -179.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 568' ' ' ILE . . . . . . . . . . . . . 22.3 mm -69.71 -52.19 34.1 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 CA-C-N 116.075 -0.511 . . . . 0.0 112.331 -179.127 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 569' ' ' LEU . . . . . 0.474 ' HG ' ' HA ' ' A' ' 522' ' ' ILE . 2.7 mm? -64.22 -23.46 67.32 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-O 121.1 0.476 . . . . 0.0 110.968 177.619 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 570' ' ' LYS . . . . . . . . . . . . . 16.3 ttmm -70.96 -12.4 61.51 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.646 177.073 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 571' ' ' TYR . . . . . 0.434 ' HB2' HE21 ' A' ' 593' ' ' GLN . 59.9 t80 -102.77 -18.07 15.31 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.872 -0.603 . . . . 0.0 111.222 -177.644 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 572' ' ' HIS . . . . . . . . . . . . . 55.4 m80 -86.43 -3.75 59.06 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.118 0.485 . . . . 0.0 110.89 -177.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 573' ' ' ILE . . . . . 0.495 HD12 HD13 ' A' ' 531' ' ' LEU . 27.0 mt -118.19 127.24 75.37 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.134 179.806 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 574' ' ' GLY . . . . . 0.567 ' HA2' ' HA ' ' A' ' 591' ' ' SER . . . -89.12 153.46 23.6 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.934 -0.65 . . . . 0.0 111.58 175.667 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 575' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -74.81 -8.7 57.23 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 120.978 0.418 . . . . 0.0 111.989 -171.482 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 576' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -160.47 162.99 33.3 Favored 'General case' 0 N--CA 1.438 -1.058 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 177.553 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 577' ' ' ILE . . . . . 0.717 ' HA ' ' OG1' ' A' ' 538' ' ' THR . 70.0 mt -78.6 124.1 36.47 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 O-C-N 124.005 0.816 . . . . 0.0 112.386 -170.695 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 578' ' ' LEU . . . . . 0.505 HD12 ' HA ' ' A' ' 583' ' ' ILE . 42.3 tp -122.9 102.09 7.81 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.1 -0.955 . . . . 0.0 109.082 173.428 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 579' ' ' VAL . . . . . . . . . . . . . 30.1 m -96.54 157.39 3.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.84 -177.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 580' ' ' SER . . . . . . . . . . . . . 31.8 t -58.44 -38.96 78.56 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.351 -179.534 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 581' ' ' GLY . . . . . . . . . . . . . . . -74.48 9.96 9.37 Favored Glycine 0 N--CA 1.449 -0.486 0 CA-C-N 115.74 -0.663 . . . . 0.0 113.717 -179.477 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . -162.77 42.59 0.35 Allowed Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.814 -0.707 . . . . 0.0 112.87 178.441 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 583' ' ' ILE . . . . . 0.767 HD13 ' HB2' ' A' ' 601' ' ' LEU . 30.6 mt -80.18 -65.46 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.828 0.347 . . . . 0.0 110.614 176.769 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 584' ' ' GLY . . . . . . . . . . . . . . . 99.82 63.11 0.82 Allowed Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.605 -0.807 . . . . 0.0 111.856 -177.063 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 585' ' ' ALA . . . . . . . . . . . . . . . 67.63 -75.57 0.06 Allowed 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 123.389 0.676 . . . . 0.0 111.96 -179.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 586' ' ' LEU . . . . . 0.981 ' HG ' ' HB3' ' A' ' 600' ' ' SER . 6.5 tt -151.32 129.85 12.2 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.904 0.383 . . . . 0.0 110.237 -178.268 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 587' ' ' VAL . . . . . . . . . . . . . 94.5 t -133.59 133.6 57.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.752 -178.042 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 588' ' ' ARG . . . . . . . . . . . . . 71.8 mtt180 -84.26 102.78 12.92 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 173.044 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 589' ' ' LEU . . . . . . . . . . . . . 60.3 tp -90.51 111.98 23.47 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.584 0.707 . . . . 0.0 110.788 -173.401 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 590' ' ' LYS . . . . . . . . . . . . . 46.5 pttt -60.3 137.35 58.14 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 114.93 -1.032 . . . . 0.0 110.634 176.516 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 591' ' ' SER . . . . . 0.567 ' HA ' ' HA2' ' A' ' 574' ' ' GLY . 44.9 p -99.24 172.59 7.26 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.161 175.861 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 592' ' ' LEU . . . . . 0.424 HD22 ' O ' ' A' ' 573' ' ' ILE . 2.9 mm? -58.76 -22.54 58.22 Favored 'General case' 0 CA--C 1.529 0.173 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 179.593 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 593' ' ' GLN . . . . . 0.732 ' HG3' ' H ' ' A' ' 595' ' ' ASP . 5.8 pt20 -85.34 -29.9 24.12 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.63 -0.428 . . . . 0.0 111.145 178.345 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 594' ' ' GLY . . . . . 0.426 ' N ' ' HG3' ' A' ' 593' ' ' GLN . . . 122.06 -18.76 8.39 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.611 -0.804 . . . . 0.0 113.136 -177.313 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 595' ' ' ASP . . . . . 0.732 ' H ' ' HG3' ' A' ' 593' ' ' GLN . 18.1 t70 -68.46 165.0 19.83 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-N 117.708 0.754 . . . . 0.0 110.189 178.421 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 596' ' ' LYS . . . . . . . . . . . . . 44.9 mttm -109.45 113.37 26.11 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.189 -170.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 597' ' ' LEU . . . . . . . . . . . . . 58.3 mt -79.55 125.76 30.01 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.042 175.233 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 598' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -78.85 84.64 4.88 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 120.612 -0.435 . . . . 0.0 110.163 176.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 599' ' ' VAL . . . . . . . . . . . . . 38.1 t -97.92 121.4 48.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 121.217 0.532 . . . . 0.0 109.588 178.528 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 600' ' ' SER . . . . . 0.981 ' HB3' ' HG ' ' A' ' 586' ' ' LEU . 8.2 p -139.64 160.13 40.57 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-O 120.872 0.367 . . . . 0.0 111.377 -175.429 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 601' ' ' LEU . . . . . 0.767 ' HB2' HD13 ' A' ' 583' ' ' ILE . 39.4 tp -118.45 109.92 16.81 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.852 -179.388 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 602' ' ' LYS . . . . . . . . . . . . . 43.6 mmtm -121.53 114.96 21.96 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.132 -0.485 . . . . 0.0 109.826 178.173 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 603' ' ' ASN . . . . . . . . . . . . . 16.7 m120 58.92 38.52 24.39 Favored 'General case' 0 N--CA 1.465 0.31 0 O-C-N 123.316 0.385 . . . . 0.0 110.526 178.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 604' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 66.34 17.25 10.66 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.236 -179.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 605' ' ' VAL . . . . . . . . . . . . . 61.2 t -110.05 121.86 63.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 175.032 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 606' ' ' VAL . . . . . . . . . . . . . 25.1 t -85.83 131.35 34.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.395 -178.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 607' ' ' SER . . . . . . . . . . . . . 42.1 m -131.24 131.43 43.91 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.356 176.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 608' ' ' VAL . . . . . 0.435 HG13 HD23 ' A' ' 632' ' ' LEU . 3.6 p -115.2 111.82 37.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.86 178.609 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 609' ' ' ASN . . . . . 0.494 ' O ' ' HB3' ' A' ' 610' ' ' LYS . 91.6 m-20 60.89 35.47 19.23 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.921 -175.04 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 610' ' ' LYS . . . . . 0.494 ' HB3' ' O ' ' A' ' 609' ' ' ASN . 83.9 tttt 82.28 -24.99 0.16 Allowed 'General case' 0 N--CA 1.47 0.547 0 O-C-N 124.544 1.152 . . . . 0.0 111.795 -177.634 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 611' ' ' GLU . . . . . 0.415 ' HA ' ' HD3' ' A' ' 612' ' ' PRO . 11.0 mm-40 -67.81 127.47 93.36 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.064 0.459 . . . . 0.0 110.602 -179.208 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 612' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 611' ' ' GLU . 3.1 Cg_exo -74.76 130.74 13.83 Favored 'Trans proline' 0 N--CA 1.459 -0.526 0 C-N-CA 123.099 2.533 . . . . 0.0 112.701 -175.034 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 613' ' ' VAL . . . . . . . . . . . . . 96.7 t -79.71 125.9 38.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.568 175.295 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 614' ' ' ALA . . . . . 0.601 ' HB2' HG22 ' A' ' 629' ' ' THR . . . -78.94 -36.79 41.15 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.789 -176.463 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 615' ' ' GLU . . . . . 0.414 ' HB2' ' HB ' ' A' ' 627' ' ' VAL . 9.8 mm-40 -152.48 94.65 3.18 Favored Pre-proline 0 N--CA 1.467 0.393 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.848 -177.114 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 616' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -90.48 162.88 4.41 Favored 'Trans proline' 0 N--CA 1.46 -0.46 0 C-N-CA 123.139 2.56 . . . . 0.0 113.562 179.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 76.07 33.22 0.59 Allowed 'General case' 0 CA--C 1.506 -0.743 0 CA-C-O 122.103 0.954 . . . . 0.0 110.261 165.264 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 618' ' ' ILE . . . . . 0.514 ' HB ' ' O ' ' A' ' 625' ' ' VAL . 22.7 mt -82.19 97.72 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.36 0 CA-C-N 113.936 -1.484 . . . . 0.0 109.449 178.569 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 619' ' ' MET . . . . . 0.412 ' HA ' ' CE ' ' A' ' 619' ' ' MET . 2.8 mmt -62.39 111.28 1.95 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 114.948 -1.024 . . . . 0.0 111.939 -177.196 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 620' ' ' ALA . . . . . . . . . . . . . . . -110.73 -179.49 3.76 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 171.639 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 621' ' ' THR . . . . . . . . . . . . . 35.2 m -69.66 -46.86 65.18 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-O 120.886 0.374 . . . . 0.0 111.633 -177.566 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 622' ' ' ASN . . . . . 0.615 ' HB3' ' HA ' ' A' ' 534' ' ' GLU . 24.0 p-10 -116.72 32.81 5.93 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.827 -174.045 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 623' ' ' GLY . . . . . 0.597 ' HA2' HD12 ' A' ' 577' ' ' ILE . . . 150.67 -159.65 28.24 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.527 -0.844 . . . . 0.0 112.46 176.77 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 624' ' ' VAL . . . . . . . . . . . . . 9.8 m -123.4 165.95 19.04 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.753 0 CA-C-O 121.909 0.861 . . . . 0.0 111.352 176.111 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 625' ' ' VAL . . . . . 0.514 ' O ' ' HB ' ' A' ' 618' ' ' ILE . 89.8 t -128.51 107.33 15.75 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.193 0 CA-C-N 113.584 -1.644 . . . . 0.0 109.43 177.742 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 626' ' ' HIS . . . . . . . . . . . . . 28.4 m-70 -95.41 103.31 15.17 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 177.192 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 627' ' ' VAL . . . . . 0.535 HG21 ' CZ ' ' A' ' 515' ' ' PHE . 41.8 t -62.75 130.85 27.81 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.0 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 628' ' ' ILE . . . . . 0.542 HD12 ' HB3' ' A' ' 540' ' ' PHE . 3.9 pt -124.85 143.64 37.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 121.193 0.52 . . . . 0.0 111.145 178.647 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 629' ' ' THR . . . . . 0.601 HG22 ' HB2' ' A' ' 614' ' ' ALA . 24.5 p -88.31 7.46 32.19 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.965 -0.561 . . . . 0.0 112.329 -178.485 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 630' ' ' ASN . . . . . . . . . . . . . 65.7 t30 -150.05 174.08 13.14 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 176.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 631' ' ' VAL . . . . . 0.565 HG22 ' HB3' ' A' ' 546' ' ' ALA . 48.9 t -101.19 133.81 43.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.036 -178.102 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 632' ' ' LEU . . . . . 0.435 HD23 HG13 ' A' ' 608' ' ' VAL . 95.9 mt -79.23 116.78 19.7 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-O 121.312 0.577 . . . . 0.0 111.149 -175.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 633' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -122.98 116.67 28.74 Favored Pre-proline 0 C--N 1.317 -0.814 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.083 179.464 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 634' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo . . . . . 0 C--O 1.249 1.057 0 C-N-CA 122.349 2.032 . . . . 0.0 112.266 -179.421 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.67 0 N-CA-C 111.11 -0.796 . . . . 0.0 111.11 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 504' ' ' THR . . . . . 0.602 ' HA ' HG22 ' A' ' 621' ' ' THR . 47.7 p -81.25 172.36 13.72 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 117.065 0.432 . . . . 0.0 110.292 177.884 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 505' ' ' VAL . . . . . 0.649 HG21 HG21 ' A' ' 625' ' ' VAL . 5.0 p -54.66 -47.96 72.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.682 -179.179 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 506' ' ' MET . . . . . 0.591 ' HA ' HD13 ' A' ' 509' ' ' LEU . 2.8 ppp? -81.79 -17.09 48.78 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.519 -0.473 . . . . 0.0 111.077 -178.66 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 507' ' ' ASP . . . . . 0.492 ' HA ' ' HB2' ' A' ' 510' ' ' LYS . 27.6 t70 -68.13 -29.89 68.9 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 173.19 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 508' ' ' VAL . . . . . . . . . . . . . 84.9 t -61.79 -49.33 84.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.824 -0.626 . . . . 0.0 109.578 171.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 509' ' ' LEU . . . . . 1.008 ' HG ' ' HB3' ' A' ' 515' ' ' PHE . 9.6 mp -53.78 -42.36 68.21 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 121.617 0.722 . . . . 0.0 111.25 171.701 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 510' ' ' LYS . . . . . 0.494 ' HD3' ' SD ' ' A' ' 506' ' ' MET . 0.7 OUTLIER -68.59 -20.43 64.51 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 114.769 -1.105 . . . . 0.0 111.467 -177.937 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 511' ' ' GLY . . . . . . . . . . . . . . . -96.82 -0.91 60.2 Favored Glycine 0 N--CA 1.437 -1.252 0 C-N-CA 120.8 -0.714 . . . . 0.0 111.617 177.208 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 512' ' ' ASP . . . . . 0.404 ' O ' ' HB2' ' A' ' 516' ' ' SER . 27.0 t70 -117.98 148.84 41.82 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.513 0.673 . . . . 0.0 112.39 -176.527 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -75.56 -34.96 60.75 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.428 -179.513 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 514' ' ' ARG . . . . . . . . . . . . . 35.6 mtt180 -79.0 -53.25 7.22 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.085 -174.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 515' ' ' PHE . . . . . 1.008 ' HB3' ' HG ' ' A' ' 509' ' ' LEU . 14.4 m-30 -64.27 -17.12 63.31 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.066 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 516' ' ' SER . . . . . 0.404 ' HB2' ' O ' ' A' ' 512' ' ' ASP . 39.6 t -58.03 -31.06 66.63 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.304 -178.247 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 517' ' ' MET . . . . . 0.565 ' HE1' ' HA ' ' A' ' 544' ' ' ASN . 47.7 mtm -72.39 -30.7 64.9 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.742 0.306 . . . . 0.0 110.441 178.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 518' ' ' LEU . . . . . 0.538 HD22 HD23 ' A' ' 509' ' ' LEU . 47.7 tp -70.23 -34.07 72.42 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 173.46 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 519' ' ' VAL . . . . . . . . . . . . . 56.7 t -61.41 -33.04 55.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 121.096 0.474 . . . . 0.0 109.774 174.162 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 520' ' ' ALA . . . . . . . . . . . . . . . -67.0 -40.59 87.38 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.325 177.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 521' ' ' ALA . . . . . . . . . . . . . . . -66.69 -47.75 71.44 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.151 176.236 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 522' ' ' ILE . . . . . 0.438 HG13 ' O ' ' A' ' 518' ' ' LEU . 87.9 mt -56.34 -43.01 76.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.752 176.575 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 523' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -62.69 -47.91 81.6 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.125 178.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 40.1 m -66.61 -36.42 82.55 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.062 -176.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 525' ' ' ALA . . . . . . . . . . . . . . . -78.58 -28.3 45.83 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.484 -0.326 . . . . 0.0 110.968 177.289 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 526' ' ' GLY . . . . . . . . . . . . . . . 82.02 38.04 14.37 Favored Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 121.286 -0.483 . . . . 0.0 112.931 177.277 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 527' ' ' LEU . . . . . . . . . . . . . 97.5 mt -111.07 20.41 17.46 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.765 0.317 . . . . 0.0 111.209 -177.568 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 528' ' ' THR . . . . . . . . . . . . . 8.8 m -62.08 -37.08 83.68 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.724 -177.535 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 529' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -63.44 -31.62 72.83 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 121.025 0.44 . . . . 0.0 110.681 -178.045 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 530' ' ' THR . . . . . . . . . . . . . 27.0 m -59.84 -46.63 88.66 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.078 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 531' ' ' LEU . . . . . 0.496 HD22 HD13 ' A' ' 573' ' ' ILE . 67.1 mt -93.05 11.44 27.57 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.161 0.505 . . . . 0.0 111.268 -178.094 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 532' ' ' ASN . . . . . . . . . . . . . 58.2 t30 -91.47 -51.01 5.48 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.55 -178.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 533' ' ' ARG . . . . . . . . . . . . . 1.7 tpt180 -68.43 146.1 53.5 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.733 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 534' ' ' GLU . . . . . 0.605 ' HA ' ' HB3' ' A' ' 622' ' ' ASN . 23.2 pm0 -76.6 143.74 40.03 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 121.322 0.582 . . . . 0.0 110.537 -179.345 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 535' ' ' GLY . . . . . 0.405 ' H ' ' HB2' ' A' ' 622' ' ' ASN . . . 177.2 -139.57 4.44 Favored Glycine 0 N--CA 1.446 -0.655 0 N-CA-C 110.117 -1.193 . . . . 0.0 110.117 -176.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 536' ' ' VAL . . . . . . . . . . . . . 33.0 m -124.48 130.31 73.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 117.31 0.555 . . . . 0.0 110.612 176.277 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 537' ' ' TYR . . . . . . . . . . . . . 76.0 m-85 -153.07 152.42 31.31 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.635 -178.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 538' ' ' THR . . . . . 0.734 ' OG1' ' HA ' ' A' ' 577' ' ' ILE . 30.7 m -134.89 102.38 5.22 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.403 174.031 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 539' ' ' VAL . . . . . 0.614 HG23 HG23 ' A' ' 573' ' ' ILE . 39.2 t -109.92 127.0 67.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 120.976 0.417 . . . . 0.0 111.694 -172.66 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 540' ' ' PHE . . . . . 0.623 ' HB3' HD11 ' A' ' 628' ' ' ILE . 87.9 m-85 -95.38 109.01 21.23 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 172.264 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 541' ' ' ALA . . . . . 0.462 ' HA ' HD21 ' A' ' 518' ' ' LEU . . . -96.01 111.23 55.53 Favored Pre-proline 0 C--N 1.322 -0.618 0 CA-C-N 116.628 -0.26 . . . . 0.0 111.193 -176.418 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 542' ' ' PRO . . . . . 0.6 ' HA ' HG13 ' A' ' 628' ' ' ILE . 18.5 Cg_endo -66.91 130.05 22.21 Favored 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 122.141 1.894 . . . . 0.0 110.967 175.251 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 17.4 p -96.4 -174.78 3.15 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.509 -0.769 . . . . 0.0 112.55 -171.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 544' ' ' ASN . . . . . 0.565 ' HA ' ' HE1' ' A' ' 517' ' ' MET . 8.5 t30 -49.76 -37.15 28.48 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 114.746 -1.115 . . . . 0.0 111.715 178.056 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 545' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -65.0 -28.62 69.63 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.976 -175.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 546' ' ' ALA . . . . . 0.588 ' HB1' HG22 ' A' ' 631' ' ' VAL . . . -79.08 -58.46 3.22 Favored 'General case' 0 CA--C 1.516 -0.348 0 CA-C-O 121.082 0.468 . . . . 0.0 111.616 -176.149 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 547' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -64.62 -29.85 70.86 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.727 -0.669 . . . . 0.0 111.548 -175.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 548' ' ' ARG . . . . . . . . . . . . . 47.3 ttp180 -66.66 -30.68 71.0 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.923 0.392 . . . . 0.0 110.46 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 549' ' ' ALA . . . . . . . . . . . . . . . -86.89 -10.57 53.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.461 -176.016 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 550' ' ' LEU . . . . . 0.466 ' HA ' ' HD3' ' A' ' 551' ' ' PRO . 88.2 mt -70.79 122.78 87.79 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 120.922 0.392 . . . . 0.0 110.978 -178.112 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 551' ' ' PRO . . . . . 0.466 ' HD3' ' HA ' ' A' ' 550' ' ' LEU . 16.5 Cg_exo -68.89 157.72 60.75 Favored 'Trans proline' 0 C--O 1.236 0.375 0 C-N-CA 123.327 2.685 . . . . 0.0 111.853 -178.294 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 552' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -44.17 -53.01 5.11 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 123.831 3.021 . . . . 0.0 113.225 -177.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 553' ' ' ARG . . . . . . . . . . . . . 23.2 mtm180 -63.2 -48.35 78.67 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 120.715 0.293 . . . . 0.0 111.513 -175.575 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -63.74 -52.77 58.99 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.736 -174.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 555' ' ' ARG . . . . . . . . . . . . . 19.6 ptt180 -66.34 -29.16 69.3 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.274 -177.474 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 29.2 t -75.6 -24.06 56.5 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.615 0.245 . . . . 0.0 110.834 -178.256 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 557' ' ' ARG . . . . . . . . . . . . . 12.3 tpp180 -82.94 -46.52 12.83 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.53 -0.304 . . . . 0.0 110.265 178.281 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 558' ' ' LEU . . . . . . . . . . . . . 51.2 tp -61.17 -41.56 97.01 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.768 179.223 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 559' ' ' LEU . . . . . 0.663 HD22 HD21 ' A' ' 565' ' ' LEU . 80.5 mt -91.83 6.35 46.45 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.195 0.522 . . . . 0.0 110.552 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 560' ' ' GLY . . . . . . . . . . . . . . . -96.72 -39.58 4.09 Favored Glycine 0 N--CA 1.444 -0.769 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.685 179.502 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 561' ' ' ASP . . . . . 0.473 ' CB ' ' HG2' ' A' ' 564' ' ' GLU . 6.1 m-20 -103.81 119.89 39.85 Favored 'General case' 0 N--CA 1.445 -0.708 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 177.139 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 562' ' ' ALA . . . . . . . . . . . . . . . -65.74 -28.84 69.34 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.986 0.422 . . . . 0.0 111.153 -176.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 563' ' ' LYS . . . . . . . . . . . . . 4.2 mptp? -69.6 -36.84 76.57 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.1 179.02 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 564' ' ' GLU . . . . . 0.473 ' HG2' ' CB ' ' A' ' 561' ' ' ASP . 8.7 mm-40 -62.96 -40.4 97.57 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 179.384 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 565' ' ' LEU . . . . . 0.663 HD21 HD22 ' A' ' 559' ' ' LEU . 48.3 mt -57.07 -50.2 73.5 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.72 176.129 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 566' ' ' ALA . . . . . . . . . . . . . . . -60.48 -53.97 51.19 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.588 179.224 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 567' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -58.95 -49.96 75.88 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.811 -0.631 . . . . 0.0 112.207 -177.24 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 568' ' ' ILE . . . . . . . . . . . . . 40.7 mm -63.99 -40.4 88.93 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 CA-C-O 120.577 0.227 . . . . 0.0 111.557 -178.503 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 569' ' ' LEU . . . . . 0.459 ' HB3' ' O ' ' A' ' 565' ' ' LEU . 0.1 OUTLIER -72.58 -29.2 63.32 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 122.058 -0.401 . . . . 0.0 110.204 -177.344 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 570' ' ' LYS . . . . . . . . . . . . . 25.2 mtpp -62.19 -29.08 70.12 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.091 0.472 . . . . 0.0 110.684 174.086 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 571' ' ' TYR . . . . . 0.521 ' HB2' ' NE2' ' A' ' 593' ' ' GLN . 55.2 t80 -75.46 -18.8 59.77 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.416 178.402 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 572' ' ' HIS . . . . . . . . . . . . . 64.7 m80 -87.64 -12.4 45.64 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.75 0.309 . . . . 0.0 111.331 -177.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 573' ' ' ILE . . . . . 0.614 HG23 HG23 ' A' ' 539' ' ' VAL . 28.7 mt -110.84 118.1 56.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 120.834 0.349 . . . . 0.0 111.18 -178.854 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 574' ' ' GLY . . . . . 0.43 ' HA2' ' HA ' ' A' ' 591' ' ' SER . . . -95.49 145.74 17.89 Favored Glycine 0 N--CA 1.446 -0.698 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 170.584 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 575' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -93.34 16.94 12.13 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 117.524 0.662 . . . . 0.0 111.119 -174.584 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 576' ' ' GLU . . . . . 0.506 ' HB2' HD23 ' A' ' 589' ' ' LEU . 48.8 mt-10 -137.55 124.08 20.88 Favored 'General case' 0 CA--C 1.512 -0.512 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 179.496 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 577' ' ' ILE . . . . . 0.734 ' HA ' ' OG1' ' A' ' 538' ' ' THR . 72.4 mt -67.43 117.74 9.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 O-C-N 123.612 0.57 . . . . 0.0 111.369 -173.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 578' ' ' LEU . . . . . 0.674 HD13 HG12 ' A' ' 583' ' ' ILE . 3.3 tm? -117.03 114.21 23.44 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.038 -0.983 . . . . 0.0 109.499 178.653 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 579' ' ' VAL . . . . . . . . . . . . . 29.4 m -108.59 163.4 6.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 177.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 580' ' ' SER . . . . . . . . . . . . . 23.6 t -59.39 -41.86 90.39 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.956 0.407 . . . . 0.0 110.857 -176.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 581' ' ' GLY . . . . . . . . . . . . . . . -77.57 19.79 3.79 Favored Glycine 0 CA--C 1.523 0.54 0 C-N-CA 120.777 -0.725 . . . . 0.0 113.152 -179.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . -142.35 16.54 2.5 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.473 178.547 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 583' ' ' ILE . . . . . 0.674 HG12 HD13 ' A' ' 578' ' ' LEU . 32.3 mt -85.33 -42.36 16.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.925 0.393 . . . . 0.0 110.95 179.601 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 584' ' ' GLY . . . . . . . . . . . . . . . 81.01 -87.71 1.36 Allowed Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.48 -0.867 . . . . 0.0 111.66 -178.171 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 585' ' ' ALA . . . . . . . . . . . . . . . -130.44 -66.7 0.76 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.003 0.43 . . . . 0.0 109.855 176.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 586' ' ' LEU . . . . . 0.809 ' HG ' ' HB2' ' A' ' 600' ' ' SER . 3.6 tt -142.21 134.56 27.83 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 174.871 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 587' ' ' VAL . . . . . . . . . . . . . 10.7 p -125.15 138.44 54.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-O 121.14 0.495 . . . . 0.0 110.955 -174.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 588' ' ' ARG . . . . . . . . . . . . . 95.2 mtt180 -99.35 101.75 13.14 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 178.564 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 589' ' ' LEU . . . . . 0.506 HD23 ' HB2' ' A' ' 576' ' ' GLU . 0.6 OUTLIER -109.05 127.04 53.77 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.008 -176.528 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 590' ' ' LYS . . . . . 0.433 ' HE3' ' OE2' ' A' ' 576' ' ' GLU . 22.5 pttp -86.21 145.0 27.16 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.107 0.479 . . . . 0.0 111.002 -176.67 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 591' ' ' SER . . . . . 0.43 ' HA ' ' HA2' ' A' ' 574' ' ' GLY . 79.4 p -95.79 177.84 5.64 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.296 -178.856 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 592' ' ' LEU . . . . . . . . . . . . . 49.1 mt -70.96 -13.87 62.16 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.906 0.384 . . . . 0.0 110.56 179.083 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 593' ' ' GLN . . . . . 0.521 ' NE2' ' HB2' ' A' ' 571' ' ' TYR . 9.4 tt0 -85.74 -29.55 23.8 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.046 -177.449 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 594' ' ' GLY . . . . . . . . . . . . . . . 121.0 -27.09 6.55 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.935 -0.65 . . . . 0.0 111.678 -177.34 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 595' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -73.78 166.04 24.04 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.013 0.435 . . . . 0.0 110.892 176.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 596' ' ' LYS . . . . . 0.498 ' O ' ' HD2' ' A' ' 596' ' ' LYS . 0.1 OUTLIER -105.32 141.75 36.29 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.045 -179.601 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 597' ' ' LEU . . . . . 0.451 HD23 ' O ' ' A' ' 571' ' ' TYR . 71.0 mt -92.24 120.27 32.64 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.448 -0.796 . . . . 0.0 108.935 172.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 598' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 -81.29 84.15 6.68 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.188 0.518 . . . . 0.0 109.799 -176.289 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 599' ' ' VAL . . . . . . . . . . . . . 42.1 t -98.07 133.77 38.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.086 -175.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 600' ' ' SER . . . . . 0.809 ' HB2' ' HG ' ' A' ' 586' ' ' LEU . 29.7 t -144.66 167.86 21.54 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 121.325 0.583 . . . . 0.0 110.569 -177.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 601' ' ' LEU . . . . . 0.443 HD13 HD13 ' A' ' 583' ' ' ILE . 31.3 tp -131.45 107.6 9.02 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 114.93 -1.032 . . . . 0.0 109.275 -178.345 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 602' ' ' LYS . . . . . . . . . . . . . 24.7 ttmm -119.0 113.76 21.48 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.217 -0.447 . . . . 0.0 109.85 -177.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 603' ' ' ASN . . . . . 0.448 ' O ' ' HB2' ' A' ' 604' ' ' ASN . 14.2 m120 59.48 32.88 22.0 Favored 'General case' 0 N--CA 1.466 0.338 0 O-C-N 123.43 0.456 . . . . 0.0 110.435 -177.87 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 604' ' ' ASN . . . . . 0.448 ' HB2' ' O ' ' A' ' 603' ' ' ASN . 11.2 m120 73.15 10.59 5.19 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 115.205 -0.907 . . . . 0.0 111.939 -179.013 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 605' ' ' VAL . . . . . . . . . . . . . 61.1 t -97.97 119.98 46.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 174.08 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 606' ' ' VAL . . . . . . . . . . . . . 19.7 t -81.0 136.67 22.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.727 -178.506 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 607' ' ' SER . . . . . . . . . . . . . 8.2 p -142.25 147.92 37.26 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.481 178.62 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 608' ' ' VAL . . . . . . . . . . . . . 7.0 p -131.56 117.38 35.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.122 177.455 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 609' ' ' ASN . . . . . 0.493 ' O ' ' HB2' ' A' ' 610' ' ' LYS . 88.6 m-20 61.35 31.58 19.23 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.676 -178.61 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 610' ' ' LYS . . . . . 0.493 ' HB2' ' O ' ' A' ' 609' ' ' ASN . 11.7 mmmm 79.58 -2.47 2.12 Favored 'General case' 0 N--CA 1.472 0.664 0 O-C-N 124.283 0.989 . . . . 0.0 111.725 -178.133 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 611' ' ' GLU . . . . . 0.479 ' HA ' ' HD3' ' A' ' 612' ' ' PRO . 4.4 mm-40 -93.42 125.81 52.68 Favored Pre-proline 0 C--N 1.33 -0.241 0 N-CA-C 109.654 -0.498 . . . . 0.0 109.654 177.269 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 612' ' ' PRO . . . . . 0.479 ' HD3' ' HA ' ' A' ' 611' ' ' GLU . 8.4 Cg_exo -72.31 144.57 41.58 Favored 'Trans proline' 0 N--CA 1.463 -0.295 0 C-N-CA 122.985 2.457 . . . . 0.0 112.982 -176.252 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 613' ' ' VAL . . . . . 0.419 HG11 ' HB3' ' A' ' 616' ' ' PRO . 98.7 t -86.17 125.97 40.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.61 175.318 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 614' ' ' ALA . . . . . 0.538 ' HB3' HG23 ' A' ' 629' ' ' THR . . . -80.75 -28.48 36.48 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.69 -0.687 . . . . 0.0 111.721 -174.368 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 615' ' ' GLU . . . . . 0.53 ' HB3' ' CG2' ' A' ' 627' ' ' VAL . 10.1 tp10 -161.46 93.97 1.39 Allowed Pre-proline 0 C--N 1.328 -0.363 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 -179.019 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 616' ' ' PRO . . . . . 0.419 ' HB3' HG11 ' A' ' 613' ' ' VAL . 65.4 Cg_endo -89.33 161.04 5.58 Favored 'Trans proline' 0 N--CA 1.46 -0.494 0 C-N-CA 123.353 2.702 . . . . 0.0 113.81 -177.209 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 77.05 32.7 0.47 Allowed 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 121.962 0.887 . . . . 0.0 110.343 164.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 618' ' ' ILE . . . . . 0.466 ' CG2' ' HB ' ' A' ' 625' ' ' VAL . 13.2 mt -75.81 111.28 12.04 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.909 0 CA-C-N 114.498 -1.228 . . . . 0.0 109.694 175.342 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 619' ' ' MET . . . . . 0.499 ' HA ' ' HE1' ' A' ' 619' ' ' MET . 9.5 mmt -74.86 122.65 23.7 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.809 -0.632 . . . . 0.0 112.114 -175.254 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 620' ' ' ALA . . . . . . . . . . . . . . . -122.47 161.05 24.29 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 172.432 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 621' ' ' THR . . . . . 0.602 HG22 ' HA ' ' A' ' 504' ' ' THR . 9.9 t -69.32 -30.13 68.11 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.587 -0.445 . . . . 0.0 111.823 -174.512 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 622' ' ' ASN . . . . . 0.605 ' HB3' ' HA ' ' A' ' 534' ' ' GLU . 29.3 p-10 -118.07 28.26 8.49 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 111.921 0.341 . . . . 0.0 111.921 -178.027 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 623' ' ' GLY . . . . . . . . . . . . . . . 155.68 -160.68 30.12 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.171 -1.014 . . . . 0.0 112.444 176.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 624' ' ' VAL . . . . . . . . . . . . . 8.8 p -128.66 157.44 41.3 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 N-CA-C 110.04 -0.356 . . . . 0.0 110.04 179.001 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 625' ' ' VAL . . . . . 0.649 HG21 HG21 ' A' ' 505' ' ' VAL . 42.8 t -125.02 136.18 61.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 116.246 -0.434 . . . . 0.0 109.932 -179.222 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 626' ' ' HIS . . . . . . . . . . . . . 95.6 m-70 -122.57 112.07 17.57 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-O 121.067 0.461 . . . . 0.0 109.982 175.558 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 627' ' ' VAL . . . . . 0.779 HG22 ' HZ ' ' A' ' 515' ' ' PHE . 67.7 t -67.45 129.01 31.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.061 179.402 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 628' ' ' ILE . . . . . 0.623 HD11 ' HB3' ' A' ' 540' ' ' PHE . 9.2 pt -126.02 146.11 32.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.158 0.504 . . . . 0.0 110.932 175.398 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 629' ' ' THR . . . . . 0.538 HG23 ' HB3' ' A' ' 614' ' ' ALA . 35.3 p -95.22 -1.55 51.4 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.042 179.764 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 630' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -125.29 163.07 23.34 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.846 -0.615 . . . . 0.0 109.691 -175.693 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 631' ' ' VAL . . . . . 0.588 HG22 ' HB1' ' A' ' 546' ' ' ALA . 58.5 t -99.3 123.23 51.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 177.548 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 632' ' ' LEU . . . . . . . . . . . . . 80.4 mt -80.88 116.3 20.79 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.144 0.497 . . . . 0.0 111.338 -177.4 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 633' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 -120.15 129.92 25.1 Favored Pre-proline 0 C--N 1.321 -0.651 0 CA-C-N 115.648 -0.706 . . . . 0.0 109.1 176.461 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 634' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo . . . . . 0 C--O 1.249 1.047 0 C-N-CA 123.296 2.664 . . . . 0.0 112.826 -179.543 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.634 0 N-CA-C 112.029 -0.428 . . . . 0.0 112.029 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 504' ' ' THR . . . . . 0.45 ' HA ' HG23 ' A' ' 621' ' ' THR . 41.1 p -78.92 170.46 16.65 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 110.446 -0.205 . . . . 0.0 110.446 178.589 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 505' ' ' VAL . . . . . 0.718 ' O ' ' HG ' ' A' ' 509' ' ' LEU . 10.7 m -60.54 -34.09 56.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 175.061 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 506' ' ' MET . . . . . 0.429 ' HE3' HG23 ' A' ' 528' ' ' THR . 93.5 mmm -65.03 -34.78 79.25 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-O 120.809 0.338 . . . . 0.0 110.357 177.354 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 507' ' ' ASP . . . . . 0.538 ' HA ' ' HE3' ' A' ' 510' ' ' LYS . 29.9 t70 -70.29 -44.06 69.14 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.183 178.298 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 508' ' ' VAL . . . . . 0.437 HG22 ' O ' ' A' ' 504' ' ' THR . 67.7 t -59.24 -42.94 88.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.886 177.595 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 509' ' ' LEU . . . . . 0.718 ' HG ' ' O ' ' A' ' 505' ' ' VAL . 71.7 mt -68.51 -32.0 71.65 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.512 -178.199 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 510' ' ' LYS . . . . . 0.538 ' HE3' ' HA ' ' A' ' 507' ' ' ASP . 22.9 pttp -88.11 -13.54 41.08 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.184 0.516 . . . . 0.0 110.048 -178.309 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 511' ' ' GLY . . . . . . . . . . . . . . . -84.51 -8.65 82.85 Favored Glycine 0 N--CA 1.442 -0.912 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.562 174.31 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 512' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -116.24 135.72 53.65 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.604 0.24 . . . . 0.0 110.477 178.216 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -64.39 -36.89 85.63 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.844 -176.052 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 514' ' ' ARG . . . . . 0.7 ' HD3' HG21 ' A' ' 543' ' ' THR . 74.8 mtt180 -73.45 -46.94 45.32 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.305 0.574 . . . . 0.0 110.245 -176.731 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 515' ' ' PHE . . . . . 0.964 ' HZ ' HG21 ' A' ' 627' ' ' VAL . 13.9 m-30 -67.42 -18.11 64.98 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.99 -178.546 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 66.2 m -57.43 -36.86 71.9 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.362 -0.381 . . . . 0.0 112.018 -177.593 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 517' ' ' MET . . . . . 0.522 ' HE1' ' HA ' ' A' ' 544' ' ' ASN . 44.7 mtm -72.32 -33.25 67.21 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.752 -0.379 . . . . 0.0 110.177 -179.454 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 518' ' ' LEU . . . . . . . . . . . . . 66.1 tp -64.06 -38.72 92.11 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.088 -0.505 . . . . 0.0 109.908 173.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 519' ' ' VAL . . . . . 0.423 HG22 ' O ' ' A' ' 515' ' ' PHE . 56.7 t -57.33 -36.12 51.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 121.156 0.503 . . . . 0.0 109.875 174.399 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 520' ' ' ALA . . . . . . . . . . . . . . . -70.29 -38.84 75.1 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.326 179.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 521' ' ' ALA . . . . . . . . . . . . . . . -65.79 -48.87 70.32 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.508 176.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 522' ' ' ILE . . . . . . . . . . . . . 94.7 mt -57.06 -41.42 77.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.828 -0.623 . . . . 0.0 110.872 176.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 523' ' ' GLN . . . . . . . . . . . . . 33.8 tt0 -64.95 -43.48 92.58 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.2 177.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 20.3 t -70.74 -31.36 68.16 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.538 -176.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 525' ' ' ALA . . . . . 0.514 ' HB2' ' HB3' ' A' ' 565' ' ' LEU . . . -88.94 -27.1 21.16 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.726 0.298 . . . . 0.0 111.473 -179.242 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 526' ' ' GLY . . . . . . . . . . . . . . . 87.13 49.65 3.93 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.867 -0.683 . . . . 0.0 112.391 178.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 527' ' ' LEU . . . . . 0.407 ' HA ' HD11 ' A' ' 527' ' ' LEU . 4.3 mm? -111.5 8.78 21.2 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.151 0.5 . . . . 0.0 110.691 178.042 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 528' ' ' THR . . . . . 0.429 HG23 ' HE3' ' A' ' 506' ' ' MET . 5.9 m -60.42 -33.93 73.22 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.464 -177.612 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 529' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -61.29 -33.64 73.89 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.114 -178.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 530' ' ' THR . . . . . . . . . . . . . 30.4 m -70.29 -48.32 57.23 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.998 -0.547 . . . . 0.0 111.279 -176.315 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 531' ' ' LEU . . . . . 0.524 ' HB3' ' CG2' ' A' ' 505' ' ' VAL . 31.4 mt -85.96 6.21 29.68 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.323 0.582 . . . . 0.0 111.403 -175.674 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 532' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -83.95 -37.76 21.88 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.091 179.356 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 533' ' ' ARG . . . . . . . . . . . . . 76.6 mtm180 -79.44 131.54 36.11 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.862 -178.475 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 534' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -75.03 127.54 33.46 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.524 179.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 535' ' ' GLY . . . . . . . . . . . . . . . -174.26 -132.22 1.52 Allowed Glycine 0 CA--C 1.502 -0.721 0 N-CA-C 110.265 -1.134 . . . . 0.0 110.265 -179.574 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 536' ' ' VAL . . . . . . . . . . . . . 33.9 m -124.36 129.25 74.0 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-O 121.261 0.553 . . . . 0.0 110.719 177.584 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 537' ' ' TYR . . . . . . . . . . . . . 80.4 m-85 -154.86 150.35 27.38 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.161 179.266 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 538' ' ' THR . . . . . 0.709 ' OG1' ' HA ' ' A' ' 577' ' ' ILE . 34.1 m -120.26 102.2 8.33 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 173.723 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 539' ' ' VAL . . . . . 0.483 HG21 HG23 ' A' ' 573' ' ' ILE . 44.2 t -105.11 123.87 59.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.498 -173.035 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 540' ' ' PHE . . . . . 0.574 ' HB3' HD11 ' A' ' 628' ' ' ILE . 93.7 m-85 -95.94 112.86 24.47 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 174.341 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -101.72 110.66 62.56 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-O 120.935 0.398 . . . . 0.0 110.809 -176.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 542' ' ' PRO . . . . . 0.632 ' HA ' HG13 ' A' ' 628' ' ' ILE . 16.9 Cg_exo -69.24 138.98 40.84 Favored 'Trans proline' 0 N--CA 1.461 -0.393 0 C-N-CA 123.11 2.54 . . . . 0.0 112.118 178.332 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 543' ' ' THR . . . . . 0.7 HG21 ' HD3' ' A' ' 514' ' ' ARG . 36.8 p -82.53 179.9 7.64 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.239 -178.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 544' ' ' ASN . . . . . 0.522 ' HA ' ' HE1' ' A' ' 517' ' ' MET . 14.9 m120 -56.65 -34.84 67.72 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.885 0.374 . . . . 0.0 111.181 179.522 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 545' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -73.07 -23.38 60.54 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.759 -174.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -69.16 -51.32 39.34 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-O 121.283 0.563 . . . . 0.0 110.709 179.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 547' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -71.65 -20.86 61.9 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.601 -179.369 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 548' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.62 -29.06 62.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.989 -0.551 . . . . 0.0 109.677 176.353 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 549' ' ' ALA . . . . . . . . . . . . . . . -89.32 2.91 53.71 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.368 -175.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 550' ' ' LEU . . . . . 0.438 ' HA ' ' HD3' ' A' ' 551' ' ' PRO . 75.3 mt -72.83 137.24 79.84 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.561 178.641 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 551' ' ' PRO . . . . . 0.596 ' HD2' ' HB2' ' A' ' 554' ' ' GLU . 17.5 Cg_exo -66.55 150.63 83.94 Favored 'Trans proline' 0 N--CA 1.461 -0.392 0 C-N-CA 122.819 2.346 . . . . 0.0 112.108 -177.364 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 552' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_exo -53.4 -28.28 43.35 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 123.247 2.632 . . . . 0.0 112.98 -179.236 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 553' ' ' ARG . . . . . . . . . . . . . 23.0 mmt180 -81.11 -54.29 5.66 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.061 0.458 . . . . 0.0 110.041 -179.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 554' ' ' GLU . . . . . 0.596 ' HB2' ' HD2' ' A' ' 551' ' ' PRO . 3.3 mp0 -62.88 -37.64 87.7 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.52 -0.764 . . . . 0.0 112.201 -177.017 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 555' ' ' ARG . . . . . . . . . . . . . 36.5 ptt180 -63.79 -35.11 79.52 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.793 -0.363 . . . . 0.0 110.611 178.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 34.7 m -73.88 -32.05 63.43 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.224 0.535 . . . . 0.0 110.197 179.345 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 557' ' ' ARG . . . . . . . . . . . . . 63.5 mtp180 -68.05 -58.63 4.18 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.624 175.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 558' ' ' LEU . . . . . 0.587 ' O ' ' HG ' ' A' ' 565' ' ' LEU . 27.3 tp -62.39 -42.47 99.45 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.285 -172.729 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 559' ' ' LEU . . . . . . . . . . . . . 80.5 mt -88.21 13.0 12.34 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.972 0.415 . . . . 0.0 111.105 -178.152 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 560' ' ' GLY . . . . . . . . . . . . . . . -122.35 -41.2 0.48 Allowed Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.911 -0.662 . . . . 0.0 112.188 178.283 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 561' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -99.52 116.75 32.37 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.924 0.392 . . . . 0.0 110.428 -179.395 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 562' ' ' ALA . . . . . . . . . . . . . . . -68.45 -21.55 64.64 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.788 -175.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 563' ' ' LYS . . . . . . . . . . . . . 59.6 tttm -78.78 -48.33 15.04 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 110.22 -0.289 . . . . 0.0 110.22 -178.599 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 564' ' ' GLU . . . . . 0.499 ' O ' HG12 ' A' ' 568' ' ' ILE . 40.7 mt-10 -57.65 -38.1 74.47 Favored 'General case' 0 C--N 1.332 -0.169 0 O-C-N 123.248 0.343 . . . . 0.0 110.107 177.233 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 565' ' ' LEU . . . . . 0.587 ' HG ' ' O ' ' A' ' 558' ' ' LEU . 3.7 mt -55.06 -54.16 46.64 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.63 174.512 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 566' ' ' ALA . . . . . . . . . . . . . . . -62.94 -37.76 88.34 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.475 -178.515 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 567' ' ' ASN . . . . . . . . . . . . . 12.1 m120 -67.41 -41.69 84.47 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.171 -178.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 568' ' ' ILE . . . . . 0.499 HG12 ' O ' ' A' ' 564' ' ' GLU . 48.8 mm -69.29 -34.3 62.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.903 0.382 . . . . 0.0 110.736 178.596 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 569' ' ' LEU . . . . . 0.549 ' HG ' ' O ' ' A' ' 565' ' ' LEU . 77.1 mt -64.72 -36.7 85.14 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.814 0.34 . . . . 0.0 110.881 177.037 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 570' ' ' LYS . . . . . 0.771 ' HE3' ' HA ' ' A' ' 593' ' ' GLN . 26.5 mtpp -63.93 -13.62 47.13 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.017 177.451 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 571' ' ' TYR . . . . . . . . . . . . . 7.5 t80 -97.38 -16.0 20.43 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.069 -177.462 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 572' ' ' HIS . . . . . . . . . . . . . 59.6 m80 -95.31 -12.25 26.46 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.958 0.409 . . . . 0.0 111.274 -178.488 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 573' ' ' ILE . . . . . 0.483 HD11 HD21 ' A' ' 531' ' ' LEU . 21.3 mt -108.65 123.01 64.07 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.204 178.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 574' ' ' GLY . . . . . 0.535 ' HA2' ' HA ' ' A' ' 591' ' ' SER . . . -92.92 151.2 20.34 Favored Glycine 0 N--CA 1.447 -0.591 0 N-CA-C 111.505 -0.638 . . . . 0.0 111.505 175.137 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 575' ' ' ASP . . . . . 0.485 ' HB3' ' HE3' ' A' ' 590' ' ' LYS . 19.3 t70 -70.35 -21.18 62.91 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 112.879 0.696 . . . . 0.0 112.879 -171.07 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 576' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -149.67 153.06 36.4 Favored 'General case' 0 N--CA 1.439 -1.025 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 -174.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 577' ' ' ILE . . . . . 0.709 ' HA ' ' OG1' ' A' ' 538' ' ' THR . 77.3 mt -72.95 126.44 33.61 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 O-C-N 124.028 0.83 . . . . 0.0 112.14 -171.399 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 578' ' ' LEU . . . . . 0.563 HD23 ' HB ' ' A' ' 587' ' ' VAL . 41.9 tp -126.84 105.26 8.53 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 114.998 -1.001 . . . . 0.0 109.146 173.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 579' ' ' VAL . . . . . 0.49 ' CG1' ' H ' ' A' ' 581' ' ' GLY . 1.0 OUTLIER -102.08 167.57 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.106 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.11 -177.441 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 580' ' ' SER . . . . . 0.44 ' N ' HG13 ' A' ' 579' ' ' VAL . 20.2 m -57.82 -25.93 61.3 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.364 -0.835 . . . . 0.0 111.67 -175.164 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 581' ' ' GLY . . . . . 0.49 ' H ' ' CG1' ' A' ' 579' ' ' VAL . . . -87.29 -2.84 82.59 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.523 -176.799 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . -110.69 -18.59 8.34 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.37 -179.195 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 583' ' ' ILE . . . . . 0.405 HG13 ' O ' ' A' ' 579' ' ' VAL . 51.2 mt -70.96 -63.38 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.726 0.298 . . . . 0.0 111.2 -177.512 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 584' ' ' GLY . . . . . . . . . . . . . . . 81.53 -63.23 4.38 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.283 -178.175 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 585' ' ' ALA . . . . . . . . . . . . . . . -134.71 -71.01 0.49 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.781 0.324 . . . . 0.0 110.286 178.143 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 586' ' ' LEU . . . . . 0.553 HD12 ' HB3' ' A' ' 600' ' ' SER . 45.5 tp -147.27 132.68 18.59 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.44 -179.448 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 587' ' ' VAL . . . . . 0.563 ' HB ' HD23 ' A' ' 578' ' ' LEU . 57.5 t -137.93 129.17 38.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 116.022 -0.536 . . . . 0.0 109.661 176.655 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 588' ' ' ARG . . . . . 0.409 ' HG2' ' OE2' ' A' ' 598' ' ' GLU . 55.2 mtm180 -85.74 109.84 18.92 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.05 -179.251 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 589' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -95.79 124.88 40.0 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.812 -174.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 590' ' ' LYS . . . . . 0.485 ' HE3' ' HB3' ' A' ' 575' ' ' ASP . 47.4 pttt -77.96 138.93 39.12 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.11 0.481 . . . . 0.0 110.125 177.365 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 591' ' ' SER . . . . . 0.535 ' HA ' ' HA2' ' A' ' 574' ' ' GLY . 80.2 p -104.27 166.24 10.53 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.338 -177.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 592' ' ' LEU . . . . . . . . . . . . . 10.1 mp -68.73 -7.81 37.06 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.246 0.461 . . . . 0.0 112.246 178.173 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 593' ' ' GLN . . . . . 0.771 ' HA ' ' HE3' ' A' ' 570' ' ' LYS . 5.4 tt0 -80.61 -29.03 36.89 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.206 0.527 . . . . 0.0 109.661 173.455 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 594' ' ' GLY . . . . . . . . . . . . . . . 106.55 -13.56 42.86 Favored Glycine 0 N--CA 1.441 -0.993 0 N-CA-C 110.717 -0.953 . . . . 0.0 110.717 -172.327 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 595' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -81.36 -174.43 4.92 Favored 'General case' 0 C--O 1.237 0.396 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 179.304 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 596' ' ' LYS . . . . . . . . . . . . . 59.0 pttt -115.33 135.18 54.41 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.175 0.512 . . . . 0.0 111.422 -171.521 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 597' ' ' LEU . . . . . . . . . . . . . 57.6 mt -106.04 114.46 28.61 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 168.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 598' ' ' GLU . . . . . 0.409 ' OE2' ' HG2' ' A' ' 588' ' ' ARG . 1.0 OUTLIER -83.4 92.07 7.48 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 -179.929 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 599' ' ' VAL . . . . . 0.522 ' HA ' ' O ' ' A' ' 607' ' ' SER . 43.2 t -98.4 118.78 45.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 121.245 0.545 . . . . 0.0 110.411 -177.175 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 600' ' ' SER . . . . . 0.553 ' HB3' HD12 ' A' ' 586' ' ' LEU . 2.7 p -129.43 151.77 49.7 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.059 -178.097 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 601' ' ' LEU . . . . . . . . . . . . . 47.6 tp -113.04 108.03 16.77 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.374 179.418 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 602' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -131.12 127.27 37.74 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.361 -177.336 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 603' ' ' ASN . . . . . . . . . . . . . 66.2 t30 62.49 27.45 16.28 Favored 'General case' 0 N--CA 1.464 0.273 0 O-C-N 123.652 0.595 . . . . 0.0 109.946 -178.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 604' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 69.19 12.72 8.53 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 115.137 -0.938 . . . . 0.0 111.513 -177.57 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 605' ' ' VAL . . . . . . . . . . . . . 48.6 t -110.85 123.33 66.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 176.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 606' ' ' VAL . . . . . 0.429 ' HB ' ' HB ' ' A' ' 613' ' ' VAL . 42.0 t -72.52 148.33 9.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.25 -179.8 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 607' ' ' SER . . . . . 0.522 ' O ' ' HA ' ' A' ' 599' ' ' VAL . 4.5 p -141.52 140.62 33.5 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.221 -0.445 . . . . 0.0 109.983 179.789 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 608' ' ' VAL . . . . . . . . . . . . . 3.8 p -126.13 110.36 23.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-O 121.059 0.456 . . . . 0.0 110.315 179.025 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 609' ' ' ASN . . . . . 0.463 ' O ' ' HB3' ' A' ' 610' ' ' LYS . 92.9 m-20 55.48 54.07 8.97 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.87 -179.64 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 610' ' ' LYS . . . . . 0.463 ' HB3' ' O ' ' A' ' 609' ' ' ASN . 61.8 tttp 77.59 -27.32 0.17 Allowed 'General case' 0 N--CA 1.469 0.475 0 CA-C-N 115.525 -0.762 . . . . 0.0 111.721 178.77 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 611' ' ' GLU . . . . . 0.532 ' HB3' ' ND2' ' A' ' 630' ' ' ASN . 6.0 mm-40 -80.35 123.42 83.05 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 120.646 0.26 . . . . 0.0 110.978 -178.482 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 612' ' ' PRO . . . . . 0.481 ' HD3' ' HA ' ' A' ' 611' ' ' GLU . 7.9 Cg_exo -72.75 145.05 40.39 Favored 'Trans proline' 0 CA--C 1.531 0.367 0 C-N-CA 123.0 2.467 . . . . 0.0 113.11 -178.73 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 613' ' ' VAL . . . . . 0.429 ' HB ' ' HB ' ' A' ' 606' ' ' VAL . 70.7 t -91.44 139.23 18.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.951 176.631 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 614' ' ' ALA . . . . . 0.538 ' HB1' HG23 ' A' ' 629' ' ' THR . . . -86.13 -36.21 19.71 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.125 -0.489 . . . . 0.0 112.063 -175.787 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 615' ' ' GLU . . . . . . . . . . . . . 20.4 tp10 -157.78 99.74 1.84 Allowed Pre-proline 0 C--N 1.327 -0.401 0 CA-C-O 121.046 0.45 . . . . 0.0 110.306 -176.593 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 616' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -90.13 168.87 4.36 Favored 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 123.326 2.684 . . . . 0.0 113.844 -178.318 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 77.29 32.74 0.44 Allowed 'General case' 0 CA--C 1.508 -0.657 0 CA-C-O 122.073 0.94 . . . . 0.0 111.025 163.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 618' ' ' ILE . . . . . 0.538 ' HB ' ' O ' ' A' ' 625' ' ' VAL . 18.1 mt -83.3 98.98 5.55 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.147 0 CA-C-N 114.149 -1.387 . . . . 0.0 109.29 174.198 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 619' ' ' MET . . . . . 0.401 ' HA ' ' CE ' ' A' ' 619' ' ' MET . 0.0 OUTLIER -77.96 130.08 36.1 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.777 -174.965 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 620' ' ' ALA . . . . . . . . . . . . . . . -130.76 177.04 7.71 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.524 173.599 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 621' ' ' THR . . . . . 0.45 HG23 ' HA ' ' A' ' 504' ' ' THR . 10.7 t -81.07 -14.58 57.68 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.44 -0.504 . . . . 0.0 111.59 -177.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 622' ' ' ASN . . . . . 0.468 ' HB2' HG13 ' A' ' 505' ' ' VAL . 7.5 m120 -102.69 -0.34 31.89 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.697 0.284 . . . . 0.0 110.643 179.311 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 623' ' ' GLY . . . . . 0.592 ' HA2' HD12 ' A' ' 577' ' ' ILE . . . 145.62 -140.12 8.75 Favored Glycine 0 N--CA 1.445 -0.76 0 C-N-CA 120.379 -0.915 . . . . 0.0 112.596 180.0 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 624' ' ' VAL . . . . . . . . . . . . . 4.8 p -126.45 156.02 36.97 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-O 120.898 0.38 . . . . 0.0 109.981 179.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 625' ' ' VAL . . . . . 0.538 ' O ' ' HB ' ' A' ' 618' ' ' ILE . 61.4 t -125.55 136.98 59.14 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.534 179.803 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 626' ' ' HIS . . . . . . . . . . . . . 94.3 m-70 -119.2 115.9 25.18 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-O 120.866 0.365 . . . . 0.0 110.052 177.242 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 627' ' ' VAL . . . . . 0.964 HG21 ' HZ ' ' A' ' 515' ' ' PHE . 38.6 t -70.18 124.95 27.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.334 177.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 628' ' ' ILE . . . . . 0.632 HG13 ' HA ' ' A' ' 542' ' ' PRO . 3.8 pt -123.97 145.03 31.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-O 121.368 0.604 . . . . 0.0 111.3 178.358 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 629' ' ' THR . . . . . 0.661 ' HA ' ' HG1' ' A' ' 543' ' ' THR . 22.7 p -94.11 7.48 45.03 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.788 0.804 . . . . 0.0 109.836 179.782 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 630' ' ' ASN . . . . . 0.532 ' ND2' ' HB3' ' A' ' 611' ' ' GLU . 6.1 p30 -141.19 166.05 25.84 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 114.33 -1.305 . . . . 0.0 109.52 -177.164 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 631' ' ' VAL . . . . . 0.422 HG13 HD21 ' A' ' 550' ' ' LEU . 2.7 p -125.91 123.53 64.34 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.982 0 N-CA-C 110.26 -0.274 . . . . 0.0 110.26 -179.643 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 632' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -63.19 120.27 11.18 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-O 121.085 0.469 . . . . 0.0 111.092 -177.024 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 633' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -126.96 110.45 21.94 Favored Pre-proline 0 C--N 1.319 -0.743 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 178.188 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 634' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo . . . . . 0 C--O 1.249 1.05 0 C-N-CA 123.013 2.475 . . . . 0.0 111.872 -178.7 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.595 0 CA-C-O 121.068 0.26 . . . . 0.0 112.933 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 65.6 p -87.52 -176.04 5.44 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.728 0.299 . . . . 0.0 111.165 -176.205 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 505' ' ' VAL . . . . . 0.607 ' O ' ' HG ' ' A' ' 509' ' ' LEU . 21.4 t -54.16 -41.63 52.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.388 175.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 506' ' ' MET . . . . . 0.495 ' HE1' HD13 ' A' ' 531' ' ' LEU . 4.1 mmt -55.11 -43.07 73.7 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.538 179.013 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 507' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -61.68 -39.68 92.27 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.996 0.427 . . . . 0.0 111.022 179.395 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 508' ' ' VAL . . . . . . . . . . . . . 43.2 t -65.53 -46.38 89.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.512 179.074 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 509' ' ' LEU . . . . . 0.607 ' HG ' ' O ' ' A' ' 505' ' ' VAL . 39.0 mt -68.92 -20.8 64.24 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.482 -175.537 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -89.35 -15.99 32.06 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.329 -178.067 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 511' ' ' GLY . . . . . . . . . . . . . . . -82.07 -9.75 84.8 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.751 -0.738 . . . . 0.0 111.445 177.365 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 512' ' ' ASP . . . . . 0.478 ' O ' ' HB2' ' A' ' 516' ' ' SER . 28.1 t70 -120.3 146.99 45.57 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.521 -0.34 . . . . 0.0 110.872 179.359 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -75.52 -32.97 60.69 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.831 0.348 . . . . 0.0 111.434 -178.36 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 514' ' ' ARG . . . . . 0.462 ' HD3' ' HB ' ' A' ' 543' ' ' THR . 78.7 mtt180 -74.78 -49.39 21.03 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.128 0.49 . . . . 0.0 109.711 -176.749 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 515' ' ' PHE . . . . . . . . . . . . . 15.2 m-30 -65.67 -26.0 67.59 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.809 178.684 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 516' ' ' SER . . . . . 0.478 ' HB2' ' O ' ' A' ' 512' ' ' ASP . 15.9 t -65.34 -26.53 68.07 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.111 -179.219 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 517' ' ' MET . . . . . 0.546 ' HE2' ' HA ' ' A' ' 544' ' ' ASN . 33.9 mtm -72.02 -35.21 69.34 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 176.018 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 518' ' ' LEU . . . . . . . . . . . . . 61.4 tp -64.68 -39.13 93.14 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.716 173.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 519' ' ' VAL . . . . . . . . . . . . . 86.0 t -55.06 -36.85 40.43 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.147 0 CA-C-O 121.163 0.506 . . . . 0.0 110.277 174.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 520' ' ' ALA . . . . . . . . . . . . . . . -70.99 -42.82 69.17 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.77 -179.423 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 521' ' ' ALA . . . . . . . . . . . . . . . -64.49 -48.65 74.42 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.623 177.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 522' ' ' ILE . . . . . 0.588 HG21 ' HB2' ' A' ' 527' ' ' LEU . 88.6 mt -59.48 -38.85 77.31 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.923 178.694 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 523' ' ' GLN . . . . . 0.416 HE21 ' HB3' ' A' ' 523' ' ' GLN . 0.9 OUTLIER -64.71 -44.22 90.94 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.343 177.417 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 13.6 t -68.69 -35.87 77.76 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.749 -178.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 525' ' ' ALA . . . . . 0.413 ' HB3' ' HB2' ' A' ' 566' ' ' ALA . . . -73.85 -28.05 61.4 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.849 0.357 . . . . 0.0 111.354 179.344 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 526' ' ' GLY . . . . . . . . . . . . . . . 90.18 48.54 3.52 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.385 179.129 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 527' ' ' LEU . . . . . 0.588 ' HB2' HG21 ' A' ' 522' ' ' ILE . 93.1 mt -124.32 26.35 7.41 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.06 0.457 . . . . 0.0 110.233 178.578 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 528' ' ' THR . . . . . . . . . . . . . 24.5 m -74.86 -36.47 62.32 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.206 -175.37 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 529' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -57.82 -36.25 71.99 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.685 -179.511 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 530' ' ' THR . . . . . . . . . . . . . 4.0 m -58.95 -43.13 91.2 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.653 -176.439 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 531' ' ' LEU . . . . . 0.495 HD13 ' HE1' ' A' ' 506' ' ' MET . 59.1 mt -94.77 14.03 22.65 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.342 -175.582 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 532' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -90.98 -49.47 6.4 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.788 -178.028 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 533' ' ' ARG . . . . . 0.555 ' HG2' ' OE1' ' A' ' 534' ' ' GLU . 18.6 ttp180 -89.87 172.55 8.81 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 -178.662 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 534' ' ' GLU . . . . . 0.574 ' HA ' ' CB ' ' A' ' 622' ' ' ASN . 1.6 pm0 -90.56 -179.18 5.5 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-O 121.446 0.641 . . . . 0.0 111.634 -179.684 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 535' ' ' GLY . . . . . . . . . . . . . . . 142.66 -145.17 15.02 Favored Glycine 0 N--CA 1.446 -0.665 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -172.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 536' ' ' VAL . . . . . 0.459 ' HB ' HG13 ' A' ' 577' ' ' ILE . 29.1 m -127.63 130.64 70.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 117.774 0.787 . . . . 0.0 110.487 174.074 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 537' ' ' TYR . . . . . . . . . . . . . 93.2 m-85 -148.47 148.31 30.11 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.84 -179.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 538' ' ' THR . . . . . 0.764 ' OG1' ' HA ' ' A' ' 577' ' ' ILE . 37.0 m -127.6 102.01 6.65 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 174.182 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 539' ' ' VAL . . . . . 0.505 HG22 HG23 ' A' ' 573' ' ' ILE . 40.3 t -108.93 131.13 60.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.203 -173.449 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 540' ' ' PHE . . . . . 0.551 ' HB3' HD11 ' A' ' 628' ' ' ILE . 92.9 m-85 -101.48 109.98 21.9 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.376 174.685 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -96.02 115.48 65.59 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.498 -178.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 542' ' ' PRO . . . . . 0.559 ' HA ' HG13 ' A' ' 628' ' ' ILE . 6.7 Cg_exo -73.79 135.18 21.15 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 122.872 2.382 . . . . 0.0 111.619 178.176 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 543' ' ' THR . . . . . 0.462 ' HB ' ' HD3' ' A' ' 514' ' ' ARG . 34.4 p -75.98 -178.16 4.23 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.06 -179.092 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 544' ' ' ASN . . . . . 0.546 ' HA ' ' HE2' ' A' ' 517' ' ' MET . 26.0 t-20 -67.27 -32.88 74.18 Favored 'General case' 0 CA--C 1.517 -0.308 0 N-CA-C 110.351 -0.24 . . . . 0.0 110.351 -177.574 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 545' ' ' GLU . . . . . 0.444 ' CD ' ' H ' ' A' ' 545' ' ' GLU . 1.6 mp0 -59.77 -35.43 74.6 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.246 178.205 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 546' ' ' ALA . . . . . 0.608 ' HB2' HG21 ' A' ' 631' ' ' VAL . . . -62.06 -47.51 84.35 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-O 121.275 0.56 . . . . 0.0 110.724 179.347 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 547' ' ' PHE . . . . . 0.626 ' HA ' HD23 ' A' ' 550' ' ' LEU . 94.2 m-85 -78.28 -21.95 49.02 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.797 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 548' ' ' ARG . . . . . . . . . . . . . 20.6 tpp180 -72.61 -35.04 67.76 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.963 177.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 549' ' ' ALA . . . . . . . . . . . . . . . -74.24 -16.08 60.97 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.278 -179.563 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 550' ' ' LEU . . . . . 0.904 HD13 ' HB3' ' A' ' 555' ' ' ARG . 0.2 OUTLIER -98.55 130.5 27.88 Favored Pre-proline 0 N--CA 1.445 -0.712 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 -179.298 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 551' ' ' PRO . . . . . 0.585 ' HD2' ' HB2' ' A' ' 554' ' ' GLU . 5.0 Cg_exo -77.26 160.52 32.67 Favored 'Trans proline' 0 CA--C 1.528 0.212 0 C-N-CA 123.705 2.937 . . . . 0.0 113.488 -169.145 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 552' ' ' PRO . . . . . 0.704 ' HA ' ' HG2' ' A' ' 555' ' ' ARG . 15.0 Cg_endo -58.88 -35.64 98.26 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 123.088 2.525 . . . . 0.0 112.21 176.453 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 553' ' ' ARG . . . . . . . . . . . . . 25.2 tpp180 -61.56 -47.39 85.73 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.383 179.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 554' ' ' GLU . . . . . 0.585 ' HB2' ' HD2' ' A' ' 551' ' ' PRO . 18.9 mm-40 -73.76 -44.96 54.66 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.314 -178.752 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 555' ' ' ARG . . . . . 0.904 ' HB3' HD13 ' A' ' 550' ' ' LEU . 14.4 ptp180 -59.06 -41.31 87.64 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 120.711 -0.396 . . . . 0.0 110.798 -179.173 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 13.1 t -65.02 -36.61 84.96 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.903 0.382 . . . . 0.0 110.457 -178.248 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 557' ' ' ARG . . . . . . . . . . . . . 16.3 mmm180 -61.34 -46.26 90.96 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.883 176.143 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 558' ' ' LEU . . . . . . . . . . . . . 51.7 tp -70.85 -56.35 6.49 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.188 -0.914 . . . . 0.0 111.586 -177.29 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 559' ' ' LEU . . . . . 0.706 ' HG ' ' O ' ' A' ' 555' ' ' ARG . 3.9 pp -73.77 -8.6 56.65 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 120.951 -0.3 . . . . 0.0 111.452 -174.662 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 560' ' ' GLY . . . . . . . . . . . . . . . -66.87 -34.46 87.24 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.958 -0.639 . . . . 0.0 111.605 175.283 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 561' ' ' ASP . . . . . 0.473 ' OD2' ' HB3' ' A' ' 563' ' ' LYS . 14.7 t70 -111.59 121.56 45.47 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.829 0.347 . . . . 0.0 110.673 -179.55 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 562' ' ' ALA . . . . . . . . . . . . . . . -65.45 -28.87 69.54 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.161 -178.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 563' ' ' LYS . . . . . 0.473 ' HB3' ' OD2' ' A' ' 561' ' ' ASP . 14.5 ttpp -66.09 -52.16 51.34 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.267 -178.604 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 564' ' ' GLU . . . . . 0.466 ' HA ' ' HB3' ' A' ' 567' ' ' ASN . 8.9 mt-10 -71.76 -24.43 61.77 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.584 -179.487 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 565' ' ' LEU . . . . . 0.482 HD22 ' HA ' ' A' ' 565' ' ' LEU . 9.9 mt -59.39 -55.16 38.22 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 109.368 -0.605 . . . . 0.0 109.368 169.606 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 566' ' ' ALA . . . . . 0.413 ' HB2' ' HB3' ' A' ' 525' ' ' ALA . . . -64.4 -34.75 78.91 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.343 179.274 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 567' ' ' ASN . . . . . 0.466 ' HB3' ' HA ' ' A' ' 564' ' ' GLU . 3.4 t-20 -56.43 -54.47 45.33 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.154 -179.854 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 568' ' ' ILE . . . . . . . . . . . . . 48.9 mm -70.93 -37.32 67.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.746 0.308 . . . . 0.0 111.068 -177.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 569' ' ' LEU . . . . . 0.41 ' HG ' ' O ' ' A' ' 565' ' ' LEU . 95.5 mt -65.2 -33.45 76.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.041 0.448 . . . . 0.0 110.946 178.289 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 570' ' ' LYS . . . . . 0.561 ' HE2' ' HA ' ' A' ' 593' ' ' GLN . 80.0 tttt -67.2 -16.73 64.48 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.559 -178.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 571' ' ' TYR . . . . . 0.462 ' HB2' ' NE2' ' A' ' 593' ' ' GLN . 45.5 t80 -89.98 -17.76 27.27 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.04 177.595 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 572' ' ' HIS . . . . . . . . . . . . . 53.2 m80 -86.07 -10.3 55.18 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.722 0.296 . . . . 0.0 111.158 -177.549 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 573' ' ' ILE . . . . . 0.505 HG23 HG22 ' A' ' 539' ' ' VAL . 31.2 mt -109.79 120.84 61.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.808 -179.137 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 574' ' ' GLY . . . . . 0.571 ' HA2' ' HA ' ' A' ' 591' ' ' SER . . . -98.62 148.26 18.79 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.909 -0.663 . . . . 0.0 111.663 175.052 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 575' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -93.4 9.07 37.97 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 111.936 0.347 . . . . 0.0 111.936 -173.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 576' ' ' GLU . . . . . 0.438 ' O ' HD23 ' A' ' 589' ' ' LEU . 12.2 pt-20 -144.92 133.32 21.84 Favored 'General case' 0 CA--C 1.508 -0.652 0 N-CA-C 109.765 -0.458 . . . . 0.0 109.765 178.616 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 577' ' ' ILE . . . . . 0.764 ' HA ' ' OG1' ' A' ' 538' ' ' THR . 76.3 mt -75.32 117.2 19.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.435 -175.513 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 578' ' ' LEU . . . . . 0.439 ' HB2' HD22 ' A' ' 589' ' ' LEU . 48.7 tp -118.41 108.65 15.31 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.318 -0.856 . . . . 0.0 109.858 176.841 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 579' ' ' VAL . . . . . . . . . . . . . 29.0 m -91.26 160.67 2.68 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.135 177.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 580' ' ' SER . . . . . . . . . . . . . 6.1 p -58.18 -42.81 86.89 Favored 'General case' 0 C--N 1.328 -0.355 0 O-C-N 123.292 0.37 . . . . 0.0 111.436 -176.613 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 581' ' ' GLY . . . . . . . . . . . . . . . -71.78 -11.86 73.9 Favored Glycine 0 CA--C 1.521 0.412 0 C-N-CA 120.964 -0.636 . . . . 0.0 113.087 -178.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . -96.71 -9.96 55.85 Favored Glycine 0 N--CA 1.454 -0.135 0 C-N-CA 121.043 -0.599 . . . . 0.0 112.508 -179.179 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 583' ' ' ILE . . . . . . . . . . . . . 58.7 mt -70.38 -60.21 2.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 121.06 0.457 . . . . 0.0 110.926 -178.295 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 584' ' ' GLY . . . . . . . . . . . . . . . 82.15 -89.04 1.44 Allowed Glycine 0 N--CA 1.444 -0.775 0 C-N-CA 120.55 -0.833 . . . . 0.0 111.383 -176.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 585' ' ' ALA . . . . . . . . . . . . . . . -102.71 -75.12 0.61 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.087 0.47 . . . . 0.0 110.351 178.184 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 586' ' ' LEU . . . . . 0.91 ' HG ' ' HB2' ' A' ' 600' ' ' SER . 5.7 tt -155.23 134.05 12.08 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 179.227 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 587' ' ' VAL . . . . . 0.436 ' N ' HD23 ' A' ' 586' ' ' LEU . 61.9 t -132.22 137.11 55.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 N-CA-C 110.199 -0.297 . . . . 0.0 110.199 -178.111 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 588' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -84.98 112.57 20.71 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 177.519 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 589' ' ' LEU . . . . . 0.653 ' HB3' ' HB2' ' A' ' 597' ' ' LEU . 1.9 tm? -89.9 121.09 31.69 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 -177.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 590' ' ' LYS . . . . . . . . . . . . . 33.8 mttp -87.86 131.16 34.65 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 121.303 0.573 . . . . 0.0 111.239 -172.315 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 591' ' ' SER . . . . . 0.571 ' HA ' ' HA2' ' A' ' 574' ' ' GLY . 84.0 p -97.41 159.78 14.72 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 114.973 -1.012 . . . . 0.0 110.718 -177.038 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 592' ' ' LEU . . . . . . . . . . . . . 9.9 mp -63.45 -21.18 66.16 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.491 177.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 593' ' ' GLN . . . . . 0.561 ' HA ' ' HE2' ' A' ' 570' ' ' LYS . 7.6 tt0 -73.0 -29.12 62.8 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.068 0.461 . . . . 0.0 110.291 175.895 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 594' ' ' GLY . . . . . . . . . . . . . . . 112.75 -14.21 24.54 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.172 -179.26 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 595' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -79.65 169.0 18.62 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-O 121.127 0.489 . . . . 0.0 111.106 179.268 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 596' ' ' LYS . . . . . . . . . . . . . 20.0 pttp -106.89 123.42 48.14 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.579 -174.25 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 597' ' ' LEU . . . . . 0.653 ' HB2' ' HB3' ' A' ' 589' ' ' LEU . 40.1 mt -87.73 122.14 31.03 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.947 173.526 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 598' ' ' GLU . . . . . 0.757 ' O ' ' HA ' ' A' ' 608' ' ' VAL . 18.2 tt0 -75.89 94.05 3.3 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.234 177.702 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 599' ' ' VAL . . . . . . . . . . . . . 41.5 t -107.84 121.71 61.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-O 121.317 0.58 . . . . 0.0 110.32 178.32 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 600' ' ' SER . . . . . 0.91 ' HB2' ' HG ' ' A' ' 586' ' ' LEU . 34.9 t -141.8 168.71 19.1 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.703 -177.13 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 601' ' ' LEU . . . . . . . . . . . . . 42.4 tp -135.95 107.78 7.07 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.111 -0.95 . . . . 0.0 108.738 -178.479 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 602' ' ' LYS . . . . . 0.603 ' O ' HG13 ' A' ' 605' ' ' VAL . 57.0 mtpt -131.02 114.33 15.06 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.076 -172.832 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 603' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 57.83 47.16 15.78 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.704 177.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 604' ' ' ASN . . . . . . . . . . . . . 13.9 m120 71.97 9.32 6.09 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 114.855 -1.066 . . . . 0.0 112.967 174.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 605' ' ' VAL . . . . . 0.603 HG13 ' O ' ' A' ' 602' ' ' LYS . 7.6 p -118.2 134.26 62.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 C-N-CA 120.146 -0.621 . . . . 0.0 110.326 173.829 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 606' ' ' VAL . . . . . 0.803 HG13 ' HB ' ' A' ' 613' ' ' VAL . 3.9 p -101.64 136.93 31.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.043 178.318 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 607' ' ' SER . . . . . . . . . . . . . 45.0 m -136.93 151.03 48.58 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.759 -177.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 608' ' ' VAL . . . . . 0.757 ' HA ' ' O ' ' A' ' 598' ' ' GLU . 4.3 p -128.62 108.41 17.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.411 0.624 . . . . 0.0 110.059 176.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 609' ' ' ASN . . . . . 0.411 ' O ' ' HB2' ' A' ' 610' ' ' LYS . 64.0 m-80 60.34 47.98 8.41 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.638 -176.415 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 610' ' ' LYS . . . . . 0.411 ' HB2' ' O ' ' A' ' 609' ' ' ASN . 56.0 mtpt 73.17 -19.02 0.34 Allowed 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 115.534 -0.757 . . . . 0.0 112.097 -178.533 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 611' ' ' GLU . . . . . 0.418 ' HA ' ' HD3' ' A' ' 612' ' ' PRO . 5.2 mm-40 -79.16 123.74 84.71 Favored Pre-proline 0 C--N 1.331 -0.213 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 -179.359 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 612' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 611' ' ' GLU . 7.3 Cg_exo -73.12 136.12 24.07 Favored 'Trans proline' 0 C--O 1.236 0.382 0 C-N-CA 123.235 2.623 . . . . 0.0 112.939 -176.193 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 613' ' ' VAL . . . . . 0.803 ' HB ' HG13 ' A' ' 606' ' ' VAL . 93.7 t -81.83 130.5 35.7 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.92 175.712 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 614' ' ' ALA . . . . . . . . . . . . . . . -78.44 -33.39 48.55 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.503 -176.239 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 615' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -165.47 107.53 0.77 Allowed Pre-proline 0 C--O 1.233 0.197 0 CA-C-O 120.835 0.35 . . . . 0.0 110.576 -179.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 616' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_endo -89.32 156.37 5.52 Favored 'Trans proline' 0 N--CA 1.459 -0.524 0 C-N-CA 123.29 2.66 . . . . 0.0 114.008 -178.065 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 35.3 t70 77.95 61.94 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 122.687 1.232 . . . . 0.0 110.463 166.524 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 618' ' ' ILE . . . . . 0.448 ' HB ' ' O ' ' A' ' 625' ' ' VAL . 7.9 mt -104.73 112.83 39.95 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.301 0 CA-C-N 113.757 -1.565 . . . . 0.0 108.438 174.695 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 619' ' ' MET . . . . . 0.488 ' HA ' ' HE2' ' A' ' 619' ' ' MET . 4.9 mmt -77.83 131.36 37.53 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 -170.588 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 620' ' ' ALA . . . . . . . . . . . . . . . -130.23 162.6 28.57 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 114.995 -1.002 . . . . 0.0 108.466 170.318 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 621' ' ' THR . . . . . . . . . . . . . 5.7 t -73.86 -20.37 60.44 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 120.502 -0.479 . . . . 0.0 111.351 -175.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 622' ' ' ASN . . . . . 0.574 ' CB ' ' HA ' ' A' ' 534' ' ' GLU . 28.2 p-10 -116.84 15.54 15.28 Favored 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 120.642 -0.423 . . . . 0.0 111.986 -177.362 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 623' ' ' GLY . . . . . 0.597 ' HA2' HD11 ' A' ' 577' ' ' ILE . . . 157.07 -156.22 27.03 Favored Glycine 0 N--CA 1.443 -0.872 0 C-N-CA 119.97 -1.109 . . . . 0.0 112.762 179.437 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 624' ' ' VAL . . . . . . . . . . . . . 6.3 p -131.22 156.11 42.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-O 121.033 0.444 . . . . 0.0 110.115 -178.201 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 625' ' ' VAL . . . . . 0.562 HG21 HG11 ' A' ' 505' ' ' VAL . 42.6 t -123.74 132.93 70.56 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.645 179.416 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 626' ' ' HIS . . . . . . . . . . . . . 96.2 m-70 -119.16 115.35 24.05 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 174.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 627' ' ' VAL . . . . . . . . . . . . . 40.4 t -69.87 123.74 24.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.719 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 628' ' ' ILE . . . . . 0.559 HG13 ' HA ' ' A' ' 542' ' ' PRO . 8.1 pt -117.51 143.28 28.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 121.192 0.52 . . . . 0.0 111.063 176.436 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 629' ' ' THR . . . . . . . . . . . . . 8.4 t -94.85 5.77 50.93 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.369 -178.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 630' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -135.96 165.83 24.76 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.052 -179.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 631' ' ' VAL . . . . . 0.608 HG21 ' HB2' ' A' ' 546' ' ' ALA . 0.7 OUTLIER -98.17 130.14 47.38 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.886 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.755 175.91 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 632' ' ' LEU . . . . . 0.655 HD23 HG12 ' A' ' 608' ' ' VAL . 96.1 mt -77.32 115.93 17.51 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.242 0.544 . . . . 0.0 110.922 -177.355 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 633' ' ' GLN . . . . . 0.506 ' HA ' HE21 ' A' ' 633' ' ' GLN . 0.1 OUTLIER -118.51 117.18 34.63 Favored Pre-proline 0 C--N 1.322 -0.599 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.937 -178.221 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 634' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo . . . . . 0 C--O 1.251 1.133 0 C-N-CA 122.65 2.233 . . . . 0.0 111.944 177.42 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.703 0 N-CA-C 111.697 -0.561 . . . . 0.0 111.697 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 78.9 p -86.14 173.11 10.06 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.912 0.356 . . . . 0.0 110.536 -179.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 505' ' ' VAL . . . . . 0.53 ' O ' ' HG ' ' A' ' 509' ' ' LEU . 24.2 t -53.57 -40.6 42.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 121.224 0.535 . . . . 0.0 110.009 175.098 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 506' ' ' MET . . . . . 0.411 ' HE2' ' HA ' ' A' ' 528' ' ' THR . 7.4 mmt -56.5 -40.65 75.32 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.021 -0.991 . . . . 0.0 112.296 179.809 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 507' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -67.63 -40.91 84.6 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 121.035 0.445 . . . . 0.0 110.564 -179.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 508' ' ' VAL . . . . . . . . . . . . . 62.1 t -60.66 -41.38 87.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.416 178.601 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 509' ' ' LEU . . . . . 0.53 ' HG ' ' O ' ' A' ' 505' ' ' VAL . 53.9 mt -75.33 -23.26 57.24 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.693 -179.853 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 510' ' ' LYS . . . . . 0.856 ' HB3' ' HZ2' ' A' ' 510' ' ' LYS . 1.6 mmmp? -85.8 -33.36 21.38 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.084 -176.688 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 511' ' ' GLY . . . . . . . . . . . . . . . -73.4 -10.75 79.45 Favored Glycine 0 N--CA 1.445 -0.741 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.928 178.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 512' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -110.23 148.61 31.53 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.24 0.543 . . . . 0.0 111.278 -178.2 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -75.19 -33.0 61.37 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.617 -177.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 514' ' ' ARG . . . . . 0.613 ' H ' ' HD2' ' A' ' 514' ' ' ARG . 0.3 OUTLIER -88.46 -45.06 10.26 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.059 0.457 . . . . 0.0 110.039 -171.906 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 515' ' ' PHE . . . . . 0.674 ' HZ ' HG21 ' A' ' 627' ' ' VAL . 14.8 m-30 -63.9 -24.69 67.84 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.155 177.523 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 26.5 t -60.76 -36.4 78.85 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.887 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 517' ' ' MET . . . . . 0.517 ' HE3' ' HA ' ' A' ' 544' ' ' ASN . 59.3 mtm -65.39 -34.5 78.44 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-O 121.003 0.43 . . . . 0.0 110.093 177.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 518' ' ' LEU . . . . . . . . . . . . . 56.1 tp -66.96 -39.8 87.33 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.436 174.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 519' ' ' VAL . . . . . . . . . . . . . 58.1 t -54.84 -37.66 41.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-O 121.093 0.473 . . . . 0.0 109.808 174.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 520' ' ' ALA . . . . . . . . . . . . . . . -65.02 -39.98 94.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.627 -179.268 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 521' ' ' ALA . . . . . . . . . . . . . . . -69.08 -43.58 74.27 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.465 176.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 522' ' ' ILE . . . . . . . . . . . . . 89.3 mt -58.01 -41.81 81.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.224 177.05 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 523' ' ' GLN . . . . . 0.697 ' HA ' HE21 ' A' ' 523' ' ' GLN . 0.0 OUTLIER -65.22 -23.96 67.22 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-O 121.011 0.434 . . . . 0.0 111.405 178.774 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 30.0 t -79.66 -41.11 27.6 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.535 177.501 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 525' ' ' ALA . . . . . . . . . . . . . . . -82.29 -29.0 31.4 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.118 0.414 . . . . 0.0 112.118 -176.625 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 526' ' ' GLY . . . . . . . . . . . . . . . 95.08 25.45 14.39 Favored Glycine 0 CA--C 1.519 0.327 0 C-N-CA 120.546 -0.835 . . . . 0.0 113.332 176.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 527' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -91.58 8.39 36.88 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 121.173 0.511 . . . . 0.0 110.171 178.342 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 528' ' ' THR . . . . . 0.411 ' HA ' ' HE2' ' A' ' 506' ' ' MET . 16.9 m -57.87 -44.05 86.4 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.439 -0.8 . . . . 0.0 111.238 -178.282 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 529' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -65.48 -31.31 72.31 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.026 -0.533 . . . . 0.0 111.352 -176.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 530' ' ' THR . . . . . . . . . . . . . 12.4 m -63.21 -46.57 86.4 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.108 -179.238 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 531' ' ' LEU . . . . . . . . . . . . . 42.4 mt -90.44 8.28 34.5 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 120.978 0.418 . . . . 0.0 111.236 -177.156 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 532' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -95.01 -25.15 16.61 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.019 -177.195 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 533' ' ' ARG . . . . . . . . . . . . . 69.1 mtm180 -92.39 157.69 16.47 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.345 -177.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 534' ' ' GLU . . . . . 0.554 ' HA ' ' HB3' ' A' ' 622' ' ' ASN . 12.7 pt-20 -78.75 162.76 25.92 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.758 178.567 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 535' ' ' GLY . . . . . . . . . . . . . . . 139.05 -138.63 9.5 Favored Glycine 0 N--CA 1.446 -0.67 0 N-CA-C 110.302 -1.119 . . . . 0.0 110.302 -176.113 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 536' ' ' VAL . . . . . 0.551 ' HB ' HG13 ' A' ' 577' ' ' ILE . 35.3 m -127.07 129.06 71.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 121.229 0.538 . . . . 0.0 111.043 176.417 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 537' ' ' TYR . . . . . 0.425 ' O ' ' HA3' ' A' ' 623' ' ' GLY . 69.2 m-85 -153.07 130.89 11.66 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.595 -0.729 . . . . 0.0 109.695 179.003 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 538' ' ' THR . . . . . 0.695 ' OG1' ' HA ' ' A' ' 577' ' ' ILE . 28.3 m -114.62 106.3 14.08 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.961 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 539' ' ' VAL . . . . . . . . . . . . . 40.0 t -112.15 130.86 65.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-O 121.021 0.439 . . . . 0.0 111.35 -174.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 540' ' ' PHE . . . . . 0.491 ' HB3' HD13 ' A' ' 628' ' ' ILE . 87.5 m-85 -97.68 111.2 23.58 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 174.056 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -101.73 118.38 59.7 Favored Pre-proline 0 C--N 1.325 -0.471 0 CA-C-O 120.669 0.271 . . . . 0.0 110.887 -177.029 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 542' ' ' PRO . . . . . 0.565 ' HA ' HG13 ' A' ' 628' ' ' ILE . 7.4 Cg_exo -74.08 141.52 29.71 Favored 'Trans proline' 0 N--CA 1.461 -0.401 0 C-N-CA 123.155 2.57 . . . . 0.0 112.149 178.339 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 61.0 p -81.66 -176.61 6.15 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.683 -179.124 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 544' ' ' ASN . . . . . 0.517 ' HA ' ' HE3' ' A' ' 517' ' ' MET . 3.9 t-20 -61.13 -32.7 72.39 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 121.352 0.596 . . . . 0.0 110.162 179.067 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 545' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -59.5 -40.48 87.22 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.037 -0.983 . . . . 0.0 110.939 -179.517 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 546' ' ' ALA . . . . . 0.615 ' HB1' HG21 ' A' ' 631' ' ' VAL . . . -61.54 -50.18 73.7 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.559 -177.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 547' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -69.51 -20.86 63.7 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.136 -177.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 548' ' ' ARG . . . . . . . . . . . . . 30.5 tpt180 -83.37 -33.89 25.71 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.056 0.455 . . . . 0.0 110.236 177.527 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 549' ' ' ALA . . . . . . . . . . . . . . . -75.5 -21.38 58.06 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.375 -0.83 . . . . 0.0 111.441 -179.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 550' ' ' LEU . . . . . 0.473 ' HA ' ' HD3' ' A' ' 551' ' ' PRO . 73.5 mt -69.85 129.1 91.38 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-O 120.772 0.32 . . . . 0.0 111.058 178.385 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 551' ' ' PRO . . . . . 0.473 ' HD3' ' HA ' ' A' ' 550' ' ' LEU . 5.1 Cg_exo -77.78 148.29 25.32 Favored 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 123.061 2.508 . . . . 0.0 111.209 -179.207 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 552' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -53.85 -34.42 75.6 Favored 'Trans proline' 0 N--CA 1.471 0.194 0 C-N-CA 122.915 2.41 . . . . 0.0 112.435 -178.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 553' ' ' ARG . . . . . . . . . . . . . 34.8 mtp180 -62.24 -42.78 99.62 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.539 179.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -83.78 -35.01 24.65 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.808 0.337 . . . . 0.0 110.84 179.589 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 555' ' ' ARG . . . . . . . . . . . . . 14.4 mtp180 -58.05 -42.56 85.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.137 176.108 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 28.5 t -59.93 -28.55 67.71 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.863 -178.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 557' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -67.14 -62.91 1.2 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.357 0.599 . . . . 0.0 110.193 176.377 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 558' ' ' LEU . . . . . 0.569 ' O ' ' HG ' ' A' ' 565' ' ' LEU . 53.2 tp -68.88 -52.66 27.25 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.26 -0.882 . . . . 0.0 112.107 -172.422 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 559' ' ' LEU . . . . . . . . . . . . . 72.5 mt -80.33 4.74 16.87 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.802 -170.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 560' ' ' GLY . . . . . . . . . . . . . . . -123.66 3.97 9.33 Favored Glycine 0 N--CA 1.446 -0.7 0 C-N-CA 120.381 -0.914 . . . . 0.0 112.619 -179.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 561' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -135.82 128.67 31.16 Favored 'General case' 0 C--N 1.326 -0.431 0 O-C-N 122.538 -0.389 . . . . 0.0 111.051 -178.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 562' ' ' ALA . . . . . . . . . . . . . . . -70.32 -38.54 74.95 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.677 -176.132 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 563' ' ' LYS . . . . . 0.478 ' HG2' ' OE1' ' A' ' 564' ' ' GLU . 31.4 tttm -66.65 -47.87 71.18 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.036 -178.394 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 564' ' ' GLU . . . . . 0.478 ' OE1' ' HG2' ' A' ' 563' ' ' LYS . 5.7 mm-40 -67.33 -36.0 80.54 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.602 -0.272 . . . . 0.0 110.786 -179.436 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 565' ' ' LEU . . . . . 0.569 ' HG ' ' O ' ' A' ' 558' ' ' LEU . 6.6 mt -56.62 -52.52 64.56 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-O 120.893 0.377 . . . . 0.0 110.331 174.812 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 566' ' ' ALA . . . . . 0.502 ' O ' ' HG3' ' A' ' 570' ' ' LYS . . . -61.16 -48.71 80.34 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.34 -179.038 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 567' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -59.84 -48.08 83.15 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.822 -177.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 568' ' ' ILE . . . . . . . . . . . . . 43.4 mm -69.47 -35.27 65.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.706 0.289 . . . . 0.0 111.459 -178.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 569' ' ' LEU . . . . . 0.476 ' HG ' ' O ' ' A' ' 565' ' ' LEU . 61.2 mt -66.23 -36.95 84.35 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.813 -0.355 . . . . 0.0 110.59 177.128 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 570' ' ' LYS . . . . . 0.502 ' HG3' ' O ' ' A' ' 566' ' ' ALA . 53.2 mtpt -69.33 -9.84 55.16 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.682 0.277 . . . . 0.0 111.061 177.355 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 571' ' ' TYR . . . . . 0.464 ' HB2' HE21 ' A' ' 593' ' ' GLN . 33.9 t80 -92.78 -18.93 22.29 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.87 0.367 . . . . 0.0 110.525 179.065 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 572' ' ' HIS . . . . . . . . . . . . . 67.2 m80 -92.93 -7.08 47.06 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.17 0.509 . . . . 0.0 110.581 179.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 573' ' ' ILE . . . . . . . . . . . . . 54.0 mt -113.75 124.12 70.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.885 179.018 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 574' ' ' GLY . . . . . 0.494 ' HA3' HD23 ' A' ' 589' ' ' LEU . . . -113.95 149.7 18.67 Favored Glycine 0 N--CA 1.445 -0.74 0 N-CA-C 110.575 -1.01 . . . . 0.0 110.575 171.48 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 575' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -100.35 24.51 8.73 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 117.553 0.677 . . . . 0.0 110.879 -177.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 576' ' ' GLU . . . . . 0.407 ' HG3' ' HG ' ' A' ' 589' ' ' LEU . 14.8 pt-20 -136.21 125.88 25.46 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 175.426 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 577' ' ' ILE . . . . . 0.695 ' HA ' ' OG1' ' A' ' 538' ' ' THR . 61.2 mt -77.57 115.07 18.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.147 -175.423 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 578' ' ' LEU . . . . . 0.528 HD12 ' HA ' ' A' ' 583' ' ' ILE . 48.7 tp -121.67 103.44 8.89 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.267 -0.879 . . . . 0.0 109.791 177.85 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 579' ' ' VAL . . . . . 0.476 ' O ' HG13 ' A' ' 583' ' ' ILE . 30.4 m -95.36 162.41 2.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.964 178.035 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 580' ' ' SER . . . . . . . . . . . . . 15.3 m -56.6 -45.93 81.14 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 123.354 0.409 . . . . 0.0 111.914 -175.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 581' ' ' GLY . . . . . . . . . . . . . . . -70.43 -21.17 77.42 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.52 -0.848 . . . . 0.0 112.619 -179.104 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . -99.43 2.64 57.6 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.876 -0.678 . . . . 0.0 113.296 -175.222 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 583' ' ' ILE . . . . . 0.528 ' HA ' HD12 ' A' ' 578' ' ' LEU . 62.7 mt -67.75 -65.21 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 117.183 0.491 . . . . 0.0 111.1 179.142 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 584' ' ' GLY . . . . . . . . . . . . . . . 78.83 78.32 0.84 Allowed Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.241 -0.981 . . . . 0.0 111.556 -175.388 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 585' ' ' ALA . . . . . . . . . . . . . . . 70.68 -80.12 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 123.303 0.641 . . . . 0.0 111.88 -178.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 586' ' ' LEU . . . . . 0.967 ' HG ' ' HB3' ' A' ' 600' ' ' SER . 6.4 tt -151.32 129.02 11.54 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.7 0.286 . . . . 0.0 110.654 -175.458 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 587' ' ' VAL . . . . . . . . . . . . . 68.3 t -148.02 119.65 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.848 -0.614 . . . . 0.0 109.62 179.107 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 588' ' ' ARG . . . . . 0.533 ' HG2' ' HA ' ' A' ' 598' ' ' GLU . 92.3 mtt180 -85.36 123.06 30.39 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.125 0.488 . . . . 0.0 110.875 -179.131 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 589' ' ' LEU . . . . . 0.499 HD11 ' HB3' ' A' ' 578' ' ' LEU . 6.2 tt -90.56 125.63 35.68 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 114.749 -1.114 . . . . 0.0 109.77 -172.775 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 590' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -76.72 132.31 39.24 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.169 0.509 . . . . 0.0 110.774 -179.157 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 591' ' ' SER . . . . . . . . . . . . . 78.3 p -99.76 159.85 14.75 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.744 -176.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 592' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -58.01 -25.64 61.37 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 116.187 -0.46 . . . . 0.0 112.053 179.177 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 593' ' ' GLN . . . . . 0.464 HE21 ' HB2' ' A' ' 571' ' ' TYR . 4.0 tt0 -68.39 -27.09 65.91 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.175 0.512 . . . . 0.0 110.664 178.763 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 594' ' ' GLY . . . . . . . . . . . . . . . 107.17 -4.95 35.72 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.744 -0.741 . . . . 0.0 111.369 -174.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 595' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -88.81 -176.78 5.34 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 179.22 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 596' ' ' LYS . . . . . 0.674 ' N ' ' HD3' ' A' ' 596' ' ' LYS . 0.0 OUTLIER -125.56 129.74 50.29 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.078 0.466 . . . . 0.0 110.875 -172.283 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 597' ' ' LEU . . . . . . . . . . . . . 59.7 mt -93.46 119.53 32.65 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.63 177.453 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 598' ' ' GLU . . . . . 0.533 ' HA ' ' HG2' ' A' ' 588' ' ' ARG . 10.7 tp10 -75.76 86.55 2.77 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.356 -179.74 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 599' ' ' VAL . . . . . . . . . . . . . 49.3 t -105.86 125.43 61.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 121.198 0.523 . . . . 0.0 110.395 -179.415 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 600' ' ' SER . . . . . 0.967 ' HB3' ' HG ' ' A' ' 586' ' ' LEU . 3.0 p -142.72 157.43 44.66 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.107 -179.114 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 601' ' ' LEU . . . . . 0.491 ' HB2' HD13 ' A' ' 583' ' ' ILE . 33.9 tp -123.06 122.92 39.66 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.096 -177.525 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 602' ' ' LYS . . . . . . . . . . . . . 34.9 ttmt -139.42 109.26 6.32 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.712 0.292 . . . . 0.0 110.515 -177.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 603' ' ' ASN . . . . . . . . . . . . . 18.7 m120 61.75 46.77 6.74 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.61 178.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 604' ' ' ASN . . . . . . . . . . . . . 15.9 t-20 76.64 -8.77 1.61 Allowed 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 115.307 -0.86 . . . . 0.0 111.777 177.277 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 605' ' ' VAL . . . . . . . . . . . . . 49.0 t -94.14 126.43 46.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-O 120.75 0.309 . . . . 0.0 110.198 -179.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 606' ' ' VAL . . . . . 0.564 HG13 ' HB ' ' A' ' 613' ' ' VAL . 6.7 p -108.76 131.11 60.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.625 -179.665 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 607' ' ' SER . . . . . . . . . . . . . 45.2 p -131.92 144.4 50.81 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.2 -179.203 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 608' ' ' VAL . . . . . 0.475 ' HA ' ' O ' ' A' ' 598' ' ' GLU . 4.4 p -118.83 115.04 46.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.81 176.205 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 609' ' ' ASN . . . . . . . . . . . . . 95.7 m-20 61.79 32.33 18.2 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.093 -176.378 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 610' ' ' LYS . . . . . 0.635 ' HZ1' ' HB2' ' A' ' 610' ' ' LYS . 0.0 OUTLIER 81.48 -6.18 1.54 Allowed 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 114.792 -1.094 . . . . 0.0 111.134 -179.176 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 611' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -87.11 111.34 40.13 Favored Pre-proline 0 C--N 1.326 -0.42 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 177.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 612' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -65.41 135.23 41.83 Favored 'Trans proline' 0 N--CA 1.462 -0.361 0 C-N-CA 122.634 2.223 . . . . 0.0 112.185 -178.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 613' ' ' VAL . . . . . 0.564 ' HB ' HG13 ' A' ' 606' ' ' VAL . 89.8 t -73.84 125.01 32.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.068 177.823 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 614' ' ' ALA . . . . . 0.624 ' HB3' HG23 ' A' ' 629' ' ' THR . . . -64.65 -45.34 87.18 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.748 -177.82 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 615' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -154.46 99.04 2.48 Favored Pre-proline 0 N--CA 1.466 0.374 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.782 -177.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 616' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -88.87 162.29 6.09 Favored 'Trans proline' 0 N--CA 1.459 -0.51 0 C-N-CA 123.026 2.484 . . . . 0.0 114.195 -176.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 37.5 t0 77.33 46.93 0.06 Allowed 'General case' 0 C--O 1.234 0.272 0 CA-C-O 122.735 1.255 . . . . 0.0 110.114 165.238 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 618' ' ' ILE . . . . . 0.483 ' HB ' ' O ' ' A' ' 625' ' ' VAL . 11.6 mt -90.63 113.5 26.62 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.812 0 CA-C-N 113.503 -1.681 . . . . 0.0 109.674 174.302 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 619' ' ' MET . . . . . 0.474 ' HA ' ' HE3' ' A' ' 619' ' ' MET . 7.7 mmt -77.2 133.48 38.9 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 -170.207 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 620' ' ' ALA . . . . . . . . . . . . . . . -130.31 170.92 13.5 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 115.113 -0.949 . . . . 0.0 108.802 170.097 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 621' ' ' THR . . . . . . . . . . . . . 5.0 t -81.32 -23.99 37.47 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.775 -0.37 . . . . 0.0 111.056 -178.53 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 622' ' ' ASN . . . . . 0.554 ' HB3' ' HA ' ' A' ' 534' ' ' GLU . 29.7 p-10 -117.11 22.64 12.4 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.844 0.354 . . . . 0.0 111.066 -176.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 623' ' ' GLY . . . . . 0.465 ' HA2' HD12 ' A' ' 577' ' ' ILE . . . 152.52 -147.11 16.38 Favored Glycine 0 N--CA 1.444 -0.796 0 C-N-CA 120.231 -0.985 . . . . 0.0 112.68 177.469 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 624' ' ' VAL . . . . . . . . . . . . . 9.5 p -144.46 158.51 14.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 -177.37 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 625' ' ' VAL . . . . . 0.483 ' O ' ' HB ' ' A' ' 618' ' ' ILE . 60.9 t -125.85 135.4 64.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 -179.828 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 626' ' ' HIS . . . . . . . . . . . . . 95.5 m-70 -119.33 116.15 25.61 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.23 -0.441 . . . . 0.0 109.946 175.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 627' ' ' VAL . . . . . 0.674 HG21 ' HZ ' ' A' ' 515' ' ' PHE . 48.3 t -70.24 125.67 28.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.281 179.75 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 628' ' ' ILE . . . . . 0.565 HG13 ' HA ' ' A' ' 542' ' ' PRO . 7.9 pt -121.28 145.88 27.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 121.32 0.581 . . . . 0.0 111.018 176.679 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 629' ' ' THR . . . . . 0.624 HG23 ' HB3' ' A' ' 614' ' ' ALA . 16.9 p -90.35 -3.33 57.81 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.493 -0.776 . . . . 0.0 112.197 -176.737 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 630' ' ' ASN . . . . . . . . . . . . . 64.1 t30 -141.91 175.05 10.03 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.503 -0.555 . . . . 0.0 109.503 -179.405 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 631' ' ' VAL . . . . . 0.615 HG21 ' HB1' ' A' ' 546' ' ' ALA . 51.2 t -106.21 123.79 61.13 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 N-CA-C 109.484 -0.562 . . . . 0.0 109.484 -178.729 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 632' ' ' LEU . . . . . 0.4 HD23 HG13 ' A' ' 608' ' ' VAL . 88.4 mt -68.24 126.08 28.44 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.042 0.449 . . . . 0.0 111.46 -173.069 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 633' ' ' GLN . . . . . . . . . . . . . 82.9 mm-40 -118.44 119.77 32.64 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.058 -178.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 634' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo . . . . . 0 C--O 1.251 1.139 0 C-N-CA 122.685 2.257 . . . . 0.0 112.171 177.59 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 500' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.058 0 CA-C-O 120.768 0.318 . . . . 0.0 110.875 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 501' ' ' GLY . . . . . . . . . . . . . . . 97.16 164.56 32.31 Favored Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 120.938 -0.649 . . . . 0.0 111.695 -177.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 502' ' ' MET . . . . . . . . . . . . . 4.7 mpp? -108.29 -65.65 1.11 Allowed 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.868 0.366 . . . . 0.0 110.112 178.456 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . -158.87 -128.59 1.0 Allowed Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.132 177.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 504' ' ' THR . . . . . 0.55 ' HA ' HG22 ' A' ' 621' ' ' THR . 33.7 p -78.85 172.35 13.88 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.539 0.209 . . . . 0.0 110.582 179.29 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 505' ' ' VAL . . . . . 0.704 ' O ' ' HG ' ' A' ' 509' ' ' LEU . 13.0 m -57.85 -34.96 49.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.696 -0.229 . . . . 0.0 110.929 176.125 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 506' ' ' MET . . . . . 0.499 ' HE1' HG21 ' A' ' 528' ' ' THR . 95.0 mmm -61.5 -35.93 79.07 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-O 120.77 0.319 . . . . 0.0 110.928 178.687 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 507' ' ' ASP . . . . . 0.737 ' HA ' ' HE3' ' A' ' 510' ' ' LYS . 23.0 t70 -67.49 -35.85 79.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.279 -178.686 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 508' ' ' VAL . . . . . . . . . . . . . 45.8 t -71.92 -41.37 69.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 115.63 -0.713 . . . . 0.0 110.58 178.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 509' ' ' LEU . . . . . 0.704 ' HG ' ' O ' ' A' ' 505' ' ' VAL . 77.4 mt -62.73 -31.74 72.73 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.745 -176.672 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 510' ' ' LYS . . . . . 0.737 ' HE3' ' HA ' ' A' ' 507' ' ' ASP . 22.8 pttp -88.62 -13.71 39.25 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.061 0.458 . . . . 0.0 110.618 -177.741 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 511' ' ' GLY . . . . . . . . . . . . . . . -85.21 -11.57 75.48 Favored Glycine 0 N--CA 1.442 -0.947 0 C-N-CA 120.463 -0.875 . . . . 0.0 110.976 175.34 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 512' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -108.84 134.58 51.34 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.894 0.378 . . . . 0.0 110.194 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -72.88 -22.52 60.75 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.537 -176.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 514' ' ' ARG . . . . . 0.532 ' HG2' HD22 ' A' ' 544' ' ' ASN . 63.9 mtm180 -84.16 -33.85 24.14 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 120.987 0.422 . . . . 0.0 110.352 -176.799 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 515' ' ' PHE . . . . . 0.983 ' HZ ' HG22 ' A' ' 627' ' ' VAL . 11.5 m-30 -81.1 -7.73 59.62 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.408 -179.788 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 23.2 t -58.93 -43.32 91.14 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.872 -174.186 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 517' ' ' MET . . . . . . . . . . . . . 4.3 mpp? -67.18 -30.35 70.28 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-O 120.879 0.371 . . . . 0.0 110.504 179.346 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 518' ' ' LEU . . . . . 0.474 HD22 ' HA ' ' A' ' 541' ' ' ALA . 61.8 tp -68.68 -41.28 79.44 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.66 -0.416 . . . . 0.0 109.903 177.1 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 519' ' ' VAL . . . . . 0.432 ' O ' ' HG3' ' A' ' 523' ' ' GLN . 61.3 t -56.94 -36.42 50.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.086 0.47 . . . . 0.0 109.955 175.067 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 520' ' ' ALA . . . . . . . . . . . . . . . -69.67 -39.46 77.01 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.436 -179.451 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 521' ' ' ALA . . . . . . . . . . . . . . . -67.26 -46.65 73.07 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.299 176.091 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 522' ' ' ILE . . . . . 0.416 HG13 ' O ' ' A' ' 518' ' ' LEU . 71.5 mt -55.07 -45.46 76.98 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.072 177.248 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 523' ' ' GLN . . . . . 0.432 ' HG3' ' O ' ' A' ' 519' ' ' VAL . 26.3 mt-30 -65.46 -44.73 86.28 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.314 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 24.2 t -69.71 -32.46 71.04 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.567 -176.648 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 525' ' ' ALA . . . . . 0.48 ' HB3' ' HB2' ' A' ' 566' ' ' ALA . . . -86.32 -25.48 25.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.725 0.298 . . . . 0.0 111.265 -179.37 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 526' ' ' GLY . . . . . . . . . . . . . . . 90.76 31.71 9.87 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 121.009 -0.615 . . . . 0.0 112.564 177.424 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 527' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -92.16 -4.7 53.86 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.549 0.214 . . . . 0.0 111.303 -179.114 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 528' ' ' THR . . . . . 0.499 HG21 ' HE1' ' A' ' 506' ' ' MET . 8.1 m -54.24 -37.85 65.12 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.824 -176.428 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 529' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -62.84 -19.51 64.18 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 112.219 0.452 . . . . 0.0 112.219 -176.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 530' ' ' THR . . . . . 0.421 ' HB ' HD21 ' A' ' 531' ' ' LEU . 84.8 m -75.06 -54.7 6.71 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.94 0.4 . . . . 0.0 110.18 177.266 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 531' ' ' LEU . . . . . 0.426 ' HB3' HG22 ' A' ' 505' ' ' VAL . 1.4 mm? -75.53 -5.33 44.69 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.26 179.457 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 532' ' ' ASN . . . . . . . . . . . . . 61.3 t30 -81.44 -5.8 58.28 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.196 178.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 533' ' ' ARG . . . . . . . . . . . . . 29.6 mmm180 -110.12 146.9 34.67 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.283 178.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 534' ' ' GLU . . . . . 0.658 ' HA ' ' CB ' ' A' ' 622' ' ' ASN . 35.7 mt-10 -90.74 155.25 18.94 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.893 0.378 . . . . 0.0 110.253 177.572 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 535' ' ' GLY . . . . . . . . . . . . . . . 151.83 -132.74 3.9 Favored Glycine 0 N--CA 1.447 -0.62 0 N-CA-C 110.834 -0.907 . . . . 0.0 110.834 -174.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 536' ' ' VAL . . . . . 0.441 ' HA ' HD12 ' A' ' 577' ' ' ILE . 33.8 m -123.17 128.41 74.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 120.965 0.412 . . . . 0.0 110.851 177.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 537' ' ' TYR . . . . . . . . . . . . . 82.2 m-85 -155.16 152.94 30.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.057 179.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 538' ' ' THR . . . . . 0.647 ' OG1' ' HA ' ' A' ' 577' ' ' ILE . 94.6 m -130.42 102.8 6.33 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.213 -0.449 . . . . 0.0 109.994 174.825 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 539' ' ' VAL . . . . . . . . . . . . . 26.6 t -100.89 125.75 54.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 120.937 0.399 . . . . 0.0 111.411 -172.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 540' ' ' PHE . . . . . 0.535 ' HB3' HD13 ' A' ' 628' ' ' ILE . 97.3 m-85 -98.47 111.57 23.88 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 173.362 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 541' ' ' ALA . . . . . 0.474 ' HA ' HD22 ' A' ' 518' ' ' LEU . . . -102.08 115.41 64.69 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 116.651 -0.25 . . . . 0.0 111.263 -176.799 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 542' ' ' PRO . . . . . 0.495 ' HA ' HG13 ' A' ' 628' ' ' ILE . 13.4 Cg_exo -71.02 141.02 39.17 Favored 'Trans proline' 0 N--CA 1.463 -0.279 0 C-N-CA 123.146 2.564 . . . . 0.0 112.195 177.376 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 41.7 p -85.85 -177.03 6.25 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.058 178.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 544' ' ' ASN . . . . . 0.532 HD22 ' HG2' ' A' ' 514' ' ' ARG . 0.5 OUTLIER -59.72 -40.36 87.71 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 121.387 0.613 . . . . 0.0 109.958 -179.057 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 545' ' ' GLU . . . . . 0.438 ' CD ' ' H ' ' A' ' 545' ' ' GLU . 3.3 mp0 -58.15 -39.11 77.97 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 114.736 -1.12 . . . . 0.0 110.812 -178.148 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 546' ' ' ALA . . . . . 0.563 ' HB3' HG13 ' A' ' 631' ' ' VAL . . . -63.96 -43.51 95.59 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.027 0.441 . . . . 0.0 111.232 -178.4 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 547' ' ' PHE . . . . . . . . . . . . . 75.1 m-85 -72.87 -27.75 62.1 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.151 -179.007 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 548' ' ' ARG . . . . . 0.439 ' O ' ' HD2' ' A' ' 548' ' ' ARG . 5.5 tmm_? -80.33 -29.07 38.04 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.219 0.533 . . . . 0.0 109.912 179.161 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 549' ' ' ALA . . . . . . . . . . . . . . . -76.09 -17.68 59.51 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.232 179.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 550' ' ' LEU . . . . . 0.691 ' HB3' ' HB3' ' A' ' 555' ' ' ARG . 20.0 mt -58.31 134.3 84.94 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.089 178.116 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 551' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 550' ' ' LEU . 28.0 Cg_exo -62.84 143.9 92.55 Favored 'Trans proline' 0 C--O 1.234 0.308 0 C-N-CA 122.909 2.406 . . . . 0.0 111.766 -179.582 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 552' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -53.67 -38.0 84.16 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 123.261 2.64 . . . . 0.0 112.249 -177.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 553' ' ' ARG . . . . . . . . . . . . . 22.4 mmm180 -69.05 -52.92 23.56 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.851 -178.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 18.2 mt-10 -66.69 -51.22 58.53 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.712 -0.676 . . . . 0.0 112.42 -175.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 555' ' ' ARG . . . . . 0.691 ' HB3' ' HB3' ' A' ' 550' ' ' LEU . 18.6 ptt180 -67.4 -27.64 67.26 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 120.445 -0.502 . . . . 0.0 111.396 -175.063 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 47.1 t -71.21 -31.55 67.75 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.733 0.301 . . . . 0.0 110.701 177.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 557' ' ' ARG . . . . . 0.414 HH11 ' HD3' ' A' ' 557' ' ' ARG . 8.7 tpt180 -83.28 -53.03 6.06 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.487 -179.411 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 558' ' ' LEU . . . . . 0.521 HD21 ' HB3' ' A' ' 564' ' ' GLU . 0.3 OUTLIER -57.48 -47.36 82.11 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.23 -0.896 . . . . 0.0 111.429 -174.602 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 559' ' ' LEU . . . . . 0.663 HD23 HD23 ' A' ' 565' ' ' LEU . 93.5 mt -77.81 0.7 22.78 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.563 -175.161 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 560' ' ' GLY . . . . . . . . . . . . . . . -97.2 -11.51 52.05 Favored Glycine 0 N--CA 1.445 -0.746 0 C-N-CA 120.444 -0.884 . . . . 0.0 112.585 -178.287 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 561' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -132.23 127.91 36.78 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.923 0.392 . . . . 0.0 111.205 -177.282 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 562' ' ' ALA . . . . . . . . . . . . . . . -64.31 -29.24 70.33 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.909 -0.587 . . . . 0.0 112.227 -176.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 563' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -78.71 -39.85 35.34 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 -177.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 564' ' ' GLU . . . . . 0.521 ' HB3' HD21 ' A' ' 558' ' ' LEU . 44.5 mt-10 -64.25 -34.52 78.3 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.164 -0.471 . . . . 0.0 109.937 175.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 565' ' ' LEU . . . . . 0.663 HD23 HD23 ' A' ' 559' ' ' LEU . 58.1 mt -64.34 -52.42 58.49 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.986 175.031 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 566' ' ' ALA . . . . . 0.48 ' HB2' ' HB3' ' A' ' 525' ' ' ALA . . . -56.4 -40.71 75.09 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.821 -176.548 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 567' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -60.97 -47.91 84.27 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.757 -177.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 568' ' ' ILE . . . . . . . . . . . . . 50.6 mm -69.87 -33.42 55.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.389 -177.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 569' ' ' LEU . . . . . 0.426 ' HG ' ' O ' ' A' ' 565' ' ' LEU . 78.7 mt -65.98 -33.47 75.89 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.541 -0.3 . . . . 0.0 111.517 -179.15 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 570' ' ' LYS . . . . . 0.509 ' HE3' ' HA ' ' A' ' 593' ' ' GLN . 28.0 mtpp -66.94 -18.7 65.5 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.135 179.807 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 571' ' ' TYR . . . . . . . . . . . . . 20.5 t80 -87.12 -18.26 30.88 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.223 178.366 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 572' ' ' HIS . . . . . . . . . . . . . 62.5 m80 -89.09 -12.14 42.02 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.883 0.373 . . . . 0.0 111.403 -178.487 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 573' ' ' ILE . . . . . 0.408 ' O ' HD23 ' A' ' 592' ' ' LEU . 38.5 mt -108.64 119.69 58.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.359 179.105 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 574' ' ' GLY . . . . . 0.555 ' HA2' ' HA ' ' A' ' 591' ' ' SER . . . -91.97 151.24 20.68 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.99 -0.624 . . . . 0.0 111.941 177.179 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 575' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -93.99 9.3 38.11 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.087 0.47 . . . . 0.0 110.703 -173.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 576' ' ' GLU . . . . . 0.559 ' OE1' ' HG2' ' A' ' 590' ' ' LYS . 42.8 mt-10 -142.08 126.12 17.3 Favored 'General case' 0 CA--C 1.511 -0.521 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.951 -176.063 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 577' ' ' ILE . . . . . 0.647 ' HA ' ' OG1' ' A' ' 538' ' ' THR . 58.5 mt -76.06 105.11 4.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 121.218 0.532 . . . . 0.0 111.235 -177.861 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 578' ' ' LEU . . . . . 0.446 ' HG ' HG11 ' A' ' 587' ' ' VAL . 3.9 mm? -119.7 100.79 7.47 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.153 176.644 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 579' ' ' VAL . . . . . 0.536 ' O ' HG13 ' A' ' 583' ' ' ILE . 34.0 m -86.82 166.89 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 109.614 -0.514 . . . . 0.0 109.614 175.079 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 580' ' ' SER . . . . . . . . . . . . . 20.8 m -57.12 -40.13 76.5 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.893 0.377 . . . . 0.0 111.226 -176.084 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 581' ' ' GLY . . . . . . . . . . . . . . . -76.26 -8.7 85.61 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.783 -179.412 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . -103.24 -27.12 6.65 Favored Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.918 -177.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 583' ' ' ILE . . . . . 0.536 HG13 ' O ' ' A' ' 579' ' ' VAL . 77.1 mt -60.27 -59.02 4.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 120.893 0.377 . . . . 0.0 111.548 -178.158 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 584' ' ' GLY . . . . . . . . . . . . . . . 94.23 -81.29 0.96 Allowed Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.236 -178.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 585' ' ' ALA . . . . . . . . . . . . . . . -128.07 -62.26 1.06 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.753 0.311 . . . . 0.0 110.929 179.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 586' ' ' LEU . . . . . 0.947 ' HG ' ' HB3' ' A' ' 600' ' ' SER . 3.9 tt -155.3 140.2 17.25 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 178.344 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 587' ' ' VAL . . . . . 0.523 ' N ' HD23 ' A' ' 586' ' ' LEU . 9.3 p -142.18 136.92 29.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-O 121.102 0.477 . . . . 0.0 111.086 -178.515 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 588' ' ' ARG . . . . . . . . . . . . . 8.2 ttt180 -85.03 101.49 12.44 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.625 174.182 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 589' ' ' LEU . . . . . . . . . . . . . 2.7 tt -97.53 128.77 44.54 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.45 -0.796 . . . . 0.0 109.456 -175.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 590' ' ' LYS . . . . . 0.559 ' HG2' ' OE1' ' A' ' 576' ' ' GLU . 27.8 pttt -82.03 143.65 31.41 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 120.691 -0.404 . . . . 0.0 110.795 178.706 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 591' ' ' SER . . . . . 0.555 ' HA ' ' HA2' ' A' ' 574' ' ' GLY . 80.3 p -105.1 165.15 11.29 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.597 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 592' ' ' LEU . . . . . 0.408 HD23 ' O ' ' A' ' 573' ' ' ILE . 3.5 mm? -66.88 -9.17 35.08 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 178.572 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 593' ' ' GLN . . . . . 0.509 ' HA ' ' HE3' ' A' ' 570' ' ' LYS . 7.9 tt0 -86.01 -29.46 23.46 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.103 0.477 . . . . 0.0 110.359 176.283 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 594' ' ' GLY . . . . . . . . . . . . . . . 117.94 -21.21 10.42 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.559 -0.829 . . . . 0.0 111.784 -176.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 595' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -78.37 179.28 7.08 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 109.271 -0.641 . . . . 0.0 109.271 177.271 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 596' ' ' LYS . . . . . 0.713 ' H ' ' HD3' ' A' ' 596' ' ' LYS . 0.0 OUTLIER -115.8 140.29 49.36 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-O 121.027 0.442 . . . . 0.0 110.316 -175.741 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 597' ' ' LEU . . . . . . . . . . . . . 71.0 mt -101.39 117.17 34.41 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.934 -0.575 . . . . 0.0 109.601 173.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 598' ' ' GLU . . . . . 0.482 ' OE1' ' HG2' ' A' ' 596' ' ' LYS . 1.6 mp0 -80.89 84.86 6.3 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.204 0.525 . . . . 0.0 110.006 178.225 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 599' ' ' VAL . . . . . . . . . . . . . 26.1 t -93.29 126.53 45.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.586 -0.733 . . . . 0.0 109.738 -179.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 600' ' ' SER . . . . . 0.947 ' HB3' ' HG ' ' A' ' 586' ' ' LEU . 23.9 p -135.01 159.33 41.84 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.251 0.548 . . . . 0.0 111.692 -178.32 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 601' ' ' LEU . . . . . . . . . . . . . 27.5 tp -130.45 108.77 10.21 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.014 -0.994 . . . . 0.0 109.0 179.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 602' ' ' LYS . . . . . . . . . . . . . 8.6 ptpp? -137.07 131.68 33.09 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 110.113 -0.329 . . . . 0.0 110.113 -179.037 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 603' ' ' ASN . . . . . . . . . . . . . 14.1 m120 65.06 25.54 12.58 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.743 -176.466 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 604' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 71.59 10.3 6.43 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 114.952 -1.022 . . . . 0.0 110.164 -177.286 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 605' ' ' VAL . . . . . . . . . . . . . 62.1 t -101.11 119.23 48.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.936 177.004 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 606' ' ' VAL . . . . . 0.691 HG12 ' HB ' ' A' ' 613' ' ' VAL . 5.6 p -91.11 137.31 22.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 121.104 0.478 . . . . 0.0 110.635 178.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 607' ' ' SER . . . . . . . . . . . . . 18.5 m -143.34 140.02 30.35 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.862 -179.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 608' ' ' VAL . . . . . . . . . . . . . 3.8 p -113.63 114.3 46.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.637 176.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 609' ' ' ASN . . . . . . . . . . . . . 84.4 m-20 57.04 44.55 22.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.244 -175.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 610' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 76.9 -19.67 0.41 Allowed 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.141 0.977 . . . . 0.0 112.443 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 611' ' ' GLU . . . . . 0.469 ' HA ' ' HD3' ' A' ' 612' ' ' PRO . 46.7 mm-40 -79.28 121.27 82.79 Favored Pre-proline 0 C--N 1.332 -0.172 0 CA-C-O 120.831 0.348 . . . . 0.0 110.386 179.085 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 612' ' ' PRO . . . . . 0.469 ' HD3' ' HA ' ' A' ' 611' ' ' GLU . 11.7 Cg_exo -70.39 146.56 56.67 Favored 'Trans proline' 0 CA--C 1.529 0.255 0 C-N-CA 123.038 2.492 . . . . 0.0 112.935 -178.422 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 613' ' ' VAL . . . . . 0.691 ' HB ' HG12 ' A' ' 606' ' ' VAL . 85.4 t -87.85 135.63 25.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.979 177.604 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 614' ' ' ALA . . . . . . . . . . . . . . . -84.5 -31.91 24.22 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.553 -175.349 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 615' ' ' GLU . . . . . 0.489 ' HB3' ' CG2' ' A' ' 627' ' ' VAL . 8.7 tp10 -161.92 92.32 1.37 Allowed Pre-proline 0 C--N 1.327 -0.407 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 -177.597 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 616' ' ' PRO . . . . . 0.452 ' HB3' HG13 ' A' ' 613' ' ' VAL . 60.8 Cg_endo -89.77 165.67 5.02 Favored 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 123.078 2.519 . . . . 0.0 114.035 -176.315 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 617' ' ' ASP . . . . . 0.436 ' OD2' ' HB ' ' A' ' 579' ' ' VAL . 0.9 OUTLIER 76.81 34.54 0.43 Allowed 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 122.33 1.062 . . . . 0.0 110.514 165.78 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 618' ' ' ILE . . . . . 0.531 ' HB ' ' O ' ' A' ' 625' ' ' VAL . 13.6 mt -78.02 109.59 12.8 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.969 0 CA-C-N 113.92 -1.491 . . . . 0.0 109.327 172.254 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 619' ' ' MET . . . . . 0.462 ' HA ' ' HE1' ' A' ' 619' ' ' MET . 8.0 mmt -80.08 131.34 35.74 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.87 -0.604 . . . . 0.0 112.034 -174.13 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 620' ' ' ALA . . . . . . . . . . . . . . . -130.6 173.07 11.24 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.262 173.358 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 621' ' ' THR . . . . . 0.55 HG22 ' HA ' ' A' ' 504' ' ' THR . 6.3 t -72.14 -29.4 64.01 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.887 0.375 . . . . 0.0 111.239 -176.857 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 622' ' ' ASN . . . . . 0.658 ' CB ' ' HA ' ' A' ' 534' ' ' GLU . 28.7 p-10 -117.34 22.7 12.29 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 112.168 0.433 . . . . 0.0 112.168 -173.745 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 623' ' ' GLY . . . . . . . . . . . . . . . 151.05 -154.85 25.82 Favored Glycine 0 N--CA 1.442 -0.919 0 C-N-CA 119.631 -1.271 . . . . 0.0 113.056 176.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 624' ' ' VAL . . . . . 0.474 HG22 HG11 ' A' ' 579' ' ' VAL . 9.7 p -129.65 159.0 42.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 N-CA-C 109.932 -0.395 . . . . 0.0 109.932 -179.707 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 625' ' ' VAL . . . . . 0.531 ' O ' ' HB ' ' A' ' 618' ' ' ILE . 67.9 t -128.04 132.3 68.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.819 178.606 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 626' ' ' HIS . . . . . . . . . . . . . 69.6 m-70 -118.46 112.3 19.77 Favored 'General case' 0 N--CA 1.445 -0.68 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 177.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 627' ' ' VAL . . . . . 0.983 HG22 ' HZ ' ' A' ' 515' ' ' PHE . 38.5 t -64.38 126.11 22.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.146 178.757 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 628' ' ' ILE . . . . . 0.535 HD13 ' HB3' ' A' ' 540' ' ' PHE . 5.4 pt -121.06 142.52 36.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.064 0.459 . . . . 0.0 110.701 176.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 629' ' ' THR . . . . . . . . . . . . . 9.5 t -97.31 2.87 51.2 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.778 0.799 . . . . 0.0 109.851 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 630' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -132.77 157.56 44.64 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.086 -0.961 . . . . 0.0 108.833 178.1 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 631' ' ' VAL . . . . . 0.563 HG13 ' HB3' ' A' ' 546' ' ' ALA . 23.8 m -92.79 156.28 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.015 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 176.363 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 632' ' ' LEU . . . . . . . . . . . . . 92.2 mt -106.1 110.89 23.3 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-O 121.281 0.562 . . . . 0.0 110.521 -178.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 633' ' ' GLN . . . . . 0.471 ' HA ' ' HD3' ' A' ' 634' ' ' PRO . 53.8 mt-30 -117.44 130.76 24.44 Favored Pre-proline 0 C--N 1.319 -0.735 0 CA-C-N 115.122 -0.944 . . . . 0.0 109.936 -177.675 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 634' ' ' PRO . . . . . 0.471 ' HD3' ' HA ' ' A' ' 633' ' ' GLN . 14.2 Cg_exo . . . . . 0 C--O 1.25 1.113 0 C-N-CA 122.814 2.343 . . . . 0.0 111.722 177.528 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 500' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 0.995 0 CA-C-O 120.755 0.312 . . . . 0.0 110.506 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 501' ' ' GLY . . . . . . . . . . . . . . . 103.03 -132.71 11.12 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.786 -0.721 . . . . 0.0 111.89 178.558 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 502' ' ' MET . . . . . . . . . . . . . 48.7 ttm -75.79 94.92 3.37 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.959 0.409 . . . . 0.0 110.19 179.053 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . -153.41 -175.77 25.14 Favored Glycine 0 N--CA 1.448 -0.545 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.77 179.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 31.5 p -90.01 -179.28 5.66 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.366 0.127 . . . . 0.0 110.875 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 505' ' ' VAL . . . . . 0.661 ' O ' ' HG ' ' A' ' 509' ' ' LEU . 22.2 t -50.43 -47.61 26.49 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.275 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.223 179.826 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 506' ' ' MET . . . . . 0.578 ' HE1' HG21 ' A' ' 528' ' ' THR . 90.8 mmm -57.37 -34.81 69.22 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.993 -176.135 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 507' ' ' ASP . . . . . 0.576 ' HA ' ' HZ1' ' A' ' 510' ' ' LYS . 12.1 t70 -76.13 -35.64 59.16 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.799 0.333 . . . . 0.0 110.133 -178.675 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 508' ' ' VAL . . . . . . . . . . . . . 64.3 t -66.0 -39.61 85.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.473 178.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 509' ' ' LEU . . . . . 0.661 ' HG ' ' O ' ' A' ' 505' ' ' VAL . 22.8 mt -65.61 -19.92 66.11 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.048 -178.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 510' ' ' LYS . . . . . 0.576 ' HZ1' ' HA ' ' A' ' 507' ' ' ASP . 30.2 mtmm -81.62 -24.96 36.08 Favored 'General case' 0 CA--C 1.514 -0.432 0 CA-C-O 121.223 0.535 . . . . 0.0 110.024 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 511' ' ' GLY . . . . . . . . . . . . . . . -80.38 -8.17 87.83 Favored Glycine 0 N--CA 1.443 -0.872 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.806 179.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 512' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -118.9 152.99 35.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.341 0.591 . . . . 0.0 111.769 -178.423 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 43.2 t-20 -76.82 -39.41 51.41 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.408 -0.815 . . . . 0.0 111.095 -178.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 514' ' ' ARG . . . . . . . . . . . . . 3.0 mpp_? -80.58 -34.31 35.39 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.105 0.479 . . . . 0.0 110.808 -171.565 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 515' ' ' PHE . . . . . 0.534 ' CZ ' HG23 ' A' ' 627' ' ' VAL . 14.5 m-30 -75.99 -8.25 56.51 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.827 178.798 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 16.8 t -59.05 -38.55 79.62 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.673 -176.071 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 517' ' ' MET . . . . . 0.519 ' HE1' ' HA ' ' A' ' 544' ' ' ASN . 3.4 mpp? -68.61 -26.56 65.42 Favored 'General case' 0 CA--C 1.519 -0.219 0 C-N-CA 120.787 -0.365 . . . . 0.0 111.025 -179.821 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 518' ' ' LEU . . . . . 0.575 HD23 HD11 ' A' ' 522' ' ' ILE . 3.3 mt -65.49 -43.29 90.64 Favored 'General case' 0 CA--C 1.517 -0.312 0 C-N-CA 120.261 -0.575 . . . . 0.0 109.554 174.201 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 519' ' ' VAL . . . . . 0.673 ' O ' ' HB2' ' A' ' 523' ' ' GLN . 30.1 t -55.09 -31.68 26.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.129 0.49 . . . . 0.0 110.41 178.455 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 520' ' ' ALA . . . . . . . . . . . . . . . -84.29 -46.71 11.51 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.46 178.497 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 521' ' ' ALA . . . . . . . . . . . . . . . -64.73 -52.52 56.64 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.872 0.368 . . . . 0.0 110.934 -178.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 522' ' ' ILE . . . . . 0.575 HD11 HD23 ' A' ' 518' ' ' LEU . 41.2 mt -59.67 -26.93 36.45 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.306 177.75 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 523' ' ' GLN . . . . . 0.673 ' HB2' ' O ' ' A' ' 519' ' ' VAL . 7.5 tp-100 -69.49 -51.98 30.8 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.398 179.297 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 38.7 t -71.53 -23.37 61.76 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.587 -176.03 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 525' ' ' ALA . . . . . . . . . . . . . . . -81.87 -17.81 46.03 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 120.972 -0.291 . . . . 0.0 111.266 178.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 526' ' ' GLY . . . . . . . . . . . . . . . 82.86 22.68 57.42 Favored Glycine 0 N--CA 1.453 -0.193 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.852 179.276 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 527' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -98.01 4.74 49.3 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.873 0.368 . . . . 0.0 110.776 -179.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 528' ' ' THR . . . . . 0.578 HG21 ' HE1' ' A' ' 506' ' ' MET . 15.5 m -59.99 -37.0 78.38 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.422 -177.109 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 529' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -64.79 -28.73 69.77 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.732 -178.068 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 530' ' ' THR . . . . . 0.542 ' HB ' HD23 ' A' ' 531' ' ' LEU . 26.4 m -64.29 -59.27 4.59 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.98 -179.415 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 531' ' ' LEU . . . . . 0.542 HD23 ' HB ' ' A' ' 530' ' ' THR . 1.7 mm? -76.57 5.83 6.8 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-O 120.869 0.366 . . . . 0.0 111.524 -179.189 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 532' ' ' ASN . . . . . . . . . . . . . 64.7 t30 -86.26 -27.14 24.61 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.37 0.605 . . . . 0.0 109.716 177.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 533' ' ' ARG . . . . . . . . . . . . . 12.7 mmm180 -92.13 160.34 15.24 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.672 178.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 534' ' ' GLU . . . . . 0.767 ' HA ' ' HB3' ' A' ' 622' ' ' ASN . 40.9 mt-10 -87.71 179.35 6.52 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 120.76 -0.376 . . . . 0.0 110.25 177.232 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 535' ' ' GLY . . . . . . . . . . . . . . . 134.86 -145.3 17.41 Favored Glycine 0 N--CA 1.445 -0.764 0 N-CA-C 110.675 -0.97 . . . . 0.0 110.675 -175.108 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 536' ' ' VAL . . . . . . . . . . . . . 34.5 m -123.07 130.37 74.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-O 121.07 0.462 . . . . 0.0 110.057 176.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 537' ' ' TYR . . . . . . . . . . . . . 71.2 m-85 -152.46 153.73 34.11 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.057 -178.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 538' ' ' THR . . . . . 0.755 ' OG1' ' HA ' ' A' ' 577' ' ' ILE . 50.4 m -132.1 103.71 6.41 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 174.673 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 539' ' ' VAL . . . . . . . . . . . . . 47.9 t -105.71 124.65 60.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.926 -173.228 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 540' ' ' PHE . . . . . 0.575 ' HB3' HD12 ' A' ' 628' ' ' ILE . 99.0 m-85 -95.85 111.08 23.15 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 173.328 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -97.82 112.97 62.98 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.712 -176.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 542' ' ' PRO . . . . . 0.491 ' HA ' HG13 ' A' ' 628' ' ' ILE . 7.9 Cg_exo -73.12 135.75 23.46 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 122.702 2.268 . . . . 0.0 110.708 174.302 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 40.4 p -76.96 179.31 6.28 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.529 -177.216 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 544' ' ' ASN . . . . . 0.519 ' HA ' ' HE1' ' A' ' 517' ' ' MET . 25.0 t-20 -62.41 -33.73 75.37 Favored 'General case' 0 CA--C 1.52 -0.185 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 178.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 545' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -54.28 -45.09 72.41 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.19 -0.913 . . . . 0.0 110.759 178.152 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 546' ' ' ALA . . . . . 0.489 ' O ' HD21 ' A' ' 550' ' ' LEU . . . -67.06 -49.12 66.17 Favored 'General case' 0 CA--C 1.514 -0.431 0 CA-C-O 121.018 0.437 . . . . 0.0 111.283 -179.18 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 547' ' ' PHE . . . . . . . . . . . . . 29.9 m-85 -64.24 -25.61 68.14 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.705 -0.68 . . . . 0.0 111.315 -177.32 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 548' ' ' ARG . . . . . . . . . . . . . 23.8 ttm180 -86.7 -28.02 23.36 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.273 0.559 . . . . 0.0 110.179 178.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 549' ' ' ALA . . . . . . . . . . . . . . . -79.63 -10.51 59.8 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.242 -0.89 . . . . 0.0 112.103 -176.235 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 550' ' ' LEU . . . . . 0.519 ' HB2' ' HG3' ' A' ' 555' ' ' ARG . 0.1 OUTLIER -54.23 143.47 44.55 Favored Pre-proline 0 N--CA 1.454 -0.23 0 CA-C-O 120.759 0.314 . . . . 0.0 110.671 174.503 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 551' ' ' PRO . . . . . 0.627 ' HD2' ' HB2' ' A' ' 554' ' ' GLU . 2.6 Cg_endo -80.02 142.04 15.24 Favored 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 123.125 2.55 . . . . 0.0 110.547 -172.567 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 552' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_exo -43.47 -39.87 9.73 Favored 'Trans proline' 0 CA--C 1.533 0.458 0 C-N-CA 123.139 2.56 . . . . 0.0 113.348 -176.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 553' ' ' ARG . . . . . . . . . . . . . 44.7 mtp180 -68.3 -52.14 37.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.862 0.363 . . . . 0.0 111.721 177.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 554' ' ' GLU . . . . . 0.627 ' HB2' ' HD2' ' A' ' 551' ' ' PRO . 5.1 mm-40 -83.15 -42.72 17.0 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.911 -171.843 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 555' ' ' ARG . . . . . 0.519 ' HG3' ' HB2' ' A' ' 550' ' ' LEU . 26.1 ttt180 -46.87 -55.76 7.45 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 122.697 0.399 . . . . 0.0 111.429 173.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 14.8 m -62.45 -31.98 72.78 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.123 -178.159 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 557' ' ' ARG . . . . . . . . . . . . . 24.4 ttt180 -69.42 -59.24 3.12 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.587 176.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 558' ' ' LEU . . . . . 0.837 HD23 ' HB3' ' A' ' 564' ' ' GLU . 0.7 OUTLIER -60.2 -50.47 73.54 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.507 -175.406 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 559' ' ' LEU . . . . . . . . . . . . . 74.6 mt -87.95 19.53 3.53 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.632 -177.368 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 560' ' ' GLY . . . . . . . . . . . . . . . -125.4 4.11 8.21 Favored Glycine 0 N--CA 1.445 -0.706 0 CA-C-N 115.949 -0.568 . . . . 0.0 111.928 179.459 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 561' ' ' ASP . . . . . 0.481 ' OD2' ' HB3' ' A' ' 563' ' ' LYS . 18.0 t70 -142.59 142.24 32.11 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.653 0.264 . . . . 0.0 110.666 179.443 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 562' ' ' ALA . . . . . . . . . . . . . . . -76.51 -32.26 58.19 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.856 -177.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 563' ' ' LYS . . . . . 0.481 ' HB3' ' OD2' ' A' ' 561' ' ' ASP . 13.1 ttpt -69.0 -49.51 57.16 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.136 179.772 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 564' ' ' GLU . . . . . 0.837 ' HB3' HD23 ' A' ' 558' ' ' LEU . 59.7 mm-40 -52.07 -48.83 64.47 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.729 176.387 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 565' ' ' LEU . . . . . . . . . . . . . 39.5 mt -56.02 -55.2 35.71 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.416 177.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 566' ' ' ALA . . . . . . . . . . . . . . . -57.13 -48.06 79.6 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.55 -175.38 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 567' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -61.25 -45.62 93.78 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.637 -176.205 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 568' ' ' ILE . . . . . 0.692 HG13 HD22 ' A' ' 558' ' ' LEU . 47.7 mm -74.17 -34.9 39.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.828 -176.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 569' ' ' LEU . . . . . . . . . . . . . 66.4 mt -68.04 -33.31 74.33 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.962 -0.295 . . . . 0.0 111.01 179.632 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 570' ' ' LYS . . . . . 0.733 ' HE3' ' HA ' ' A' ' 593' ' ' GLN . 26.9 mtpp -62.97 -18.5 63.29 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.939 0.4 . . . . 0.0 111.012 175.61 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 571' ' ' TYR . . . . . 0.489 ' O ' HD21 ' A' ' 597' ' ' LEU . 25.9 t80 -91.75 -17.85 24.78 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.895 -177.136 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 572' ' ' HIS . . . . . . . . . . . . . 61.5 m80 -90.72 -14.72 31.59 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.866 0.365 . . . . 0.0 111.053 -179.287 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 573' ' ' ILE . . . . . . . . . . . . . 42.9 mt -103.83 116.4 47.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.318 178.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 574' ' ' GLY . . . . . 0.533 ' HA2' ' HA ' ' A' ' 591' ' ' SER . . . -97.95 153.86 20.14 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 121.013 -0.613 . . . . 0.0 111.723 176.043 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 575' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -90.96 -6.46 54.03 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.252 0.549 . . . . 0.0 111.062 -176.196 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 576' ' ' GLU . . . . . 0.455 ' HB2' HD23 ' A' ' 589' ' ' LEU . 24.9 mt-10 -129.11 122.75 30.54 Favored 'General case' 0 CA--C 1.508 -0.663 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 -170.245 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 577' ' ' ILE . . . . . 0.755 ' HA ' ' OG1' ' A' ' 538' ' ' THR . 61.5 mt -73.05 116.55 15.42 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.943 -175.233 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 578' ' ' LEU . . . . . 0.551 HD13 ' HA ' ' A' ' 583' ' ' ILE . 23.5 tp -127.03 113.41 16.43 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.442 179.057 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 579' ' ' VAL . . . . . 0.467 ' O ' HG13 ' A' ' 583' ' ' ILE . 35.8 m -104.96 163.1 4.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.177 178.086 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 580' ' ' SER . . . . . . . . . . . . . 32.8 t -56.48 -47.74 78.6 Favored 'General case' 0 C--N 1.331 -0.228 0 O-C-N 123.32 0.388 . . . . 0.0 110.887 -176.282 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 581' ' ' GLY . . . . . . . . . . . . . . . -74.73 8.27 15.76 Favored Glycine 0 CA--C 1.521 0.411 0 C-N-CA 120.941 -0.647 . . . . 0.0 113.327 -178.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . -131.77 9.87 5.48 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.511 -0.852 . . . . 0.0 113.109 179.245 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 583' ' ' ILE . . . . . 0.551 ' HA ' HD13 ' A' ' 578' ' ' LEU . 47.0 mt -78.02 -77.54 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.956 0.378 . . . . 0.0 110.877 178.779 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 584' ' ' GLY . . . . . . . . . . . . . . . 84.72 81.69 1.05 Allowed Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.495 -0.859 . . . . 0.0 112.069 -175.314 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 585' ' ' ALA . . . . . . . . . . . . . . . 71.73 -74.69 0.08 Allowed 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 123.578 0.751 . . . . 0.0 112.084 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 586' ' ' LEU . . . . . 0.642 ' HG ' ' HB2' ' A' ' 600' ' ' SER . 2.3 tt -164.71 142.2 6.37 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.571 0.225 . . . . 0.0 110.422 -176.755 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 587' ' ' VAL . . . . . 0.539 ' N ' HD23 ' A' ' 586' ' ' LEU . 91.2 t -140.14 139.75 36.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.23 -178.697 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 588' ' ' ARG . . . . . 0.4 ' HA ' ' HD3' ' A' ' 588' ' ' ARG . 34.0 mmt180 -85.57 105.51 16.21 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.927 0.394 . . . . 0.0 110.138 177.122 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 589' ' ' LEU . . . . . 0.455 HD23 ' HB2' ' A' ' 576' ' ' GLU . 0.3 OUTLIER -99.86 124.62 45.36 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.374 -177.189 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 590' ' ' LYS . . . . . . . . . . . . . 47.4 mtpt -90.48 140.1 30.06 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.466 0.65 . . . . 0.0 111.563 -177.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 591' ' ' SER . . . . . 0.533 ' HA ' ' HA2' ' A' ' 574' ' ' GLY . 78.0 p -102.15 166.47 10.58 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.367 -177.542 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 592' ' ' LEU . . . . . . . . . . . . . 9.9 mp -67.44 -7.21 23.56 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 112.527 0.566 . . . . 0.0 112.527 178.235 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 593' ' ' GLN . . . . . 0.733 ' HA ' ' HE3' ' A' ' 570' ' ' LYS . 4.6 tt0 -76.74 -29.2 56.05 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 171.708 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 594' ' ' GLY . . . . . . . . . . . . . . . 113.41 -20.36 18.61 Favored Glycine 0 N--CA 1.444 -0.791 0 CA-C-N 115.203 -0.908 . . . . 0.0 111.62 -177.15 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 595' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -84.08 -178.57 7.0 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 120.984 0.421 . . . . 0.0 109.867 -179.594 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 596' ' ' LYS . . . . . 0.723 ' H ' ' HD3' ' A' ' 596' ' ' LYS . 0.0 OUTLIER -118.72 136.96 53.66 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.796 -172.272 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 597' ' ' LEU . . . . . 0.489 HD21 ' O ' ' A' ' 571' ' ' TYR . 56.6 mt -90.51 142.55 27.63 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.648 179.609 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 598' ' ' GLU . . . . . 0.558 ' O ' ' HA ' ' A' ' 608' ' ' VAL . 13.7 tp10 -86.01 82.2 8.2 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 178.497 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 599' ' ' VAL . . . . . 0.449 HG13 HD21 ' A' ' 578' ' ' LEU . 25.8 t -104.58 121.88 56.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 121.128 0.489 . . . . 0.0 110.081 -176.879 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 600' ' ' SER . . . . . 0.642 ' HB2' ' HG ' ' A' ' 586' ' ' LEU . 37.4 t -141.23 168.39 19.89 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.499 0.666 . . . . 0.0 110.96 -172.626 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 601' ' ' LEU . . . . . 0.493 ' HB2' HD11 ' A' ' 583' ' ' ILE . 52.7 tp -140.45 108.27 5.67 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 114.535 -1.211 . . . . 0.0 108.955 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 602' ' ' LYS . . . . . . . . . . . . . 65.1 mttp -120.79 107.12 12.35 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.903 -177.239 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 603' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 63.42 42.86 6.41 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.613 177.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 604' ' ' ASN . . . . . . . . . . . . . 66.6 t30 72.95 14.65 4.75 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.608 178.067 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 605' ' ' VAL . . . . . . . . . . . . . 56.6 t -110.51 114.01 45.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.997 175.495 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 606' ' ' VAL . . . . . 0.723 HG11 ' HB ' ' A' ' 613' ' ' VAL . 6.6 p -84.97 140.16 16.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.2 0.524 . . . . 0.0 110.935 -179.01 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 607' ' ' SER . . . . . . . . . . . . . 7.4 p -142.19 154.58 44.94 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.835 -178.197 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 608' ' ' VAL . . . . . 0.558 ' HA ' ' O ' ' A' ' 598' ' ' GLU . 7.5 p -142.65 119.89 6.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.147 178.006 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 609' ' ' ASN . . . . . 0.824 ' HB2' HD21 ' A' ' 632' ' ' LEU . 4.0 m-20 59.88 50.04 7.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.131 173.715 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 610' ' ' LYS . . . . . 0.496 ' HE3' ' HB2' ' A' ' 610' ' ' LYS . 35.6 mtmt 77.15 -21.91 0.31 Allowed 'General case' 0 N--CA 1.476 0.826 0 O-C-N 123.66 0.6 . . . . 0.0 111.378 179.819 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 611' ' ' GLU . . . . . 0.402 ' H ' ' C ' ' A' ' 609' ' ' ASN . 48.6 mm-40 -90.96 140.91 26.19 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.732 -176.879 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 612' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -81.26 141.58 12.89 Favored 'Trans proline' 0 N--CA 1.458 -0.603 0 C-N-CA 122.134 1.889 . . . . 0.0 111.459 173.589 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 613' ' ' VAL . . . . . 0.723 ' HB ' HG11 ' A' ' 606' ' ' VAL . 99.5 t -74.34 120.59 23.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 176.76 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 614' ' ' ALA . . . . . 0.498 ' HB1' HG21 ' A' ' 629' ' ' THR . . . -76.5 -26.22 55.05 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.868 -172.815 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 615' ' ' GLU . . . . . 0.591 ' HB3' ' HB ' ' A' ' 627' ' ' VAL . 17.4 tt0 -165.49 89.25 0.94 Allowed Pre-proline 0 C--N 1.325 -0.49 0 CA-C-O 121.189 0.519 . . . . 0.0 109.832 -174.417 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 616' ' ' PRO . . . . . 0.432 ' HB3' HG13 ' A' ' 613' ' ' VAL . 72.0 Cg_endo -88.82 163.57 6.14 Favored 'Trans proline' 0 N--CA 1.456 -0.732 0 C-N-CA 123.059 2.506 . . . . 0.0 113.708 -175.669 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 26.6 t0 78.43 64.61 0.03 OUTLIER 'General case' 0 CA--C 1.51 -0.567 0 CA-C-O 123.024 1.392 . . . . 0.0 110.594 169.38 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 618' ' ' ILE . . . . . 0.511 ' HB ' ' O ' ' A' ' 625' ' ' VAL . 24.4 mt -115.86 102.21 13.38 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.278 0 CA-C-N 112.795 -2.002 . . . . 0.0 108.573 176.058 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 619' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.73 135.7 37.21 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.707 -0.679 . . . . 0.0 112.812 -169.313 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 620' ' ' ALA . . . . . . . . . . . . . . . -129.1 176.72 7.68 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.329 -0.851 . . . . 0.0 108.795 171.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 621' ' ' THR . . . . . . . . . . . . . 4.5 t -82.75 -21.71 34.6 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.603 -0.439 . . . . 0.0 110.874 -179.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 622' ' ' ASN . . . . . 0.767 ' HB3' ' HA ' ' A' ' 534' ' ' GLU . 27.4 p-10 -116.24 22.11 13.13 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.719 0.295 . . . . 0.0 111.441 -176.692 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 623' ' ' GLY . . . . . . . . . . . . . . . 147.47 -150.88 23.18 Favored Glycine 0 N--CA 1.443 -0.859 0 C-N-CA 120.332 -0.937 . . . . 0.0 112.626 177.229 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 624' ' ' VAL . . . . . . . . . . . . . 6.3 p -135.79 158.46 39.41 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 -179.164 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 625' ' ' VAL . . . . . 0.511 ' O ' ' HB ' ' A' ' 618' ' ' ILE . 46.8 t -123.93 136.87 58.87 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.675 178.764 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 626' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 -122.79 121.13 35.55 Favored 'General case' 0 N--CA 1.445 -0.681 0 N-CA-C 109.908 -0.405 . . . . 0.0 109.908 175.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 627' ' ' VAL . . . . . 0.591 ' HB ' ' HB3' ' A' ' 615' ' ' GLU . 60.8 t -70.21 130.67 34.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.56 179.025 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 628' ' ' ILE . . . . . 0.575 HD12 ' HB3' ' A' ' 540' ' ' PHE . 7.2 pt -127.34 150.19 33.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.819 176.199 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 629' ' ' THR . . . . . 0.498 HG21 ' HB1' ' A' ' 614' ' ' ALA . 16.6 p -94.91 2.83 55.45 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.91 -176.283 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 630' ' ' ASN . . . . . . . . . . . . . 66.1 m-20 -144.08 168.76 19.24 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.409 -177.39 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 631' ' ' VAL . . . . . . . . . . . . . 97.2 t -95.91 125.74 48.65 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 115.426 -0.807 . . . . 0.0 109.206 176.518 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 632' ' ' LEU . . . . . 0.824 HD21 ' HB2' ' A' ' 609' ' ' ASN . 89.6 mt -70.87 114.41 8.91 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-O 121.33 0.586 . . . . 0.0 110.893 -174.602 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 633' ' ' GLN . . . . . 0.491 ' HA ' ' HD3' ' A' ' 634' ' ' PRO . 85.7 mm-40 -102.47 131.17 22.74 Favored Pre-proline 0 C--N 1.317 -0.835 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.947 -177.095 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 634' ' ' PRO . . . . . 0.491 ' HD3' ' HA ' ' A' ' 633' ' ' GLN . 4.9 Cg_exo . . . . . 0 C--O 1.253 1.25 0 C-N-CA 123.051 2.501 . . . . 0.0 111.569 176.25 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 500' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.053 0 N-CA-C 110.189 -0.3 . . . . 0.0 110.189 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 501' ' ' GLY . . . . . . . . . . . . . . . 148.72 2.59 0.37 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.495 -178.308 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 502' ' ' MET . . . . . . . . . . . . . 24.7 mmt 67.88 -174.45 0.19 Allowed 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 121.012 0.434 . . . . 0.0 111.511 178.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 99.04 164.77 29.99 Favored Glycine 0 N--CA 1.447 -0.57 0 N-CA-C 111.311 -0.715 . . . . 0.0 111.311 -176.423 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 504' ' ' THR . . . . . 0.452 ' O ' HG22 ' A' ' 508' ' ' VAL . 38.8 p -81.47 156.95 25.07 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 120.83 -0.348 . . . . 0.0 110.307 179.118 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 7.1 p -49.55 -39.2 13.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.892 -0.595 . . . . 0.0 112.359 -176.099 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 506' ' ' MET . . . . . 0.487 ' HG2' ' HB2' ' A' ' 531' ' ' LEU . 2.9 ppp? -83.82 -21.86 31.96 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.806 0.336 . . . . 0.0 111.524 -177.109 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 507' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -86.22 -28.89 23.58 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.042 0.448 . . . . 0.0 110.645 -178.238 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 508' ' ' VAL . . . . . 0.452 HG22 ' O ' ' A' ' 504' ' ' THR . 87.5 t -61.89 -27.58 42.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.297 175.394 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 509' ' ' LEU . . . . . . . . . . . . . 25.3 mt -65.05 -19.54 66.04 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.536 -179.099 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 5.3 mptt -76.25 -24.15 54.53 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.022 0.439 . . . . 0.0 110.481 -179.068 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 511' ' ' GLY . . . . . . . . . . . . . . . -80.56 -10.11 85.63 Favored Glycine 0 N--CA 1.444 -0.773 0 C-N-CA 120.407 -0.902 . . . . 0.0 111.179 177.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 512' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -114.86 137.62 51.75 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.26 0.552 . . . . 0.0 111.714 -176.253 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 9.9 p30 -77.34 -19.76 55.85 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 115.526 -0.761 . . . . 0.0 112.459 -177.214 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 514' ' ' ARG . . . . . . . . . . . . . 5.3 tpp180 -89.04 -28.54 20.08 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 120.687 0.279 . . . . 0.0 110.988 -170.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 515' ' ' PHE . . . . . 0.609 ' CZ ' HG23 ' A' ' 627' ' ' VAL . 9.5 m-85 -92.83 8.62 38.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.682 178.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 13.0 p -55.37 -44.8 76.36 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.066 -0.515 . . . . 0.0 112.376 -176.145 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 517' ' ' MET . . . . . 0.445 ' HE1' ' HB2' ' A' ' 517' ' ' MET . 2.8 mpp? -63.36 -31.29 72.4 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.502 0.191 . . . . 0.0 111.09 179.642 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 518' ' ' LEU . . . . . . . . . . . . . 44.2 tp -70.63 -36.38 73.41 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 120.502 -0.479 . . . . 0.0 110.207 -179.408 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 519' ' ' VAL . . . . . . . . . . . . . 59.1 t -58.94 -37.7 68.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.257 0.551 . . . . 0.0 109.559 174.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 520' ' ' ALA . . . . . . . . . . . . . . . -71.61 -40.98 69.46 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.644 -178.225 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 521' ' ' ALA . . . . . . . . . . . . . . . -63.96 -50.41 68.72 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.927 178.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 522' ' ' ILE . . . . . . . . . . . . . 72.9 mt -60.88 -40.43 85.25 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.894 179.115 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 523' ' ' GLN . . . . . . . . . . . . . 59.2 tt0 -61.78 -46.28 90.22 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.864 178.543 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 27.5 m -67.68 -47.52 69.22 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.495 -177.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 525' ' ' ALA . . . . . . . . . . . . . . . -70.77 -28.46 64.69 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.642 0.258 . . . . 0.0 111.504 -179.044 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 526' ' ' GLY . . . . . . . . . . . . . . . 85.54 41.49 7.31 Favored Glycine 0 C--O 1.227 -0.323 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.61 178.119 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 527' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -102.06 13.0 35.95 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.909 0.385 . . . . 0.0 110.863 -178.548 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 528' ' ' THR . . . . . . . . . . . . . 18.7 m -65.17 -33.99 77.31 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.117 -178.163 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 529' ' ' GLU . . . . . . . . . . . . . 28.9 mm-40 -55.44 -43.69 75.64 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.814 -176.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 530' ' ' THR . . . . . . . . . . . . . 22.1 m -66.27 -43.08 87.45 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.293 -176.124 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 531' ' ' LEU . . . . . 0.487 ' HB2' ' HG2' ' A' ' 506' ' ' MET . 68.8 mt -87.67 14.09 9.16 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.027 0.441 . . . . 0.0 111.314 -174.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 532' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -89.56 -29.5 18.86 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.756 178.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 533' ' ' ARG . . . . . 0.432 HH11 ' HD2' ' A' ' 533' ' ' ARG . 4.2 tpp180 -86.09 143.84 27.85 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.415 -0.812 . . . . 0.0 110.245 179.069 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 534' ' ' GLU . . . . . 0.657 ' HA ' ' CB ' ' A' ' 622' ' ' ASN . 42.8 tt0 -79.93 147.66 31.55 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.078 0.466 . . . . 0.0 110.515 176.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 535' ' ' GLY . . . . . . . . . . . . . . . 169.0 -136.33 4.01 Favored Glycine 0 N--CA 1.445 -0.75 0 N-CA-C 110.4 -1.08 . . . . 0.0 110.4 -177.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 536' ' ' VAL . . . . . 0.53 ' HB ' HG13 ' A' ' 577' ' ' ILE . 34.0 m -124.22 129.79 73.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 117.297 0.549 . . . . 0.0 110.411 177.518 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 537' ' ' TYR . . . . . . . . . . . . . 82.4 m-85 -154.19 146.55 23.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.934 -0.575 . . . . 0.0 109.926 -179.033 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 538' ' ' THR . . . . . 0.748 ' OG1' ' HA ' ' A' ' 577' ' ' ILE . 55.7 m -136.76 100.36 4.3 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 120.813 0.339 . . . . 0.0 110.117 175.235 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 539' ' ' VAL . . . . . 0.619 ' HA ' ' O ' ' A' ' 572' ' ' HIS . 1.3 p -115.17 132.09 65.48 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-O 121.392 0.615 . . . . 0.0 111.242 -177.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 540' ' ' PHE . . . . . . . . . . . . . 68.4 m-85 -89.1 117.16 27.9 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.003 -0.999 . . . . 0.0 109.693 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 541' ' ' ALA . . . . . 0.411 ' HA ' ' HD3' ' A' ' 542' ' ' PRO . . . -93.67 114.42 62.96 Favored Pre-proline 0 C--N 1.326 -0.435 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.575 -179.34 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 542' ' ' PRO . . . . . 0.619 ' HA ' HG13 ' A' ' 628' ' ' ILE . 7.9 Cg_exo -72.88 131.47 17.03 Favored 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 122.88 2.387 . . . . 0.0 111.516 177.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 75.2 p -71.87 175.48 5.77 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.574 179.364 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 544' ' ' ASN . . . . . . . . . . . . . 10.7 p30 -72.67 -21.21 61.11 Favored 'General case' 0 CA--C 1.519 -0.221 0 C-N-CA 120.094 -0.643 . . . . 0.0 109.449 179.05 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 545' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -62.18 -35.7 79.63 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.74 174.319 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 546' ' ' ALA . . . . . 0.565 ' HB3' HG22 ' A' ' 631' ' ' VAL . . . -70.13 -48.31 58.03 Favored 'General case' 0 CA--C 1.513 -0.474 0 CA-C-O 121.19 0.519 . . . . 0.0 110.772 178.838 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 547' ' ' PHE . . . . . . . . . . . . . 64.2 m-85 -68.14 -23.72 64.91 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.331 -177.575 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 548' ' ' ARG . . . . . . . . . . . . . 43.7 mtm180 -86.78 -21.9 26.23 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-O 120.706 0.289 . . . . 0.0 110.863 175.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 549' ' ' ALA . . . . . . . . . . . . . . . -85.66 -5.59 59.25 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.969 0.414 . . . . 0.0 110.682 177.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 550' ' ' LEU . . . . . 0.523 HD13 HG23 ' A' ' 631' ' ' VAL . 93.5 mt -75.74 134.27 72.43 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.264 176.172 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 551' ' ' PRO . . . . . 0.492 ' HD3' ' HA ' ' A' ' 550' ' ' LEU . 12.4 Cg_exo -69.99 148.02 62.68 Favored 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 122.7 2.267 . . . . 0.0 110.568 179.034 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 552' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_exo -50.83 -41.73 53.98 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.576 2.184 . . . . 0.0 112.072 -178.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 553' ' ' ARG . . . . . . . . . . . . . 22.8 tpt180 -57.25 -52.16 66.46 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.287 178.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -65.88 -55.29 17.73 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 111.824 0.305 . . . . 0.0 111.824 -176.328 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 555' ' ' ARG . . . . . 0.446 ' HG2' ' O ' ' A' ' 551' ' ' PRO . 30.8 ptt180 -63.96 -32.65 74.26 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 -175.699 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 32.1 m -74.94 -31.69 61.57 Favored 'General case' 0 N--CA 1.464 0.262 0 O-C-N 122.083 -0.385 . . . . 0.0 110.936 179.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 557' ' ' ARG . . . . . . . . . . . . . 73.7 ttt180 -69.65 -47.79 62.14 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.976 0.417 . . . . 0.0 109.964 176.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 558' ' ' LEU . . . . . 0.551 ' HG ' HD22 ' A' ' 565' ' ' LEU . 40.1 tp -60.56 -44.83 95.72 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.493 -178.131 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 559' ' ' LEU . . . . . 0.609 HD23 HD23 ' A' ' 565' ' ' LEU . 96.7 mt -81.98 4.55 22.29 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.065 0.459 . . . . 0.0 110.898 -179.452 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 560' ' ' GLY . . . . . . . . . . . . . . . -85.0 -22.61 52.14 Favored Glycine 0 N--CA 1.439 -1.114 0 C-N-CA 120.663 -0.78 . . . . 0.0 112.012 179.158 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 561' ' ' ASP . . . . . 0.672 ' HB3' ' HG2' ' A' ' 564' ' ' GLU . 11.9 t70 -139.38 142.7 37.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.939 0.399 . . . . 0.0 110.691 -178.037 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 562' ' ' ALA . . . . . . . . . . . . . . . -77.58 -29.04 51.86 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.821 -175.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 563' ' ' LYS . . . . . . . . . . . . . 27.2 ttpp -73.16 -39.03 65.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.815 0.341 . . . . 0.0 110.203 -178.231 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 564' ' ' GLU . . . . . 0.672 ' HG2' ' HB3' ' A' ' 561' ' ' ASP . 3.3 mm-40 -62.89 -42.5 99.8 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.436 178.728 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 565' ' ' LEU . . . . . 0.609 HD23 HD23 ' A' ' 559' ' ' LEU . 69.3 mt -55.81 -51.35 67.77 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.489 174.5 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 566' ' ' ALA . . . . . . . . . . . . . . . -58.07 -44.01 87.28 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.535 -178.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 567' ' ' ASN . . . . . . . . . . . . . 4.9 t30 -67.65 -32.86 73.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.189 -177.294 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 568' ' ' ILE . . . . . 0.501 HG12 ' O ' ' A' ' 564' ' ' GLU . 47.9 mm -72.94 -40.25 59.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 120.86 0.362 . . . . 0.0 110.386 176.73 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 569' ' ' LEU . . . . . 0.502 ' HG ' ' O ' ' A' ' 565' ' ' LEU . 96.0 mt -63.01 -42.92 99.96 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.301 179.673 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 570' ' ' LYS . . . . . 0.659 ' HE2' ' HA ' ' A' ' 593' ' ' GLN . 17.5 ptmt -70.86 -8.05 49.94 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.113 -178.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 571' ' ' TYR . . . . . 0.457 ' HB2' HE21 ' A' ' 593' ' ' GLN . 62.3 t80 -93.81 -18.76 21.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.962 0.41 . . . . 0.0 110.392 174.609 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 572' ' ' HIS . . . . . 0.619 ' O ' ' HA ' ' A' ' 539' ' ' VAL . 47.4 m80 -91.07 -20.18 22.34 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.748 179.643 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 573' ' ' ILE . . . . . 0.425 HG13 ' O ' ' A' ' 569' ' ' LEU . 27.2 mt -96.07 116.62 38.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.526 177.469 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 574' ' ' GLY . . . . . 0.583 ' HA2' ' HA ' ' A' ' 591' ' ' SER . . . -88.61 156.01 26.32 Favored Glycine 0 N--CA 1.449 -0.473 0 N-CA-C 111.78 -0.528 . . . . 0.0 111.78 176.297 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 575' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -82.75 -3.19 56.2 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 112.219 0.451 . . . . 0.0 112.219 -172.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 576' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -152.7 157.72 41.31 Favored 'General case' 0 N--CA 1.44 -0.967 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 -174.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 577' ' ' ILE . . . . . 0.748 ' HA ' ' OG1' ' A' ' 538' ' ' THR . 68.7 mt -92.56 117.59 36.27 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-N 115.76 -0.655 . . . . 0.0 112.055 -172.709 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 578' ' ' LEU . . . . . 0.549 HD22 HD12 ' A' ' 589' ' ' LEU . 3.4 mm? -123.99 102.3 7.69 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.389 175.544 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 579' ' ' VAL . . . . . 0.509 ' O ' HG13 ' A' ' 583' ' ' ILE . 30.9 m -97.28 172.11 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.07 179.36 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 580' ' ' SER . . . . . 0.505 ' HA ' HD13 ' A' ' 601' ' ' LEU . 27.6 m -54.72 -36.49 64.78 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.5 179.549 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 581' ' ' GLY . . . . . . . . . . . . . . . -80.81 -1.02 89.23 Favored Glycine 0 CA--C 1.521 0.425 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.982 -179.13 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . -114.4 -38.92 1.06 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.526 -0.845 . . . . 0.0 113.001 -177.554 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 583' ' ' ILE . . . . . 0.509 HG13 ' O ' ' A' ' 579' ' ' VAL . 63.8 mt -60.03 -57.69 10.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 120.692 0.282 . . . . 0.0 111.555 -176.292 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 584' ' ' GLY . . . . . . . . . . . . . . . 78.9 -66.47 3.37 Favored Glycine 0 CA--C 1.52 0.356 0 C-N-CA 120.924 -0.655 . . . . 0.0 113.327 176.523 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 585' ' ' ALA . . . . . . . . . . . . . . . -130.02 -68.61 0.7 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.532 0.206 . . . . 0.0 111.549 -176.382 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 586' ' ' LEU . . . . . 0.538 HD13 ' HB3' ' A' ' 600' ' ' SER . 41.2 tp -153.57 128.62 9.64 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.773 0.32 . . . . 0.0 110.569 -179.85 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 587' ' ' VAL . . . . . . . . . . . . . 57.9 t -137.03 127.47 39.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.627 178.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 588' ' ' ARG . . . . . 0.423 ' HG2' ' HG2' ' A' ' 598' ' ' GLU . 72.8 mtt180 -85.54 109.02 18.22 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.485 0.659 . . . . 0.0 109.909 176.662 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 589' ' ' LEU . . . . . 0.549 HD12 HD22 ' A' ' 578' ' ' LEU . 34.7 tp -91.22 113.78 26.13 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 114.806 -1.088 . . . . 0.0 110.214 -175.53 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 590' ' ' LYS . . . . . . . . . . . . . 25.6 pttm -76.46 134.82 39.43 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.635 -0.505 . . . . 0.0 109.635 177.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 591' ' ' SER . . . . . 0.583 ' HA ' ' HA2' ' A' ' 574' ' ' GLY . 79.7 p -99.08 166.88 11.04 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.128 -177.442 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 592' ' ' LEU . . . . . . . . . . . . . 10.3 mp -63.86 -12.9 40.5 Favored 'General case' 0 C--N 1.333 -0.123 0 N-CA-C 112.211 0.449 . . . . 0.0 112.211 178.244 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 593' ' ' GLN . . . . . 0.659 ' HA ' ' HE2' ' A' ' 570' ' ' LYS . 5.0 tt0 -77.55 -29.32 52.2 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.391 0.615 . . . . 0.0 109.854 174.825 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 594' ' ' GLY . . . . . . . . . . . . . . . 111.48 -16.53 26.61 Favored Glycine 0 N--CA 1.447 -0.588 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.423 -174.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 595' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -79.0 178.6 7.9 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 179.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 596' ' ' LYS . . . . . . . . . . . . . 56.6 mttp -124.43 121.4 34.8 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.281 0.562 . . . . 0.0 111.983 -169.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 597' ' ' LEU . . . . . . . . . . . . . 67.5 mt -90.38 116.54 28.4 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.235 -0.893 . . . . 0.0 109.306 173.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 598' ' ' GLU . . . . . 0.423 ' HG2' ' HG2' ' A' ' 588' ' ' ARG . 46.9 mt-10 -89.13 92.75 9.32 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 121.456 0.646 . . . . 0.0 110.092 -177.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 599' ' ' VAL . . . . . . . . . . . . . 23.4 t -96.53 125.64 49.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.051 -0.977 . . . . 0.0 110.146 -176.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 600' ' ' SER . . . . . 0.538 ' HB3' HD13 ' A' ' 586' ' ' LEU . 18.2 p -125.78 156.87 38.79 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.445 -179.383 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 601' ' ' LEU . . . . . 0.505 HD13 ' HA ' ' A' ' 580' ' ' SER . 0.3 OUTLIER -127.75 109.9 12.1 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.261 -179.626 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 602' ' ' LYS . . . . . 0.42 ' HE2' ' HB2' ' A' ' 602' ' ' LYS . 25.8 mtmm -128.87 123.0 31.58 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.25 -0.887 . . . . 0.0 109.806 -171.73 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 603' ' ' ASN . . . . . 0.449 ' O ' ' HB2' ' A' ' 604' ' ' ASN . 13.3 m120 64.38 25.93 13.49 Favored 'General case' 0 N--CA 1.466 0.34 0 O-C-N 123.571 0.544 . . . . 0.0 109.778 178.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 604' ' ' ASN . . . . . 0.449 ' HB2' ' O ' ' A' ' 603' ' ' ASN . 88.5 m-20 71.84 14.26 5.97 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.324 -175.633 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 605' ' ' VAL . . . . . . . . . . . . . 44.8 t -107.98 119.84 58.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.129 -0.487 . . . . 0.0 109.809 173.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 606' ' ' VAL . . . . . 0.806 HG12 ' HB ' ' A' ' 613' ' ' VAL . 5.2 p -86.67 139.8 16.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 121.026 0.441 . . . . 0.0 110.887 -178.6 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 607' ' ' SER . . . . . . . . . . . . . 2.9 m -140.71 135.19 31.33 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.474 -178.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 608' ' ' VAL . . . . . . . . . . . . . 3.7 p -111.48 119.95 60.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 177.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 609' ' ' ASN . . . . . 0.529 ' O ' ' HB2' ' A' ' 610' ' ' LYS . 5.3 m-20 59.22 37.18 23.9 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.485 177.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 610' ' ' LYS . . . . . 0.529 ' HB2' ' O ' ' A' ' 609' ' ' ASN . 34.4 mmtp 81.34 -15.44 0.72 Allowed 'General case' 0 N--CA 1.475 0.797 0 O-C-N 124.171 0.919 . . . . 0.0 112.326 -178.716 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 611' ' ' GLU . . . . . 0.413 ' HA ' ' HD3' ' A' ' 612' ' ' PRO . 18.1 mm-40 -84.8 138.55 37.63 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 120.8 0.333 . . . . 0.0 111.072 -178.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 612' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 611' ' ' GLU . 1.9 Cg_endo -82.02 134.02 8.03 Favored 'Trans proline' 0 N--CA 1.46 -0.468 0 C-N-CA 123.387 2.724 . . . . 0.0 113.274 -176.471 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 613' ' ' VAL . . . . . 0.806 ' HB ' HG12 ' A' ' 606' ' ' VAL . 50.3 t -81.57 130.89 35.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.053 175.773 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 614' ' ' ALA . . . . . . . . . . . . . . . -71.21 -42.72 68.58 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.173 -176.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 615' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -162.82 103.82 1.04 Allowed Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.27 0.557 . . . . 0.0 110.576 -178.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 616' ' ' PRO . . . . . 0.402 ' O ' ' HB2' ' A' ' 617' ' ' ASP . 65.0 Cg_endo -89.85 171.2 4.13 Favored 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 123.539 2.826 . . . . 0.0 113.411 -177.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 617' ' ' ASP . . . . . 0.402 ' HB2' ' O ' ' A' ' 616' ' ' PRO . 1.1 m-20 79.0 28.28 0.4 Allowed 'General case' 0 CA--C 1.508 -0.664 0 CA-C-N 115.123 -0.944 . . . . 0.0 111.373 164.721 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 618' ' ' ILE . . . . . 0.498 ' HB ' ' O ' ' A' ' 625' ' ' VAL . 18.5 mt -74.87 103.42 2.73 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 CA-C-N 114.591 -1.186 . . . . 0.0 109.085 171.505 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 619' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.77 132.96 38.32 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.841 -0.618 . . . . 0.0 112.391 -171.094 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 620' ' ' ALA . . . . . . . . . . . . . . . -127.92 173.61 9.87 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 170.408 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 621' ' ' THR . . . . . . . . . . . . . 4.7 t -75.56 -31.72 60.13 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 120.385 -0.526 . . . . 0.0 111.217 -174.374 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 622' ' ' ASN . . . . . 0.657 ' CB ' ' HA ' ' A' ' 534' ' ' GLU . 31.8 p-10 -117.39 21.76 12.87 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 111.946 0.35 . . . . 0.0 111.946 -176.325 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 623' ' ' GLY . . . . . . . . . . . . . . . 165.36 -167.71 39.03 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.159 -1.019 . . . . 0.0 112.87 178.526 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 624' ' ' VAL . . . . . 0.426 HG22 HG13 ' A' ' 579' ' ' VAL . 5.8 p -133.09 155.43 41.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 178.671 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 625' ' ' VAL . . . . . 0.498 ' O ' ' HB ' ' A' ' 618' ' ' ILE . 49.6 t -120.2 127.84 75.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.188 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 626' ' ' HIS . . . . . . . . . . . . . 46.9 m-70 -113.76 110.27 19.89 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.155 -0.475 . . . . 0.0 109.774 175.409 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 627' ' ' VAL . . . . . 0.609 HG23 ' CZ ' ' A' ' 515' ' ' PHE . 22.9 t -65.56 124.85 21.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.044 -179.741 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 628' ' ' ILE . . . . . 0.619 HG13 ' HA ' ' A' ' 542' ' ' PRO . 8.2 pt -116.86 143.77 26.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-O 121.353 0.596 . . . . 0.0 110.732 175.276 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 629' ' ' THR . . . . . . . . . . . . . 10.3 t -95.59 12.33 30.01 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-O 122.216 1.008 . . . . 0.0 109.318 -179.322 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 630' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 -139.19 176.66 8.51 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 114.381 -1.281 . . . . 0.0 109.359 -176.32 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 631' ' ' VAL . . . . . 0.565 HG22 ' HB3' ' A' ' 546' ' ' ALA . 61.6 t -116.64 144.26 24.78 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 172.366 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 632' ' ' LEU . . . . . . . . . . . . . 87.8 mt -96.58 118.26 32.69 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.018 0.437 . . . . 0.0 110.735 -177.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 633' ' ' GLN . . . . . . . . . . . . . 27.0 mp0 -96.64 116.79 66.27 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.089 -177.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 634' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo . . . . . 0 N--CA 1.452 -0.951 0 C-N-CA 122.902 2.401 . . . . 0.0 111.113 173.403 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 500' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.155 0 CA-C-O 120.672 0.272 . . . . 0.0 110.33 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 501' ' ' GLY . . . . . . . . . . . . . . . 152.6 -117.81 0.84 Allowed Glycine 0 N--CA 1.444 -0.819 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.114 178.076 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 502' ' ' MET . . . . . . . . . . . . . 50.9 ttm -178.51 -40.79 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 -178.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 138.88 149.01 5.37 Favored Glycine 0 N--CA 1.445 -0.728 0 CA-C-N 114.999 -1.0 . . . . 0.0 110.987 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 504' ' ' THR . . . . . 0.459 ' O ' HG22 ' A' ' 508' ' ' VAL . 46.7 p -75.88 165.75 24.54 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 117.165 0.483 . . . . 0.0 110.118 178.495 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 505' ' ' VAL . . . . . 0.652 ' O ' ' HG ' ' A' ' 509' ' ' LEU . 14.7 p -60.0 -31.66 48.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 120.991 0.424 . . . . 0.0 110.307 179.809 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 506' ' ' MET . . . . . 0.48 ' O ' ' HG2' ' A' ' 510' ' ' LYS . 5.7 tpp -69.31 -43.17 74.31 Favored 'General case' 0 N--CA 1.437 -1.112 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.688 178.198 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 507' ' ' ASP . . . . . 0.567 ' HA ' ' CG ' ' A' ' 510' ' ' LYS . 31.5 t70 -67.29 -32.5 73.53 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.882 0.373 . . . . 0.0 110.557 -178.435 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 508' ' ' VAL . . . . . 0.459 HG22 ' O ' ' A' ' 504' ' ' THR . 90.0 t -62.27 -35.72 70.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.519 176.087 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 509' ' ' LEU . . . . . 0.652 ' HG ' ' O ' ' A' ' 505' ' ' VAL . 61.3 mt -74.44 -37.44 63.28 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.164 -178.602 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 510' ' ' LYS . . . . . 0.567 ' CG ' ' HA ' ' A' ' 507' ' ' ASP . 10.8 ptmm? -84.27 -13.13 53.38 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.284 -178.303 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 511' ' ' GLY . . . . . . . . . . . . . . . -85.7 -11.92 73.16 Favored Glycine 0 N--CA 1.441 -0.987 0 N-CA-C 111.169 -0.772 . . . . 0.0 111.169 173.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 512' ' ' ASP . . . . . 0.559 ' O ' ' HB2' ' A' ' 516' ' ' SER . 26.6 t70 -104.22 152.54 22.05 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.826 0.346 . . . . 0.0 111.122 179.825 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 42.4 m-80 -76.28 -33.32 59.1 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.864 -176.243 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 514' ' ' ARG . . . . . . . . . . . . . 26.2 mmt180 -82.88 -49.95 9.13 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.908 0.385 . . . . 0.0 110.086 -176.039 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 515' ' ' PHE . . . . . 0.982 ' HZ ' HG23 ' A' ' 627' ' ' VAL . 4.2 m-30 -66.97 -17.83 65.1 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.505 -177.458 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 516' ' ' SER . . . . . 0.559 ' HB2' ' O ' ' A' ' 512' ' ' ASP . 16.3 t -57.54 -41.9 81.84 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.665 -176.476 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 517' ' ' MET . . . . . 0.415 ' HE3' ' HB2' ' A' ' 517' ' ' MET . 3.4 ppp? -76.49 -24.96 53.8 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.881 0.372 . . . . 0.0 110.643 -178.426 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 518' ' ' LEU . . . . . 0.581 HD22 ' HD2' ' A' ' 542' ' ' PRO . 39.4 tp -66.8 -37.86 85.37 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 170.01 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 519' ' ' VAL . . . . . 0.454 ' O ' ' HG2' ' A' ' 523' ' ' GLN . 85.4 t -58.21 -34.46 49.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 174.498 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 520' ' ' ALA . . . . . . . . . . . . . . . -63.76 -38.26 90.43 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.937 0.399 . . . . 0.0 110.17 177.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 521' ' ' ALA . . . . . 0.402 ' HA ' HD22 ' A' ' 565' ' ' LEU . . . -66.61 -43.11 85.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.267 174.392 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 522' ' ' ILE . . . . . 0.548 HG21 ' HB2' ' A' ' 527' ' ' LEU . 76.6 mt -59.73 -39.49 79.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.269 177.381 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 523' ' ' GLN . . . . . 0.454 ' HG2' ' O ' ' A' ' 519' ' ' VAL . 16.1 mm100 -62.82 -33.93 76.25 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-O 121.087 0.47 . . . . 0.0 111.152 177.727 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 8.3 t -81.67 -36.2 29.05 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.321 -179.399 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 525' ' ' ALA . . . . . 0.468 ' HB3' ' HA ' ' A' ' 566' ' ' ALA . . . -78.18 -29.84 48.73 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.922 -178.859 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 526' ' ' GLY . . . . . . . . . . . . . . . 85.14 50.53 4.06 Favored Glycine 0 CA--C 1.52 0.355 0 C-N-CA 121.025 -0.607 . . . . 0.0 112.801 179.319 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 527' ' ' LEU . . . . . 0.548 ' HB2' HG21 ' A' ' 522' ' ' ILE . 4.0 mm? -113.12 5.91 17.31 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.875 0.369 . . . . 0.0 110.518 177.825 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 528' ' ' THR . . . . . 0.477 HG23 ' HE3' ' A' ' 506' ' ' MET . 4.4 m -62.29 -48.1 81.37 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.528 -175.404 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 529' ' ' GLU . . . . . 0.521 ' O ' ' HG3' ' A' ' 533' ' ' ARG . 29.9 mp0 -57.95 -40.89 81.64 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.883 0.373 . . . . 0.0 110.581 178.553 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 530' ' ' THR . . . . . . . . . . . . . 40.4 m -62.14 -45.98 91.02 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.558 -177.316 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 531' ' ' LEU . . . . . 0.48 HD22 HD13 ' A' ' 573' ' ' ILE . 61.5 mt -82.59 -4.91 58.39 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -175.378 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 532' ' ' ASN . . . . . . . . . . . . . 67.1 t30 -89.09 -18.24 27.65 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.273 0.558 . . . . 0.0 110.043 178.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 533' ' ' ARG . . . . . 0.521 ' HG3' ' O ' ' A' ' 529' ' ' GLU . 32.9 mtp85 -83.08 136.69 34.39 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.205 -179.215 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 534' ' ' GLU . . . . . 0.547 ' HA ' ' HB3' ' A' ' 622' ' ' ASN . 11.5 pt-20 -71.56 156.13 39.76 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.868 178.257 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 535' ' ' GLY . . . . . . . . . . . . . . . 147.05 -136.59 6.21 Favored Glycine 0 N--CA 1.445 -0.759 0 N-CA-C 110.43 -1.068 . . . . 0.0 110.43 -176.064 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 536' ' ' VAL . . . . . 0.453 ' HB ' HG13 ' A' ' 577' ' ' ILE . 34.3 m -124.08 130.08 73.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-O 121.142 0.496 . . . . 0.0 110.813 179.005 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 537' ' ' TYR . . . . . . . . . . . . . 84.4 m-85 -152.87 146.98 25.47 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.385 178.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 538' ' ' THR . . . . . 0.675 ' OG1' ' HA ' ' A' ' 577' ' ' ILE . 67.2 m -132.98 102.6 5.68 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 175.413 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 539' ' ' VAL . . . . . 0.42 HG22 HG22 ' A' ' 573' ' ' ILE . 48.5 t -107.31 122.88 62.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.085 0.469 . . . . 0.0 111.44 -172.788 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 540' ' ' PHE . . . . . 0.458 ' HB3' HD12 ' A' ' 628' ' ' ILE . 84.8 m-85 -91.77 107.15 19.0 Favored 'General case' 0 N--CA 1.447 -0.613 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 172.759 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -97.2 113.71 63.59 Favored Pre-proline 0 C--N 1.323 -0.577 0 CA-C-O 120.713 0.292 . . . . 0.0 110.924 -176.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 542' ' ' PRO . . . . . 0.61 ' HA ' HG13 ' A' ' 628' ' ' ILE . 7.9 Cg_exo -72.44 138.16 29.36 Favored 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 123.04 2.494 . . . . 0.0 111.427 177.886 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 60.8 p -74.22 -179.11 3.7 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.526 178.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 544' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -62.35 -33.64 75.1 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.172 0.511 . . . . 0.0 109.742 179.603 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 545' ' ' GLU . . . . . . . . . . . . . 14.1 mp0 -63.85 -27.44 69.17 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 114.798 -1.092 . . . . 0.0 111.499 -178.004 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 546' ' ' ALA . . . . . 0.591 ' HB3' HG22 ' A' ' 631' ' ' VAL . . . -64.24 -55.61 20.32 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.354 0.597 . . . . 0.0 110.514 179.142 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 547' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -70.63 -21.48 62.63 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.644 179.127 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 548' ' ' ARG . . . . . . . . . . . . . 75.2 ttt180 -74.81 -36.82 62.45 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.117 177.611 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 549' ' ' ALA . . . . . . . . . . . . . . . -62.03 -34.38 76.11 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.456 176.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 550' ' ' LEU . . . . . 0.503 ' HA ' ' HD3' ' A' ' 551' ' ' PRO . 81.2 mt -65.53 132.24 95.01 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.392 175.82 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 551' ' ' PRO . . . . . 0.503 ' HD3' ' HA ' ' A' ' 550' ' ' LEU . 21.3 Cg_exo -64.58 147.9 90.3 Favored 'Trans proline' 0 N--CA 1.463 -0.29 0 C-N-CA 122.98 2.453 . . . . 0.0 111.856 -173.723 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 552' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -48.89 -35.51 31.54 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 123.177 2.584 . . . . 0.0 113.351 -177.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 553' ' ' ARG . . . . . . . . . . . . . 56.2 ttp180 -73.57 -45.52 52.81 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.771 0.32 . . . . 0.0 110.842 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 554' ' ' GLU . . . . . 0.474 ' HB2' ' HD2' ' A' ' 551' ' ' PRO . 20.5 mm-40 -74.09 -41.66 61.34 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.454 -175.061 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 555' ' ' ARG . . . . . . . . . . . . . 5.5 ptp180 -61.75 -33.6 74.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.877 0.37 . . . . 0.0 110.024 177.451 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 7.9 t -71.5 -36.94 71.27 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.2 -0.455 . . . . 0.0 109.808 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 557' ' ' ARG . . . . . . . . . . . . . 79.8 mtt180 -61.22 -49.5 76.91 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.378 176.236 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 558' ' ' LEU . . . . . 0.489 HD23 HG13 ' A' ' 568' ' ' ILE . 2.1 tm? -57.95 -52.33 65.94 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.057 -0.974 . . . . 0.0 110.457 -178.54 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 559' ' ' LEU . . . . . 0.718 ' HA ' HD13 ' A' ' 565' ' ' LEU . 86.4 mt -76.78 -3.75 39.9 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.378 -175.352 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 560' ' ' GLY . . . . . . . . . . . . . . . -72.57 -22.54 78.93 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 121.168 -0.539 . . . . 0.0 112.534 -179.316 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 561' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -141.63 126.17 17.82 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 122.53 -0.394 . . . . 0.0 110.674 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 562' ' ' ALA . . . . . 0.416 ' HA ' HD12 ' A' ' 565' ' ' LEU . . . -59.46 -22.81 62.07 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.764 -0.653 . . . . 0.0 112.384 -176.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 563' ' ' LYS . . . . . . . . . . . . . 57.9 tttp -63.69 -40.3 96.47 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.358 0.599 . . . . 0.0 110.395 179.275 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 564' ' ' GLU . . . . . 0.435 ' HB3' HD21 ' A' ' 558' ' ' LEU . 7.7 mm-40 -68.55 -40.47 80.64 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.987 -178.011 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 565' ' ' LEU . . . . . 0.718 HD13 ' HA ' ' A' ' 559' ' ' LEU . 8.2 mp -57.19 -47.29 81.62 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.115 174.6 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 566' ' ' ALA . . . . . 0.621 ' O ' ' HB2' ' A' ' 570' ' ' LYS . . . -60.2 -40.18 89.17 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.245 -0.889 . . . . 0.0 111.666 -177.744 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 567' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -75.53 -47.12 28.27 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 120.916 -0.314 . . . . 0.0 111.318 -176.013 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 568' ' ' ILE . . . . . 0.489 HG13 HD23 ' A' ' 558' ' ' LEU . 28.5 mm -65.29 -48.85 81.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 112.465 0.543 . . . . 0.0 112.465 -177.728 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 569' ' ' LEU . . . . . 0.41 ' O ' HD11 ' A' ' 569' ' ' LEU . 0.6 OUTLIER -71.33 -21.84 61.99 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.736 -0.385 . . . . 0.0 110.433 -175.879 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 570' ' ' LYS . . . . . 0.621 ' HB2' ' O ' ' A' ' 566' ' ' ALA . 78.3 tttt -67.56 -22.17 65.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.214 0.531 . . . . 0.0 110.434 178.846 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 571' ' ' TYR . . . . . 0.457 ' CE1' ' HB3' ' A' ' 595' ' ' ASP . 15.3 t80 -77.89 -18.05 56.62 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.711 177.268 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 572' ' ' HIS . . . . . . . . . . . . . 74.4 m80 -88.56 -12.44 42.74 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.658 -176.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 573' ' ' ILE . . . . . 0.48 HD13 HD22 ' A' ' 531' ' ' LEU . 47.7 mt -104.42 114.28 43.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.627 179.615 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 574' ' ' GLY . . . . . 0.659 ' HA2' ' HA ' ' A' ' 591' ' ' SER . . . -99.4 152.99 19.61 Favored Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 121.06 -0.59 . . . . 0.0 111.777 176.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 575' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -96.79 16.13 20.04 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.064 0.459 . . . . 0.0 111.31 -175.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 576' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -139.27 122.17 16.62 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.139 -177.409 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 577' ' ' ILE . . . . . 0.675 ' HA ' ' OG1' ' A' ' 538' ' ' THR . 63.3 mt -79.95 101.27 4.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.272 0.558 . . . . 0.0 110.681 -179.024 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 578' ' ' LEU . . . . . . . . . . . . . 96.7 mt -118.91 102.48 8.82 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.393 -0.821 . . . . 0.0 109.879 178.045 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 579' ' ' VAL . . . . . . . . . . . . . 27.1 m -90.82 178.43 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.361 178.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 580' ' ' SER . . . . . . . . . . . . . 13.0 m -53.57 -38.77 64.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.26 -179.039 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 581' ' ' GLY . . . . . . . . . . . . . . . -86.53 23.66 9.77 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 121.13 -0.557 . . . . 0.0 112.824 -178.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . -138.63 6.82 3.28 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.595 177.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 583' ' ' ILE . . . . . . . . . . . . . 37.4 mt -83.95 -47.75 17.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.968 0.414 . . . . 0.0 110.977 -178.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 584' ' ' GLY . . . . . . . . . . . . . . . 79.39 -69.18 3.03 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.929 -0.653 . . . . 0.0 112.07 -178.024 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 585' ' ' ALA . . . . . . . . . . . . . . . -143.18 -69.87 0.33 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.862 0.363 . . . . 0.0 110.321 179.53 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 586' ' ' LEU . . . . . 0.803 ' HG ' ' HB2' ' A' ' 600' ' ' SER . 3.9 tt -151.33 131.15 13.24 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 176.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 587' ' ' VAL . . . . . 0.418 ' N ' HD22 ' A' ' 586' ' ' LEU . 7.8 p -143.99 137.23 23.93 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.173 -175.137 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 588' ' ' ARG . . . . . . . . . . . . . 35.0 ptt180 -88.04 108.52 19.27 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.414 0.626 . . . . 0.0 110.561 178.278 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 589' ' ' LEU . . . . . . . . . . . . . 3.8 tt -91.04 114.47 27.0 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 -178.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 590' ' ' LYS . . . . . 0.606 ' HB2' ' NZ ' ' A' ' 590' ' ' LYS . 9.6 mtmp? -72.43 148.69 44.93 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 121.273 0.559 . . . . 0.0 111.411 -174.062 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 591' ' ' SER . . . . . 0.659 ' HA ' ' HA2' ' A' ' 574' ' ' GLY . 68.7 p -112.09 158.63 19.37 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.823 -179.104 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 592' ' ' LEU . . . . . 0.482 ' O ' ' HE2' ' A' ' 570' ' ' LYS . 10.0 mp -62.26 -19.82 63.62 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.933 178.355 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 593' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -69.5 -29.69 67.38 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.806 -0.358 . . . . 0.0 110.537 176.477 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 594' ' ' GLY . . . . . . . . . . . . . . . 115.97 -4.85 20.46 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.674 -0.775 . . . . 0.0 112.745 -178.324 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 595' ' ' ASP . . . . . 0.474 ' CG ' ' H ' ' A' ' 596' ' ' LYS . 11.2 t70 -101.29 -168.94 1.62 Allowed 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 175.768 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 596' ' ' LYS . . . . . 0.547 ' N ' ' HD3' ' A' ' 596' ' ' LYS . 0.0 OUTLIER -135.05 131.83 37.48 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.007 0.432 . . . . 0.0 111.3 -172.881 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 597' ' ' LEU . . . . . 0.655 ' HB3' HG21 ' A' ' 608' ' ' VAL . 2.7 mm? -82.32 115.89 21.58 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 169.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 598' ' ' GLU . . . . . . . . . . . . . 57.8 mt-10 -84.42 92.43 8.05 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-O 121.626 0.727 . . . . 0.0 109.775 179.039 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 599' ' ' VAL . . . . . 0.456 ' HA ' ' O ' ' A' ' 607' ' ' SER . 61.1 t -93.64 132.41 37.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 114.619 -1.173 . . . . 0.0 110.118 -176.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 600' ' ' SER . . . . . 0.803 ' HB2' ' HG ' ' A' ' 586' ' ' LEU . 29.6 t -131.95 165.43 23.95 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-O 121.215 0.531 . . . . 0.0 110.286 179.69 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 601' ' ' LEU . . . . . . . . . . . . . 33.3 tp -136.89 108.07 6.79 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 114.929 -1.032 . . . . 0.0 109.609 -177.055 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 602' ' ' LYS . . . . . . . . . . . . . 11.3 ptmm? -134.77 118.19 16.78 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.899 -178.31 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 603' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 63.0 28.87 16.39 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 121.542 0.686 . . . . 0.0 109.539 -174.492 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 604' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 69.16 5.98 5.4 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 115.053 -0.976 . . . . 0.0 111.903 -177.368 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 605' ' ' VAL . . . . . . . . . . . . . 46.3 t -86.86 108.13 17.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 109.419 -0.585 . . . . 0.0 109.419 175.278 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 606' ' ' VAL . . . . . 0.712 HG11 ' HB ' ' A' ' 613' ' ' VAL . 6.1 p -84.33 134.41 27.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.934 -178.21 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 607' ' ' SER . . . . . 0.456 ' O ' ' HA ' ' A' ' 599' ' ' VAL . 3.3 p -139.03 142.58 38.25 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.72 -178.709 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 608' ' ' VAL . . . . . 0.655 HG21 ' HB3' ' A' ' 597' ' ' LEU . 3.0 p -122.07 112.78 36.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 116.238 -0.437 . . . . 0.0 109.962 179.159 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 609' ' ' ASN . . . . . 0.416 ' O ' ' HB3' ' A' ' 610' ' ' LYS . 87.7 m-20 56.57 44.76 23.48 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.763 -178.82 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 610' ' ' LYS . . . . . 0.416 ' HB3' ' O ' ' A' ' 609' ' ' ASN . 48.8 tttp 81.19 -26.19 0.15 Allowed 'General case' 0 N--CA 1.472 0.642 0 O-C-N 124.097 0.873 . . . . 0.0 111.701 179.096 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 611' ' ' GLU . . . . . 0.477 ' HA ' ' HD3' ' A' ' 612' ' ' PRO . 5.6 mm-40 -78.6 135.09 60.67 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 120.647 0.26 . . . . 0.0 110.393 -177.22 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 612' ' ' PRO . . . . . 0.477 ' HD3' ' HA ' ' A' ' 611' ' ' GLU . 4.9 Cg_exo -79.38 138.86 14.22 Favored 'Trans proline' 0 N--CA 1.462 -0.381 0 C-N-CA 123.038 2.492 . . . . 0.0 112.988 -176.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 613' ' ' VAL . . . . . 0.712 ' HB ' HG11 ' A' ' 606' ' ' VAL . 94.7 t -84.34 124.39 39.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.581 175.177 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 614' ' ' ALA . . . . . 0.493 ' HB1' HG23 ' A' ' 629' ' ' THR . . . -76.14 -31.41 58.58 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.573 -174.816 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 615' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -162.61 93.85 1.22 Allowed Pre-proline 0 C--N 1.325 -0.485 0 CA-C-O 121.184 0.516 . . . . 0.0 110.275 -176.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 616' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -89.32 165.24 5.5 Favored 'Trans proline' 0 N--CA 1.456 -0.708 0 C-N-CA 123.113 2.542 . . . . 0.0 113.422 -178.206 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 26.4 t0 77.36 40.63 0.16 Allowed 'General case' 0 CA--C 1.516 -0.345 0 CA-C-O 122.708 1.242 . . . . 0.0 110.092 165.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 618' ' ' ILE . . . . . 0.444 ' HB ' ' O ' ' A' ' 625' ' ' VAL . 17.8 mt -89.04 109.29 20.04 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.999 0 CA-C-N 113.776 -1.556 . . . . 0.0 109.266 173.226 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 619' ' ' MET . . . . . 0.46 ' HA ' ' HE1' ' A' ' 619' ' ' MET . 6.8 mmt -73.41 133.12 43.66 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.686 -0.688 . . . . 0.0 112.355 -173.086 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 620' ' ' ALA . . . . . . . . . . . . . . . -131.06 166.33 21.27 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 108.96 -0.755 . . . . 0.0 108.96 172.051 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 621' ' ' THR . . . . . 0.447 HG22 ' HA ' ' A' ' 504' ' ' THR . 1.2 t -72.82 -33.45 66.21 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.455 -0.498 . . . . 0.0 111.361 -174.167 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 622' ' ' ASN . . . . . 0.547 ' HB3' ' HA ' ' A' ' 534' ' ' GLU . 28.5 p-10 -117.83 24.02 11.31 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.656 0.265 . . . . 0.0 111.556 -176.016 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 623' ' ' GLY . . . . . 0.411 ' HA2' ' CD1' ' A' ' 577' ' ' ILE . . . 162.55 -160.13 32.42 Favored Glycine 0 N--CA 1.442 -0.922 0 C-N-CA 120.187 -1.006 . . . . 0.0 112.816 178.386 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 624' ' ' VAL . . . . . . . . . . . . . 8.5 p -134.83 157.29 40.9 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 179.448 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 625' ' ' VAL . . . . . 0.444 ' O ' ' HB ' ' A' ' 618' ' ' ILE . 59.4 t -122.77 134.13 66.87 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.163 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 626' ' ' HIS . . . . . . . . . . . . . 95.7 m-70 -121.47 112.95 19.16 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 175.033 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 627' ' ' VAL . . . . . 0.982 HG23 ' HZ ' ' A' ' 515' ' ' PHE . 37.1 t -68.22 128.89 32.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.844 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 628' ' ' ILE . . . . . 0.61 HG13 ' HA ' ' A' ' 542' ' ' PRO . 6.4 pt -126.71 147.35 31.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 121.22 0.533 . . . . 0.0 111.043 175.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 629' ' ' THR . . . . . 0.493 HG23 ' HB1' ' A' ' 614' ' ' ALA . 30.1 p -96.43 -1.47 47.42 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.401 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 630' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -126.17 158.95 34.27 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.64 -174.273 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 631' ' ' VAL . . . . . 0.591 HG22 ' HB3' ' A' ' 546' ' ' ALA . 2.3 t -96.06 122.42 47.54 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.7 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 177.116 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 632' ' ' LEU . . . . . 0.406 HD23 HG11 ' A' ' 608' ' ' VAL . 96.2 mt -71.83 110.67 6.51 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.485 0.66 . . . . 0.0 110.401 -177.362 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 633' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -120.92 120.76 29.2 Favored Pre-proline 0 C--N 1.318 -0.802 0 CA-C-N 114.907 -1.042 . . . . 0.0 109.649 -175.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 634' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_exo . . . . . 0 C--O 1.249 1.07 0 C-N-CA 122.752 2.301 . . . . 0.0 111.754 -179.867 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 500' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.934 0 CA-C-O 121.118 0.485 . . . . 0.0 110.264 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 501' ' ' GLY . . . . . . . . . . . . . . . 161.22 -79.59 0.15 Allowed Glycine 0 N--CA 1.448 -0.545 0 N-CA-C 111.279 -0.728 . . . . 0.0 111.279 -179.312 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 502' ' ' MET . . . . . . . . . . . . . 93.9 mmm -124.15 85.29 2.39 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.095 0.474 . . . . 0.0 110.392 178.308 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . -129.25 -154.84 8.33 Favored Glycine 0 N--CA 1.445 -0.714 0 N-CA-C 111.252 -0.739 . . . . 0.0 111.252 177.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 39.1 p -71.9 175.63 5.66 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 177.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 505' ' ' VAL . . . . . 0.641 ' O ' ' HG ' ' A' ' 509' ' ' LEU . 8.5 t -54.63 -38.71 43.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 121.146 0.498 . . . . 0.0 110.261 178.07 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 506' ' ' MET . . . . . . . . . . . . . 16.5 mmt -63.55 -35.1 79.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.787 -178.628 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 507' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -62.91 -28.84 70.33 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.267 0.556 . . . . 0.0 110.27 -178.091 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 508' ' ' VAL . . . . . . . . . . . . . 47.3 t -87.41 -43.11 15.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.797 179.147 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 509' ' ' LEU . . . . . 0.641 ' HG ' ' O ' ' A' ' 505' ' ' VAL . 69.7 mt -64.73 -24.22 67.5 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 121.097 0.475 . . . . 0.0 111.907 -176.01 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -85.71 -21.57 28.24 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.402 -176.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 511' ' ' GLY . . . . . . . . . . . . . . . -81.27 -9.54 85.86 Favored Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 120.665 -0.778 . . . . 0.0 111.53 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 512' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -109.84 148.18 31.99 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.16 0.505 . . . . 0.0 111.607 -178.406 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -76.51 -21.4 55.81 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.757 -0.656 . . . . 0.0 112.521 -176.488 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 514' ' ' ARG . . . . . 0.668 ' HB3' ' HA ' ' A' ' 543' ' ' THR . 9.8 mmt180 -89.97 -51.38 5.51 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.495 0.664 . . . . 0.0 109.496 -177.716 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 515' ' ' PHE . . . . . 0.972 ' HZ ' HG23 ' A' ' 627' ' ' VAL . 9.1 m-30 -62.31 -29.38 70.4 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 114.664 -1.153 . . . . 0.0 111.25 -175.583 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 2.7 p -62.82 -25.7 68.39 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 -175.055 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 517' ' ' MET . . . . . . . . . . . . . 48.4 ttp -80.91 -37.78 29.07 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 175.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 518' ' ' LEU . . . . . 0.42 HD23 ' HD2' ' A' ' 542' ' ' PRO . 66.5 tp -57.81 -39.11 76.81 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.234 171.39 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 519' ' ' VAL . . . . . 0.497 HG21 ' O ' ' A' ' 515' ' ' PHE . 86.6 t -53.76 -37.52 32.62 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 CA-C-O 121.058 0.456 . . . . 0.0 110.582 175.111 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 520' ' ' ALA . . . . . . . . . . . . . . . -71.64 -35.24 70.32 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.441 -178.132 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 521' ' ' ALA . . . . . . . . . . . . . . . -68.59 -48.14 64.93 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.491 176.439 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 522' ' ' ILE . . . . . 0.411 HG22 ' HB2' ' A' ' 527' ' ' LEU . 69.2 mt -59.55 -37.01 68.13 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.886 177.402 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 523' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -61.98 -52.93 62.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.015 177.837 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 40.8 m -62.0 -34.25 75.83 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.735 -178.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 525' ' ' ALA . . . . . . . . . . . . . . . -77.69 -12.01 59.93 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.479 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 526' ' ' GLY . . . . . . . . . . . . . . . 72.73 34.6 59.41 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 121.061 -0.59 . . . . 0.0 112.958 178.093 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 527' ' ' LEU . . . . . 0.411 ' HB2' HG22 ' A' ' 522' ' ' ILE . 95.2 mt -109.13 10.31 26.0 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.901 0.381 . . . . 0.0 110.49 -179.834 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 528' ' ' THR . . . . . . . . . . . . . 8.1 m -57.08 -43.18 81.92 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 -173.003 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 529' ' ' GLU . . . . . 0.494 ' O ' ' HG2' ' A' ' 533' ' ' ARG . 11.5 pt-20 -70.34 -17.01 63.05 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 111.826 0.306 . . . . 0.0 111.826 -174.091 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 530' ' ' THR . . . . . . . . . . . . . 78.0 m -62.77 -49.17 76.05 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.83 0.348 . . . . 0.0 110.613 178.531 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 531' ' ' LEU . . . . . 0.415 ' HB3' ' HB ' ' A' ' 505' ' ' VAL . 1.9 mm? -75.49 -14.51 60.43 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.19 178.25 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 532' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -78.47 -32.94 48.57 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.603 179.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 533' ' ' ARG . . . . . 0.494 ' HG2' ' O ' ' A' ' 529' ' ' GLU . 30.7 mmm180 -66.91 123.18 19.45 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.334 178.128 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 534' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -71.69 94.79 1.39 Allowed 'General case' 0 N--CA 1.443 -0.82 0 CA-C-O 122.627 1.203 . . . . 0.0 110.697 176.129 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 535' ' ' GLY . . . . . . . . . . . . . . . -161.85 175.06 38.41 Favored Glycine 0 N--CA 1.441 -1.001 0 N-CA-C 108.092 -2.003 . . . . 0.0 108.092 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 536' ' ' VAL . . . . . 0.641 ' HB ' HG13 ' A' ' 577' ' ' ILE . 33.9 m -87.32 131.42 35.2 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 118.405 1.103 . . . . 0.0 111.87 -167.489 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 537' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -150.48 144.31 25.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.051 -0.977 . . . . 0.0 109.964 179.406 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 538' ' ' THR . . . . . . . . . . . . . 22.6 m -108.32 102.91 11.99 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 173.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 539' ' ' VAL . . . . . 0.54 HG23 HG11 ' A' ' 505' ' ' VAL . 47.2 t -100.88 123.24 53.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 120.864 0.364 . . . . 0.0 111.641 -173.231 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 540' ' ' PHE . . . . . 0.498 ' HB3' HD12 ' A' ' 628' ' ' ILE . 97.6 m-85 -102.34 110.0 21.83 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 173.835 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -103.21 112.61 65.85 Favored Pre-proline 0 C--N 1.324 -0.537 0 CA-C-O 120.748 0.308 . . . . 0.0 110.863 -175.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 542' ' ' PRO . . . . . 0.572 ' HA ' HG13 ' A' ' 628' ' ' ILE . 11.8 Cg_exo -71.5 142.26 40.13 Favored 'Trans proline' 0 N--CA 1.461 -0.4 0 C-N-CA 123.028 2.485 . . . . 0.0 112.146 178.554 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 543' ' ' THR . . . . . 0.668 ' HA ' ' HB3' ' A' ' 514' ' ' ARG . 44.9 p -78.13 175.42 10.16 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.736 178.241 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 544' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -73.72 -24.17 59.87 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.821 -0.352 . . . . 0.0 110.478 -176.56 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 545' ' ' GLU . . . . . 0.431 ' OE2' ' HB ' ' A' ' 543' ' ' THR . 1.9 mp0 -64.35 -33.17 75.22 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 110.043 -0.355 . . . . 0.0 110.043 177.492 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 546' ' ' ALA . . . . . 0.622 ' HB3' HG21 ' A' ' 631' ' ' VAL . . . -59.76 -49.62 77.02 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.592 177.848 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 547' ' ' PHE . . . . . 0.4 ' HA ' ' HG ' ' A' ' 550' ' ' LEU . 88.9 m-85 -68.98 -21.81 64.13 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.79 -179.634 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 548' ' ' ARG . . . . . . . . . . . . . 30.5 ttm180 -79.12 -28.17 42.92 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.868 179.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 549' ' ' ALA . . . . . . . . . . . . . . . -96.41 1.07 51.37 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.452 -176.379 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 550' ' ' LEU . . . . . 0.429 ' HG ' ' O ' ' A' ' 546' ' ' ALA . 75.0 mt -67.35 137.72 93.88 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.564 179.71 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 551' ' ' PRO . . . . . 0.541 ' HD2' ' HB2' ' A' ' 554' ' ' GLU . 16.0 Cg_exo -68.1 155.81 68.13 Favored 'Trans proline' 0 C--O 1.235 0.368 0 C-N-CA 123.036 2.491 . . . . 0.0 111.437 179.593 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 552' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -43.93 -55.29 3.17 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 123.861 3.041 . . . . 0.0 113.598 -176.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 553' ' ' ARG . . . . . 0.401 ' O ' ' HG3' ' A' ' 557' ' ' ARG . 8.6 ptm180 -63.5 -38.76 92.35 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 -177.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 554' ' ' GLU . . . . . 0.541 ' HB2' ' HD2' ' A' ' 551' ' ' PRO . 4.5 mm-40 -73.22 -49.48 27.67 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.827 0.346 . . . . 0.0 111.04 -174.301 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 555' ' ' ARG . . . . . 0.409 ' HB3' ' HB2' ' A' ' 550' ' ' LEU . 20.6 ptt180 -66.53 -28.39 68.51 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.11 -179.285 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 47.6 t -73.37 -29.99 63.0 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.712 0.291 . . . . 0.0 110.757 179.522 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 557' ' ' ARG . . . . . 0.401 ' HG3' ' O ' ' A' ' 553' ' ' ARG . 22.2 mtp180 -83.04 -53.63 5.67 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.023 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 558' ' ' LEU . . . . . 0.59 ' O ' ' HG ' ' A' ' 565' ' ' LEU . 47.2 tp -63.91 -40.43 96.49 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.655 0.264 . . . . 0.0 111.564 -174.297 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 559' ' ' LEU . . . . . . . . . . . . . 63.7 mt -94.11 13.23 23.77 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.052 0.453 . . . . 0.0 110.98 -178.144 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 560' ' ' GLY . . . . . . . . . . . . . . . -126.12 -48.66 0.19 Allowed Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.609 -0.805 . . . . 0.0 112.469 -178.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 561' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -86.24 116.15 24.24 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.97 0.414 . . . . 0.0 110.548 -176.44 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 562' ' ' ALA . . . . . . . . . . . . . . . -68.71 -21.9 64.37 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.537 -176.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 563' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -81.33 -45.74 15.73 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 -178.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 564' ' ' GLU . . . . . 0.425 ' O ' HG12 ' A' ' 568' ' ' ILE . 29.2 mt-10 -69.69 -25.18 63.76 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.481 177.8 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 565' ' ' LEU . . . . . 0.59 ' HG ' ' O ' ' A' ' 558' ' ' LEU . 4.0 mt -58.77 -55.85 29.72 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.957 0.408 . . . . 0.0 109.946 170.797 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 566' ' ' ALA . . . . . 0.566 ' O ' ' HG3' ' A' ' 570' ' ' LYS . . . -62.51 -26.97 68.82 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.843 178.444 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 567' ' ' ASN . . . . . 0.451 ' C ' HD21 ' A' ' 567' ' ' ASN . 0.2 OUTLIER -73.18 -55.24 6.73 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.985 179.362 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 568' ' ' ILE . . . . . 0.425 HG12 ' O ' ' A' ' 564' ' ' GLU . 50.8 mm -68.81 -34.65 65.7 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 CA-C-O 120.701 0.286 . . . . 0.0 111.738 -175.113 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 569' ' ' LEU . . . . . 0.431 ' HG ' ' O ' ' A' ' 565' ' ' LEU . 87.1 mt -63.12 -25.63 68.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.799 0.333 . . . . 0.0 111.227 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 570' ' ' LYS . . . . . 0.566 ' HG3' ' O ' ' A' ' 566' ' ' ALA . 62.5 mttp -69.5 -13.93 62.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.893 0.378 . . . . 0.0 111.099 178.018 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 571' ' ' TYR . . . . . . . . . . . . . 15.6 t80 -94.72 -7.86 39.38 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.149 0.5 . . . . 0.0 110.506 -177.21 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 572' ' ' HIS . . . . . . . . . . . . . 75.8 m80 -101.03 -9.21 21.64 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.71 -179.227 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 573' ' ' ILE . . . . . 0.413 ' O ' HD23 ' A' ' 592' ' ' LEU . 29.3 mt -111.9 123.13 67.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.418 178.233 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 574' ' ' GLY . . . . . 0.493 ' HA2' ' HA ' ' A' ' 591' ' ' SER . . . -98.87 167.39 21.85 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.21 176.388 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 575' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -92.24 -4.8 53.56 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 113.112 0.782 . . . . 0.0 113.112 -168.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 576' ' ' GLU . . . . . 0.72 ' HB2' HD21 ' A' ' 589' ' ' LEU . 70.0 mm-40 -128.77 -167.08 1.72 Allowed 'General case' 0 CA--C 1.504 -0.812 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 179.783 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 577' ' ' ILE . . . . . 0.641 HG13 ' HB ' ' A' ' 536' ' ' VAL . 82.0 mt -112.42 105.32 18.56 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 N-CA-C 110.051 -0.352 . . . . 0.0 110.051 167.773 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 578' ' ' LEU . . . . . 0.639 HD23 HG12 ' A' ' 587' ' ' VAL . 0.3 OUTLIER -100.86 115.27 29.97 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 178.644 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 579' ' ' VAL . . . . . . . . . . . . . 30.6 m -113.69 163.73 10.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.496 179.384 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 580' ' ' SER . . . . . 0.414 ' C ' ' H ' ' A' ' 582' ' ' GLY . 49.6 p -62.33 -33.8 75.39 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-O 120.868 0.366 . . . . 0.0 111.03 -178.67 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 581' ' ' GLY . . . . . . . . . . . . . . . -77.32 22.9 2.41 Favored Glycine 0 CA--C 1.519 0.287 0 C-N-CA 121.207 -0.52 . . . . 0.0 112.543 179.529 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 582' ' ' GLY . . . . . 0.414 ' H ' ' C ' ' A' ' 580' ' ' SER . . . -140.58 23.64 2.66 Favored Glycine 0 N--CA 1.445 -0.757 0 N-CA-C 111.543 -0.623 . . . . 0.0 111.543 176.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 583' ' ' ILE . . . . . . . . . . . . . 2.5 mt -122.3 98.94 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 CA-C-O 121.152 0.501 . . . . 0.0 110.38 179.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 584' ' ' GLY . . . . . . . . . . . . . . . -82.15 -20.59 62.48 Favored Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 120.63 -0.795 . . . . 0.0 111.781 176.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 585' ' ' ALA . . . . . . . . . . . . . . . -163.19 -79.77 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.921 0.391 . . . . 0.0 110.328 178.028 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 586' ' ' LEU . . . . . 0.774 HD12 ' HB3' ' A' ' 598' ' ' GLU . 53.4 tp -135.92 132.6 36.68 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.173 179.681 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 587' ' ' VAL . . . . . 0.639 HG12 HD23 ' A' ' 578' ' ' LEU . 42.8 t -127.21 116.52 44.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.185 177.343 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 588' ' ' ARG . . . . . 0.855 ' HG2' ' HG2' ' A' ' 598' ' ' GLU . 96.7 mtt180 -85.43 103.59 14.46 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.142 0.496 . . . . 0.0 109.966 176.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 589' ' ' LEU . . . . . 0.72 HD21 ' HB2' ' A' ' 576' ' ' GLU . 0.7 OUTLIER -101.18 125.15 47.78 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.312 -0.858 . . . . 0.0 108.772 -177.309 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 590' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -65.05 149.97 48.92 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.088 0.47 . . . . 0.0 111.552 -177.751 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 591' ' ' SER . . . . . 0.493 ' HA ' ' HA2' ' A' ' 574' ' ' GLY . 54.4 p -111.17 158.3 19.07 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.493 174.414 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 592' ' ' LEU . . . . . 0.413 HD23 ' O ' ' A' ' 573' ' ' ILE . 3.3 mm? -60.74 -18.23 53.37 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 112.068 0.395 . . . . 0.0 112.068 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 593' ' ' GLN . . . . . 0.449 ' N ' ' HB3' ' A' ' 570' ' ' LYS . 4.8 tt0 -71.51 -29.04 64.34 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.027 0.441 . . . . 0.0 110.352 176.649 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 594' ' ' GLY . . . . . . . . . . . . . . . 109.3 -6.72 32.18 Favored Glycine 0 N--CA 1.443 -0.891 0 C-N-CA 120.72 -0.753 . . . . 0.0 111.683 -173.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 595' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -89.93 -174.59 4.31 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 176.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 596' ' ' LYS . . . . . 0.549 ' H ' ' HD3' ' A' ' 596' ' ' LYS . 0.0 OUTLIER -121.66 132.76 54.83 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.206 0.527 . . . . 0.0 111.287 -172.509 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 597' ' ' LEU . . . . . 0.617 ' HA ' HD22 ' A' ' 609' ' ' ASN . 42.6 mt -101.17 115.28 30.12 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 172.17 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 598' ' ' GLU . . . . . 0.855 ' HG2' ' HG2' ' A' ' 588' ' ' ARG . 46.3 mt-10 -89.42 91.78 8.86 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-O 121.203 0.525 . . . . 0.0 109.863 -179.135 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 599' ' ' VAL . . . . . . . . . . . . . 20.3 t -86.6 121.2 37.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 115.267 -0.879 . . . . 0.0 108.871 179.506 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 600' ' ' SER . . . . . . . . . . . . . 3.5 p -130.59 156.32 45.05 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.56 -174.008 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 601' ' ' LEU . . . . . . . . . . . . . 21.3 tp -126.35 107.3 10.17 Favored 'General case' 0 N--CA 1.445 -0.724 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 175.368 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 602' ' ' LYS . . . . . 0.529 ' HG2' ' OD1' ' A' ' 603' ' ' ASN . 36.1 ttpt -127.7 118.91 24.7 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.965 -175.71 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 603' ' ' ASN . . . . . 0.529 ' OD1' ' HG2' ' A' ' 602' ' ' LYS . 18.1 m120 61.47 35.93 17.38 Favored 'General case' 0 C--N 1.331 -0.217 0 O-C-N 123.346 0.404 . . . . 0.0 109.946 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 604' ' ' ASN . . . . . . . . . . . . . 14.2 m120 72.45 4.77 5.1 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 115.144 -0.935 . . . . 0.0 111.669 179.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 605' ' ' VAL . . . . . . . . . . . . . 58.6 t -103.56 123.54 57.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 110.273 -0.269 . . . . 0.0 110.273 178.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 606' ' ' VAL . . . . . 0.596 HG11 ' HB ' ' A' ' 613' ' ' VAL . 7.1 p -88.41 129.33 39.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 121.175 0.512 . . . . 0.0 110.8 -179.352 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 607' ' ' SER . . . . . 0.411 ' HA ' ' HA ' ' A' ' 612' ' ' PRO . 2.8 p -133.16 152.49 51.94 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.984 -179.76 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 608' ' ' VAL . . . . . 0.407 ' O ' HG13 ' A' ' 608' ' ' VAL . 2.6 p -133.91 104.73 6.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.863 179.676 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 609' ' ' ASN . . . . . 0.617 HD22 ' HA ' ' A' ' 597' ' ' LEU . 89.2 m-20 55.8 66.43 1.21 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.84 -178.43 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 610' ' ' LYS . . . . . 0.52 ' HB3' ' O ' ' A' ' 609' ' ' ASN . 58.9 tptt 78.56 -42.81 0.34 Allowed 'General case' 0 N--CA 1.47 0.575 0 CA-C-N 115.724 -0.671 . . . . 0.0 112.715 178.365 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 611' ' ' GLU . . . . . 0.457 ' HA ' ' HD3' ' A' ' 612' ' ' PRO . 4.5 mm-40 -88.99 137.66 29.57 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-O 120.79 0.329 . . . . 0.0 111.463 -172.599 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 612' ' ' PRO . . . . . 0.457 ' HD3' ' HA ' ' A' ' 611' ' ' GLU . 5.8 Cg_exo -77.65 153.91 30.46 Favored 'Trans proline' 0 N--CA 1.459 -0.501 0 C-N-CA 122.917 2.412 . . . . 0.0 112.445 179.236 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 613' ' ' VAL . . . . . 0.596 ' HB ' HG11 ' A' ' 606' ' ' VAL . 24.7 t -94.52 134.11 33.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.341 177.319 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 614' ' ' ALA . . . . . 0.462 ' HB2' HG21 ' A' ' 629' ' ' THR . . . -74.18 -47.1 37.88 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.533 -175.746 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 615' ' ' GLU . . . . . 0.445 ' HB3' ' CG2' ' A' ' 627' ' ' VAL . 36.7 tt0 -147.76 101.64 3.69 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-O 120.969 0.414 . . . . 0.0 110.332 -177.423 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 616' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -90.01 162.57 4.9 Favored 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 123.228 2.619 . . . . 0.0 113.866 -178.414 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 26.8 m-20 77.64 28.79 0.55 Allowed 'General case' 0 CA--C 1.508 -0.635 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.77 163.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 618' ' ' ILE . . . . . 0.574 ' HB ' ' O ' ' A' ' 625' ' ' VAL . 20.2 mt -71.92 108.73 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.081 0 CA-C-N 114.505 -1.225 . . . . 0.0 109.03 173.38 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 619' ' ' MET . . . . . 0.448 ' HA ' ' HE1' ' A' ' 619' ' ' MET . 5.7 mmt -79.04 129.29 34.29 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.769 -0.65 . . . . 0.0 112.547 -171.422 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 620' ' ' ALA . . . . . . . . . . . . . . . -118.71 174.91 6.0 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 169.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 621' ' ' THR . . . . . . . . . . . . . 6.0 t -75.19 -25.46 58.27 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.319 -0.552 . . . . 0.0 110.939 -178.115 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 622' ' ' ASN . . . . . 0.452 ' O ' ' HA ' ' A' ' 536' ' ' VAL . 22.9 p-10 -116.88 -9.2 11.22 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 112.481 0.548 . . . . 0.0 112.481 -175.359 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 623' ' ' GLY . . . . . . . . . . . . . . . -169.66 -160.7 18.55 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 119.369 -1.396 . . . . 0.0 113.202 -175.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 624' ' ' VAL . . . . . . . . . . . . . 5.6 p -130.13 155.27 41.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 -178.541 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 625' ' ' VAL . . . . . 0.574 ' O ' ' HB ' ' A' ' 618' ' ' ILE . 61.5 t -126.05 135.39 64.0 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.935 179.199 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 626' ' ' HIS . . . . . . . . . . . . . 82.4 m-70 -120.92 114.43 21.54 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.687 177.081 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 627' ' ' VAL . . . . . 0.972 HG23 ' HZ ' ' A' ' 515' ' ' PHE . 29.9 t -67.09 124.11 21.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.418 177.544 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 628' ' ' ILE . . . . . 0.572 HG13 ' HA ' ' A' ' 542' ' ' PRO . 4.4 pt -121.43 142.36 37.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-O 121.124 0.488 . . . . 0.0 110.565 175.273 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 629' ' ' THR . . . . . 0.462 HG21 ' HB2' ' A' ' 614' ' ' ALA . 37.8 p -89.12 -7.44 55.74 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.194 -178.151 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 630' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -129.05 160.43 32.8 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.649 -175.316 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 631' ' ' VAL . . . . . 0.622 HG21 ' HB3' ' A' ' 546' ' ' ALA . 81.1 t -95.11 128.98 45.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 179.479 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 632' ' ' LEU . . . . . . . . . . . . . 96.3 mt -80.92 111.51 17.46 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.313 0.578 . . . . 0.0 110.619 -178.403 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 633' ' ' GLN . . . . . 0.449 ' HA ' ' HD3' ' A' ' 634' ' ' PRO . 51.3 mt-30 -110.84 131.48 22.1 Favored Pre-proline 0 C--N 1.318 -0.761 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.619 -179.397 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 634' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 633' ' ' GLN . 5.6 Cg_exo . . . . . 0 C--O 1.248 0.998 0 C-N-CA 122.971 2.447 . . . . 0.0 111.179 175.307 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 500' ' ' ALA . . . . . 0.467 ' HA ' ' OE2' ' A' ' 534' ' ' GLU . . . . . . . . 0 N--CA 1.478 0.959 0 CA-C-O 121.201 0.524 . . . . 0.0 111.153 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 501' ' ' GLY . . . . . . . . . . . . . . . -161.03 -101.22 0.16 Allowed Glycine 0 N--CA 1.447 -0.568 0 N-CA-C 111.067 -0.813 . . . . 0.0 111.067 177.284 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 502' ' ' MET . . . . . . . . . . . . . 26.2 ttt -150.15 -74.59 0.16 Allowed 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 110.13 -0.322 . . . . 0.0 110.13 176.336 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . -104.51 130.85 10.39 Favored Glycine 0 N--CA 1.442 -0.904 0 C-N-CA 120.481 -0.866 . . . . 0.0 111.574 179.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 26.5 p -69.7 176.23 3.72 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 177.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 505' ' ' VAL . . . . . 0.702 ' O ' ' HG ' ' A' ' 509' ' ' LEU . 15.8 m -58.0 -32.04 42.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 C-N-CA 120.775 -0.37 . . . . 0.0 110.387 175.512 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 506' ' ' MET . . . . . . . . . . . . . 11.0 mmt -62.41 -43.74 98.1 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.271 176.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 507' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -61.39 -44.75 96.62 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 120.869 0.366 . . . . 0.0 110.84 179.454 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 508' ' ' VAL . . . . . . . . . . . . . 60.9 t -60.92 -45.51 98.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.745 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 509' ' ' LEU . . . . . 0.702 ' HG ' ' O ' ' A' ' 505' ' ' VAL . 77.5 mt -68.48 -36.23 78.65 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.218 -177.752 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 510' ' ' LYS . . . . . 0.448 ' HE2' HG11 ' A' ' 519' ' ' VAL . 54.4 mttm -77.28 -26.73 52.64 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.272 0.558 . . . . 0.0 110.011 -178.341 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 511' ' ' GLY . . . . . . . . . . . . . . . -71.48 -15.21 75.12 Favored Glycine 0 N--CA 1.445 -0.758 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.678 176.593 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 512' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -106.64 145.77 31.55 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.983 0.42 . . . . 0.0 111.04 179.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 -75.55 -25.23 56.97 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.207 -175.002 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 514' ' ' ARG . . . . . 0.413 ' HB3' ' HA ' ' A' ' 543' ' ' THR . 3.0 mpt_? -86.32 -50.0 7.25 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.305 0.574 . . . . 0.0 109.833 -178.189 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 515' ' ' PHE . . . . . 0.535 ' CZ ' HG21 ' A' ' 627' ' ' VAL . 11.5 m-30 -66.49 -27.0 67.44 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.635 -175.461 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 5.1 p -63.38 -30.21 71.38 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.657 0.265 . . . . 0.0 111.71 -178.52 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 517' ' ' MET . . . . . 0.498 ' HE1' ' HA ' ' A' ' 544' ' ' ASN . 54.7 mtm -69.78 -34.37 73.66 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 176.474 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 518' ' ' LEU . . . . . 0.5 HD21 ' HD2' ' A' ' 542' ' ' PRO . 51.9 tp -67.58 -40.04 84.84 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.372 173.362 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 519' ' ' VAL . . . . . 0.448 HG11 ' HE2' ' A' ' 510' ' ' LYS . 86.7 t -55.74 -37.09 45.44 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.371 0 CA-C-N 116.223 -0.444 . . . . 0.0 109.925 174.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 520' ' ' ALA . . . . . . . . . . . . . . . -63.74 -38.61 91.77 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.402 -179.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 521' ' ' ALA . . . . . . . . . . . . . . . -67.86 -51.39 48.78 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.825 0.345 . . . . 0.0 110.327 176.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 522' ' ' ILE . . . . . 0.474 ' HA ' ' HG ' ' A' ' 569' ' ' LEU . 62.1 mt -57.74 -40.83 77.71 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 CA-C-O 121.216 0.531 . . . . 0.0 111.164 178.136 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 523' ' ' GLN . . . . . 0.464 ' HA ' ' OG1' ' A' ' 528' ' ' THR . 21.5 tt0 -70.06 -39.21 75.79 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.408 -0.815 . . . . 0.0 110.762 -175.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 43.6 m -72.83 -31.16 64.6 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.93 0.395 . . . . 0.0 110.715 178.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 525' ' ' ALA . . . . . 0.629 ' HB3' ' HA ' ' A' ' 566' ' ' ALA . . . -74.86 -19.92 59.96 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.226 0.536 . . . . 0.0 110.524 176.817 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 526' ' ' GLY . . . . . . . . . . . . . . . 84.46 37.52 10.73 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.774 -0.726 . . . . 0.0 113.153 176.119 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 527' ' ' LEU . . . . . . . . . . . . . 9.1 mp -112.35 15.24 20.38 Favored 'General case' 0 C--N 1.326 -0.416 0 O-C-N 122.599 -0.353 . . . . 0.0 110.957 177.117 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 528' ' ' THR . . . . . 0.464 ' OG1' ' HA ' ' A' ' 523' ' ' GLN . 14.6 m -62.08 -33.74 74.99 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.579 -178.233 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 529' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -69.4 -24.85 63.91 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.551 -177.39 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 530' ' ' THR . . . . . 0.642 ' HB ' HD23 ' A' ' 531' ' ' LEU . 11.0 m -63.14 -53.36 54.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.062 0.458 . . . . 0.0 110.58 179.524 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 531' ' ' LEU . . . . . 0.642 HD23 ' HB ' ' A' ' 530' ' ' THR . 1.8 mm? -79.43 6.11 11.04 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.907 -178.808 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 532' ' ' ASN . . . . . . . . . . . . . 37.5 t-20 -87.83 -28.06 21.87 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.35 0.595 . . . . 0.0 109.428 179.441 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 533' ' ' ARG . . . . . . . . . . . . . 9.5 ttp180 -79.22 137.17 37.3 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.608 -0.723 . . . . 0.0 110.492 178.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 534' ' ' GLU . . . . . 0.615 ' HA ' ' HB3' ' A' ' 622' ' ' ASN . 48.5 mt-10 -77.04 133.91 38.95 Favored 'General case' 0 C--O 1.233 0.191 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 175.188 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 535' ' ' GLY . . . . . . . . . . . . . . . 173.7 -137.64 4.16 Favored Glycine 0 CA--C 1.501 -0.826 0 N-CA-C 110.675 -0.97 . . . . 0.0 110.675 -178.579 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 536' ' ' VAL . . . . . 0.45 ' HB ' HG13 ' A' ' 577' ' ' ILE . 33.8 m -119.52 130.27 74.27 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-O 121.077 0.465 . . . . 0.0 110.963 178.555 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 537' ' ' TYR . . . . . . . . . . . . . 75.8 m-85 -151.25 146.42 26.05 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.636 178.22 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 538' ' ' THR . . . . . 0.717 ' OG1' ' HA ' ' A' ' 577' ' ' ILE . 30.9 m -120.02 101.56 7.93 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 171.3 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 539' ' ' VAL . . . . . . . . . . . . . 51.8 t -103.46 127.34 57.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.115 -174.276 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 540' ' ' PHE . . . . . 0.542 ' HB3' HD12 ' A' ' 628' ' ' ILE . 94.8 m-85 -100.09 112.67 24.97 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 175.675 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 541' ' ' ALA . . . . . 0.456 ' HA ' HD21 ' A' ' 518' ' ' LEU . . . -105.93 113.0 64.2 Favored Pre-proline 0 C--N 1.325 -0.487 0 CA-C-O 120.705 0.288 . . . . 0.0 111.423 -176.788 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 542' ' ' PRO . . . . . 0.5 ' HD2' HD21 ' A' ' 518' ' ' LEU . 13.2 Cg_exo -71.02 142.24 41.94 Favored 'Trans proline' 0 N--CA 1.463 -0.29 0 C-N-CA 123.068 2.512 . . . . 0.0 112.079 176.693 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 543' ' ' THR . . . . . 0.413 ' HA ' ' HB3' ' A' ' 514' ' ' ARG . 40.9 p -80.4 179.56 7.64 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.017 178.732 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 544' ' ' ASN . . . . . 0.498 ' HA ' ' HE1' ' A' ' 517' ' ' MET . 7.9 t30 -61.78 -34.37 75.74 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.639 -179.168 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 545' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -62.82 -30.11 71.23 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.107 -176.131 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 546' ' ' ALA . . . . . 0.565 ' HB3' HG22 ' A' ' 631' ' ' VAL . . . -64.95 -49.73 69.2 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.301 0.572 . . . . 0.0 110.634 179.145 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 547' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -69.76 -22.04 63.39 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.784 -178.342 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 548' ' ' ARG . . . . . 0.512 ' O ' ' HD2' ' A' ' 548' ' ' ARG . 5.0 tmm_? -84.48 -35.71 22.78 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.859 -179.107 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 549' ' ' ALA . . . . . . . . . . . . . . . -69.36 -29.97 67.88 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.335 176.42 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 550' ' ' LEU . . . . . 0.469 ' HA ' ' HD3' ' A' ' 551' ' ' PRO . 70.8 mt -64.6 131.49 95.13 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.546 175.877 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 551' ' ' PRO . . . . . 0.472 ' HD2' ' HB2' ' A' ' 554' ' ' GLU . 6.9 Cg_exo -72.56 145.71 42.59 Favored 'Trans proline' 0 N--CA 1.459 -0.548 0 C-N-CA 122.828 2.352 . . . . 0.0 111.609 -177.309 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 552' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -53.86 -30.45 57.84 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 123.074 2.516 . . . . 0.0 112.082 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 553' ' ' ARG . . . . . . . . . . . . . 58.7 ttp180 -66.68 -54.71 20.2 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.806 177.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 554' ' ' GLU . . . . . 0.472 ' HB2' ' HD2' ' A' ' 551' ' ' PRO . 0.9 OUTLIER -65.15 -48.9 71.9 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.909 -175.939 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 555' ' ' ARG . . . . . . . . . . . . . 14.3 ptm180 -60.18 -39.23 85.73 Favored 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 121.12 -0.232 . . . . 0.0 111.464 -176.101 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 50.0 m -71.52 -27.5 63.24 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 111.683 0.253 . . . . 0.0 111.683 -175.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 557' ' ' ARG . . . . . . . . . . . . . 33.0 ttm180 -75.96 -43.28 45.39 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.053 0.454 . . . . 0.0 109.781 177.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 558' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -66.71 -42.88 85.67 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.218 -179.383 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 559' ' ' LEU . . . . . 0.725 HD22 HD22 ' A' ' 565' ' ' LEU . 63.7 mt -83.13 0.13 46.6 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.047 -178.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 560' ' ' GLY . . . . . . . . . . . . . . . -88.13 -9.63 70.12 Favored Glycine 0 N--CA 1.453 -0.196 0 CA-C-N 116.039 -0.528 . . . . 0.0 112.612 -178.25 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 561' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -127.86 129.92 47.73 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 178.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 562' ' ' ALA . . . . . . . . . . . . . . . -76.9 -28.23 55.26 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 111.927 0.343 . . . . 0.0 111.927 -175.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 563' ' ' LYS . . . . . 0.468 ' HD2' ' N ' ' A' ' 563' ' ' LYS . 0.5 OUTLIER -80.36 -35.28 35.68 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 -177.125 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 564' ' ' GLU . . . . . . . . . . . . . 21.4 mm-40 -61.14 -43.96 98.06 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 171.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 565' ' ' LEU . . . . . 0.725 HD22 HD22 ' A' ' 559' ' ' LEU . 60.3 mt -57.5 -53.36 59.03 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.74 175.261 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 566' ' ' ALA . . . . . 0.629 ' HA ' ' HB3' ' A' ' 525' ' ' ALA . . . -55.75 -26.18 44.38 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.218 -178.825 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 567' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -86.59 -35.12 19.64 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.808 -179.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 568' ' ' ILE . . . . . . . . . . . . . 22.3 mm -69.71 -52.19 34.1 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 CA-C-N 116.075 -0.511 . . . . 0.0 112.331 -179.127 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 569' ' ' LEU . . . . . 0.474 ' HG ' ' HA ' ' A' ' 522' ' ' ILE . 2.7 mm? -64.22 -23.46 67.32 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-O 121.1 0.476 . . . . 0.0 110.968 177.619 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 570' ' ' LYS . . . . . . . . . . . . . 16.3 ttmm -70.96 -12.4 61.51 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.646 177.073 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 571' ' ' TYR . . . . . 0.434 ' HB2' HE21 ' A' ' 593' ' ' GLN . 59.9 t80 -102.77 -18.07 15.31 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.872 -0.603 . . . . 0.0 111.222 -177.644 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 572' ' ' HIS . . . . . . . . . . . . . 55.4 m80 -86.43 -3.75 59.06 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.118 0.485 . . . . 0.0 110.89 -177.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 573' ' ' ILE . . . . . 0.495 HD12 HD13 ' A' ' 531' ' ' LEU . 27.0 mt -118.19 127.24 75.37 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.134 179.806 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 574' ' ' GLY . . . . . 0.567 ' HA2' ' HA ' ' A' ' 591' ' ' SER . . . -89.12 153.46 23.6 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.934 -0.65 . . . . 0.0 111.58 175.667 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 575' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -74.81 -8.7 57.23 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 120.978 0.418 . . . . 0.0 111.989 -171.482 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 576' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -160.47 162.99 33.3 Favored 'General case' 0 N--CA 1.438 -1.058 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 177.553 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 577' ' ' ILE . . . . . 0.717 ' HA ' ' OG1' ' A' ' 538' ' ' THR . 70.0 mt -78.6 124.1 36.47 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 O-C-N 124.005 0.816 . . . . 0.0 112.386 -170.695 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 578' ' ' LEU . . . . . 0.505 HD12 ' HA ' ' A' ' 583' ' ' ILE . 42.3 tp -122.9 102.09 7.81 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.1 -0.955 . . . . 0.0 109.082 173.428 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 579' ' ' VAL . . . . . . . . . . . . . 30.1 m -96.54 157.39 3.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.84 -177.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 580' ' ' SER . . . . . . . . . . . . . 31.8 t -58.44 -38.96 78.56 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.351 -179.534 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 581' ' ' GLY . . . . . . . . . . . . . . . -74.48 9.96 9.37 Favored Glycine 0 N--CA 1.449 -0.486 0 CA-C-N 115.74 -0.663 . . . . 0.0 113.717 -179.477 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . -162.77 42.59 0.35 Allowed Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.814 -0.707 . . . . 0.0 112.87 178.441 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 583' ' ' ILE . . . . . 0.767 HD13 ' HB2' ' A' ' 601' ' ' LEU . 30.6 mt -80.18 -65.46 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.828 0.347 . . . . 0.0 110.614 176.769 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 584' ' ' GLY . . . . . . . . . . . . . . . 99.82 63.11 0.82 Allowed Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.605 -0.807 . . . . 0.0 111.856 -177.063 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 585' ' ' ALA . . . . . . . . . . . . . . . 67.63 -75.57 0.06 Allowed 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 123.389 0.676 . . . . 0.0 111.96 -179.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 586' ' ' LEU . . . . . 0.981 ' HG ' ' HB3' ' A' ' 600' ' ' SER . 6.5 tt -151.32 129.85 12.2 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.904 0.383 . . . . 0.0 110.237 -178.268 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 587' ' ' VAL . . . . . . . . . . . . . 94.5 t -133.59 133.6 57.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.752 -178.042 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 588' ' ' ARG . . . . . . . . . . . . . 71.8 mtt180 -84.26 102.78 12.92 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 173.044 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 589' ' ' LEU . . . . . . . . . . . . . 60.3 tp -90.51 111.98 23.47 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.584 0.707 . . . . 0.0 110.788 -173.401 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 590' ' ' LYS . . . . . . . . . . . . . 46.5 pttt -60.3 137.35 58.14 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 114.93 -1.032 . . . . 0.0 110.634 176.516 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 591' ' ' SER . . . . . 0.567 ' HA ' ' HA2' ' A' ' 574' ' ' GLY . 44.9 p -99.24 172.59 7.26 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.161 175.861 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 592' ' ' LEU . . . . . 0.424 HD22 ' O ' ' A' ' 573' ' ' ILE . 2.9 mm? -58.76 -22.54 58.22 Favored 'General case' 0 CA--C 1.529 0.173 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 179.593 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 593' ' ' GLN . . . . . 0.732 ' HG3' ' H ' ' A' ' 595' ' ' ASP . 5.8 pt20 -85.34 -29.9 24.12 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.63 -0.428 . . . . 0.0 111.145 178.345 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 594' ' ' GLY . . . . . 0.426 ' N ' ' HG3' ' A' ' 593' ' ' GLN . . . 122.06 -18.76 8.39 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.611 -0.804 . . . . 0.0 113.136 -177.313 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 595' ' ' ASP . . . . . 0.732 ' H ' ' HG3' ' A' ' 593' ' ' GLN . 18.1 t70 -68.46 165.0 19.83 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-N 117.708 0.754 . . . . 0.0 110.189 178.421 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 596' ' ' LYS . . . . . . . . . . . . . 44.9 mttm -109.45 113.37 26.11 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.189 -170.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 597' ' ' LEU . . . . . . . . . . . . . 58.3 mt -79.55 125.76 30.01 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.042 175.233 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 598' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -78.85 84.64 4.88 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 120.612 -0.435 . . . . 0.0 110.163 176.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 599' ' ' VAL . . . . . . . . . . . . . 38.1 t -97.92 121.4 48.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 121.217 0.532 . . . . 0.0 109.588 178.528 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 600' ' ' SER . . . . . 0.981 ' HB3' ' HG ' ' A' ' 586' ' ' LEU . 8.2 p -139.64 160.13 40.57 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-O 120.872 0.367 . . . . 0.0 111.377 -175.429 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 601' ' ' LEU . . . . . 0.767 ' HB2' HD13 ' A' ' 583' ' ' ILE . 39.4 tp -118.45 109.92 16.81 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.852 -179.388 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 602' ' ' LYS . . . . . . . . . . . . . 43.6 mmtm -121.53 114.96 21.96 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.132 -0.485 . . . . 0.0 109.826 178.173 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 603' ' ' ASN . . . . . . . . . . . . . 16.7 m120 58.92 38.52 24.39 Favored 'General case' 0 N--CA 1.465 0.31 0 O-C-N 123.316 0.385 . . . . 0.0 110.526 178.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 604' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 66.34 17.25 10.66 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.236 -179.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 605' ' ' VAL . . . . . . . . . . . . . 61.2 t -110.05 121.86 63.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 175.032 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 606' ' ' VAL . . . . . . . . . . . . . 25.1 t -85.83 131.35 34.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.395 -178.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 607' ' ' SER . . . . . . . . . . . . . 42.1 m -131.24 131.43 43.91 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.356 176.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 608' ' ' VAL . . . . . 0.435 HG13 HD23 ' A' ' 632' ' ' LEU . 3.6 p -115.2 111.82 37.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.86 178.609 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 609' ' ' ASN . . . . . 0.494 ' O ' ' HB3' ' A' ' 610' ' ' LYS . 91.6 m-20 60.89 35.47 19.23 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.921 -175.04 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 610' ' ' LYS . . . . . 0.494 ' HB3' ' O ' ' A' ' 609' ' ' ASN . 83.9 tttt 82.28 -24.99 0.16 Allowed 'General case' 0 N--CA 1.47 0.547 0 O-C-N 124.544 1.152 . . . . 0.0 111.795 -177.634 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 611' ' ' GLU . . . . . 0.415 ' HA ' ' HD3' ' A' ' 612' ' ' PRO . 11.0 mm-40 -67.81 127.47 93.36 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.064 0.459 . . . . 0.0 110.602 -179.208 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 612' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 611' ' ' GLU . 3.1 Cg_exo -74.76 130.74 13.83 Favored 'Trans proline' 0 N--CA 1.459 -0.526 0 C-N-CA 123.099 2.533 . . . . 0.0 112.701 -175.034 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 613' ' ' VAL . . . . . . . . . . . . . 96.7 t -79.71 125.9 38.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.568 175.295 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 614' ' ' ALA . . . . . 0.601 ' HB2' HG22 ' A' ' 629' ' ' THR . . . -78.94 -36.79 41.15 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.789 -176.463 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 615' ' ' GLU . . . . . 0.414 ' HB2' ' HB ' ' A' ' 627' ' ' VAL . 9.8 mm-40 -152.48 94.65 3.18 Favored Pre-proline 0 N--CA 1.467 0.393 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.848 -177.114 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 616' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -90.48 162.88 4.41 Favored 'Trans proline' 0 N--CA 1.46 -0.46 0 C-N-CA 123.139 2.56 . . . . 0.0 113.562 179.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 76.07 33.22 0.59 Allowed 'General case' 0 CA--C 1.506 -0.743 0 CA-C-O 122.103 0.954 . . . . 0.0 110.261 165.264 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 618' ' ' ILE . . . . . 0.514 ' HB ' ' O ' ' A' ' 625' ' ' VAL . 22.7 mt -82.19 97.72 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.36 0 CA-C-N 113.936 -1.484 . . . . 0.0 109.449 178.569 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 619' ' ' MET . . . . . 0.412 ' HA ' ' CE ' ' A' ' 619' ' ' MET . 2.8 mmt -62.39 111.28 1.95 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 114.948 -1.024 . . . . 0.0 111.939 -177.196 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 620' ' ' ALA . . . . . . . . . . . . . . . -110.73 -179.49 3.76 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 171.639 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 621' ' ' THR . . . . . . . . . . . . . 35.2 m -69.66 -46.86 65.18 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-O 120.886 0.374 . . . . 0.0 111.633 -177.566 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 622' ' ' ASN . . . . . 0.615 ' HB3' ' HA ' ' A' ' 534' ' ' GLU . 24.0 p-10 -116.72 32.81 5.93 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.827 -174.045 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 623' ' ' GLY . . . . . 0.597 ' HA2' HD12 ' A' ' 577' ' ' ILE . . . 150.67 -159.65 28.24 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.527 -0.844 . . . . 0.0 112.46 176.77 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 624' ' ' VAL . . . . . . . . . . . . . 9.8 m -123.4 165.95 19.04 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.753 0 CA-C-O 121.909 0.861 . . . . 0.0 111.352 176.111 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 625' ' ' VAL . . . . . 0.514 ' O ' ' HB ' ' A' ' 618' ' ' ILE . 89.8 t -128.51 107.33 15.75 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.193 0 CA-C-N 113.584 -1.644 . . . . 0.0 109.43 177.742 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 626' ' ' HIS . . . . . . . . . . . . . 28.4 m-70 -95.41 103.31 15.17 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 177.192 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 627' ' ' VAL . . . . . 0.535 HG21 ' CZ ' ' A' ' 515' ' ' PHE . 41.8 t -62.75 130.85 27.81 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.0 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 628' ' ' ILE . . . . . 0.542 HD12 ' HB3' ' A' ' 540' ' ' PHE . 3.9 pt -124.85 143.64 37.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 121.193 0.52 . . . . 0.0 111.145 178.647 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 629' ' ' THR . . . . . 0.601 HG22 ' HB2' ' A' ' 614' ' ' ALA . 24.5 p -88.31 7.46 32.19 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.965 -0.561 . . . . 0.0 112.329 -178.485 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 630' ' ' ASN . . . . . . . . . . . . . 65.7 t30 -150.05 174.08 13.14 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 176.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 631' ' ' VAL . . . . . 0.565 HG22 ' HB3' ' A' ' 546' ' ' ALA . 48.9 t -101.19 133.81 43.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.036 -178.102 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 632' ' ' LEU . . . . . 0.435 HD23 HG13 ' A' ' 608' ' ' VAL . 95.9 mt -79.23 116.78 19.7 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-O 121.312 0.577 . . . . 0.0 111.149 -175.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 633' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -122.98 116.67 28.74 Favored Pre-proline 0 C--N 1.317 -0.814 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.083 179.464 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 634' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo . . . . . 0 C--O 1.249 1.057 0 C-N-CA 122.349 2.032 . . . . 0.0 112.266 -179.421 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 500' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.101 0 CA-C-O 120.677 0.275 . . . . 0.0 110.711 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 501' ' ' GLY . . . . . . . . . . . . . . . 111.68 114.07 3.39 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 121.044 -0.598 . . . . 0.0 111.709 179.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 502' ' ' MET . . . . . . . . . . . . . 61.4 mtm -117.91 8.29 12.55 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.149 0.5 . . . . 0.0 110.42 -179.123 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . -172.35 -176.29 41.01 Favored Glycine 0 N--CA 1.446 -0.67 0 N-CA-C 111.11 -0.796 . . . . 0.0 111.11 179.298 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 504' ' ' THR . . . . . 0.602 ' HA ' HG22 ' A' ' 621' ' ' THR . 47.7 p -81.25 172.36 13.72 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 117.065 0.432 . . . . 0.0 110.292 177.884 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 505' ' ' VAL . . . . . 0.649 HG21 HG21 ' A' ' 625' ' ' VAL . 5.0 p -54.66 -47.96 72.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.682 -179.179 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 506' ' ' MET . . . . . 0.591 ' HA ' HD13 ' A' ' 509' ' ' LEU . 2.8 ppp? -81.79 -17.09 48.78 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.519 -0.473 . . . . 0.0 111.077 -178.66 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 507' ' ' ASP . . . . . 0.492 ' HA ' ' HB2' ' A' ' 510' ' ' LYS . 27.6 t70 -68.13 -29.89 68.9 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 173.19 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 508' ' ' VAL . . . . . . . . . . . . . 84.9 t -61.79 -49.33 84.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.824 -0.626 . . . . 0.0 109.578 171.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 509' ' ' LEU . . . . . 1.008 ' HG ' ' HB3' ' A' ' 515' ' ' PHE . 9.6 mp -53.78 -42.36 68.21 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 121.617 0.722 . . . . 0.0 111.25 171.701 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 510' ' ' LYS . . . . . 0.494 ' HD3' ' SD ' ' A' ' 506' ' ' MET . 0.7 OUTLIER -68.59 -20.43 64.51 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 114.769 -1.105 . . . . 0.0 111.467 -177.937 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 511' ' ' GLY . . . . . . . . . . . . . . . -96.82 -0.91 60.2 Favored Glycine 0 N--CA 1.437 -1.252 0 C-N-CA 120.8 -0.714 . . . . 0.0 111.617 177.208 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 512' ' ' ASP . . . . . 0.404 ' O ' ' HB2' ' A' ' 516' ' ' SER . 27.0 t70 -117.98 148.84 41.82 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.513 0.673 . . . . 0.0 112.39 -176.527 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -75.56 -34.96 60.75 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.428 -179.513 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 514' ' ' ARG . . . . . . . . . . . . . 35.6 mtt180 -79.0 -53.25 7.22 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.085 -174.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 515' ' ' PHE . . . . . 1.008 ' HB3' ' HG ' ' A' ' 509' ' ' LEU . 14.4 m-30 -64.27 -17.12 63.31 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.066 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 516' ' ' SER . . . . . 0.404 ' HB2' ' O ' ' A' ' 512' ' ' ASP . 39.6 t -58.03 -31.06 66.63 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.304 -178.247 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 517' ' ' MET . . . . . 0.565 ' HE1' ' HA ' ' A' ' 544' ' ' ASN . 47.7 mtm -72.39 -30.7 64.9 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.742 0.306 . . . . 0.0 110.441 178.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 518' ' ' LEU . . . . . 0.538 HD22 HD23 ' A' ' 509' ' ' LEU . 47.7 tp -70.23 -34.07 72.42 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 173.46 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 519' ' ' VAL . . . . . . . . . . . . . 56.7 t -61.41 -33.04 55.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 121.096 0.474 . . . . 0.0 109.774 174.162 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 520' ' ' ALA . . . . . . . . . . . . . . . -67.0 -40.59 87.38 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.325 177.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 521' ' ' ALA . . . . . . . . . . . . . . . -66.69 -47.75 71.44 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.151 176.236 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 522' ' ' ILE . . . . . 0.438 HG13 ' O ' ' A' ' 518' ' ' LEU . 87.9 mt -56.34 -43.01 76.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.752 176.575 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 523' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -62.69 -47.91 81.6 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.125 178.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 40.1 m -66.61 -36.42 82.55 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.062 -176.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 525' ' ' ALA . . . . . . . . . . . . . . . -78.58 -28.3 45.83 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.484 -0.326 . . . . 0.0 110.968 177.289 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 526' ' ' GLY . . . . . . . . . . . . . . . 82.02 38.04 14.37 Favored Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 121.286 -0.483 . . . . 0.0 112.931 177.277 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 527' ' ' LEU . . . . . . . . . . . . . 97.5 mt -111.07 20.41 17.46 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.765 0.317 . . . . 0.0 111.209 -177.568 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 528' ' ' THR . . . . . . . . . . . . . 8.8 m -62.08 -37.08 83.68 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.724 -177.535 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 529' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -63.44 -31.62 72.83 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 121.025 0.44 . . . . 0.0 110.681 -178.045 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 530' ' ' THR . . . . . . . . . . . . . 27.0 m -59.84 -46.63 88.66 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.078 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 531' ' ' LEU . . . . . 0.496 HD22 HD13 ' A' ' 573' ' ' ILE . 67.1 mt -93.05 11.44 27.57 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.161 0.505 . . . . 0.0 111.268 -178.094 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 532' ' ' ASN . . . . . . . . . . . . . 58.2 t30 -91.47 -51.01 5.48 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.55 -178.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 533' ' ' ARG . . . . . . . . . . . . . 1.7 tpt180 -68.43 146.1 53.5 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.733 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 534' ' ' GLU . . . . . 0.605 ' HA ' ' HB3' ' A' ' 622' ' ' ASN . 23.2 pm0 -76.6 143.74 40.03 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 121.322 0.582 . . . . 0.0 110.537 -179.345 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 535' ' ' GLY . . . . . 0.405 ' H ' ' HB2' ' A' ' 622' ' ' ASN . . . 177.2 -139.57 4.44 Favored Glycine 0 N--CA 1.446 -0.655 0 N-CA-C 110.117 -1.193 . . . . 0.0 110.117 -176.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 536' ' ' VAL . . . . . . . . . . . . . 33.0 m -124.48 130.31 73.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 117.31 0.555 . . . . 0.0 110.612 176.277 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 537' ' ' TYR . . . . . . . . . . . . . 76.0 m-85 -153.07 152.42 31.31 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.635 -178.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 538' ' ' THR . . . . . 0.734 ' OG1' ' HA ' ' A' ' 577' ' ' ILE . 30.7 m -134.89 102.38 5.22 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.403 174.031 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 539' ' ' VAL . . . . . 0.614 HG23 HG23 ' A' ' 573' ' ' ILE . 39.2 t -109.92 127.0 67.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 120.976 0.417 . . . . 0.0 111.694 -172.66 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 540' ' ' PHE . . . . . 0.623 ' HB3' HD11 ' A' ' 628' ' ' ILE . 87.9 m-85 -95.38 109.01 21.23 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 172.264 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 541' ' ' ALA . . . . . 0.462 ' HA ' HD21 ' A' ' 518' ' ' LEU . . . -96.01 111.23 55.53 Favored Pre-proline 0 C--N 1.322 -0.618 0 CA-C-N 116.628 -0.26 . . . . 0.0 111.193 -176.418 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 542' ' ' PRO . . . . . 0.6 ' HA ' HG13 ' A' ' 628' ' ' ILE . 18.5 Cg_endo -66.91 130.05 22.21 Favored 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 122.141 1.894 . . . . 0.0 110.967 175.251 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 17.4 p -96.4 -174.78 3.15 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.509 -0.769 . . . . 0.0 112.55 -171.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 544' ' ' ASN . . . . . 0.565 ' HA ' ' HE1' ' A' ' 517' ' ' MET . 8.5 t30 -49.76 -37.15 28.48 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 114.746 -1.115 . . . . 0.0 111.715 178.056 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 545' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -65.0 -28.62 69.63 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.976 -175.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 546' ' ' ALA . . . . . 0.588 ' HB1' HG22 ' A' ' 631' ' ' VAL . . . -79.08 -58.46 3.22 Favored 'General case' 0 CA--C 1.516 -0.348 0 CA-C-O 121.082 0.468 . . . . 0.0 111.616 -176.149 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 547' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -64.62 -29.85 70.86 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.727 -0.669 . . . . 0.0 111.548 -175.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 548' ' ' ARG . . . . . . . . . . . . . 47.3 ttp180 -66.66 -30.68 71.0 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.923 0.392 . . . . 0.0 110.46 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 549' ' ' ALA . . . . . . . . . . . . . . . -86.89 -10.57 53.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.461 -176.016 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 550' ' ' LEU . . . . . 0.466 ' HA ' ' HD3' ' A' ' 551' ' ' PRO . 88.2 mt -70.79 122.78 87.79 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 120.922 0.392 . . . . 0.0 110.978 -178.112 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 551' ' ' PRO . . . . . 0.466 ' HD3' ' HA ' ' A' ' 550' ' ' LEU . 16.5 Cg_exo -68.89 157.72 60.75 Favored 'Trans proline' 0 C--O 1.236 0.375 0 C-N-CA 123.327 2.685 . . . . 0.0 111.853 -178.294 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 552' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -44.17 -53.01 5.11 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 123.831 3.021 . . . . 0.0 113.225 -177.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 553' ' ' ARG . . . . . . . . . . . . . 23.2 mtm180 -63.2 -48.35 78.67 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 120.715 0.293 . . . . 0.0 111.513 -175.575 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -63.74 -52.77 58.99 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.736 -174.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 555' ' ' ARG . . . . . . . . . . . . . 19.6 ptt180 -66.34 -29.16 69.3 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.274 -177.474 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 29.2 t -75.6 -24.06 56.5 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.615 0.245 . . . . 0.0 110.834 -178.256 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 557' ' ' ARG . . . . . . . . . . . . . 12.3 tpp180 -82.94 -46.52 12.83 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.53 -0.304 . . . . 0.0 110.265 178.281 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 558' ' ' LEU . . . . . . . . . . . . . 51.2 tp -61.17 -41.56 97.01 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.768 179.223 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 559' ' ' LEU . . . . . 0.663 HD22 HD21 ' A' ' 565' ' ' LEU . 80.5 mt -91.83 6.35 46.45 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.195 0.522 . . . . 0.0 110.552 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 560' ' ' GLY . . . . . . . . . . . . . . . -96.72 -39.58 4.09 Favored Glycine 0 N--CA 1.444 -0.769 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.685 179.502 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 561' ' ' ASP . . . . . 0.473 ' CB ' ' HG2' ' A' ' 564' ' ' GLU . 6.1 m-20 -103.81 119.89 39.85 Favored 'General case' 0 N--CA 1.445 -0.708 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 177.139 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 562' ' ' ALA . . . . . . . . . . . . . . . -65.74 -28.84 69.34 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.986 0.422 . . . . 0.0 111.153 -176.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 563' ' ' LYS . . . . . . . . . . . . . 4.2 mptp? -69.6 -36.84 76.57 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.1 179.02 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 564' ' ' GLU . . . . . 0.473 ' HG2' ' CB ' ' A' ' 561' ' ' ASP . 8.7 mm-40 -62.96 -40.4 97.57 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 179.384 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 565' ' ' LEU . . . . . 0.663 HD21 HD22 ' A' ' 559' ' ' LEU . 48.3 mt -57.07 -50.2 73.5 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.72 176.129 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 566' ' ' ALA . . . . . . . . . . . . . . . -60.48 -53.97 51.19 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.588 179.224 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 567' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -58.95 -49.96 75.88 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.811 -0.631 . . . . 0.0 112.207 -177.24 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 568' ' ' ILE . . . . . . . . . . . . . 40.7 mm -63.99 -40.4 88.93 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 CA-C-O 120.577 0.227 . . . . 0.0 111.557 -178.503 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 569' ' ' LEU . . . . . 0.459 ' HB3' ' O ' ' A' ' 565' ' ' LEU . 0.1 OUTLIER -72.58 -29.2 63.32 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 122.058 -0.401 . . . . 0.0 110.204 -177.344 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 570' ' ' LYS . . . . . . . . . . . . . 25.2 mtpp -62.19 -29.08 70.12 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.091 0.472 . . . . 0.0 110.684 174.086 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 571' ' ' TYR . . . . . 0.521 ' HB2' ' NE2' ' A' ' 593' ' ' GLN . 55.2 t80 -75.46 -18.8 59.77 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.416 178.402 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 572' ' ' HIS . . . . . . . . . . . . . 64.7 m80 -87.64 -12.4 45.64 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.75 0.309 . . . . 0.0 111.331 -177.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 573' ' ' ILE . . . . . 0.614 HG23 HG23 ' A' ' 539' ' ' VAL . 28.7 mt -110.84 118.1 56.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 120.834 0.349 . . . . 0.0 111.18 -178.854 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 574' ' ' GLY . . . . . 0.43 ' HA2' ' HA ' ' A' ' 591' ' ' SER . . . -95.49 145.74 17.89 Favored Glycine 0 N--CA 1.446 -0.698 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 170.584 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 575' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -93.34 16.94 12.13 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 117.524 0.662 . . . . 0.0 111.119 -174.584 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 576' ' ' GLU . . . . . 0.506 ' HB2' HD23 ' A' ' 589' ' ' LEU . 48.8 mt-10 -137.55 124.08 20.88 Favored 'General case' 0 CA--C 1.512 -0.512 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 179.496 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 577' ' ' ILE . . . . . 0.734 ' HA ' ' OG1' ' A' ' 538' ' ' THR . 72.4 mt -67.43 117.74 9.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 O-C-N 123.612 0.57 . . . . 0.0 111.369 -173.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 578' ' ' LEU . . . . . 0.674 HD13 HG12 ' A' ' 583' ' ' ILE . 3.3 tm? -117.03 114.21 23.44 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.038 -0.983 . . . . 0.0 109.499 178.653 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 579' ' ' VAL . . . . . . . . . . . . . 29.4 m -108.59 163.4 6.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 177.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 580' ' ' SER . . . . . . . . . . . . . 23.6 t -59.39 -41.86 90.39 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.956 0.407 . . . . 0.0 110.857 -176.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 581' ' ' GLY . . . . . . . . . . . . . . . -77.57 19.79 3.79 Favored Glycine 0 CA--C 1.523 0.54 0 C-N-CA 120.777 -0.725 . . . . 0.0 113.152 -179.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . -142.35 16.54 2.5 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.473 178.547 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 583' ' ' ILE . . . . . 0.674 HG12 HD13 ' A' ' 578' ' ' LEU . 32.3 mt -85.33 -42.36 16.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.925 0.393 . . . . 0.0 110.95 179.601 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 584' ' ' GLY . . . . . . . . . . . . . . . 81.01 -87.71 1.36 Allowed Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.48 -0.867 . . . . 0.0 111.66 -178.171 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 585' ' ' ALA . . . . . . . . . . . . . . . -130.44 -66.7 0.76 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.003 0.43 . . . . 0.0 109.855 176.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 586' ' ' LEU . . . . . 0.809 ' HG ' ' HB2' ' A' ' 600' ' ' SER . 3.6 tt -142.21 134.56 27.83 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 174.871 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 587' ' ' VAL . . . . . . . . . . . . . 10.7 p -125.15 138.44 54.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-O 121.14 0.495 . . . . 0.0 110.955 -174.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 588' ' ' ARG . . . . . . . . . . . . . 95.2 mtt180 -99.35 101.75 13.14 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 178.564 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 589' ' ' LEU . . . . . 0.506 HD23 ' HB2' ' A' ' 576' ' ' GLU . 0.6 OUTLIER -109.05 127.04 53.77 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.008 -176.528 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 590' ' ' LYS . . . . . 0.433 ' HE3' ' OE2' ' A' ' 576' ' ' GLU . 22.5 pttp -86.21 145.0 27.16 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.107 0.479 . . . . 0.0 111.002 -176.67 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 591' ' ' SER . . . . . 0.43 ' HA ' ' HA2' ' A' ' 574' ' ' GLY . 79.4 p -95.79 177.84 5.64 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.296 -178.856 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 592' ' ' LEU . . . . . . . . . . . . . 49.1 mt -70.96 -13.87 62.16 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.906 0.384 . . . . 0.0 110.56 179.083 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 593' ' ' GLN . . . . . 0.521 ' NE2' ' HB2' ' A' ' 571' ' ' TYR . 9.4 tt0 -85.74 -29.55 23.8 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.046 -177.449 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 594' ' ' GLY . . . . . . . . . . . . . . . 121.0 -27.09 6.55 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.935 -0.65 . . . . 0.0 111.678 -177.34 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 595' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -73.78 166.04 24.04 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.013 0.435 . . . . 0.0 110.892 176.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 596' ' ' LYS . . . . . 0.498 ' O ' ' HD2' ' A' ' 596' ' ' LYS . 0.1 OUTLIER -105.32 141.75 36.29 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.045 -179.601 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 597' ' ' LEU . . . . . 0.451 HD23 ' O ' ' A' ' 571' ' ' TYR . 71.0 mt -92.24 120.27 32.64 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.448 -0.796 . . . . 0.0 108.935 172.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 598' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 -81.29 84.15 6.68 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.188 0.518 . . . . 0.0 109.799 -176.289 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 599' ' ' VAL . . . . . . . . . . . . . 42.1 t -98.07 133.77 38.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.086 -175.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 600' ' ' SER . . . . . 0.809 ' HB2' ' HG ' ' A' ' 586' ' ' LEU . 29.7 t -144.66 167.86 21.54 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 121.325 0.583 . . . . 0.0 110.569 -177.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 601' ' ' LEU . . . . . 0.443 HD13 HD13 ' A' ' 583' ' ' ILE . 31.3 tp -131.45 107.6 9.02 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 114.93 -1.032 . . . . 0.0 109.275 -178.345 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 602' ' ' LYS . . . . . . . . . . . . . 24.7 ttmm -119.0 113.76 21.48 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.217 -0.447 . . . . 0.0 109.85 -177.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 603' ' ' ASN . . . . . 0.448 ' O ' ' HB2' ' A' ' 604' ' ' ASN . 14.2 m120 59.48 32.88 22.0 Favored 'General case' 0 N--CA 1.466 0.338 0 O-C-N 123.43 0.456 . . . . 0.0 110.435 -177.87 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 604' ' ' ASN . . . . . 0.448 ' HB2' ' O ' ' A' ' 603' ' ' ASN . 11.2 m120 73.15 10.59 5.19 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 115.205 -0.907 . . . . 0.0 111.939 -179.013 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 605' ' ' VAL . . . . . . . . . . . . . 61.1 t -97.97 119.98 46.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 174.08 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 606' ' ' VAL . . . . . . . . . . . . . 19.7 t -81.0 136.67 22.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.727 -178.506 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 607' ' ' SER . . . . . . . . . . . . . 8.2 p -142.25 147.92 37.26 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.481 178.62 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 608' ' ' VAL . . . . . . . . . . . . . 7.0 p -131.56 117.38 35.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.122 177.455 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 609' ' ' ASN . . . . . 0.493 ' O ' ' HB2' ' A' ' 610' ' ' LYS . 88.6 m-20 61.35 31.58 19.23 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.676 -178.61 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 610' ' ' LYS . . . . . 0.493 ' HB2' ' O ' ' A' ' 609' ' ' ASN . 11.7 mmmm 79.58 -2.47 2.12 Favored 'General case' 0 N--CA 1.472 0.664 0 O-C-N 124.283 0.989 . . . . 0.0 111.725 -178.133 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 611' ' ' GLU . . . . . 0.479 ' HA ' ' HD3' ' A' ' 612' ' ' PRO . 4.4 mm-40 -93.42 125.81 52.68 Favored Pre-proline 0 C--N 1.33 -0.241 0 N-CA-C 109.654 -0.498 . . . . 0.0 109.654 177.269 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 612' ' ' PRO . . . . . 0.479 ' HD3' ' HA ' ' A' ' 611' ' ' GLU . 8.4 Cg_exo -72.31 144.57 41.58 Favored 'Trans proline' 0 N--CA 1.463 -0.295 0 C-N-CA 122.985 2.457 . . . . 0.0 112.982 -176.252 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 613' ' ' VAL . . . . . 0.419 HG11 ' HB3' ' A' ' 616' ' ' PRO . 98.7 t -86.17 125.97 40.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.61 175.318 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 614' ' ' ALA . . . . . 0.538 ' HB3' HG23 ' A' ' 629' ' ' THR . . . -80.75 -28.48 36.48 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.69 -0.687 . . . . 0.0 111.721 -174.368 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 615' ' ' GLU . . . . . 0.53 ' HB3' ' CG2' ' A' ' 627' ' ' VAL . 10.1 tp10 -161.46 93.97 1.39 Allowed Pre-proline 0 C--N 1.328 -0.363 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 -179.019 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 616' ' ' PRO . . . . . 0.419 ' HB3' HG11 ' A' ' 613' ' ' VAL . 65.4 Cg_endo -89.33 161.04 5.58 Favored 'Trans proline' 0 N--CA 1.46 -0.494 0 C-N-CA 123.353 2.702 . . . . 0.0 113.81 -177.209 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 77.05 32.7 0.47 Allowed 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 121.962 0.887 . . . . 0.0 110.343 164.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 618' ' ' ILE . . . . . 0.466 ' CG2' ' HB ' ' A' ' 625' ' ' VAL . 13.2 mt -75.81 111.28 12.04 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.909 0 CA-C-N 114.498 -1.228 . . . . 0.0 109.694 175.342 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 619' ' ' MET . . . . . 0.499 ' HA ' ' HE1' ' A' ' 619' ' ' MET . 9.5 mmt -74.86 122.65 23.7 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.809 -0.632 . . . . 0.0 112.114 -175.254 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 620' ' ' ALA . . . . . . . . . . . . . . . -122.47 161.05 24.29 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 172.432 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 621' ' ' THR . . . . . 0.602 HG22 ' HA ' ' A' ' 504' ' ' THR . 9.9 t -69.32 -30.13 68.11 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.587 -0.445 . . . . 0.0 111.823 -174.512 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 622' ' ' ASN . . . . . 0.605 ' HB3' ' HA ' ' A' ' 534' ' ' GLU . 29.3 p-10 -118.07 28.26 8.49 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 111.921 0.341 . . . . 0.0 111.921 -178.027 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 623' ' ' GLY . . . . . . . . . . . . . . . 155.68 -160.68 30.12 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.171 -1.014 . . . . 0.0 112.444 176.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 624' ' ' VAL . . . . . . . . . . . . . 8.8 p -128.66 157.44 41.3 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 N-CA-C 110.04 -0.356 . . . . 0.0 110.04 179.001 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 625' ' ' VAL . . . . . 0.649 HG21 HG21 ' A' ' 505' ' ' VAL . 42.8 t -125.02 136.18 61.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 116.246 -0.434 . . . . 0.0 109.932 -179.222 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 626' ' ' HIS . . . . . . . . . . . . . 95.6 m-70 -122.57 112.07 17.57 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-O 121.067 0.461 . . . . 0.0 109.982 175.558 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 627' ' ' VAL . . . . . 0.779 HG22 ' HZ ' ' A' ' 515' ' ' PHE . 67.7 t -67.45 129.01 31.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.061 179.402 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 628' ' ' ILE . . . . . 0.623 HD11 ' HB3' ' A' ' 540' ' ' PHE . 9.2 pt -126.02 146.11 32.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.158 0.504 . . . . 0.0 110.932 175.398 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 629' ' ' THR . . . . . 0.538 HG23 ' HB3' ' A' ' 614' ' ' ALA . 35.3 p -95.22 -1.55 51.4 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.042 179.764 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 630' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -125.29 163.07 23.34 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.846 -0.615 . . . . 0.0 109.691 -175.693 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 631' ' ' VAL . . . . . 0.588 HG22 ' HB1' ' A' ' 546' ' ' ALA . 58.5 t -99.3 123.23 51.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 177.548 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 632' ' ' LEU . . . . . . . . . . . . . 80.4 mt -80.88 116.3 20.79 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.144 0.497 . . . . 0.0 111.338 -177.4 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 633' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 -120.15 129.92 25.1 Favored Pre-proline 0 C--N 1.321 -0.651 0 CA-C-N 115.648 -0.706 . . . . 0.0 109.1 176.461 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 634' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo . . . . . 0 C--O 1.249 1.047 0 C-N-CA 123.296 2.664 . . . . 0.0 112.826 -179.543 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 500' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.022 0 N-CA-C 110.245 -0.28 . . . . 0.0 110.245 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 501' ' ' GLY . . . . . . . . . . . . . . . 166.79 114.91 0.31 Allowed Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 120.596 -0.811 . . . . 0.0 112.314 -179.524 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 502' ' ' MET . . . . . . . . . . . . . 49.6 mtm 68.78 155.22 0.12 Allowed 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 123.288 0.635 . . . . 0.0 111.428 179.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . -130.71 130.1 6.02 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.865 -0.684 . . . . 0.0 112.029 177.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 504' ' ' THR . . . . . 0.45 ' HA ' HG23 ' A' ' 621' ' ' THR . 41.1 p -78.92 170.46 16.65 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 110.446 -0.205 . . . . 0.0 110.446 178.589 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 505' ' ' VAL . . . . . 0.718 ' O ' ' HG ' ' A' ' 509' ' ' LEU . 10.7 m -60.54 -34.09 56.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 175.061 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 506' ' ' MET . . . . . 0.429 ' HE3' HG23 ' A' ' 528' ' ' THR . 93.5 mmm -65.03 -34.78 79.25 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-O 120.809 0.338 . . . . 0.0 110.357 177.354 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 507' ' ' ASP . . . . . 0.538 ' HA ' ' HE3' ' A' ' 510' ' ' LYS . 29.9 t70 -70.29 -44.06 69.14 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.183 178.298 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 508' ' ' VAL . . . . . 0.437 HG22 ' O ' ' A' ' 504' ' ' THR . 67.7 t -59.24 -42.94 88.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.886 177.595 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 509' ' ' LEU . . . . . 0.718 ' HG ' ' O ' ' A' ' 505' ' ' VAL . 71.7 mt -68.51 -32.0 71.65 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.512 -178.199 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 510' ' ' LYS . . . . . 0.538 ' HE3' ' HA ' ' A' ' 507' ' ' ASP . 22.9 pttp -88.11 -13.54 41.08 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.184 0.516 . . . . 0.0 110.048 -178.309 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 511' ' ' GLY . . . . . . . . . . . . . . . -84.51 -8.65 82.85 Favored Glycine 0 N--CA 1.442 -0.912 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.562 174.31 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 512' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -116.24 135.72 53.65 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.604 0.24 . . . . 0.0 110.477 178.216 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -64.39 -36.89 85.63 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.844 -176.052 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 514' ' ' ARG . . . . . 0.7 ' HD3' HG21 ' A' ' 543' ' ' THR . 74.8 mtt180 -73.45 -46.94 45.32 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.305 0.574 . . . . 0.0 110.245 -176.731 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 515' ' ' PHE . . . . . 0.964 ' HZ ' HG21 ' A' ' 627' ' ' VAL . 13.9 m-30 -67.42 -18.11 64.98 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.99 -178.546 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 66.2 m -57.43 -36.86 71.9 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.362 -0.381 . . . . 0.0 112.018 -177.593 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 517' ' ' MET . . . . . 0.522 ' HE1' ' HA ' ' A' ' 544' ' ' ASN . 44.7 mtm -72.32 -33.25 67.21 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.752 -0.379 . . . . 0.0 110.177 -179.454 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 518' ' ' LEU . . . . . . . . . . . . . 66.1 tp -64.06 -38.72 92.11 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.088 -0.505 . . . . 0.0 109.908 173.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 519' ' ' VAL . . . . . 0.423 HG22 ' O ' ' A' ' 515' ' ' PHE . 56.7 t -57.33 -36.12 51.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 121.156 0.503 . . . . 0.0 109.875 174.399 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 520' ' ' ALA . . . . . . . . . . . . . . . -70.29 -38.84 75.1 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.326 179.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 521' ' ' ALA . . . . . . . . . . . . . . . -65.79 -48.87 70.32 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.508 176.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 522' ' ' ILE . . . . . . . . . . . . . 94.7 mt -57.06 -41.42 77.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.828 -0.623 . . . . 0.0 110.872 176.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 523' ' ' GLN . . . . . . . . . . . . . 33.8 tt0 -64.95 -43.48 92.58 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.2 177.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 20.3 t -70.74 -31.36 68.16 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.538 -176.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 525' ' ' ALA . . . . . 0.514 ' HB2' ' HB3' ' A' ' 565' ' ' LEU . . . -88.94 -27.1 21.16 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.726 0.298 . . . . 0.0 111.473 -179.242 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 526' ' ' GLY . . . . . . . . . . . . . . . 87.13 49.65 3.93 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.867 -0.683 . . . . 0.0 112.391 178.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 527' ' ' LEU . . . . . 0.407 ' HA ' HD11 ' A' ' 527' ' ' LEU . 4.3 mm? -111.5 8.78 21.2 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.151 0.5 . . . . 0.0 110.691 178.042 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 528' ' ' THR . . . . . 0.429 HG23 ' HE3' ' A' ' 506' ' ' MET . 5.9 m -60.42 -33.93 73.22 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.464 -177.612 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 529' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -61.29 -33.64 73.89 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.114 -178.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 530' ' ' THR . . . . . . . . . . . . . 30.4 m -70.29 -48.32 57.23 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.998 -0.547 . . . . 0.0 111.279 -176.315 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 531' ' ' LEU . . . . . 0.524 ' HB3' ' CG2' ' A' ' 505' ' ' VAL . 31.4 mt -85.96 6.21 29.68 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.323 0.582 . . . . 0.0 111.403 -175.674 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 532' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -83.95 -37.76 21.88 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.091 179.356 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 533' ' ' ARG . . . . . . . . . . . . . 76.6 mtm180 -79.44 131.54 36.11 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.862 -178.475 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 534' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -75.03 127.54 33.46 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.524 179.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 535' ' ' GLY . . . . . . . . . . . . . . . -174.26 -132.22 1.52 Allowed Glycine 0 CA--C 1.502 -0.721 0 N-CA-C 110.265 -1.134 . . . . 0.0 110.265 -179.574 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 536' ' ' VAL . . . . . . . . . . . . . 33.9 m -124.36 129.25 74.0 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-O 121.261 0.553 . . . . 0.0 110.719 177.584 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 537' ' ' TYR . . . . . . . . . . . . . 80.4 m-85 -154.86 150.35 27.38 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.161 179.266 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 538' ' ' THR . . . . . 0.709 ' OG1' ' HA ' ' A' ' 577' ' ' ILE . 34.1 m -120.26 102.2 8.33 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 173.723 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 539' ' ' VAL . . . . . 0.483 HG21 HG23 ' A' ' 573' ' ' ILE . 44.2 t -105.11 123.87 59.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.498 -173.035 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 540' ' ' PHE . . . . . 0.574 ' HB3' HD11 ' A' ' 628' ' ' ILE . 93.7 m-85 -95.94 112.86 24.47 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 174.341 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -101.72 110.66 62.56 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-O 120.935 0.398 . . . . 0.0 110.809 -176.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 542' ' ' PRO . . . . . 0.632 ' HA ' HG13 ' A' ' 628' ' ' ILE . 16.9 Cg_exo -69.24 138.98 40.84 Favored 'Trans proline' 0 N--CA 1.461 -0.393 0 C-N-CA 123.11 2.54 . . . . 0.0 112.118 178.332 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 543' ' ' THR . . . . . 0.7 HG21 ' HD3' ' A' ' 514' ' ' ARG . 36.8 p -82.53 179.9 7.64 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.239 -178.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 544' ' ' ASN . . . . . 0.522 ' HA ' ' HE1' ' A' ' 517' ' ' MET . 14.9 m120 -56.65 -34.84 67.72 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.885 0.374 . . . . 0.0 111.181 179.522 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 545' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -73.07 -23.38 60.54 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.759 -174.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -69.16 -51.32 39.34 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-O 121.283 0.563 . . . . 0.0 110.709 179.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 547' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -71.65 -20.86 61.9 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.601 -179.369 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 548' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.62 -29.06 62.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.989 -0.551 . . . . 0.0 109.677 176.353 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 549' ' ' ALA . . . . . . . . . . . . . . . -89.32 2.91 53.71 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.368 -175.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 550' ' ' LEU . . . . . 0.438 ' HA ' ' HD3' ' A' ' 551' ' ' PRO . 75.3 mt -72.83 137.24 79.84 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.561 178.641 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 551' ' ' PRO . . . . . 0.596 ' HD2' ' HB2' ' A' ' 554' ' ' GLU . 17.5 Cg_exo -66.55 150.63 83.94 Favored 'Trans proline' 0 N--CA 1.461 -0.392 0 C-N-CA 122.819 2.346 . . . . 0.0 112.108 -177.364 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 552' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_exo -53.4 -28.28 43.35 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 123.247 2.632 . . . . 0.0 112.98 -179.236 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 553' ' ' ARG . . . . . . . . . . . . . 23.0 mmt180 -81.11 -54.29 5.66 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.061 0.458 . . . . 0.0 110.041 -179.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 554' ' ' GLU . . . . . 0.596 ' HB2' ' HD2' ' A' ' 551' ' ' PRO . 3.3 mp0 -62.88 -37.64 87.7 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.52 -0.764 . . . . 0.0 112.201 -177.017 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 555' ' ' ARG . . . . . . . . . . . . . 36.5 ptt180 -63.79 -35.11 79.52 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.793 -0.363 . . . . 0.0 110.611 178.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 34.7 m -73.88 -32.05 63.43 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.224 0.535 . . . . 0.0 110.197 179.345 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 557' ' ' ARG . . . . . . . . . . . . . 63.5 mtp180 -68.05 -58.63 4.18 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.624 175.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 558' ' ' LEU . . . . . 0.587 ' O ' ' HG ' ' A' ' 565' ' ' LEU . 27.3 tp -62.39 -42.47 99.45 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.285 -172.729 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 559' ' ' LEU . . . . . . . . . . . . . 80.5 mt -88.21 13.0 12.34 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.972 0.415 . . . . 0.0 111.105 -178.152 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 560' ' ' GLY . . . . . . . . . . . . . . . -122.35 -41.2 0.48 Allowed Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.911 -0.662 . . . . 0.0 112.188 178.283 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 561' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -99.52 116.75 32.37 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.924 0.392 . . . . 0.0 110.428 -179.395 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 562' ' ' ALA . . . . . . . . . . . . . . . -68.45 -21.55 64.64 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.788 -175.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 563' ' ' LYS . . . . . . . . . . . . . 59.6 tttm -78.78 -48.33 15.04 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 110.22 -0.289 . . . . 0.0 110.22 -178.599 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 564' ' ' GLU . . . . . 0.499 ' O ' HG12 ' A' ' 568' ' ' ILE . 40.7 mt-10 -57.65 -38.1 74.47 Favored 'General case' 0 C--N 1.332 -0.169 0 O-C-N 123.248 0.343 . . . . 0.0 110.107 177.233 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 565' ' ' LEU . . . . . 0.587 ' HG ' ' O ' ' A' ' 558' ' ' LEU . 3.7 mt -55.06 -54.16 46.64 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.63 174.512 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 566' ' ' ALA . . . . . . . . . . . . . . . -62.94 -37.76 88.34 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.475 -178.515 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 567' ' ' ASN . . . . . . . . . . . . . 12.1 m120 -67.41 -41.69 84.47 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.171 -178.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 568' ' ' ILE . . . . . 0.499 HG12 ' O ' ' A' ' 564' ' ' GLU . 48.8 mm -69.29 -34.3 62.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.903 0.382 . . . . 0.0 110.736 178.596 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 569' ' ' LEU . . . . . 0.549 ' HG ' ' O ' ' A' ' 565' ' ' LEU . 77.1 mt -64.72 -36.7 85.14 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.814 0.34 . . . . 0.0 110.881 177.037 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 570' ' ' LYS . . . . . 0.771 ' HE3' ' HA ' ' A' ' 593' ' ' GLN . 26.5 mtpp -63.93 -13.62 47.13 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.017 177.451 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 571' ' ' TYR . . . . . . . . . . . . . 7.5 t80 -97.38 -16.0 20.43 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.069 -177.462 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 572' ' ' HIS . . . . . . . . . . . . . 59.6 m80 -95.31 -12.25 26.46 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.958 0.409 . . . . 0.0 111.274 -178.488 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 573' ' ' ILE . . . . . 0.483 HD11 HD21 ' A' ' 531' ' ' LEU . 21.3 mt -108.65 123.01 64.07 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.204 178.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 574' ' ' GLY . . . . . 0.535 ' HA2' ' HA ' ' A' ' 591' ' ' SER . . . -92.92 151.2 20.34 Favored Glycine 0 N--CA 1.447 -0.591 0 N-CA-C 111.505 -0.638 . . . . 0.0 111.505 175.137 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 575' ' ' ASP . . . . . 0.485 ' HB3' ' HE3' ' A' ' 590' ' ' LYS . 19.3 t70 -70.35 -21.18 62.91 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 112.879 0.696 . . . . 0.0 112.879 -171.07 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 576' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -149.67 153.06 36.4 Favored 'General case' 0 N--CA 1.439 -1.025 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 -174.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 577' ' ' ILE . . . . . 0.709 ' HA ' ' OG1' ' A' ' 538' ' ' THR . 77.3 mt -72.95 126.44 33.61 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 O-C-N 124.028 0.83 . . . . 0.0 112.14 -171.399 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 578' ' ' LEU . . . . . 0.563 HD23 ' HB ' ' A' ' 587' ' ' VAL . 41.9 tp -126.84 105.26 8.53 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 114.998 -1.001 . . . . 0.0 109.146 173.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 579' ' ' VAL . . . . . 0.49 ' CG1' ' H ' ' A' ' 581' ' ' GLY . 1.0 OUTLIER -102.08 167.57 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.106 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.11 -177.441 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 580' ' ' SER . . . . . 0.44 ' N ' HG13 ' A' ' 579' ' ' VAL . 20.2 m -57.82 -25.93 61.3 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.364 -0.835 . . . . 0.0 111.67 -175.164 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 581' ' ' GLY . . . . . 0.49 ' H ' ' CG1' ' A' ' 579' ' ' VAL . . . -87.29 -2.84 82.59 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.523 -176.799 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . -110.69 -18.59 8.34 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.37 -179.195 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 583' ' ' ILE . . . . . 0.405 HG13 ' O ' ' A' ' 579' ' ' VAL . 51.2 mt -70.96 -63.38 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.726 0.298 . . . . 0.0 111.2 -177.512 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 584' ' ' GLY . . . . . . . . . . . . . . . 81.53 -63.23 4.38 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.283 -178.175 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 585' ' ' ALA . . . . . . . . . . . . . . . -134.71 -71.01 0.49 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.781 0.324 . . . . 0.0 110.286 178.143 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 586' ' ' LEU . . . . . 0.553 HD12 ' HB3' ' A' ' 600' ' ' SER . 45.5 tp -147.27 132.68 18.59 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.44 -179.448 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 587' ' ' VAL . . . . . 0.563 ' HB ' HD23 ' A' ' 578' ' ' LEU . 57.5 t -137.93 129.17 38.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 116.022 -0.536 . . . . 0.0 109.661 176.655 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 588' ' ' ARG . . . . . 0.409 ' HG2' ' OE2' ' A' ' 598' ' ' GLU . 55.2 mtm180 -85.74 109.84 18.92 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.05 -179.251 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 589' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -95.79 124.88 40.0 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.812 -174.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 590' ' ' LYS . . . . . 0.485 ' HE3' ' HB3' ' A' ' 575' ' ' ASP . 47.4 pttt -77.96 138.93 39.12 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.11 0.481 . . . . 0.0 110.125 177.365 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 591' ' ' SER . . . . . 0.535 ' HA ' ' HA2' ' A' ' 574' ' ' GLY . 80.2 p -104.27 166.24 10.53 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.338 -177.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 592' ' ' LEU . . . . . . . . . . . . . 10.1 mp -68.73 -7.81 37.06 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.246 0.461 . . . . 0.0 112.246 178.173 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 593' ' ' GLN . . . . . 0.771 ' HA ' ' HE3' ' A' ' 570' ' ' LYS . 5.4 tt0 -80.61 -29.03 36.89 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.206 0.527 . . . . 0.0 109.661 173.455 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 594' ' ' GLY . . . . . . . . . . . . . . . 106.55 -13.56 42.86 Favored Glycine 0 N--CA 1.441 -0.993 0 N-CA-C 110.717 -0.953 . . . . 0.0 110.717 -172.327 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 595' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -81.36 -174.43 4.92 Favored 'General case' 0 C--O 1.237 0.396 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 179.304 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 596' ' ' LYS . . . . . . . . . . . . . 59.0 pttt -115.33 135.18 54.41 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.175 0.512 . . . . 0.0 111.422 -171.521 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 597' ' ' LEU . . . . . . . . . . . . . 57.6 mt -106.04 114.46 28.61 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 168.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 598' ' ' GLU . . . . . 0.409 ' OE2' ' HG2' ' A' ' 588' ' ' ARG . 1.0 OUTLIER -83.4 92.07 7.48 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 -179.929 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 599' ' ' VAL . . . . . 0.522 ' HA ' ' O ' ' A' ' 607' ' ' SER . 43.2 t -98.4 118.78 45.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 121.245 0.545 . . . . 0.0 110.411 -177.175 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 600' ' ' SER . . . . . 0.553 ' HB3' HD12 ' A' ' 586' ' ' LEU . 2.7 p -129.43 151.77 49.7 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.059 -178.097 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 601' ' ' LEU . . . . . . . . . . . . . 47.6 tp -113.04 108.03 16.77 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.374 179.418 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 602' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -131.12 127.27 37.74 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.361 -177.336 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 603' ' ' ASN . . . . . . . . . . . . . 66.2 t30 62.49 27.45 16.28 Favored 'General case' 0 N--CA 1.464 0.273 0 O-C-N 123.652 0.595 . . . . 0.0 109.946 -178.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 604' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 69.19 12.72 8.53 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 115.137 -0.938 . . . . 0.0 111.513 -177.57 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 605' ' ' VAL . . . . . . . . . . . . . 48.6 t -110.85 123.33 66.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 176.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 606' ' ' VAL . . . . . 0.429 ' HB ' ' HB ' ' A' ' 613' ' ' VAL . 42.0 t -72.52 148.33 9.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.25 -179.8 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 607' ' ' SER . . . . . 0.522 ' O ' ' HA ' ' A' ' 599' ' ' VAL . 4.5 p -141.52 140.62 33.5 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.221 -0.445 . . . . 0.0 109.983 179.789 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 608' ' ' VAL . . . . . . . . . . . . . 3.8 p -126.13 110.36 23.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-O 121.059 0.456 . . . . 0.0 110.315 179.025 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 609' ' ' ASN . . . . . 0.463 ' O ' ' HB3' ' A' ' 610' ' ' LYS . 92.9 m-20 55.48 54.07 8.97 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.87 -179.64 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 610' ' ' LYS . . . . . 0.463 ' HB3' ' O ' ' A' ' 609' ' ' ASN . 61.8 tttp 77.59 -27.32 0.17 Allowed 'General case' 0 N--CA 1.469 0.475 0 CA-C-N 115.525 -0.762 . . . . 0.0 111.721 178.77 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 611' ' ' GLU . . . . . 0.532 ' HB3' ' ND2' ' A' ' 630' ' ' ASN . 6.0 mm-40 -80.35 123.42 83.05 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 120.646 0.26 . . . . 0.0 110.978 -178.482 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 612' ' ' PRO . . . . . 0.481 ' HD3' ' HA ' ' A' ' 611' ' ' GLU . 7.9 Cg_exo -72.75 145.05 40.39 Favored 'Trans proline' 0 CA--C 1.531 0.367 0 C-N-CA 123.0 2.467 . . . . 0.0 113.11 -178.73 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 613' ' ' VAL . . . . . 0.429 ' HB ' ' HB ' ' A' ' 606' ' ' VAL . 70.7 t -91.44 139.23 18.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.951 176.631 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 614' ' ' ALA . . . . . 0.538 ' HB1' HG23 ' A' ' 629' ' ' THR . . . -86.13 -36.21 19.71 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.125 -0.489 . . . . 0.0 112.063 -175.787 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 615' ' ' GLU . . . . . . . . . . . . . 20.4 tp10 -157.78 99.74 1.84 Allowed Pre-proline 0 C--N 1.327 -0.401 0 CA-C-O 121.046 0.45 . . . . 0.0 110.306 -176.593 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 616' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -90.13 168.87 4.36 Favored 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 123.326 2.684 . . . . 0.0 113.844 -178.318 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 77.29 32.74 0.44 Allowed 'General case' 0 CA--C 1.508 -0.657 0 CA-C-O 122.073 0.94 . . . . 0.0 111.025 163.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 618' ' ' ILE . . . . . 0.538 ' HB ' ' O ' ' A' ' 625' ' ' VAL . 18.1 mt -83.3 98.98 5.55 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.147 0 CA-C-N 114.149 -1.387 . . . . 0.0 109.29 174.198 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 619' ' ' MET . . . . . 0.401 ' HA ' ' CE ' ' A' ' 619' ' ' MET . 0.0 OUTLIER -77.96 130.08 36.1 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.777 -174.965 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 620' ' ' ALA . . . . . . . . . . . . . . . -130.76 177.04 7.71 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.524 173.599 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 621' ' ' THR . . . . . 0.45 HG23 ' HA ' ' A' ' 504' ' ' THR . 10.7 t -81.07 -14.58 57.68 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.44 -0.504 . . . . 0.0 111.59 -177.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 622' ' ' ASN . . . . . 0.468 ' HB2' HG13 ' A' ' 505' ' ' VAL . 7.5 m120 -102.69 -0.34 31.89 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.697 0.284 . . . . 0.0 110.643 179.311 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 623' ' ' GLY . . . . . 0.592 ' HA2' HD12 ' A' ' 577' ' ' ILE . . . 145.62 -140.12 8.75 Favored Glycine 0 N--CA 1.445 -0.76 0 C-N-CA 120.379 -0.915 . . . . 0.0 112.596 180.0 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 624' ' ' VAL . . . . . . . . . . . . . 4.8 p -126.45 156.02 36.97 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-O 120.898 0.38 . . . . 0.0 109.981 179.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 625' ' ' VAL . . . . . 0.538 ' O ' ' HB ' ' A' ' 618' ' ' ILE . 61.4 t -125.55 136.98 59.14 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.534 179.803 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 626' ' ' HIS . . . . . . . . . . . . . 94.3 m-70 -119.2 115.9 25.18 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-O 120.866 0.365 . . . . 0.0 110.052 177.242 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 627' ' ' VAL . . . . . 0.964 HG21 ' HZ ' ' A' ' 515' ' ' PHE . 38.6 t -70.18 124.95 27.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.334 177.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 628' ' ' ILE . . . . . 0.632 HG13 ' HA ' ' A' ' 542' ' ' PRO . 3.8 pt -123.97 145.03 31.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-O 121.368 0.604 . . . . 0.0 111.3 178.358 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 629' ' ' THR . . . . . 0.661 ' HA ' ' HG1' ' A' ' 543' ' ' THR . 22.7 p -94.11 7.48 45.03 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.788 0.804 . . . . 0.0 109.836 179.782 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 630' ' ' ASN . . . . . 0.532 ' ND2' ' HB3' ' A' ' 611' ' ' GLU . 6.1 p30 -141.19 166.05 25.84 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 114.33 -1.305 . . . . 0.0 109.52 -177.164 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 631' ' ' VAL . . . . . 0.422 HG13 HD21 ' A' ' 550' ' ' LEU . 2.7 p -125.91 123.53 64.34 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.982 0 N-CA-C 110.26 -0.274 . . . . 0.0 110.26 -179.643 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 632' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -63.19 120.27 11.18 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-O 121.085 0.469 . . . . 0.0 111.092 -177.024 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 633' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -126.96 110.45 21.94 Favored Pre-proline 0 C--N 1.319 -0.743 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 178.188 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 634' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo . . . . . 0 C--O 1.249 1.05 0 C-N-CA 123.013 2.475 . . . . 0.0 111.872 -178.7 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 500' ' ' ALA . . . . . 0.597 ' HB1' ' HA3' ' A' ' 511' ' ' GLY . . . . . . . . 0 N--CA 1.479 0.995 0 CA-C-O 120.899 0.38 . . . . 0.0 110.469 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 501' ' ' GLY . . . . . . . . . . . . . . . 98.8 13.27 40.94 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.667 -0.778 . . . . 0.0 111.484 -177.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 502' ' ' MET . . . . . . . . . . . . . 2.4 mpt? -106.4 -23.85 12.4 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.856 0.36 . . . . 0.0 110.094 179.004 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . -129.38 -126.91 2.89 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.381 -0.914 . . . . 0.0 112.933 -178.165 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 65.6 p -87.52 -176.04 5.44 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.728 0.299 . . . . 0.0 111.165 -176.205 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 505' ' ' VAL . . . . . 0.607 ' O ' ' HG ' ' A' ' 509' ' ' LEU . 21.4 t -54.16 -41.63 52.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.388 175.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 506' ' ' MET . . . . . 0.495 ' HE1' HD13 ' A' ' 531' ' ' LEU . 4.1 mmt -55.11 -43.07 73.7 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.538 179.013 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 507' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -61.68 -39.68 92.27 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.996 0.427 . . . . 0.0 111.022 179.395 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 508' ' ' VAL . . . . . . . . . . . . . 43.2 t -65.53 -46.38 89.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.512 179.074 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 509' ' ' LEU . . . . . 0.607 ' HG ' ' O ' ' A' ' 505' ' ' VAL . 39.0 mt -68.92 -20.8 64.24 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.482 -175.537 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -89.35 -15.99 32.06 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.329 -178.067 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 511' ' ' GLY . . . . . 0.597 ' HA3' ' HB1' ' A' ' 500' ' ' ALA . . . -82.07 -9.75 84.8 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.751 -0.738 . . . . 0.0 111.445 177.365 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 512' ' ' ASP . . . . . 0.478 ' O ' ' HB2' ' A' ' 516' ' ' SER . 28.1 t70 -120.3 146.99 45.57 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.521 -0.34 . . . . 0.0 110.872 179.359 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -75.52 -32.97 60.69 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.831 0.348 . . . . 0.0 111.434 -178.36 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 514' ' ' ARG . . . . . 0.462 ' HD3' ' HB ' ' A' ' 543' ' ' THR . 78.7 mtt180 -74.78 -49.39 21.03 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.128 0.49 . . . . 0.0 109.711 -176.749 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 515' ' ' PHE . . . . . . . . . . . . . 15.2 m-30 -65.67 -26.0 67.59 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.809 178.684 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 516' ' ' SER . . . . . 0.478 ' HB2' ' O ' ' A' ' 512' ' ' ASP . 15.9 t -65.34 -26.53 68.07 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.111 -179.219 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 517' ' ' MET . . . . . 0.546 ' HE2' ' HA ' ' A' ' 544' ' ' ASN . 33.9 mtm -72.02 -35.21 69.34 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 176.018 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 518' ' ' LEU . . . . . . . . . . . . . 61.4 tp -64.68 -39.13 93.14 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.716 173.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 519' ' ' VAL . . . . . . . . . . . . . 86.0 t -55.06 -36.85 40.43 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.147 0 CA-C-O 121.163 0.506 . . . . 0.0 110.277 174.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 520' ' ' ALA . . . . . . . . . . . . . . . -70.99 -42.82 69.17 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.77 -179.423 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 521' ' ' ALA . . . . . . . . . . . . . . . -64.49 -48.65 74.42 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.623 177.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 522' ' ' ILE . . . . . 0.588 HG21 ' HB2' ' A' ' 527' ' ' LEU . 88.6 mt -59.48 -38.85 77.31 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.923 178.694 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 523' ' ' GLN . . . . . 0.416 HE21 ' HB3' ' A' ' 523' ' ' GLN . 0.9 OUTLIER -64.71 -44.22 90.94 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.343 177.417 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 13.6 t -68.69 -35.87 77.76 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.749 -178.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 525' ' ' ALA . . . . . 0.413 ' HB3' ' HB2' ' A' ' 566' ' ' ALA . . . -73.85 -28.05 61.4 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.849 0.357 . . . . 0.0 111.354 179.344 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 526' ' ' GLY . . . . . . . . . . . . . . . 90.18 48.54 3.52 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.385 179.129 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 527' ' ' LEU . . . . . 0.588 ' HB2' HG21 ' A' ' 522' ' ' ILE . 93.1 mt -124.32 26.35 7.41 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.06 0.457 . . . . 0.0 110.233 178.578 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 528' ' ' THR . . . . . . . . . . . . . 24.5 m -74.86 -36.47 62.32 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.206 -175.37 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 529' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -57.82 -36.25 71.99 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.685 -179.511 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 530' ' ' THR . . . . . . . . . . . . . 4.0 m -58.95 -43.13 91.2 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.653 -176.439 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 531' ' ' LEU . . . . . 0.495 HD13 ' HE1' ' A' ' 506' ' ' MET . 59.1 mt -94.77 14.03 22.65 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.342 -175.582 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 532' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -90.98 -49.47 6.4 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.788 -178.028 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 533' ' ' ARG . . . . . 0.555 ' HG2' ' OE1' ' A' ' 534' ' ' GLU . 18.6 ttp180 -89.87 172.55 8.81 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 -178.662 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 534' ' ' GLU . . . . . 0.574 ' HA ' ' CB ' ' A' ' 622' ' ' ASN . 1.6 pm0 -90.56 -179.18 5.5 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-O 121.446 0.641 . . . . 0.0 111.634 -179.684 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 535' ' ' GLY . . . . . . . . . . . . . . . 142.66 -145.17 15.02 Favored Glycine 0 N--CA 1.446 -0.665 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -172.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 536' ' ' VAL . . . . . 0.459 ' HB ' HG13 ' A' ' 577' ' ' ILE . 29.1 m -127.63 130.64 70.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 117.774 0.787 . . . . 0.0 110.487 174.074 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 537' ' ' TYR . . . . . . . . . . . . . 93.2 m-85 -148.47 148.31 30.11 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.84 -179.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 538' ' ' THR . . . . . 0.764 ' OG1' ' HA ' ' A' ' 577' ' ' ILE . 37.0 m -127.6 102.01 6.65 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 174.182 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 539' ' ' VAL . . . . . 0.505 HG22 HG23 ' A' ' 573' ' ' ILE . 40.3 t -108.93 131.13 60.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.203 -173.449 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 540' ' ' PHE . . . . . 0.551 ' HB3' HD11 ' A' ' 628' ' ' ILE . 92.9 m-85 -101.48 109.98 21.9 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.376 174.685 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -96.02 115.48 65.59 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.498 -178.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 542' ' ' PRO . . . . . 0.559 ' HA ' HG13 ' A' ' 628' ' ' ILE . 6.7 Cg_exo -73.79 135.18 21.15 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 122.872 2.382 . . . . 0.0 111.619 178.176 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 543' ' ' THR . . . . . 0.462 ' HB ' ' HD3' ' A' ' 514' ' ' ARG . 34.4 p -75.98 -178.16 4.23 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.06 -179.092 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 544' ' ' ASN . . . . . 0.546 ' HA ' ' HE2' ' A' ' 517' ' ' MET . 26.0 t-20 -67.27 -32.88 74.18 Favored 'General case' 0 CA--C 1.517 -0.308 0 N-CA-C 110.351 -0.24 . . . . 0.0 110.351 -177.574 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 545' ' ' GLU . . . . . 0.444 ' CD ' ' H ' ' A' ' 545' ' ' GLU . 1.6 mp0 -59.77 -35.43 74.6 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.246 178.205 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 546' ' ' ALA . . . . . 0.608 ' HB2' HG21 ' A' ' 631' ' ' VAL . . . -62.06 -47.51 84.35 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-O 121.275 0.56 . . . . 0.0 110.724 179.347 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 547' ' ' PHE . . . . . 0.626 ' HA ' HD23 ' A' ' 550' ' ' LEU . 94.2 m-85 -78.28 -21.95 49.02 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.797 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 548' ' ' ARG . . . . . . . . . . . . . 20.6 tpp180 -72.61 -35.04 67.76 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.963 177.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 549' ' ' ALA . . . . . . . . . . . . . . . -74.24 -16.08 60.97 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.278 -179.563 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 550' ' ' LEU . . . . . 0.904 HD13 ' HB3' ' A' ' 555' ' ' ARG . 0.2 OUTLIER -98.55 130.5 27.88 Favored Pre-proline 0 N--CA 1.445 -0.712 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 -179.298 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 551' ' ' PRO . . . . . 0.585 ' HD2' ' HB2' ' A' ' 554' ' ' GLU . 5.0 Cg_exo -77.26 160.52 32.67 Favored 'Trans proline' 0 CA--C 1.528 0.212 0 C-N-CA 123.705 2.937 . . . . 0.0 113.488 -169.145 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 552' ' ' PRO . . . . . 0.704 ' HA ' ' HG2' ' A' ' 555' ' ' ARG . 15.0 Cg_endo -58.88 -35.64 98.26 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 123.088 2.525 . . . . 0.0 112.21 176.453 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 553' ' ' ARG . . . . . . . . . . . . . 25.2 tpp180 -61.56 -47.39 85.73 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.383 179.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 554' ' ' GLU . . . . . 0.585 ' HB2' ' HD2' ' A' ' 551' ' ' PRO . 18.9 mm-40 -73.76 -44.96 54.66 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.314 -178.752 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 555' ' ' ARG . . . . . 0.904 ' HB3' HD13 ' A' ' 550' ' ' LEU . 14.4 ptp180 -59.06 -41.31 87.64 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 120.711 -0.396 . . . . 0.0 110.798 -179.173 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 13.1 t -65.02 -36.61 84.96 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.903 0.382 . . . . 0.0 110.457 -178.248 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 557' ' ' ARG . . . . . . . . . . . . . 16.3 mmm180 -61.34 -46.26 90.96 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.883 176.143 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 558' ' ' LEU . . . . . . . . . . . . . 51.7 tp -70.85 -56.35 6.49 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.188 -0.914 . . . . 0.0 111.586 -177.29 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 559' ' ' LEU . . . . . 0.706 ' HG ' ' O ' ' A' ' 555' ' ' ARG . 3.9 pp -73.77 -8.6 56.65 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 120.951 -0.3 . . . . 0.0 111.452 -174.662 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 560' ' ' GLY . . . . . . . . . . . . . . . -66.87 -34.46 87.24 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.958 -0.639 . . . . 0.0 111.605 175.283 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 561' ' ' ASP . . . . . 0.473 ' OD2' ' HB3' ' A' ' 563' ' ' LYS . 14.7 t70 -111.59 121.56 45.47 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.829 0.347 . . . . 0.0 110.673 -179.55 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 562' ' ' ALA . . . . . . . . . . . . . . . -65.45 -28.87 69.54 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.161 -178.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 563' ' ' LYS . . . . . 0.473 ' HB3' ' OD2' ' A' ' 561' ' ' ASP . 14.5 ttpp -66.09 -52.16 51.34 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.267 -178.604 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 564' ' ' GLU . . . . . 0.466 ' HA ' ' HB3' ' A' ' 567' ' ' ASN . 8.9 mt-10 -71.76 -24.43 61.77 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.584 -179.487 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 565' ' ' LEU . . . . . 0.482 HD22 ' HA ' ' A' ' 565' ' ' LEU . 9.9 mt -59.39 -55.16 38.22 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 109.368 -0.605 . . . . 0.0 109.368 169.606 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 566' ' ' ALA . . . . . 0.413 ' HB2' ' HB3' ' A' ' 525' ' ' ALA . . . -64.4 -34.75 78.91 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.343 179.274 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 567' ' ' ASN . . . . . 0.466 ' HB3' ' HA ' ' A' ' 564' ' ' GLU . 3.4 t-20 -56.43 -54.47 45.33 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.154 -179.854 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 568' ' ' ILE . . . . . . . . . . . . . 48.9 mm -70.93 -37.32 67.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.746 0.308 . . . . 0.0 111.068 -177.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 569' ' ' LEU . . . . . 0.41 ' HG ' ' O ' ' A' ' 565' ' ' LEU . 95.5 mt -65.2 -33.45 76.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.041 0.448 . . . . 0.0 110.946 178.289 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 570' ' ' LYS . . . . . 0.561 ' HE2' ' HA ' ' A' ' 593' ' ' GLN . 80.0 tttt -67.2 -16.73 64.48 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.559 -178.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 571' ' ' TYR . . . . . 0.462 ' HB2' ' NE2' ' A' ' 593' ' ' GLN . 45.5 t80 -89.98 -17.76 27.27 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.04 177.595 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 572' ' ' HIS . . . . . . . . . . . . . 53.2 m80 -86.07 -10.3 55.18 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.722 0.296 . . . . 0.0 111.158 -177.549 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 573' ' ' ILE . . . . . 0.505 HG23 HG22 ' A' ' 539' ' ' VAL . 31.2 mt -109.79 120.84 61.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.808 -179.137 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 574' ' ' GLY . . . . . 0.571 ' HA2' ' HA ' ' A' ' 591' ' ' SER . . . -98.62 148.26 18.79 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.909 -0.663 . . . . 0.0 111.663 175.052 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 575' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -93.4 9.07 37.97 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 111.936 0.347 . . . . 0.0 111.936 -173.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 576' ' ' GLU . . . . . 0.438 ' O ' HD23 ' A' ' 589' ' ' LEU . 12.2 pt-20 -144.92 133.32 21.84 Favored 'General case' 0 CA--C 1.508 -0.652 0 N-CA-C 109.765 -0.458 . . . . 0.0 109.765 178.616 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 577' ' ' ILE . . . . . 0.764 ' HA ' ' OG1' ' A' ' 538' ' ' THR . 76.3 mt -75.32 117.2 19.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.435 -175.513 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 578' ' ' LEU . . . . . 0.439 ' HB2' HD22 ' A' ' 589' ' ' LEU . 48.7 tp -118.41 108.65 15.31 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.318 -0.856 . . . . 0.0 109.858 176.841 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 579' ' ' VAL . . . . . . . . . . . . . 29.0 m -91.26 160.67 2.68 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.135 177.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 580' ' ' SER . . . . . . . . . . . . . 6.1 p -58.18 -42.81 86.89 Favored 'General case' 0 C--N 1.328 -0.355 0 O-C-N 123.292 0.37 . . . . 0.0 111.436 -176.613 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 581' ' ' GLY . . . . . . . . . . . . . . . -71.78 -11.86 73.9 Favored Glycine 0 CA--C 1.521 0.412 0 C-N-CA 120.964 -0.636 . . . . 0.0 113.087 -178.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . -96.71 -9.96 55.85 Favored Glycine 0 N--CA 1.454 -0.135 0 C-N-CA 121.043 -0.599 . . . . 0.0 112.508 -179.179 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 583' ' ' ILE . . . . . . . . . . . . . 58.7 mt -70.38 -60.21 2.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 121.06 0.457 . . . . 0.0 110.926 -178.295 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 584' ' ' GLY . . . . . . . . . . . . . . . 82.15 -89.04 1.44 Allowed Glycine 0 N--CA 1.444 -0.775 0 C-N-CA 120.55 -0.833 . . . . 0.0 111.383 -176.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 585' ' ' ALA . . . . . . . . . . . . . . . -102.71 -75.12 0.61 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.087 0.47 . . . . 0.0 110.351 178.184 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 586' ' ' LEU . . . . . 0.91 ' HG ' ' HB2' ' A' ' 600' ' ' SER . 5.7 tt -155.23 134.05 12.08 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 179.227 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 587' ' ' VAL . . . . . 0.436 ' N ' HD23 ' A' ' 586' ' ' LEU . 61.9 t -132.22 137.11 55.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 N-CA-C 110.199 -0.297 . . . . 0.0 110.199 -178.111 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 588' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -84.98 112.57 20.71 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 177.519 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 589' ' ' LEU . . . . . 0.653 ' HB3' ' HB2' ' A' ' 597' ' ' LEU . 1.9 tm? -89.9 121.09 31.69 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 -177.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 590' ' ' LYS . . . . . . . . . . . . . 33.8 mttp -87.86 131.16 34.65 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 121.303 0.573 . . . . 0.0 111.239 -172.315 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 591' ' ' SER . . . . . 0.571 ' HA ' ' HA2' ' A' ' 574' ' ' GLY . 84.0 p -97.41 159.78 14.72 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 114.973 -1.012 . . . . 0.0 110.718 -177.038 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 592' ' ' LEU . . . . . . . . . . . . . 9.9 mp -63.45 -21.18 66.16 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.491 177.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 593' ' ' GLN . . . . . 0.561 ' HA ' ' HE2' ' A' ' 570' ' ' LYS . 7.6 tt0 -73.0 -29.12 62.8 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.068 0.461 . . . . 0.0 110.291 175.895 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 594' ' ' GLY . . . . . . . . . . . . . . . 112.75 -14.21 24.54 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.172 -179.26 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 595' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -79.65 169.0 18.62 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-O 121.127 0.489 . . . . 0.0 111.106 179.268 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 596' ' ' LYS . . . . . . . . . . . . . 20.0 pttp -106.89 123.42 48.14 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.579 -174.25 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 597' ' ' LEU . . . . . 0.653 ' HB2' ' HB3' ' A' ' 589' ' ' LEU . 40.1 mt -87.73 122.14 31.03 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.947 173.526 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 598' ' ' GLU . . . . . 0.757 ' O ' ' HA ' ' A' ' 608' ' ' VAL . 18.2 tt0 -75.89 94.05 3.3 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.234 177.702 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 599' ' ' VAL . . . . . . . . . . . . . 41.5 t -107.84 121.71 61.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-O 121.317 0.58 . . . . 0.0 110.32 178.32 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 600' ' ' SER . . . . . 0.91 ' HB2' ' HG ' ' A' ' 586' ' ' LEU . 34.9 t -141.8 168.71 19.1 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.703 -177.13 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 601' ' ' LEU . . . . . . . . . . . . . 42.4 tp -135.95 107.78 7.07 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.111 -0.95 . . . . 0.0 108.738 -178.479 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 602' ' ' LYS . . . . . 0.603 ' O ' HG13 ' A' ' 605' ' ' VAL . 57.0 mtpt -131.02 114.33 15.06 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.076 -172.832 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 603' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 57.83 47.16 15.78 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.704 177.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 604' ' ' ASN . . . . . . . . . . . . . 13.9 m120 71.97 9.32 6.09 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 114.855 -1.066 . . . . 0.0 112.967 174.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 605' ' ' VAL . . . . . 0.603 HG13 ' O ' ' A' ' 602' ' ' LYS . 7.6 p -118.2 134.26 62.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 C-N-CA 120.146 -0.621 . . . . 0.0 110.326 173.829 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 606' ' ' VAL . . . . . 0.803 HG13 ' HB ' ' A' ' 613' ' ' VAL . 3.9 p -101.64 136.93 31.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.043 178.318 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 607' ' ' SER . . . . . . . . . . . . . 45.0 m -136.93 151.03 48.58 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.759 -177.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 608' ' ' VAL . . . . . 0.757 ' HA ' ' O ' ' A' ' 598' ' ' GLU . 4.3 p -128.62 108.41 17.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.411 0.624 . . . . 0.0 110.059 176.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 609' ' ' ASN . . . . . 0.411 ' O ' ' HB2' ' A' ' 610' ' ' LYS . 64.0 m-80 60.34 47.98 8.41 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.638 -176.415 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 610' ' ' LYS . . . . . 0.411 ' HB2' ' O ' ' A' ' 609' ' ' ASN . 56.0 mtpt 73.17 -19.02 0.34 Allowed 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 115.534 -0.757 . . . . 0.0 112.097 -178.533 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 611' ' ' GLU . . . . . 0.418 ' HA ' ' HD3' ' A' ' 612' ' ' PRO . 5.2 mm-40 -79.16 123.74 84.71 Favored Pre-proline 0 C--N 1.331 -0.213 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 -179.359 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 612' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 611' ' ' GLU . 7.3 Cg_exo -73.12 136.12 24.07 Favored 'Trans proline' 0 C--O 1.236 0.382 0 C-N-CA 123.235 2.623 . . . . 0.0 112.939 -176.193 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 613' ' ' VAL . . . . . 0.803 ' HB ' HG13 ' A' ' 606' ' ' VAL . 93.7 t -81.83 130.5 35.7 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.92 175.712 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 614' ' ' ALA . . . . . . . . . . . . . . . -78.44 -33.39 48.55 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.503 -176.239 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 615' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -165.47 107.53 0.77 Allowed Pre-proline 0 C--O 1.233 0.197 0 CA-C-O 120.835 0.35 . . . . 0.0 110.576 -179.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 616' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_endo -89.32 156.37 5.52 Favored 'Trans proline' 0 N--CA 1.459 -0.524 0 C-N-CA 123.29 2.66 . . . . 0.0 114.008 -178.065 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 35.3 t70 77.95 61.94 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 122.687 1.232 . . . . 0.0 110.463 166.524 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 618' ' ' ILE . . . . . 0.448 ' HB ' ' O ' ' A' ' 625' ' ' VAL . 7.9 mt -104.73 112.83 39.95 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.301 0 CA-C-N 113.757 -1.565 . . . . 0.0 108.438 174.695 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 619' ' ' MET . . . . . 0.488 ' HA ' ' HE2' ' A' ' 619' ' ' MET . 4.9 mmt -77.83 131.36 37.53 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 -170.588 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 620' ' ' ALA . . . . . . . . . . . . . . . -130.23 162.6 28.57 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 114.995 -1.002 . . . . 0.0 108.466 170.318 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 621' ' ' THR . . . . . . . . . . . . . 5.7 t -73.86 -20.37 60.44 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 120.502 -0.479 . . . . 0.0 111.351 -175.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 622' ' ' ASN . . . . . 0.574 ' CB ' ' HA ' ' A' ' 534' ' ' GLU . 28.2 p-10 -116.84 15.54 15.28 Favored 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 120.642 -0.423 . . . . 0.0 111.986 -177.362 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 623' ' ' GLY . . . . . 0.597 ' HA2' HD11 ' A' ' 577' ' ' ILE . . . 157.07 -156.22 27.03 Favored Glycine 0 N--CA 1.443 -0.872 0 C-N-CA 119.97 -1.109 . . . . 0.0 112.762 179.437 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 624' ' ' VAL . . . . . . . . . . . . . 6.3 p -131.22 156.11 42.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-O 121.033 0.444 . . . . 0.0 110.115 -178.201 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 625' ' ' VAL . . . . . 0.562 HG21 HG11 ' A' ' 505' ' ' VAL . 42.6 t -123.74 132.93 70.56 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.645 179.416 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 626' ' ' HIS . . . . . . . . . . . . . 96.2 m-70 -119.16 115.35 24.05 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 174.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 627' ' ' VAL . . . . . . . . . . . . . 40.4 t -69.87 123.74 24.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.719 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 628' ' ' ILE . . . . . 0.559 HG13 ' HA ' ' A' ' 542' ' ' PRO . 8.1 pt -117.51 143.28 28.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 121.192 0.52 . . . . 0.0 111.063 176.436 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 629' ' ' THR . . . . . . . . . . . . . 8.4 t -94.85 5.77 50.93 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.369 -178.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 630' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -135.96 165.83 24.76 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.052 -179.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 631' ' ' VAL . . . . . 0.608 HG21 ' HB2' ' A' ' 546' ' ' ALA . 0.7 OUTLIER -98.17 130.14 47.38 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.886 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.755 175.91 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 632' ' ' LEU . . . . . 0.655 HD23 HG12 ' A' ' 608' ' ' VAL . 96.1 mt -77.32 115.93 17.51 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.242 0.544 . . . . 0.0 110.922 -177.355 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 633' ' ' GLN . . . . . 0.506 ' HA ' HE21 ' A' ' 633' ' ' GLN . 0.1 OUTLIER -118.51 117.18 34.63 Favored Pre-proline 0 C--N 1.322 -0.599 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.937 -178.221 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 634' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo . . . . . 0 C--O 1.251 1.133 0 C-N-CA 122.65 2.233 . . . . 0.0 111.944 177.42 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 500' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.064 0 CA-C-O 120.843 0.354 . . . . 0.0 110.869 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 501' ' ' GLY . . . . . . . . . . . . . . . -152.44 -174.01 22.54 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.923 -0.656 . . . . 0.0 111.652 178.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 502' ' ' MET . . . . . . . . . . . . . 21.1 ptp -63.06 121.87 14.67 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.036 0.446 . . . . 0.0 110.444 177.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . -163.72 -178.45 37.36 Favored Glycine 0 N--CA 1.445 -0.703 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.697 179.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 78.9 p -86.14 173.11 10.06 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.912 0.356 . . . . 0.0 110.536 -179.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 505' ' ' VAL . . . . . 0.53 ' O ' ' HG ' ' A' ' 509' ' ' LEU . 24.2 t -53.57 -40.6 42.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 121.224 0.535 . . . . 0.0 110.009 175.098 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 506' ' ' MET . . . . . 0.411 ' HE2' ' HA ' ' A' ' 528' ' ' THR . 7.4 mmt -56.5 -40.65 75.32 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.021 -0.991 . . . . 0.0 112.296 179.809 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 507' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -67.63 -40.91 84.6 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 121.035 0.445 . . . . 0.0 110.564 -179.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 508' ' ' VAL . . . . . . . . . . . . . 62.1 t -60.66 -41.38 87.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.416 178.601 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 509' ' ' LEU . . . . . 0.53 ' HG ' ' O ' ' A' ' 505' ' ' VAL . 53.9 mt -75.33 -23.26 57.24 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.693 -179.853 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 510' ' ' LYS . . . . . 0.856 ' HB3' ' HZ2' ' A' ' 510' ' ' LYS . 1.6 mmmp? -85.8 -33.36 21.38 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.084 -176.688 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 511' ' ' GLY . . . . . . . . . . . . . . . -73.4 -10.75 79.45 Favored Glycine 0 N--CA 1.445 -0.741 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.928 178.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 512' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -110.23 148.61 31.53 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.24 0.543 . . . . 0.0 111.278 -178.2 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -75.19 -33.0 61.37 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.617 -177.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 514' ' ' ARG . . . . . 0.613 ' H ' ' HD2' ' A' ' 514' ' ' ARG . 0.3 OUTLIER -88.46 -45.06 10.26 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.059 0.457 . . . . 0.0 110.039 -171.906 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 515' ' ' PHE . . . . . 0.674 ' HZ ' HG21 ' A' ' 627' ' ' VAL . 14.8 m-30 -63.9 -24.69 67.84 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.155 177.523 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 26.5 t -60.76 -36.4 78.85 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.887 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 517' ' ' MET . . . . . 0.517 ' HE3' ' HA ' ' A' ' 544' ' ' ASN . 59.3 mtm -65.39 -34.5 78.44 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-O 121.003 0.43 . . . . 0.0 110.093 177.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 518' ' ' LEU . . . . . . . . . . . . . 56.1 tp -66.96 -39.8 87.33 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.436 174.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 519' ' ' VAL . . . . . . . . . . . . . 58.1 t -54.84 -37.66 41.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-O 121.093 0.473 . . . . 0.0 109.808 174.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 520' ' ' ALA . . . . . . . . . . . . . . . -65.02 -39.98 94.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.627 -179.268 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 521' ' ' ALA . . . . . . . . . . . . . . . -69.08 -43.58 74.27 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.465 176.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 522' ' ' ILE . . . . . . . . . . . . . 89.3 mt -58.01 -41.81 81.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.224 177.05 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 523' ' ' GLN . . . . . 0.697 ' HA ' HE21 ' A' ' 523' ' ' GLN . 0.0 OUTLIER -65.22 -23.96 67.22 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-O 121.011 0.434 . . . . 0.0 111.405 178.774 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 30.0 t -79.66 -41.11 27.6 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.535 177.501 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 525' ' ' ALA . . . . . . . . . . . . . . . -82.29 -29.0 31.4 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.118 0.414 . . . . 0.0 112.118 -176.625 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 526' ' ' GLY . . . . . . . . . . . . . . . 95.08 25.45 14.39 Favored Glycine 0 CA--C 1.519 0.327 0 C-N-CA 120.546 -0.835 . . . . 0.0 113.332 176.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 527' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -91.58 8.39 36.88 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 121.173 0.511 . . . . 0.0 110.171 178.342 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 528' ' ' THR . . . . . 0.411 ' HA ' ' HE2' ' A' ' 506' ' ' MET . 16.9 m -57.87 -44.05 86.4 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.439 -0.8 . . . . 0.0 111.238 -178.282 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 529' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -65.48 -31.31 72.31 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.026 -0.533 . . . . 0.0 111.352 -176.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 530' ' ' THR . . . . . . . . . . . . . 12.4 m -63.21 -46.57 86.4 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.108 -179.238 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 531' ' ' LEU . . . . . . . . . . . . . 42.4 mt -90.44 8.28 34.5 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 120.978 0.418 . . . . 0.0 111.236 -177.156 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 532' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -95.01 -25.15 16.61 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.019 -177.195 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 533' ' ' ARG . . . . . . . . . . . . . 69.1 mtm180 -92.39 157.69 16.47 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.345 -177.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 534' ' ' GLU . . . . . 0.554 ' HA ' ' HB3' ' A' ' 622' ' ' ASN . 12.7 pt-20 -78.75 162.76 25.92 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.758 178.567 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 535' ' ' GLY . . . . . . . . . . . . . . . 139.05 -138.63 9.5 Favored Glycine 0 N--CA 1.446 -0.67 0 N-CA-C 110.302 -1.119 . . . . 0.0 110.302 -176.113 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 536' ' ' VAL . . . . . 0.551 ' HB ' HG13 ' A' ' 577' ' ' ILE . 35.3 m -127.07 129.06 71.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 121.229 0.538 . . . . 0.0 111.043 176.417 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 537' ' ' TYR . . . . . 0.425 ' O ' ' HA3' ' A' ' 623' ' ' GLY . 69.2 m-85 -153.07 130.89 11.66 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.595 -0.729 . . . . 0.0 109.695 179.003 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 538' ' ' THR . . . . . 0.695 ' OG1' ' HA ' ' A' ' 577' ' ' ILE . 28.3 m -114.62 106.3 14.08 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.961 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 539' ' ' VAL . . . . . . . . . . . . . 40.0 t -112.15 130.86 65.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-O 121.021 0.439 . . . . 0.0 111.35 -174.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 540' ' ' PHE . . . . . 0.491 ' HB3' HD13 ' A' ' 628' ' ' ILE . 87.5 m-85 -97.68 111.2 23.58 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 174.056 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -101.73 118.38 59.7 Favored Pre-proline 0 C--N 1.325 -0.471 0 CA-C-O 120.669 0.271 . . . . 0.0 110.887 -177.029 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 542' ' ' PRO . . . . . 0.565 ' HA ' HG13 ' A' ' 628' ' ' ILE . 7.4 Cg_exo -74.08 141.52 29.71 Favored 'Trans proline' 0 N--CA 1.461 -0.401 0 C-N-CA 123.155 2.57 . . . . 0.0 112.149 178.339 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 61.0 p -81.66 -176.61 6.15 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.683 -179.124 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 544' ' ' ASN . . . . . 0.517 ' HA ' ' HE3' ' A' ' 517' ' ' MET . 3.9 t-20 -61.13 -32.7 72.39 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 121.352 0.596 . . . . 0.0 110.162 179.067 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 545' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -59.5 -40.48 87.22 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.037 -0.983 . . . . 0.0 110.939 -179.517 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 546' ' ' ALA . . . . . 0.615 ' HB1' HG21 ' A' ' 631' ' ' VAL . . . -61.54 -50.18 73.7 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.559 -177.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 547' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -69.51 -20.86 63.7 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.136 -177.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 548' ' ' ARG . . . . . . . . . . . . . 30.5 tpt180 -83.37 -33.89 25.71 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.056 0.455 . . . . 0.0 110.236 177.527 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 549' ' ' ALA . . . . . . . . . . . . . . . -75.5 -21.38 58.06 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.375 -0.83 . . . . 0.0 111.441 -179.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 550' ' ' LEU . . . . . 0.473 ' HA ' ' HD3' ' A' ' 551' ' ' PRO . 73.5 mt -69.85 129.1 91.38 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-O 120.772 0.32 . . . . 0.0 111.058 178.385 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 551' ' ' PRO . . . . . 0.473 ' HD3' ' HA ' ' A' ' 550' ' ' LEU . 5.1 Cg_exo -77.78 148.29 25.32 Favored 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 123.061 2.508 . . . . 0.0 111.209 -179.207 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 552' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -53.85 -34.42 75.6 Favored 'Trans proline' 0 N--CA 1.471 0.194 0 C-N-CA 122.915 2.41 . . . . 0.0 112.435 -178.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 553' ' ' ARG . . . . . . . . . . . . . 34.8 mtp180 -62.24 -42.78 99.62 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.539 179.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -83.78 -35.01 24.65 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.808 0.337 . . . . 0.0 110.84 179.589 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 555' ' ' ARG . . . . . . . . . . . . . 14.4 mtp180 -58.05 -42.56 85.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.137 176.108 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 28.5 t -59.93 -28.55 67.71 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.863 -178.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 557' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -67.14 -62.91 1.2 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.357 0.599 . . . . 0.0 110.193 176.377 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 558' ' ' LEU . . . . . 0.569 ' O ' ' HG ' ' A' ' 565' ' ' LEU . 53.2 tp -68.88 -52.66 27.25 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.26 -0.882 . . . . 0.0 112.107 -172.422 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 559' ' ' LEU . . . . . . . . . . . . . 72.5 mt -80.33 4.74 16.87 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.802 -170.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 560' ' ' GLY . . . . . . . . . . . . . . . -123.66 3.97 9.33 Favored Glycine 0 N--CA 1.446 -0.7 0 C-N-CA 120.381 -0.914 . . . . 0.0 112.619 -179.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 561' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -135.82 128.67 31.16 Favored 'General case' 0 C--N 1.326 -0.431 0 O-C-N 122.538 -0.389 . . . . 0.0 111.051 -178.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 562' ' ' ALA . . . . . . . . . . . . . . . -70.32 -38.54 74.95 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.677 -176.132 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 563' ' ' LYS . . . . . 0.478 ' HG2' ' OE1' ' A' ' 564' ' ' GLU . 31.4 tttm -66.65 -47.87 71.18 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.036 -178.394 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 564' ' ' GLU . . . . . 0.478 ' OE1' ' HG2' ' A' ' 563' ' ' LYS . 5.7 mm-40 -67.33 -36.0 80.54 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.602 -0.272 . . . . 0.0 110.786 -179.436 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 565' ' ' LEU . . . . . 0.569 ' HG ' ' O ' ' A' ' 558' ' ' LEU . 6.6 mt -56.62 -52.52 64.56 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-O 120.893 0.377 . . . . 0.0 110.331 174.812 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 566' ' ' ALA . . . . . 0.502 ' O ' ' HG3' ' A' ' 570' ' ' LYS . . . -61.16 -48.71 80.34 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.34 -179.038 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 567' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -59.84 -48.08 83.15 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.822 -177.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 568' ' ' ILE . . . . . . . . . . . . . 43.4 mm -69.47 -35.27 65.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.706 0.289 . . . . 0.0 111.459 -178.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 569' ' ' LEU . . . . . 0.476 ' HG ' ' O ' ' A' ' 565' ' ' LEU . 61.2 mt -66.23 -36.95 84.35 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.813 -0.355 . . . . 0.0 110.59 177.128 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 570' ' ' LYS . . . . . 0.502 ' HG3' ' O ' ' A' ' 566' ' ' ALA . 53.2 mtpt -69.33 -9.84 55.16 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.682 0.277 . . . . 0.0 111.061 177.355 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 571' ' ' TYR . . . . . 0.464 ' HB2' HE21 ' A' ' 593' ' ' GLN . 33.9 t80 -92.78 -18.93 22.29 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.87 0.367 . . . . 0.0 110.525 179.065 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 572' ' ' HIS . . . . . . . . . . . . . 67.2 m80 -92.93 -7.08 47.06 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.17 0.509 . . . . 0.0 110.581 179.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 573' ' ' ILE . . . . . . . . . . . . . 54.0 mt -113.75 124.12 70.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.885 179.018 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 574' ' ' GLY . . . . . 0.494 ' HA3' HD23 ' A' ' 589' ' ' LEU . . . -113.95 149.7 18.67 Favored Glycine 0 N--CA 1.445 -0.74 0 N-CA-C 110.575 -1.01 . . . . 0.0 110.575 171.48 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 575' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -100.35 24.51 8.73 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 117.553 0.677 . . . . 0.0 110.879 -177.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 576' ' ' GLU . . . . . 0.407 ' HG3' ' HG ' ' A' ' 589' ' ' LEU . 14.8 pt-20 -136.21 125.88 25.46 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 175.426 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 577' ' ' ILE . . . . . 0.695 ' HA ' ' OG1' ' A' ' 538' ' ' THR . 61.2 mt -77.57 115.07 18.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.147 -175.423 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 578' ' ' LEU . . . . . 0.528 HD12 ' HA ' ' A' ' 583' ' ' ILE . 48.7 tp -121.67 103.44 8.89 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.267 -0.879 . . . . 0.0 109.791 177.85 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 579' ' ' VAL . . . . . 0.476 ' O ' HG13 ' A' ' 583' ' ' ILE . 30.4 m -95.36 162.41 2.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.964 178.035 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 580' ' ' SER . . . . . . . . . . . . . 15.3 m -56.6 -45.93 81.14 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 123.354 0.409 . . . . 0.0 111.914 -175.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 581' ' ' GLY . . . . . . . . . . . . . . . -70.43 -21.17 77.42 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.52 -0.848 . . . . 0.0 112.619 -179.104 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . -99.43 2.64 57.6 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.876 -0.678 . . . . 0.0 113.296 -175.222 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 583' ' ' ILE . . . . . 0.528 ' HA ' HD12 ' A' ' 578' ' ' LEU . 62.7 mt -67.75 -65.21 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 117.183 0.491 . . . . 0.0 111.1 179.142 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 584' ' ' GLY . . . . . . . . . . . . . . . 78.83 78.32 0.84 Allowed Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.241 -0.981 . . . . 0.0 111.556 -175.388 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 585' ' ' ALA . . . . . . . . . . . . . . . 70.68 -80.12 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 123.303 0.641 . . . . 0.0 111.88 -178.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 586' ' ' LEU . . . . . 0.967 ' HG ' ' HB3' ' A' ' 600' ' ' SER . 6.4 tt -151.32 129.02 11.54 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.7 0.286 . . . . 0.0 110.654 -175.458 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 587' ' ' VAL . . . . . . . . . . . . . 68.3 t -148.02 119.65 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.848 -0.614 . . . . 0.0 109.62 179.107 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 588' ' ' ARG . . . . . 0.533 ' HG2' ' HA ' ' A' ' 598' ' ' GLU . 92.3 mtt180 -85.36 123.06 30.39 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.125 0.488 . . . . 0.0 110.875 -179.131 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 589' ' ' LEU . . . . . 0.499 HD11 ' HB3' ' A' ' 578' ' ' LEU . 6.2 tt -90.56 125.63 35.68 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 114.749 -1.114 . . . . 0.0 109.77 -172.775 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 590' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -76.72 132.31 39.24 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.169 0.509 . . . . 0.0 110.774 -179.157 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 591' ' ' SER . . . . . . . . . . . . . 78.3 p -99.76 159.85 14.75 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.744 -176.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 592' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -58.01 -25.64 61.37 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 116.187 -0.46 . . . . 0.0 112.053 179.177 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 593' ' ' GLN . . . . . 0.464 HE21 ' HB2' ' A' ' 571' ' ' TYR . 4.0 tt0 -68.39 -27.09 65.91 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.175 0.512 . . . . 0.0 110.664 178.763 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 594' ' ' GLY . . . . . . . . . . . . . . . 107.17 -4.95 35.72 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.744 -0.741 . . . . 0.0 111.369 -174.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 595' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -88.81 -176.78 5.34 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 179.22 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 596' ' ' LYS . . . . . 0.674 ' N ' ' HD3' ' A' ' 596' ' ' LYS . 0.0 OUTLIER -125.56 129.74 50.29 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.078 0.466 . . . . 0.0 110.875 -172.283 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 597' ' ' LEU . . . . . . . . . . . . . 59.7 mt -93.46 119.53 32.65 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.63 177.453 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 598' ' ' GLU . . . . . 0.533 ' HA ' ' HG2' ' A' ' 588' ' ' ARG . 10.7 tp10 -75.76 86.55 2.77 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.356 -179.74 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 599' ' ' VAL . . . . . . . . . . . . . 49.3 t -105.86 125.43 61.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 121.198 0.523 . . . . 0.0 110.395 -179.415 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 600' ' ' SER . . . . . 0.967 ' HB3' ' HG ' ' A' ' 586' ' ' LEU . 3.0 p -142.72 157.43 44.66 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.107 -179.114 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 601' ' ' LEU . . . . . 0.491 ' HB2' HD13 ' A' ' 583' ' ' ILE . 33.9 tp -123.06 122.92 39.66 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.096 -177.525 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 602' ' ' LYS . . . . . . . . . . . . . 34.9 ttmt -139.42 109.26 6.32 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.712 0.292 . . . . 0.0 110.515 -177.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 603' ' ' ASN . . . . . . . . . . . . . 18.7 m120 61.75 46.77 6.74 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.61 178.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 604' ' ' ASN . . . . . . . . . . . . . 15.9 t-20 76.64 -8.77 1.61 Allowed 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 115.307 -0.86 . . . . 0.0 111.777 177.277 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 605' ' ' VAL . . . . . . . . . . . . . 49.0 t -94.14 126.43 46.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-O 120.75 0.309 . . . . 0.0 110.198 -179.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 606' ' ' VAL . . . . . 0.564 HG13 ' HB ' ' A' ' 613' ' ' VAL . 6.7 p -108.76 131.11 60.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.625 -179.665 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 607' ' ' SER . . . . . . . . . . . . . 45.2 p -131.92 144.4 50.81 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.2 -179.203 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 608' ' ' VAL . . . . . 0.475 ' HA ' ' O ' ' A' ' 598' ' ' GLU . 4.4 p -118.83 115.04 46.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.81 176.205 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 609' ' ' ASN . . . . . . . . . . . . . 95.7 m-20 61.79 32.33 18.2 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.093 -176.378 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 610' ' ' LYS . . . . . 0.635 ' HZ1' ' HB2' ' A' ' 610' ' ' LYS . 0.0 OUTLIER 81.48 -6.18 1.54 Allowed 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 114.792 -1.094 . . . . 0.0 111.134 -179.176 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 611' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -87.11 111.34 40.13 Favored Pre-proline 0 C--N 1.326 -0.42 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 177.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 612' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -65.41 135.23 41.83 Favored 'Trans proline' 0 N--CA 1.462 -0.361 0 C-N-CA 122.634 2.223 . . . . 0.0 112.185 -178.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 613' ' ' VAL . . . . . 0.564 ' HB ' HG13 ' A' ' 606' ' ' VAL . 89.8 t -73.84 125.01 32.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.068 177.823 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 614' ' ' ALA . . . . . 0.624 ' HB3' HG23 ' A' ' 629' ' ' THR . . . -64.65 -45.34 87.18 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.748 -177.82 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 615' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -154.46 99.04 2.48 Favored Pre-proline 0 N--CA 1.466 0.374 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.782 -177.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 616' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -88.87 162.29 6.09 Favored 'Trans proline' 0 N--CA 1.459 -0.51 0 C-N-CA 123.026 2.484 . . . . 0.0 114.195 -176.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 37.5 t0 77.33 46.93 0.06 Allowed 'General case' 0 C--O 1.234 0.272 0 CA-C-O 122.735 1.255 . . . . 0.0 110.114 165.238 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 618' ' ' ILE . . . . . 0.483 ' HB ' ' O ' ' A' ' 625' ' ' VAL . 11.6 mt -90.63 113.5 26.62 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.812 0 CA-C-N 113.503 -1.681 . . . . 0.0 109.674 174.302 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 619' ' ' MET . . . . . 0.474 ' HA ' ' HE3' ' A' ' 619' ' ' MET . 7.7 mmt -77.2 133.48 38.9 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 -170.207 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 620' ' ' ALA . . . . . . . . . . . . . . . -130.31 170.92 13.5 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 115.113 -0.949 . . . . 0.0 108.802 170.097 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 621' ' ' THR . . . . . . . . . . . . . 5.0 t -81.32 -23.99 37.47 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.775 -0.37 . . . . 0.0 111.056 -178.53 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 622' ' ' ASN . . . . . 0.554 ' HB3' ' HA ' ' A' ' 534' ' ' GLU . 29.7 p-10 -117.11 22.64 12.4 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.844 0.354 . . . . 0.0 111.066 -176.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 623' ' ' GLY . . . . . 0.465 ' HA2' HD12 ' A' ' 577' ' ' ILE . . . 152.52 -147.11 16.38 Favored Glycine 0 N--CA 1.444 -0.796 0 C-N-CA 120.231 -0.985 . . . . 0.0 112.68 177.469 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 624' ' ' VAL . . . . . . . . . . . . . 9.5 p -144.46 158.51 14.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 -177.37 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 625' ' ' VAL . . . . . 0.483 ' O ' ' HB ' ' A' ' 618' ' ' ILE . 60.9 t -125.85 135.4 64.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 -179.828 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 626' ' ' HIS . . . . . . . . . . . . . 95.5 m-70 -119.33 116.15 25.61 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.23 -0.441 . . . . 0.0 109.946 175.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 627' ' ' VAL . . . . . 0.674 HG21 ' HZ ' ' A' ' 515' ' ' PHE . 48.3 t -70.24 125.67 28.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.281 179.75 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 628' ' ' ILE . . . . . 0.565 HG13 ' HA ' ' A' ' 542' ' ' PRO . 7.9 pt -121.28 145.88 27.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 121.32 0.581 . . . . 0.0 111.018 176.679 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 629' ' ' THR . . . . . 0.624 HG23 ' HB3' ' A' ' 614' ' ' ALA . 16.9 p -90.35 -3.33 57.81 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.493 -0.776 . . . . 0.0 112.197 -176.737 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 630' ' ' ASN . . . . . . . . . . . . . 64.1 t30 -141.91 175.05 10.03 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.503 -0.555 . . . . 0.0 109.503 -179.405 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 631' ' ' VAL . . . . . 0.615 HG21 ' HB1' ' A' ' 546' ' ' ALA . 51.2 t -106.21 123.79 61.13 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 N-CA-C 109.484 -0.562 . . . . 0.0 109.484 -178.729 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 632' ' ' LEU . . . . . 0.4 HD23 HG13 ' A' ' 608' ' ' VAL . 88.4 mt -68.24 126.08 28.44 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.042 0.449 . . . . 0.0 111.46 -173.069 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 633' ' ' GLN . . . . . . . . . . . . . 82.9 mm-40 -118.44 119.77 32.64 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.058 -178.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 634' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo . . . . . 0 C--O 1.251 1.139 0 C-N-CA 122.685 2.257 . . . . 0.0 112.171 177.59 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.619 0 N-CA-C 112.132 -0.387 . . . . 0.0 112.132 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 504' ' ' THR . . . . . 0.602 ' HA ' HG22 ' A' ' 621' ' ' THR . 33.7 p -78.85 172.35 13.88 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.539 0.209 . . . . 0.0 110.582 179.29 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 505' ' ' VAL . . . . . 0.713 ' O ' ' HG ' ' A' ' 509' ' ' LEU . 13.0 m -57.85 -34.96 49.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.696 -0.229 . . . . 0.0 110.929 176.125 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 506' ' ' MET . . . . . . . . . . . . . 95.0 mmm -61.5 -35.93 79.07 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-O 120.77 0.319 . . . . 0.0 110.928 178.687 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 507' ' ' ASP . . . . . 0.748 ' HA ' ' HE3' ' A' ' 510' ' ' LYS . 23.0 t70 -67.49 -35.85 79.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.279 -178.686 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 508' ' ' VAL . . . . . . . . . . . . . 45.8 t -71.92 -41.37 69.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 115.63 -0.713 . . . . 0.0 110.58 178.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 509' ' ' LEU . . . . . 0.713 ' HG ' ' O ' ' A' ' 505' ' ' VAL . 77.4 mt -62.73 -31.74 72.73 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.745 -176.672 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 510' ' ' LYS . . . . . 0.748 ' HE3' ' HA ' ' A' ' 507' ' ' ASP . 22.8 pttp -88.62 -13.71 39.25 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.061 0.458 . . . . 0.0 110.618 -177.741 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 511' ' ' GLY . . . . . . . . . . . . . . . -85.21 -11.57 75.48 Favored Glycine 0 N--CA 1.442 -0.947 0 C-N-CA 120.463 -0.875 . . . . 0.0 110.976 175.34 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 512' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -108.84 134.58 51.34 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.894 0.378 . . . . 0.0 110.194 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -72.88 -22.52 60.75 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.537 -176.547 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 514' ' ' ARG . . . . . . . . . . . . . 63.9 mtm180 -84.16 -33.85 24.14 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 120.987 0.422 . . . . 0.0 110.352 -176.799 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 515' ' ' PHE . . . . . 0.995 ' HZ ' HG22 ' A' ' 627' ' ' VAL . 11.5 m-30 -81.1 -7.73 59.62 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.408 -179.788 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 23.2 t -58.93 -43.32 91.14 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.872 -174.186 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 517' ' ' MET . . . . . . . . . . . . . 4.3 mpp? -67.18 -30.35 70.28 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-O 120.879 0.371 . . . . 0.0 110.504 179.346 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 518' ' ' LEU . . . . . 0.484 HD22 ' HA ' ' A' ' 541' ' ' ALA . 61.8 tp -68.68 -41.28 79.44 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.66 -0.416 . . . . 0.0 109.903 177.1 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 519' ' ' VAL . . . . . 0.426 ' O ' ' HG3' ' A' ' 523' ' ' GLN . 61.3 t -56.94 -36.42 50.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.086 0.47 . . . . 0.0 109.955 175.067 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 520' ' ' ALA . . . . . . . . . . . . . . . -69.67 -39.46 77.01 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.436 -179.451 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 521' ' ' ALA . . . . . . . . . . . . . . . -67.26 -46.65 73.07 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.299 176.091 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 522' ' ' ILE . . . . . 0.416 HG13 ' O ' ' A' ' 518' ' ' LEU . 71.5 mt -55.07 -45.46 76.98 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.072 177.248 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 523' ' ' GLN . . . . . 0.426 ' HG3' ' O ' ' A' ' 519' ' ' VAL . 92.8 mt-30 -65.46 -44.73 86.28 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.314 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 24.2 t -69.71 -32.46 71.04 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.567 -176.648 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 525' ' ' ALA . . . . . 0.521 ' HB1' ' HB2' ' A' ' 566' ' ' ALA . . . -86.32 -25.48 25.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.725 0.298 . . . . 0.0 111.265 -179.37 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 526' ' ' GLY . . . . . . . . . . . . . . . 90.76 31.71 9.87 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 121.009 -0.615 . . . . 0.0 112.564 177.424 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 527' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -92.16 -4.7 53.86 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.549 0.214 . . . . 0.0 111.303 -179.114 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 528' ' ' THR . . . . . . . . . . . . . 8.1 m -54.24 -37.85 65.12 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.824 -176.428 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 529' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -62.84 -19.51 64.18 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 112.219 0.452 . . . . 0.0 112.219 -176.798 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 530' ' ' THR . . . . . . . . . . . . . 84.8 m -75.06 -54.7 6.71 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.94 0.4 . . . . 0.0 110.18 177.266 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 531' ' ' LEU . . . . . 0.666 ' H ' HD22 ' A' ' 531' ' ' LEU . 1.4 mm? -75.53 -5.33 44.69 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.26 179.457 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 532' ' ' ASN . . . . . . . . . . . . . 61.3 t30 -81.44 -5.8 58.28 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.196 178.726 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 533' ' ' ARG . . . . . . . . . . . . . 29.6 mmm180 -110.12 146.9 34.67 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.283 178.68 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 534' ' ' GLU . . . . . 0.673 ' HA ' ' CB ' ' A' ' 622' ' ' ASN . 35.7 mt-10 -90.74 155.25 18.94 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.893 0.378 . . . . 0.0 110.253 177.572 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 535' ' ' GLY . . . . . . . . . . . . . . . 151.83 -132.74 3.9 Favored Glycine 0 N--CA 1.447 -0.62 0 N-CA-C 110.834 -0.907 . . . . 0.0 110.834 -174.374 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 536' ' ' VAL . . . . . 0.442 ' HA ' HD11 ' A' ' 577' ' ' ILE . 33.8 m -123.17 128.41 74.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 120.965 0.412 . . . . 0.0 110.851 177.888 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 537' ' ' TYR . . . . . . . . . . . . . 82.2 m-85 -155.16 152.94 30.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.057 179.526 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 538' ' ' THR . . . . . 0.663 ' OG1' ' HA ' ' A' ' 577' ' ' ILE . 94.6 m -130.42 102.8 6.33 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.213 -0.449 . . . . 0.0 109.994 174.825 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 539' ' ' VAL . . . . . . . . . . . . . 26.6 t -100.89 125.75 54.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 120.937 0.399 . . . . 0.0 111.411 -172.886 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 540' ' ' PHE . . . . . 0.608 ' HB3' HD13 ' A' ' 628' ' ' ILE . 97.3 m-85 -98.47 111.57 23.88 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 173.362 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 541' ' ' ALA . . . . . 0.484 ' HA ' HD22 ' A' ' 518' ' ' LEU . . . -102.08 115.41 64.69 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 116.651 -0.25 . . . . 0.0 111.263 -176.799 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 542' ' ' PRO . . . . . 0.47 ' HA ' HG13 ' A' ' 628' ' ' ILE . 13.4 Cg_exo -71.02 141.02 39.17 Favored 'Trans proline' 0 N--CA 1.463 -0.279 0 C-N-CA 123.146 2.564 . . . . 0.0 112.195 177.376 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 41.7 p -85.85 -177.03 6.25 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.058 178.763 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 544' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -59.72 -40.36 87.71 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 121.387 0.613 . . . . 0.0 109.958 -179.057 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 545' ' ' GLU . . . . . 0.511 ' CD ' ' H ' ' A' ' 545' ' ' GLU . 3.3 mp0 -58.15 -39.11 77.97 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 114.736 -1.12 . . . . 0.0 110.812 -178.148 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 546' ' ' ALA . . . . . 0.621 ' HB1' HG13 ' A' ' 631' ' ' VAL . . . -63.96 -43.51 95.59 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.027 0.441 . . . . 0.0 111.232 -178.4 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 547' ' ' PHE . . . . . . . . . . . . . 75.1 m-85 -72.87 -27.75 62.1 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.151 -179.007 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 548' ' ' ARG . . . . . 0.443 ' O ' ' HD2' ' A' ' 548' ' ' ARG . 5.5 tmm_? -80.33 -29.07 38.04 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.219 0.533 . . . . 0.0 109.912 179.161 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 549' ' ' ALA . . . . . . . . . . . . . . . -76.09 -17.68 59.51 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.232 179.657 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 550' ' ' LEU . . . . . 0.715 ' HB3' ' HB3' ' A' ' 555' ' ' ARG . 20.0 mt -58.31 134.3 84.94 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.089 178.116 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 551' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 550' ' ' LEU . 28.0 Cg_exo -62.84 143.9 92.55 Favored 'Trans proline' 0 C--O 1.234 0.308 0 C-N-CA 122.909 2.406 . . . . 0.0 111.766 -179.582 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 552' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -53.67 -38.0 84.16 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 123.261 2.64 . . . . 0.0 112.249 -177.7 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 553' ' ' ARG . . . . . . . . . . . . . 22.4 mmm180 -69.05 -52.92 23.56 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.851 -178.52 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 18.2 mt-10 -66.69 -51.22 58.53 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.712 -0.676 . . . . 0.0 112.42 -175.924 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 555' ' ' ARG . . . . . 0.715 ' HB3' ' HB3' ' A' ' 550' ' ' LEU . 18.6 ptt180 -67.4 -27.64 67.26 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 120.445 -0.502 . . . . 0.0 111.396 -175.063 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 47.1 t -71.21 -31.55 67.75 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.733 0.301 . . . . 0.0 110.701 177.858 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 557' ' ' ARG . . . . . 0.427 HH11 ' HD3' ' A' ' 557' ' ' ARG . 8.7 tpt180 -83.28 -53.03 6.06 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.487 -179.411 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 558' ' ' LEU . . . . . 0.55 HD22 ' HB3' ' A' ' 564' ' ' GLU . 0.3 OUTLIER -57.48 -47.36 82.11 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.23 -0.896 . . . . 0.0 111.429 -174.602 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 559' ' ' LEU . . . . . 0.676 HD23 HD21 ' A' ' 565' ' ' LEU . 93.5 mt -77.81 0.7 22.78 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.563 -175.161 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 560' ' ' GLY . . . . . . . . . . . . . . . -97.2 -11.51 52.05 Favored Glycine 0 N--CA 1.445 -0.746 0 C-N-CA 120.444 -0.884 . . . . 0.0 112.585 -178.287 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 561' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -132.23 127.91 36.78 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.923 0.392 . . . . 0.0 111.205 -177.282 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 562' ' ' ALA . . . . . . . . . . . . . . . -64.31 -29.24 70.33 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.909 -0.587 . . . . 0.0 112.227 -176.896 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 563' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -78.71 -39.85 35.34 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 -177.472 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 564' ' ' GLU . . . . . 0.55 ' HB3' HD22 ' A' ' 558' ' ' LEU . 44.5 mt-10 -64.25 -34.52 78.3 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.164 -0.471 . . . . 0.0 109.937 175.935 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 565' ' ' LEU . . . . . 0.676 HD21 HD23 ' A' ' 559' ' ' LEU . 58.1 mt -64.34 -52.42 58.49 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.986 175.031 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 566' ' ' ALA . . . . . 0.521 ' HB2' ' HB1' ' A' ' 525' ' ' ALA . . . -56.4 -40.71 75.09 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.821 -176.548 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 567' ' ' ASN . . . . . . . . . . . . . 47.5 t30 -60.97 -47.91 84.27 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.757 -177.882 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 568' ' ' ILE . . . . . . . . . . . . . 50.6 mm -69.87 -33.42 55.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.389 -177.583 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 569' ' ' LEU . . . . . 0.436 ' HG ' ' O ' ' A' ' 565' ' ' LEU . 78.7 mt -65.98 -33.47 75.89 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.541 -0.3 . . . . 0.0 111.517 -179.15 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 570' ' ' LYS . . . . . 0.53 ' HE3' ' HA ' ' A' ' 593' ' ' GLN . 28.0 mtpp -66.94 -18.7 65.5 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.135 179.807 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 571' ' ' TYR . . . . . . . . . . . . . 20.5 t80 -87.12 -18.26 30.88 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.223 178.366 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 572' ' ' HIS . . . . . . . . . . . . . 62.5 m80 -89.09 -12.14 42.02 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.883 0.373 . . . . 0.0 111.403 -178.487 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 573' ' ' ILE . . . . . 0.406 ' O ' HD23 ' A' ' 592' ' ' LEU . 38.5 mt -108.64 119.69 58.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.359 179.105 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 574' ' ' GLY . . . . . 0.572 ' HA2' ' HA ' ' A' ' 591' ' ' SER . . . -91.97 151.24 20.68 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.99 -0.624 . . . . 0.0 111.941 177.179 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 575' ' ' ASP . . . . . 0.414 ' HB3' ' HG3' ' A' ' 590' ' ' LYS . 6.4 t70 -93.99 9.3 38.11 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.087 0.47 . . . . 0.0 110.703 -173.782 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 576' ' ' GLU . . . . . 0.572 ' OE1' ' HG2' ' A' ' 590' ' ' LYS . 42.8 mt-10 -142.08 126.12 17.3 Favored 'General case' 0 CA--C 1.511 -0.521 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.951 -176.063 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 577' ' ' ILE . . . . . 0.663 ' HA ' ' OG1' ' A' ' 538' ' ' THR . 58.5 mt -76.06 105.11 4.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 121.218 0.532 . . . . 0.0 111.235 -177.861 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 578' ' ' LEU . . . . . 0.438 ' HG ' HG11 ' A' ' 587' ' ' VAL . 3.9 mm? -119.7 100.79 7.47 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.153 176.644 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 579' ' ' VAL . . . . . 0.544 ' O ' HG13 ' A' ' 583' ' ' ILE . 34.0 m -86.82 166.89 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 109.614 -0.514 . . . . 0.0 109.614 175.079 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 580' ' ' SER . . . . . . . . . . . . . 20.8 m -57.12 -40.13 76.5 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.893 0.377 . . . . 0.0 111.226 -176.084 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 581' ' ' GLY . . . . . . . . . . . . . . . -76.26 -8.7 85.61 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.783 -179.412 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . -103.24 -27.12 6.65 Favored Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.918 -177.564 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 583' ' ' ILE . . . . . 0.544 HG13 ' O ' ' A' ' 579' ' ' VAL . 77.1 mt -60.27 -59.02 4.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 120.893 0.377 . . . . 0.0 111.548 -178.158 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 584' ' ' GLY . . . . . . . . . . . . . . . 94.23 -81.29 0.96 Allowed Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.236 -178.823 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 585' ' ' ALA . . . . . . . . . . . . . . . -128.07 -62.26 1.06 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.753 0.311 . . . . 0.0 110.929 179.782 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 586' ' ' LEU . . . . . 0.958 ' HG ' ' HB3' ' A' ' 600' ' ' SER . 3.9 tt -155.3 140.2 17.25 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 178.344 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 587' ' ' VAL . . . . . 0.521 ' N ' HD23 ' A' ' 586' ' ' LEU . 9.3 p -142.18 136.92 29.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-O 121.102 0.477 . . . . 0.0 111.086 -178.515 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 588' ' ' ARG . . . . . . . . . . . . . 8.2 ttt180 -85.03 101.49 12.44 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.625 174.182 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 589' ' ' LEU . . . . . . . . . . . . . 2.7 tt -97.53 128.77 44.54 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.45 -0.796 . . . . 0.0 109.456 -175.843 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 590' ' ' LYS . . . . . 0.572 ' HG2' ' OE1' ' A' ' 576' ' ' GLU . 27.8 pttt -82.03 143.65 31.41 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 120.691 -0.404 . . . . 0.0 110.795 178.706 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 591' ' ' SER . . . . . 0.572 ' HA ' ' HA2' ' A' ' 574' ' ' GLY . 80.3 p -105.1 165.15 11.29 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.597 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 592' ' ' LEU . . . . . 0.406 HD23 ' O ' ' A' ' 573' ' ' ILE . 3.5 mm? -66.88 -9.17 35.08 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 178.572 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 593' ' ' GLN . . . . . 0.53 ' HA ' ' HE3' ' A' ' 570' ' ' LYS . 57.2 tt0 -86.01 -29.46 23.46 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.103 0.477 . . . . 0.0 110.359 176.283 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 594' ' ' GLY . . . . . . . . . . . . . . . 117.94 -21.21 10.42 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.559 -0.829 . . . . 0.0 111.784 -176.834 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 595' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -78.37 179.28 7.08 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 109.271 -0.641 . . . . 0.0 109.271 177.271 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 596' ' ' LYS . . . . . 0.803 ' H ' ' HD3' ' A' ' 596' ' ' LYS . 0.0 OUTLIER -115.8 140.29 49.36 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-O 121.027 0.442 . . . . 0.0 110.316 -175.741 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 597' ' ' LEU . . . . . . . . . . . . . 71.0 mt -101.39 117.17 34.41 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.934 -0.575 . . . . 0.0 109.601 173.752 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 598' ' ' GLU . . . . . 0.498 ' OE1' ' HG2' ' A' ' 596' ' ' LYS . 1.6 mp0 -80.89 84.86 6.3 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.204 0.525 . . . . 0.0 110.006 178.225 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 599' ' ' VAL . . . . . . . . . . . . . 26.1 t -93.29 126.53 45.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.586 -0.733 . . . . 0.0 109.738 -179.727 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 600' ' ' SER . . . . . 0.958 ' HB3' ' HG ' ' A' ' 586' ' ' LEU . 23.9 p -135.01 159.33 41.84 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.251 0.548 . . . . 0.0 111.692 -178.32 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 601' ' ' LEU . . . . . . . . . . . . . 27.5 tp -130.45 108.77 10.21 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.014 -0.994 . . . . 0.0 109.0 179.524 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 602' ' ' LYS . . . . . . . . . . . . . 8.6 ptpp? -137.07 131.68 33.09 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 110.113 -0.329 . . . . 0.0 110.113 -179.037 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 603' ' ' ASN . . . . . . . . . . . . . 84.9 m-20 65.06 25.54 12.58 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.743 -176.466 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 604' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 71.59 10.3 6.43 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 114.952 -1.022 . . . . 0.0 110.164 -177.286 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 605' ' ' VAL . . . . . . . . . . . . . 62.1 t -101.11 119.23 48.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.936 177.004 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 606' ' ' VAL . . . . . 0.686 HG13 ' HB ' ' A' ' 613' ' ' VAL . 5.6 p -91.11 137.31 22.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 121.104 0.478 . . . . 0.0 110.635 178.94 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 607' ' ' SER . . . . . . . . . . . . . 18.5 m -143.34 140.02 30.35 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.862 -179.457 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 608' ' ' VAL . . . . . . . . . . . . . 3.8 p -113.63 114.3 46.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.637 176.777 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 609' ' ' ASN . . . . . . . . . . . . . 84.4 m-20 57.04 44.55 22.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.244 -175.993 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 610' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 76.9 -19.67 0.41 Allowed 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.141 0.977 . . . . 0.0 112.443 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 611' ' ' GLU . . . . . 0.477 ' HA ' ' HD3' ' A' ' 612' ' ' PRO . 46.7 mm-40 -79.28 121.27 82.79 Favored Pre-proline 0 C--N 1.332 -0.172 0 CA-C-O 120.831 0.348 . . . . 0.0 110.386 179.085 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 612' ' ' PRO . . . . . 0.477 ' HD3' ' HA ' ' A' ' 611' ' ' GLU . 11.7 Cg_exo -70.39 146.56 56.67 Favored 'Trans proline' 0 CA--C 1.529 0.255 0 C-N-CA 123.038 2.492 . . . . 0.0 112.935 -178.422 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 613' ' ' VAL . . . . . 0.686 ' HB ' HG13 ' A' ' 606' ' ' VAL . 85.4 t -87.85 135.63 25.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.979 177.604 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 614' ' ' ALA . . . . . . . . . . . . . . . -84.5 -31.91 24.22 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.553 -175.349 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 615' ' ' GLU . . . . . 0.499 ' HB3' ' CG2' ' A' ' 627' ' ' VAL . 8.7 tp10 -161.92 92.32 1.37 Allowed Pre-proline 0 C--N 1.327 -0.407 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 -177.597 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 616' ' ' PRO . . . . . 0.408 ' HB3' HG11 ' A' ' 613' ' ' VAL . 60.8 Cg_endo -89.77 165.67 5.02 Favored 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 123.078 2.519 . . . . 0.0 114.035 -176.315 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 617' ' ' ASP . . . . . 0.447 ' OD2' ' HB ' ' A' ' 579' ' ' VAL . 0.9 OUTLIER 76.81 34.54 0.43 Allowed 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 122.33 1.062 . . . . 0.0 110.514 165.78 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 618' ' ' ILE . . . . . 0.513 ' HB ' ' O ' ' A' ' 625' ' ' VAL . 13.6 mt -78.02 109.59 12.8 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.969 0 CA-C-N 113.92 -1.491 . . . . 0.0 109.327 172.254 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 619' ' ' MET . . . . . . . . . . . . . 8.0 mmt -80.08 131.34 35.74 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.87 -0.604 . . . . 0.0 112.034 -174.13 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 620' ' ' ALA . . . . . . . . . . . . . . . -130.6 173.07 11.24 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.262 173.358 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 621' ' ' THR . . . . . 0.602 HG22 ' HA ' ' A' ' 504' ' ' THR . 6.3 t -72.14 -29.4 64.01 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.887 0.375 . . . . 0.0 111.239 -176.857 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 622' ' ' ASN . . . . . 0.673 ' CB ' ' HA ' ' A' ' 534' ' ' GLU . 28.7 p-10 -117.34 22.7 12.29 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 112.168 0.433 . . . . 0.0 112.168 -173.745 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 623' ' ' GLY . . . . . . . . . . . . . . . 151.05 -154.85 25.82 Favored Glycine 0 N--CA 1.442 -0.919 0 C-N-CA 119.631 -1.271 . . . . 0.0 113.056 176.836 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 624' ' ' VAL . . . . . 0.503 HG21 HG12 ' A' ' 579' ' ' VAL . 9.7 p -129.65 159.0 42.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 N-CA-C 109.932 -0.395 . . . . 0.0 109.932 -179.707 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 625' ' ' VAL . . . . . 0.513 ' O ' ' HB ' ' A' ' 618' ' ' ILE . 67.9 t -128.04 132.3 68.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.819 178.606 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 626' ' ' HIS . . . . . . . . . . . . . 69.6 m-70 -118.46 112.3 19.77 Favored 'General case' 0 N--CA 1.445 -0.68 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 177.509 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 627' ' ' VAL . . . . . 0.995 HG22 ' HZ ' ' A' ' 515' ' ' PHE . 38.5 t -64.38 126.11 22.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.146 178.757 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 628' ' ' ILE . . . . . 0.608 HD13 ' HB3' ' A' ' 540' ' ' PHE . 5.4 pt -121.06 142.52 36.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.064 0.459 . . . . 0.0 110.701 176.0 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 629' ' ' THR . . . . . . . . . . . . . 9.5 t -97.31 2.87 51.2 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.778 0.799 . . . . 0.0 109.851 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 630' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -132.77 157.56 44.64 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.086 -0.961 . . . . 0.0 108.833 178.1 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 631' ' ' VAL . . . . . 0.621 HG13 ' HB1' ' A' ' 546' ' ' ALA . 23.8 m -92.79 156.28 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.015 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 176.363 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 632' ' ' LEU . . . . . . . . . . . . . 92.2 mt -106.1 110.89 23.3 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-O 121.281 0.562 . . . . 0.0 110.521 -178.446 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 633' ' ' GLN . . . . . 0.481 ' HA ' ' HD3' ' A' ' 634' ' ' PRO . 53.8 mt-30 -117.44 130.76 24.44 Favored Pre-proline 0 C--N 1.319 -0.735 0 CA-C-N 115.122 -0.944 . . . . 0.0 109.936 -177.675 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 634' ' ' PRO . . . . . 0.481 ' HD3' ' HA ' ' A' ' 633' ' ' GLN . 14.2 Cg_exo . . . . . 0 C--O 1.25 1.113 0 C-N-CA 122.814 2.343 . . . . 0.0 111.722 177.528 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.545 0 N-CA-C 111.77 -0.532 . . . . 0.0 111.77 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 31.5 p -90.01 -179.28 5.66 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.366 0.127 . . . . 0.0 110.875 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 505' ' ' VAL . . . . . 0.672 ' O ' ' HG ' ' A' ' 509' ' ' LEU . 22.2 t -50.43 -47.61 26.49 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.275 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.223 179.826 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 506' ' ' MET . . . . . 0.473 ' HG2' ' HB2' ' A' ' 531' ' ' LEU . 90.8 mmm -57.37 -34.81 69.22 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.993 -176.135 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 507' ' ' ASP . . . . . 0.468 ' HA ' ' NZ ' ' A' ' 510' ' ' LYS . 12.1 t70 -76.13 -35.64 59.16 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.799 0.333 . . . . 0.0 110.133 -178.675 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 508' ' ' VAL . . . . . . . . . . . . . 64.3 t -66.0 -39.61 85.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.473 178.868 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 509' ' ' LEU . . . . . 0.672 ' HG ' ' O ' ' A' ' 505' ' ' VAL . 22.8 mt -65.61 -19.92 66.11 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.048 -178.97 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 510' ' ' LYS . . . . . 0.468 ' NZ ' ' HA ' ' A' ' 507' ' ' ASP . 30.2 mtmm -81.62 -24.96 36.08 Favored 'General case' 0 CA--C 1.514 -0.432 0 CA-C-O 121.223 0.535 . . . . 0.0 110.024 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 511' ' ' GLY . . . . . . . . . . . . . . . -80.38 -8.17 87.83 Favored Glycine 0 N--CA 1.443 -0.872 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.806 179.715 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 512' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -118.9 152.99 35.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.341 0.591 . . . . 0.0 111.769 -178.423 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 43.2 t-20 -76.82 -39.41 51.41 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.408 -0.815 . . . . 0.0 111.095 -178.856 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 514' ' ' ARG . . . . . . . . . . . . . 3.0 mpp_? -80.58 -34.31 35.39 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.105 0.479 . . . . 0.0 110.808 -171.565 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 515' ' ' PHE . . . . . 0.544 ' CZ ' HG22 ' A' ' 627' ' ' VAL . 14.5 m-30 -75.99 -8.25 56.51 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.827 178.798 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 16.8 t -59.05 -38.55 79.62 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.673 -176.071 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 517' ' ' MET . . . . . 0.546 ' HE3' ' HA ' ' A' ' 544' ' ' ASN . 3.4 mpp? -68.61 -26.56 65.42 Favored 'General case' 0 CA--C 1.519 -0.219 0 C-N-CA 120.787 -0.365 . . . . 0.0 111.025 -179.821 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 518' ' ' LEU . . . . . 0.557 HD13 HD11 ' A' ' 522' ' ' ILE . 3.3 mt -65.49 -43.29 90.64 Favored 'General case' 0 CA--C 1.517 -0.312 0 C-N-CA 120.261 -0.575 . . . . 0.0 109.554 174.201 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 519' ' ' VAL . . . . . 0.692 ' O ' ' HB2' ' A' ' 523' ' ' GLN . 30.1 t -55.09 -31.68 26.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.129 0.49 . . . . 0.0 110.41 178.455 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 520' ' ' ALA . . . . . . . . . . . . . . . -84.29 -46.71 11.51 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.46 178.497 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 521' ' ' ALA . . . . . . . . . . . . . . . -64.73 -52.52 56.64 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.872 0.368 . . . . 0.0 110.934 -178.926 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 522' ' ' ILE . . . . . 0.557 HD11 HD13 ' A' ' 518' ' ' LEU . 41.2 mt -59.67 -26.93 36.45 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.306 177.75 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 523' ' ' GLN . . . . . 0.692 ' HB2' ' O ' ' A' ' 519' ' ' VAL . 49.8 tp60 -69.49 -51.98 30.8 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.398 179.297 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 38.7 t -71.53 -23.37 61.76 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.587 -176.03 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 525' ' ' ALA . . . . . . . . . . . . . . . -81.87 -17.81 46.03 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 120.972 -0.291 . . . . 0.0 111.266 178.49 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 526' ' ' GLY . . . . . . . . . . . . . . . 82.86 22.68 57.42 Favored Glycine 0 N--CA 1.453 -0.193 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.852 179.276 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 527' ' ' LEU . . . . . 0.409 HD13 ' HA ' ' A' ' 527' ' ' LEU . 4.2 mm? -98.01 4.74 49.3 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.873 0.368 . . . . 0.0 110.776 -179.709 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 528' ' ' THR . . . . . 0.419 ' OG1' ' HA ' ' A' ' 523' ' ' GLN . 15.5 m -59.99 -37.0 78.38 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.422 -177.109 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 529' ' ' GLU . . . . . 0.436 ' H ' ' HG2' ' A' ' 529' ' ' GLU . 7.1 pt-20 -64.79 -28.73 69.77 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.732 -178.068 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 530' ' ' THR . . . . . 0.535 ' HB ' HD22 ' A' ' 531' ' ' LEU . 26.4 m -64.29 -59.27 4.59 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.98 -179.415 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 531' ' ' LEU . . . . . 0.577 ' H ' HD22 ' A' ' 531' ' ' LEU . 1.7 mm? -76.57 5.83 6.8 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-O 120.869 0.366 . . . . 0.0 111.524 -179.189 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 532' ' ' ASN . . . . . . . . . . . . . 64.7 t30 -86.26 -27.14 24.61 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.37 0.605 . . . . 0.0 109.716 177.788 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 533' ' ' ARG . . . . . . . . . . . . . 12.7 mmm180 -92.13 160.34 15.24 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.672 178.845 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 534' ' ' GLU . . . . . 0.798 ' HA ' ' HB3' ' A' ' 622' ' ' ASN . 40.9 mt-10 -87.71 179.35 6.52 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 120.76 -0.376 . . . . 0.0 110.25 177.232 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 535' ' ' GLY . . . . . . . . . . . . . . . 134.86 -145.3 17.41 Favored Glycine 0 N--CA 1.445 -0.764 0 N-CA-C 110.675 -0.97 . . . . 0.0 110.675 -175.108 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 536' ' ' VAL . . . . . 0.407 ' HB ' HG13 ' A' ' 577' ' ' ILE . 34.5 m -123.07 130.37 74.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-O 121.07 0.462 . . . . 0.0 110.057 176.866 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 537' ' ' TYR . . . . . . . . . . . . . 71.2 m-85 -152.46 153.73 34.11 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.057 -178.611 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 538' ' ' THR . . . . . 0.764 ' OG1' ' HA ' ' A' ' 577' ' ' ILE . 50.4 m -132.1 103.71 6.41 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 174.673 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 539' ' ' VAL . . . . . . . . . . . . . 47.9 t -105.71 124.65 60.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.926 -173.228 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 540' ' ' PHE . . . . . 0.567 ' HB3' HD13 ' A' ' 628' ' ' ILE . 99.0 m-85 -95.85 111.08 23.15 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 173.328 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -97.82 112.97 62.98 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.712 -176.53 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 542' ' ' PRO . . . . . 0.471 ' HA ' HG13 ' A' ' 628' ' ' ILE . 7.9 Cg_exo -73.12 135.75 23.46 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 122.702 2.268 . . . . 0.0 110.708 174.302 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 40.4 p -76.96 179.31 6.28 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.529 -177.216 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 544' ' ' ASN . . . . . 0.546 ' HA ' ' HE3' ' A' ' 517' ' ' MET . 25.0 t-20 -62.41 -33.73 75.37 Favored 'General case' 0 CA--C 1.52 -0.185 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 178.991 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 545' ' ' GLU . . . . . 0.428 ' CD ' ' H ' ' A' ' 545' ' ' GLU . 1.6 mp0 -54.28 -45.09 72.41 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.19 -0.913 . . . . 0.0 110.759 178.152 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 546' ' ' ALA . . . . . 0.455 ' O ' HD23 ' A' ' 550' ' ' LEU . . . -67.06 -49.12 66.17 Favored 'General case' 0 CA--C 1.514 -0.431 0 CA-C-O 121.018 0.437 . . . . 0.0 111.283 -179.18 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 547' ' ' PHE . . . . . . . . . . . . . 29.9 m-85 -64.24 -25.61 68.14 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.705 -0.68 . . . . 0.0 111.315 -177.32 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 548' ' ' ARG . . . . . . . . . . . . . 23.8 ttm180 -86.7 -28.02 23.36 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.273 0.559 . . . . 0.0 110.179 178.526 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 549' ' ' ALA . . . . . . . . . . . . . . . -79.63 -10.51 59.8 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.242 -0.89 . . . . 0.0 112.103 -176.235 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 550' ' ' LEU . . . . . 0.511 ' HB2' ' HG3' ' A' ' 555' ' ' ARG . 0.1 OUTLIER -54.23 143.47 44.55 Favored Pre-proline 0 N--CA 1.454 -0.23 0 CA-C-O 120.759 0.314 . . . . 0.0 110.671 174.503 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 551' ' ' PRO . . . . . 0.637 ' HD2' ' HB2' ' A' ' 554' ' ' GLU . 2.6 Cg_endo -80.02 142.04 15.24 Favored 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 123.125 2.55 . . . . 0.0 110.547 -172.567 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 552' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_exo -43.47 -39.87 9.73 Favored 'Trans proline' 0 CA--C 1.533 0.458 0 C-N-CA 123.139 2.56 . . . . 0.0 113.348 -176.637 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 553' ' ' ARG . . . . . . . . . . . . . 44.7 mtp180 -68.3 -52.14 37.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.862 0.363 . . . . 0.0 111.721 177.934 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 554' ' ' GLU . . . . . 0.637 ' HB2' ' HD2' ' A' ' 551' ' ' PRO . 5.1 mm-40 -83.15 -42.72 17.0 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.911 -171.843 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 555' ' ' ARG . . . . . 0.511 ' HG3' ' HB2' ' A' ' 550' ' ' LEU . 26.1 ttt180 -46.87 -55.76 7.45 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 122.697 0.399 . . . . 0.0 111.429 173.918 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 14.8 m -62.45 -31.98 72.78 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.123 -178.159 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 557' ' ' ARG . . . . . . . . . . . . . 24.4 ttt180 -69.42 -59.24 3.12 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.587 176.703 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 558' ' ' LEU . . . . . 0.859 HD22 ' HB3' ' A' ' 564' ' ' GLU . 0.7 OUTLIER -60.2 -50.47 73.54 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.507 -175.406 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 559' ' ' LEU . . . . . . . . . . . . . 74.6 mt -87.95 19.53 3.53 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.632 -177.368 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 560' ' ' GLY . . . . . . . . . . . . . . . -125.4 4.11 8.21 Favored Glycine 0 N--CA 1.445 -0.706 0 CA-C-N 115.949 -0.568 . . . . 0.0 111.928 179.459 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 561' ' ' ASP . . . . . 0.495 ' OD2' ' HB3' ' A' ' 563' ' ' LYS . 18.0 t70 -142.59 142.24 32.11 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.653 0.264 . . . . 0.0 110.666 179.443 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 562' ' ' ALA . . . . . . . . . . . . . . . -76.51 -32.26 58.19 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.856 -177.657 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 563' ' ' LYS . . . . . 0.495 ' HB3' ' OD2' ' A' ' 561' ' ' ASP . 13.1 ttpt -69.0 -49.51 57.16 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.136 179.772 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 564' ' ' GLU . . . . . 0.859 ' HB3' HD22 ' A' ' 558' ' ' LEU . 59.7 mm-40 -52.07 -48.83 64.47 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.729 176.387 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 565' ' ' LEU . . . . . . . . . . . . . 39.5 mt -56.02 -55.2 35.71 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.416 177.992 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 566' ' ' ALA . . . . . . . . . . . . . . . -57.13 -48.06 79.6 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.55 -175.38 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 567' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -61.25 -45.62 93.78 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.637 -176.205 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 568' ' ' ILE . . . . . 0.714 HG13 HD21 ' A' ' 558' ' ' LEU . 47.7 mm -74.17 -34.9 39.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.828 -176.936 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 569' ' ' LEU . . . . . . . . . . . . . 66.4 mt -68.04 -33.31 74.33 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.962 -0.295 . . . . 0.0 111.01 179.632 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 570' ' ' LYS . . . . . 0.766 ' HE3' ' HA ' ' A' ' 593' ' ' GLN . 26.9 mtpp -62.97 -18.5 63.29 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.939 0.4 . . . . 0.0 111.012 175.61 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 571' ' ' TYR . . . . . 0.506 ' O ' HD21 ' A' ' 597' ' ' LEU . 25.9 t80 -91.75 -17.85 24.78 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.895 -177.136 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 572' ' ' HIS . . . . . . . . . . . . . 61.5 m80 -90.72 -14.72 31.59 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.866 0.365 . . . . 0.0 111.053 -179.287 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 573' ' ' ILE . . . . . . . . . . . . . 42.9 mt -103.83 116.4 47.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.318 178.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 574' ' ' GLY . . . . . 0.545 ' HA2' ' HA ' ' A' ' 591' ' ' SER . . . -97.95 153.86 20.14 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 121.013 -0.613 . . . . 0.0 111.723 176.043 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 575' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -90.96 -6.46 54.03 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.252 0.549 . . . . 0.0 111.062 -176.196 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 576' ' ' GLU . . . . . 0.449 ' HB2' HD21 ' A' ' 589' ' ' LEU . 24.9 mt-10 -129.11 122.75 30.54 Favored 'General case' 0 CA--C 1.508 -0.663 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 -170.245 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 577' ' ' ILE . . . . . 0.764 ' HA ' ' OG1' ' A' ' 538' ' ' THR . 61.5 mt -73.05 116.55 15.42 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.943 -175.233 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 578' ' ' LEU . . . . . 0.574 HD11 ' HA ' ' A' ' 583' ' ' ILE . 23.5 tp -127.03 113.41 16.43 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.442 179.057 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 579' ' ' VAL . . . . . 0.488 ' O ' HG13 ' A' ' 583' ' ' ILE . 35.8 m -104.96 163.1 4.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.177 178.086 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 580' ' ' SER . . . . . . . . . . . . . 32.8 t -56.48 -47.74 78.6 Favored 'General case' 0 C--N 1.331 -0.228 0 O-C-N 123.32 0.388 . . . . 0.0 110.887 -176.282 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 581' ' ' GLY . . . . . . . . . . . . . . . -74.73 8.27 15.76 Favored Glycine 0 CA--C 1.521 0.411 0 C-N-CA 120.941 -0.647 . . . . 0.0 113.327 -178.988 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . -131.77 9.87 5.48 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.511 -0.852 . . . . 0.0 113.109 179.245 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 583' ' ' ILE . . . . . 0.574 ' HA ' HD11 ' A' ' 578' ' ' LEU . 47.0 mt -78.02 -77.54 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.956 0.378 . . . . 0.0 110.877 178.779 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 584' ' ' GLY . . . . . . . . . . . . . . . 84.72 81.69 1.05 Allowed Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.495 -0.859 . . . . 0.0 112.069 -175.314 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 585' ' ' ALA . . . . . . . . . . . . . . . 71.73 -74.69 0.08 Allowed 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 123.578 0.751 . . . . 0.0 112.084 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 586' ' ' LEU . . . . . 0.61 ' HG ' ' HB2' ' A' ' 600' ' ' SER . 2.3 tt -164.71 142.2 6.37 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.571 0.225 . . . . 0.0 110.422 -176.755 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 587' ' ' VAL . . . . . 0.522 ' N ' HD23 ' A' ' 586' ' ' LEU . 91.2 t -140.14 139.75 36.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.23 -178.697 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 588' ' ' ARG . . . . . 0.406 ' HD3' ' HA ' ' A' ' 588' ' ' ARG . 34.0 mmt180 -85.57 105.51 16.21 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.927 0.394 . . . . 0.0 110.138 177.122 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 589' ' ' LEU . . . . . 0.449 HD21 ' HB2' ' A' ' 576' ' ' GLU . 0.3 OUTLIER -99.86 124.62 45.36 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.374 -177.189 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 590' ' ' LYS . . . . . . . . . . . . . 47.4 mtpt -90.48 140.1 30.06 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.466 0.65 . . . . 0.0 111.563 -177.628 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 591' ' ' SER . . . . . 0.545 ' HA ' ' HA2' ' A' ' 574' ' ' GLY . 78.0 p -102.15 166.47 10.58 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.367 -177.542 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 592' ' ' LEU . . . . . . . . . . . . . 9.9 mp -67.44 -7.21 23.56 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 112.527 0.566 . . . . 0.0 112.527 178.235 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 593' ' ' GLN . . . . . 0.766 ' HA ' ' HE3' ' A' ' 570' ' ' LYS . 23.2 tt0 -76.74 -29.2 56.05 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 171.708 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 594' ' ' GLY . . . . . . . . . . . . . . . 113.41 -20.36 18.61 Favored Glycine 0 N--CA 1.444 -0.791 0 CA-C-N 115.203 -0.908 . . . . 0.0 111.62 -177.15 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 595' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -84.08 -178.57 7.0 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 120.984 0.421 . . . . 0.0 109.867 -179.594 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 596' ' ' LYS . . . . . 0.788 ' H ' ' HD3' ' A' ' 596' ' ' LYS . 0.0 OUTLIER -118.72 136.96 53.66 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.796 -172.272 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 597' ' ' LEU . . . . . 0.506 HD21 ' O ' ' A' ' 571' ' ' TYR . 56.6 mt -90.51 142.55 27.63 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.648 179.609 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 598' ' ' GLU . . . . . 0.559 ' O ' ' HA ' ' A' ' 608' ' ' VAL . 13.7 tp10 -86.01 82.2 8.2 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 178.497 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 599' ' ' VAL . . . . . 0.439 HG11 HD23 ' A' ' 578' ' ' LEU . 25.8 t -104.58 121.88 56.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 121.128 0.489 . . . . 0.0 110.081 -176.879 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 600' ' ' SER . . . . . 0.61 ' HB2' ' HG ' ' A' ' 586' ' ' LEU . 37.4 t -141.23 168.39 19.89 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.499 0.666 . . . . 0.0 110.96 -172.626 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 601' ' ' LEU . . . . . 0.516 ' HB2' HD12 ' A' ' 583' ' ' ILE . 52.7 tp -140.45 108.27 5.67 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 114.535 -1.211 . . . . 0.0 108.955 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 602' ' ' LYS . . . . . . . . . . . . . 65.1 mttp -120.79 107.12 12.35 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.903 -177.239 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 603' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 63.42 42.86 6.41 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.613 177.503 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 604' ' ' ASN . . . . . . . . . . . . . 66.6 t30 72.95 14.65 4.75 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.608 178.067 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 605' ' ' VAL . . . . . . . . . . . . . 56.6 t -110.51 114.01 45.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.997 175.495 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 606' ' ' VAL . . . . . 0.738 HG13 ' HB ' ' A' ' 613' ' ' VAL . 6.6 p -84.97 140.16 16.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.2 0.524 . . . . 0.0 110.935 -179.01 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 607' ' ' SER . . . . . . . . . . . . . 7.4 p -142.19 154.58 44.94 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.835 -178.197 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 608' ' ' VAL . . . . . 0.559 ' HA ' ' O ' ' A' ' 598' ' ' GLU . 7.5 p -142.65 119.89 6.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.147 178.006 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 609' ' ' ASN . . . . . 0.832 ' HB2' HD22 ' A' ' 632' ' ' LEU . 4.0 m-20 59.88 50.04 7.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.131 173.715 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 610' ' ' LYS . . . . . 0.495 ' HE3' ' HB2' ' A' ' 610' ' ' LYS . 35.6 mtmt 77.15 -21.91 0.31 Allowed 'General case' 0 N--CA 1.476 0.826 0 O-C-N 123.66 0.6 . . . . 0.0 111.378 179.819 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 611' ' ' GLU . . . . . . . . . . . . . 48.6 mm-40 -90.96 140.91 26.19 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.732 -176.879 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 612' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -81.26 141.58 12.89 Favored 'Trans proline' 0 N--CA 1.458 -0.603 0 C-N-CA 122.134 1.889 . . . . 0.0 111.459 173.589 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 613' ' ' VAL . . . . . 0.738 ' HB ' HG13 ' A' ' 606' ' ' VAL . 99.5 t -74.34 120.59 23.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 176.76 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 614' ' ' ALA . . . . . 0.527 ' HB2' HG23 ' A' ' 629' ' ' THR . . . -76.5 -26.22 55.05 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.868 -172.815 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 615' ' ' GLU . . . . . 0.604 ' HB3' ' HB ' ' A' ' 627' ' ' VAL . 17.4 tt0 -165.49 89.25 0.94 Allowed Pre-proline 0 C--N 1.325 -0.49 0 CA-C-O 121.189 0.519 . . . . 0.0 109.832 -174.417 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 616' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -88.82 163.57 6.14 Favored 'Trans proline' 0 N--CA 1.456 -0.732 0 C-N-CA 123.059 2.506 . . . . 0.0 113.708 -175.669 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 26.6 t0 78.43 64.61 0.03 OUTLIER 'General case' 0 CA--C 1.51 -0.567 0 CA-C-O 123.024 1.392 . . . . 0.0 110.594 169.38 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 618' ' ' ILE . . . . . 0.498 ' HB ' ' O ' ' A' ' 625' ' ' VAL . 24.4 mt -115.86 102.21 13.38 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.278 0 CA-C-N 112.795 -2.002 . . . . 0.0 108.573 176.058 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 619' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.73 135.7 37.21 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.707 -0.679 . . . . 0.0 112.812 -169.313 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 620' ' ' ALA . . . . . . . . . . . . . . . -129.1 176.72 7.68 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.329 -0.851 . . . . 0.0 108.795 171.98 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 621' ' ' THR . . . . . . . . . . . . . 4.5 t -82.75 -21.71 34.6 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.603 -0.439 . . . . 0.0 110.874 -179.83 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 622' ' ' ASN . . . . . 0.798 ' HB3' ' HA ' ' A' ' 534' ' ' GLU . 27.4 p-10 -116.24 22.11 13.13 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.719 0.295 . . . . 0.0 111.441 -176.692 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 623' ' ' GLY . . . . . . . . . . . . . . . 147.47 -150.88 23.18 Favored Glycine 0 N--CA 1.443 -0.859 0 C-N-CA 120.332 -0.937 . . . . 0.0 112.626 177.229 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 624' ' ' VAL . . . . . . . . . . . . . 6.3 p -135.79 158.46 39.41 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 -179.164 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 625' ' ' VAL . . . . . 0.498 ' O ' ' HB ' ' A' ' 618' ' ' ILE . 46.8 t -123.93 136.87 58.87 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.675 178.764 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 626' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 -122.79 121.13 35.55 Favored 'General case' 0 N--CA 1.445 -0.681 0 N-CA-C 109.908 -0.405 . . . . 0.0 109.908 175.726 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 627' ' ' VAL . . . . . 0.604 ' HB ' ' HB3' ' A' ' 615' ' ' GLU . 60.8 t -70.21 130.67 34.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.56 179.025 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 628' ' ' ILE . . . . . 0.567 HD13 ' HB3' ' A' ' 540' ' ' PHE . 7.2 pt -127.34 150.19 33.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.819 176.199 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 629' ' ' THR . . . . . 0.527 HG23 ' HB2' ' A' ' 614' ' ' ALA . 16.6 p -94.91 2.83 55.45 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.91 -176.283 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 630' ' ' ASN . . . . . . . . . . . . . 66.1 m-20 -144.08 168.76 19.24 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.409 -177.39 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 631' ' ' VAL . . . . . . . . . . . . . 97.2 t -95.91 125.74 48.65 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 115.426 -0.807 . . . . 0.0 109.206 176.518 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 632' ' ' LEU . . . . . 0.832 HD22 ' HB2' ' A' ' 609' ' ' ASN . 89.6 mt -70.87 114.41 8.91 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-O 121.33 0.586 . . . . 0.0 110.893 -174.602 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 633' ' ' GLN . . . . . 0.512 ' HA ' ' HD3' ' A' ' 634' ' ' PRO . 85.7 mm-40 -102.47 131.17 22.74 Favored Pre-proline 0 C--N 1.317 -0.835 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.947 -177.095 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 634' ' ' PRO . . . . . 0.512 ' HD3' ' HA ' ' A' ' 633' ' ' GLN . 4.9 Cg_exo . . . . . 0 C--O 1.253 1.25 0 C-N-CA 123.051 2.501 . . . . 0.0 111.569 176.25 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.57 0 N-CA-C 111.311 -0.715 . . . . 0.0 111.311 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 504' ' ' THR . . . . . 0.48 ' O ' HG23 ' A' ' 508' ' ' VAL . 38.8 p -81.47 156.95 25.07 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 120.83 -0.348 . . . . 0.0 110.307 179.118 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 7.1 p -49.55 -39.2 13.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.892 -0.595 . . . . 0.0 112.359 -176.099 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 506' ' ' MET . . . . . 0.517 ' HG2' ' HB2' ' A' ' 531' ' ' LEU . 2.9 ppp? -83.82 -21.86 31.96 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.806 0.336 . . . . 0.0 111.524 -177.109 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 507' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -86.22 -28.89 23.58 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.042 0.448 . . . . 0.0 110.645 -178.238 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 508' ' ' VAL . . . . . 0.48 HG23 ' O ' ' A' ' 504' ' ' THR . 87.5 t -61.89 -27.58 42.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.297 175.394 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 509' ' ' LEU . . . . . . . . . . . . . 25.3 mt -65.05 -19.54 66.04 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.536 -179.099 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 510' ' ' LYS . . . . . 0.433 ' HE3' HG13 ' A' ' 519' ' ' VAL . 5.3 mptt -76.25 -24.15 54.53 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.022 0.439 . . . . 0.0 110.481 -179.068 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 511' ' ' GLY . . . . . . . . . . . . . . . -80.56 -10.11 85.63 Favored Glycine 0 N--CA 1.444 -0.773 0 C-N-CA 120.407 -0.902 . . . . 0.0 111.179 177.827 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 512' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -114.86 137.62 51.75 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.26 0.552 . . . . 0.0 111.714 -176.253 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 9.9 p30 -77.34 -19.76 55.85 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 115.526 -0.761 . . . . 0.0 112.459 -177.214 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 514' ' ' ARG . . . . . . . . . . . . . 5.3 tpp180 -89.04 -28.54 20.08 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 120.687 0.279 . . . . 0.0 110.988 -170.765 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 515' ' ' PHE . . . . . 0.607 ' CZ ' HG22 ' A' ' 627' ' ' VAL . 9.5 m-85 -92.83 8.62 38.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.682 178.941 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 13.0 p -55.37 -44.8 76.36 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.066 -0.515 . . . . 0.0 112.376 -176.145 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 517' ' ' MET . . . . . . . . . . . . . 2.8 mpp? -63.36 -31.29 72.4 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.502 0.191 . . . . 0.0 111.09 179.642 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 518' ' ' LEU . . . . . 0.409 HD22 ' HA ' ' A' ' 541' ' ' ALA . 44.2 tp -70.63 -36.38 73.41 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 120.502 -0.479 . . . . 0.0 110.207 -179.408 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 519' ' ' VAL . . . . . 0.433 HG13 ' HE3' ' A' ' 510' ' ' LYS . 59.1 t -58.94 -37.7 68.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.257 0.551 . . . . 0.0 109.559 174.834 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 520' ' ' ALA . . . . . . . . . . . . . . . -71.61 -40.98 69.46 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.644 -178.225 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 521' ' ' ALA . . . . . . . . . . . . . . . -63.96 -50.41 68.72 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.927 178.871 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 522' ' ' ILE . . . . . . . . . . . . . 72.9 mt -60.88 -40.43 85.25 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.894 179.115 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 523' ' ' GLN . . . . . . . . . . . . . 59.2 tt0 -61.78 -46.28 90.22 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.864 178.543 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 27.5 m -67.68 -47.52 69.22 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.495 -177.713 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 525' ' ' ALA . . . . . 0.413 ' HB1' ' HB2' ' A' ' 566' ' ' ALA . . . -70.77 -28.46 64.69 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.642 0.258 . . . . 0.0 111.504 -179.044 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 526' ' ' GLY . . . . . . . . . . . . . . . 85.54 41.49 7.31 Favored Glycine 0 C--O 1.227 -0.323 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.61 178.119 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 527' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -102.06 13.0 35.95 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.909 0.385 . . . . 0.0 110.863 -178.548 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 528' ' ' THR . . . . . . . . . . . . . 18.7 m -65.17 -33.99 77.31 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.117 -178.163 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 529' ' ' GLU . . . . . . . . . . . . . 28.9 mm-40 -55.44 -43.69 75.64 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.814 -176.681 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 530' ' ' THR . . . . . . . . . . . . . 22.1 m -66.27 -43.08 87.45 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.293 -176.124 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 531' ' ' LEU . . . . . 0.517 ' HB2' ' HG2' ' A' ' 506' ' ' MET . 68.8 mt -87.67 14.09 9.16 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.027 0.441 . . . . 0.0 111.314 -174.887 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 532' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -89.56 -29.5 18.86 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.756 178.499 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 533' ' ' ARG . . . . . 0.449 HH11 ' HD2' ' A' ' 533' ' ' ARG . 4.2 tpp180 -86.09 143.84 27.85 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.415 -0.812 . . . . 0.0 110.245 179.069 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 534' ' ' GLU . . . . . 0.673 ' HA ' ' CB ' ' A' ' 622' ' ' ASN . 42.8 tt0 -79.93 147.66 31.55 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.078 0.466 . . . . 0.0 110.515 176.994 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 535' ' ' GLY . . . . . . . . . . . . . . . 169.0 -136.33 4.01 Favored Glycine 0 N--CA 1.445 -0.75 0 N-CA-C 110.4 -1.08 . . . . 0.0 110.4 -177.51 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 536' ' ' VAL . . . . . 0.534 ' HB ' HG13 ' A' ' 577' ' ' ILE . 34.0 m -124.22 129.79 73.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 117.297 0.549 . . . . 0.0 110.411 177.518 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 537' ' ' TYR . . . . . . . . . . . . . 82.4 m-85 -154.19 146.55 23.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.934 -0.575 . . . . 0.0 109.926 -179.033 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 538' ' ' THR . . . . . 0.766 ' OG1' ' HA ' ' A' ' 577' ' ' ILE . 55.7 m -136.76 100.36 4.3 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 120.813 0.339 . . . . 0.0 110.117 175.235 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 539' ' ' VAL . . . . . 0.632 ' HA ' ' O ' ' A' ' 572' ' ' HIS . 1.3 p -115.17 132.09 65.48 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-O 121.392 0.615 . . . . 0.0 111.242 -177.998 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 540' ' ' PHE . . . . . . . . . . . . . 68.4 m-85 -89.1 117.16 27.9 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.003 -0.999 . . . . 0.0 109.693 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 541' ' ' ALA . . . . . 0.427 ' HA ' ' HD3' ' A' ' 542' ' ' PRO . . . -93.67 114.42 62.96 Favored Pre-proline 0 C--N 1.326 -0.435 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.575 -179.34 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 542' ' ' PRO . . . . . 0.595 ' HA ' HG13 ' A' ' 628' ' ' ILE . 7.9 Cg_exo -72.88 131.47 17.03 Favored 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 122.88 2.387 . . . . 0.0 111.516 177.944 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 75.2 p -71.87 175.48 5.77 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.574 179.364 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 544' ' ' ASN . . . . . . . . . . . . . 10.7 p30 -72.67 -21.21 61.11 Favored 'General case' 0 CA--C 1.519 -0.221 0 C-N-CA 120.094 -0.643 . . . . 0.0 109.449 179.05 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 545' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -62.18 -35.7 79.63 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.74 174.319 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 546' ' ' ALA . . . . . 0.558 ' HB1' HG23 ' A' ' 631' ' ' VAL . . . -70.13 -48.31 58.03 Favored 'General case' 0 CA--C 1.513 -0.474 0 CA-C-O 121.19 0.519 . . . . 0.0 110.772 178.838 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 547' ' ' PHE . . . . . . . . . . . . . 64.2 m-85 -68.14 -23.72 64.91 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.331 -177.575 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 548' ' ' ARG . . . . . 0.405 ' HD2' HH11 ' A' ' 548' ' ' ARG . 43.7 mtm180 -86.78 -21.9 26.23 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-O 120.706 0.289 . . . . 0.0 110.863 175.746 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 549' ' ' ALA . . . . . . . . . . . . . . . -85.66 -5.59 59.25 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.969 0.414 . . . . 0.0 110.682 177.936 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 550' ' ' LEU . . . . . 0.538 HD11 HG21 ' A' ' 631' ' ' VAL . 93.5 mt -75.74 134.27 72.43 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.264 176.172 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 551' ' ' PRO . . . . . 0.498 ' HD3' ' HA ' ' A' ' 550' ' ' LEU . 12.4 Cg_exo -69.99 148.02 62.68 Favored 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 122.7 2.267 . . . . 0.0 110.568 179.034 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 552' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_exo -50.83 -41.73 53.98 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.576 2.184 . . . . 0.0 112.072 -178.5 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 553' ' ' ARG . . . . . . . . . . . . . 22.8 tpt180 -57.25 -52.16 66.46 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.287 178.982 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -65.88 -55.29 17.73 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 111.824 0.305 . . . . 0.0 111.824 -176.328 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 555' ' ' ARG . . . . . 0.458 ' HG2' ' O ' ' A' ' 551' ' ' PRO . 30.8 ptt180 -63.96 -32.65 74.26 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 -175.699 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 32.1 m -74.94 -31.69 61.57 Favored 'General case' 0 N--CA 1.464 0.262 0 O-C-N 122.083 -0.385 . . . . 0.0 110.936 179.588 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 557' ' ' ARG . . . . . . . . . . . . . 73.7 ttt180 -69.65 -47.79 62.14 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.976 0.417 . . . . 0.0 109.964 176.756 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 558' ' ' LEU . . . . . 0.563 ' HG ' HD23 ' A' ' 565' ' ' LEU . 40.1 tp -60.56 -44.83 95.72 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.493 -178.131 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 559' ' ' LEU . . . . . 0.629 HD23 HD21 ' A' ' 565' ' ' LEU . 96.7 mt -81.98 4.55 22.29 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.065 0.459 . . . . 0.0 110.898 -179.452 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 560' ' ' GLY . . . . . . . . . . . . . . . -85.0 -22.61 52.14 Favored Glycine 0 N--CA 1.439 -1.114 0 C-N-CA 120.663 -0.78 . . . . 0.0 112.012 179.158 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 561' ' ' ASP . . . . . 0.695 ' HB3' ' HG2' ' A' ' 564' ' ' GLU . 11.9 t70 -139.38 142.7 37.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.939 0.399 . . . . 0.0 110.691 -178.037 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 562' ' ' ALA . . . . . . . . . . . . . . . -77.58 -29.04 51.86 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.821 -175.972 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 563' ' ' LYS . . . . . . . . . . . . . 27.2 ttpp -73.16 -39.03 65.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.815 0.341 . . . . 0.0 110.203 -178.231 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 564' ' ' GLU . . . . . 0.695 ' HG2' ' HB3' ' A' ' 561' ' ' ASP . 3.3 mm-40 -62.89 -42.5 99.8 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.436 178.728 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 565' ' ' LEU . . . . . 0.629 HD21 HD23 ' A' ' 559' ' ' LEU . 69.3 mt -55.81 -51.35 67.77 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.489 174.5 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 566' ' ' ALA . . . . . 0.413 ' HB2' ' HB1' ' A' ' 525' ' ' ALA . . . -58.07 -44.01 87.28 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.535 -178.923 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 567' ' ' ASN . . . . . . . . . . . . . 4.9 t30 -67.65 -32.86 73.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.189 -177.294 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 568' ' ' ILE . . . . . 0.522 HG12 ' O ' ' A' ' 564' ' ' GLU . 47.9 mm -72.94 -40.25 59.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 120.86 0.362 . . . . 0.0 110.386 176.73 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 569' ' ' LEU . . . . . 0.51 ' HG ' ' O ' ' A' ' 565' ' ' LEU . 96.0 mt -63.01 -42.92 99.96 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.301 179.673 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 570' ' ' LYS . . . . . 0.682 ' HE2' ' HA ' ' A' ' 593' ' ' GLN . 17.5 ptmt -70.86 -8.05 49.94 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.113 -178.957 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 571' ' ' TYR . . . . . . . . . . . . . 62.3 t80 -93.81 -18.76 21.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.962 0.41 . . . . 0.0 110.392 174.609 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 572' ' ' HIS . . . . . 0.632 ' O ' ' HA ' ' A' ' 539' ' ' VAL . 47.4 m80 -91.07 -20.18 22.34 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.748 179.643 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 573' ' ' ILE . . . . . 0.425 HG13 ' O ' ' A' ' 569' ' ' LEU . 27.2 mt -96.07 116.62 38.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.526 177.469 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 574' ' ' GLY . . . . . 0.592 ' HA2' ' HA ' ' A' ' 591' ' ' SER . . . -88.61 156.01 26.32 Favored Glycine 0 N--CA 1.449 -0.473 0 N-CA-C 111.78 -0.528 . . . . 0.0 111.78 176.297 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 575' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -82.75 -3.19 56.2 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 112.219 0.451 . . . . 0.0 112.219 -172.963 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 576' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -152.7 157.72 41.31 Favored 'General case' 0 N--CA 1.44 -0.967 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 -174.722 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 577' ' ' ILE . . . . . 0.766 ' HA ' ' OG1' ' A' ' 538' ' ' THR . 68.7 mt -92.56 117.59 36.27 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-N 115.76 -0.655 . . . . 0.0 112.055 -172.709 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 578' ' ' LEU . . . . . 0.579 HD23 HD13 ' A' ' 589' ' ' LEU . 3.4 mm? -123.99 102.3 7.69 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.389 175.544 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 579' ' ' VAL . . . . . 0.508 ' O ' HG13 ' A' ' 583' ' ' ILE . 30.9 m -97.28 172.11 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.07 179.36 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 580' ' ' SER . . . . . 0.532 ' HA ' HD11 ' A' ' 601' ' ' LEU . 27.6 m -54.72 -36.49 64.78 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.5 179.549 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 581' ' ' GLY . . . . . . . . . . . . . . . -80.81 -1.02 89.23 Favored Glycine 0 CA--C 1.521 0.425 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.982 -179.13 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . -114.4 -38.92 1.06 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.526 -0.845 . . . . 0.0 113.001 -177.554 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 583' ' ' ILE . . . . . 0.56 ' HB ' HD12 ' A' ' 601' ' ' LEU . 63.8 mt -60.03 -57.69 10.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 120.692 0.282 . . . . 0.0 111.555 -176.292 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 584' ' ' GLY . . . . . . . . . . . . . . . 78.9 -66.47 3.37 Favored Glycine 0 CA--C 1.52 0.356 0 C-N-CA 120.924 -0.655 . . . . 0.0 113.327 176.523 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 585' ' ' ALA . . . . . . . . . . . . . . . -130.02 -68.61 0.7 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.532 0.206 . . . . 0.0 111.549 -176.382 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 586' ' ' LEU . . . . . 0.579 HD13 ' HB3' ' A' ' 600' ' ' SER . 41.2 tp -153.57 128.62 9.64 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.773 0.32 . . . . 0.0 110.569 -179.85 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 587' ' ' VAL . . . . . . . . . . . . . 57.9 t -137.03 127.47 39.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.627 178.421 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 588' ' ' ARG . . . . . 0.442 ' HG2' ' HG2' ' A' ' 598' ' ' GLU . 72.8 mtt180 -85.54 109.02 18.22 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.485 0.659 . . . . 0.0 109.909 176.662 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 589' ' ' LEU . . . . . 0.579 HD13 HD23 ' A' ' 578' ' ' LEU . 34.7 tp -91.22 113.78 26.13 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 114.806 -1.088 . . . . 0.0 110.214 -175.53 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 590' ' ' LYS . . . . . . . . . . . . . 25.6 pttm -76.46 134.82 39.43 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.635 -0.505 . . . . 0.0 109.635 177.798 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 591' ' ' SER . . . . . 0.592 ' HA ' ' HA2' ' A' ' 574' ' ' GLY . 79.7 p -99.08 166.88 11.04 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.128 -177.442 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 592' ' ' LEU . . . . . . . . . . . . . 10.3 mp -63.86 -12.9 40.5 Favored 'General case' 0 C--N 1.333 -0.123 0 N-CA-C 112.211 0.449 . . . . 0.0 112.211 178.244 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 593' ' ' GLN . . . . . 0.682 ' HA ' ' HE2' ' A' ' 570' ' ' LYS . 24.7 tt0 -77.55 -29.32 52.2 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.391 0.615 . . . . 0.0 109.854 174.825 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 594' ' ' GLY . . . . . . . . . . . . . . . 111.48 -16.53 26.61 Favored Glycine 0 N--CA 1.447 -0.588 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.423 -174.585 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 595' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -79.0 178.6 7.9 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 179.813 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 596' ' ' LYS . . . . . . . . . . . . . 56.6 mttp -124.43 121.4 34.8 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.281 0.562 . . . . 0.0 111.983 -169.572 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 597' ' ' LEU . . . . . . . . . . . . . 67.5 mt -90.38 116.54 28.4 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.235 -0.893 . . . . 0.0 109.306 173.527 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 598' ' ' GLU . . . . . 0.442 ' HG2' ' HG2' ' A' ' 588' ' ' ARG . 46.9 mt-10 -89.13 92.75 9.32 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 121.456 0.646 . . . . 0.0 110.092 -177.942 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 599' ' ' VAL . . . . . . . . . . . . . 23.4 t -96.53 125.64 49.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.051 -0.977 . . . . 0.0 110.146 -176.793 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 600' ' ' SER . . . . . 0.579 ' HB3' HD13 ' A' ' 586' ' ' LEU . 18.2 p -125.78 156.87 38.79 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.445 -179.383 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 601' ' ' LEU . . . . . 0.56 HD12 ' HB ' ' A' ' 583' ' ' ILE . 0.3 OUTLIER -127.75 109.9 12.1 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.261 -179.626 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 602' ' ' LYS . . . . . 0.4 ' HE2' ' HB2' ' A' ' 602' ' ' LYS . 25.8 mtmm -128.87 123.0 31.58 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.25 -0.887 . . . . 0.0 109.806 -171.73 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 603' ' ' ASN . . . . . 0.448 ' O ' ' HB2' ' A' ' 604' ' ' ASN . 13.3 m120 64.38 25.93 13.49 Favored 'General case' 0 N--CA 1.466 0.34 0 O-C-N 123.571 0.544 . . . . 0.0 109.778 178.928 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 604' ' ' ASN . . . . . 0.448 ' HB2' ' O ' ' A' ' 603' ' ' ASN . 88.5 m-20 71.84 14.26 5.97 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.324 -175.633 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 605' ' ' VAL . . . . . . . . . . . . . 44.8 t -107.98 119.84 58.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.129 -0.487 . . . . 0.0 109.809 173.785 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 606' ' ' VAL . . . . . 0.806 HG13 ' HB ' ' A' ' 613' ' ' VAL . 5.2 p -86.67 139.8 16.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 121.026 0.441 . . . . 0.0 110.887 -178.6 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 607' ' ' SER . . . . . . . . . . . . . 2.9 m -140.71 135.19 31.33 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.474 -178.811 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 608' ' ' VAL . . . . . 0.413 HG13 HD21 ' A' ' 632' ' ' LEU . 3.7 p -111.48 119.95 60.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 177.64 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 609' ' ' ASN . . . . . 0.52 ' O ' ' HB2' ' A' ' 610' ' ' LYS . 5.3 m-20 59.22 37.18 23.9 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.485 177.897 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 610' ' ' LYS . . . . . 0.52 ' HB2' ' O ' ' A' ' 609' ' ' ASN . 34.4 mmtp 81.34 -15.44 0.72 Allowed 'General case' 0 N--CA 1.475 0.797 0 O-C-N 124.171 0.919 . . . . 0.0 112.326 -178.716 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 611' ' ' GLU . . . . . 0.425 ' HA ' ' HD3' ' A' ' 612' ' ' PRO . 18.1 mm-40 -84.8 138.55 37.63 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 120.8 0.333 . . . . 0.0 111.072 -178.988 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 612' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 611' ' ' GLU . 1.9 Cg_endo -82.02 134.02 8.03 Favored 'Trans proline' 0 N--CA 1.46 -0.468 0 C-N-CA 123.387 2.724 . . . . 0.0 113.274 -176.471 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 613' ' ' VAL . . . . . 0.806 ' HB ' HG13 ' A' ' 606' ' ' VAL . 50.3 t -81.57 130.89 35.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.053 175.773 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 614' ' ' ALA . . . . . . . . . . . . . . . -71.21 -42.72 68.58 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.173 -176.871 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 615' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -162.82 103.82 1.04 Allowed Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.27 0.557 . . . . 0.0 110.576 -178.656 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 616' ' ' PRO . . . . . 0.404 ' O ' ' HB2' ' A' ' 617' ' ' ASP . 65.0 Cg_endo -89.85 171.2 4.13 Favored 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 123.539 2.826 . . . . 0.0 113.411 -177.909 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 617' ' ' ASP . . . . . 0.404 ' HB2' ' O ' ' A' ' 616' ' ' PRO . 1.1 m-20 79.0 28.28 0.4 Allowed 'General case' 0 CA--C 1.508 -0.664 0 CA-C-N 115.123 -0.944 . . . . 0.0 111.373 164.721 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 618' ' ' ILE . . . . . 0.48 ' HB ' ' O ' ' A' ' 625' ' ' VAL . 18.5 mt -74.87 103.42 2.73 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 CA-C-N 114.591 -1.186 . . . . 0.0 109.085 171.505 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 619' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.77 132.96 38.32 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.841 -0.618 . . . . 0.0 112.391 -171.094 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 620' ' ' ALA . . . . . . . . . . . . . . . -127.92 173.61 9.87 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 170.408 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 621' ' ' THR . . . . . . . . . . . . . 4.7 t -75.56 -31.72 60.13 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 120.385 -0.526 . . . . 0.0 111.217 -174.374 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 622' ' ' ASN . . . . . 0.673 ' CB ' ' HA ' ' A' ' 534' ' ' GLU . 31.8 p-10 -117.39 21.76 12.87 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 111.946 0.35 . . . . 0.0 111.946 -176.325 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 623' ' ' GLY . . . . . . . . . . . . . . . 165.36 -167.71 39.03 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.159 -1.019 . . . . 0.0 112.87 178.526 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 624' ' ' VAL . . . . . 0.436 HG21 HG12 ' A' ' 579' ' ' VAL . 5.8 p -133.09 155.43 41.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 178.671 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 625' ' ' VAL . . . . . 0.48 ' O ' ' HB ' ' A' ' 618' ' ' ILE . 49.6 t -120.2 127.84 75.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.188 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 626' ' ' HIS . . . . . . . . . . . . . 46.9 m-70 -113.76 110.27 19.89 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.155 -0.475 . . . . 0.0 109.774 175.409 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 627' ' ' VAL . . . . . 0.607 HG22 ' CZ ' ' A' ' 515' ' ' PHE . 22.9 t -65.56 124.85 21.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.044 -179.741 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 628' ' ' ILE . . . . . 0.595 HG13 ' HA ' ' A' ' 542' ' ' PRO . 8.2 pt -116.86 143.77 26.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-O 121.353 0.596 . . . . 0.0 110.732 175.276 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 629' ' ' THR . . . . . . . . . . . . . 10.3 t -95.59 12.33 30.01 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-O 122.216 1.008 . . . . 0.0 109.318 -179.322 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 630' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 -139.19 176.66 8.51 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 114.381 -1.281 . . . . 0.0 109.359 -176.32 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 631' ' ' VAL . . . . . 0.558 HG23 ' HB1' ' A' ' 546' ' ' ALA . 61.6 t -116.64 144.26 24.78 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 172.366 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 632' ' ' LEU . . . . . 0.413 HD21 HG13 ' A' ' 608' ' ' VAL . 87.8 mt -96.58 118.26 32.69 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.018 0.437 . . . . 0.0 110.735 -177.889 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 633' ' ' GLN . . . . . . . . . . . . . 27.0 mp0 -96.64 116.79 66.27 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.089 -177.995 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 634' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo . . . . . 0 N--CA 1.452 -0.951 0 C-N-CA 122.902 2.401 . . . . 0.0 111.113 173.403 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.728 0 N-CA-C 110.987 -0.845 . . . . 0.0 110.987 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 504' ' ' THR . . . . . 0.491 ' HA ' HG22 ' A' ' 621' ' ' THR . 46.7 p -75.88 165.75 24.54 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 117.165 0.483 . . . . 0.0 110.118 178.495 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 505' ' ' VAL . . . . . 0.66 ' O ' ' HG ' ' A' ' 509' ' ' LEU . 14.7 p -60.0 -31.66 48.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 120.991 0.424 . . . . 0.0 110.307 179.809 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 506' ' ' MET . . . . . 0.487 ' O ' ' HG2' ' A' ' 510' ' ' LYS . 5.7 tpp -69.31 -43.17 74.31 Favored 'General case' 0 N--CA 1.437 -1.112 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.688 178.198 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 507' ' ' ASP . . . . . 0.566 ' HA ' ' CG ' ' A' ' 510' ' ' LYS . 31.5 t70 -67.29 -32.5 73.53 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.882 0.373 . . . . 0.0 110.557 -178.435 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 508' ' ' VAL . . . . . 0.479 HG23 ' O ' ' A' ' 504' ' ' THR . 90.0 t -62.27 -35.72 70.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.519 176.087 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 509' ' ' LEU . . . . . 0.66 ' HG ' ' O ' ' A' ' 505' ' ' VAL . 61.3 mt -74.44 -37.44 63.28 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.164 -178.602 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 510' ' ' LYS . . . . . 0.566 ' CG ' ' HA ' ' A' ' 507' ' ' ASP . 10.8 ptmm? -84.27 -13.13 53.38 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.284 -178.303 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 511' ' ' GLY . . . . . . . . . . . . . . . -85.7 -11.92 73.16 Favored Glycine 0 N--CA 1.441 -0.987 0 N-CA-C 111.169 -0.772 . . . . 0.0 111.169 173.719 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 512' ' ' ASP . . . . . 0.57 ' O ' ' HB2' ' A' ' 516' ' ' SER . 26.6 t70 -104.22 152.54 22.05 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.826 0.346 . . . . 0.0 111.122 179.825 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 42.4 m-80 -76.28 -33.32 59.1 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.864 -176.243 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 514' ' ' ARG . . . . . 0.415 ' HB3' ' HA ' ' A' ' 543' ' ' THR . 26.2 mmt180 -82.88 -49.95 9.13 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.908 0.385 . . . . 0.0 110.086 -176.039 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 515' ' ' PHE . . . . . 1.012 ' HZ ' HG22 ' A' ' 627' ' ' VAL . 4.2 m-30 -66.97 -17.83 65.1 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.505 -177.458 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 516' ' ' SER . . . . . 0.57 ' HB2' ' O ' ' A' ' 512' ' ' ASP . 16.3 t -57.54 -41.9 81.84 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.665 -176.476 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 517' ' ' MET . . . . . . . . . . . . . 3.4 ppp? -76.49 -24.96 53.8 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.881 0.372 . . . . 0.0 110.643 -178.426 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 518' ' ' LEU . . . . . 0.628 HD22 ' HD2' ' A' ' 542' ' ' PRO . 39.4 tp -66.8 -37.86 85.37 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 170.01 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 519' ' ' VAL . . . . . 0.468 ' O ' ' HG2' ' A' ' 523' ' ' GLN . 85.4 t -58.21 -34.46 49.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 174.498 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 520' ' ' ALA . . . . . . . . . . . . . . . -63.76 -38.26 90.43 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.937 0.399 . . . . 0.0 110.17 177.586 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 521' ' ' ALA . . . . . 0.419 ' HA ' HD23 ' A' ' 565' ' ' LEU . . . -66.61 -43.11 85.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.267 174.392 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 522' ' ' ILE . . . . . 0.567 HG23 ' HB2' ' A' ' 527' ' ' LEU . 76.6 mt -59.73 -39.49 79.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.269 177.381 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 523' ' ' GLN . . . . . 0.468 ' HG2' ' O ' ' A' ' 519' ' ' VAL . 16.1 mm100 -62.82 -33.93 76.25 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-O 121.087 0.47 . . . . 0.0 111.152 177.727 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 8.3 t -81.67 -36.2 29.05 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.321 -179.399 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 525' ' ' ALA . . . . . 0.406 ' HB1' ' HA ' ' A' ' 566' ' ' ALA . . . -78.18 -29.84 48.73 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.922 -178.859 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 526' ' ' GLY . . . . . . . . . . . . . . . 85.14 50.53 4.06 Favored Glycine 0 CA--C 1.52 0.355 0 C-N-CA 121.025 -0.607 . . . . 0.0 112.801 179.319 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 527' ' ' LEU . . . . . 0.567 ' HB2' HG23 ' A' ' 522' ' ' ILE . 4.0 mm? -113.12 5.91 17.31 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.875 0.369 . . . . 0.0 110.518 177.825 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 528' ' ' THR . . . . . . . . . . . . . 4.4 m -62.29 -48.1 81.37 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.528 -175.404 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 529' ' ' GLU . . . . . 0.539 ' O ' ' HG3' ' A' ' 533' ' ' ARG . 29.9 mp0 -57.95 -40.89 81.64 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.883 0.373 . . . . 0.0 110.581 178.553 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 530' ' ' THR . . . . . . . . . . . . . 40.4 m -62.14 -45.98 91.02 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.558 -177.316 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 531' ' ' LEU . . . . . 0.518 HD21 HD13 ' A' ' 573' ' ' ILE . 61.5 mt -82.59 -4.91 58.39 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -175.378 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 532' ' ' ASN . . . . . . . . . . . . . 67.1 t30 -89.09 -18.24 27.65 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.273 0.558 . . . . 0.0 110.043 178.971 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 533' ' ' ARG . . . . . 0.539 ' HG3' ' O ' ' A' ' 529' ' ' GLU . 32.9 mtp85 -83.08 136.69 34.39 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.205 -179.215 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 534' ' ' GLU . . . . . 0.574 ' HA ' ' HB3' ' A' ' 622' ' ' ASN . 11.5 pt-20 -71.56 156.13 39.76 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.868 178.257 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 535' ' ' GLY . . . . . . . . . . . . . . . 147.05 -136.59 6.21 Favored Glycine 0 N--CA 1.445 -0.759 0 N-CA-C 110.43 -1.068 . . . . 0.0 110.43 -176.064 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 536' ' ' VAL . . . . . 0.455 ' HB ' HG13 ' A' ' 577' ' ' ILE . 34.3 m -124.08 130.08 73.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-O 121.142 0.496 . . . . 0.0 110.813 179.005 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 537' ' ' TYR . . . . . . . . . . . . . 84.4 m-85 -152.87 146.98 25.47 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.385 178.734 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 538' ' ' THR . . . . . 0.685 ' OG1' ' HA ' ' A' ' 577' ' ' ILE . 67.2 m -132.98 102.6 5.68 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 175.413 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 539' ' ' VAL . . . . . 0.448 HG22 HG23 ' A' ' 573' ' ' ILE . 48.5 t -107.31 122.88 62.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.085 0.469 . . . . 0.0 111.44 -172.788 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 540' ' ' PHE . . . . . 0.479 ' HB3' HD13 ' A' ' 628' ' ' ILE . 84.8 m-85 -91.77 107.15 19.0 Favored 'General case' 0 N--CA 1.447 -0.613 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 172.759 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 541' ' ' ALA . . . . . 0.442 ' HA ' ' HD3' ' A' ' 542' ' ' PRO . . . -97.2 113.71 63.59 Favored Pre-proline 0 C--N 1.323 -0.577 0 CA-C-O 120.713 0.292 . . . . 0.0 110.924 -176.932 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 542' ' ' PRO . . . . . 0.628 ' HD2' HD22 ' A' ' 518' ' ' LEU . 7.9 Cg_exo -72.44 138.16 29.36 Favored 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 123.04 2.494 . . . . 0.0 111.427 177.886 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 543' ' ' THR . . . . . 0.415 ' HA ' ' HB3' ' A' ' 514' ' ' ARG . 60.8 p -74.22 -179.11 3.7 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.526 178.946 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 544' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -62.35 -33.64 75.1 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.172 0.511 . . . . 0.0 109.742 179.603 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 545' ' ' GLU . . . . . 0.414 ' HA ' ' HB3' ' A' ' 548' ' ' ARG . 14.1 mp0 -63.85 -27.44 69.17 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 114.798 -1.092 . . . . 0.0 111.499 -178.004 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 546' ' ' ALA . . . . . 0.605 ' HB1' HG22 ' A' ' 631' ' ' VAL . . . -64.24 -55.61 20.32 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.354 0.597 . . . . 0.0 110.514 179.142 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 547' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -70.63 -21.48 62.63 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.644 179.127 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 548' ' ' ARG . . . . . 0.414 ' HB3' ' HA ' ' A' ' 545' ' ' GLU . 75.2 ttt180 -74.81 -36.82 62.45 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.117 177.611 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 549' ' ' ALA . . . . . . . . . . . . . . . -62.03 -34.38 76.11 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.456 176.781 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 550' ' ' LEU . . . . . 0.51 ' HA ' ' HD3' ' A' ' 551' ' ' PRO . 81.2 mt -65.53 132.24 95.01 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.392 175.82 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 551' ' ' PRO . . . . . 0.51 ' HD3' ' HA ' ' A' ' 550' ' ' LEU . 21.3 Cg_exo -64.58 147.9 90.3 Favored 'Trans proline' 0 N--CA 1.463 -0.29 0 C-N-CA 122.98 2.453 . . . . 0.0 111.856 -173.723 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 552' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 551' ' ' PRO . 86.7 Cg_exo -48.89 -35.51 31.54 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 123.177 2.584 . . . . 0.0 113.351 -177.722 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 553' ' ' ARG . . . . . . . . . . . . . 56.2 ttp180 -73.57 -45.52 52.81 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.771 0.32 . . . . 0.0 110.842 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 554' ' ' GLU . . . . . 0.474 ' HB2' ' HD2' ' A' ' 551' ' ' PRO . 20.5 mm-40 -74.09 -41.66 61.34 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.454 -175.061 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 555' ' ' ARG . . . . . . . . . . . . . 5.5 ptp180 -61.75 -33.6 74.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.877 0.37 . . . . 0.0 110.024 177.451 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 7.9 t -71.5 -36.94 71.27 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.2 -0.455 . . . . 0.0 109.808 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 557' ' ' ARG . . . . . . . . . . . . . 79.8 mtt180 -61.22 -49.5 76.91 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.378 176.236 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 558' ' ' LEU . . . . . 0.506 HD21 HG13 ' A' ' 568' ' ' ILE . 2.1 tm? -57.95 -52.33 65.94 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.057 -0.974 . . . . 0.0 110.457 -178.54 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 559' ' ' LEU . . . . . 0.766 ' HA ' HD11 ' A' ' 565' ' ' LEU . 86.4 mt -76.78 -3.75 39.9 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.378 -175.352 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 560' ' ' GLY . . . . . . . . . . . . . . . -72.57 -22.54 78.93 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 121.168 -0.539 . . . . 0.0 112.534 -179.316 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 561' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -141.63 126.17 17.82 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 122.53 -0.394 . . . . 0.0 110.674 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 562' ' ' ALA . . . . . 0.434 ' HA ' HD13 ' A' ' 565' ' ' LEU . . . -59.46 -22.81 62.07 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.764 -0.653 . . . . 0.0 112.384 -176.969 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 563' ' ' LYS . . . . . . . . . . . . . 57.9 tttp -63.69 -40.3 96.47 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.358 0.599 . . . . 0.0 110.395 179.275 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 564' ' ' GLU . . . . . 0.458 ' HB3' HD22 ' A' ' 558' ' ' LEU . 7.7 mm-40 -68.55 -40.47 80.64 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.987 -178.011 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 565' ' ' LEU . . . . . 0.766 HD11 ' HA ' ' A' ' 559' ' ' LEU . 8.2 mp -57.19 -47.29 81.62 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.115 174.6 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 566' ' ' ALA . . . . . 0.64 ' O ' ' HB2' ' A' ' 570' ' ' LYS . . . -60.2 -40.18 89.17 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.245 -0.889 . . . . 0.0 111.666 -177.744 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 567' ' ' ASN . . . . . . . . . . . . . 66.2 t30 -75.53 -47.12 28.27 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 120.916 -0.314 . . . . 0.0 111.318 -176.013 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 568' ' ' ILE . . . . . 0.506 HG13 HD21 ' A' ' 558' ' ' LEU . 28.5 mm -65.29 -48.85 81.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 112.465 0.543 . . . . 0.0 112.465 -177.728 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 569' ' ' LEU . . . . . 0.401 HD12 ' C ' ' A' ' 569' ' ' LEU . 0.6 OUTLIER -71.33 -21.84 61.99 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.736 -0.385 . . . . 0.0 110.433 -175.879 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 570' ' ' LYS . . . . . 0.64 ' HB2' ' O ' ' A' ' 566' ' ' ALA . 78.3 tttt -67.56 -22.17 65.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.214 0.531 . . . . 0.0 110.434 178.846 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 571' ' ' TYR . . . . . 0.456 ' CE1' ' HB3' ' A' ' 595' ' ' ASP . 15.3 t80 -77.89 -18.05 56.62 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.711 177.268 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 572' ' ' HIS . . . . . . . . . . . . . 74.4 m80 -88.56 -12.44 42.74 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.658 -176.706 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 573' ' ' ILE . . . . . 0.518 HD13 HD21 ' A' ' 531' ' ' LEU . 47.7 mt -104.42 114.28 43.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.627 179.615 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 574' ' ' GLY . . . . . 0.68 ' HA2' ' HA ' ' A' ' 591' ' ' SER . . . -99.4 152.99 19.61 Favored Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 121.06 -0.59 . . . . 0.0 111.777 176.938 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 575' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -96.79 16.13 20.04 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.064 0.459 . . . . 0.0 111.31 -175.845 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 576' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -139.27 122.17 16.62 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.139 -177.409 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 577' ' ' ILE . . . . . 0.685 ' HA ' ' OG1' ' A' ' 538' ' ' THR . 63.3 mt -79.95 101.27 4.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.272 0.558 . . . . 0.0 110.681 -179.024 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 578' ' ' LEU . . . . . . . . . . . . . 96.7 mt -118.91 102.48 8.82 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.393 -0.821 . . . . 0.0 109.879 178.045 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 579' ' ' VAL . . . . . . . . . . . . . 27.1 m -90.82 178.43 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.361 178.877 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 580' ' ' SER . . . . . . . . . . . . . 13.0 m -53.57 -38.77 64.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.26 -179.039 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 581' ' ' GLY . . . . . . . . . . . . . . . -86.53 23.66 9.77 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 121.13 -0.557 . . . . 0.0 112.824 -178.553 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . -138.63 6.82 3.28 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.595 177.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 583' ' ' ILE . . . . . . . . . . . . . 37.4 mt -83.95 -47.75 17.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.968 0.414 . . . . 0.0 110.977 -178.516 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 584' ' ' GLY . . . . . . . . . . . . . . . 79.39 -69.18 3.03 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.929 -0.653 . . . . 0.0 112.07 -178.024 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 585' ' ' ALA . . . . . . . . . . . . . . . -143.18 -69.87 0.33 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.862 0.363 . . . . 0.0 110.321 179.53 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 586' ' ' LEU . . . . . 0.8 ' HG ' ' HB2' ' A' ' 600' ' ' SER . 3.9 tt -151.33 131.15 13.24 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 176.984 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 587' ' ' VAL . . . . . 0.413 ' N ' HD23 ' A' ' 586' ' ' LEU . 7.8 p -143.99 137.23 23.93 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.173 -175.137 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 588' ' ' ARG . . . . . . . . . . . . . 35.0 ptt180 -88.04 108.52 19.27 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.414 0.626 . . . . 0.0 110.561 178.278 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 589' ' ' LEU . . . . . . . . . . . . . 3.8 tt -91.04 114.47 27.0 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 -178.97 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 590' ' ' LYS . . . . . 0.606 ' HB2' ' NZ ' ' A' ' 590' ' ' LYS . 9.6 mtmp? -72.43 148.69 44.93 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 121.273 0.559 . . . . 0.0 111.411 -174.062 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 591' ' ' SER . . . . . 0.68 ' HA ' ' HA2' ' A' ' 574' ' ' GLY . 68.7 p -112.09 158.63 19.37 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.823 -179.104 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 592' ' ' LEU . . . . . 0.493 ' O ' ' HE2' ' A' ' 570' ' ' LYS . 10.0 mp -62.26 -19.82 63.62 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.933 178.355 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 593' ' ' GLN . . . . . . . . . . . . . 48.8 tt0 -69.5 -29.69 67.38 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.806 -0.358 . . . . 0.0 110.537 176.477 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 594' ' ' GLY . . . . . . . . . . . . . . . 115.97 -4.85 20.46 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.674 -0.775 . . . . 0.0 112.745 -178.324 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 595' ' ' ASP . . . . . 0.456 ' HB3' ' CE1' ' A' ' 571' ' ' TYR . 11.2 t70 -101.29 -168.94 1.62 Allowed 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 175.768 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 596' ' ' LYS . . . . . 0.549 ' N ' ' HD3' ' A' ' 596' ' ' LYS . 0.0 OUTLIER -135.05 131.83 37.48 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.007 0.432 . . . . 0.0 111.3 -172.881 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 597' ' ' LEU . . . . . 0.677 ' HB3' HG23 ' A' ' 608' ' ' VAL . 2.7 mm? -82.32 115.89 21.58 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 169.998 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 598' ' ' GLU . . . . . . . . . . . . . 57.8 mt-10 -84.42 92.43 8.05 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-O 121.626 0.727 . . . . 0.0 109.775 179.039 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 599' ' ' VAL . . . . . 0.46 ' HA ' ' O ' ' A' ' 607' ' ' SER . 61.1 t -93.64 132.41 37.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 114.619 -1.173 . . . . 0.0 110.118 -176.893 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 600' ' ' SER . . . . . 0.8 ' HB2' ' HG ' ' A' ' 586' ' ' LEU . 29.6 t -131.95 165.43 23.95 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-O 121.215 0.531 . . . . 0.0 110.286 179.69 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 601' ' ' LEU . . . . . . . . . . . . . 33.3 tp -136.89 108.07 6.79 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 114.929 -1.032 . . . . 0.0 109.609 -177.055 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 602' ' ' LYS . . . . . . . . . . . . . 11.3 ptmm? -134.77 118.19 16.78 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.899 -178.31 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 603' ' ' ASN . . . . . . . . . . . . . 66.9 t30 63.0 28.87 16.39 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 121.542 0.686 . . . . 0.0 109.539 -174.492 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 604' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 69.16 5.98 5.4 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 115.053 -0.976 . . . . 0.0 111.903 -177.368 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 605' ' ' VAL . . . . . . . . . . . . . 46.3 t -86.86 108.13 17.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 109.419 -0.585 . . . . 0.0 109.419 175.278 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 606' ' ' VAL . . . . . 0.726 HG13 ' HB ' ' A' ' 613' ' ' VAL . 6.1 p -84.33 134.41 27.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.934 -178.21 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 607' ' ' SER . . . . . 0.46 ' O ' ' HA ' ' A' ' 599' ' ' VAL . 3.3 p -139.03 142.58 38.25 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.72 -178.709 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 608' ' ' VAL . . . . . 0.677 HG23 ' HB3' ' A' ' 597' ' ' LEU . 3.0 p -122.07 112.78 36.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 116.238 -0.437 . . . . 0.0 109.962 179.159 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 609' ' ' ASN . . . . . 0.43 ' O ' ' HB3' ' A' ' 610' ' ' LYS . 87.7 m-20 56.57 44.76 23.48 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.763 -178.82 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 610' ' ' LYS . . . . . 0.43 ' HB3' ' O ' ' A' ' 609' ' ' ASN . 48.8 tttp 81.19 -26.19 0.15 Allowed 'General case' 0 N--CA 1.472 0.642 0 O-C-N 124.097 0.873 . . . . 0.0 111.701 179.096 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 611' ' ' GLU . . . . . 0.492 ' HA ' ' HD3' ' A' ' 612' ' ' PRO . 5.6 mm-40 -78.6 135.09 60.67 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 120.647 0.26 . . . . 0.0 110.393 -177.22 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 612' ' ' PRO . . . . . 0.492 ' HD3' ' HA ' ' A' ' 611' ' ' GLU . 4.9 Cg_exo -79.38 138.86 14.22 Favored 'Trans proline' 0 N--CA 1.462 -0.381 0 C-N-CA 123.038 2.492 . . . . 0.0 112.988 -176.99 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 613' ' ' VAL . . . . . 0.726 ' HB ' HG13 ' A' ' 606' ' ' VAL . 94.7 t -84.34 124.39 39.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.581 175.177 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 614' ' ' ALA . . . . . 0.547 ' HB2' HG23 ' A' ' 629' ' ' THR . . . -76.14 -31.41 58.58 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.573 -174.816 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 615' ' ' GLU . . . . . 0.402 ' HB3' ' CG2' ' A' ' 627' ' ' VAL . 28.1 tt0 -162.61 93.85 1.22 Allowed Pre-proline 0 C--N 1.325 -0.485 0 CA-C-O 121.184 0.516 . . . . 0.0 110.275 -176.915 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 616' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -89.32 165.24 5.5 Favored 'Trans proline' 0 N--CA 1.456 -0.708 0 C-N-CA 123.113 2.542 . . . . 0.0 113.422 -178.206 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 26.4 t0 77.36 40.63 0.16 Allowed 'General case' 0 CA--C 1.516 -0.345 0 CA-C-O 122.708 1.242 . . . . 0.0 110.092 165.767 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 618' ' ' ILE . . . . . 0.428 ' HB ' ' O ' ' A' ' 625' ' ' VAL . 17.8 mt -89.04 109.29 20.04 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.999 0 CA-C-N 113.776 -1.556 . . . . 0.0 109.266 173.226 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 619' ' ' MET . . . . . . . . . . . . . 6.8 mmt -73.41 133.12 43.66 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.686 -0.688 . . . . 0.0 112.355 -173.086 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 620' ' ' ALA . . . . . . . . . . . . . . . -131.06 166.33 21.27 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 108.96 -0.755 . . . . 0.0 108.96 172.051 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 621' ' ' THR . . . . . 0.491 HG22 ' HA ' ' A' ' 504' ' ' THR . 1.2 t -72.82 -33.45 66.21 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.455 -0.498 . . . . 0.0 111.361 -174.167 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 622' ' ' ASN . . . . . 0.574 ' HB3' ' HA ' ' A' ' 534' ' ' GLU . 28.5 p-10 -117.83 24.02 11.31 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.656 0.265 . . . . 0.0 111.556 -176.016 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 623' ' ' GLY . . . . . 0.42 ' HA2' ' CD1' ' A' ' 577' ' ' ILE . . . 162.55 -160.13 32.42 Favored Glycine 0 N--CA 1.442 -0.922 0 C-N-CA 120.187 -1.006 . . . . 0.0 112.816 178.386 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 624' ' ' VAL . . . . . . . . . . . . . 8.5 p -134.83 157.29 40.9 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 179.448 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 625' ' ' VAL . . . . . 0.428 ' O ' ' HB ' ' A' ' 618' ' ' ILE . 59.4 t -122.77 134.13 66.87 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.163 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 626' ' ' HIS . . . . . . . . . . . . . 95.7 m-70 -121.47 112.95 19.16 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 175.033 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 627' ' ' VAL . . . . . 1.012 HG22 ' HZ ' ' A' ' 515' ' ' PHE . 37.1 t -68.22 128.89 32.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.844 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 628' ' ' ILE . . . . . 0.574 HG13 ' HA ' ' A' ' 542' ' ' PRO . 6.4 pt -126.71 147.35 31.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 121.22 0.533 . . . . 0.0 111.043 175.982 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 629' ' ' THR . . . . . 0.547 HG23 ' HB2' ' A' ' 614' ' ' ALA . 30.1 p -96.43 -1.47 47.42 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.401 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 630' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -126.17 158.95 34.27 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.64 -174.273 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 631' ' ' VAL . . . . . 0.605 HG22 ' HB1' ' A' ' 546' ' ' ALA . 2.3 t -96.06 122.42 47.54 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.7 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 177.116 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 632' ' ' LEU . . . . . 0.457 HD21 HG13 ' A' ' 608' ' ' VAL . 96.2 mt -71.83 110.67 6.51 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.485 0.66 . . . . 0.0 110.401 -177.362 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 633' ' ' GLN . . . . . . . . . . . . . 58.1 tp60 -120.92 120.76 29.2 Favored Pre-proline 0 C--N 1.318 -0.802 0 CA-C-N 114.907 -1.042 . . . . 0.0 109.649 -175.655 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 634' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_exo . . . . . 0 C--O 1.249 1.07 0 C-N-CA 122.752 2.301 . . . . 0.0 111.754 -179.867 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.714 0 N-CA-C 111.252 -0.739 . . . . 0.0 111.252 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 39.1 p -71.9 175.63 5.66 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 177.858 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 505' ' ' VAL . . . . . 0.648 ' O ' ' HG ' ' A' ' 509' ' ' LEU . 8.5 t -54.63 -38.71 43.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 121.146 0.498 . . . . 0.0 110.261 178.07 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 506' ' ' MET . . . . . . . . . . . . . 16.5 mmt -63.55 -35.1 79.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.787 -178.628 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 507' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -62.91 -28.84 70.33 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.267 0.556 . . . . 0.0 110.27 -178.091 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 508' ' ' VAL . . . . . . . . . . . . . 47.3 t -87.41 -43.11 15.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.797 179.147 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 509' ' ' LEU . . . . . 0.648 ' HG ' ' O ' ' A' ' 505' ' ' VAL . 69.7 mt -64.73 -24.22 67.5 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 121.097 0.475 . . . . 0.0 111.907 -176.01 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -85.71 -21.57 28.24 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.402 -176.689 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 511' ' ' GLY . . . . . . . . . . . . . . . -81.27 -9.54 85.86 Favored Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 120.665 -0.778 . . . . 0.0 111.53 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 512' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -109.84 148.18 31.99 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.16 0.505 . . . . 0.0 111.607 -178.406 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -76.51 -21.4 55.81 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.757 -0.656 . . . . 0.0 112.521 -176.488 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 514' ' ' ARG . . . . . 0.692 ' HB3' ' HA ' ' A' ' 543' ' ' THR . 9.8 mmt180 -89.97 -51.38 5.51 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.495 0.664 . . . . 0.0 109.496 -177.716 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 515' ' ' PHE . . . . . 0.967 ' HZ ' HG22 ' A' ' 627' ' ' VAL . 9.1 m-30 -62.31 -29.38 70.4 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 114.664 -1.153 . . . . 0.0 111.25 -175.583 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 2.7 p -62.82 -25.7 68.39 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 -175.055 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 517' ' ' MET . . . . . . . . . . . . . 48.4 ttp -80.91 -37.78 29.07 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 175.881 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 518' ' ' LEU . . . . . 0.462 HD22 ' HD2' ' A' ' 542' ' ' PRO . 66.5 tp -57.81 -39.11 76.81 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.234 171.39 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 519' ' ' VAL . . . . . 0.505 HG23 ' O ' ' A' ' 515' ' ' PHE . 86.6 t -53.76 -37.52 32.62 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 CA-C-O 121.058 0.456 . . . . 0.0 110.582 175.111 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 520' ' ' ALA . . . . . . . . . . . . . . . -71.64 -35.24 70.32 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.441 -178.132 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 521' ' ' ALA . . . . . . . . . . . . . . . -68.59 -48.14 64.93 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.491 176.439 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 522' ' ' ILE . . . . . 0.432 HG23 ' HB2' ' A' ' 527' ' ' LEU . 69.2 mt -59.55 -37.01 68.13 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.886 177.402 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 523' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -61.98 -52.93 62.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.015 177.837 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 40.8 m -62.0 -34.25 75.83 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.735 -178.386 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 525' ' ' ALA . . . . . . . . . . . . . . . -77.69 -12.01 59.93 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.479 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 526' ' ' GLY . . . . . . . . . . . . . . . 72.73 34.6 59.41 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 121.061 -0.59 . . . . 0.0 112.958 178.093 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 527' ' ' LEU . . . . . 0.432 ' HB2' HG23 ' A' ' 522' ' ' ILE . 95.2 mt -109.13 10.31 26.0 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.901 0.381 . . . . 0.0 110.49 -179.834 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 528' ' ' THR . . . . . . . . . . . . . 8.1 m -57.08 -43.18 81.92 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 -173.003 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 529' ' ' GLU . . . . . 0.499 ' O ' ' HG2' ' A' ' 533' ' ' ARG . 11.5 pt-20 -70.34 -17.01 63.05 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 111.826 0.306 . . . . 0.0 111.826 -174.091 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 530' ' ' THR . . . . . . . . . . . . . 78.0 m -62.77 -49.17 76.05 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.83 0.348 . . . . 0.0 110.613 178.531 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 531' ' ' LEU . . . . . 0.592 ' H ' HD22 ' A' ' 531' ' ' LEU . 1.9 mm? -75.49 -14.51 60.43 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.19 178.25 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 532' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -78.47 -32.94 48.57 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.603 179.559 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 533' ' ' ARG . . . . . 0.499 ' HG2' ' O ' ' A' ' 529' ' ' GLU . 30.7 mmm180 -66.91 123.18 19.45 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.334 178.128 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 534' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -71.69 94.79 1.39 Allowed 'General case' 0 N--CA 1.443 -0.82 0 CA-C-O 122.627 1.203 . . . . 0.0 110.697 176.129 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 535' ' ' GLY . . . . . . . . . . . . . . . -161.85 175.06 38.41 Favored Glycine 0 N--CA 1.441 -1.001 0 N-CA-C 108.092 -2.003 . . . . 0.0 108.092 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 536' ' ' VAL . . . . . 0.647 ' HB ' HG13 ' A' ' 577' ' ' ILE . 33.9 m -87.32 131.42 35.2 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 118.405 1.103 . . . . 0.0 111.87 -167.489 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 537' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -150.48 144.31 25.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.051 -0.977 . . . . 0.0 109.964 179.406 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 538' ' ' THR . . . . . . . . . . . . . 22.6 m -108.32 102.91 11.99 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 173.716 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 539' ' ' VAL . . . . . 0.55 HG21 HG11 ' A' ' 505' ' ' VAL . 47.2 t -100.88 123.24 53.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 120.864 0.364 . . . . 0.0 111.641 -173.231 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 540' ' ' PHE . . . . . 0.549 ' HB3' HD13 ' A' ' 628' ' ' ILE . 97.6 m-85 -102.34 110.0 21.83 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 173.835 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -103.21 112.61 65.85 Favored Pre-proline 0 C--N 1.324 -0.537 0 CA-C-O 120.748 0.308 . . . . 0.0 110.863 -175.944 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 542' ' ' PRO . . . . . 0.542 ' HA ' HG13 ' A' ' 628' ' ' ILE . 11.8 Cg_exo -71.5 142.26 40.13 Favored 'Trans proline' 0 N--CA 1.461 -0.4 0 C-N-CA 123.028 2.485 . . . . 0.0 112.146 178.554 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 543' ' ' THR . . . . . 0.692 ' HA ' ' HB3' ' A' ' 514' ' ' ARG . 44.9 p -78.13 175.42 10.16 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.736 178.241 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 544' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -73.72 -24.17 59.87 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.821 -0.352 . . . . 0.0 110.478 -176.56 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 545' ' ' GLU . . . . . 0.436 ' OE2' ' HB ' ' A' ' 543' ' ' THR . 1.9 mp0 -64.35 -33.17 75.22 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 110.043 -0.355 . . . . 0.0 110.043 177.492 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 546' ' ' ALA . . . . . 0.673 ' HB1' HG23 ' A' ' 631' ' ' VAL . . . -59.76 -49.62 77.02 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.592 177.848 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 547' ' ' PHE . . . . . 0.402 ' HA ' ' HG ' ' A' ' 550' ' ' LEU . 88.9 m-85 -68.98 -21.81 64.13 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.79 -179.634 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 548' ' ' ARG . . . . . . . . . . . . . 30.5 ttm180 -79.12 -28.17 42.92 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.868 179.683 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 549' ' ' ALA . . . . . . . . . . . . . . . -96.41 1.07 51.37 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.452 -176.379 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 550' ' ' LEU . . . . . 0.439 ' HG ' ' O ' ' A' ' 546' ' ' ALA . 75.0 mt -67.35 137.72 93.88 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.564 179.71 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 551' ' ' PRO . . . . . 0.533 ' HD2' ' HB2' ' A' ' 554' ' ' GLU . 16.0 Cg_exo -68.1 155.81 68.13 Favored 'Trans proline' 0 C--O 1.235 0.368 0 C-N-CA 123.036 2.491 . . . . 0.0 111.437 179.593 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 552' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -43.93 -55.29 3.17 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 123.861 3.041 . . . . 0.0 113.598 -176.918 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 553' ' ' ARG . . . . . . . . . . . . . 8.6 ptm180 -63.5 -38.76 92.35 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 -177.91 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 554' ' ' GLU . . . . . 0.533 ' HB2' ' HD2' ' A' ' 551' ' ' PRO . 4.5 mm-40 -73.22 -49.48 27.67 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.827 0.346 . . . . 0.0 111.04 -174.301 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 555' ' ' ARG . . . . . 0.438 ' HB3' ' HB2' ' A' ' 550' ' ' LEU . 20.6 ptt180 -66.53 -28.39 68.51 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.11 -179.285 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 47.6 t -73.37 -29.99 63.0 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.712 0.291 . . . . 0.0 110.757 179.522 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 557' ' ' ARG . . . . . . . . . . . . . 22.2 mtp180 -83.04 -53.63 5.67 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.023 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 558' ' ' LEU . . . . . 0.587 ' O ' ' HG ' ' A' ' 565' ' ' LEU . 47.2 tp -63.91 -40.43 96.49 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.655 0.264 . . . . 0.0 111.564 -174.297 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 559' ' ' LEU . . . . . . . . . . . . . 63.7 mt -94.11 13.23 23.77 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.052 0.453 . . . . 0.0 110.98 -178.144 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 560' ' ' GLY . . . . . . . . . . . . . . . -126.12 -48.66 0.19 Allowed Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.609 -0.805 . . . . 0.0 112.469 -178.584 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 561' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -86.24 116.15 24.24 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.97 0.414 . . . . 0.0 110.548 -176.44 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 562' ' ' ALA . . . . . . . . . . . . . . . -68.71 -21.9 64.37 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.537 -176.386 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 563' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -81.33 -45.74 15.73 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 -178.761 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 564' ' ' GLU . . . . . 0.445 ' O ' HG12 ' A' ' 568' ' ' ILE . 29.2 mt-10 -69.69 -25.18 63.76 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.481 177.8 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 565' ' ' LEU . . . . . 0.587 ' HG ' ' O ' ' A' ' 558' ' ' LEU . 4.0 mt -58.77 -55.85 29.72 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.957 0.408 . . . . 0.0 109.946 170.797 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 566' ' ' ALA . . . . . 0.567 ' O ' ' HG3' ' A' ' 570' ' ' LYS . . . -62.51 -26.97 68.82 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.843 178.444 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 567' ' ' ASN . . . . . . . . . . . . . 36.5 t-20 -73.18 -55.24 6.73 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.985 179.362 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 568' ' ' ILE . . . . . 0.445 HG12 ' O ' ' A' ' 564' ' ' GLU . 50.8 mm -68.81 -34.65 65.7 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 CA-C-O 120.701 0.286 . . . . 0.0 111.738 -175.113 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 569' ' ' LEU . . . . . 0.444 ' HG ' ' O ' ' A' ' 565' ' ' LEU . 87.1 mt -63.12 -25.63 68.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.799 0.333 . . . . 0.0 111.227 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 570' ' ' LYS . . . . . 0.567 ' HG3' ' O ' ' A' ' 566' ' ' ALA . 62.5 mttp -69.5 -13.93 62.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.893 0.378 . . . . 0.0 111.099 178.018 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 571' ' ' TYR . . . . . . . . . . . . . 15.6 t80 -94.72 -7.86 39.38 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.149 0.5 . . . . 0.0 110.506 -177.21 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 572' ' ' HIS . . . . . . . . . . . . . 75.8 m80 -101.03 -9.21 21.64 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.71 -179.227 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 573' ' ' ILE . . . . . 0.408 ' O ' HD23 ' A' ' 592' ' ' LEU . 29.3 mt -111.9 123.13 67.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.418 178.233 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 574' ' ' GLY . . . . . 0.495 ' HA2' ' HA ' ' A' ' 591' ' ' SER . . . -98.87 167.39 21.85 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.21 176.388 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 575' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -92.24 -4.8 53.56 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 113.112 0.782 . . . . 0.0 113.112 -168.949 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 576' ' ' GLU . . . . . 0.735 ' HB2' HD21 ' A' ' 589' ' ' LEU . 70.0 mm-40 -128.77 -167.08 1.72 Allowed 'General case' 0 CA--C 1.504 -0.812 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 179.783 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 577' ' ' ILE . . . . . 0.647 HG13 ' HB ' ' A' ' 536' ' ' VAL . 82.0 mt -112.42 105.32 18.56 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 N-CA-C 110.051 -0.352 . . . . 0.0 110.051 167.773 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 578' ' ' LEU . . . . . 0.657 HD21 HG11 ' A' ' 587' ' ' VAL . 0.3 OUTLIER -100.86 115.27 29.97 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 178.644 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 579' ' ' VAL . . . . . . . . . . . . . 30.6 m -113.69 163.73 10.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.496 179.384 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 580' ' ' SER . . . . . . . . . . . . . 49.6 p -62.33 -33.8 75.39 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-O 120.868 0.366 . . . . 0.0 111.03 -178.67 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 581' ' ' GLY . . . . . . . . . . . . . . . -77.32 22.9 2.41 Favored Glycine 0 CA--C 1.519 0.287 0 C-N-CA 121.207 -0.52 . . . . 0.0 112.543 179.529 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . -140.58 23.64 2.66 Favored Glycine 0 N--CA 1.445 -0.757 0 N-CA-C 111.543 -0.623 . . . . 0.0 111.543 176.992 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 583' ' ' ILE . . . . . . . . . . . . . 2.5 mt -122.3 98.94 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 CA-C-O 121.152 0.501 . . . . 0.0 110.38 179.779 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 584' ' ' GLY . . . . . . . . . . . . . . . -82.15 -20.59 62.48 Favored Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 120.63 -0.795 . . . . 0.0 111.781 176.783 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 585' ' ' ALA . . . . . . . . . . . . . . . -163.19 -79.77 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.921 0.391 . . . . 0.0 110.328 178.028 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 586' ' ' LEU . . . . . 0.789 HD11 ' HB3' ' A' ' 598' ' ' GLU . 53.4 tp -135.92 132.6 36.68 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.173 179.681 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 587' ' ' VAL . . . . . 0.657 HG11 HD21 ' A' ' 578' ' ' LEU . 42.8 t -127.21 116.52 44.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.185 177.343 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 588' ' ' ARG . . . . . 0.871 ' HG2' ' HG2' ' A' ' 598' ' ' GLU . 96.7 mtt180 -85.43 103.59 14.46 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.142 0.496 . . . . 0.0 109.966 176.992 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 589' ' ' LEU . . . . . 0.735 HD21 ' HB2' ' A' ' 576' ' ' GLU . 0.7 OUTLIER -101.18 125.15 47.78 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.312 -0.858 . . . . 0.0 108.772 -177.309 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 590' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -65.05 149.97 48.92 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.088 0.47 . . . . 0.0 111.552 -177.751 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 591' ' ' SER . . . . . 0.495 ' HA ' ' HA2' ' A' ' 574' ' ' GLY . 54.4 p -111.17 158.3 19.07 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.493 174.414 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 592' ' ' LEU . . . . . 0.408 HD23 ' O ' ' A' ' 573' ' ' ILE . 3.3 mm? -60.74 -18.23 53.37 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 112.068 0.395 . . . . 0.0 112.068 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 593' ' ' GLN . . . . . 0.461 ' N ' ' HB3' ' A' ' 570' ' ' LYS . 26.7 tt0 -71.51 -29.04 64.34 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.027 0.441 . . . . 0.0 110.352 176.649 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 594' ' ' GLY . . . . . . . . . . . . . . . 109.3 -6.72 32.18 Favored Glycine 0 N--CA 1.443 -0.891 0 C-N-CA 120.72 -0.753 . . . . 0.0 111.683 -173.889 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 595' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -89.93 -174.59 4.31 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 176.792 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 596' ' ' LYS . . . . . 0.598 ' H ' ' HD3' ' A' ' 596' ' ' LYS . 0.0 OUTLIER -121.66 132.76 54.83 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.206 0.527 . . . . 0.0 111.287 -172.509 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 597' ' ' LEU . . . . . 0.668 ' HA ' HD21 ' A' ' 609' ' ' ASN . 42.6 mt -101.17 115.28 30.12 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 172.17 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 598' ' ' GLU . . . . . 0.871 ' HG2' ' HG2' ' A' ' 588' ' ' ARG . 46.3 mt-10 -89.42 91.78 8.86 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-O 121.203 0.525 . . . . 0.0 109.863 -179.135 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 599' ' ' VAL . . . . . . . . . . . . . 20.3 t -86.6 121.2 37.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 115.267 -0.879 . . . . 0.0 108.871 179.506 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 600' ' ' SER . . . . . . . . . . . . . 3.5 p -130.59 156.32 45.05 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.56 -174.008 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 601' ' ' LEU . . . . . . . . . . . . . 21.3 tp -126.35 107.3 10.17 Favored 'General case' 0 N--CA 1.445 -0.724 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 175.368 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 602' ' ' LYS . . . . . 0.542 ' HG2' ' OD1' ' A' ' 603' ' ' ASN . 36.1 ttpt -127.7 118.91 24.7 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.965 -175.71 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 603' ' ' ASN . . . . . 0.542 ' OD1' ' HG2' ' A' ' 602' ' ' LYS . 18.1 m120 61.47 35.93 17.38 Favored 'General case' 0 C--N 1.331 -0.217 0 O-C-N 123.346 0.404 . . . . 0.0 109.946 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 604' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 72.45 4.77 5.1 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 115.144 -0.935 . . . . 0.0 111.669 179.673 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 605' ' ' VAL . . . . . . . . . . . . . 58.6 t -103.56 123.54 57.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 110.273 -0.269 . . . . 0.0 110.273 178.727 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 606' ' ' VAL . . . . . 0.603 HG13 ' HB ' ' A' ' 613' ' ' VAL . 7.1 p -88.41 129.33 39.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 121.175 0.512 . . . . 0.0 110.8 -179.352 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 607' ' ' SER . . . . . 0.455 ' HA ' ' HA ' ' A' ' 612' ' ' PRO . 2.8 p -133.16 152.49 51.94 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.984 -179.76 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 608' ' ' VAL . . . . . . . . . . . . . 2.6 p -133.91 104.73 6.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.863 179.676 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 609' ' ' ASN . . . . . 0.668 HD21 ' HA ' ' A' ' 597' ' ' LEU . 89.2 m-20 55.8 66.43 1.21 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.84 -178.43 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 610' ' ' LYS . . . . . 0.526 ' HB3' ' O ' ' A' ' 609' ' ' ASN . 58.9 tptt 78.56 -42.81 0.34 Allowed 'General case' 0 N--CA 1.47 0.575 0 CA-C-N 115.724 -0.671 . . . . 0.0 112.715 178.365 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 611' ' ' GLU . . . . . 0.48 ' HA ' ' HD3' ' A' ' 612' ' ' PRO . 4.5 mm-40 -88.99 137.66 29.57 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-O 120.79 0.329 . . . . 0.0 111.463 -172.599 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 612' ' ' PRO . . . . . 0.48 ' HD3' ' HA ' ' A' ' 611' ' ' GLU . 5.8 Cg_exo -77.65 153.91 30.46 Favored 'Trans proline' 0 N--CA 1.459 -0.501 0 C-N-CA 122.917 2.412 . . . . 0.0 112.445 179.236 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 613' ' ' VAL . . . . . 0.603 ' HB ' HG13 ' A' ' 606' ' ' VAL . 24.7 t -94.52 134.11 33.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.341 177.319 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 614' ' ' ALA . . . . . 0.503 ' HB2' HG23 ' A' ' 629' ' ' THR . . . -74.18 -47.1 37.88 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.533 -175.746 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 615' ' ' GLU . . . . . 0.457 ' HB3' ' CG2' ' A' ' 627' ' ' VAL . 36.7 tt0 -147.76 101.64 3.69 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-O 120.969 0.414 . . . . 0.0 110.332 -177.423 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 616' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -90.01 162.57 4.9 Favored 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 123.228 2.619 . . . . 0.0 113.866 -178.414 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 26.8 m-20 77.64 28.79 0.55 Allowed 'General case' 0 CA--C 1.508 -0.635 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.77 163.873 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 618' ' ' ILE . . . . . 0.557 ' HB ' ' O ' ' A' ' 625' ' ' VAL . 20.2 mt -71.92 108.73 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.081 0 CA-C-N 114.505 -1.225 . . . . 0.0 109.03 173.38 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 619' ' ' MET . . . . . . . . . . . . . 5.7 mmt -79.04 129.29 34.29 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.769 -0.65 . . . . 0.0 112.547 -171.422 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 620' ' ' ALA . . . . . . . . . . . . . . . -118.71 174.91 6.0 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 169.0 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 621' ' ' THR . . . . . . . . . . . . . 6.0 t -75.19 -25.46 58.27 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.319 -0.552 . . . . 0.0 110.939 -178.115 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 622' ' ' ASN . . . . . 0.464 ' O ' ' HA ' ' A' ' 536' ' ' VAL . 22.9 p-10 -116.88 -9.2 11.22 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 112.481 0.548 . . . . 0.0 112.481 -175.359 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 623' ' ' GLY . . . . . . . . . . . . . . . -169.66 -160.7 18.55 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 119.369 -1.396 . . . . 0.0 113.202 -175.635 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 624' ' ' VAL . . . . . . . . . . . . . 5.6 p -130.13 155.27 41.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 -178.541 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 625' ' ' VAL . . . . . 0.557 ' O ' ' HB ' ' A' ' 618' ' ' ILE . 61.5 t -126.05 135.39 64.0 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.935 179.199 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 626' ' ' HIS . . . . . . . . . . . . . 82.4 m-70 -120.92 114.43 21.54 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.687 177.081 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 627' ' ' VAL . . . . . 0.967 HG22 ' HZ ' ' A' ' 515' ' ' PHE . 29.9 t -67.09 124.11 21.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.418 177.544 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 628' ' ' ILE . . . . . 0.549 HD13 ' HB3' ' A' ' 540' ' ' PHE . 4.4 pt -121.43 142.36 37.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-O 121.124 0.488 . . . . 0.0 110.565 175.273 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 629' ' ' THR . . . . . 0.503 HG23 ' HB2' ' A' ' 614' ' ' ALA . 37.8 p -89.12 -7.44 55.74 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.194 -178.151 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 630' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -129.05 160.43 32.8 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.649 -175.316 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 631' ' ' VAL . . . . . 0.673 HG23 ' HB1' ' A' ' 546' ' ' ALA . 81.1 t -95.11 128.98 45.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 179.479 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 632' ' ' LEU . . . . . . . . . . . . . 96.3 mt -80.92 111.51 17.46 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.313 0.578 . . . . 0.0 110.619 -178.403 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 633' ' ' GLN . . . . . 0.449 ' HA ' ' HD3' ' A' ' 634' ' ' PRO . 51.3 mt-30 -110.84 131.48 22.1 Favored Pre-proline 0 C--N 1.318 -0.761 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.619 -179.397 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 634' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 633' ' ' GLN . 5.6 Cg_exo . . . . . 0 C--O 1.248 0.998 0 C-N-CA 122.971 2.447 . . . . 0.0 111.179 175.307 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.904 0 N-CA-C 111.574 -0.61 . . . . 0.0 111.574 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 26.5 p -69.7 176.23 3.72 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 177.59 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 505' ' ' VAL . . . . . 0.712 ' O ' ' HG ' ' A' ' 509' ' ' LEU . 15.8 m -58.0 -32.04 42.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 C-N-CA 120.775 -0.37 . . . . 0.0 110.387 175.512 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 506' ' ' MET . . . . . . . . . . . . . 11.0 mmt -62.41 -43.74 98.1 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.271 176.814 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 507' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -61.39 -44.75 96.62 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 120.869 0.366 . . . . 0.0 110.84 179.454 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 508' ' ' VAL . . . . . . . . . . . . . 60.9 t -60.92 -45.51 98.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.745 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 509' ' ' LEU . . . . . 0.712 ' HG ' ' O ' ' A' ' 505' ' ' VAL . 77.5 mt -68.48 -36.23 78.65 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.218 -177.752 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 510' ' ' LYS . . . . . 0.41 ' HE2' HG11 ' A' ' 519' ' ' VAL . 54.4 mttm -77.28 -26.73 52.64 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.272 0.558 . . . . 0.0 110.011 -178.341 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 511' ' ' GLY . . . . . . . . . . . . . . . -71.48 -15.21 75.12 Favored Glycine 0 N--CA 1.445 -0.758 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.678 176.593 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 512' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -106.64 145.77 31.55 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.983 0.42 . . . . 0.0 111.04 179.65 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 -75.55 -25.23 56.97 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.207 -175.002 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 514' ' ' ARG . . . . . 0.431 ' HB3' ' HA ' ' A' ' 543' ' ' THR . 3.0 mpt_? -86.32 -50.0 7.25 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.305 0.574 . . . . 0.0 109.833 -178.189 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 515' ' ' PHE . . . . . 0.542 ' CZ ' HG22 ' A' ' 627' ' ' VAL . 11.5 m-30 -66.49 -27.0 67.44 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.635 -175.461 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 5.1 p -63.38 -30.21 71.38 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.657 0.265 . . . . 0.0 111.71 -178.52 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 517' ' ' MET . . . . . . . . . . . . . 54.7 mtm -69.78 -34.37 73.66 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 176.474 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 518' ' ' LEU . . . . . 0.545 HD22 ' HD2' ' A' ' 542' ' ' PRO . 51.9 tp -67.58 -40.04 84.84 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.372 173.362 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 519' ' ' VAL . . . . . 0.41 HG11 ' HE2' ' A' ' 510' ' ' LYS . 86.7 t -55.74 -37.09 45.44 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.371 0 CA-C-N 116.223 -0.444 . . . . 0.0 109.925 174.925 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 520' ' ' ALA . . . . . . . . . . . . . . . -63.74 -38.61 91.77 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.402 -179.691 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 521' ' ' ALA . . . . . . . . . . . . . . . -67.86 -51.39 48.78 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.825 0.345 . . . . 0.0 110.327 176.994 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 522' ' ' ILE . . . . . 0.527 ' HA ' ' HG ' ' A' ' 569' ' ' LEU . 62.1 mt -57.74 -40.83 77.71 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 CA-C-O 121.216 0.531 . . . . 0.0 111.164 178.136 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 523' ' ' GLN . . . . . 0.474 ' HA ' ' OG1' ' A' ' 528' ' ' THR . 21.5 tt0 -70.06 -39.21 75.79 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.408 -0.815 . . . . 0.0 110.762 -175.996 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 43.6 m -72.83 -31.16 64.6 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.93 0.395 . . . . 0.0 110.715 178.66 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 525' ' ' ALA . . . . . 0.652 ' HB1' ' HA ' ' A' ' 566' ' ' ALA . . . -74.86 -19.92 59.96 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.226 0.536 . . . . 0.0 110.524 176.817 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 526' ' ' GLY . . . . . . . . . . . . . . . 84.46 37.52 10.73 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.774 -0.726 . . . . 0.0 113.153 176.119 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 527' ' ' LEU . . . . . . . . . . . . . 9.1 mp -112.35 15.24 20.38 Favored 'General case' 0 C--N 1.326 -0.416 0 O-C-N 122.599 -0.353 . . . . 0.0 110.957 177.117 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 528' ' ' THR . . . . . 0.474 ' OG1' ' HA ' ' A' ' 523' ' ' GLN . 14.6 m -62.08 -33.74 74.99 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.579 -178.233 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 529' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -69.4 -24.85 63.91 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.551 -177.39 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 530' ' ' THR . . . . . 0.615 ' HB ' HD22 ' A' ' 531' ' ' LEU . 11.0 m -63.14 -53.36 54.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.062 0.458 . . . . 0.0 110.58 179.524 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 531' ' ' LEU . . . . . 0.615 HD22 ' HB ' ' A' ' 530' ' ' THR . 1.8 mm? -79.43 6.11 11.04 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.907 -178.808 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 532' ' ' ASN . . . . . . . . . . . . . 37.5 t-20 -87.83 -28.06 21.87 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.35 0.595 . . . . 0.0 109.428 179.441 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 533' ' ' ARG . . . . . . . . . . . . . 9.5 ttp180 -79.22 137.17 37.3 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.608 -0.723 . . . . 0.0 110.492 178.679 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 534' ' ' GLU . . . . . 0.645 ' HA ' ' HB3' ' A' ' 622' ' ' ASN . 48.5 mt-10 -77.04 133.91 38.95 Favored 'General case' 0 C--O 1.233 0.191 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 175.188 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 535' ' ' GLY . . . . . . . . . . . . . . . 173.7 -137.64 4.16 Favored Glycine 0 CA--C 1.501 -0.826 0 N-CA-C 110.675 -0.97 . . . . 0.0 110.675 -178.579 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 536' ' ' VAL . . . . . 0.459 ' HB ' HG13 ' A' ' 577' ' ' ILE . 33.8 m -119.52 130.27 74.27 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-O 121.077 0.465 . . . . 0.0 110.963 178.555 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 537' ' ' TYR . . . . . . . . . . . . . 75.8 m-85 -151.25 146.42 26.05 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.636 178.22 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 538' ' ' THR . . . . . 0.73 ' OG1' ' HA ' ' A' ' 577' ' ' ILE . 30.9 m -120.02 101.56 7.93 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 171.3 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 539' ' ' VAL . . . . . . . . . . . . . 51.8 t -103.46 127.34 57.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.115 -174.276 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 540' ' ' PHE . . . . . 0.57 ' HB3' HD13 ' A' ' 628' ' ' ILE . 94.8 m-85 -100.09 112.67 24.97 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 175.675 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 541' ' ' ALA . . . . . 0.465 ' HA ' HD22 ' A' ' 518' ' ' LEU . . . -105.93 113.0 64.2 Favored Pre-proline 0 C--N 1.325 -0.487 0 CA-C-O 120.705 0.288 . . . . 0.0 111.423 -176.788 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 542' ' ' PRO . . . . . 0.545 ' HD2' HD22 ' A' ' 518' ' ' LEU . 13.2 Cg_exo -71.02 142.24 41.94 Favored 'Trans proline' 0 N--CA 1.463 -0.29 0 C-N-CA 123.068 2.512 . . . . 0.0 112.079 176.693 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 543' ' ' THR . . . . . 0.431 ' HA ' ' HB3' ' A' ' 514' ' ' ARG . 40.9 p -80.4 179.56 7.64 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.017 178.732 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 544' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -61.78 -34.37 75.74 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.639 -179.168 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 545' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -62.82 -30.11 71.23 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.107 -176.131 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 546' ' ' ALA . . . . . 0.566 ' HB1' HG23 ' A' ' 631' ' ' VAL . . . -64.95 -49.73 69.2 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.301 0.572 . . . . 0.0 110.634 179.145 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 547' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -69.76 -22.04 63.39 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.784 -178.342 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 548' ' ' ARG . . . . . 0.514 ' O ' ' HD2' ' A' ' 548' ' ' ARG . 5.0 tmm_? -84.48 -35.71 22.78 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.859 -179.107 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 549' ' ' ALA . . . . . . . . . . . . . . . -69.36 -29.97 67.88 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.335 176.42 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 550' ' ' LEU . . . . . 0.472 ' HA ' ' HD3' ' A' ' 551' ' ' PRO . 70.8 mt -64.6 131.49 95.13 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.546 175.877 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 551' ' ' PRO . . . . . 0.477 ' HD2' ' HB2' ' A' ' 554' ' ' GLU . 6.9 Cg_exo -72.56 145.71 42.59 Favored 'Trans proline' 0 N--CA 1.459 -0.548 0 C-N-CA 122.828 2.352 . . . . 0.0 111.609 -177.309 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 552' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 551' ' ' PRO . 50.0 Cg_exo -53.86 -30.45 57.84 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 123.074 2.516 . . . . 0.0 112.082 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 553' ' ' ARG . . . . . . . . . . . . . 58.7 ttp180 -66.68 -54.71 20.2 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.806 177.711 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 554' ' ' GLU . . . . . 0.477 ' HB2' ' HD2' ' A' ' 551' ' ' PRO . 0.9 OUTLIER -65.15 -48.9 71.9 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.909 -175.939 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 555' ' ' ARG . . . . . 0.405 ' HG2' ' O ' ' A' ' 551' ' ' PRO . 14.3 ptm180 -60.18 -39.23 85.73 Favored 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 121.12 -0.232 . . . . 0.0 111.464 -176.101 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 50.0 m -71.52 -27.5 63.24 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 111.683 0.253 . . . . 0.0 111.683 -175.611 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 557' ' ' ARG . . . . . . . . . . . . . 33.0 ttm180 -75.96 -43.28 45.39 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.053 0.454 . . . . 0.0 109.781 177.824 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 558' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -66.71 -42.88 85.67 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.218 -179.383 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 559' ' ' LEU . . . . . 0.77 HD23 HD21 ' A' ' 565' ' ' LEU . 63.7 mt -83.13 0.13 46.6 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.047 -178.931 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 560' ' ' GLY . . . . . . . . . . . . . . . -88.13 -9.63 70.12 Favored Glycine 0 N--CA 1.453 -0.196 0 CA-C-N 116.039 -0.528 . . . . 0.0 112.612 -178.25 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 561' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -127.86 129.92 47.73 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 178.916 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 562' ' ' ALA . . . . . . . . . . . . . . . -76.9 -28.23 55.26 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 111.927 0.343 . . . . 0.0 111.927 -175.65 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 563' ' ' LYS . . . . . 0.476 ' HD2' ' N ' ' A' ' 563' ' ' LYS . 0.5 OUTLIER -80.36 -35.28 35.68 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 -177.125 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 564' ' ' GLU . . . . . . . . . . . . . 21.4 mm-40 -61.14 -43.96 98.06 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 171.762 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 565' ' ' LEU . . . . . 0.77 HD21 HD23 ' A' ' 559' ' ' LEU . 60.3 mt -57.5 -53.36 59.03 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.74 175.261 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 566' ' ' ALA . . . . . 0.652 ' HA ' ' HB1' ' A' ' 525' ' ' ALA . . . -55.75 -26.18 44.38 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.218 -178.825 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 567' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -86.59 -35.12 19.64 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.808 -179.817 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 568' ' ' ILE . . . . . . . . . . . . . 22.3 mm -69.71 -52.19 34.1 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 CA-C-N 116.075 -0.511 . . . . 0.0 112.331 -179.127 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 569' ' ' LEU . . . . . 0.527 ' HG ' ' HA ' ' A' ' 522' ' ' ILE . 2.7 mm? -64.22 -23.46 67.32 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-O 121.1 0.476 . . . . 0.0 110.968 177.619 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 570' ' ' LYS . . . . . . . . . . . . . 16.3 ttmm -70.96 -12.4 61.51 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.646 177.073 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 571' ' ' TYR . . . . . . . . . . . . . 59.9 t80 -102.77 -18.07 15.31 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.872 -0.603 . . . . 0.0 111.222 -177.644 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 572' ' ' HIS . . . . . . . . . . . . . 55.4 m80 -86.43 -3.75 59.06 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.118 0.485 . . . . 0.0 110.89 -177.872 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 573' ' ' ILE . . . . . 0.513 HD13 HD11 ' A' ' 531' ' ' LEU . 27.0 mt -118.19 127.24 75.37 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.134 179.806 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 574' ' ' GLY . . . . . 0.571 ' HA2' ' HA ' ' A' ' 591' ' ' SER . . . -89.12 153.46 23.6 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.934 -0.65 . . . . 0.0 111.58 175.667 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 575' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -74.81 -8.7 57.23 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 120.978 0.418 . . . . 0.0 111.989 -171.482 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 576' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -160.47 162.99 33.3 Favored 'General case' 0 N--CA 1.438 -1.058 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 177.553 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 577' ' ' ILE . . . . . 0.73 ' HA ' ' OG1' ' A' ' 538' ' ' THR . 70.0 mt -78.6 124.1 36.47 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 O-C-N 124.005 0.816 . . . . 0.0 112.386 -170.695 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 578' ' ' LEU . . . . . 0.517 HD11 ' HA ' ' A' ' 583' ' ' ILE . 42.3 tp -122.9 102.09 7.81 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.1 -0.955 . . . . 0.0 109.082 173.428 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 579' ' ' VAL . . . . . . . . . . . . . 30.1 m -96.54 157.39 3.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.84 -177.758 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 580' ' ' SER . . . . . . . . . . . . . 31.8 t -58.44 -38.96 78.56 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.351 -179.534 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 581' ' ' GLY . . . . . . . . . . . . . . . -74.48 9.96 9.37 Favored Glycine 0 N--CA 1.449 -0.486 0 CA-C-N 115.74 -0.663 . . . . 0.0 113.717 -179.477 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . -162.77 42.59 0.35 Allowed Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.814 -0.707 . . . . 0.0 112.87 178.441 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 583' ' ' ILE . . . . . 0.777 HD12 ' HB2' ' A' ' 601' ' ' LEU . 30.6 mt -80.18 -65.46 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.828 0.347 . . . . 0.0 110.614 176.769 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 584' ' ' GLY . . . . . . . . . . . . . . . 99.82 63.11 0.82 Allowed Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.605 -0.807 . . . . 0.0 111.856 -177.063 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 585' ' ' ALA . . . . . . . . . . . . . . . 67.63 -75.57 0.06 Allowed 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 123.389 0.676 . . . . 0.0 111.96 -179.611 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 586' ' ' LEU . . . . . 0.998 ' HG ' ' HB3' ' A' ' 600' ' ' SER . 6.5 tt -151.32 129.85 12.2 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.904 0.383 . . . . 0.0 110.237 -178.268 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 587' ' ' VAL . . . . . . . . . . . . . 94.5 t -133.59 133.6 57.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.752 -178.042 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 588' ' ' ARG . . . . . . . . . . . . . 71.8 mtt180 -84.26 102.78 12.92 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 173.044 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 589' ' ' LEU . . . . . . . . . . . . . 60.3 tp -90.51 111.98 23.47 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.584 0.707 . . . . 0.0 110.788 -173.401 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 590' ' ' LYS . . . . . . . . . . . . . 46.5 pttt -60.3 137.35 58.14 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 114.93 -1.032 . . . . 0.0 110.634 176.516 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 591' ' ' SER . . . . . 0.571 ' HA ' ' HA2' ' A' ' 574' ' ' GLY . 44.9 p -99.24 172.59 7.26 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.161 175.861 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 592' ' ' LEU . . . . . 0.423 HD23 ' O ' ' A' ' 573' ' ' ILE . 2.9 mm? -58.76 -22.54 58.22 Favored 'General case' 0 CA--C 1.529 0.173 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 179.593 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 593' ' ' GLN . . . . . 0.749 ' HG3' ' H ' ' A' ' 595' ' ' ASP . 6.1 pt20 -85.34 -29.9 24.12 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.63 -0.428 . . . . 0.0 111.145 178.345 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 594' ' ' GLY . . . . . 0.433 ' N ' ' HG3' ' A' ' 593' ' ' GLN . . . 122.06 -18.76 8.39 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.611 -0.804 . . . . 0.0 113.136 -177.313 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 595' ' ' ASP . . . . . 0.749 ' H ' ' HG3' ' A' ' 593' ' ' GLN . 18.1 t70 -68.46 165.0 19.83 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-N 117.708 0.754 . . . . 0.0 110.189 178.421 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 596' ' ' LYS . . . . . . . . . . . . . 44.9 mttm -109.45 113.37 26.11 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.189 -170.666 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 597' ' ' LEU . . . . . . . . . . . . . 58.3 mt -79.55 125.76 30.01 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.042 175.233 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 598' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -78.85 84.64 4.88 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 120.612 -0.435 . . . . 0.0 110.163 176.946 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 599' ' ' VAL . . . . . . . . . . . . . 38.1 t -97.92 121.4 48.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 121.217 0.532 . . . . 0.0 109.588 178.528 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 600' ' ' SER . . . . . 0.998 ' HB3' ' HG ' ' A' ' 586' ' ' LEU . 8.2 p -139.64 160.13 40.57 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-O 120.872 0.367 . . . . 0.0 111.377 -175.429 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 601' ' ' LEU . . . . . 0.777 ' HB2' HD12 ' A' ' 583' ' ' ILE . 39.4 tp -118.45 109.92 16.81 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.852 -179.388 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 602' ' ' LYS . . . . . . . . . . . . . 43.6 mmtm -121.53 114.96 21.96 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.132 -0.485 . . . . 0.0 109.826 178.173 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 603' ' ' ASN . . . . . . . . . . . . . 16.7 m120 58.92 38.52 24.39 Favored 'General case' 0 N--CA 1.465 0.31 0 O-C-N 123.316 0.385 . . . . 0.0 110.526 178.708 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 604' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 66.34 17.25 10.66 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.236 -179.455 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 605' ' ' VAL . . . . . . . . . . . . . 61.2 t -110.05 121.86 63.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 175.032 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 606' ' ' VAL . . . . . . . . . . . . . 25.1 t -85.83 131.35 34.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.395 -178.793 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 607' ' ' SER . . . . . . . . . . . . . 42.1 m -131.24 131.43 43.91 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.356 176.833 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 608' ' ' VAL . . . . . 0.462 HG13 HD21 ' A' ' 632' ' ' LEU . 3.6 p -115.2 111.82 37.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.86 178.609 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 609' ' ' ASN . . . . . 0.506 ' O ' ' HB3' ' A' ' 610' ' ' LYS . 91.6 m-20 60.89 35.47 19.23 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.921 -175.04 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 610' ' ' LYS . . . . . 0.506 ' HB3' ' O ' ' A' ' 609' ' ' ASN . 83.9 tttt 82.28 -24.99 0.16 Allowed 'General case' 0 N--CA 1.47 0.547 0 O-C-N 124.544 1.152 . . . . 0.0 111.795 -177.634 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 611' ' ' GLU . . . . . 0.429 ' HA ' ' HD3' ' A' ' 612' ' ' PRO . 11.0 mm-40 -67.81 127.47 93.36 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.064 0.459 . . . . 0.0 110.602 -179.208 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 612' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 611' ' ' GLU . 3.1 Cg_exo -74.76 130.74 13.83 Favored 'Trans proline' 0 N--CA 1.459 -0.526 0 C-N-CA 123.099 2.533 . . . . 0.0 112.701 -175.034 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 613' ' ' VAL . . . . . . . . . . . . . 96.7 t -79.71 125.9 38.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.568 175.295 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 614' ' ' ALA . . . . . 0.649 ' HB2' HG23 ' A' ' 629' ' ' THR . . . -78.94 -36.79 41.15 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.789 -176.463 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 615' ' ' GLU . . . . . 0.425 ' HB2' ' HB ' ' A' ' 627' ' ' VAL . 9.8 mm-40 -152.48 94.65 3.18 Favored Pre-proline 0 N--CA 1.467 0.393 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.848 -177.114 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 616' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -90.48 162.88 4.41 Favored 'Trans proline' 0 N--CA 1.46 -0.46 0 C-N-CA 123.139 2.56 . . . . 0.0 113.562 179.749 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 617' ' ' ASP . . . . . 0.434 ' H ' ' CE1' ' A' ' 626' ' ' HIS . 5.0 m-20 76.07 33.22 0.59 Allowed 'General case' 0 CA--C 1.506 -0.743 0 CA-C-O 122.103 0.954 . . . . 0.0 110.261 165.264 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 618' ' ' ILE . . . . . 0.506 ' HB ' ' O ' ' A' ' 625' ' ' VAL . 22.7 mt -82.19 97.72 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.36 0 CA-C-N 113.936 -1.484 . . . . 0.0 109.449 178.569 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 619' ' ' MET . . . . . 0.41 ' HA ' ' CE ' ' A' ' 619' ' ' MET . 2.8 mmt -62.39 111.28 1.95 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 114.948 -1.024 . . . . 0.0 111.939 -177.196 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 620' ' ' ALA . . . . . . . . . . . . . . . -110.73 -179.49 3.76 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 171.639 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 621' ' ' THR . . . . . . . . . . . . . 35.2 m -69.66 -46.86 65.18 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-O 120.886 0.374 . . . . 0.0 111.633 -177.566 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 622' ' ' ASN . . . . . 0.645 ' HB3' ' HA ' ' A' ' 534' ' ' GLU . 24.0 p-10 -116.72 32.81 5.93 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.827 -174.045 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 623' ' ' GLY . . . . . 0.611 ' HA2' HD11 ' A' ' 577' ' ' ILE . . . 150.67 -159.65 28.24 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.527 -0.844 . . . . 0.0 112.46 176.77 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 624' ' ' VAL . . . . . . . . . . . . . 9.8 m -123.4 165.95 19.04 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.753 0 CA-C-O 121.909 0.861 . . . . 0.0 111.352 176.111 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 625' ' ' VAL . . . . . 0.506 ' O ' ' HB ' ' A' ' 618' ' ' ILE . 89.8 t -128.51 107.33 15.75 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.193 0 CA-C-N 113.584 -1.644 . . . . 0.0 109.43 177.742 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 626' ' ' HIS . . . . . 0.434 ' CE1' ' H ' ' A' ' 617' ' ' ASP . 28.4 m-70 -95.41 103.31 15.17 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 177.192 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 627' ' ' VAL . . . . . 0.542 HG22 ' CZ ' ' A' ' 515' ' ' PHE . 41.8 t -62.75 130.85 27.81 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.0 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 628' ' ' ILE . . . . . 0.57 HD13 ' HB3' ' A' ' 540' ' ' PHE . 3.9 pt -124.85 143.64 37.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 121.193 0.52 . . . . 0.0 111.145 178.647 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 629' ' ' THR . . . . . 0.649 HG23 ' HB2' ' A' ' 614' ' ' ALA . 24.5 p -88.31 7.46 32.19 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.965 -0.561 . . . . 0.0 112.329 -178.485 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 630' ' ' ASN . . . . . . . . . . . . . 65.7 t30 -150.05 174.08 13.14 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 176.703 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 631' ' ' VAL . . . . . 0.566 HG23 ' HB1' ' A' ' 546' ' ' ALA . 48.9 t -101.19 133.81 43.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.036 -178.102 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 632' ' ' LEU . . . . . 0.462 HD21 HG13 ' A' ' 608' ' ' VAL . 95.9 mt -79.23 116.78 19.7 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-O 121.312 0.577 . . . . 0.0 111.149 -175.883 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 633' ' ' GLN . . . . . . . . . . . . . 54.0 tt0 -122.98 116.67 28.74 Favored Pre-proline 0 C--N 1.317 -0.814 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.083 179.464 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 634' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo . . . . . 0 C--O 1.249 1.057 0 C-N-CA 122.349 2.032 . . . . 0.0 112.266 -179.421 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.67 0 N-CA-C 111.11 -0.796 . . . . 0.0 111.11 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 504' ' ' THR . . . . . 0.626 ' HA ' HG22 ' A' ' 621' ' ' THR . 47.7 p -81.25 172.36 13.72 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 117.065 0.432 . . . . 0.0 110.292 177.884 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 505' ' ' VAL . . . . . 0.661 HG23 HG22 ' A' ' 625' ' ' VAL . 5.0 p -54.66 -47.96 72.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.682 -179.179 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 506' ' ' MET . . . . . 0.601 ' HA ' HD13 ' A' ' 509' ' ' LEU . 2.8 ppp? -81.79 -17.09 48.78 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.519 -0.473 . . . . 0.0 111.077 -178.66 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 507' ' ' ASP . . . . . 0.497 ' HA ' ' HB2' ' A' ' 510' ' ' LYS . 27.6 t70 -68.13 -29.89 68.9 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 173.19 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 508' ' ' VAL . . . . . . . . . . . . . 84.9 t -61.79 -49.33 84.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.824 -0.626 . . . . 0.0 109.578 171.931 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 509' ' ' LEU . . . . . 1.055 ' HG ' ' HB3' ' A' ' 515' ' ' PHE . 9.6 mp -53.78 -42.36 68.21 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 121.617 0.722 . . . . 0.0 111.25 171.701 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 510' ' ' LYS . . . . . 0.507 ' HD3' ' SD ' ' A' ' 506' ' ' MET . 0.7 OUTLIER -68.59 -20.43 64.51 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 114.769 -1.105 . . . . 0.0 111.467 -177.937 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 511' ' ' GLY . . . . . . . . . . . . . . . -96.82 -0.91 60.2 Favored Glycine 0 N--CA 1.437 -1.252 0 C-N-CA 120.8 -0.714 . . . . 0.0 111.617 177.208 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 512' ' ' ASP . . . . . 0.421 ' O ' ' HB2' ' A' ' 516' ' ' SER . 27.0 t70 -117.98 148.84 41.82 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.513 0.673 . . . . 0.0 112.39 -176.527 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -75.56 -34.96 60.75 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.428 -179.513 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 514' ' ' ARG . . . . . . . . . . . . . 35.6 mtt180 -79.0 -53.25 7.22 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.085 -174.72 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 515' ' ' PHE . . . . . 1.055 ' HB3' ' HG ' ' A' ' 509' ' ' LEU . 14.4 m-30 -64.27 -17.12 63.31 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.066 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 516' ' ' SER . . . . . 0.421 ' HB2' ' O ' ' A' ' 512' ' ' ASP . 39.6 t -58.03 -31.06 66.63 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.304 -178.247 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 517' ' ' MET . . . . . 0.489 ' HE3' ' HB2' ' A' ' 517' ' ' MET . 47.7 mtm -72.39 -30.7 64.9 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.742 0.306 . . . . 0.0 110.441 178.908 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 518' ' ' LEU . . . . . 0.608 HD23 HD21 ' A' ' 509' ' ' LEU . 47.7 tp -70.23 -34.07 72.42 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 173.46 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 519' ' ' VAL . . . . . 0.419 ' CG2' ' HB3' ' A' ' 509' ' ' LEU . 56.7 t -61.41 -33.04 55.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 121.096 0.474 . . . . 0.0 109.774 174.162 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 520' ' ' ALA . . . . . . . . . . . . . . . -67.0 -40.59 87.38 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.325 177.739 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 521' ' ' ALA . . . . . . . . . . . . . . . -66.69 -47.75 71.44 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.151 176.236 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 522' ' ' ILE . . . . . 0.434 HG13 ' O ' ' A' ' 518' ' ' LEU . 87.9 mt -56.34 -43.01 76.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.752 176.575 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 523' ' ' GLN . . . . . . . . . . . . . 43.8 tt0 -62.69 -47.91 81.6 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.125 178.611 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 40.1 m -66.61 -36.42 82.55 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.062 -176.944 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 525' ' ' ALA . . . . . . . . . . . . . . . -78.58 -28.3 45.83 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.484 -0.326 . . . . 0.0 110.968 177.289 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 526' ' ' GLY . . . . . . . . . . . . . . . 82.02 38.04 14.37 Favored Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 121.286 -0.483 . . . . 0.0 112.931 177.277 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 527' ' ' LEU . . . . . . . . . . . . . 97.5 mt -111.07 20.41 17.46 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.765 0.317 . . . . 0.0 111.209 -177.568 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 528' ' ' THR . . . . . . . . . . . . . 8.8 m -62.08 -37.08 83.68 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.724 -177.535 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 529' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -63.44 -31.62 72.83 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 121.025 0.44 . . . . 0.0 110.681 -178.045 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 530' ' ' THR . . . . . . . . . . . . . 27.0 m -59.84 -46.63 88.66 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.078 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 531' ' ' LEU . . . . . 0.524 HD21 HD13 ' A' ' 573' ' ' ILE . 67.1 mt -93.05 11.44 27.57 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.161 0.505 . . . . 0.0 111.268 -178.094 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 532' ' ' ASN . . . . . . . . . . . . . 58.2 t30 -91.47 -51.01 5.48 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.55 -178.703 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 533' ' ' ARG . . . . . . . . . . . . . 1.7 tpt180 -68.43 146.1 53.5 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.733 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 534' ' ' GLU . . . . . 0.641 ' HA ' ' HB3' ' A' ' 622' ' ' ASN . 23.2 pm0 -76.6 143.74 40.03 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 121.322 0.582 . . . . 0.0 110.537 -179.345 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 535' ' ' GLY . . . . . 0.414 ' H ' ' HB2' ' A' ' 622' ' ' ASN . . . 177.2 -139.57 4.44 Favored Glycine 0 N--CA 1.446 -0.655 0 N-CA-C 110.117 -1.193 . . . . 0.0 110.117 -176.911 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 536' ' ' VAL . . . . . . . . . . . . . 33.0 m -124.48 130.31 73.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 117.31 0.555 . . . . 0.0 110.612 176.277 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 537' ' ' TYR . . . . . . . . . . . . . 76.0 m-85 -153.07 152.42 31.31 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.635 -178.488 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 538' ' ' THR . . . . . 0.74 ' OG1' ' HA ' ' A' ' 577' ' ' ILE . 30.7 m -134.89 102.38 5.22 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.403 174.031 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 539' ' ' VAL . . . . . 0.667 HG22 HG23 ' A' ' 573' ' ' ILE . 39.2 t -109.92 127.0 67.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 120.976 0.417 . . . . 0.0 111.694 -172.66 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 540' ' ' PHE . . . . . 0.529 ' HB3' HD13 ' A' ' 628' ' ' ILE . 87.9 m-85 -95.38 109.01 21.23 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 172.264 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 541' ' ' ALA . . . . . 0.473 ' HA ' HD22 ' A' ' 518' ' ' LEU . . . -96.01 111.23 55.53 Favored Pre-proline 0 C--N 1.322 -0.618 0 CA-C-N 116.628 -0.26 . . . . 0.0 111.193 -176.418 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 542' ' ' PRO . . . . . 0.581 ' HA ' HG13 ' A' ' 628' ' ' ILE . 18.5 Cg_endo -66.91 130.05 22.21 Favored 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 122.141 1.894 . . . . 0.0 110.967 175.251 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 17.4 p -96.4 -174.78 3.15 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.509 -0.769 . . . . 0.0 112.55 -171.778 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 544' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -49.76 -37.15 28.48 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 114.746 -1.115 . . . . 0.0 111.715 178.056 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 545' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -65.0 -28.62 69.63 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.976 -175.675 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 546' ' ' ALA . . . . . 0.621 ' HB1' HG23 ' A' ' 631' ' ' VAL . . . -79.08 -58.46 3.22 Favored 'General case' 0 CA--C 1.516 -0.348 0 CA-C-O 121.082 0.468 . . . . 0.0 111.616 -176.149 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 547' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -64.62 -29.85 70.86 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.727 -0.669 . . . . 0.0 111.548 -175.925 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 548' ' ' ARG . . . . . . . . . . . . . 47.3 ttp180 -66.66 -30.68 71.0 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.923 0.392 . . . . 0.0 110.46 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 549' ' ' ALA . . . . . . . . . . . . . . . -86.89 -10.57 53.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.461 -176.016 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 550' ' ' LEU . . . . . 0.491 HD11 HG21 ' A' ' 631' ' ' VAL . 88.2 mt -70.79 122.78 87.79 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 120.922 0.392 . . . . 0.0 110.978 -178.112 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 551' ' ' PRO . . . . . 0.477 ' HD3' ' HA ' ' A' ' 550' ' ' LEU . 16.5 Cg_exo -68.89 157.72 60.75 Favored 'Trans proline' 0 C--O 1.236 0.375 0 C-N-CA 123.327 2.685 . . . . 0.0 111.853 -178.294 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 552' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -44.17 -53.01 5.11 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 123.831 3.021 . . . . 0.0 113.225 -177.985 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 553' ' ' ARG . . . . . . . . . . . . . 23.2 mtm180 -63.2 -48.35 78.67 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 120.715 0.293 . . . . 0.0 111.513 -175.575 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -63.74 -52.77 58.99 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.736 -174.709 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 555' ' ' ARG . . . . . . . . . . . . . 19.6 ptt180 -66.34 -29.16 69.3 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.274 -177.474 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 29.2 t -75.6 -24.06 56.5 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.615 0.245 . . . . 0.0 110.834 -178.256 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 557' ' ' ARG . . . . . . . . . . . . . 12.3 tpp180 -82.94 -46.52 12.83 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.53 -0.304 . . . . 0.0 110.265 178.281 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 558' ' ' LEU . . . . . . . . . . . . . 51.2 tp -61.17 -41.56 97.01 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.768 179.223 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 559' ' ' LEU . . . . . 0.672 HD23 HD21 ' A' ' 565' ' ' LEU . 80.5 mt -91.83 6.35 46.45 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.195 0.522 . . . . 0.0 110.552 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 560' ' ' GLY . . . . . . . . . . . . . . . -96.72 -39.58 4.09 Favored Glycine 0 N--CA 1.444 -0.769 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.685 179.502 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 561' ' ' ASP . . . . . 0.514 ' HB2' ' HG2' ' A' ' 564' ' ' GLU . 6.1 m-20 -103.81 119.89 39.85 Favored 'General case' 0 N--CA 1.445 -0.708 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 177.139 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 562' ' ' ALA . . . . . . . . . . . . . . . -65.74 -28.84 69.34 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.986 0.422 . . . . 0.0 111.153 -176.777 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 563' ' ' LYS . . . . . . . . . . . . . 4.2 mptp? -69.6 -36.84 76.57 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.1 179.02 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 564' ' ' GLU . . . . . 0.514 ' HG2' ' HB2' ' A' ' 561' ' ' ASP . 8.7 mm-40 -62.96 -40.4 97.57 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 179.384 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 565' ' ' LEU . . . . . 0.672 HD21 HD23 ' A' ' 559' ' ' LEU . 48.3 mt -57.07 -50.2 73.5 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.72 176.129 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 566' ' ' ALA . . . . . . . . . . . . . . . -60.48 -53.97 51.19 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.588 179.224 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 567' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -58.95 -49.96 75.88 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.811 -0.631 . . . . 0.0 112.207 -177.24 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 568' ' ' ILE . . . . . . . . . . . . . 40.7 mm -63.99 -40.4 88.93 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 CA-C-O 120.577 0.227 . . . . 0.0 111.557 -178.503 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 569' ' ' LEU . . . . . 0.464 ' HB3' ' O ' ' A' ' 565' ' ' LEU . 0.1 OUTLIER -72.58 -29.2 63.32 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 122.058 -0.401 . . . . 0.0 110.204 -177.344 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 570' ' ' LYS . . . . . . . . . . . . . 25.2 mtpp -62.19 -29.08 70.12 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.091 0.472 . . . . 0.0 110.684 174.086 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 571' ' ' TYR . . . . . 0.46 ' O ' HD21 ' A' ' 597' ' ' LEU . 55.2 t80 -75.46 -18.8 59.77 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.416 178.402 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 572' ' ' HIS . . . . . . . . . . . . . 64.7 m80 -87.64 -12.4 45.64 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.75 0.309 . . . . 0.0 111.331 -177.917 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 573' ' ' ILE . . . . . 0.667 HG23 HG22 ' A' ' 539' ' ' VAL . 28.7 mt -110.84 118.1 56.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 120.834 0.349 . . . . 0.0 111.18 -178.854 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 574' ' ' GLY . . . . . 0.449 ' HA2' ' HA ' ' A' ' 591' ' ' SER . . . -95.49 145.74 17.89 Favored Glycine 0 N--CA 1.446 -0.698 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 170.584 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 575' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -93.34 16.94 12.13 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 117.524 0.662 . . . . 0.0 111.119 -174.584 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 576' ' ' GLU . . . . . 0.518 ' HB2' HD21 ' A' ' 589' ' ' LEU . 48.8 mt-10 -137.55 124.08 20.88 Favored 'General case' 0 CA--C 1.512 -0.512 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 179.496 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 577' ' ' ILE . . . . . 0.74 ' HA ' ' OG1' ' A' ' 538' ' ' THR . 72.4 mt -67.43 117.74 9.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 O-C-N 123.612 0.57 . . . . 0.0 111.369 -173.879 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 578' ' ' LEU . . . . . 0.685 HD11 HG12 ' A' ' 583' ' ' ILE . 3.3 tm? -117.03 114.21 23.44 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.038 -0.983 . . . . 0.0 109.499 178.653 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 579' ' ' VAL . . . . . . . . . . . . . 29.4 m -108.59 163.4 6.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 177.994 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 580' ' ' SER . . . . . . . . . . . . . 23.6 t -59.39 -41.86 90.39 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.956 0.407 . . . . 0.0 110.857 -176.742 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 581' ' ' GLY . . . . . . . . . . . . . . . -77.57 19.79 3.79 Favored Glycine 0 CA--C 1.523 0.54 0 C-N-CA 120.777 -0.725 . . . . 0.0 113.152 -179.608 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . -142.35 16.54 2.5 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.473 178.547 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 583' ' ' ILE . . . . . 0.685 HG12 HD11 ' A' ' 578' ' ' LEU . 32.3 mt -85.33 -42.36 16.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.925 0.393 . . . . 0.0 110.95 179.601 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 584' ' ' GLY . . . . . . . . . . . . . . . 81.01 -87.71 1.36 Allowed Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.48 -0.867 . . . . 0.0 111.66 -178.171 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 585' ' ' ALA . . . . . . . . . . . . . . . -130.44 -66.7 0.76 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.003 0.43 . . . . 0.0 109.855 176.883 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 586' ' ' LEU . . . . . 0.8 ' HG ' ' HB2' ' A' ' 600' ' ' SER . 3.6 tt -142.21 134.56 27.83 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 174.871 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 587' ' ' VAL . . . . . . . . . . . . . 10.7 p -125.15 138.44 54.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-O 121.14 0.495 . . . . 0.0 110.955 -174.787 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 588' ' ' ARG . . . . . . . . . . . . . 95.2 mtt180 -99.35 101.75 13.14 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 178.564 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 589' ' ' LEU . . . . . 0.518 HD21 ' HB2' ' A' ' 576' ' ' GLU . 0.6 OUTLIER -109.05 127.04 53.77 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.008 -176.528 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 590' ' ' LYS . . . . . 0.435 ' HE3' ' OE2' ' A' ' 576' ' ' GLU . 22.5 pttp -86.21 145.0 27.16 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.107 0.479 . . . . 0.0 111.002 -176.67 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 591' ' ' SER . . . . . 0.449 ' HA ' ' HA2' ' A' ' 574' ' ' GLY . 79.4 p -95.79 177.84 5.64 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.296 -178.856 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 592' ' ' LEU . . . . . . . . . . . . . 49.1 mt -70.96 -13.87 62.16 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.906 0.384 . . . . 0.0 110.56 179.083 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 593' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -85.74 -29.55 23.8 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.046 -177.449 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 594' ' ' GLY . . . . . . . . . . . . . . . 121.0 -27.09 6.55 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.935 -0.65 . . . . 0.0 111.678 -177.34 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 595' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -73.78 166.04 24.04 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.013 0.435 . . . . 0.0 110.892 176.612 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 596' ' ' LYS . . . . . 0.508 ' O ' ' HD2' ' A' ' 596' ' ' LYS . 0.1 OUTLIER -105.32 141.75 36.29 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.045 -179.601 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 597' ' ' LEU . . . . . 0.46 HD21 ' O ' ' A' ' 571' ' ' TYR . 71.0 mt -92.24 120.27 32.64 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.448 -0.796 . . . . 0.0 108.935 172.966 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 598' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 -81.29 84.15 6.68 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.188 0.518 . . . . 0.0 109.799 -176.289 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 599' ' ' VAL . . . . . . . . . . . . . 42.1 t -98.07 133.77 38.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.086 -175.447 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 600' ' ' SER . . . . . 0.8 ' HB2' ' HG ' ' A' ' 586' ' ' LEU . 29.7 t -144.66 167.86 21.54 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 121.325 0.583 . . . . 0.0 110.569 -177.888 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 601' ' ' LEU . . . . . 0.464 HD13 HD12 ' A' ' 583' ' ' ILE . 31.3 tp -131.45 107.6 9.02 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 114.93 -1.032 . . . . 0.0 109.275 -178.345 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 602' ' ' LYS . . . . . . . . . . . . . 24.7 ttmm -119.0 113.76 21.48 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.217 -0.447 . . . . 0.0 109.85 -177.0 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 603' ' ' ASN . . . . . 0.451 ' O ' ' HB2' ' A' ' 604' ' ' ASN . 91.2 m-20 59.48 32.88 22.0 Favored 'General case' 0 N--CA 1.466 0.338 0 O-C-N 123.43 0.456 . . . . 0.0 110.435 -177.87 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 604' ' ' ASN . . . . . 0.451 ' HB2' ' O ' ' A' ' 603' ' ' ASN . 11.2 m120 73.15 10.59 5.19 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 115.205 -0.907 . . . . 0.0 111.939 -179.013 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 605' ' ' VAL . . . . . . . . . . . . . 61.1 t -97.97 119.98 46.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 174.08 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 606' ' ' VAL . . . . . . . . . . . . . 19.7 t -81.0 136.67 22.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.727 -178.506 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 607' ' ' SER . . . . . . . . . . . . . 8.2 p -142.25 147.92 37.26 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.481 178.62 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 608' ' ' VAL . . . . . . . . . . . . . 7.0 p -131.56 117.38 35.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.122 177.455 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 609' ' ' ASN . . . . . 0.487 ' O ' ' HB2' ' A' ' 610' ' ' LYS . 88.6 m-20 61.35 31.58 19.23 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.676 -178.61 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 610' ' ' LYS . . . . . 0.487 ' HB2' ' O ' ' A' ' 609' ' ' ASN . 11.7 mmmm 79.58 -2.47 2.12 Favored 'General case' 0 N--CA 1.472 0.664 0 O-C-N 124.283 0.989 . . . . 0.0 111.725 -178.133 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 611' ' ' GLU . . . . . 0.485 ' HA ' ' HD3' ' A' ' 612' ' ' PRO . 4.4 mm-40 -93.42 125.81 52.68 Favored Pre-proline 0 C--N 1.33 -0.241 0 N-CA-C 109.654 -0.498 . . . . 0.0 109.654 177.269 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 612' ' ' PRO . . . . . 0.485 ' HD3' ' HA ' ' A' ' 611' ' ' GLU . 8.4 Cg_exo -72.31 144.57 41.58 Favored 'Trans proline' 0 N--CA 1.463 -0.295 0 C-N-CA 122.985 2.457 . . . . 0.0 112.982 -176.252 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 613' ' ' VAL . . . . . . . . . . . . . 98.7 t -86.17 125.97 40.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.61 175.318 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 614' ' ' ALA . . . . . 0.559 ' HB2' HG23 ' A' ' 629' ' ' THR . . . -80.75 -28.48 36.48 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.69 -0.687 . . . . 0.0 111.721 -174.368 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 615' ' ' GLU . . . . . 0.54 ' HB3' ' CG2' ' A' ' 627' ' ' VAL . 10.1 tp10 -161.46 93.97 1.39 Allowed Pre-proline 0 C--N 1.328 -0.363 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 -179.019 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 616' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -89.33 161.04 5.58 Favored 'Trans proline' 0 N--CA 1.46 -0.494 0 C-N-CA 123.353 2.702 . . . . 0.0 113.81 -177.209 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 77.05 32.7 0.47 Allowed 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 121.962 0.887 . . . . 0.0 110.343 164.772 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 618' ' ' ILE . . . . . 0.474 ' CG2' ' HB ' ' A' ' 625' ' ' VAL . 13.2 mt -75.81 111.28 12.04 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.909 0 CA-C-N 114.498 -1.228 . . . . 0.0 109.694 175.342 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 619' ' ' MET . . . . . . . . . . . . . 9.5 mmt -74.86 122.65 23.7 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.809 -0.632 . . . . 0.0 112.114 -175.254 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 620' ' ' ALA . . . . . . . . . . . . . . . -122.47 161.05 24.29 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 172.432 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 621' ' ' THR . . . . . 0.626 HG22 ' HA ' ' A' ' 504' ' ' THR . 9.9 t -69.32 -30.13 68.11 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.587 -0.445 . . . . 0.0 111.823 -174.512 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 622' ' ' ASN . . . . . 0.641 ' HB3' ' HA ' ' A' ' 534' ' ' GLU . 29.3 p-10 -118.07 28.26 8.49 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 111.921 0.341 . . . . 0.0 111.921 -178.027 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 623' ' ' GLY . . . . . . . . . . . . . . . 155.68 -160.68 30.12 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.171 -1.014 . . . . 0.0 112.444 176.882 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 624' ' ' VAL . . . . . . . . . . . . . 8.8 p -128.66 157.44 41.3 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 N-CA-C 110.04 -0.356 . . . . 0.0 110.04 179.001 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 625' ' ' VAL . . . . . 0.661 HG22 HG23 ' A' ' 505' ' ' VAL . 42.8 t -125.02 136.18 61.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 116.246 -0.434 . . . . 0.0 109.932 -179.222 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 626' ' ' HIS . . . . . . . . . . . . . 95.6 m-70 -122.57 112.07 17.57 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-O 121.067 0.461 . . . . 0.0 109.982 175.558 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 627' ' ' VAL . . . . . 0.795 HG22 ' HZ ' ' A' ' 515' ' ' PHE . 67.7 t -67.45 129.01 31.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.061 179.402 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 628' ' ' ILE . . . . . 0.581 HG13 ' HA ' ' A' ' 542' ' ' PRO . 9.2 pt -126.02 146.11 32.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.158 0.504 . . . . 0.0 110.932 175.398 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 629' ' ' THR . . . . . 0.559 HG23 ' HB2' ' A' ' 614' ' ' ALA . 35.3 p -95.22 -1.55 51.4 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.042 179.764 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 630' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -125.29 163.07 23.34 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.846 -0.615 . . . . 0.0 109.691 -175.693 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 631' ' ' VAL . . . . . 0.621 HG23 ' HB1' ' A' ' 546' ' ' ALA . 58.5 t -99.3 123.23 51.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 177.548 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 632' ' ' LEU . . . . . . . . . . . . . 80.4 mt -80.88 116.3 20.79 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.144 0.497 . . . . 0.0 111.338 -177.4 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 633' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 -120.15 129.92 25.1 Favored Pre-proline 0 C--N 1.321 -0.651 0 CA-C-N 115.648 -0.706 . . . . 0.0 109.1 176.461 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 634' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo . . . . . 0 C--O 1.249 1.047 0 C-N-CA 123.296 2.664 . . . . 0.0 112.826 -179.543 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.634 0 N-CA-C 112.029 -0.428 . . . . 0.0 112.029 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 504' ' ' THR . . . . . 0.469 ' HA ' HG22 ' A' ' 621' ' ' THR . 41.1 p -78.92 170.46 16.65 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 110.446 -0.205 . . . . 0.0 110.446 178.589 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 505' ' ' VAL . . . . . 0.726 ' O ' ' HG ' ' A' ' 509' ' ' LEU . 10.7 m -60.54 -34.09 56.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 175.061 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 506' ' ' MET . . . . . . . . . . . . . 93.5 mmm -65.03 -34.78 79.25 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-O 120.809 0.338 . . . . 0.0 110.357 177.354 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 507' ' ' ASP . . . . . 0.537 ' HA ' ' HE3' ' A' ' 510' ' ' LYS . 29.9 t70 -70.29 -44.06 69.14 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.183 178.298 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 508' ' ' VAL . . . . . 0.448 HG23 ' O ' ' A' ' 504' ' ' THR . 67.7 t -59.24 -42.94 88.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.886 177.595 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 509' ' ' LEU . . . . . 0.726 ' HG ' ' O ' ' A' ' 505' ' ' VAL . 71.7 mt -68.51 -32.0 71.65 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.512 -178.199 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 510' ' ' LYS . . . . . 0.537 ' HE3' ' HA ' ' A' ' 507' ' ' ASP . 22.9 pttp -88.11 -13.54 41.08 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.184 0.516 . . . . 0.0 110.048 -178.309 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 511' ' ' GLY . . . . . . . . . . . . . . . -84.51 -8.65 82.85 Favored Glycine 0 N--CA 1.442 -0.912 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.562 174.31 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 512' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -116.24 135.72 53.65 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.604 0.24 . . . . 0.0 110.477 178.216 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 42.2 t30 -64.39 -36.89 85.63 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.844 -176.052 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 514' ' ' ARG . . . . . 0.698 ' HD3' HG22 ' A' ' 543' ' ' THR . 74.8 mtt180 -73.45 -46.94 45.32 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.305 0.574 . . . . 0.0 110.245 -176.731 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 515' ' ' PHE . . . . . 0.975 ' HZ ' HG22 ' A' ' 627' ' ' VAL . 13.9 m-30 -67.42 -18.11 64.98 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.99 -178.546 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 66.2 m -57.43 -36.86 71.9 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.362 -0.381 . . . . 0.0 112.018 -177.593 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 517' ' ' MET . . . . . 0.545 ' HE1' ' HA ' ' A' ' 544' ' ' ASN . 44.7 mtm -72.32 -33.25 67.21 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.752 -0.379 . . . . 0.0 110.177 -179.454 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 518' ' ' LEU . . . . . 0.41 HD22 ' HA ' ' A' ' 541' ' ' ALA . 66.1 tp -64.06 -38.72 92.11 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.088 -0.505 . . . . 0.0 109.908 173.94 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 519' ' ' VAL . . . . . 0.433 HG23 ' O ' ' A' ' 515' ' ' PHE . 56.7 t -57.33 -36.12 51.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 121.156 0.503 . . . . 0.0 109.875 174.399 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 520' ' ' ALA . . . . . . . . . . . . . . . -70.29 -38.84 75.1 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.326 179.549 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 521' ' ' ALA . . . . . . . . . . . . . . . -65.79 -48.87 70.32 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.508 176.754 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 522' ' ' ILE . . . . . . . . . . . . . 94.7 mt -57.06 -41.42 77.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.828 -0.623 . . . . 0.0 110.872 176.5 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 523' ' ' GLN . . . . . . . . . . . . . 33.8 tt0 -64.95 -43.48 92.58 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.2 177.915 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 20.3 t -70.74 -31.36 68.16 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.538 -176.642 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 525' ' ' ALA . . . . . 0.549 ' HB2' ' HB3' ' A' ' 565' ' ' LEU . . . -88.94 -27.1 21.16 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.726 0.298 . . . . 0.0 111.473 -179.242 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 526' ' ' GLY . . . . . . . . . . . . . . . 87.13 49.65 3.93 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.867 -0.683 . . . . 0.0 112.391 178.78 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 527' ' ' LEU . . . . . 0.411 ' HA ' HD13 ' A' ' 527' ' ' LEU . 4.3 mm? -111.5 8.78 21.2 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.151 0.5 . . . . 0.0 110.691 178.042 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 528' ' ' THR . . . . . . . . . . . . . 5.9 m -60.42 -33.93 73.22 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.464 -177.612 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 529' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -61.29 -33.64 73.89 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.114 -178.633 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 530' ' ' THR . . . . . . . . . . . . . 30.4 m -70.29 -48.32 57.23 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.998 -0.547 . . . . 0.0 111.279 -176.315 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 531' ' ' LEU . . . . . 0.539 ' HB3' ' CG2' ' A' ' 505' ' ' VAL . 31.4 mt -85.96 6.21 29.68 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.323 0.582 . . . . 0.0 111.403 -175.674 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 532' ' ' ASN . . . . . . . . . . . . . 53.0 t30 -83.95 -37.76 21.88 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.091 179.356 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 533' ' ' ARG . . . . . . . . . . . . . 76.6 mtm180 -79.44 131.54 36.11 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.862 -178.475 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 534' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -75.03 127.54 33.46 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.524 179.671 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 535' ' ' GLY . . . . . . . . . . . . . . . -174.26 -132.22 1.52 Allowed Glycine 0 CA--C 1.502 -0.721 0 N-CA-C 110.265 -1.134 . . . . 0.0 110.265 -179.574 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 536' ' ' VAL . . . . . . . . . . . . . 33.9 m -124.36 129.25 74.0 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-O 121.261 0.553 . . . . 0.0 110.719 177.584 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 537' ' ' TYR . . . . . . . . . . . . . 80.4 m-85 -154.86 150.35 27.38 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.161 179.266 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 538' ' ' THR . . . . . 0.723 ' OG1' ' HA ' ' A' ' 577' ' ' ILE . 34.1 m -120.26 102.2 8.33 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 173.723 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 539' ' ' VAL . . . . . 0.502 HG22 HG23 ' A' ' 573' ' ' ILE . 44.2 t -105.11 123.87 59.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.498 -173.035 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 540' ' ' PHE . . . . . 0.607 ' HB3' HD13 ' A' ' 628' ' ' ILE . 93.7 m-85 -95.94 112.86 24.47 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 174.341 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 541' ' ' ALA . . . . . 0.41 ' HA ' HD22 ' A' ' 518' ' ' LEU . . . -101.72 110.66 62.56 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-O 120.935 0.398 . . . . 0.0 110.809 -176.751 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 542' ' ' PRO . . . . . 0.624 ' HA ' HG13 ' A' ' 628' ' ' ILE . 16.9 Cg_exo -69.24 138.98 40.84 Favored 'Trans proline' 0 N--CA 1.461 -0.393 0 C-N-CA 123.11 2.54 . . . . 0.0 112.118 178.332 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 543' ' ' THR . . . . . 0.698 HG22 ' HD3' ' A' ' 514' ' ' ARG . 36.8 p -82.53 179.9 7.64 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.239 -178.912 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 544' ' ' ASN . . . . . 0.545 ' HA ' ' HE1' ' A' ' 517' ' ' MET . 14.9 m120 -56.65 -34.84 67.72 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.885 0.374 . . . . 0.0 111.181 179.522 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 545' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -73.07 -23.38 60.54 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.759 -174.906 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -69.16 -51.32 39.34 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-O 121.283 0.563 . . . . 0.0 110.709 179.826 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 547' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -71.65 -20.86 61.9 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.601 -179.369 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 548' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.62 -29.06 62.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.989 -0.551 . . . . 0.0 109.677 176.353 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 549' ' ' ALA . . . . . . . . . . . . . . . -89.32 2.91 53.71 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.368 -175.815 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 550' ' ' LEU . . . . . 0.458 ' HA ' ' HD3' ' A' ' 551' ' ' PRO . 75.3 mt -72.83 137.24 79.84 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.561 178.641 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 551' ' ' PRO . . . . . 0.593 ' HD2' ' HB2' ' A' ' 554' ' ' GLU . 17.5 Cg_exo -66.55 150.63 83.94 Favored 'Trans proline' 0 N--CA 1.461 -0.392 0 C-N-CA 122.819 2.346 . . . . 0.0 112.108 -177.364 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 552' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 551' ' ' PRO . 60.0 Cg_exo -53.4 -28.28 43.35 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 123.247 2.632 . . . . 0.0 112.98 -179.236 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 553' ' ' ARG . . . . . . . . . . . . . 23.0 mmt180 -81.11 -54.29 5.66 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.061 0.458 . . . . 0.0 110.041 -179.691 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 554' ' ' GLU . . . . . 0.593 ' HB2' ' HD2' ' A' ' 551' ' ' PRO . 3.3 mp0 -62.88 -37.64 87.7 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.52 -0.764 . . . . 0.0 112.201 -177.017 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 555' ' ' ARG . . . . . . . . . . . . . 36.5 ptt180 -63.79 -35.11 79.52 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.793 -0.363 . . . . 0.0 110.611 178.979 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 34.7 m -73.88 -32.05 63.43 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.224 0.535 . . . . 0.0 110.197 179.345 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 557' ' ' ARG . . . . . . . . . . . . . 63.5 mtp180 -68.05 -58.63 4.18 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.624 175.862 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 558' ' ' LEU . . . . . 0.598 ' O ' ' HG ' ' A' ' 565' ' ' LEU . 27.3 tp -62.39 -42.47 99.45 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.285 -172.729 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 559' ' ' LEU . . . . . . . . . . . . . 80.5 mt -88.21 13.0 12.34 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.972 0.415 . . . . 0.0 111.105 -178.152 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 560' ' ' GLY . . . . . . . . . . . . . . . -122.35 -41.2 0.48 Allowed Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.911 -0.662 . . . . 0.0 112.188 178.283 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 561' ' ' ASP . . . . . 0.4 ' OD1' ' HB3' ' A' ' 563' ' ' LYS . 16.9 t70 -99.52 116.75 32.37 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.924 0.392 . . . . 0.0 110.428 -179.395 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 562' ' ' ALA . . . . . . . . . . . . . . . -68.45 -21.55 64.64 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.788 -175.893 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 563' ' ' LYS . . . . . 0.4 ' HB3' ' OD1' ' A' ' 561' ' ' ASP . 59.6 tttm -78.78 -48.33 15.04 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 110.22 -0.289 . . . . 0.0 110.22 -178.599 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 564' ' ' GLU . . . . . 0.519 ' O ' HG12 ' A' ' 568' ' ' ILE . 40.7 mt-10 -57.65 -38.1 74.47 Favored 'General case' 0 C--N 1.332 -0.169 0 O-C-N 123.248 0.343 . . . . 0.0 110.107 177.233 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 565' ' ' LEU . . . . . 0.598 ' HG ' ' O ' ' A' ' 558' ' ' LEU . 3.7 mt -55.06 -54.16 46.64 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.63 174.512 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 566' ' ' ALA . . . . . . . . . . . . . . . -62.94 -37.76 88.34 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.475 -178.515 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 567' ' ' ASN . . . . . . . . . . . . . 12.1 m120 -67.41 -41.69 84.47 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.171 -178.76 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 568' ' ' ILE . . . . . 0.519 HG12 ' O ' ' A' ' 564' ' ' GLU . 48.8 mm -69.29 -34.3 62.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.903 0.382 . . . . 0.0 110.736 178.596 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 569' ' ' LEU . . . . . 0.558 ' HG ' ' O ' ' A' ' 565' ' ' LEU . 77.1 mt -64.72 -36.7 85.14 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.814 0.34 . . . . 0.0 110.881 177.037 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 570' ' ' LYS . . . . . 0.797 ' HE3' ' HA ' ' A' ' 593' ' ' GLN . 26.5 mtpp -63.93 -13.62 47.13 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.017 177.451 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 571' ' ' TYR . . . . . 0.419 ' O ' HD21 ' A' ' 597' ' ' LEU . 7.5 t80 -97.38 -16.0 20.43 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.069 -177.462 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 572' ' ' HIS . . . . . . . . . . . . . 59.6 m80 -95.31 -12.25 26.46 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.958 0.409 . . . . 0.0 111.274 -178.488 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 573' ' ' ILE . . . . . 0.521 HD13 HD21 ' A' ' 531' ' ' LEU . 21.3 mt -108.65 123.01 64.07 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.204 178.96 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 574' ' ' GLY . . . . . 0.547 ' HA2' ' HA ' ' A' ' 591' ' ' SER . . . -92.92 151.2 20.34 Favored Glycine 0 N--CA 1.447 -0.591 0 N-CA-C 111.505 -0.638 . . . . 0.0 111.505 175.137 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 575' ' ' ASP . . . . . 0.483 ' HB3' ' HE3' ' A' ' 590' ' ' LYS . 19.3 t70 -70.35 -21.18 62.91 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 112.879 0.696 . . . . 0.0 112.879 -171.07 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 576' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -149.67 153.06 36.4 Favored 'General case' 0 N--CA 1.439 -1.025 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 -174.69 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 577' ' ' ILE . . . . . 0.723 ' HA ' ' OG1' ' A' ' 538' ' ' THR . 77.3 mt -72.95 126.44 33.61 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 O-C-N 124.028 0.83 . . . . 0.0 112.14 -171.399 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 578' ' ' LEU . . . . . 0.572 HD21 ' HB ' ' A' ' 587' ' ' VAL . 41.9 tp -126.84 105.26 8.53 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 114.998 -1.001 . . . . 0.0 109.146 173.997 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 579' ' ' VAL . . . . . 0.525 ' CG1' ' H ' ' A' ' 581' ' ' GLY . 1.0 OUTLIER -102.08 167.57 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.106 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.11 -177.441 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 580' ' ' SER . . . . . 0.415 ' N ' HG13 ' A' ' 579' ' ' VAL . 20.2 m -57.82 -25.93 61.3 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.364 -0.835 . . . . 0.0 111.67 -175.164 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 581' ' ' GLY . . . . . 0.525 ' H ' ' CG1' ' A' ' 579' ' ' VAL . . . -87.29 -2.84 82.59 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.523 -176.799 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . -110.69 -18.59 8.34 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.37 -179.195 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 583' ' ' ILE . . . . . 0.412 HG13 ' O ' ' A' ' 579' ' ' VAL . 51.2 mt -70.96 -63.38 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.726 0.298 . . . . 0.0 111.2 -177.512 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 584' ' ' GLY . . . . . . . . . . . . . . . 81.53 -63.23 4.38 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.283 -178.175 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 585' ' ' ALA . . . . . . . . . . . . . . . -134.71 -71.01 0.49 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.781 0.324 . . . . 0.0 110.286 178.143 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 586' ' ' LEU . . . . . 0.54 HD13 ' HB3' ' A' ' 600' ' ' SER . 45.5 tp -147.27 132.68 18.59 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.44 -179.448 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 587' ' ' VAL . . . . . 0.572 ' HB ' HD21 ' A' ' 578' ' ' LEU . 57.5 t -137.93 129.17 38.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 116.022 -0.536 . . . . 0.0 109.661 176.655 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 588' ' ' ARG . . . . . 0.402 ' HG2' ' OE2' ' A' ' 598' ' ' GLU . 55.2 mtm180 -85.74 109.84 18.92 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.05 -179.251 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 589' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -95.79 124.88 40.0 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.812 -174.992 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 590' ' ' LYS . . . . . 0.483 ' HE3' ' HB3' ' A' ' 575' ' ' ASP . 47.4 pttt -77.96 138.93 39.12 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.11 0.481 . . . . 0.0 110.125 177.365 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 591' ' ' SER . . . . . 0.547 ' HA ' ' HA2' ' A' ' 574' ' ' GLY . 80.2 p -104.27 166.24 10.53 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.338 -177.953 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 592' ' ' LEU . . . . . . . . . . . . . 10.1 mp -68.73 -7.81 37.06 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.246 0.461 . . . . 0.0 112.246 178.173 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 593' ' ' GLN . . . . . 0.797 ' HA ' ' HE3' ' A' ' 570' ' ' LYS . 29.1 tt0 -80.61 -29.03 36.89 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.206 0.527 . . . . 0.0 109.661 173.455 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 594' ' ' GLY . . . . . . . . . . . . . . . 106.55 -13.56 42.86 Favored Glycine 0 N--CA 1.441 -0.993 0 N-CA-C 110.717 -0.953 . . . . 0.0 110.717 -172.327 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 595' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -81.36 -174.43 4.92 Favored 'General case' 0 C--O 1.237 0.396 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 179.304 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 596' ' ' LYS . . . . . . . . . . . . . 59.0 pttt -115.33 135.18 54.41 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.175 0.512 . . . . 0.0 111.422 -171.521 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 597' ' ' LEU . . . . . 0.419 HD21 ' O ' ' A' ' 571' ' ' TYR . 57.6 mt -106.04 114.46 28.61 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 168.771 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 598' ' ' GLU . . . . . 0.43 ' HG3' HD11 ' A' ' 586' ' ' LEU . 1.0 OUTLIER -83.4 92.07 7.48 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 -179.929 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 599' ' ' VAL . . . . . 0.525 ' HA ' ' O ' ' A' ' 607' ' ' SER . 43.2 t -98.4 118.78 45.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 121.245 0.545 . . . . 0.0 110.411 -177.175 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 600' ' ' SER . . . . . 0.54 ' HB3' HD13 ' A' ' 586' ' ' LEU . 2.7 p -129.43 151.77 49.7 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.059 -178.097 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 601' ' ' LEU . . . . . . . . . . . . . 47.6 tp -113.04 108.03 16.77 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.374 179.418 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 602' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -131.12 127.27 37.74 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.361 -177.336 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 603' ' ' ASN . . . . . . . . . . . . . 66.2 t30 62.49 27.45 16.28 Favored 'General case' 0 N--CA 1.464 0.273 0 O-C-N 123.652 0.595 . . . . 0.0 109.946 -178.603 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 604' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 69.19 12.72 8.53 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 115.137 -0.938 . . . . 0.0 111.513 -177.57 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 605' ' ' VAL . . . . . . . . . . . . . 48.6 t -110.85 123.33 66.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 176.828 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 606' ' ' VAL . . . . . 0.441 ' HB ' ' HB ' ' A' ' 613' ' ' VAL . 42.0 t -72.52 148.33 9.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.25 -179.8 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 607' ' ' SER . . . . . 0.525 ' O ' ' HA ' ' A' ' 599' ' ' VAL . 4.5 p -141.52 140.62 33.5 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.221 -0.445 . . . . 0.0 109.983 179.789 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 608' ' ' VAL . . . . . . . . . . . . . 3.8 p -126.13 110.36 23.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-O 121.059 0.456 . . . . 0.0 110.315 179.025 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 609' ' ' ASN . . . . . 0.473 ' O ' ' HB3' ' A' ' 610' ' ' LYS . 92.9 m-20 55.48 54.07 8.97 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.87 -179.64 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 610' ' ' LYS . . . . . 0.473 ' HB3' ' O ' ' A' ' 609' ' ' ASN . 61.8 tttp 77.59 -27.32 0.17 Allowed 'General case' 0 N--CA 1.469 0.475 0 CA-C-N 115.525 -0.762 . . . . 0.0 111.721 178.77 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 611' ' ' GLU . . . . . 0.533 ' HB3' ' ND2' ' A' ' 630' ' ' ASN . 6.0 mm-40 -80.35 123.42 83.05 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 120.646 0.26 . . . . 0.0 110.978 -178.482 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 612' ' ' PRO . . . . . 0.494 ' HD3' ' HA ' ' A' ' 611' ' ' GLU . 7.9 Cg_exo -72.75 145.05 40.39 Favored 'Trans proline' 0 CA--C 1.531 0.367 0 C-N-CA 123.0 2.467 . . . . 0.0 113.11 -178.73 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 613' ' ' VAL . . . . . 0.441 ' HB ' ' HB ' ' A' ' 606' ' ' VAL . 70.7 t -91.44 139.23 18.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.951 176.631 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 614' ' ' ALA . . . . . 0.569 ' HB2' HG23 ' A' ' 629' ' ' THR . . . -86.13 -36.21 19.71 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.125 -0.489 . . . . 0.0 112.063 -175.787 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 615' ' ' GLU . . . . . . . . . . . . . 20.4 tp10 -157.78 99.74 1.84 Allowed Pre-proline 0 C--N 1.327 -0.401 0 CA-C-O 121.046 0.45 . . . . 0.0 110.306 -176.593 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 616' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -90.13 168.87 4.36 Favored 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 123.326 2.684 . . . . 0.0 113.844 -178.318 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 77.29 32.74 0.44 Allowed 'General case' 0 CA--C 1.508 -0.657 0 CA-C-O 122.073 0.94 . . . . 0.0 111.025 163.611 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 618' ' ' ILE . . . . . 0.529 ' HB ' ' O ' ' A' ' 625' ' ' VAL . 18.1 mt -83.3 98.98 5.55 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.147 0 CA-C-N 114.149 -1.387 . . . . 0.0 109.29 174.198 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 619' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.96 130.08 36.1 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.777 -174.965 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 620' ' ' ALA . . . . . . . . . . . . . . . -130.76 177.04 7.71 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.524 173.599 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 621' ' ' THR . . . . . 0.469 HG22 ' HA ' ' A' ' 504' ' ' THR . 10.7 t -81.07 -14.58 57.68 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.44 -0.504 . . . . 0.0 111.59 -177.937 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 622' ' ' ASN . . . . . 0.504 ' HB2' HG13 ' A' ' 505' ' ' VAL . 7.5 m120 -102.69 -0.34 31.89 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.697 0.284 . . . . 0.0 110.643 179.311 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 623' ' ' GLY . . . . . 0.68 ' HA2' HD11 ' A' ' 577' ' ' ILE . . . 145.62 -140.12 8.75 Favored Glycine 0 N--CA 1.445 -0.76 0 C-N-CA 120.379 -0.915 . . . . 0.0 112.596 180.0 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 624' ' ' VAL . . . . . . . . . . . . . 4.8 p -126.45 156.02 36.97 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-O 120.898 0.38 . . . . 0.0 109.981 179.817 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 625' ' ' VAL . . . . . 0.529 ' O ' ' HB ' ' A' ' 618' ' ' ILE . 61.4 t -125.55 136.98 59.14 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.534 179.803 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 626' ' ' HIS . . . . . . . . . . . . . 94.3 m-70 -119.2 115.9 25.18 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-O 120.866 0.365 . . . . 0.0 110.052 177.242 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 627' ' ' VAL . . . . . 0.975 HG22 ' HZ ' ' A' ' 515' ' ' PHE . 38.6 t -70.18 124.95 27.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.334 177.865 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 628' ' ' ILE . . . . . 0.624 HG13 ' HA ' ' A' ' 542' ' ' PRO . 3.8 pt -123.97 145.03 31.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-O 121.368 0.604 . . . . 0.0 111.3 178.358 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 629' ' ' THR . . . . . 0.569 HG23 ' HB2' ' A' ' 614' ' ' ALA . 22.7 p -94.11 7.48 45.03 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.788 0.804 . . . . 0.0 109.836 179.782 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 630' ' ' ASN . . . . . 0.533 ' ND2' ' HB3' ' A' ' 611' ' ' GLU . 6.1 p30 -141.19 166.05 25.84 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 114.33 -1.305 . . . . 0.0 109.52 -177.164 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 631' ' ' VAL . . . . . 0.445 HG11 HD21 ' A' ' 550' ' ' LEU . 2.7 p -125.91 123.53 64.34 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.982 0 N-CA-C 110.26 -0.274 . . . . 0.0 110.26 -179.643 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 632' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -63.19 120.27 11.18 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-O 121.085 0.469 . . . . 0.0 111.092 -177.024 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 633' ' ' GLN . . . . . . . . . . . . . 57.1 tp60 -126.96 110.45 21.94 Favored Pre-proline 0 C--N 1.319 -0.743 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 178.188 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 634' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo . . . . . 0 C--O 1.249 1.05 0 C-N-CA 123.013 2.475 . . . . 0.0 111.872 -178.7 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.595 0 CA-C-O 121.068 0.26 . . . . 0.0 112.933 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 65.6 p -87.52 -176.04 5.44 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.728 0.299 . . . . 0.0 111.165 -176.205 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 505' ' ' VAL . . . . . 0.617 ' O ' ' HG ' ' A' ' 509' ' ' LEU . 21.4 t -54.16 -41.63 52.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.388 175.997 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 506' ' ' MET . . . . . . . . . . . . . 4.1 mmt -55.11 -43.07 73.7 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.538 179.013 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 507' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -61.68 -39.68 92.27 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.996 0.427 . . . . 0.0 111.022 179.395 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 508' ' ' VAL . . . . . . . . . . . . . 43.2 t -65.53 -46.38 89.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.512 179.074 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 509' ' ' LEU . . . . . 0.617 ' HG ' ' O ' ' A' ' 505' ' ' VAL . 39.0 mt -68.92 -20.8 64.24 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.482 -175.537 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -89.35 -15.99 32.06 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.329 -178.067 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 511' ' ' GLY . . . . . . . . . . . . . . . -82.07 -9.75 84.8 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.751 -0.738 . . . . 0.0 111.445 177.365 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 512' ' ' ASP . . . . . 0.5 ' O ' ' HB2' ' A' ' 516' ' ' SER . 28.1 t70 -120.3 146.99 45.57 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.521 -0.34 . . . . 0.0 110.872 179.359 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -75.52 -32.97 60.69 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.831 0.348 . . . . 0.0 111.434 -178.36 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 514' ' ' ARG . . . . . 0.48 ' HD3' ' HB ' ' A' ' 543' ' ' THR . 78.7 mtt180 -74.78 -49.39 21.03 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.128 0.49 . . . . 0.0 109.711 -176.749 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 515' ' ' PHE . . . . . 0.404 ' HZ ' HG22 ' A' ' 627' ' ' VAL . 15.2 m-30 -65.67 -26.0 67.59 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.809 178.684 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 516' ' ' SER . . . . . 0.5 ' HB2' ' O ' ' A' ' 512' ' ' ASP . 15.9 t -65.34 -26.53 68.07 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.111 -179.219 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 517' ' ' MET . . . . . 0.482 ' HE2' ' HB2' ' A' ' 517' ' ' MET . 33.9 mtm -72.02 -35.21 69.34 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 176.018 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 518' ' ' LEU . . . . . . . . . . . . . 61.4 tp -64.68 -39.13 93.14 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.716 173.837 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 519' ' ' VAL . . . . . . . . . . . . . 86.0 t -55.06 -36.85 40.43 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.147 0 CA-C-O 121.163 0.506 . . . . 0.0 110.277 174.506 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 520' ' ' ALA . . . . . . . . . . . . . . . -70.99 -42.82 69.17 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.77 -179.423 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 521' ' ' ALA . . . . . . . . . . . . . . . -64.49 -48.65 74.42 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.623 177.581 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 522' ' ' ILE . . . . . 0.626 HG23 ' HB2' ' A' ' 527' ' ' LEU . 88.6 mt -59.48 -38.85 77.31 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.923 178.694 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 523' ' ' GLN . . . . . . . . . . . . . 22.0 tm0? -64.71 -44.22 90.94 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.343 177.417 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 13.6 t -68.69 -35.87 77.76 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.749 -178.506 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 525' ' ' ALA . . . . . 0.452 ' HB1' ' HB2' ' A' ' 566' ' ' ALA . . . -73.85 -28.05 61.4 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.849 0.357 . . . . 0.0 111.354 179.344 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 526' ' ' GLY . . . . . . . . . . . . . . . 90.18 48.54 3.52 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.385 179.129 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 527' ' ' LEU . . . . . 0.626 ' HB2' HG23 ' A' ' 522' ' ' ILE . 93.1 mt -124.32 26.35 7.41 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.06 0.457 . . . . 0.0 110.233 178.578 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 528' ' ' THR . . . . . . . . . . . . . 24.5 m -74.86 -36.47 62.32 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.206 -175.37 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 529' ' ' GLU . . . . . 0.464 ' CD ' ' H ' ' A' ' 529' ' ' GLU . 1.9 mp0 -57.82 -36.25 71.99 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.685 -179.511 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 530' ' ' THR . . . . . . . . . . . . . 4.0 m -58.95 -43.13 91.2 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.653 -176.439 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 531' ' ' LEU . . . . . . . . . . . . . 59.1 mt -94.77 14.03 22.65 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.342 -175.582 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 532' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -90.98 -49.47 6.4 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.788 -178.028 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 533' ' ' ARG . . . . . 0.561 ' HG2' ' OE1' ' A' ' 534' ' ' GLU . 18.6 ttp180 -89.87 172.55 8.81 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 -178.662 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 534' ' ' GLU . . . . . 0.584 ' HA ' ' CB ' ' A' ' 622' ' ' ASN . 1.6 pm0 -90.56 -179.18 5.5 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-O 121.446 0.641 . . . . 0.0 111.634 -179.684 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 535' ' ' GLY . . . . . . . . . . . . . . . 142.66 -145.17 15.02 Favored Glycine 0 N--CA 1.446 -0.665 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -172.806 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 536' ' ' VAL . . . . . 0.466 ' HB ' HG13 ' A' ' 577' ' ' ILE . 29.1 m -127.63 130.64 70.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 117.774 0.787 . . . . 0.0 110.487 174.074 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 537' ' ' TYR . . . . . . . . . . . . . 93.2 m-85 -148.47 148.31 30.11 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.84 -179.765 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 538' ' ' THR . . . . . 0.775 ' OG1' ' HA ' ' A' ' 577' ' ' ILE . 37.0 m -127.6 102.01 6.65 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 174.182 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 539' ' ' VAL . . . . . 0.525 HG22 HG23 ' A' ' 573' ' ' ILE . 40.3 t -108.93 131.13 60.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.203 -173.449 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 540' ' ' PHE . . . . . 0.52 ' HB3' HD13 ' A' ' 628' ' ' ILE . 92.9 m-85 -101.48 109.98 21.9 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.376 174.685 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -96.02 115.48 65.59 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.498 -178.662 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 542' ' ' PRO . . . . . 0.524 ' HA ' HG13 ' A' ' 628' ' ' ILE . 6.7 Cg_exo -73.79 135.18 21.15 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 122.872 2.382 . . . . 0.0 111.619 178.176 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 543' ' ' THR . . . . . 0.48 ' HB ' ' HD3' ' A' ' 514' ' ' ARG . 34.4 p -75.98 -178.16 4.23 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.06 -179.092 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 544' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -67.27 -32.88 74.18 Favored 'General case' 0 CA--C 1.517 -0.308 0 N-CA-C 110.351 -0.24 . . . . 0.0 110.351 -177.574 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 545' ' ' GLU . . . . . 0.518 ' CD ' ' H ' ' A' ' 545' ' ' GLU . 1.6 mp0 -59.77 -35.43 74.6 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.246 178.205 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 546' ' ' ALA . . . . . 0.625 ' HB1' HG22 ' A' ' 631' ' ' VAL . . . -62.06 -47.51 84.35 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-O 121.275 0.56 . . . . 0.0 110.724 179.347 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 547' ' ' PHE . . . . . 0.651 ' HA ' HD23 ' A' ' 550' ' ' LEU . 94.2 m-85 -78.28 -21.95 49.02 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.797 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 548' ' ' ARG . . . . . . . . . . . . . 20.6 tpp180 -72.61 -35.04 67.76 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.963 177.95 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 549' ' ' ALA . . . . . . . . . . . . . . . -74.24 -16.08 60.97 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.278 -179.563 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 550' ' ' LEU . . . . . 0.806 HD11 ' HB3' ' A' ' 555' ' ' ARG . 0.2 OUTLIER -98.55 130.5 27.88 Favored Pre-proline 0 N--CA 1.445 -0.712 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 -179.298 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 551' ' ' PRO . . . . . 0.59 ' HD2' ' HB2' ' A' ' 554' ' ' GLU . 5.0 Cg_exo -77.26 160.52 32.67 Favored 'Trans proline' 0 CA--C 1.528 0.212 0 C-N-CA 123.705 2.937 . . . . 0.0 113.488 -169.145 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 552' ' ' PRO . . . . . 0.778 ' HA ' ' HG2' ' A' ' 555' ' ' ARG . 15.0 Cg_endo -58.88 -35.64 98.26 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 123.088 2.525 . . . . 0.0 112.21 176.453 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 553' ' ' ARG . . . . . . . . . . . . . 25.2 tpp180 -61.56 -47.39 85.73 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.383 179.591 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 554' ' ' GLU . . . . . 0.59 ' HB2' ' HD2' ' A' ' 551' ' ' PRO . 18.9 mm-40 -73.76 -44.96 54.66 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.314 -178.752 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 555' ' ' ARG . . . . . 0.806 ' HB3' HD11 ' A' ' 550' ' ' LEU . 14.4 ptp180 -59.06 -41.31 87.64 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 120.711 -0.396 . . . . 0.0 110.798 -179.173 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 13.1 t -65.02 -36.61 84.96 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.903 0.382 . . . . 0.0 110.457 -178.248 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 557' ' ' ARG . . . . . . . . . . . . . 16.3 mmm180 -61.34 -46.26 90.96 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.883 176.143 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 558' ' ' LEU . . . . . . . . . . . . . 51.7 tp -70.85 -56.35 6.49 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.188 -0.914 . . . . 0.0 111.586 -177.29 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 559' ' ' LEU . . . . . 0.715 ' HG ' ' O ' ' A' ' 555' ' ' ARG . 3.9 pp -73.77 -8.6 56.65 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 120.951 -0.3 . . . . 0.0 111.452 -174.662 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 560' ' ' GLY . . . . . . . . . . . . . . . -66.87 -34.46 87.24 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.958 -0.639 . . . . 0.0 111.605 175.283 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 561' ' ' ASP . . . . . 0.471 ' OD2' ' HB3' ' A' ' 563' ' ' LYS . 14.7 t70 -111.59 121.56 45.47 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.829 0.347 . . . . 0.0 110.673 -179.55 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 562' ' ' ALA . . . . . . . . . . . . . . . -65.45 -28.87 69.54 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.161 -178.631 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 563' ' ' LYS . . . . . 0.471 ' HB3' ' OD2' ' A' ' 561' ' ' ASP . 14.5 ttpp -66.09 -52.16 51.34 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.267 -178.604 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 564' ' ' GLU . . . . . 0.512 ' HA ' ' HB3' ' A' ' 567' ' ' ASN . 8.9 mt-10 -71.76 -24.43 61.77 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.584 -179.487 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 565' ' ' LEU . . . . . 0.489 HD23 ' HA ' ' A' ' 565' ' ' LEU . 9.9 mt -59.39 -55.16 38.22 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 109.368 -0.605 . . . . 0.0 109.368 169.606 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 566' ' ' ALA . . . . . 0.452 ' HB2' ' HB1' ' A' ' 525' ' ' ALA . . . -64.4 -34.75 78.91 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.343 179.274 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 567' ' ' ASN . . . . . 0.512 ' HB3' ' HA ' ' A' ' 564' ' ' GLU . 39.9 t30 -56.43 -54.47 45.33 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.154 -179.854 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 568' ' ' ILE . . . . . . . . . . . . . 48.9 mm -70.93 -37.32 67.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.746 0.308 . . . . 0.0 111.068 -177.739 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 569' ' ' LEU . . . . . 0.419 ' HG ' ' O ' ' A' ' 565' ' ' LEU . 95.5 mt -65.2 -33.45 76.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.041 0.448 . . . . 0.0 110.946 178.289 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 570' ' ' LYS . . . . . 0.565 ' HE2' ' HA ' ' A' ' 593' ' ' GLN . 80.0 tttt -67.2 -16.73 64.48 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.559 -178.946 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 571' ' ' TYR . . . . . . . . . . . . . 45.5 t80 -89.98 -17.76 27.27 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.04 177.595 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 572' ' ' HIS . . . . . . . . . . . . . 53.2 m80 -86.07 -10.3 55.18 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.722 0.296 . . . . 0.0 111.158 -177.549 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 573' ' ' ILE . . . . . 0.525 HG23 HG22 ' A' ' 539' ' ' VAL . 31.2 mt -109.79 120.84 61.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.808 -179.137 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 574' ' ' GLY . . . . . 0.586 ' HA2' ' HA ' ' A' ' 591' ' ' SER . . . -98.62 148.26 18.79 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.909 -0.663 . . . . 0.0 111.663 175.052 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 575' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -93.4 9.07 37.97 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 111.936 0.347 . . . . 0.0 111.936 -173.693 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 576' ' ' GLU . . . . . 0.441 ' O ' HD21 ' A' ' 589' ' ' LEU . 12.2 pt-20 -144.92 133.32 21.84 Favored 'General case' 0 CA--C 1.508 -0.652 0 N-CA-C 109.765 -0.458 . . . . 0.0 109.765 178.616 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 577' ' ' ILE . . . . . 0.775 ' HA ' ' OG1' ' A' ' 538' ' ' THR . 76.3 mt -75.32 117.2 19.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.435 -175.513 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 578' ' ' LEU . . . . . 0.45 ' HB2' HD23 ' A' ' 589' ' ' LEU . 48.7 tp -118.41 108.65 15.31 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.318 -0.856 . . . . 0.0 109.858 176.841 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 579' ' ' VAL . . . . . . . . . . . . . 29.0 m -91.26 160.67 2.68 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.135 177.688 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 580' ' ' SER . . . . . . . . . . . . . 6.1 p -58.18 -42.81 86.89 Favored 'General case' 0 C--N 1.328 -0.355 0 O-C-N 123.292 0.37 . . . . 0.0 111.436 -176.613 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 581' ' ' GLY . . . . . . . . . . . . . . . -71.78 -11.86 73.9 Favored Glycine 0 CA--C 1.521 0.412 0 C-N-CA 120.964 -0.636 . . . . 0.0 113.087 -178.928 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . -96.71 -9.96 55.85 Favored Glycine 0 N--CA 1.454 -0.135 0 C-N-CA 121.043 -0.599 . . . . 0.0 112.508 -179.179 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 583' ' ' ILE . . . . . . . . . . . . . 58.7 mt -70.38 -60.21 2.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 121.06 0.457 . . . . 0.0 110.926 -178.295 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 584' ' ' GLY . . . . . . . . . . . . . . . 82.15 -89.04 1.44 Allowed Glycine 0 N--CA 1.444 -0.775 0 C-N-CA 120.55 -0.833 . . . . 0.0 111.383 -176.604 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 585' ' ' ALA . . . . . . . . . . . . . . . -102.71 -75.12 0.61 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.087 0.47 . . . . 0.0 110.351 178.184 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 586' ' ' LEU . . . . . 0.882 ' HG ' ' HB2' ' A' ' 600' ' ' SER . 5.7 tt -155.23 134.05 12.08 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 179.227 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 587' ' ' VAL . . . . . 0.442 ' N ' HD23 ' A' ' 586' ' ' LEU . 61.9 t -132.22 137.11 55.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 N-CA-C 110.199 -0.297 . . . . 0.0 110.199 -178.111 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 588' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -84.98 112.57 20.71 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 177.519 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 589' ' ' LEU . . . . . 0.672 ' HB3' ' HB2' ' A' ' 597' ' ' LEU . 1.9 tm? -89.9 121.09 31.69 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 -177.916 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 590' ' ' LYS . . . . . . . . . . . . . 33.8 mttp -87.86 131.16 34.65 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 121.303 0.573 . . . . 0.0 111.239 -172.315 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 591' ' ' SER . . . . . 0.586 ' HA ' ' HA2' ' A' ' 574' ' ' GLY . 84.0 p -97.41 159.78 14.72 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 114.973 -1.012 . . . . 0.0 110.718 -177.038 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 592' ' ' LEU . . . . . . . . . . . . . 9.9 mp -63.45 -21.18 66.16 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.491 177.631 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 593' ' ' GLN . . . . . 0.565 ' HA ' ' HE2' ' A' ' 570' ' ' LYS . 55.7 tt0 -73.0 -29.12 62.8 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.068 0.461 . . . . 0.0 110.291 175.895 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 594' ' ' GLY . . . . . . . . . . . . . . . 112.75 -14.21 24.54 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.172 -179.26 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 595' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -79.65 169.0 18.62 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-O 121.127 0.489 . . . . 0.0 111.106 179.268 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 596' ' ' LYS . . . . . . . . . . . . . 20.0 pttp -106.89 123.42 48.14 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.579 -174.25 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 597' ' ' LEU . . . . . 0.672 ' HB2' ' HB3' ' A' ' 589' ' ' LEU . 40.1 mt -87.73 122.14 31.03 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.947 173.526 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 598' ' ' GLU . . . . . 0.761 ' O ' ' HA ' ' A' ' 608' ' ' VAL . 18.2 tt0 -75.89 94.05 3.3 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.234 177.702 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 599' ' ' VAL . . . . . . . . . . . . . 41.5 t -107.84 121.71 61.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-O 121.317 0.58 . . . . 0.0 110.32 178.32 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 600' ' ' SER . . . . . 0.882 ' HB2' ' HG ' ' A' ' 586' ' ' LEU . 34.9 t -141.8 168.71 19.1 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.703 -177.13 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 601' ' ' LEU . . . . . . . . . . . . . 42.4 tp -135.95 107.78 7.07 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.111 -0.95 . . . . 0.0 108.738 -178.479 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 602' ' ' LYS . . . . . 0.606 ' O ' HG12 ' A' ' 605' ' ' VAL . 57.0 mtpt -131.02 114.33 15.06 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.076 -172.832 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 603' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 57.83 47.16 15.78 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.704 177.663 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 604' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 71.97 9.32 6.09 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 114.855 -1.066 . . . . 0.0 112.967 174.683 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 605' ' ' VAL . . . . . 0.606 HG12 ' O ' ' A' ' 602' ' ' LYS . 7.6 p -118.2 134.26 62.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 C-N-CA 120.146 -0.621 . . . . 0.0 110.326 173.829 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 606' ' ' VAL . . . . . 0.812 HG13 ' HB ' ' A' ' 613' ' ' VAL . 3.9 p -101.64 136.93 31.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.043 178.318 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 607' ' ' SER . . . . . . . . . . . . . 45.0 m -136.93 151.03 48.58 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.759 -177.585 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 608' ' ' VAL . . . . . 0.761 ' HA ' ' O ' ' A' ' 598' ' ' GLU . 4.3 p -128.62 108.41 17.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.411 0.624 . . . . 0.0 110.059 176.956 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 609' ' ' ASN . . . . . 0.407 ' O ' ' HB2' ' A' ' 610' ' ' LYS . 25.0 m120 60.34 47.98 8.41 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.638 -176.415 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 610' ' ' LYS . . . . . 0.407 ' HB2' ' O ' ' A' ' 609' ' ' ASN . 56.0 mtpt 73.17 -19.02 0.34 Allowed 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 115.534 -0.757 . . . . 0.0 112.097 -178.533 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 611' ' ' GLU . . . . . 0.428 ' HA ' ' HD3' ' A' ' 612' ' ' PRO . 5.2 mm-40 -79.16 123.74 84.71 Favored Pre-proline 0 C--N 1.331 -0.213 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 -179.359 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 612' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 611' ' ' GLU . 7.3 Cg_exo -73.12 136.12 24.07 Favored 'Trans proline' 0 C--O 1.236 0.382 0 C-N-CA 123.235 2.623 . . . . 0.0 112.939 -176.193 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 613' ' ' VAL . . . . . 0.812 ' HB ' HG13 ' A' ' 606' ' ' VAL . 93.7 t -81.83 130.5 35.7 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.92 175.712 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 614' ' ' ALA . . . . . . . . . . . . . . . -78.44 -33.39 48.55 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.503 -176.239 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 615' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -165.47 107.53 0.77 Allowed Pre-proline 0 C--O 1.233 0.197 0 CA-C-O 120.835 0.35 . . . . 0.0 110.576 -179.673 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 616' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_endo -89.32 156.37 5.52 Favored 'Trans proline' 0 N--CA 1.459 -0.524 0 C-N-CA 123.29 2.66 . . . . 0.0 114.008 -178.065 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 35.3 t70 77.95 61.94 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 122.687 1.232 . . . . 0.0 110.463 166.524 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 618' ' ' ILE . . . . . 0.435 ' HB ' ' O ' ' A' ' 625' ' ' VAL . 7.9 mt -104.73 112.83 39.95 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.301 0 CA-C-N 113.757 -1.565 . . . . 0.0 108.438 174.695 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 619' ' ' MET . . . . . 0.467 ' HA ' ' CE ' ' A' ' 619' ' ' MET . 4.9 mmt -77.83 131.36 37.53 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 -170.588 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 620' ' ' ALA . . . . . . . . . . . . . . . -130.23 162.6 28.57 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 114.995 -1.002 . . . . 0.0 108.466 170.318 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 621' ' ' THR . . . . . . . . . . . . . 5.7 t -73.86 -20.37 60.44 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 120.502 -0.479 . . . . 0.0 111.351 -175.753 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 622' ' ' ASN . . . . . 0.584 ' CB ' ' HA ' ' A' ' 534' ' ' GLU . 28.2 p-10 -116.84 15.54 15.28 Favored 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 120.642 -0.423 . . . . 0.0 111.986 -177.362 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 623' ' ' GLY . . . . . 0.635 ' HA2' HD11 ' A' ' 577' ' ' ILE . . . 157.07 -156.22 27.03 Favored Glycine 0 N--CA 1.443 -0.872 0 C-N-CA 119.97 -1.109 . . . . 0.0 112.762 179.437 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 624' ' ' VAL . . . . . . . . . . . . . 6.3 p -131.22 156.11 42.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-O 121.033 0.444 . . . . 0.0 110.115 -178.201 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 625' ' ' VAL . . . . . 0.541 HG22 HG13 ' A' ' 505' ' ' VAL . 42.6 t -123.74 132.93 70.56 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.645 179.416 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 626' ' ' HIS . . . . . . . . . . . . . 96.2 m-70 -119.16 115.35 24.05 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 174.883 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 627' ' ' VAL . . . . . 0.404 HG22 ' HZ ' ' A' ' 515' ' ' PHE . 40.4 t -69.87 123.74 24.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.719 -179.8 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 628' ' ' ILE . . . . . 0.524 HG13 ' HA ' ' A' ' 542' ' ' PRO . 8.1 pt -117.51 143.28 28.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 121.192 0.52 . . . . 0.0 111.063 176.436 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 629' ' ' THR . . . . . . . . . . . . . 8.4 t -94.85 5.77 50.93 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.369 -178.857 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 630' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -135.96 165.83 24.76 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.052 -179.437 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 631' ' ' VAL . . . . . 0.625 HG22 ' HB1' ' A' ' 546' ' ' ALA . 0.7 OUTLIER -98.17 130.14 47.38 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.886 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.755 175.91 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 632' ' ' LEU . . . . . 0.662 HD21 HG13 ' A' ' 608' ' ' VAL . 96.1 mt -77.32 115.93 17.51 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.242 0.544 . . . . 0.0 110.922 -177.355 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 633' ' ' GLN . . . . . . . . . . . . . 7.1 tp60 -118.51 117.18 34.63 Favored Pre-proline 0 C--N 1.322 -0.599 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.937 -178.221 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 634' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo . . . . . 0 C--O 1.251 1.133 0 C-N-CA 122.65 2.233 . . . . 0.0 111.944 177.42 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.703 0 N-CA-C 111.697 -0.561 . . . . 0.0 111.697 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 78.9 p -86.14 173.11 10.06 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.912 0.356 . . . . 0.0 110.536 -179.359 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 505' ' ' VAL . . . . . 0.538 ' O ' ' HG ' ' A' ' 509' ' ' LEU . 24.2 t -53.57 -40.6 42.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 121.224 0.535 . . . . 0.0 110.009 175.098 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 506' ' ' MET . . . . . . . . . . . . . 7.4 mmt -56.5 -40.65 75.32 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.021 -0.991 . . . . 0.0 112.296 179.809 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 507' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -67.63 -40.91 84.6 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 121.035 0.445 . . . . 0.0 110.564 -179.821 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 508' ' ' VAL . . . . . . . . . . . . . 62.1 t -60.66 -41.38 87.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.416 178.601 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 509' ' ' LEU . . . . . 0.538 ' HG ' ' O ' ' A' ' 505' ' ' VAL . 53.9 mt -75.33 -23.26 57.24 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.693 -179.853 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 510' ' ' LYS . . . . . 0.567 ' HB3' ' NZ ' ' A' ' 510' ' ' LYS . 1.6 mmmp? -85.8 -33.36 21.38 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.084 -176.688 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 511' ' ' GLY . . . . . . . . . . . . . . . -73.4 -10.75 79.45 Favored Glycine 0 N--CA 1.445 -0.741 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.928 178.702 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 512' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -110.23 148.61 31.53 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.24 0.543 . . . . 0.0 111.278 -178.2 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -75.19 -33.0 61.37 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.617 -177.73 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 514' ' ' ARG . . . . . 0.682 ' H ' ' HD2' ' A' ' 514' ' ' ARG . 0.3 OUTLIER -88.46 -45.06 10.26 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.059 0.457 . . . . 0.0 110.039 -171.906 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 515' ' ' PHE . . . . . 0.708 ' HZ ' HG22 ' A' ' 627' ' ' VAL . 14.8 m-30 -63.9 -24.69 67.84 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.155 177.523 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 26.5 t -60.76 -36.4 78.85 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.887 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 517' ' ' MET . . . . . . . . . . . . . 59.3 mtm -65.39 -34.5 78.44 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-O 121.003 0.43 . . . . 0.0 110.093 177.957 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 518' ' ' LEU . . . . . . . . . . . . . 56.1 tp -66.96 -39.8 87.33 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.436 174.661 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 519' ' ' VAL . . . . . . . . . . . . . 58.1 t -54.84 -37.66 41.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-O 121.093 0.473 . . . . 0.0 109.808 174.823 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 520' ' ' ALA . . . . . . . . . . . . . . . -65.02 -39.98 94.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.627 -179.268 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 521' ' ' ALA . . . . . . . . . . . . . . . -69.08 -43.58 74.27 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.465 176.438 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 522' ' ' ILE . . . . . . . . . . . . . 89.3 mt -58.01 -41.81 81.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.224 177.05 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 523' ' ' GLN . . . . . . . . . . . . . 17.6 mm-40 -65.22 -23.96 67.22 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-O 121.011 0.434 . . . . 0.0 111.405 178.774 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 30.0 t -79.66 -41.11 27.6 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.535 177.501 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 525' ' ' ALA . . . . . . . . . . . . . . . -82.29 -29.0 31.4 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.118 0.414 . . . . 0.0 112.118 -176.625 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 526' ' ' GLY . . . . . . . . . . . . . . . 95.08 25.45 14.39 Favored Glycine 0 CA--C 1.519 0.327 0 C-N-CA 120.546 -0.835 . . . . 0.0 113.332 176.883 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 527' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -91.58 8.39 36.88 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 121.173 0.511 . . . . 0.0 110.171 178.342 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 528' ' ' THR . . . . . . . . . . . . . 16.9 m -57.87 -44.05 86.4 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.439 -0.8 . . . . 0.0 111.238 -178.282 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 529' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -65.48 -31.31 72.31 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.026 -0.533 . . . . 0.0 111.352 -176.732 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 530' ' ' THR . . . . . . . . . . . . . 12.4 m -63.21 -46.57 86.4 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.108 -179.238 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 531' ' ' LEU . . . . . . . . . . . . . 42.4 mt -90.44 8.28 34.5 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 120.978 0.418 . . . . 0.0 111.236 -177.156 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 532' ' ' ASN . . . . . . . . . . . . . 63.1 t30 -95.01 -25.15 16.61 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.019 -177.195 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 533' ' ' ARG . . . . . . . . . . . . . 69.1 mtm180 -92.39 157.69 16.47 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.345 -177.819 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 534' ' ' GLU . . . . . 0.583 ' HA ' ' HB3' ' A' ' 622' ' ' ASN . 12.7 pt-20 -78.75 162.76 25.92 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.758 178.567 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 535' ' ' GLY . . . . . . . . . . . . . . . 139.05 -138.63 9.5 Favored Glycine 0 N--CA 1.446 -0.67 0 N-CA-C 110.302 -1.119 . . . . 0.0 110.302 -176.113 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 536' ' ' VAL . . . . . 0.556 ' HB ' HG13 ' A' ' 577' ' ' ILE . 35.3 m -127.07 129.06 71.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 121.229 0.538 . . . . 0.0 111.043 176.417 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 537' ' ' TYR . . . . . 0.436 ' O ' ' HA3' ' A' ' 623' ' ' GLY . 69.2 m-85 -153.07 130.89 11.66 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.595 -0.729 . . . . 0.0 109.695 179.003 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 538' ' ' THR . . . . . 0.707 ' OG1' ' HA ' ' A' ' 577' ' ' ILE . 28.3 m -114.62 106.3 14.08 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.961 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 539' ' ' VAL . . . . . . . . . . . . . 40.0 t -112.15 130.86 65.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-O 121.021 0.439 . . . . 0.0 111.35 -174.954 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 540' ' ' PHE . . . . . 0.474 ' HB3' HD13 ' A' ' 628' ' ' ILE . 87.5 m-85 -97.68 111.2 23.58 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 174.056 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 541' ' ' ALA . . . . . 0.404 ' HA ' ' HD3' ' A' ' 542' ' ' PRO . . . -101.73 118.38 59.7 Favored Pre-proline 0 C--N 1.325 -0.471 0 CA-C-O 120.669 0.271 . . . . 0.0 110.887 -177.029 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 542' ' ' PRO . . . . . 0.539 ' HA ' HG13 ' A' ' 628' ' ' ILE . 7.4 Cg_exo -74.08 141.52 29.71 Favored 'Trans proline' 0 N--CA 1.461 -0.401 0 C-N-CA 123.155 2.57 . . . . 0.0 112.149 178.339 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 61.0 p -81.66 -176.61 6.15 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.683 -179.124 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 544' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -61.13 -32.7 72.39 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 121.352 0.596 . . . . 0.0 110.162 179.067 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 545' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -59.5 -40.48 87.22 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.037 -0.983 . . . . 0.0 110.939 -179.517 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 546' ' ' ALA . . . . . 0.693 ' HB1' HG23 ' A' ' 631' ' ' VAL . . . -61.54 -50.18 73.7 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.559 -177.993 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 547' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -69.51 -20.86 63.7 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.136 -177.884 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 548' ' ' ARG . . . . . . . . . . . . . 30.5 tpt180 -83.37 -33.89 25.71 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.056 0.455 . . . . 0.0 110.236 177.527 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 549' ' ' ALA . . . . . . . . . . . . . . . -75.5 -21.38 58.06 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.375 -0.83 . . . . 0.0 111.441 -179.69 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 550' ' ' LEU . . . . . 0.617 HD11 HG21 ' A' ' 631' ' ' VAL . 73.5 mt -69.85 129.1 91.38 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-O 120.772 0.32 . . . . 0.0 111.058 178.385 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 551' ' ' PRO . . . . . 0.487 ' HD3' ' HA ' ' A' ' 550' ' ' LEU . 5.1 Cg_exo -77.78 148.29 25.32 Favored 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 123.061 2.508 . . . . 0.0 111.209 -179.207 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 552' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 551' ' ' PRO . 50.1 Cg_exo -53.85 -34.42 75.6 Favored 'Trans proline' 0 N--CA 1.471 0.194 0 C-N-CA 122.915 2.41 . . . . 0.0 112.435 -178.768 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 553' ' ' ARG . . . . . . . . . . . . . 34.8 mtp180 -62.24 -42.78 99.62 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.539 179.77 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -83.78 -35.01 24.65 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.808 0.337 . . . . 0.0 110.84 179.589 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 555' ' ' ARG . . . . . . . . . . . . . 14.4 mtp180 -58.05 -42.56 85.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.137 176.108 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 28.5 t -59.93 -28.55 67.71 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.863 -178.561 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 557' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -67.14 -62.91 1.2 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.357 0.599 . . . . 0.0 110.193 176.377 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 558' ' ' LEU . . . . . 0.573 ' O ' ' HG ' ' A' ' 565' ' ' LEU . 53.2 tp -68.88 -52.66 27.25 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.26 -0.882 . . . . 0.0 112.107 -172.422 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 559' ' ' LEU . . . . . . . . . . . . . 72.5 mt -80.33 4.74 16.87 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.802 -170.739 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 560' ' ' GLY . . . . . . . . . . . . . . . -123.66 3.97 9.33 Favored Glycine 0 N--CA 1.446 -0.7 0 C-N-CA 120.381 -0.914 . . . . 0.0 112.619 -179.794 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 561' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -135.82 128.67 31.16 Favored 'General case' 0 C--N 1.326 -0.431 0 O-C-N 122.538 -0.389 . . . . 0.0 111.051 -178.676 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 562' ' ' ALA . . . . . . . . . . . . . . . -70.32 -38.54 74.95 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.677 -176.132 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 563' ' ' LYS . . . . . 0.48 ' HG2' ' OE1' ' A' ' 564' ' ' GLU . 31.4 tttm -66.65 -47.87 71.18 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.036 -178.394 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 564' ' ' GLU . . . . . 0.48 ' OE1' ' HG2' ' A' ' 563' ' ' LYS . 5.7 mm-40 -67.33 -36.0 80.54 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.602 -0.272 . . . . 0.0 110.786 -179.436 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 565' ' ' LEU . . . . . 0.573 ' HG ' ' O ' ' A' ' 558' ' ' LEU . 6.6 mt -56.62 -52.52 64.56 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-O 120.893 0.377 . . . . 0.0 110.331 174.812 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 566' ' ' ALA . . . . . 0.5 ' O ' ' HG3' ' A' ' 570' ' ' LYS . . . -61.16 -48.71 80.34 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.34 -179.038 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 567' ' ' ASN . . . . . . . . . . . . . 9.8 t30 -59.84 -48.08 83.15 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.822 -177.861 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 568' ' ' ILE . . . . . . . . . . . . . 43.4 mm -69.47 -35.27 65.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.706 0.289 . . . . 0.0 111.459 -178.698 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 569' ' ' LEU . . . . . 0.49 ' HG ' ' O ' ' A' ' 565' ' ' LEU . 61.2 mt -66.23 -36.95 84.35 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.813 -0.355 . . . . 0.0 110.59 177.128 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 570' ' ' LYS . . . . . 0.5 ' HG3' ' O ' ' A' ' 566' ' ' ALA . 53.2 mtpt -69.33 -9.84 55.16 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.682 0.277 . . . . 0.0 111.061 177.355 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 571' ' ' TYR . . . . . 0.408 ' O ' HD21 ' A' ' 597' ' ' LEU . 33.9 t80 -92.78 -18.93 22.29 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.87 0.367 . . . . 0.0 110.525 179.065 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 572' ' ' HIS . . . . . . . . . . . . . 67.2 m80 -92.93 -7.08 47.06 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.17 0.509 . . . . 0.0 110.581 179.75 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 573' ' ' ILE . . . . . . . . . . . . . 54.0 mt -113.75 124.12 70.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.885 179.018 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 574' ' ' GLY . . . . . 0.502 ' HA3' ' CD2' ' A' ' 589' ' ' LEU . . . -113.95 149.7 18.67 Favored Glycine 0 N--CA 1.445 -0.74 0 N-CA-C 110.575 -1.01 . . . . 0.0 110.575 171.48 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 575' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -100.35 24.51 8.73 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 117.553 0.677 . . . . 0.0 110.879 -177.0 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 576' ' ' GLU . . . . . 0.421 ' HG3' ' HG ' ' A' ' 589' ' ' LEU . 14.8 pt-20 -136.21 125.88 25.46 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 175.426 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 577' ' ' ILE . . . . . 0.707 ' HA ' ' OG1' ' A' ' 538' ' ' THR . 61.2 mt -77.57 115.07 18.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.147 -175.423 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 578' ' ' LEU . . . . . 0.562 HD11 ' HA ' ' A' ' 583' ' ' ILE . 48.7 tp -121.67 103.44 8.89 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.267 -0.879 . . . . 0.0 109.791 177.85 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 579' ' ' VAL . . . . . 0.497 ' O ' HG13 ' A' ' 583' ' ' ILE . 30.4 m -95.36 162.41 2.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.964 178.035 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 580' ' ' SER . . . . . . . . . . . . . 15.3 m -56.6 -45.93 81.14 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 123.354 0.409 . . . . 0.0 111.914 -175.722 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 581' ' ' GLY . . . . . . . . . . . . . . . -70.43 -21.17 77.42 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.52 -0.848 . . . . 0.0 112.619 -179.104 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . -99.43 2.64 57.6 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.876 -0.678 . . . . 0.0 113.296 -175.222 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 583' ' ' ILE . . . . . 0.562 ' HA ' HD11 ' A' ' 578' ' ' LEU . 62.7 mt -67.75 -65.21 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 117.183 0.491 . . . . 0.0 111.1 179.142 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 584' ' ' GLY . . . . . . . . . . . . . . . 78.83 78.32 0.84 Allowed Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.241 -0.981 . . . . 0.0 111.556 -175.388 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 585' ' ' ALA . . . . . . . . . . . . . . . 70.68 -80.12 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 123.303 0.641 . . . . 0.0 111.88 -178.884 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 586' ' ' LEU . . . . . 0.96 ' HG ' ' HB3' ' A' ' 600' ' ' SER . 6.4 tt -151.32 129.02 11.54 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.7 0.286 . . . . 0.0 110.654 -175.458 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 587' ' ' VAL . . . . . . . . . . . . . 68.3 t -148.02 119.65 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.848 -0.614 . . . . 0.0 109.62 179.107 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 588' ' ' ARG . . . . . 0.551 ' HG2' ' HA ' ' A' ' 598' ' ' GLU . 92.3 mtt180 -85.36 123.06 30.39 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.125 0.488 . . . . 0.0 110.875 -179.131 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 589' ' ' LEU . . . . . 0.527 HD12 ' HB3' ' A' ' 578' ' ' LEU . 6.2 tt -90.56 125.63 35.68 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 114.749 -1.114 . . . . 0.0 109.77 -172.775 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 590' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -76.72 132.31 39.24 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.169 0.509 . . . . 0.0 110.774 -179.157 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 591' ' ' SER . . . . . . . . . . . . . 78.3 p -99.76 159.85 14.75 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.744 -176.885 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 592' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -58.01 -25.64 61.37 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 116.187 -0.46 . . . . 0.0 112.053 179.177 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 593' ' ' GLN . . . . . . . . . . . . . 19.3 tt0 -68.39 -27.09 65.91 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.175 0.512 . . . . 0.0 110.664 178.763 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 594' ' ' GLY . . . . . . . . . . . . . . . 107.17 -4.95 35.72 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.744 -0.741 . . . . 0.0 111.369 -174.663 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 595' ' ' ASP . . . . . 0.401 ' HB3' ' CE1' ' A' ' 571' ' ' TYR . 2.2 t70 -88.81 -176.78 5.34 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 179.22 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 596' ' ' LYS . . . . . 0.679 ' N ' ' HD3' ' A' ' 596' ' ' LYS . 0.0 OUTLIER -125.56 129.74 50.29 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.078 0.466 . . . . 0.0 110.875 -172.283 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 597' ' ' LEU . . . . . 0.408 HD21 ' O ' ' A' ' 571' ' ' TYR . 59.7 mt -93.46 119.53 32.65 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.63 177.453 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 598' ' ' GLU . . . . . 0.551 ' HA ' ' HG2' ' A' ' 588' ' ' ARG . 10.7 tp10 -75.76 86.55 2.77 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.356 -179.74 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 599' ' ' VAL . . . . . . . . . . . . . 49.3 t -105.86 125.43 61.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 121.198 0.523 . . . . 0.0 110.395 -179.415 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 600' ' ' SER . . . . . 0.96 ' HB3' ' HG ' ' A' ' 586' ' ' LEU . 3.0 p -142.72 157.43 44.66 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.107 -179.114 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 601' ' ' LEU . . . . . 0.494 ' HB2' HD12 ' A' ' 583' ' ' ILE . 33.9 tp -123.06 122.92 39.66 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.096 -177.525 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 602' ' ' LYS . . . . . . . . . . . . . 34.9 ttmt -139.42 109.26 6.32 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.712 0.292 . . . . 0.0 110.515 -177.482 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 603' ' ' ASN . . . . . . . . . . . . . 18.7 m120 61.75 46.77 6.74 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.61 178.963 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 604' ' ' ASN . . . . . . . . . . . . . 15.9 t-20 76.64 -8.77 1.61 Allowed 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 115.307 -0.86 . . . . 0.0 111.777 177.277 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 605' ' ' VAL . . . . . . . . . . . . . 49.0 t -94.14 126.43 46.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-O 120.75 0.309 . . . . 0.0 110.198 -179.789 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 606' ' ' VAL . . . . . 0.553 HG13 ' HB ' ' A' ' 613' ' ' VAL . 6.7 p -108.76 131.11 60.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.625 -179.665 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 607' ' ' SER . . . . . . . . . . . . . 45.2 p -131.92 144.4 50.81 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.2 -179.203 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 608' ' ' VAL . . . . . 0.473 ' HA ' ' O ' ' A' ' 598' ' ' GLU . 4.4 p -118.83 115.04 46.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.81 176.205 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 609' ' ' ASN . . . . . . . . . . . . . 95.7 m-20 61.79 32.33 18.2 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.093 -176.378 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 610' ' ' LYS . . . . . 0.533 ' NZ ' ' HB2' ' A' ' 610' ' ' LYS . 0.0 OUTLIER 81.48 -6.18 1.54 Allowed 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 114.792 -1.094 . . . . 0.0 111.134 -179.176 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 611' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -87.11 111.34 40.13 Favored Pre-proline 0 C--N 1.326 -0.42 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 177.438 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 612' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -65.41 135.23 41.83 Favored 'Trans proline' 0 N--CA 1.462 -0.361 0 C-N-CA 122.634 2.223 . . . . 0.0 112.185 -178.901 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 613' ' ' VAL . . . . . 0.553 ' HB ' HG13 ' A' ' 606' ' ' VAL . 89.8 t -73.84 125.01 32.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.068 177.823 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 614' ' ' ALA . . . . . 0.69 ' HB2' HG23 ' A' ' 629' ' ' THR . . . -64.65 -45.34 87.18 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.748 -177.82 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 615' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -154.46 99.04 2.48 Favored Pre-proline 0 N--CA 1.466 0.374 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.782 -177.91 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 616' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -88.87 162.29 6.09 Favored 'Trans proline' 0 N--CA 1.459 -0.51 0 C-N-CA 123.026 2.484 . . . . 0.0 114.195 -176.836 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 37.5 t0 77.33 46.93 0.06 Allowed 'General case' 0 C--O 1.234 0.272 0 CA-C-O 122.735 1.255 . . . . 0.0 110.114 165.238 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 618' ' ' ILE . . . . . 0.474 ' HB ' ' O ' ' A' ' 625' ' ' VAL . 11.6 mt -90.63 113.5 26.62 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.812 0 CA-C-N 113.503 -1.681 . . . . 0.0 109.674 174.302 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 619' ' ' MET . . . . . . . . . . . . . 7.7 mmt -77.2 133.48 38.9 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 -170.207 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 620' ' ' ALA . . . . . . . . . . . . . . . -130.31 170.92 13.5 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 115.113 -0.949 . . . . 0.0 108.802 170.097 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 621' ' ' THR . . . . . . . . . . . . . 5.0 t -81.32 -23.99 37.47 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.775 -0.37 . . . . 0.0 111.056 -178.53 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 622' ' ' ASN . . . . . 0.583 ' HB3' ' HA ' ' A' ' 534' ' ' GLU . 29.7 p-10 -117.11 22.64 12.4 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.844 0.354 . . . . 0.0 111.066 -176.953 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 623' ' ' GLY . . . . . 0.47 ' HA2' HD11 ' A' ' 577' ' ' ILE . . . 152.52 -147.11 16.38 Favored Glycine 0 N--CA 1.444 -0.796 0 C-N-CA 120.231 -0.985 . . . . 0.0 112.68 177.469 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 624' ' ' VAL . . . . . . . . . . . . . 9.5 p -144.46 158.51 14.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 -177.37 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 625' ' ' VAL . . . . . 0.474 ' O ' ' HB ' ' A' ' 618' ' ' ILE . 60.9 t -125.85 135.4 64.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 -179.828 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 626' ' ' HIS . . . . . . . . . . . . . 95.5 m-70 -119.33 116.15 25.61 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.23 -0.441 . . . . 0.0 109.946 175.748 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 627' ' ' VAL . . . . . 0.708 HG22 ' HZ ' ' A' ' 515' ' ' PHE . 48.3 t -70.24 125.67 28.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.281 179.75 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 628' ' ' ILE . . . . . 0.539 HG13 ' HA ' ' A' ' 542' ' ' PRO . 7.9 pt -121.28 145.88 27.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 121.32 0.581 . . . . 0.0 111.018 176.679 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 629' ' ' THR . . . . . 0.69 HG23 ' HB2' ' A' ' 614' ' ' ALA . 16.9 p -90.35 -3.33 57.81 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.493 -0.776 . . . . 0.0 112.197 -176.737 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 630' ' ' ASN . . . . . . . . . . . . . 64.1 t30 -141.91 175.05 10.03 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.503 -0.555 . . . . 0.0 109.503 -179.405 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 631' ' ' VAL . . . . . 0.693 HG23 ' HB1' ' A' ' 546' ' ' ALA . 51.2 t -106.21 123.79 61.13 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 N-CA-C 109.484 -0.562 . . . . 0.0 109.484 -178.729 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 632' ' ' LEU . . . . . 0.4 HD21 HG13 ' A' ' 608' ' ' VAL . 88.4 mt -68.24 126.08 28.44 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.042 0.449 . . . . 0.0 111.46 -173.069 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 633' ' ' GLN . . . . . . . . . . . . . 82.9 mm-40 -118.44 119.77 32.64 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.058 -178.979 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 634' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo . . . . . 0 C--O 1.251 1.139 0 C-N-CA 122.685 2.257 . . . . 0.0 112.171 177.59 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 500' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.058 0 CA-C-O 120.768 0.318 . . . . 0.0 110.875 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 501' ' ' GLY . . . . . . . . . . . . . . . 97.16 164.56 32.31 Favored Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 120.938 -0.649 . . . . 0.0 111.695 -177.834 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 502' ' ' MET . . . . . . . . . . . . . 4.7 mpp? -108.29 -65.65 1.11 Allowed 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.868 0.366 . . . . 0.0 110.112 178.456 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . -158.87 -128.59 1.0 Allowed Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.132 177.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 504' ' ' THR . . . . . 0.602 ' HA ' HG22 ' A' ' 621' ' ' THR . 33.7 p -78.85 172.35 13.88 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.539 0.209 . . . . 0.0 110.582 179.29 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 505' ' ' VAL . . . . . 0.713 ' O ' ' HG ' ' A' ' 509' ' ' LEU . 13.0 m -57.85 -34.96 49.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.696 -0.229 . . . . 0.0 110.929 176.125 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 506' ' ' MET . . . . . . . . . . . . . 95.0 mmm -61.5 -35.93 79.07 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-O 120.77 0.319 . . . . 0.0 110.928 178.687 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 507' ' ' ASP . . . . . 0.748 ' HA ' ' HE3' ' A' ' 510' ' ' LYS . 23.0 t70 -67.49 -35.85 79.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.279 -178.686 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 508' ' ' VAL . . . . . . . . . . . . . 45.8 t -71.92 -41.37 69.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 115.63 -0.713 . . . . 0.0 110.58 178.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 509' ' ' LEU . . . . . 0.713 ' HG ' ' O ' ' A' ' 505' ' ' VAL . 77.4 mt -62.73 -31.74 72.73 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.745 -176.672 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 510' ' ' LYS . . . . . 0.748 ' HE3' ' HA ' ' A' ' 507' ' ' ASP . 22.8 pttp -88.62 -13.71 39.25 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.061 0.458 . . . . 0.0 110.618 -177.741 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 511' ' ' GLY . . . . . . . . . . . . . . . -85.21 -11.57 75.48 Favored Glycine 0 N--CA 1.442 -0.947 0 C-N-CA 120.463 -0.875 . . . . 0.0 110.976 175.34 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 512' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -108.84 134.58 51.34 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.894 0.378 . . . . 0.0 110.194 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -72.88 -22.52 60.75 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.537 -176.547 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 514' ' ' ARG . . . . . . . . . . . . . 63.9 mtm180 -84.16 -33.85 24.14 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 120.987 0.422 . . . . 0.0 110.352 -176.799 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 515' ' ' PHE . . . . . 0.995 ' HZ ' HG22 ' A' ' 627' ' ' VAL . 11.5 m-30 -81.1 -7.73 59.62 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.408 -179.788 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 23.2 t -58.93 -43.32 91.14 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.872 -174.186 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 517' ' ' MET . . . . . . . . . . . . . 4.3 mpp? -67.18 -30.35 70.28 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-O 120.879 0.371 . . . . 0.0 110.504 179.346 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 518' ' ' LEU . . . . . 0.484 HD22 ' HA ' ' A' ' 541' ' ' ALA . 61.8 tp -68.68 -41.28 79.44 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.66 -0.416 . . . . 0.0 109.903 177.1 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 519' ' ' VAL . . . . . 0.426 ' O ' ' HG3' ' A' ' 523' ' ' GLN . 61.3 t -56.94 -36.42 50.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.086 0.47 . . . . 0.0 109.955 175.067 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 520' ' ' ALA . . . . . . . . . . . . . . . -69.67 -39.46 77.01 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.436 -179.451 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 521' ' ' ALA . . . . . . . . . . . . . . . -67.26 -46.65 73.07 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.299 176.091 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 522' ' ' ILE . . . . . 0.416 HG13 ' O ' ' A' ' 518' ' ' LEU . 71.5 mt -55.07 -45.46 76.98 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.072 177.248 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 523' ' ' GLN . . . . . 0.426 ' HG3' ' O ' ' A' ' 519' ' ' VAL . 92.8 mt-30 -65.46 -44.73 86.28 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.314 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 24.2 t -69.71 -32.46 71.04 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.567 -176.648 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 525' ' ' ALA . . . . . 0.521 ' HB1' ' HB2' ' A' ' 566' ' ' ALA . . . -86.32 -25.48 25.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.725 0.298 . . . . 0.0 111.265 -179.37 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 526' ' ' GLY . . . . . . . . . . . . . . . 90.76 31.71 9.87 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 121.009 -0.615 . . . . 0.0 112.564 177.424 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 527' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -92.16 -4.7 53.86 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.549 0.214 . . . . 0.0 111.303 -179.114 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 528' ' ' THR . . . . . . . . . . . . . 8.1 m -54.24 -37.85 65.12 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.824 -176.428 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 529' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -62.84 -19.51 64.18 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 112.219 0.452 . . . . 0.0 112.219 -176.798 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 530' ' ' THR . . . . . . . . . . . . . 84.8 m -75.06 -54.7 6.71 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.94 0.4 . . . . 0.0 110.18 177.266 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 531' ' ' LEU . . . . . 0.666 ' H ' HD22 ' A' ' 531' ' ' LEU . 1.4 mm? -75.53 -5.33 44.69 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.26 179.457 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 532' ' ' ASN . . . . . . . . . . . . . 61.3 t30 -81.44 -5.8 58.28 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.196 178.726 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 533' ' ' ARG . . . . . . . . . . . . . 29.6 mmm180 -110.12 146.9 34.67 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.283 178.68 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 534' ' ' GLU . . . . . 0.673 ' HA ' ' CB ' ' A' ' 622' ' ' ASN . 35.7 mt-10 -90.74 155.25 18.94 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.893 0.378 . . . . 0.0 110.253 177.572 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 535' ' ' GLY . . . . . . . . . . . . . . . 151.83 -132.74 3.9 Favored Glycine 0 N--CA 1.447 -0.62 0 N-CA-C 110.834 -0.907 . . . . 0.0 110.834 -174.374 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 536' ' ' VAL . . . . . 0.442 ' HA ' HD11 ' A' ' 577' ' ' ILE . 33.8 m -123.17 128.41 74.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 120.965 0.412 . . . . 0.0 110.851 177.888 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 537' ' ' TYR . . . . . . . . . . . . . 82.2 m-85 -155.16 152.94 30.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.057 179.526 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 538' ' ' THR . . . . . 0.663 ' OG1' ' HA ' ' A' ' 577' ' ' ILE . 94.6 m -130.42 102.8 6.33 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.213 -0.449 . . . . 0.0 109.994 174.825 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 539' ' ' VAL . . . . . . . . . . . . . 26.6 t -100.89 125.75 54.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 120.937 0.399 . . . . 0.0 111.411 -172.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 540' ' ' PHE . . . . . 0.608 ' HB3' HD13 ' A' ' 628' ' ' ILE . 97.3 m-85 -98.47 111.57 23.88 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 173.362 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 541' ' ' ALA . . . . . 0.484 ' HA ' HD22 ' A' ' 518' ' ' LEU . . . -102.08 115.41 64.69 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 116.651 -0.25 . . . . 0.0 111.263 -176.799 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 542' ' ' PRO . . . . . 0.47 ' HA ' HG13 ' A' ' 628' ' ' ILE . 13.4 Cg_exo -71.02 141.02 39.17 Favored 'Trans proline' 0 N--CA 1.463 -0.279 0 C-N-CA 123.146 2.564 . . . . 0.0 112.195 177.376 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 41.7 p -85.85 -177.03 6.25 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.058 178.763 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 544' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -59.72 -40.36 87.71 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 121.387 0.613 . . . . 0.0 109.958 -179.057 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 545' ' ' GLU . . . . . 0.511 ' CD ' ' H ' ' A' ' 545' ' ' GLU . 3.3 mp0 -58.15 -39.11 77.97 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 114.736 -1.12 . . . . 0.0 110.812 -178.148 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 546' ' ' ALA . . . . . 0.621 ' HB1' HG13 ' A' ' 631' ' ' VAL . . . -63.96 -43.51 95.59 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.027 0.441 . . . . 0.0 111.232 -178.4 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 547' ' ' PHE . . . . . . . . . . . . . 75.1 m-85 -72.87 -27.75 62.1 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.151 -179.007 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 548' ' ' ARG . . . . . 0.443 ' O ' ' HD2' ' A' ' 548' ' ' ARG . 5.5 tmm_? -80.33 -29.07 38.04 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.219 0.533 . . . . 0.0 109.912 179.161 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 549' ' ' ALA . . . . . . . . . . . . . . . -76.09 -17.68 59.51 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.232 179.657 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 550' ' ' LEU . . . . . 0.715 ' HB3' ' HB3' ' A' ' 555' ' ' ARG . 20.0 mt -58.31 134.3 84.94 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.089 178.116 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 551' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 550' ' ' LEU . 28.0 Cg_exo -62.84 143.9 92.55 Favored 'Trans proline' 0 C--O 1.234 0.308 0 C-N-CA 122.909 2.406 . . . . 0.0 111.766 -179.582 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 552' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -53.67 -38.0 84.16 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 123.261 2.64 . . . . 0.0 112.249 -177.7 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 553' ' ' ARG . . . . . . . . . . . . . 22.4 mmm180 -69.05 -52.92 23.56 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.851 -178.52 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 18.2 mt-10 -66.69 -51.22 58.53 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.712 -0.676 . . . . 0.0 112.42 -175.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 555' ' ' ARG . . . . . 0.715 ' HB3' ' HB3' ' A' ' 550' ' ' LEU . 18.6 ptt180 -67.4 -27.64 67.26 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 120.445 -0.502 . . . . 0.0 111.396 -175.063 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 47.1 t -71.21 -31.55 67.75 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.733 0.301 . . . . 0.0 110.701 177.858 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 557' ' ' ARG . . . . . 0.427 HH11 ' HD3' ' A' ' 557' ' ' ARG . 8.7 tpt180 -83.28 -53.03 6.06 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.487 -179.411 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 558' ' ' LEU . . . . . 0.55 HD22 ' HB3' ' A' ' 564' ' ' GLU . 0.3 OUTLIER -57.48 -47.36 82.11 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.23 -0.896 . . . . 0.0 111.429 -174.602 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 559' ' ' LEU . . . . . 0.676 HD23 HD21 ' A' ' 565' ' ' LEU . 93.5 mt -77.81 0.7 22.78 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.563 -175.161 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 560' ' ' GLY . . . . . . . . . . . . . . . -97.2 -11.51 52.05 Favored Glycine 0 N--CA 1.445 -0.746 0 C-N-CA 120.444 -0.884 . . . . 0.0 112.585 -178.287 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 561' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -132.23 127.91 36.78 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.923 0.392 . . . . 0.0 111.205 -177.282 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 562' ' ' ALA . . . . . . . . . . . . . . . -64.31 -29.24 70.33 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.909 -0.587 . . . . 0.0 112.227 -176.896 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 563' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -78.71 -39.85 35.34 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 -177.472 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 564' ' ' GLU . . . . . 0.55 ' HB3' HD22 ' A' ' 558' ' ' LEU . 44.5 mt-10 -64.25 -34.52 78.3 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.164 -0.471 . . . . 0.0 109.937 175.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 565' ' ' LEU . . . . . 0.676 HD21 HD23 ' A' ' 559' ' ' LEU . 58.1 mt -64.34 -52.42 58.49 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.986 175.031 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 566' ' ' ALA . . . . . 0.521 ' HB2' ' HB1' ' A' ' 525' ' ' ALA . . . -56.4 -40.71 75.09 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.821 -176.548 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 567' ' ' ASN . . . . . . . . . . . . . 47.5 t30 -60.97 -47.91 84.27 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.757 -177.882 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 568' ' ' ILE . . . . . . . . . . . . . 50.6 mm -69.87 -33.42 55.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.389 -177.583 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 569' ' ' LEU . . . . . 0.436 ' HG ' ' O ' ' A' ' 565' ' ' LEU . 78.7 mt -65.98 -33.47 75.89 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.541 -0.3 . . . . 0.0 111.517 -179.15 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 570' ' ' LYS . . . . . 0.53 ' HE3' ' HA ' ' A' ' 593' ' ' GLN . 28.0 mtpp -66.94 -18.7 65.5 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.135 179.807 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 571' ' ' TYR . . . . . . . . . . . . . 20.5 t80 -87.12 -18.26 30.88 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.223 178.366 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 572' ' ' HIS . . . . . . . . . . . . . 62.5 m80 -89.09 -12.14 42.02 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.883 0.373 . . . . 0.0 111.403 -178.487 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 573' ' ' ILE . . . . . 0.406 ' O ' HD23 ' A' ' 592' ' ' LEU . 38.5 mt -108.64 119.69 58.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.359 179.105 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 574' ' ' GLY . . . . . 0.572 ' HA2' ' HA ' ' A' ' 591' ' ' SER . . . -91.97 151.24 20.68 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.99 -0.624 . . . . 0.0 111.941 177.179 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 575' ' ' ASP . . . . . 0.414 ' HB3' ' HG3' ' A' ' 590' ' ' LYS . 6.4 t70 -93.99 9.3 38.11 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.087 0.47 . . . . 0.0 110.703 -173.782 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 576' ' ' GLU . . . . . 0.572 ' OE1' ' HG2' ' A' ' 590' ' ' LYS . 42.8 mt-10 -142.08 126.12 17.3 Favored 'General case' 0 CA--C 1.511 -0.521 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.951 -176.063 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 577' ' ' ILE . . . . . 0.663 ' HA ' ' OG1' ' A' ' 538' ' ' THR . 58.5 mt -76.06 105.11 4.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 121.218 0.532 . . . . 0.0 111.235 -177.861 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 578' ' ' LEU . . . . . 0.438 ' HG ' HG11 ' A' ' 587' ' ' VAL . 3.9 mm? -119.7 100.79 7.47 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.153 176.644 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 579' ' ' VAL . . . . . 0.544 ' O ' HG13 ' A' ' 583' ' ' ILE . 34.0 m -86.82 166.89 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 109.614 -0.514 . . . . 0.0 109.614 175.079 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 580' ' ' SER . . . . . . . . . . . . . 20.8 m -57.12 -40.13 76.5 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.893 0.377 . . . . 0.0 111.226 -176.084 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 581' ' ' GLY . . . . . . . . . . . . . . . -76.26 -8.7 85.61 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.783 -179.412 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . -103.24 -27.12 6.65 Favored Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.918 -177.564 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 583' ' ' ILE . . . . . 0.544 HG13 ' O ' ' A' ' 579' ' ' VAL . 77.1 mt -60.27 -59.02 4.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 120.893 0.377 . . . . 0.0 111.548 -178.158 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 584' ' ' GLY . . . . . . . . . . . . . . . 94.23 -81.29 0.96 Allowed Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.236 -178.823 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 585' ' ' ALA . . . . . . . . . . . . . . . -128.07 -62.26 1.06 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.753 0.311 . . . . 0.0 110.929 179.782 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 586' ' ' LEU . . . . . 0.958 ' HG ' ' HB3' ' A' ' 600' ' ' SER . 3.9 tt -155.3 140.2 17.25 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 178.344 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 587' ' ' VAL . . . . . 0.521 ' N ' HD23 ' A' ' 586' ' ' LEU . 9.3 p -142.18 136.92 29.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-O 121.102 0.477 . . . . 0.0 111.086 -178.515 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 588' ' ' ARG . . . . . . . . . . . . . 8.2 ttt180 -85.03 101.49 12.44 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.625 174.182 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 589' ' ' LEU . . . . . . . . . . . . . 2.7 tt -97.53 128.77 44.54 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.45 -0.796 . . . . 0.0 109.456 -175.843 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 590' ' ' LYS . . . . . 0.572 ' HG2' ' OE1' ' A' ' 576' ' ' GLU . 27.8 pttt -82.03 143.65 31.41 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 120.691 -0.404 . . . . 0.0 110.795 178.706 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 591' ' ' SER . . . . . 0.572 ' HA ' ' HA2' ' A' ' 574' ' ' GLY . 80.3 p -105.1 165.15 11.29 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.597 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 592' ' ' LEU . . . . . 0.406 HD23 ' O ' ' A' ' 573' ' ' ILE . 3.5 mm? -66.88 -9.17 35.08 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 178.572 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 593' ' ' GLN . . . . . 0.53 ' HA ' ' HE3' ' A' ' 570' ' ' LYS . 57.2 tt0 -86.01 -29.46 23.46 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.103 0.477 . . . . 0.0 110.359 176.283 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 594' ' ' GLY . . . . . . . . . . . . . . . 117.94 -21.21 10.42 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.559 -0.829 . . . . 0.0 111.784 -176.834 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 595' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -78.37 179.28 7.08 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 109.271 -0.641 . . . . 0.0 109.271 177.271 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 596' ' ' LYS . . . . . 0.803 ' H ' ' HD3' ' A' ' 596' ' ' LYS . 0.0 OUTLIER -115.8 140.29 49.36 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-O 121.027 0.442 . . . . 0.0 110.316 -175.741 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 597' ' ' LEU . . . . . . . . . . . . . 71.0 mt -101.39 117.17 34.41 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.934 -0.575 . . . . 0.0 109.601 173.752 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 598' ' ' GLU . . . . . 0.498 ' OE1' ' HG2' ' A' ' 596' ' ' LYS . 1.6 mp0 -80.89 84.86 6.3 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.204 0.525 . . . . 0.0 110.006 178.225 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 599' ' ' VAL . . . . . . . . . . . . . 26.1 t -93.29 126.53 45.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.586 -0.733 . . . . 0.0 109.738 -179.727 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 600' ' ' SER . . . . . 0.958 ' HB3' ' HG ' ' A' ' 586' ' ' LEU . 23.9 p -135.01 159.33 41.84 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.251 0.548 . . . . 0.0 111.692 -178.32 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 601' ' ' LEU . . . . . . . . . . . . . 27.5 tp -130.45 108.77 10.21 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.014 -0.994 . . . . 0.0 109.0 179.524 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 602' ' ' LYS . . . . . . . . . . . . . 8.6 ptpp? -137.07 131.68 33.09 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 110.113 -0.329 . . . . 0.0 110.113 -179.037 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 603' ' ' ASN . . . . . . . . . . . . . 84.9 m-20 65.06 25.54 12.58 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.743 -176.466 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 604' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 71.59 10.3 6.43 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 114.952 -1.022 . . . . 0.0 110.164 -177.286 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 605' ' ' VAL . . . . . . . . . . . . . 62.1 t -101.11 119.23 48.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.936 177.004 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 606' ' ' VAL . . . . . 0.686 HG13 ' HB ' ' A' ' 613' ' ' VAL . 5.6 p -91.11 137.31 22.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 121.104 0.478 . . . . 0.0 110.635 178.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 607' ' ' SER . . . . . . . . . . . . . 18.5 m -143.34 140.02 30.35 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.862 -179.457 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 608' ' ' VAL . . . . . . . . . . . . . 3.8 p -113.63 114.3 46.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.637 176.777 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 609' ' ' ASN . . . . . . . . . . . . . 84.4 m-20 57.04 44.55 22.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.244 -175.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 610' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 76.9 -19.67 0.41 Allowed 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.141 0.977 . . . . 0.0 112.443 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 611' ' ' GLU . . . . . 0.477 ' HA ' ' HD3' ' A' ' 612' ' ' PRO . 46.7 mm-40 -79.28 121.27 82.79 Favored Pre-proline 0 C--N 1.332 -0.172 0 CA-C-O 120.831 0.348 . . . . 0.0 110.386 179.085 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 612' ' ' PRO . . . . . 0.477 ' HD3' ' HA ' ' A' ' 611' ' ' GLU . 11.7 Cg_exo -70.39 146.56 56.67 Favored 'Trans proline' 0 CA--C 1.529 0.255 0 C-N-CA 123.038 2.492 . . . . 0.0 112.935 -178.422 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 613' ' ' VAL . . . . . 0.686 ' HB ' HG13 ' A' ' 606' ' ' VAL . 85.4 t -87.85 135.63 25.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.979 177.604 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 614' ' ' ALA . . . . . . . . . . . . . . . -84.5 -31.91 24.22 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.553 -175.349 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 615' ' ' GLU . . . . . 0.499 ' HB3' ' CG2' ' A' ' 627' ' ' VAL . 8.7 tp10 -161.92 92.32 1.37 Allowed Pre-proline 0 C--N 1.327 -0.407 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 -177.597 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 616' ' ' PRO . . . . . 0.408 ' HB3' HG11 ' A' ' 613' ' ' VAL . 60.8 Cg_endo -89.77 165.67 5.02 Favored 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 123.078 2.519 . . . . 0.0 114.035 -176.315 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 617' ' ' ASP . . . . . 0.447 ' OD2' ' HB ' ' A' ' 579' ' ' VAL . 0.9 OUTLIER 76.81 34.54 0.43 Allowed 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 122.33 1.062 . . . . 0.0 110.514 165.78 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 618' ' ' ILE . . . . . 0.513 ' HB ' ' O ' ' A' ' 625' ' ' VAL . 13.6 mt -78.02 109.59 12.8 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.969 0 CA-C-N 113.92 -1.491 . . . . 0.0 109.327 172.254 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 619' ' ' MET . . . . . . . . . . . . . 8.0 mmt -80.08 131.34 35.74 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.87 -0.604 . . . . 0.0 112.034 -174.13 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 620' ' ' ALA . . . . . . . . . . . . . . . -130.6 173.07 11.24 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.262 173.358 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 621' ' ' THR . . . . . 0.602 HG22 ' HA ' ' A' ' 504' ' ' THR . 6.3 t -72.14 -29.4 64.01 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.887 0.375 . . . . 0.0 111.239 -176.857 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 622' ' ' ASN . . . . . 0.673 ' CB ' ' HA ' ' A' ' 534' ' ' GLU . 28.7 p-10 -117.34 22.7 12.29 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 112.168 0.433 . . . . 0.0 112.168 -173.745 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 623' ' ' GLY . . . . . . . . . . . . . . . 151.05 -154.85 25.82 Favored Glycine 0 N--CA 1.442 -0.919 0 C-N-CA 119.631 -1.271 . . . . 0.0 113.056 176.836 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 624' ' ' VAL . . . . . 0.503 HG21 HG12 ' A' ' 579' ' ' VAL . 9.7 p -129.65 159.0 42.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 N-CA-C 109.932 -0.395 . . . . 0.0 109.932 -179.707 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 625' ' ' VAL . . . . . 0.513 ' O ' ' HB ' ' A' ' 618' ' ' ILE . 67.9 t -128.04 132.3 68.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.819 178.606 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 626' ' ' HIS . . . . . . . . . . . . . 69.6 m-70 -118.46 112.3 19.77 Favored 'General case' 0 N--CA 1.445 -0.68 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 177.509 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 627' ' ' VAL . . . . . 0.995 HG22 ' HZ ' ' A' ' 515' ' ' PHE . 38.5 t -64.38 126.11 22.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.146 178.757 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 628' ' ' ILE . . . . . 0.608 HD13 ' HB3' ' A' ' 540' ' ' PHE . 5.4 pt -121.06 142.52 36.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.064 0.459 . . . . 0.0 110.701 176.0 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 629' ' ' THR . . . . . . . . . . . . . 9.5 t -97.31 2.87 51.2 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.778 0.799 . . . . 0.0 109.851 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 630' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -132.77 157.56 44.64 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.086 -0.961 . . . . 0.0 108.833 178.1 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 631' ' ' VAL . . . . . 0.621 HG13 ' HB1' ' A' ' 546' ' ' ALA . 23.8 m -92.79 156.28 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.015 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 176.363 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 632' ' ' LEU . . . . . . . . . . . . . 92.2 mt -106.1 110.89 23.3 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-O 121.281 0.562 . . . . 0.0 110.521 -178.446 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 633' ' ' GLN . . . . . 0.481 ' HA ' ' HD3' ' A' ' 634' ' ' PRO . 53.8 mt-30 -117.44 130.76 24.44 Favored Pre-proline 0 C--N 1.319 -0.735 0 CA-C-N 115.122 -0.944 . . . . 0.0 109.936 -177.675 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 634' ' ' PRO . . . . . 0.481 ' HD3' ' HA ' ' A' ' 633' ' ' GLN . 14.2 Cg_exo . . . . . 0 C--O 1.25 1.113 0 C-N-CA 122.814 2.343 . . . . 0.0 111.722 177.528 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 500' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 0.995 0 CA-C-O 120.755 0.312 . . . . 0.0 110.506 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 501' ' ' GLY . . . . . . . . . . . . . . . 103.03 -132.71 11.12 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.786 -0.721 . . . . 0.0 111.89 178.558 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 502' ' ' MET . . . . . . . . . . . . . 48.7 ttm -75.79 94.92 3.37 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.959 0.409 . . . . 0.0 110.19 179.053 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . -153.41 -175.77 25.14 Favored Glycine 0 N--CA 1.448 -0.545 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.77 179.668 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 31.5 p -90.01 -179.28 5.66 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.366 0.127 . . . . 0.0 110.875 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 505' ' ' VAL . . . . . 0.672 ' O ' ' HG ' ' A' ' 509' ' ' LEU . 22.2 t -50.43 -47.61 26.49 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.275 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.223 179.826 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 506' ' ' MET . . . . . 0.473 ' HG2' ' HB2' ' A' ' 531' ' ' LEU . 90.8 mmm -57.37 -34.81 69.22 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.993 -176.135 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 507' ' ' ASP . . . . . 0.468 ' HA ' ' NZ ' ' A' ' 510' ' ' LYS . 12.1 t70 -76.13 -35.64 59.16 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.799 0.333 . . . . 0.0 110.133 -178.675 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 508' ' ' VAL . . . . . . . . . . . . . 64.3 t -66.0 -39.61 85.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.473 178.868 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 509' ' ' LEU . . . . . 0.672 ' HG ' ' O ' ' A' ' 505' ' ' VAL . 22.8 mt -65.61 -19.92 66.11 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.048 -178.97 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 510' ' ' LYS . . . . . 0.468 ' NZ ' ' HA ' ' A' ' 507' ' ' ASP . 30.2 mtmm -81.62 -24.96 36.08 Favored 'General case' 0 CA--C 1.514 -0.432 0 CA-C-O 121.223 0.535 . . . . 0.0 110.024 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 511' ' ' GLY . . . . . . . . . . . . . . . -80.38 -8.17 87.83 Favored Glycine 0 N--CA 1.443 -0.872 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.806 179.715 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 512' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -118.9 152.99 35.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.341 0.591 . . . . 0.0 111.769 -178.423 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 43.2 t-20 -76.82 -39.41 51.41 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.408 -0.815 . . . . 0.0 111.095 -178.856 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 514' ' ' ARG . . . . . . . . . . . . . 3.0 mpp_? -80.58 -34.31 35.39 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.105 0.479 . . . . 0.0 110.808 -171.565 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 515' ' ' PHE . . . . . 0.544 ' CZ ' HG22 ' A' ' 627' ' ' VAL . 14.5 m-30 -75.99 -8.25 56.51 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.827 178.798 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 16.8 t -59.05 -38.55 79.62 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.673 -176.071 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 517' ' ' MET . . . . . 0.546 ' HE3' ' HA ' ' A' ' 544' ' ' ASN . 3.4 mpp? -68.61 -26.56 65.42 Favored 'General case' 0 CA--C 1.519 -0.219 0 C-N-CA 120.787 -0.365 . . . . 0.0 111.025 -179.821 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 518' ' ' LEU . . . . . 0.557 HD13 HD11 ' A' ' 522' ' ' ILE . 3.3 mt -65.49 -43.29 90.64 Favored 'General case' 0 CA--C 1.517 -0.312 0 C-N-CA 120.261 -0.575 . . . . 0.0 109.554 174.201 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 519' ' ' VAL . . . . . 0.692 ' O ' ' HB2' ' A' ' 523' ' ' GLN . 30.1 t -55.09 -31.68 26.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.129 0.49 . . . . 0.0 110.41 178.455 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 520' ' ' ALA . . . . . . . . . . . . . . . -84.29 -46.71 11.51 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.46 178.497 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 521' ' ' ALA . . . . . . . . . . . . . . . -64.73 -52.52 56.64 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.872 0.368 . . . . 0.0 110.934 -178.926 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 522' ' ' ILE . . . . . 0.557 HD11 HD13 ' A' ' 518' ' ' LEU . 41.2 mt -59.67 -26.93 36.45 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.306 177.75 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 523' ' ' GLN . . . . . 0.692 ' HB2' ' O ' ' A' ' 519' ' ' VAL . 49.8 tp60 -69.49 -51.98 30.8 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.398 179.297 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 38.7 t -71.53 -23.37 61.76 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.587 -176.03 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 525' ' ' ALA . . . . . . . . . . . . . . . -81.87 -17.81 46.03 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 120.972 -0.291 . . . . 0.0 111.266 178.49 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 526' ' ' GLY . . . . . . . . . . . . . . . 82.86 22.68 57.42 Favored Glycine 0 N--CA 1.453 -0.193 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.852 179.276 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 527' ' ' LEU . . . . . 0.409 HD13 ' HA ' ' A' ' 527' ' ' LEU . 4.2 mm? -98.01 4.74 49.3 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.873 0.368 . . . . 0.0 110.776 -179.709 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 528' ' ' THR . . . . . 0.419 ' OG1' ' HA ' ' A' ' 523' ' ' GLN . 15.5 m -59.99 -37.0 78.38 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.422 -177.109 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 529' ' ' GLU . . . . . 0.436 ' H ' ' HG2' ' A' ' 529' ' ' GLU . 7.1 pt-20 -64.79 -28.73 69.77 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.732 -178.068 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 530' ' ' THR . . . . . 0.535 ' HB ' HD22 ' A' ' 531' ' ' LEU . 26.4 m -64.29 -59.27 4.59 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.98 -179.415 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 531' ' ' LEU . . . . . 0.577 ' H ' HD22 ' A' ' 531' ' ' LEU . 1.7 mm? -76.57 5.83 6.8 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-O 120.869 0.366 . . . . 0.0 111.524 -179.189 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 532' ' ' ASN . . . . . . . . . . . . . 64.7 t30 -86.26 -27.14 24.61 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.37 0.605 . . . . 0.0 109.716 177.788 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 533' ' ' ARG . . . . . . . . . . . . . 12.7 mmm180 -92.13 160.34 15.24 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.672 178.845 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 534' ' ' GLU . . . . . 0.798 ' HA ' ' HB3' ' A' ' 622' ' ' ASN . 40.9 mt-10 -87.71 179.35 6.52 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 120.76 -0.376 . . . . 0.0 110.25 177.232 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 535' ' ' GLY . . . . . . . . . . . . . . . 134.86 -145.3 17.41 Favored Glycine 0 N--CA 1.445 -0.764 0 N-CA-C 110.675 -0.97 . . . . 0.0 110.675 -175.108 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 536' ' ' VAL . . . . . 0.407 ' HB ' HG13 ' A' ' 577' ' ' ILE . 34.5 m -123.07 130.37 74.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-O 121.07 0.462 . . . . 0.0 110.057 176.866 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 537' ' ' TYR . . . . . . . . . . . . . 71.2 m-85 -152.46 153.73 34.11 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.057 -178.611 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 538' ' ' THR . . . . . 0.764 ' OG1' ' HA ' ' A' ' 577' ' ' ILE . 50.4 m -132.1 103.71 6.41 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 174.673 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 539' ' ' VAL . . . . . . . . . . . . . 47.9 t -105.71 124.65 60.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.926 -173.228 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 540' ' ' PHE . . . . . 0.567 ' HB3' HD13 ' A' ' 628' ' ' ILE . 99.0 m-85 -95.85 111.08 23.15 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 173.328 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -97.82 112.97 62.98 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.712 -176.53 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 542' ' ' PRO . . . . . 0.471 ' HA ' HG13 ' A' ' 628' ' ' ILE . 7.9 Cg_exo -73.12 135.75 23.46 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 122.702 2.268 . . . . 0.0 110.708 174.302 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 40.4 p -76.96 179.31 6.28 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.529 -177.216 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 544' ' ' ASN . . . . . 0.546 ' HA ' ' HE3' ' A' ' 517' ' ' MET . 25.0 t-20 -62.41 -33.73 75.37 Favored 'General case' 0 CA--C 1.52 -0.185 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 178.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 545' ' ' GLU . . . . . 0.428 ' CD ' ' H ' ' A' ' 545' ' ' GLU . 1.6 mp0 -54.28 -45.09 72.41 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.19 -0.913 . . . . 0.0 110.759 178.152 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 546' ' ' ALA . . . . . 0.455 ' O ' HD23 ' A' ' 550' ' ' LEU . . . -67.06 -49.12 66.17 Favored 'General case' 0 CA--C 1.514 -0.431 0 CA-C-O 121.018 0.437 . . . . 0.0 111.283 -179.18 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 547' ' ' PHE . . . . . . . . . . . . . 29.9 m-85 -64.24 -25.61 68.14 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.705 -0.68 . . . . 0.0 111.315 -177.32 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 548' ' ' ARG . . . . . . . . . . . . . 23.8 ttm180 -86.7 -28.02 23.36 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.273 0.559 . . . . 0.0 110.179 178.526 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 549' ' ' ALA . . . . . . . . . . . . . . . -79.63 -10.51 59.8 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.242 -0.89 . . . . 0.0 112.103 -176.235 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 550' ' ' LEU . . . . . 0.511 ' HB2' ' HG3' ' A' ' 555' ' ' ARG . 0.1 OUTLIER -54.23 143.47 44.55 Favored Pre-proline 0 N--CA 1.454 -0.23 0 CA-C-O 120.759 0.314 . . . . 0.0 110.671 174.503 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 551' ' ' PRO . . . . . 0.637 ' HD2' ' HB2' ' A' ' 554' ' ' GLU . 2.6 Cg_endo -80.02 142.04 15.24 Favored 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 123.125 2.55 . . . . 0.0 110.547 -172.567 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 552' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_exo -43.47 -39.87 9.73 Favored 'Trans proline' 0 CA--C 1.533 0.458 0 C-N-CA 123.139 2.56 . . . . 0.0 113.348 -176.637 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 553' ' ' ARG . . . . . . . . . . . . . 44.7 mtp180 -68.3 -52.14 37.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.862 0.363 . . . . 0.0 111.721 177.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 554' ' ' GLU . . . . . 0.637 ' HB2' ' HD2' ' A' ' 551' ' ' PRO . 5.1 mm-40 -83.15 -42.72 17.0 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.911 -171.843 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 555' ' ' ARG . . . . . 0.511 ' HG3' ' HB2' ' A' ' 550' ' ' LEU . 26.1 ttt180 -46.87 -55.76 7.45 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 122.697 0.399 . . . . 0.0 111.429 173.918 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 14.8 m -62.45 -31.98 72.78 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.123 -178.159 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 557' ' ' ARG . . . . . . . . . . . . . 24.4 ttt180 -69.42 -59.24 3.12 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.587 176.703 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 558' ' ' LEU . . . . . 0.859 HD22 ' HB3' ' A' ' 564' ' ' GLU . 0.7 OUTLIER -60.2 -50.47 73.54 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.507 -175.406 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 559' ' ' LEU . . . . . . . . . . . . . 74.6 mt -87.95 19.53 3.53 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.632 -177.368 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 560' ' ' GLY . . . . . . . . . . . . . . . -125.4 4.11 8.21 Favored Glycine 0 N--CA 1.445 -0.706 0 CA-C-N 115.949 -0.568 . . . . 0.0 111.928 179.459 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 561' ' ' ASP . . . . . 0.495 ' OD2' ' HB3' ' A' ' 563' ' ' LYS . 18.0 t70 -142.59 142.24 32.11 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.653 0.264 . . . . 0.0 110.666 179.443 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 562' ' ' ALA . . . . . . . . . . . . . . . -76.51 -32.26 58.19 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.856 -177.657 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 563' ' ' LYS . . . . . 0.495 ' HB3' ' OD2' ' A' ' 561' ' ' ASP . 13.1 ttpt -69.0 -49.51 57.16 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.136 179.772 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 564' ' ' GLU . . . . . 0.859 ' HB3' HD22 ' A' ' 558' ' ' LEU . 59.7 mm-40 -52.07 -48.83 64.47 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.729 176.387 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 565' ' ' LEU . . . . . . . . . . . . . 39.5 mt -56.02 -55.2 35.71 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.416 177.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 566' ' ' ALA . . . . . . . . . . . . . . . -57.13 -48.06 79.6 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.55 -175.38 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 567' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -61.25 -45.62 93.78 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.637 -176.205 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 568' ' ' ILE . . . . . 0.714 HG13 HD21 ' A' ' 558' ' ' LEU . 47.7 mm -74.17 -34.9 39.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.828 -176.936 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 569' ' ' LEU . . . . . . . . . . . . . 66.4 mt -68.04 -33.31 74.33 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.962 -0.295 . . . . 0.0 111.01 179.632 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 570' ' ' LYS . . . . . 0.766 ' HE3' ' HA ' ' A' ' 593' ' ' GLN . 26.9 mtpp -62.97 -18.5 63.29 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.939 0.4 . . . . 0.0 111.012 175.61 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 571' ' ' TYR . . . . . 0.506 ' O ' HD21 ' A' ' 597' ' ' LEU . 25.9 t80 -91.75 -17.85 24.78 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.895 -177.136 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 572' ' ' HIS . . . . . . . . . . . . . 61.5 m80 -90.72 -14.72 31.59 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.866 0.365 . . . . 0.0 111.053 -179.287 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 573' ' ' ILE . . . . . . . . . . . . . 42.9 mt -103.83 116.4 47.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.318 178.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 574' ' ' GLY . . . . . 0.545 ' HA2' ' HA ' ' A' ' 591' ' ' SER . . . -97.95 153.86 20.14 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 121.013 -0.613 . . . . 0.0 111.723 176.043 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 575' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -90.96 -6.46 54.03 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.252 0.549 . . . . 0.0 111.062 -176.196 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 576' ' ' GLU . . . . . 0.449 ' HB2' HD21 ' A' ' 589' ' ' LEU . 24.9 mt-10 -129.11 122.75 30.54 Favored 'General case' 0 CA--C 1.508 -0.663 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 -170.245 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 577' ' ' ILE . . . . . 0.764 ' HA ' ' OG1' ' A' ' 538' ' ' THR . 61.5 mt -73.05 116.55 15.42 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.943 -175.233 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 578' ' ' LEU . . . . . 0.574 HD11 ' HA ' ' A' ' 583' ' ' ILE . 23.5 tp -127.03 113.41 16.43 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.442 179.057 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 579' ' ' VAL . . . . . 0.488 ' O ' HG13 ' A' ' 583' ' ' ILE . 35.8 m -104.96 163.1 4.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.177 178.086 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 580' ' ' SER . . . . . . . . . . . . . 32.8 t -56.48 -47.74 78.6 Favored 'General case' 0 C--N 1.331 -0.228 0 O-C-N 123.32 0.388 . . . . 0.0 110.887 -176.282 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 581' ' ' GLY . . . . . . . . . . . . . . . -74.73 8.27 15.76 Favored Glycine 0 CA--C 1.521 0.411 0 C-N-CA 120.941 -0.647 . . . . 0.0 113.327 -178.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . -131.77 9.87 5.48 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.511 -0.852 . . . . 0.0 113.109 179.245 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 583' ' ' ILE . . . . . 0.574 ' HA ' HD11 ' A' ' 578' ' ' LEU . 47.0 mt -78.02 -77.54 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.956 0.378 . . . . 0.0 110.877 178.779 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 584' ' ' GLY . . . . . . . . . . . . . . . 84.72 81.69 1.05 Allowed Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.495 -0.859 . . . . 0.0 112.069 -175.314 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 585' ' ' ALA . . . . . . . . . . . . . . . 71.73 -74.69 0.08 Allowed 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 123.578 0.751 . . . . 0.0 112.084 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 586' ' ' LEU . . . . . 0.61 ' HG ' ' HB2' ' A' ' 600' ' ' SER . 2.3 tt -164.71 142.2 6.37 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.571 0.225 . . . . 0.0 110.422 -176.755 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 587' ' ' VAL . . . . . 0.522 ' N ' HD23 ' A' ' 586' ' ' LEU . 91.2 t -140.14 139.75 36.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.23 -178.697 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 588' ' ' ARG . . . . . 0.406 ' HD3' ' HA ' ' A' ' 588' ' ' ARG . 34.0 mmt180 -85.57 105.51 16.21 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.927 0.394 . . . . 0.0 110.138 177.122 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 589' ' ' LEU . . . . . 0.449 HD21 ' HB2' ' A' ' 576' ' ' GLU . 0.3 OUTLIER -99.86 124.62 45.36 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.374 -177.189 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 590' ' ' LYS . . . . . . . . . . . . . 47.4 mtpt -90.48 140.1 30.06 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.466 0.65 . . . . 0.0 111.563 -177.628 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 591' ' ' SER . . . . . 0.545 ' HA ' ' HA2' ' A' ' 574' ' ' GLY . 78.0 p -102.15 166.47 10.58 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.367 -177.542 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 592' ' ' LEU . . . . . . . . . . . . . 9.9 mp -67.44 -7.21 23.56 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 112.527 0.566 . . . . 0.0 112.527 178.235 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 593' ' ' GLN . . . . . 0.766 ' HA ' ' HE3' ' A' ' 570' ' ' LYS . 23.2 tt0 -76.74 -29.2 56.05 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 171.708 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 594' ' ' GLY . . . . . . . . . . . . . . . 113.41 -20.36 18.61 Favored Glycine 0 N--CA 1.444 -0.791 0 CA-C-N 115.203 -0.908 . . . . 0.0 111.62 -177.15 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 595' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -84.08 -178.57 7.0 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 120.984 0.421 . . . . 0.0 109.867 -179.594 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 596' ' ' LYS . . . . . 0.788 ' H ' ' HD3' ' A' ' 596' ' ' LYS . 0.0 OUTLIER -118.72 136.96 53.66 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.796 -172.272 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 597' ' ' LEU . . . . . 0.506 HD21 ' O ' ' A' ' 571' ' ' TYR . 56.6 mt -90.51 142.55 27.63 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.648 179.609 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 598' ' ' GLU . . . . . 0.559 ' O ' ' HA ' ' A' ' 608' ' ' VAL . 13.7 tp10 -86.01 82.2 8.2 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 178.497 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 599' ' ' VAL . . . . . 0.439 HG11 HD23 ' A' ' 578' ' ' LEU . 25.8 t -104.58 121.88 56.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 121.128 0.489 . . . . 0.0 110.081 -176.879 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 600' ' ' SER . . . . . 0.61 ' HB2' ' HG ' ' A' ' 586' ' ' LEU . 37.4 t -141.23 168.39 19.89 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.499 0.666 . . . . 0.0 110.96 -172.626 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 601' ' ' LEU . . . . . 0.516 ' HB2' HD12 ' A' ' 583' ' ' ILE . 52.7 tp -140.45 108.27 5.67 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 114.535 -1.211 . . . . 0.0 108.955 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 602' ' ' LYS . . . . . . . . . . . . . 65.1 mttp -120.79 107.12 12.35 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.903 -177.239 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 603' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 63.42 42.86 6.41 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.613 177.503 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 604' ' ' ASN . . . . . . . . . . . . . 66.6 t30 72.95 14.65 4.75 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.608 178.067 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 605' ' ' VAL . . . . . . . . . . . . . 56.6 t -110.51 114.01 45.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.997 175.495 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 606' ' ' VAL . . . . . 0.738 HG13 ' HB ' ' A' ' 613' ' ' VAL . 6.6 p -84.97 140.16 16.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.2 0.524 . . . . 0.0 110.935 -179.01 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 607' ' ' SER . . . . . . . . . . . . . 7.4 p -142.19 154.58 44.94 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.835 -178.197 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 608' ' ' VAL . . . . . 0.559 ' HA ' ' O ' ' A' ' 598' ' ' GLU . 7.5 p -142.65 119.89 6.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.147 178.006 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 609' ' ' ASN . . . . . 0.832 ' HB2' HD22 ' A' ' 632' ' ' LEU . 4.0 m-20 59.88 50.04 7.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.131 173.715 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 610' ' ' LYS . . . . . 0.495 ' HE3' ' HB2' ' A' ' 610' ' ' LYS . 35.6 mtmt 77.15 -21.91 0.31 Allowed 'General case' 0 N--CA 1.476 0.826 0 O-C-N 123.66 0.6 . . . . 0.0 111.378 179.819 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 611' ' ' GLU . . . . . . . . . . . . . 48.6 mm-40 -90.96 140.91 26.19 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.732 -176.879 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 612' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -81.26 141.58 12.89 Favored 'Trans proline' 0 N--CA 1.458 -0.603 0 C-N-CA 122.134 1.889 . . . . 0.0 111.459 173.589 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 613' ' ' VAL . . . . . 0.738 ' HB ' HG13 ' A' ' 606' ' ' VAL . 99.5 t -74.34 120.59 23.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 176.76 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 614' ' ' ALA . . . . . 0.527 ' HB2' HG23 ' A' ' 629' ' ' THR . . . -76.5 -26.22 55.05 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.868 -172.815 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 615' ' ' GLU . . . . . 0.604 ' HB3' ' HB ' ' A' ' 627' ' ' VAL . 17.4 tt0 -165.49 89.25 0.94 Allowed Pre-proline 0 C--N 1.325 -0.49 0 CA-C-O 121.189 0.519 . . . . 0.0 109.832 -174.417 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 616' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -88.82 163.57 6.14 Favored 'Trans proline' 0 N--CA 1.456 -0.732 0 C-N-CA 123.059 2.506 . . . . 0.0 113.708 -175.669 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 26.6 t0 78.43 64.61 0.03 OUTLIER 'General case' 0 CA--C 1.51 -0.567 0 CA-C-O 123.024 1.392 . . . . 0.0 110.594 169.38 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 618' ' ' ILE . . . . . 0.498 ' HB ' ' O ' ' A' ' 625' ' ' VAL . 24.4 mt -115.86 102.21 13.38 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.278 0 CA-C-N 112.795 -2.002 . . . . 0.0 108.573 176.058 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 619' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.73 135.7 37.21 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.707 -0.679 . . . . 0.0 112.812 -169.313 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 620' ' ' ALA . . . . . . . . . . . . . . . -129.1 176.72 7.68 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.329 -0.851 . . . . 0.0 108.795 171.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 621' ' ' THR . . . . . . . . . . . . . 4.5 t -82.75 -21.71 34.6 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.603 -0.439 . . . . 0.0 110.874 -179.83 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 622' ' ' ASN . . . . . 0.798 ' HB3' ' HA ' ' A' ' 534' ' ' GLU . 27.4 p-10 -116.24 22.11 13.13 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.719 0.295 . . . . 0.0 111.441 -176.692 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 623' ' ' GLY . . . . . . . . . . . . . . . 147.47 -150.88 23.18 Favored Glycine 0 N--CA 1.443 -0.859 0 C-N-CA 120.332 -0.937 . . . . 0.0 112.626 177.229 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 624' ' ' VAL . . . . . . . . . . . . . 6.3 p -135.79 158.46 39.41 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 -179.164 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 625' ' ' VAL . . . . . 0.498 ' O ' ' HB ' ' A' ' 618' ' ' ILE . 46.8 t -123.93 136.87 58.87 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.675 178.764 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 626' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 -122.79 121.13 35.55 Favored 'General case' 0 N--CA 1.445 -0.681 0 N-CA-C 109.908 -0.405 . . . . 0.0 109.908 175.726 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 627' ' ' VAL . . . . . 0.604 ' HB ' ' HB3' ' A' ' 615' ' ' GLU . 60.8 t -70.21 130.67 34.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.56 179.025 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 628' ' ' ILE . . . . . 0.567 HD13 ' HB3' ' A' ' 540' ' ' PHE . 7.2 pt -127.34 150.19 33.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.819 176.199 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 629' ' ' THR . . . . . 0.527 HG23 ' HB2' ' A' ' 614' ' ' ALA . 16.6 p -94.91 2.83 55.45 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.91 -176.283 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 630' ' ' ASN . . . . . . . . . . . . . 66.1 m-20 -144.08 168.76 19.24 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.409 -177.39 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 631' ' ' VAL . . . . . . . . . . . . . 97.2 t -95.91 125.74 48.65 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 115.426 -0.807 . . . . 0.0 109.206 176.518 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 632' ' ' LEU . . . . . 0.832 HD22 ' HB2' ' A' ' 609' ' ' ASN . 89.6 mt -70.87 114.41 8.91 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-O 121.33 0.586 . . . . 0.0 110.893 -174.602 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 633' ' ' GLN . . . . . 0.512 ' HA ' ' HD3' ' A' ' 634' ' ' PRO . 85.7 mm-40 -102.47 131.17 22.74 Favored Pre-proline 0 C--N 1.317 -0.835 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.947 -177.095 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 634' ' ' PRO . . . . . 0.512 ' HD3' ' HA ' ' A' ' 633' ' ' GLN . 4.9 Cg_exo . . . . . 0 C--O 1.253 1.25 0 C-N-CA 123.051 2.501 . . . . 0.0 111.569 176.25 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 500' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.053 0 N-CA-C 110.189 -0.3 . . . . 0.0 110.189 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 501' ' ' GLY . . . . . . . . . . . . . . . 148.72 2.59 0.37 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.495 -178.308 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 502' ' ' MET . . . . . . . . . . . . . 24.7 mmt 67.88 -174.45 0.19 Allowed 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 121.012 0.434 . . . . 0.0 111.511 178.861 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 99.04 164.77 29.99 Favored Glycine 0 N--CA 1.447 -0.57 0 N-CA-C 111.311 -0.715 . . . . 0.0 111.311 -176.423 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 504' ' ' THR . . . . . 0.48 ' O ' HG23 ' A' ' 508' ' ' VAL . 38.8 p -81.47 156.95 25.07 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 120.83 -0.348 . . . . 0.0 110.307 179.118 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 7.1 p -49.55 -39.2 13.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.892 -0.595 . . . . 0.0 112.359 -176.099 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 506' ' ' MET . . . . . 0.517 ' HG2' ' HB2' ' A' ' 531' ' ' LEU . 2.9 ppp? -83.82 -21.86 31.96 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.806 0.336 . . . . 0.0 111.524 -177.109 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 507' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -86.22 -28.89 23.58 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.042 0.448 . . . . 0.0 110.645 -178.238 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 508' ' ' VAL . . . . . 0.48 HG23 ' O ' ' A' ' 504' ' ' THR . 87.5 t -61.89 -27.58 42.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.297 175.394 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 509' ' ' LEU . . . . . . . . . . . . . 25.3 mt -65.05 -19.54 66.04 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.536 -179.099 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 510' ' ' LYS . . . . . 0.433 ' HE3' HG13 ' A' ' 519' ' ' VAL . 5.3 mptt -76.25 -24.15 54.53 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.022 0.439 . . . . 0.0 110.481 -179.068 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 511' ' ' GLY . . . . . . . . . . . . . . . -80.56 -10.11 85.63 Favored Glycine 0 N--CA 1.444 -0.773 0 C-N-CA 120.407 -0.902 . . . . 0.0 111.179 177.827 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 512' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -114.86 137.62 51.75 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.26 0.552 . . . . 0.0 111.714 -176.253 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 9.9 p30 -77.34 -19.76 55.85 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 115.526 -0.761 . . . . 0.0 112.459 -177.214 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 514' ' ' ARG . . . . . . . . . . . . . 5.3 tpp180 -89.04 -28.54 20.08 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 120.687 0.279 . . . . 0.0 110.988 -170.765 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 515' ' ' PHE . . . . . 0.607 ' CZ ' HG22 ' A' ' 627' ' ' VAL . 9.5 m-85 -92.83 8.62 38.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.682 178.941 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 13.0 p -55.37 -44.8 76.36 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.066 -0.515 . . . . 0.0 112.376 -176.145 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 517' ' ' MET . . . . . . . . . . . . . 2.8 mpp? -63.36 -31.29 72.4 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.502 0.191 . . . . 0.0 111.09 179.642 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 518' ' ' LEU . . . . . 0.409 HD22 ' HA ' ' A' ' 541' ' ' ALA . 44.2 tp -70.63 -36.38 73.41 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 120.502 -0.479 . . . . 0.0 110.207 -179.408 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 519' ' ' VAL . . . . . 0.433 HG13 ' HE3' ' A' ' 510' ' ' LYS . 59.1 t -58.94 -37.7 68.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.257 0.551 . . . . 0.0 109.559 174.834 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 520' ' ' ALA . . . . . . . . . . . . . . . -71.61 -40.98 69.46 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.644 -178.225 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 521' ' ' ALA . . . . . . . . . . . . . . . -63.96 -50.41 68.72 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.927 178.871 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 522' ' ' ILE . . . . . . . . . . . . . 72.9 mt -60.88 -40.43 85.25 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.894 179.115 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 523' ' ' GLN . . . . . . . . . . . . . 59.2 tt0 -61.78 -46.28 90.22 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.864 178.543 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 27.5 m -67.68 -47.52 69.22 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.495 -177.713 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 525' ' ' ALA . . . . . 0.413 ' HB1' ' HB2' ' A' ' 566' ' ' ALA . . . -70.77 -28.46 64.69 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.642 0.258 . . . . 0.0 111.504 -179.044 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 526' ' ' GLY . . . . . . . . . . . . . . . 85.54 41.49 7.31 Favored Glycine 0 C--O 1.227 -0.323 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.61 178.119 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 527' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -102.06 13.0 35.95 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.909 0.385 . . . . 0.0 110.863 -178.548 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 528' ' ' THR . . . . . . . . . . . . . 18.7 m -65.17 -33.99 77.31 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.117 -178.163 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 529' ' ' GLU . . . . . . . . . . . . . 28.9 mm-40 -55.44 -43.69 75.64 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.814 -176.681 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 530' ' ' THR . . . . . . . . . . . . . 22.1 m -66.27 -43.08 87.45 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.293 -176.124 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 531' ' ' LEU . . . . . 0.517 ' HB2' ' HG2' ' A' ' 506' ' ' MET . 68.8 mt -87.67 14.09 9.16 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.027 0.441 . . . . 0.0 111.314 -174.887 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 532' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -89.56 -29.5 18.86 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.756 178.499 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 533' ' ' ARG . . . . . 0.449 HH11 ' HD2' ' A' ' 533' ' ' ARG . 4.2 tpp180 -86.09 143.84 27.85 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.415 -0.812 . . . . 0.0 110.245 179.069 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 534' ' ' GLU . . . . . 0.673 ' HA ' ' CB ' ' A' ' 622' ' ' ASN . 42.8 tt0 -79.93 147.66 31.55 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.078 0.466 . . . . 0.0 110.515 176.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 535' ' ' GLY . . . . . . . . . . . . . . . 169.0 -136.33 4.01 Favored Glycine 0 N--CA 1.445 -0.75 0 N-CA-C 110.4 -1.08 . . . . 0.0 110.4 -177.51 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 536' ' ' VAL . . . . . 0.534 ' HB ' HG13 ' A' ' 577' ' ' ILE . 34.0 m -124.22 129.79 73.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 117.297 0.549 . . . . 0.0 110.411 177.518 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 537' ' ' TYR . . . . . . . . . . . . . 82.4 m-85 -154.19 146.55 23.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.934 -0.575 . . . . 0.0 109.926 -179.033 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 538' ' ' THR . . . . . 0.766 ' OG1' ' HA ' ' A' ' 577' ' ' ILE . 55.7 m -136.76 100.36 4.3 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 120.813 0.339 . . . . 0.0 110.117 175.235 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 539' ' ' VAL . . . . . 0.632 ' HA ' ' O ' ' A' ' 572' ' ' HIS . 1.3 p -115.17 132.09 65.48 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-O 121.392 0.615 . . . . 0.0 111.242 -177.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 540' ' ' PHE . . . . . . . . . . . . . 68.4 m-85 -89.1 117.16 27.9 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.003 -0.999 . . . . 0.0 109.693 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 541' ' ' ALA . . . . . 0.427 ' HA ' ' HD3' ' A' ' 542' ' ' PRO . . . -93.67 114.42 62.96 Favored Pre-proline 0 C--N 1.326 -0.435 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.575 -179.34 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 542' ' ' PRO . . . . . 0.595 ' HA ' HG13 ' A' ' 628' ' ' ILE . 7.9 Cg_exo -72.88 131.47 17.03 Favored 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 122.88 2.387 . . . . 0.0 111.516 177.944 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 75.2 p -71.87 175.48 5.77 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.574 179.364 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 544' ' ' ASN . . . . . . . . . . . . . 10.7 p30 -72.67 -21.21 61.11 Favored 'General case' 0 CA--C 1.519 -0.221 0 C-N-CA 120.094 -0.643 . . . . 0.0 109.449 179.05 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 545' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -62.18 -35.7 79.63 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.74 174.319 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 546' ' ' ALA . . . . . 0.558 ' HB1' HG23 ' A' ' 631' ' ' VAL . . . -70.13 -48.31 58.03 Favored 'General case' 0 CA--C 1.513 -0.474 0 CA-C-O 121.19 0.519 . . . . 0.0 110.772 178.838 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 547' ' ' PHE . . . . . . . . . . . . . 64.2 m-85 -68.14 -23.72 64.91 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.331 -177.575 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 548' ' ' ARG . . . . . 0.405 ' HD2' HH11 ' A' ' 548' ' ' ARG . 43.7 mtm180 -86.78 -21.9 26.23 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-O 120.706 0.289 . . . . 0.0 110.863 175.746 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 549' ' ' ALA . . . . . . . . . . . . . . . -85.66 -5.59 59.25 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.969 0.414 . . . . 0.0 110.682 177.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 550' ' ' LEU . . . . . 0.538 HD11 HG21 ' A' ' 631' ' ' VAL . 93.5 mt -75.74 134.27 72.43 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.264 176.172 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 551' ' ' PRO . . . . . 0.498 ' HD3' ' HA ' ' A' ' 550' ' ' LEU . 12.4 Cg_exo -69.99 148.02 62.68 Favored 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 122.7 2.267 . . . . 0.0 110.568 179.034 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 552' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_exo -50.83 -41.73 53.98 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.576 2.184 . . . . 0.0 112.072 -178.5 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 553' ' ' ARG . . . . . . . . . . . . . 22.8 tpt180 -57.25 -52.16 66.46 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.287 178.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -65.88 -55.29 17.73 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 111.824 0.305 . . . . 0.0 111.824 -176.328 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 555' ' ' ARG . . . . . 0.458 ' HG2' ' O ' ' A' ' 551' ' ' PRO . 30.8 ptt180 -63.96 -32.65 74.26 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 -175.699 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 32.1 m -74.94 -31.69 61.57 Favored 'General case' 0 N--CA 1.464 0.262 0 O-C-N 122.083 -0.385 . . . . 0.0 110.936 179.588 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 557' ' ' ARG . . . . . . . . . . . . . 73.7 ttt180 -69.65 -47.79 62.14 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.976 0.417 . . . . 0.0 109.964 176.756 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 558' ' ' LEU . . . . . 0.563 ' HG ' HD23 ' A' ' 565' ' ' LEU . 40.1 tp -60.56 -44.83 95.72 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.493 -178.131 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 559' ' ' LEU . . . . . 0.629 HD23 HD21 ' A' ' 565' ' ' LEU . 96.7 mt -81.98 4.55 22.29 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.065 0.459 . . . . 0.0 110.898 -179.452 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 560' ' ' GLY . . . . . . . . . . . . . . . -85.0 -22.61 52.14 Favored Glycine 0 N--CA 1.439 -1.114 0 C-N-CA 120.663 -0.78 . . . . 0.0 112.012 179.158 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 561' ' ' ASP . . . . . 0.695 ' HB3' ' HG2' ' A' ' 564' ' ' GLU . 11.9 t70 -139.38 142.7 37.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.939 0.399 . . . . 0.0 110.691 -178.037 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 562' ' ' ALA . . . . . . . . . . . . . . . -77.58 -29.04 51.86 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.821 -175.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 563' ' ' LYS . . . . . . . . . . . . . 27.2 ttpp -73.16 -39.03 65.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.815 0.341 . . . . 0.0 110.203 -178.231 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 564' ' ' GLU . . . . . 0.695 ' HG2' ' HB3' ' A' ' 561' ' ' ASP . 3.3 mm-40 -62.89 -42.5 99.8 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.436 178.728 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 565' ' ' LEU . . . . . 0.629 HD21 HD23 ' A' ' 559' ' ' LEU . 69.3 mt -55.81 -51.35 67.77 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.489 174.5 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 566' ' ' ALA . . . . . 0.413 ' HB2' ' HB1' ' A' ' 525' ' ' ALA . . . -58.07 -44.01 87.28 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.535 -178.923 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 567' ' ' ASN . . . . . . . . . . . . . 4.9 t30 -67.65 -32.86 73.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.189 -177.294 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 568' ' ' ILE . . . . . 0.522 HG12 ' O ' ' A' ' 564' ' ' GLU . 47.9 mm -72.94 -40.25 59.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 120.86 0.362 . . . . 0.0 110.386 176.73 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 569' ' ' LEU . . . . . 0.51 ' HG ' ' O ' ' A' ' 565' ' ' LEU . 96.0 mt -63.01 -42.92 99.96 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.301 179.673 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 570' ' ' LYS . . . . . 0.682 ' HE2' ' HA ' ' A' ' 593' ' ' GLN . 17.5 ptmt -70.86 -8.05 49.94 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.113 -178.957 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 571' ' ' TYR . . . . . . . . . . . . . 62.3 t80 -93.81 -18.76 21.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.962 0.41 . . . . 0.0 110.392 174.609 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 572' ' ' HIS . . . . . 0.632 ' O ' ' HA ' ' A' ' 539' ' ' VAL . 47.4 m80 -91.07 -20.18 22.34 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.748 179.643 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 573' ' ' ILE . . . . . 0.425 HG13 ' O ' ' A' ' 569' ' ' LEU . 27.2 mt -96.07 116.62 38.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.526 177.469 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 574' ' ' GLY . . . . . 0.592 ' HA2' ' HA ' ' A' ' 591' ' ' SER . . . -88.61 156.01 26.32 Favored Glycine 0 N--CA 1.449 -0.473 0 N-CA-C 111.78 -0.528 . . . . 0.0 111.78 176.297 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 575' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -82.75 -3.19 56.2 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 112.219 0.451 . . . . 0.0 112.219 -172.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 576' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -152.7 157.72 41.31 Favored 'General case' 0 N--CA 1.44 -0.967 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 -174.722 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 577' ' ' ILE . . . . . 0.766 ' HA ' ' OG1' ' A' ' 538' ' ' THR . 68.7 mt -92.56 117.59 36.27 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-N 115.76 -0.655 . . . . 0.0 112.055 -172.709 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 578' ' ' LEU . . . . . 0.579 HD23 HD13 ' A' ' 589' ' ' LEU . 3.4 mm? -123.99 102.3 7.69 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.389 175.544 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 579' ' ' VAL . . . . . 0.508 ' O ' HG13 ' A' ' 583' ' ' ILE . 30.9 m -97.28 172.11 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.07 179.36 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 580' ' ' SER . . . . . 0.532 ' HA ' HD11 ' A' ' 601' ' ' LEU . 27.6 m -54.72 -36.49 64.78 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.5 179.549 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 581' ' ' GLY . . . . . . . . . . . . . . . -80.81 -1.02 89.23 Favored Glycine 0 CA--C 1.521 0.425 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.982 -179.13 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . -114.4 -38.92 1.06 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.526 -0.845 . . . . 0.0 113.001 -177.554 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 583' ' ' ILE . . . . . 0.56 ' HB ' HD12 ' A' ' 601' ' ' LEU . 63.8 mt -60.03 -57.69 10.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 120.692 0.282 . . . . 0.0 111.555 -176.292 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 584' ' ' GLY . . . . . . . . . . . . . . . 78.9 -66.47 3.37 Favored Glycine 0 CA--C 1.52 0.356 0 C-N-CA 120.924 -0.655 . . . . 0.0 113.327 176.523 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 585' ' ' ALA . . . . . . . . . . . . . . . -130.02 -68.61 0.7 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.532 0.206 . . . . 0.0 111.549 -176.382 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 586' ' ' LEU . . . . . 0.579 HD13 ' HB3' ' A' ' 600' ' ' SER . 41.2 tp -153.57 128.62 9.64 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.773 0.32 . . . . 0.0 110.569 -179.85 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 587' ' ' VAL . . . . . . . . . . . . . 57.9 t -137.03 127.47 39.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.627 178.421 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 588' ' ' ARG . . . . . 0.442 ' HG2' ' HG2' ' A' ' 598' ' ' GLU . 72.8 mtt180 -85.54 109.02 18.22 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.485 0.659 . . . . 0.0 109.909 176.662 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 589' ' ' LEU . . . . . 0.579 HD13 HD23 ' A' ' 578' ' ' LEU . 34.7 tp -91.22 113.78 26.13 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 114.806 -1.088 . . . . 0.0 110.214 -175.53 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 590' ' ' LYS . . . . . . . . . . . . . 25.6 pttm -76.46 134.82 39.43 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.635 -0.505 . . . . 0.0 109.635 177.798 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 591' ' ' SER . . . . . 0.592 ' HA ' ' HA2' ' A' ' 574' ' ' GLY . 79.7 p -99.08 166.88 11.04 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.128 -177.442 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 592' ' ' LEU . . . . . . . . . . . . . 10.3 mp -63.86 -12.9 40.5 Favored 'General case' 0 C--N 1.333 -0.123 0 N-CA-C 112.211 0.449 . . . . 0.0 112.211 178.244 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 593' ' ' GLN . . . . . 0.682 ' HA ' ' HE2' ' A' ' 570' ' ' LYS . 24.7 tt0 -77.55 -29.32 52.2 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.391 0.615 . . . . 0.0 109.854 174.825 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 594' ' ' GLY . . . . . . . . . . . . . . . 111.48 -16.53 26.61 Favored Glycine 0 N--CA 1.447 -0.588 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.423 -174.585 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 595' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -79.0 178.6 7.9 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 179.813 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 596' ' ' LYS . . . . . . . . . . . . . 56.6 mttp -124.43 121.4 34.8 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.281 0.562 . . . . 0.0 111.983 -169.572 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 597' ' ' LEU . . . . . . . . . . . . . 67.5 mt -90.38 116.54 28.4 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.235 -0.893 . . . . 0.0 109.306 173.527 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 598' ' ' GLU . . . . . 0.442 ' HG2' ' HG2' ' A' ' 588' ' ' ARG . 46.9 mt-10 -89.13 92.75 9.32 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 121.456 0.646 . . . . 0.0 110.092 -177.942 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 599' ' ' VAL . . . . . . . . . . . . . 23.4 t -96.53 125.64 49.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.051 -0.977 . . . . 0.0 110.146 -176.793 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 600' ' ' SER . . . . . 0.579 ' HB3' HD13 ' A' ' 586' ' ' LEU . 18.2 p -125.78 156.87 38.79 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.445 -179.383 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 601' ' ' LEU . . . . . 0.56 HD12 ' HB ' ' A' ' 583' ' ' ILE . 0.3 OUTLIER -127.75 109.9 12.1 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.261 -179.626 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 602' ' ' LYS . . . . . 0.4 ' HE2' ' HB2' ' A' ' 602' ' ' LYS . 25.8 mtmm -128.87 123.0 31.58 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.25 -0.887 . . . . 0.0 109.806 -171.73 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 603' ' ' ASN . . . . . 0.448 ' O ' ' HB2' ' A' ' 604' ' ' ASN . 13.3 m120 64.38 25.93 13.49 Favored 'General case' 0 N--CA 1.466 0.34 0 O-C-N 123.571 0.544 . . . . 0.0 109.778 178.928 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 604' ' ' ASN . . . . . 0.448 ' HB2' ' O ' ' A' ' 603' ' ' ASN . 88.5 m-20 71.84 14.26 5.97 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.324 -175.633 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 605' ' ' VAL . . . . . . . . . . . . . 44.8 t -107.98 119.84 58.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.129 -0.487 . . . . 0.0 109.809 173.785 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 606' ' ' VAL . . . . . 0.806 HG13 ' HB ' ' A' ' 613' ' ' VAL . 5.2 p -86.67 139.8 16.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 121.026 0.441 . . . . 0.0 110.887 -178.6 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 607' ' ' SER . . . . . . . . . . . . . 2.9 m -140.71 135.19 31.33 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.474 -178.811 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 608' ' ' VAL . . . . . 0.413 HG13 HD21 ' A' ' 632' ' ' LEU . 3.7 p -111.48 119.95 60.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 177.64 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 609' ' ' ASN . . . . . 0.52 ' O ' ' HB2' ' A' ' 610' ' ' LYS . 5.3 m-20 59.22 37.18 23.9 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.485 177.897 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 610' ' ' LYS . . . . . 0.52 ' HB2' ' O ' ' A' ' 609' ' ' ASN . 34.4 mmtp 81.34 -15.44 0.72 Allowed 'General case' 0 N--CA 1.475 0.797 0 O-C-N 124.171 0.919 . . . . 0.0 112.326 -178.716 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 611' ' ' GLU . . . . . 0.425 ' HA ' ' HD3' ' A' ' 612' ' ' PRO . 18.1 mm-40 -84.8 138.55 37.63 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 120.8 0.333 . . . . 0.0 111.072 -178.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 612' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 611' ' ' GLU . 1.9 Cg_endo -82.02 134.02 8.03 Favored 'Trans proline' 0 N--CA 1.46 -0.468 0 C-N-CA 123.387 2.724 . . . . 0.0 113.274 -176.471 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 613' ' ' VAL . . . . . 0.806 ' HB ' HG13 ' A' ' 606' ' ' VAL . 50.3 t -81.57 130.89 35.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.053 175.773 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 614' ' ' ALA . . . . . . . . . . . . . . . -71.21 -42.72 68.58 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.173 -176.871 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 615' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -162.82 103.82 1.04 Allowed Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.27 0.557 . . . . 0.0 110.576 -178.656 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 616' ' ' PRO . . . . . 0.404 ' O ' ' HB2' ' A' ' 617' ' ' ASP . 65.0 Cg_endo -89.85 171.2 4.13 Favored 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 123.539 2.826 . . . . 0.0 113.411 -177.909 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 617' ' ' ASP . . . . . 0.404 ' HB2' ' O ' ' A' ' 616' ' ' PRO . 1.1 m-20 79.0 28.28 0.4 Allowed 'General case' 0 CA--C 1.508 -0.664 0 CA-C-N 115.123 -0.944 . . . . 0.0 111.373 164.721 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 618' ' ' ILE . . . . . 0.48 ' HB ' ' O ' ' A' ' 625' ' ' VAL . 18.5 mt -74.87 103.42 2.73 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 CA-C-N 114.591 -1.186 . . . . 0.0 109.085 171.505 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 619' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.77 132.96 38.32 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.841 -0.618 . . . . 0.0 112.391 -171.094 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 620' ' ' ALA . . . . . . . . . . . . . . . -127.92 173.61 9.87 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 170.408 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 621' ' ' THR . . . . . . . . . . . . . 4.7 t -75.56 -31.72 60.13 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 120.385 -0.526 . . . . 0.0 111.217 -174.374 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 622' ' ' ASN . . . . . 0.673 ' CB ' ' HA ' ' A' ' 534' ' ' GLU . 31.8 p-10 -117.39 21.76 12.87 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 111.946 0.35 . . . . 0.0 111.946 -176.325 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 623' ' ' GLY . . . . . . . . . . . . . . . 165.36 -167.71 39.03 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.159 -1.019 . . . . 0.0 112.87 178.526 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 624' ' ' VAL . . . . . 0.436 HG21 HG12 ' A' ' 579' ' ' VAL . 5.8 p -133.09 155.43 41.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 178.671 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 625' ' ' VAL . . . . . 0.48 ' O ' ' HB ' ' A' ' 618' ' ' ILE . 49.6 t -120.2 127.84 75.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.188 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 626' ' ' HIS . . . . . . . . . . . . . 46.9 m-70 -113.76 110.27 19.89 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.155 -0.475 . . . . 0.0 109.774 175.409 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 627' ' ' VAL . . . . . 0.607 HG22 ' CZ ' ' A' ' 515' ' ' PHE . 22.9 t -65.56 124.85 21.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.044 -179.741 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 628' ' ' ILE . . . . . 0.595 HG13 ' HA ' ' A' ' 542' ' ' PRO . 8.2 pt -116.86 143.77 26.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-O 121.353 0.596 . . . . 0.0 110.732 175.276 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 629' ' ' THR . . . . . . . . . . . . . 10.3 t -95.59 12.33 30.01 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-O 122.216 1.008 . . . . 0.0 109.318 -179.322 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 630' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 -139.19 176.66 8.51 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 114.381 -1.281 . . . . 0.0 109.359 -176.32 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 631' ' ' VAL . . . . . 0.558 HG23 ' HB1' ' A' ' 546' ' ' ALA . 61.6 t -116.64 144.26 24.78 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 172.366 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 632' ' ' LEU . . . . . 0.413 HD21 HG13 ' A' ' 608' ' ' VAL . 87.8 mt -96.58 118.26 32.69 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.018 0.437 . . . . 0.0 110.735 -177.889 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 633' ' ' GLN . . . . . . . . . . . . . 27.0 mp0 -96.64 116.79 66.27 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.089 -177.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 634' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo . . . . . 0 N--CA 1.452 -0.951 0 C-N-CA 122.902 2.401 . . . . 0.0 111.113 173.403 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 500' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.155 0 CA-C-O 120.672 0.272 . . . . 0.0 110.33 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 501' ' ' GLY . . . . . . . . . . . . . . . 152.6 -117.81 0.84 Allowed Glycine 0 N--CA 1.444 -0.819 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.114 178.076 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 502' ' ' MET . . . . . . . . . . . . . 50.9 ttm -178.51 -40.79 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 -178.753 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 138.88 149.01 5.37 Favored Glycine 0 N--CA 1.445 -0.728 0 CA-C-N 114.999 -1.0 . . . . 0.0 110.987 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 504' ' ' THR . . . . . 0.491 ' HA ' HG22 ' A' ' 621' ' ' THR . 46.7 p -75.88 165.75 24.54 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 117.165 0.483 . . . . 0.0 110.118 178.495 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 505' ' ' VAL . . . . . 0.66 ' O ' ' HG ' ' A' ' 509' ' ' LEU . 14.7 p -60.0 -31.66 48.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 120.991 0.424 . . . . 0.0 110.307 179.809 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 506' ' ' MET . . . . . 0.487 ' O ' ' HG2' ' A' ' 510' ' ' LYS . 5.7 tpp -69.31 -43.17 74.31 Favored 'General case' 0 N--CA 1.437 -1.112 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.688 178.198 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 507' ' ' ASP . . . . . 0.566 ' HA ' ' CG ' ' A' ' 510' ' ' LYS . 31.5 t70 -67.29 -32.5 73.53 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.882 0.373 . . . . 0.0 110.557 -178.435 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 508' ' ' VAL . . . . . 0.479 HG23 ' O ' ' A' ' 504' ' ' THR . 90.0 t -62.27 -35.72 70.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.519 176.087 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 509' ' ' LEU . . . . . 0.66 ' HG ' ' O ' ' A' ' 505' ' ' VAL . 61.3 mt -74.44 -37.44 63.28 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.164 -178.602 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 510' ' ' LYS . . . . . 0.566 ' CG ' ' HA ' ' A' ' 507' ' ' ASP . 10.8 ptmm? -84.27 -13.13 53.38 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.284 -178.303 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 511' ' ' GLY . . . . . . . . . . . . . . . -85.7 -11.92 73.16 Favored Glycine 0 N--CA 1.441 -0.987 0 N-CA-C 111.169 -0.772 . . . . 0.0 111.169 173.719 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 512' ' ' ASP . . . . . 0.57 ' O ' ' HB2' ' A' ' 516' ' ' SER . 26.6 t70 -104.22 152.54 22.05 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.826 0.346 . . . . 0.0 111.122 179.825 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 42.4 m-80 -76.28 -33.32 59.1 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.864 -176.243 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 514' ' ' ARG . . . . . 0.415 ' HB3' ' HA ' ' A' ' 543' ' ' THR . 26.2 mmt180 -82.88 -49.95 9.13 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.908 0.385 . . . . 0.0 110.086 -176.039 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 515' ' ' PHE . . . . . 1.012 ' HZ ' HG22 ' A' ' 627' ' ' VAL . 4.2 m-30 -66.97 -17.83 65.1 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.505 -177.458 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 516' ' ' SER . . . . . 0.57 ' HB2' ' O ' ' A' ' 512' ' ' ASP . 16.3 t -57.54 -41.9 81.84 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.665 -176.476 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 517' ' ' MET . . . . . . . . . . . . . 3.4 ppp? -76.49 -24.96 53.8 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.881 0.372 . . . . 0.0 110.643 -178.426 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 518' ' ' LEU . . . . . 0.628 HD22 ' HD2' ' A' ' 542' ' ' PRO . 39.4 tp -66.8 -37.86 85.37 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 170.01 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 519' ' ' VAL . . . . . 0.468 ' O ' ' HG2' ' A' ' 523' ' ' GLN . 85.4 t -58.21 -34.46 49.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 174.498 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 520' ' ' ALA . . . . . . . . . . . . . . . -63.76 -38.26 90.43 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.937 0.399 . . . . 0.0 110.17 177.586 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 521' ' ' ALA . . . . . 0.419 ' HA ' HD23 ' A' ' 565' ' ' LEU . . . -66.61 -43.11 85.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.267 174.392 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 522' ' ' ILE . . . . . 0.567 HG23 ' HB2' ' A' ' 527' ' ' LEU . 76.6 mt -59.73 -39.49 79.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.269 177.381 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 523' ' ' GLN . . . . . 0.468 ' HG2' ' O ' ' A' ' 519' ' ' VAL . 16.1 mm100 -62.82 -33.93 76.25 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-O 121.087 0.47 . . . . 0.0 111.152 177.727 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 8.3 t -81.67 -36.2 29.05 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.321 -179.399 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 525' ' ' ALA . . . . . 0.406 ' HB1' ' HA ' ' A' ' 566' ' ' ALA . . . -78.18 -29.84 48.73 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.922 -178.859 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 526' ' ' GLY . . . . . . . . . . . . . . . 85.14 50.53 4.06 Favored Glycine 0 CA--C 1.52 0.355 0 C-N-CA 121.025 -0.607 . . . . 0.0 112.801 179.319 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 527' ' ' LEU . . . . . 0.567 ' HB2' HG23 ' A' ' 522' ' ' ILE . 4.0 mm? -113.12 5.91 17.31 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.875 0.369 . . . . 0.0 110.518 177.825 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 528' ' ' THR . . . . . . . . . . . . . 4.4 m -62.29 -48.1 81.37 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.528 -175.404 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 529' ' ' GLU . . . . . 0.539 ' O ' ' HG3' ' A' ' 533' ' ' ARG . 29.9 mp0 -57.95 -40.89 81.64 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.883 0.373 . . . . 0.0 110.581 178.553 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 530' ' ' THR . . . . . . . . . . . . . 40.4 m -62.14 -45.98 91.02 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.558 -177.316 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 531' ' ' LEU . . . . . 0.518 HD21 HD13 ' A' ' 573' ' ' ILE . 61.5 mt -82.59 -4.91 58.39 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -175.378 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 532' ' ' ASN . . . . . . . . . . . . . 67.1 t30 -89.09 -18.24 27.65 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.273 0.558 . . . . 0.0 110.043 178.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 533' ' ' ARG . . . . . 0.539 ' HG3' ' O ' ' A' ' 529' ' ' GLU . 32.9 mtp85 -83.08 136.69 34.39 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.205 -179.215 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 534' ' ' GLU . . . . . 0.574 ' HA ' ' HB3' ' A' ' 622' ' ' ASN . 11.5 pt-20 -71.56 156.13 39.76 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.868 178.257 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 535' ' ' GLY . . . . . . . . . . . . . . . 147.05 -136.59 6.21 Favored Glycine 0 N--CA 1.445 -0.759 0 N-CA-C 110.43 -1.068 . . . . 0.0 110.43 -176.064 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 536' ' ' VAL . . . . . 0.455 ' HB ' HG13 ' A' ' 577' ' ' ILE . 34.3 m -124.08 130.08 73.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-O 121.142 0.496 . . . . 0.0 110.813 179.005 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 537' ' ' TYR . . . . . . . . . . . . . 84.4 m-85 -152.87 146.98 25.47 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.385 178.734 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 538' ' ' THR . . . . . 0.685 ' OG1' ' HA ' ' A' ' 577' ' ' ILE . 67.2 m -132.98 102.6 5.68 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 175.413 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 539' ' ' VAL . . . . . 0.448 HG22 HG23 ' A' ' 573' ' ' ILE . 48.5 t -107.31 122.88 62.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.085 0.469 . . . . 0.0 111.44 -172.788 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 540' ' ' PHE . . . . . 0.479 ' HB3' HD13 ' A' ' 628' ' ' ILE . 84.8 m-85 -91.77 107.15 19.0 Favored 'General case' 0 N--CA 1.447 -0.613 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 172.759 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 541' ' ' ALA . . . . . 0.442 ' HA ' ' HD3' ' A' ' 542' ' ' PRO . . . -97.2 113.71 63.59 Favored Pre-proline 0 C--N 1.323 -0.577 0 CA-C-O 120.713 0.292 . . . . 0.0 110.924 -176.932 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 542' ' ' PRO . . . . . 0.628 ' HD2' HD22 ' A' ' 518' ' ' LEU . 7.9 Cg_exo -72.44 138.16 29.36 Favored 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 123.04 2.494 . . . . 0.0 111.427 177.886 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 543' ' ' THR . . . . . 0.415 ' HA ' ' HB3' ' A' ' 514' ' ' ARG . 60.8 p -74.22 -179.11 3.7 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.526 178.946 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 544' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -62.35 -33.64 75.1 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.172 0.511 . . . . 0.0 109.742 179.603 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 545' ' ' GLU . . . . . 0.414 ' HA ' ' HB3' ' A' ' 548' ' ' ARG . 14.1 mp0 -63.85 -27.44 69.17 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 114.798 -1.092 . . . . 0.0 111.499 -178.004 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 546' ' ' ALA . . . . . 0.605 ' HB1' HG22 ' A' ' 631' ' ' VAL . . . -64.24 -55.61 20.32 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.354 0.597 . . . . 0.0 110.514 179.142 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 547' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -70.63 -21.48 62.63 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.644 179.127 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 548' ' ' ARG . . . . . 0.414 ' HB3' ' HA ' ' A' ' 545' ' ' GLU . 75.2 ttt180 -74.81 -36.82 62.45 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.117 177.611 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 549' ' ' ALA . . . . . . . . . . . . . . . -62.03 -34.38 76.11 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.456 176.781 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 550' ' ' LEU . . . . . 0.51 ' HA ' ' HD3' ' A' ' 551' ' ' PRO . 81.2 mt -65.53 132.24 95.01 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.392 175.82 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 551' ' ' PRO . . . . . 0.51 ' HD3' ' HA ' ' A' ' 550' ' ' LEU . 21.3 Cg_exo -64.58 147.9 90.3 Favored 'Trans proline' 0 N--CA 1.463 -0.29 0 C-N-CA 122.98 2.453 . . . . 0.0 111.856 -173.723 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 552' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 551' ' ' PRO . 86.7 Cg_exo -48.89 -35.51 31.54 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 123.177 2.584 . . . . 0.0 113.351 -177.722 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 553' ' ' ARG . . . . . . . . . . . . . 56.2 ttp180 -73.57 -45.52 52.81 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.771 0.32 . . . . 0.0 110.842 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 554' ' ' GLU . . . . . 0.474 ' HB2' ' HD2' ' A' ' 551' ' ' PRO . 20.5 mm-40 -74.09 -41.66 61.34 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.454 -175.061 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 555' ' ' ARG . . . . . . . . . . . . . 5.5 ptp180 -61.75 -33.6 74.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.877 0.37 . . . . 0.0 110.024 177.451 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 7.9 t -71.5 -36.94 71.27 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.2 -0.455 . . . . 0.0 109.808 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 557' ' ' ARG . . . . . . . . . . . . . 79.8 mtt180 -61.22 -49.5 76.91 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.378 176.236 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 558' ' ' LEU . . . . . 0.506 HD21 HG13 ' A' ' 568' ' ' ILE . 2.1 tm? -57.95 -52.33 65.94 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.057 -0.974 . . . . 0.0 110.457 -178.54 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 559' ' ' LEU . . . . . 0.766 ' HA ' HD11 ' A' ' 565' ' ' LEU . 86.4 mt -76.78 -3.75 39.9 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.378 -175.352 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 560' ' ' GLY . . . . . . . . . . . . . . . -72.57 -22.54 78.93 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 121.168 -0.539 . . . . 0.0 112.534 -179.316 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 561' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -141.63 126.17 17.82 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 122.53 -0.394 . . . . 0.0 110.674 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 562' ' ' ALA . . . . . 0.434 ' HA ' HD13 ' A' ' 565' ' ' LEU . . . -59.46 -22.81 62.07 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.764 -0.653 . . . . 0.0 112.384 -176.969 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 563' ' ' LYS . . . . . . . . . . . . . 57.9 tttp -63.69 -40.3 96.47 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.358 0.599 . . . . 0.0 110.395 179.275 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 564' ' ' GLU . . . . . 0.458 ' HB3' HD22 ' A' ' 558' ' ' LEU . 7.7 mm-40 -68.55 -40.47 80.64 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.987 -178.011 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 565' ' ' LEU . . . . . 0.766 HD11 ' HA ' ' A' ' 559' ' ' LEU . 8.2 mp -57.19 -47.29 81.62 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.115 174.6 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 566' ' ' ALA . . . . . 0.64 ' O ' ' HB2' ' A' ' 570' ' ' LYS . . . -60.2 -40.18 89.17 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.245 -0.889 . . . . 0.0 111.666 -177.744 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 567' ' ' ASN . . . . . . . . . . . . . 66.2 t30 -75.53 -47.12 28.27 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 120.916 -0.314 . . . . 0.0 111.318 -176.013 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 568' ' ' ILE . . . . . 0.506 HG13 HD21 ' A' ' 558' ' ' LEU . 28.5 mm -65.29 -48.85 81.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 112.465 0.543 . . . . 0.0 112.465 -177.728 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 569' ' ' LEU . . . . . 0.401 HD12 ' C ' ' A' ' 569' ' ' LEU . 0.6 OUTLIER -71.33 -21.84 61.99 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.736 -0.385 . . . . 0.0 110.433 -175.879 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 570' ' ' LYS . . . . . 0.64 ' HB2' ' O ' ' A' ' 566' ' ' ALA . 78.3 tttt -67.56 -22.17 65.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.214 0.531 . . . . 0.0 110.434 178.846 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 571' ' ' TYR . . . . . 0.456 ' CE1' ' HB3' ' A' ' 595' ' ' ASP . 15.3 t80 -77.89 -18.05 56.62 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.711 177.268 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 572' ' ' HIS . . . . . . . . . . . . . 74.4 m80 -88.56 -12.44 42.74 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.658 -176.706 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 573' ' ' ILE . . . . . 0.518 HD13 HD21 ' A' ' 531' ' ' LEU . 47.7 mt -104.42 114.28 43.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.627 179.615 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 574' ' ' GLY . . . . . 0.68 ' HA2' ' HA ' ' A' ' 591' ' ' SER . . . -99.4 152.99 19.61 Favored Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 121.06 -0.59 . . . . 0.0 111.777 176.938 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 575' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -96.79 16.13 20.04 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.064 0.459 . . . . 0.0 111.31 -175.845 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 576' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -139.27 122.17 16.62 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.139 -177.409 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 577' ' ' ILE . . . . . 0.685 ' HA ' ' OG1' ' A' ' 538' ' ' THR . 63.3 mt -79.95 101.27 4.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.272 0.558 . . . . 0.0 110.681 -179.024 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 578' ' ' LEU . . . . . . . . . . . . . 96.7 mt -118.91 102.48 8.82 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.393 -0.821 . . . . 0.0 109.879 178.045 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 579' ' ' VAL . . . . . . . . . . . . . 27.1 m -90.82 178.43 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.361 178.877 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 580' ' ' SER . . . . . . . . . . . . . 13.0 m -53.57 -38.77 64.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.26 -179.039 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 581' ' ' GLY . . . . . . . . . . . . . . . -86.53 23.66 9.77 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 121.13 -0.557 . . . . 0.0 112.824 -178.553 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . -138.63 6.82 3.28 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.595 177.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 583' ' ' ILE . . . . . . . . . . . . . 37.4 mt -83.95 -47.75 17.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.968 0.414 . . . . 0.0 110.977 -178.516 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 584' ' ' GLY . . . . . . . . . . . . . . . 79.39 -69.18 3.03 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.929 -0.653 . . . . 0.0 112.07 -178.024 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 585' ' ' ALA . . . . . . . . . . . . . . . -143.18 -69.87 0.33 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.862 0.363 . . . . 0.0 110.321 179.53 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 586' ' ' LEU . . . . . 0.8 ' HG ' ' HB2' ' A' ' 600' ' ' SER . 3.9 tt -151.33 131.15 13.24 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 176.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 587' ' ' VAL . . . . . 0.413 ' N ' HD23 ' A' ' 586' ' ' LEU . 7.8 p -143.99 137.23 23.93 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.173 -175.137 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 588' ' ' ARG . . . . . . . . . . . . . 35.0 ptt180 -88.04 108.52 19.27 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.414 0.626 . . . . 0.0 110.561 178.278 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 589' ' ' LEU . . . . . . . . . . . . . 3.8 tt -91.04 114.47 27.0 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 -178.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 590' ' ' LYS . . . . . 0.606 ' HB2' ' NZ ' ' A' ' 590' ' ' LYS . 9.6 mtmp? -72.43 148.69 44.93 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 121.273 0.559 . . . . 0.0 111.411 -174.062 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 591' ' ' SER . . . . . 0.68 ' HA ' ' HA2' ' A' ' 574' ' ' GLY . 68.7 p -112.09 158.63 19.37 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.823 -179.104 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 592' ' ' LEU . . . . . 0.493 ' O ' ' HE2' ' A' ' 570' ' ' LYS . 10.0 mp -62.26 -19.82 63.62 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.933 178.355 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 593' ' ' GLN . . . . . . . . . . . . . 48.8 tt0 -69.5 -29.69 67.38 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.806 -0.358 . . . . 0.0 110.537 176.477 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 594' ' ' GLY . . . . . . . . . . . . . . . 115.97 -4.85 20.46 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.674 -0.775 . . . . 0.0 112.745 -178.324 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 595' ' ' ASP . . . . . 0.456 ' HB3' ' CE1' ' A' ' 571' ' ' TYR . 11.2 t70 -101.29 -168.94 1.62 Allowed 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 175.768 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 596' ' ' LYS . . . . . 0.549 ' N ' ' HD3' ' A' ' 596' ' ' LYS . 0.0 OUTLIER -135.05 131.83 37.48 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.007 0.432 . . . . 0.0 111.3 -172.881 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 597' ' ' LEU . . . . . 0.677 ' HB3' HG23 ' A' ' 608' ' ' VAL . 2.7 mm? -82.32 115.89 21.58 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 169.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 598' ' ' GLU . . . . . . . . . . . . . 57.8 mt-10 -84.42 92.43 8.05 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-O 121.626 0.727 . . . . 0.0 109.775 179.039 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 599' ' ' VAL . . . . . 0.46 ' HA ' ' O ' ' A' ' 607' ' ' SER . 61.1 t -93.64 132.41 37.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 114.619 -1.173 . . . . 0.0 110.118 -176.893 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 600' ' ' SER . . . . . 0.8 ' HB2' ' HG ' ' A' ' 586' ' ' LEU . 29.6 t -131.95 165.43 23.95 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-O 121.215 0.531 . . . . 0.0 110.286 179.69 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 601' ' ' LEU . . . . . . . . . . . . . 33.3 tp -136.89 108.07 6.79 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 114.929 -1.032 . . . . 0.0 109.609 -177.055 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 602' ' ' LYS . . . . . . . . . . . . . 11.3 ptmm? -134.77 118.19 16.78 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.899 -178.31 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 603' ' ' ASN . . . . . . . . . . . . . 66.9 t30 63.0 28.87 16.39 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 121.542 0.686 . . . . 0.0 109.539 -174.492 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 604' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 69.16 5.98 5.4 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 115.053 -0.976 . . . . 0.0 111.903 -177.368 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 605' ' ' VAL . . . . . . . . . . . . . 46.3 t -86.86 108.13 17.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 109.419 -0.585 . . . . 0.0 109.419 175.278 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 606' ' ' VAL . . . . . 0.726 HG13 ' HB ' ' A' ' 613' ' ' VAL . 6.1 p -84.33 134.41 27.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.934 -178.21 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 607' ' ' SER . . . . . 0.46 ' O ' ' HA ' ' A' ' 599' ' ' VAL . 3.3 p -139.03 142.58 38.25 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.72 -178.709 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 608' ' ' VAL . . . . . 0.677 HG23 ' HB3' ' A' ' 597' ' ' LEU . 3.0 p -122.07 112.78 36.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 116.238 -0.437 . . . . 0.0 109.962 179.159 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 609' ' ' ASN . . . . . 0.43 ' O ' ' HB3' ' A' ' 610' ' ' LYS . 87.7 m-20 56.57 44.76 23.48 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.763 -178.82 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 610' ' ' LYS . . . . . 0.43 ' HB3' ' O ' ' A' ' 609' ' ' ASN . 48.8 tttp 81.19 -26.19 0.15 Allowed 'General case' 0 N--CA 1.472 0.642 0 O-C-N 124.097 0.873 . . . . 0.0 111.701 179.096 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 611' ' ' GLU . . . . . 0.492 ' HA ' ' HD3' ' A' ' 612' ' ' PRO . 5.6 mm-40 -78.6 135.09 60.67 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 120.647 0.26 . . . . 0.0 110.393 -177.22 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 612' ' ' PRO . . . . . 0.492 ' HD3' ' HA ' ' A' ' 611' ' ' GLU . 4.9 Cg_exo -79.38 138.86 14.22 Favored 'Trans proline' 0 N--CA 1.462 -0.381 0 C-N-CA 123.038 2.492 . . . . 0.0 112.988 -176.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 613' ' ' VAL . . . . . 0.726 ' HB ' HG13 ' A' ' 606' ' ' VAL . 94.7 t -84.34 124.39 39.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.581 175.177 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 614' ' ' ALA . . . . . 0.547 ' HB2' HG23 ' A' ' 629' ' ' THR . . . -76.14 -31.41 58.58 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.573 -174.816 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 615' ' ' GLU . . . . . 0.402 ' HB3' ' CG2' ' A' ' 627' ' ' VAL . 28.1 tt0 -162.61 93.85 1.22 Allowed Pre-proline 0 C--N 1.325 -0.485 0 CA-C-O 121.184 0.516 . . . . 0.0 110.275 -176.915 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 616' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -89.32 165.24 5.5 Favored 'Trans proline' 0 N--CA 1.456 -0.708 0 C-N-CA 123.113 2.542 . . . . 0.0 113.422 -178.206 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 26.4 t0 77.36 40.63 0.16 Allowed 'General case' 0 CA--C 1.516 -0.345 0 CA-C-O 122.708 1.242 . . . . 0.0 110.092 165.767 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 618' ' ' ILE . . . . . 0.428 ' HB ' ' O ' ' A' ' 625' ' ' VAL . 17.8 mt -89.04 109.29 20.04 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.999 0 CA-C-N 113.776 -1.556 . . . . 0.0 109.266 173.226 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 619' ' ' MET . . . . . . . . . . . . . 6.8 mmt -73.41 133.12 43.66 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.686 -0.688 . . . . 0.0 112.355 -173.086 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 620' ' ' ALA . . . . . . . . . . . . . . . -131.06 166.33 21.27 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 108.96 -0.755 . . . . 0.0 108.96 172.051 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 621' ' ' THR . . . . . 0.491 HG22 ' HA ' ' A' ' 504' ' ' THR . 1.2 t -72.82 -33.45 66.21 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.455 -0.498 . . . . 0.0 111.361 -174.167 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 622' ' ' ASN . . . . . 0.574 ' HB3' ' HA ' ' A' ' 534' ' ' GLU . 28.5 p-10 -117.83 24.02 11.31 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.656 0.265 . . . . 0.0 111.556 -176.016 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 623' ' ' GLY . . . . . 0.42 ' HA2' ' CD1' ' A' ' 577' ' ' ILE . . . 162.55 -160.13 32.42 Favored Glycine 0 N--CA 1.442 -0.922 0 C-N-CA 120.187 -1.006 . . . . 0.0 112.816 178.386 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 624' ' ' VAL . . . . . . . . . . . . . 8.5 p -134.83 157.29 40.9 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 179.448 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 625' ' ' VAL . . . . . 0.428 ' O ' ' HB ' ' A' ' 618' ' ' ILE . 59.4 t -122.77 134.13 66.87 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.163 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 626' ' ' HIS . . . . . . . . . . . . . 95.7 m-70 -121.47 112.95 19.16 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 175.033 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 627' ' ' VAL . . . . . 1.012 HG22 ' HZ ' ' A' ' 515' ' ' PHE . 37.1 t -68.22 128.89 32.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.844 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 628' ' ' ILE . . . . . 0.574 HG13 ' HA ' ' A' ' 542' ' ' PRO . 6.4 pt -126.71 147.35 31.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 121.22 0.533 . . . . 0.0 111.043 175.982 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 629' ' ' THR . . . . . 0.547 HG23 ' HB2' ' A' ' 614' ' ' ALA . 30.1 p -96.43 -1.47 47.42 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.401 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 630' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -126.17 158.95 34.27 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.64 -174.273 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 631' ' ' VAL . . . . . 0.605 HG22 ' HB1' ' A' ' 546' ' ' ALA . 2.3 t -96.06 122.42 47.54 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.7 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 177.116 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 632' ' ' LEU . . . . . 0.457 HD21 HG13 ' A' ' 608' ' ' VAL . 96.2 mt -71.83 110.67 6.51 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.485 0.66 . . . . 0.0 110.401 -177.362 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 633' ' ' GLN . . . . . . . . . . . . . 58.1 tp60 -120.92 120.76 29.2 Favored Pre-proline 0 C--N 1.318 -0.802 0 CA-C-N 114.907 -1.042 . . . . 0.0 109.649 -175.655 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 634' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_exo . . . . . 0 C--O 1.249 1.07 0 C-N-CA 122.752 2.301 . . . . 0.0 111.754 -179.867 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 500' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.934 0 CA-C-O 121.118 0.485 . . . . 0.0 110.264 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 501' ' ' GLY . . . . . . . . . . . . . . . 161.22 -79.59 0.15 Allowed Glycine 0 N--CA 1.448 -0.545 0 N-CA-C 111.279 -0.728 . . . . 0.0 111.279 -179.312 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 502' ' ' MET . . . . . . . . . . . . . 93.9 mmm -124.15 85.29 2.39 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.095 0.474 . . . . 0.0 110.392 178.308 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . -129.25 -154.84 8.33 Favored Glycine 0 N--CA 1.445 -0.714 0 N-CA-C 111.252 -0.739 . . . . 0.0 111.252 177.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 39.1 p -71.9 175.63 5.66 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 177.858 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 505' ' ' VAL . . . . . 0.648 ' O ' ' HG ' ' A' ' 509' ' ' LEU . 8.5 t -54.63 -38.71 43.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 121.146 0.498 . . . . 0.0 110.261 178.07 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 506' ' ' MET . . . . . . . . . . . . . 16.5 mmt -63.55 -35.1 79.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.787 -178.628 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 507' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -62.91 -28.84 70.33 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.267 0.556 . . . . 0.0 110.27 -178.091 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 508' ' ' VAL . . . . . . . . . . . . . 47.3 t -87.41 -43.11 15.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.797 179.147 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 509' ' ' LEU . . . . . 0.648 ' HG ' ' O ' ' A' ' 505' ' ' VAL . 69.7 mt -64.73 -24.22 67.5 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 121.097 0.475 . . . . 0.0 111.907 -176.01 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -85.71 -21.57 28.24 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.402 -176.689 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 511' ' ' GLY . . . . . . . . . . . . . . . -81.27 -9.54 85.86 Favored Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 120.665 -0.778 . . . . 0.0 111.53 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 512' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -109.84 148.18 31.99 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.16 0.505 . . . . 0.0 111.607 -178.406 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -76.51 -21.4 55.81 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.757 -0.656 . . . . 0.0 112.521 -176.488 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 514' ' ' ARG . . . . . 0.692 ' HB3' ' HA ' ' A' ' 543' ' ' THR . 9.8 mmt180 -89.97 -51.38 5.51 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.495 0.664 . . . . 0.0 109.496 -177.716 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 515' ' ' PHE . . . . . 0.967 ' HZ ' HG22 ' A' ' 627' ' ' VAL . 9.1 m-30 -62.31 -29.38 70.4 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 114.664 -1.153 . . . . 0.0 111.25 -175.583 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 2.7 p -62.82 -25.7 68.39 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 -175.055 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 517' ' ' MET . . . . . . . . . . . . . 48.4 ttp -80.91 -37.78 29.07 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 175.881 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 518' ' ' LEU . . . . . 0.462 HD22 ' HD2' ' A' ' 542' ' ' PRO . 66.5 tp -57.81 -39.11 76.81 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.234 171.39 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 519' ' ' VAL . . . . . 0.505 HG23 ' O ' ' A' ' 515' ' ' PHE . 86.6 t -53.76 -37.52 32.62 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 CA-C-O 121.058 0.456 . . . . 0.0 110.582 175.111 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 520' ' ' ALA . . . . . . . . . . . . . . . -71.64 -35.24 70.32 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.441 -178.132 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 521' ' ' ALA . . . . . . . . . . . . . . . -68.59 -48.14 64.93 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.491 176.439 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 522' ' ' ILE . . . . . 0.432 HG23 ' HB2' ' A' ' 527' ' ' LEU . 69.2 mt -59.55 -37.01 68.13 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.886 177.402 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 523' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -61.98 -52.93 62.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.015 177.837 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 40.8 m -62.0 -34.25 75.83 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.735 -178.386 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 525' ' ' ALA . . . . . . . . . . . . . . . -77.69 -12.01 59.93 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.479 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 526' ' ' GLY . . . . . . . . . . . . . . . 72.73 34.6 59.41 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 121.061 -0.59 . . . . 0.0 112.958 178.093 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 527' ' ' LEU . . . . . 0.432 ' HB2' HG23 ' A' ' 522' ' ' ILE . 95.2 mt -109.13 10.31 26.0 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.901 0.381 . . . . 0.0 110.49 -179.834 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 528' ' ' THR . . . . . . . . . . . . . 8.1 m -57.08 -43.18 81.92 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 -173.003 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 529' ' ' GLU . . . . . 0.499 ' O ' ' HG2' ' A' ' 533' ' ' ARG . 11.5 pt-20 -70.34 -17.01 63.05 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 111.826 0.306 . . . . 0.0 111.826 -174.091 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 530' ' ' THR . . . . . . . . . . . . . 78.0 m -62.77 -49.17 76.05 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.83 0.348 . . . . 0.0 110.613 178.531 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 531' ' ' LEU . . . . . 0.592 ' H ' HD22 ' A' ' 531' ' ' LEU . 1.9 mm? -75.49 -14.51 60.43 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.19 178.25 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 532' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -78.47 -32.94 48.57 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.603 179.559 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 533' ' ' ARG . . . . . 0.499 ' HG2' ' O ' ' A' ' 529' ' ' GLU . 30.7 mmm180 -66.91 123.18 19.45 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.334 178.128 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 534' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -71.69 94.79 1.39 Allowed 'General case' 0 N--CA 1.443 -0.82 0 CA-C-O 122.627 1.203 . . . . 0.0 110.697 176.129 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 535' ' ' GLY . . . . . . . . . . . . . . . -161.85 175.06 38.41 Favored Glycine 0 N--CA 1.441 -1.001 0 N-CA-C 108.092 -2.003 . . . . 0.0 108.092 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 536' ' ' VAL . . . . . 0.647 ' HB ' HG13 ' A' ' 577' ' ' ILE . 33.9 m -87.32 131.42 35.2 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 118.405 1.103 . . . . 0.0 111.87 -167.489 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 537' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -150.48 144.31 25.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.051 -0.977 . . . . 0.0 109.964 179.406 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 538' ' ' THR . . . . . . . . . . . . . 22.6 m -108.32 102.91 11.99 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 173.716 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 539' ' ' VAL . . . . . 0.55 HG21 HG11 ' A' ' 505' ' ' VAL . 47.2 t -100.88 123.24 53.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 120.864 0.364 . . . . 0.0 111.641 -173.231 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 540' ' ' PHE . . . . . 0.549 ' HB3' HD13 ' A' ' 628' ' ' ILE . 97.6 m-85 -102.34 110.0 21.83 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 173.835 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -103.21 112.61 65.85 Favored Pre-proline 0 C--N 1.324 -0.537 0 CA-C-O 120.748 0.308 . . . . 0.0 110.863 -175.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 542' ' ' PRO . . . . . 0.542 ' HA ' HG13 ' A' ' 628' ' ' ILE . 11.8 Cg_exo -71.5 142.26 40.13 Favored 'Trans proline' 0 N--CA 1.461 -0.4 0 C-N-CA 123.028 2.485 . . . . 0.0 112.146 178.554 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 543' ' ' THR . . . . . 0.692 ' HA ' ' HB3' ' A' ' 514' ' ' ARG . 44.9 p -78.13 175.42 10.16 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.736 178.241 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 544' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -73.72 -24.17 59.87 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.821 -0.352 . . . . 0.0 110.478 -176.56 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 545' ' ' GLU . . . . . 0.436 ' OE2' ' HB ' ' A' ' 543' ' ' THR . 1.9 mp0 -64.35 -33.17 75.22 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 110.043 -0.355 . . . . 0.0 110.043 177.492 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 546' ' ' ALA . . . . . 0.673 ' HB1' HG23 ' A' ' 631' ' ' VAL . . . -59.76 -49.62 77.02 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.592 177.848 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 547' ' ' PHE . . . . . 0.402 ' HA ' ' HG ' ' A' ' 550' ' ' LEU . 88.9 m-85 -68.98 -21.81 64.13 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.79 -179.634 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 548' ' ' ARG . . . . . . . . . . . . . 30.5 ttm180 -79.12 -28.17 42.92 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.868 179.683 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 549' ' ' ALA . . . . . . . . . . . . . . . -96.41 1.07 51.37 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.452 -176.379 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 550' ' ' LEU . . . . . 0.439 ' HG ' ' O ' ' A' ' 546' ' ' ALA . 75.0 mt -67.35 137.72 93.88 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.564 179.71 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 551' ' ' PRO . . . . . 0.533 ' HD2' ' HB2' ' A' ' 554' ' ' GLU . 16.0 Cg_exo -68.1 155.81 68.13 Favored 'Trans proline' 0 C--O 1.235 0.368 0 C-N-CA 123.036 2.491 . . . . 0.0 111.437 179.593 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 552' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -43.93 -55.29 3.17 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 123.861 3.041 . . . . 0.0 113.598 -176.918 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 553' ' ' ARG . . . . . . . . . . . . . 8.6 ptm180 -63.5 -38.76 92.35 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 -177.91 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 554' ' ' GLU . . . . . 0.533 ' HB2' ' HD2' ' A' ' 551' ' ' PRO . 4.5 mm-40 -73.22 -49.48 27.67 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.827 0.346 . . . . 0.0 111.04 -174.301 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 555' ' ' ARG . . . . . 0.438 ' HB3' ' HB2' ' A' ' 550' ' ' LEU . 20.6 ptt180 -66.53 -28.39 68.51 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.11 -179.285 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 47.6 t -73.37 -29.99 63.0 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.712 0.291 . . . . 0.0 110.757 179.522 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 557' ' ' ARG . . . . . . . . . . . . . 22.2 mtp180 -83.04 -53.63 5.67 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.023 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 558' ' ' LEU . . . . . 0.587 ' O ' ' HG ' ' A' ' 565' ' ' LEU . 47.2 tp -63.91 -40.43 96.49 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.655 0.264 . . . . 0.0 111.564 -174.297 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 559' ' ' LEU . . . . . . . . . . . . . 63.7 mt -94.11 13.23 23.77 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.052 0.453 . . . . 0.0 110.98 -178.144 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 560' ' ' GLY . . . . . . . . . . . . . . . -126.12 -48.66 0.19 Allowed Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.609 -0.805 . . . . 0.0 112.469 -178.584 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 561' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -86.24 116.15 24.24 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.97 0.414 . . . . 0.0 110.548 -176.44 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 562' ' ' ALA . . . . . . . . . . . . . . . -68.71 -21.9 64.37 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.537 -176.386 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 563' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -81.33 -45.74 15.73 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 -178.761 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 564' ' ' GLU . . . . . 0.445 ' O ' HG12 ' A' ' 568' ' ' ILE . 29.2 mt-10 -69.69 -25.18 63.76 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.481 177.8 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 565' ' ' LEU . . . . . 0.587 ' HG ' ' O ' ' A' ' 558' ' ' LEU . 4.0 mt -58.77 -55.85 29.72 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.957 0.408 . . . . 0.0 109.946 170.797 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 566' ' ' ALA . . . . . 0.567 ' O ' ' HG3' ' A' ' 570' ' ' LYS . . . -62.51 -26.97 68.82 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.843 178.444 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 567' ' ' ASN . . . . . . . . . . . . . 36.5 t-20 -73.18 -55.24 6.73 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.985 179.362 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 568' ' ' ILE . . . . . 0.445 HG12 ' O ' ' A' ' 564' ' ' GLU . 50.8 mm -68.81 -34.65 65.7 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 CA-C-O 120.701 0.286 . . . . 0.0 111.738 -175.113 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 569' ' ' LEU . . . . . 0.444 ' HG ' ' O ' ' A' ' 565' ' ' LEU . 87.1 mt -63.12 -25.63 68.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.799 0.333 . . . . 0.0 111.227 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 570' ' ' LYS . . . . . 0.567 ' HG3' ' O ' ' A' ' 566' ' ' ALA . 62.5 mttp -69.5 -13.93 62.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.893 0.378 . . . . 0.0 111.099 178.018 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 571' ' ' TYR . . . . . . . . . . . . . 15.6 t80 -94.72 -7.86 39.38 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.149 0.5 . . . . 0.0 110.506 -177.21 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 572' ' ' HIS . . . . . . . . . . . . . 75.8 m80 -101.03 -9.21 21.64 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.71 -179.227 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 573' ' ' ILE . . . . . 0.408 ' O ' HD23 ' A' ' 592' ' ' LEU . 29.3 mt -111.9 123.13 67.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.418 178.233 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 574' ' ' GLY . . . . . 0.495 ' HA2' ' HA ' ' A' ' 591' ' ' SER . . . -98.87 167.39 21.85 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.21 176.388 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 575' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -92.24 -4.8 53.56 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 113.112 0.782 . . . . 0.0 113.112 -168.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 576' ' ' GLU . . . . . 0.735 ' HB2' HD21 ' A' ' 589' ' ' LEU . 70.0 mm-40 -128.77 -167.08 1.72 Allowed 'General case' 0 CA--C 1.504 -0.812 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 179.783 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 577' ' ' ILE . . . . . 0.647 HG13 ' HB ' ' A' ' 536' ' ' VAL . 82.0 mt -112.42 105.32 18.56 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 N-CA-C 110.051 -0.352 . . . . 0.0 110.051 167.773 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 578' ' ' LEU . . . . . 0.657 HD21 HG11 ' A' ' 587' ' ' VAL . 0.3 OUTLIER -100.86 115.27 29.97 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 178.644 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 579' ' ' VAL . . . . . . . . . . . . . 30.6 m -113.69 163.73 10.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.496 179.384 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 580' ' ' SER . . . . . . . . . . . . . 49.6 p -62.33 -33.8 75.39 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-O 120.868 0.366 . . . . 0.0 111.03 -178.67 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 581' ' ' GLY . . . . . . . . . . . . . . . -77.32 22.9 2.41 Favored Glycine 0 CA--C 1.519 0.287 0 C-N-CA 121.207 -0.52 . . . . 0.0 112.543 179.529 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . -140.58 23.64 2.66 Favored Glycine 0 N--CA 1.445 -0.757 0 N-CA-C 111.543 -0.623 . . . . 0.0 111.543 176.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 583' ' ' ILE . . . . . . . . . . . . . 2.5 mt -122.3 98.94 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 CA-C-O 121.152 0.501 . . . . 0.0 110.38 179.779 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 584' ' ' GLY . . . . . . . . . . . . . . . -82.15 -20.59 62.48 Favored Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 120.63 -0.795 . . . . 0.0 111.781 176.783 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 585' ' ' ALA . . . . . . . . . . . . . . . -163.19 -79.77 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.921 0.391 . . . . 0.0 110.328 178.028 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 586' ' ' LEU . . . . . 0.789 HD11 ' HB3' ' A' ' 598' ' ' GLU . 53.4 tp -135.92 132.6 36.68 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.173 179.681 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 587' ' ' VAL . . . . . 0.657 HG11 HD21 ' A' ' 578' ' ' LEU . 42.8 t -127.21 116.52 44.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.185 177.343 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 588' ' ' ARG . . . . . 0.871 ' HG2' ' HG2' ' A' ' 598' ' ' GLU . 96.7 mtt180 -85.43 103.59 14.46 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.142 0.496 . . . . 0.0 109.966 176.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 589' ' ' LEU . . . . . 0.735 HD21 ' HB2' ' A' ' 576' ' ' GLU . 0.7 OUTLIER -101.18 125.15 47.78 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.312 -0.858 . . . . 0.0 108.772 -177.309 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 590' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -65.05 149.97 48.92 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.088 0.47 . . . . 0.0 111.552 -177.751 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 591' ' ' SER . . . . . 0.495 ' HA ' ' HA2' ' A' ' 574' ' ' GLY . 54.4 p -111.17 158.3 19.07 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.493 174.414 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 592' ' ' LEU . . . . . 0.408 HD23 ' O ' ' A' ' 573' ' ' ILE . 3.3 mm? -60.74 -18.23 53.37 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 112.068 0.395 . . . . 0.0 112.068 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 593' ' ' GLN . . . . . 0.461 ' N ' ' HB3' ' A' ' 570' ' ' LYS . 26.7 tt0 -71.51 -29.04 64.34 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.027 0.441 . . . . 0.0 110.352 176.649 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 594' ' ' GLY . . . . . . . . . . . . . . . 109.3 -6.72 32.18 Favored Glycine 0 N--CA 1.443 -0.891 0 C-N-CA 120.72 -0.753 . . . . 0.0 111.683 -173.889 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 595' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -89.93 -174.59 4.31 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 176.792 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 596' ' ' LYS . . . . . 0.598 ' H ' ' HD3' ' A' ' 596' ' ' LYS . 0.0 OUTLIER -121.66 132.76 54.83 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.206 0.527 . . . . 0.0 111.287 -172.509 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 597' ' ' LEU . . . . . 0.668 ' HA ' HD21 ' A' ' 609' ' ' ASN . 42.6 mt -101.17 115.28 30.12 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 172.17 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 598' ' ' GLU . . . . . 0.871 ' HG2' ' HG2' ' A' ' 588' ' ' ARG . 46.3 mt-10 -89.42 91.78 8.86 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-O 121.203 0.525 . . . . 0.0 109.863 -179.135 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 599' ' ' VAL . . . . . . . . . . . . . 20.3 t -86.6 121.2 37.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 115.267 -0.879 . . . . 0.0 108.871 179.506 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 600' ' ' SER . . . . . . . . . . . . . 3.5 p -130.59 156.32 45.05 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.56 -174.008 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 601' ' ' LEU . . . . . . . . . . . . . 21.3 tp -126.35 107.3 10.17 Favored 'General case' 0 N--CA 1.445 -0.724 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 175.368 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 602' ' ' LYS . . . . . 0.542 ' HG2' ' OD1' ' A' ' 603' ' ' ASN . 36.1 ttpt -127.7 118.91 24.7 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.965 -175.71 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 603' ' ' ASN . . . . . 0.542 ' OD1' ' HG2' ' A' ' 602' ' ' LYS . 18.1 m120 61.47 35.93 17.38 Favored 'General case' 0 C--N 1.331 -0.217 0 O-C-N 123.346 0.404 . . . . 0.0 109.946 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 604' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 72.45 4.77 5.1 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 115.144 -0.935 . . . . 0.0 111.669 179.673 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 605' ' ' VAL . . . . . . . . . . . . . 58.6 t -103.56 123.54 57.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 110.273 -0.269 . . . . 0.0 110.273 178.727 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 606' ' ' VAL . . . . . 0.603 HG13 ' HB ' ' A' ' 613' ' ' VAL . 7.1 p -88.41 129.33 39.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 121.175 0.512 . . . . 0.0 110.8 -179.352 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 607' ' ' SER . . . . . 0.455 ' HA ' ' HA ' ' A' ' 612' ' ' PRO . 2.8 p -133.16 152.49 51.94 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.984 -179.76 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 608' ' ' VAL . . . . . . . . . . . . . 2.6 p -133.91 104.73 6.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.863 179.676 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 609' ' ' ASN . . . . . 0.668 HD21 ' HA ' ' A' ' 597' ' ' LEU . 89.2 m-20 55.8 66.43 1.21 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.84 -178.43 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 610' ' ' LYS . . . . . 0.526 ' HB3' ' O ' ' A' ' 609' ' ' ASN . 58.9 tptt 78.56 -42.81 0.34 Allowed 'General case' 0 N--CA 1.47 0.575 0 CA-C-N 115.724 -0.671 . . . . 0.0 112.715 178.365 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 611' ' ' GLU . . . . . 0.48 ' HA ' ' HD3' ' A' ' 612' ' ' PRO . 4.5 mm-40 -88.99 137.66 29.57 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-O 120.79 0.329 . . . . 0.0 111.463 -172.599 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 612' ' ' PRO . . . . . 0.48 ' HD3' ' HA ' ' A' ' 611' ' ' GLU . 5.8 Cg_exo -77.65 153.91 30.46 Favored 'Trans proline' 0 N--CA 1.459 -0.501 0 C-N-CA 122.917 2.412 . . . . 0.0 112.445 179.236 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 613' ' ' VAL . . . . . 0.603 ' HB ' HG13 ' A' ' 606' ' ' VAL . 24.7 t -94.52 134.11 33.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.341 177.319 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 614' ' ' ALA . . . . . 0.503 ' HB2' HG23 ' A' ' 629' ' ' THR . . . -74.18 -47.1 37.88 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.533 -175.746 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 615' ' ' GLU . . . . . 0.457 ' HB3' ' CG2' ' A' ' 627' ' ' VAL . 36.7 tt0 -147.76 101.64 3.69 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-O 120.969 0.414 . . . . 0.0 110.332 -177.423 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 616' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -90.01 162.57 4.9 Favored 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 123.228 2.619 . . . . 0.0 113.866 -178.414 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 26.8 m-20 77.64 28.79 0.55 Allowed 'General case' 0 CA--C 1.508 -0.635 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.77 163.873 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 618' ' ' ILE . . . . . 0.557 ' HB ' ' O ' ' A' ' 625' ' ' VAL . 20.2 mt -71.92 108.73 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.081 0 CA-C-N 114.505 -1.225 . . . . 0.0 109.03 173.38 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 619' ' ' MET . . . . . . . . . . . . . 5.7 mmt -79.04 129.29 34.29 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.769 -0.65 . . . . 0.0 112.547 -171.422 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 620' ' ' ALA . . . . . . . . . . . . . . . -118.71 174.91 6.0 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 169.0 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 621' ' ' THR . . . . . . . . . . . . . 6.0 t -75.19 -25.46 58.27 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.319 -0.552 . . . . 0.0 110.939 -178.115 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 622' ' ' ASN . . . . . 0.464 ' O ' ' HA ' ' A' ' 536' ' ' VAL . 22.9 p-10 -116.88 -9.2 11.22 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 112.481 0.548 . . . . 0.0 112.481 -175.359 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 623' ' ' GLY . . . . . . . . . . . . . . . -169.66 -160.7 18.55 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 119.369 -1.396 . . . . 0.0 113.202 -175.635 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 624' ' ' VAL . . . . . . . . . . . . . 5.6 p -130.13 155.27 41.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 -178.541 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 625' ' ' VAL . . . . . 0.557 ' O ' ' HB ' ' A' ' 618' ' ' ILE . 61.5 t -126.05 135.39 64.0 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.935 179.199 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 626' ' ' HIS . . . . . . . . . . . . . 82.4 m-70 -120.92 114.43 21.54 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.687 177.081 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 627' ' ' VAL . . . . . 0.967 HG22 ' HZ ' ' A' ' 515' ' ' PHE . 29.9 t -67.09 124.11 21.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.418 177.544 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 628' ' ' ILE . . . . . 0.549 HD13 ' HB3' ' A' ' 540' ' ' PHE . 4.4 pt -121.43 142.36 37.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-O 121.124 0.488 . . . . 0.0 110.565 175.273 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 629' ' ' THR . . . . . 0.503 HG23 ' HB2' ' A' ' 614' ' ' ALA . 37.8 p -89.12 -7.44 55.74 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.194 -178.151 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 630' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -129.05 160.43 32.8 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.649 -175.316 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 631' ' ' VAL . . . . . 0.673 HG23 ' HB1' ' A' ' 546' ' ' ALA . 81.1 t -95.11 128.98 45.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 179.479 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 632' ' ' LEU . . . . . . . . . . . . . 96.3 mt -80.92 111.51 17.46 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.313 0.578 . . . . 0.0 110.619 -178.403 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 633' ' ' GLN . . . . . 0.449 ' HA ' ' HD3' ' A' ' 634' ' ' PRO . 51.3 mt-30 -110.84 131.48 22.1 Favored Pre-proline 0 C--N 1.318 -0.761 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.619 -179.397 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 634' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 633' ' ' GLN . 5.6 Cg_exo . . . . . 0 C--O 1.248 0.998 0 C-N-CA 122.971 2.447 . . . . 0.0 111.179 175.307 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 500' ' ' ALA . . . . . 0.482 ' HA ' ' OE2' ' A' ' 534' ' ' GLU . . . . . . . . 0 N--CA 1.478 0.959 0 CA-C-O 121.201 0.524 . . . . 0.0 111.153 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 501' ' ' GLY . . . . . . . . . . . . . . . -161.03 -101.22 0.16 Allowed Glycine 0 N--CA 1.447 -0.568 0 N-CA-C 111.067 -0.813 . . . . 0.0 111.067 177.284 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 502' ' ' MET . . . . . . . . . . . . . 26.2 ttt -150.15 -74.59 0.16 Allowed 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 110.13 -0.322 . . . . 0.0 110.13 176.336 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . -104.51 130.85 10.39 Favored Glycine 0 N--CA 1.442 -0.904 0 C-N-CA 120.481 -0.866 . . . . 0.0 111.574 179.758 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 26.5 p -69.7 176.23 3.72 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 177.59 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 505' ' ' VAL . . . . . 0.712 ' O ' ' HG ' ' A' ' 509' ' ' LEU . 15.8 m -58.0 -32.04 42.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 C-N-CA 120.775 -0.37 . . . . 0.0 110.387 175.512 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 506' ' ' MET . . . . . . . . . . . . . 11.0 mmt -62.41 -43.74 98.1 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.271 176.814 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 507' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -61.39 -44.75 96.62 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 120.869 0.366 . . . . 0.0 110.84 179.454 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 508' ' ' VAL . . . . . . . . . . . . . 60.9 t -60.92 -45.51 98.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.745 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 509' ' ' LEU . . . . . 0.712 ' HG ' ' O ' ' A' ' 505' ' ' VAL . 77.5 mt -68.48 -36.23 78.65 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.218 -177.752 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 510' ' ' LYS . . . . . 0.41 ' HE2' HG11 ' A' ' 519' ' ' VAL . 54.4 mttm -77.28 -26.73 52.64 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.272 0.558 . . . . 0.0 110.011 -178.341 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 511' ' ' GLY . . . . . . . . . . . . . . . -71.48 -15.21 75.12 Favored Glycine 0 N--CA 1.445 -0.758 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.678 176.593 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 512' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -106.64 145.77 31.55 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.983 0.42 . . . . 0.0 111.04 179.65 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 -75.55 -25.23 56.97 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.207 -175.002 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 514' ' ' ARG . . . . . 0.431 ' HB3' ' HA ' ' A' ' 543' ' ' THR . 3.0 mpt_? -86.32 -50.0 7.25 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.305 0.574 . . . . 0.0 109.833 -178.189 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 515' ' ' PHE . . . . . 0.542 ' CZ ' HG22 ' A' ' 627' ' ' VAL . 11.5 m-30 -66.49 -27.0 67.44 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.635 -175.461 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 5.1 p -63.38 -30.21 71.38 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.657 0.265 . . . . 0.0 111.71 -178.52 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 517' ' ' MET . . . . . . . . . . . . . 54.7 mtm -69.78 -34.37 73.66 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 176.474 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 518' ' ' LEU . . . . . 0.545 HD22 ' HD2' ' A' ' 542' ' ' PRO . 51.9 tp -67.58 -40.04 84.84 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.372 173.362 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 519' ' ' VAL . . . . . 0.41 HG11 ' HE2' ' A' ' 510' ' ' LYS . 86.7 t -55.74 -37.09 45.44 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.371 0 CA-C-N 116.223 -0.444 . . . . 0.0 109.925 174.925 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 520' ' ' ALA . . . . . . . . . . . . . . . -63.74 -38.61 91.77 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.402 -179.691 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 521' ' ' ALA . . . . . . . . . . . . . . . -67.86 -51.39 48.78 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.825 0.345 . . . . 0.0 110.327 176.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 522' ' ' ILE . . . . . 0.527 ' HA ' ' HG ' ' A' ' 569' ' ' LEU . 62.1 mt -57.74 -40.83 77.71 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 CA-C-O 121.216 0.531 . . . . 0.0 111.164 178.136 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 523' ' ' GLN . . . . . 0.474 ' HA ' ' OG1' ' A' ' 528' ' ' THR . 21.5 tt0 -70.06 -39.21 75.79 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.408 -0.815 . . . . 0.0 110.762 -175.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 43.6 m -72.83 -31.16 64.6 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.93 0.395 . . . . 0.0 110.715 178.66 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 525' ' ' ALA . . . . . 0.652 ' HB1' ' HA ' ' A' ' 566' ' ' ALA . . . -74.86 -19.92 59.96 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.226 0.536 . . . . 0.0 110.524 176.817 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 526' ' ' GLY . . . . . . . . . . . . . . . 84.46 37.52 10.73 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.774 -0.726 . . . . 0.0 113.153 176.119 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 527' ' ' LEU . . . . . . . . . . . . . 9.1 mp -112.35 15.24 20.38 Favored 'General case' 0 C--N 1.326 -0.416 0 O-C-N 122.599 -0.353 . . . . 0.0 110.957 177.117 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 528' ' ' THR . . . . . 0.474 ' OG1' ' HA ' ' A' ' 523' ' ' GLN . 14.6 m -62.08 -33.74 74.99 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.579 -178.233 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 529' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -69.4 -24.85 63.91 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.551 -177.39 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 530' ' ' THR . . . . . 0.615 ' HB ' HD22 ' A' ' 531' ' ' LEU . 11.0 m -63.14 -53.36 54.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.062 0.458 . . . . 0.0 110.58 179.524 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 531' ' ' LEU . . . . . 0.615 HD22 ' HB ' ' A' ' 530' ' ' THR . 1.8 mm? -79.43 6.11 11.04 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.907 -178.808 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 532' ' ' ASN . . . . . . . . . . . . . 37.5 t-20 -87.83 -28.06 21.87 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.35 0.595 . . . . 0.0 109.428 179.441 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 533' ' ' ARG . . . . . . . . . . . . . 9.5 ttp180 -79.22 137.17 37.3 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.608 -0.723 . . . . 0.0 110.492 178.679 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 534' ' ' GLU . . . . . 0.645 ' HA ' ' HB3' ' A' ' 622' ' ' ASN . 48.5 mt-10 -77.04 133.91 38.95 Favored 'General case' 0 C--O 1.233 0.191 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 175.188 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 535' ' ' GLY . . . . . . . . . . . . . . . 173.7 -137.64 4.16 Favored Glycine 0 CA--C 1.501 -0.826 0 N-CA-C 110.675 -0.97 . . . . 0.0 110.675 -178.579 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 536' ' ' VAL . . . . . 0.459 ' HB ' HG13 ' A' ' 577' ' ' ILE . 33.8 m -119.52 130.27 74.27 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-O 121.077 0.465 . . . . 0.0 110.963 178.555 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 537' ' ' TYR . . . . . . . . . . . . . 75.8 m-85 -151.25 146.42 26.05 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.636 178.22 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 538' ' ' THR . . . . . 0.73 ' OG1' ' HA ' ' A' ' 577' ' ' ILE . 30.9 m -120.02 101.56 7.93 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 171.3 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 539' ' ' VAL . . . . . . . . . . . . . 51.8 t -103.46 127.34 57.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.115 -174.276 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 540' ' ' PHE . . . . . 0.57 ' HB3' HD13 ' A' ' 628' ' ' ILE . 94.8 m-85 -100.09 112.67 24.97 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 175.675 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 541' ' ' ALA . . . . . 0.465 ' HA ' HD22 ' A' ' 518' ' ' LEU . . . -105.93 113.0 64.2 Favored Pre-proline 0 C--N 1.325 -0.487 0 CA-C-O 120.705 0.288 . . . . 0.0 111.423 -176.788 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 542' ' ' PRO . . . . . 0.545 ' HD2' HD22 ' A' ' 518' ' ' LEU . 13.2 Cg_exo -71.02 142.24 41.94 Favored 'Trans proline' 0 N--CA 1.463 -0.29 0 C-N-CA 123.068 2.512 . . . . 0.0 112.079 176.693 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 543' ' ' THR . . . . . 0.431 ' HA ' ' HB3' ' A' ' 514' ' ' ARG . 40.9 p -80.4 179.56 7.64 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.017 178.732 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 544' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -61.78 -34.37 75.74 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.639 -179.168 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 545' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -62.82 -30.11 71.23 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.107 -176.131 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 546' ' ' ALA . . . . . 0.566 ' HB1' HG23 ' A' ' 631' ' ' VAL . . . -64.95 -49.73 69.2 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.301 0.572 . . . . 0.0 110.634 179.145 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 547' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -69.76 -22.04 63.39 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.784 -178.342 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 548' ' ' ARG . . . . . 0.514 ' O ' ' HD2' ' A' ' 548' ' ' ARG . 5.0 tmm_? -84.48 -35.71 22.78 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.859 -179.107 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 549' ' ' ALA . . . . . . . . . . . . . . . -69.36 -29.97 67.88 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.335 176.42 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 550' ' ' LEU . . . . . 0.472 ' HA ' ' HD3' ' A' ' 551' ' ' PRO . 70.8 mt -64.6 131.49 95.13 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.546 175.877 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 551' ' ' PRO . . . . . 0.477 ' HD2' ' HB2' ' A' ' 554' ' ' GLU . 6.9 Cg_exo -72.56 145.71 42.59 Favored 'Trans proline' 0 N--CA 1.459 -0.548 0 C-N-CA 122.828 2.352 . . . . 0.0 111.609 -177.309 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 552' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 551' ' ' PRO . 50.0 Cg_exo -53.86 -30.45 57.84 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 123.074 2.516 . . . . 0.0 112.082 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 553' ' ' ARG . . . . . . . . . . . . . 58.7 ttp180 -66.68 -54.71 20.2 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.806 177.711 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 554' ' ' GLU . . . . . 0.477 ' HB2' ' HD2' ' A' ' 551' ' ' PRO . 0.9 OUTLIER -65.15 -48.9 71.9 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.909 -175.939 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 555' ' ' ARG . . . . . 0.405 ' HG2' ' O ' ' A' ' 551' ' ' PRO . 14.3 ptm180 -60.18 -39.23 85.73 Favored 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 121.12 -0.232 . . . . 0.0 111.464 -176.101 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 50.0 m -71.52 -27.5 63.24 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 111.683 0.253 . . . . 0.0 111.683 -175.611 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 557' ' ' ARG . . . . . . . . . . . . . 33.0 ttm180 -75.96 -43.28 45.39 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.053 0.454 . . . . 0.0 109.781 177.824 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 558' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -66.71 -42.88 85.67 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.218 -179.383 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 559' ' ' LEU . . . . . 0.77 HD23 HD21 ' A' ' 565' ' ' LEU . 63.7 mt -83.13 0.13 46.6 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.047 -178.931 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 560' ' ' GLY . . . . . . . . . . . . . . . -88.13 -9.63 70.12 Favored Glycine 0 N--CA 1.453 -0.196 0 CA-C-N 116.039 -0.528 . . . . 0.0 112.612 -178.25 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 561' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -127.86 129.92 47.73 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 178.916 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 562' ' ' ALA . . . . . . . . . . . . . . . -76.9 -28.23 55.26 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 111.927 0.343 . . . . 0.0 111.927 -175.65 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 563' ' ' LYS . . . . . 0.476 ' HD2' ' N ' ' A' ' 563' ' ' LYS . 0.5 OUTLIER -80.36 -35.28 35.68 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 -177.125 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 564' ' ' GLU . . . . . . . . . . . . . 21.4 mm-40 -61.14 -43.96 98.06 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 171.762 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 565' ' ' LEU . . . . . 0.77 HD21 HD23 ' A' ' 559' ' ' LEU . 60.3 mt -57.5 -53.36 59.03 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.74 175.261 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 566' ' ' ALA . . . . . 0.652 ' HA ' ' HB1' ' A' ' 525' ' ' ALA . . . -55.75 -26.18 44.38 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.218 -178.825 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 567' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -86.59 -35.12 19.64 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.808 -179.817 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 568' ' ' ILE . . . . . . . . . . . . . 22.3 mm -69.71 -52.19 34.1 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 CA-C-N 116.075 -0.511 . . . . 0.0 112.331 -179.127 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 569' ' ' LEU . . . . . 0.527 ' HG ' ' HA ' ' A' ' 522' ' ' ILE . 2.7 mm? -64.22 -23.46 67.32 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-O 121.1 0.476 . . . . 0.0 110.968 177.619 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 570' ' ' LYS . . . . . . . . . . . . . 16.3 ttmm -70.96 -12.4 61.51 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.646 177.073 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 571' ' ' TYR . . . . . . . . . . . . . 59.9 t80 -102.77 -18.07 15.31 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.872 -0.603 . . . . 0.0 111.222 -177.644 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 572' ' ' HIS . . . . . . . . . . . . . 55.4 m80 -86.43 -3.75 59.06 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.118 0.485 . . . . 0.0 110.89 -177.872 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 573' ' ' ILE . . . . . 0.513 HD13 HD11 ' A' ' 531' ' ' LEU . 27.0 mt -118.19 127.24 75.37 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.134 179.806 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 574' ' ' GLY . . . . . 0.571 ' HA2' ' HA ' ' A' ' 591' ' ' SER . . . -89.12 153.46 23.6 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.934 -0.65 . . . . 0.0 111.58 175.667 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 575' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -74.81 -8.7 57.23 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 120.978 0.418 . . . . 0.0 111.989 -171.482 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 576' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -160.47 162.99 33.3 Favored 'General case' 0 N--CA 1.438 -1.058 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 177.553 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 577' ' ' ILE . . . . . 0.73 ' HA ' ' OG1' ' A' ' 538' ' ' THR . 70.0 mt -78.6 124.1 36.47 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 O-C-N 124.005 0.816 . . . . 0.0 112.386 -170.695 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 578' ' ' LEU . . . . . 0.517 HD11 ' HA ' ' A' ' 583' ' ' ILE . 42.3 tp -122.9 102.09 7.81 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.1 -0.955 . . . . 0.0 109.082 173.428 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 579' ' ' VAL . . . . . . . . . . . . . 30.1 m -96.54 157.39 3.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.84 -177.758 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 580' ' ' SER . . . . . . . . . . . . . 31.8 t -58.44 -38.96 78.56 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.351 -179.534 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 581' ' ' GLY . . . . . . . . . . . . . . . -74.48 9.96 9.37 Favored Glycine 0 N--CA 1.449 -0.486 0 CA-C-N 115.74 -0.663 . . . . 0.0 113.717 -179.477 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . -162.77 42.59 0.35 Allowed Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.814 -0.707 . . . . 0.0 112.87 178.441 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 583' ' ' ILE . . . . . 0.777 HD12 ' HB2' ' A' ' 601' ' ' LEU . 30.6 mt -80.18 -65.46 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.828 0.347 . . . . 0.0 110.614 176.769 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 584' ' ' GLY . . . . . . . . . . . . . . . 99.82 63.11 0.82 Allowed Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.605 -0.807 . . . . 0.0 111.856 -177.063 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 585' ' ' ALA . . . . . . . . . . . . . . . 67.63 -75.57 0.06 Allowed 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 123.389 0.676 . . . . 0.0 111.96 -179.611 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 586' ' ' LEU . . . . . 0.998 ' HG ' ' HB3' ' A' ' 600' ' ' SER . 6.5 tt -151.32 129.85 12.2 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.904 0.383 . . . . 0.0 110.237 -178.268 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 587' ' ' VAL . . . . . . . . . . . . . 94.5 t -133.59 133.6 57.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.752 -178.042 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 588' ' ' ARG . . . . . . . . . . . . . 71.8 mtt180 -84.26 102.78 12.92 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 173.044 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 589' ' ' LEU . . . . . . . . . . . . . 60.3 tp -90.51 111.98 23.47 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.584 0.707 . . . . 0.0 110.788 -173.401 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 590' ' ' LYS . . . . . . . . . . . . . 46.5 pttt -60.3 137.35 58.14 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 114.93 -1.032 . . . . 0.0 110.634 176.516 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 591' ' ' SER . . . . . 0.571 ' HA ' ' HA2' ' A' ' 574' ' ' GLY . 44.9 p -99.24 172.59 7.26 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.161 175.861 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 592' ' ' LEU . . . . . 0.423 HD23 ' O ' ' A' ' 573' ' ' ILE . 2.9 mm? -58.76 -22.54 58.22 Favored 'General case' 0 CA--C 1.529 0.173 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 179.593 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 593' ' ' GLN . . . . . 0.749 ' HG3' ' H ' ' A' ' 595' ' ' ASP . 6.1 pt20 -85.34 -29.9 24.12 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.63 -0.428 . . . . 0.0 111.145 178.345 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 594' ' ' GLY . . . . . 0.433 ' N ' ' HG3' ' A' ' 593' ' ' GLN . . . 122.06 -18.76 8.39 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.611 -0.804 . . . . 0.0 113.136 -177.313 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 595' ' ' ASP . . . . . 0.749 ' H ' ' HG3' ' A' ' 593' ' ' GLN . 18.1 t70 -68.46 165.0 19.83 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-N 117.708 0.754 . . . . 0.0 110.189 178.421 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 596' ' ' LYS . . . . . . . . . . . . . 44.9 mttm -109.45 113.37 26.11 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.189 -170.666 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 597' ' ' LEU . . . . . . . . . . . . . 58.3 mt -79.55 125.76 30.01 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.042 175.233 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 598' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -78.85 84.64 4.88 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 120.612 -0.435 . . . . 0.0 110.163 176.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 599' ' ' VAL . . . . . . . . . . . . . 38.1 t -97.92 121.4 48.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 121.217 0.532 . . . . 0.0 109.588 178.528 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 600' ' ' SER . . . . . 0.998 ' HB3' ' HG ' ' A' ' 586' ' ' LEU . 8.2 p -139.64 160.13 40.57 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-O 120.872 0.367 . . . . 0.0 111.377 -175.429 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 601' ' ' LEU . . . . . 0.777 ' HB2' HD12 ' A' ' 583' ' ' ILE . 39.4 tp -118.45 109.92 16.81 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.852 -179.388 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 602' ' ' LYS . . . . . . . . . . . . . 43.6 mmtm -121.53 114.96 21.96 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.132 -0.485 . . . . 0.0 109.826 178.173 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 603' ' ' ASN . . . . . . . . . . . . . 16.7 m120 58.92 38.52 24.39 Favored 'General case' 0 N--CA 1.465 0.31 0 O-C-N 123.316 0.385 . . . . 0.0 110.526 178.708 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 604' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 66.34 17.25 10.66 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.236 -179.455 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 605' ' ' VAL . . . . . . . . . . . . . 61.2 t -110.05 121.86 63.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 175.032 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 606' ' ' VAL . . . . . . . . . . . . . 25.1 t -85.83 131.35 34.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.395 -178.793 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 607' ' ' SER . . . . . . . . . . . . . 42.1 m -131.24 131.43 43.91 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.356 176.833 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 608' ' ' VAL . . . . . 0.462 HG13 HD21 ' A' ' 632' ' ' LEU . 3.6 p -115.2 111.82 37.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.86 178.609 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 609' ' ' ASN . . . . . 0.506 ' O ' ' HB3' ' A' ' 610' ' ' LYS . 91.6 m-20 60.89 35.47 19.23 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.921 -175.04 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 610' ' ' LYS . . . . . 0.506 ' HB3' ' O ' ' A' ' 609' ' ' ASN . 83.9 tttt 82.28 -24.99 0.16 Allowed 'General case' 0 N--CA 1.47 0.547 0 O-C-N 124.544 1.152 . . . . 0.0 111.795 -177.634 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 611' ' ' GLU . . . . . 0.429 ' HA ' ' HD3' ' A' ' 612' ' ' PRO . 11.0 mm-40 -67.81 127.47 93.36 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.064 0.459 . . . . 0.0 110.602 -179.208 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 612' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 611' ' ' GLU . 3.1 Cg_exo -74.76 130.74 13.83 Favored 'Trans proline' 0 N--CA 1.459 -0.526 0 C-N-CA 123.099 2.533 . . . . 0.0 112.701 -175.034 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 613' ' ' VAL . . . . . . . . . . . . . 96.7 t -79.71 125.9 38.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.568 175.295 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 614' ' ' ALA . . . . . 0.649 ' HB2' HG23 ' A' ' 629' ' ' THR . . . -78.94 -36.79 41.15 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.789 -176.463 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 615' ' ' GLU . . . . . 0.425 ' HB2' ' HB ' ' A' ' 627' ' ' VAL . 9.8 mm-40 -152.48 94.65 3.18 Favored Pre-proline 0 N--CA 1.467 0.393 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.848 -177.114 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 616' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -90.48 162.88 4.41 Favored 'Trans proline' 0 N--CA 1.46 -0.46 0 C-N-CA 123.139 2.56 . . . . 0.0 113.562 179.749 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 617' ' ' ASP . . . . . 0.434 ' H ' ' CE1' ' A' ' 626' ' ' HIS . 5.0 m-20 76.07 33.22 0.59 Allowed 'General case' 0 CA--C 1.506 -0.743 0 CA-C-O 122.103 0.954 . . . . 0.0 110.261 165.264 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 618' ' ' ILE . . . . . 0.506 ' HB ' ' O ' ' A' ' 625' ' ' VAL . 22.7 mt -82.19 97.72 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.36 0 CA-C-N 113.936 -1.484 . . . . 0.0 109.449 178.569 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 619' ' ' MET . . . . . 0.41 ' HA ' ' CE ' ' A' ' 619' ' ' MET . 2.8 mmt -62.39 111.28 1.95 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 114.948 -1.024 . . . . 0.0 111.939 -177.196 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 620' ' ' ALA . . . . . . . . . . . . . . . -110.73 -179.49 3.76 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 171.639 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 621' ' ' THR . . . . . . . . . . . . . 35.2 m -69.66 -46.86 65.18 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-O 120.886 0.374 . . . . 0.0 111.633 -177.566 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 622' ' ' ASN . . . . . 0.645 ' HB3' ' HA ' ' A' ' 534' ' ' GLU . 24.0 p-10 -116.72 32.81 5.93 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.827 -174.045 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 623' ' ' GLY . . . . . 0.611 ' HA2' HD11 ' A' ' 577' ' ' ILE . . . 150.67 -159.65 28.24 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.527 -0.844 . . . . 0.0 112.46 176.77 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 624' ' ' VAL . . . . . . . . . . . . . 9.8 m -123.4 165.95 19.04 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.753 0 CA-C-O 121.909 0.861 . . . . 0.0 111.352 176.111 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 625' ' ' VAL . . . . . 0.506 ' O ' ' HB ' ' A' ' 618' ' ' ILE . 89.8 t -128.51 107.33 15.75 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.193 0 CA-C-N 113.584 -1.644 . . . . 0.0 109.43 177.742 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 626' ' ' HIS . . . . . 0.434 ' CE1' ' H ' ' A' ' 617' ' ' ASP . 28.4 m-70 -95.41 103.31 15.17 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 177.192 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 627' ' ' VAL . . . . . 0.542 HG22 ' CZ ' ' A' ' 515' ' ' PHE . 41.8 t -62.75 130.85 27.81 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.0 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 628' ' ' ILE . . . . . 0.57 HD13 ' HB3' ' A' ' 540' ' ' PHE . 3.9 pt -124.85 143.64 37.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 121.193 0.52 . . . . 0.0 111.145 178.647 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 629' ' ' THR . . . . . 0.649 HG23 ' HB2' ' A' ' 614' ' ' ALA . 24.5 p -88.31 7.46 32.19 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.965 -0.561 . . . . 0.0 112.329 -178.485 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 630' ' ' ASN . . . . . . . . . . . . . 65.7 t30 -150.05 174.08 13.14 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 176.703 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 631' ' ' VAL . . . . . 0.566 HG23 ' HB1' ' A' ' 546' ' ' ALA . 48.9 t -101.19 133.81 43.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.036 -178.102 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 632' ' ' LEU . . . . . 0.462 HD21 HG13 ' A' ' 608' ' ' VAL . 95.9 mt -79.23 116.78 19.7 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-O 121.312 0.577 . . . . 0.0 111.149 -175.883 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 633' ' ' GLN . . . . . . . . . . . . . 54.0 tt0 -122.98 116.67 28.74 Favored Pre-proline 0 C--N 1.317 -0.814 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.083 179.464 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 634' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo . . . . . 0 C--O 1.249 1.057 0 C-N-CA 122.349 2.032 . . . . 0.0 112.266 -179.421 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 500' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.101 0 CA-C-O 120.677 0.275 . . . . 0.0 110.711 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 501' ' ' GLY . . . . . . . . . . . . . . . 111.68 114.07 3.39 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 121.044 -0.598 . . . . 0.0 111.709 179.696 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 502' ' ' MET . . . . . . . . . . . . . 61.4 mtm -117.91 8.29 12.55 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.149 0.5 . . . . 0.0 110.42 -179.123 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . -172.35 -176.29 41.01 Favored Glycine 0 N--CA 1.446 -0.67 0 N-CA-C 111.11 -0.796 . . . . 0.0 111.11 179.298 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 504' ' ' THR . . . . . 0.626 ' HA ' HG22 ' A' ' 621' ' ' THR . 47.7 p -81.25 172.36 13.72 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 117.065 0.432 . . . . 0.0 110.292 177.884 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 505' ' ' VAL . . . . . 0.661 HG23 HG22 ' A' ' 625' ' ' VAL . 5.0 p -54.66 -47.96 72.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.682 -179.179 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 506' ' ' MET . . . . . 0.601 ' HA ' HD13 ' A' ' 509' ' ' LEU . 2.8 ppp? -81.79 -17.09 48.78 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.519 -0.473 . . . . 0.0 111.077 -178.66 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 507' ' ' ASP . . . . . 0.497 ' HA ' ' HB2' ' A' ' 510' ' ' LYS . 27.6 t70 -68.13 -29.89 68.9 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 173.19 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 508' ' ' VAL . . . . . . . . . . . . . 84.9 t -61.79 -49.33 84.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.824 -0.626 . . . . 0.0 109.578 171.931 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 509' ' ' LEU . . . . . 1.055 ' HG ' ' HB3' ' A' ' 515' ' ' PHE . 9.6 mp -53.78 -42.36 68.21 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 121.617 0.722 . . . . 0.0 111.25 171.701 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 510' ' ' LYS . . . . . 0.507 ' HD3' ' SD ' ' A' ' 506' ' ' MET . 0.7 OUTLIER -68.59 -20.43 64.51 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 114.769 -1.105 . . . . 0.0 111.467 -177.937 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 511' ' ' GLY . . . . . . . . . . . . . . . -96.82 -0.91 60.2 Favored Glycine 0 N--CA 1.437 -1.252 0 C-N-CA 120.8 -0.714 . . . . 0.0 111.617 177.208 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 512' ' ' ASP . . . . . 0.421 ' O ' ' HB2' ' A' ' 516' ' ' SER . 27.0 t70 -117.98 148.84 41.82 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.513 0.673 . . . . 0.0 112.39 -176.527 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -75.56 -34.96 60.75 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.428 -179.513 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 514' ' ' ARG . . . . . . . . . . . . . 35.6 mtt180 -79.0 -53.25 7.22 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.085 -174.72 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 515' ' ' PHE . . . . . 1.055 ' HB3' ' HG ' ' A' ' 509' ' ' LEU . 14.4 m-30 -64.27 -17.12 63.31 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.066 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 516' ' ' SER . . . . . 0.421 ' HB2' ' O ' ' A' ' 512' ' ' ASP . 39.6 t -58.03 -31.06 66.63 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.304 -178.247 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 517' ' ' MET . . . . . 0.489 ' HE3' ' HB2' ' A' ' 517' ' ' MET . 47.7 mtm -72.39 -30.7 64.9 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.742 0.306 . . . . 0.0 110.441 178.908 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 518' ' ' LEU . . . . . 0.608 HD23 HD21 ' A' ' 509' ' ' LEU . 47.7 tp -70.23 -34.07 72.42 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 173.46 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 519' ' ' VAL . . . . . 0.419 ' CG2' ' HB3' ' A' ' 509' ' ' LEU . 56.7 t -61.41 -33.04 55.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 121.096 0.474 . . . . 0.0 109.774 174.162 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 520' ' ' ALA . . . . . . . . . . . . . . . -67.0 -40.59 87.38 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.325 177.739 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 521' ' ' ALA . . . . . . . . . . . . . . . -66.69 -47.75 71.44 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.151 176.236 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 522' ' ' ILE . . . . . 0.434 HG13 ' O ' ' A' ' 518' ' ' LEU . 87.9 mt -56.34 -43.01 76.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.752 176.575 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 523' ' ' GLN . . . . . . . . . . . . . 43.8 tt0 -62.69 -47.91 81.6 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.125 178.611 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 40.1 m -66.61 -36.42 82.55 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.062 -176.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 525' ' ' ALA . . . . . . . . . . . . . . . -78.58 -28.3 45.83 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.484 -0.326 . . . . 0.0 110.968 177.289 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 526' ' ' GLY . . . . . . . . . . . . . . . 82.02 38.04 14.37 Favored Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 121.286 -0.483 . . . . 0.0 112.931 177.277 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 527' ' ' LEU . . . . . . . . . . . . . 97.5 mt -111.07 20.41 17.46 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.765 0.317 . . . . 0.0 111.209 -177.568 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 528' ' ' THR . . . . . . . . . . . . . 8.8 m -62.08 -37.08 83.68 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.724 -177.535 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 529' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -63.44 -31.62 72.83 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 121.025 0.44 . . . . 0.0 110.681 -178.045 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 530' ' ' THR . . . . . . . . . . . . . 27.0 m -59.84 -46.63 88.66 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.078 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 531' ' ' LEU . . . . . 0.524 HD21 HD13 ' A' ' 573' ' ' ILE . 67.1 mt -93.05 11.44 27.57 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.161 0.505 . . . . 0.0 111.268 -178.094 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 532' ' ' ASN . . . . . . . . . . . . . 58.2 t30 -91.47 -51.01 5.48 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.55 -178.703 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 533' ' ' ARG . . . . . . . . . . . . . 1.7 tpt180 -68.43 146.1 53.5 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.733 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 534' ' ' GLU . . . . . 0.641 ' HA ' ' HB3' ' A' ' 622' ' ' ASN . 23.2 pm0 -76.6 143.74 40.03 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 121.322 0.582 . . . . 0.0 110.537 -179.345 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 535' ' ' GLY . . . . . 0.414 ' H ' ' HB2' ' A' ' 622' ' ' ASN . . . 177.2 -139.57 4.44 Favored Glycine 0 N--CA 1.446 -0.655 0 N-CA-C 110.117 -1.193 . . . . 0.0 110.117 -176.911 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 536' ' ' VAL . . . . . . . . . . . . . 33.0 m -124.48 130.31 73.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 117.31 0.555 . . . . 0.0 110.612 176.277 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 537' ' ' TYR . . . . . . . . . . . . . 76.0 m-85 -153.07 152.42 31.31 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.635 -178.488 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 538' ' ' THR . . . . . 0.74 ' OG1' ' HA ' ' A' ' 577' ' ' ILE . 30.7 m -134.89 102.38 5.22 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.403 174.031 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 539' ' ' VAL . . . . . 0.667 HG22 HG23 ' A' ' 573' ' ' ILE . 39.2 t -109.92 127.0 67.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 120.976 0.417 . . . . 0.0 111.694 -172.66 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 540' ' ' PHE . . . . . 0.529 ' HB3' HD13 ' A' ' 628' ' ' ILE . 87.9 m-85 -95.38 109.01 21.23 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 172.264 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 541' ' ' ALA . . . . . 0.473 ' HA ' HD22 ' A' ' 518' ' ' LEU . . . -96.01 111.23 55.53 Favored Pre-proline 0 C--N 1.322 -0.618 0 CA-C-N 116.628 -0.26 . . . . 0.0 111.193 -176.418 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 542' ' ' PRO . . . . . 0.581 ' HA ' HG13 ' A' ' 628' ' ' ILE . 18.5 Cg_endo -66.91 130.05 22.21 Favored 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 122.141 1.894 . . . . 0.0 110.967 175.251 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 17.4 p -96.4 -174.78 3.15 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.509 -0.769 . . . . 0.0 112.55 -171.778 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 544' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -49.76 -37.15 28.48 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 114.746 -1.115 . . . . 0.0 111.715 178.056 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 545' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -65.0 -28.62 69.63 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.976 -175.675 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 546' ' ' ALA . . . . . 0.621 ' HB1' HG23 ' A' ' 631' ' ' VAL . . . -79.08 -58.46 3.22 Favored 'General case' 0 CA--C 1.516 -0.348 0 CA-C-O 121.082 0.468 . . . . 0.0 111.616 -176.149 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 547' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -64.62 -29.85 70.86 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.727 -0.669 . . . . 0.0 111.548 -175.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 548' ' ' ARG . . . . . . . . . . . . . 47.3 ttp180 -66.66 -30.68 71.0 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.923 0.392 . . . . 0.0 110.46 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 549' ' ' ALA . . . . . . . . . . . . . . . -86.89 -10.57 53.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.461 -176.016 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 550' ' ' LEU . . . . . 0.491 HD11 HG21 ' A' ' 631' ' ' VAL . 88.2 mt -70.79 122.78 87.79 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 120.922 0.392 . . . . 0.0 110.978 -178.112 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 551' ' ' PRO . . . . . 0.477 ' HD3' ' HA ' ' A' ' 550' ' ' LEU . 16.5 Cg_exo -68.89 157.72 60.75 Favored 'Trans proline' 0 C--O 1.236 0.375 0 C-N-CA 123.327 2.685 . . . . 0.0 111.853 -178.294 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 552' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -44.17 -53.01 5.11 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 123.831 3.021 . . . . 0.0 113.225 -177.985 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 553' ' ' ARG . . . . . . . . . . . . . 23.2 mtm180 -63.2 -48.35 78.67 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 120.715 0.293 . . . . 0.0 111.513 -175.575 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -63.74 -52.77 58.99 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.736 -174.709 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 555' ' ' ARG . . . . . . . . . . . . . 19.6 ptt180 -66.34 -29.16 69.3 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.274 -177.474 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 29.2 t -75.6 -24.06 56.5 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.615 0.245 . . . . 0.0 110.834 -178.256 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 557' ' ' ARG . . . . . . . . . . . . . 12.3 tpp180 -82.94 -46.52 12.83 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.53 -0.304 . . . . 0.0 110.265 178.281 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 558' ' ' LEU . . . . . . . . . . . . . 51.2 tp -61.17 -41.56 97.01 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.768 179.223 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 559' ' ' LEU . . . . . 0.672 HD23 HD21 ' A' ' 565' ' ' LEU . 80.5 mt -91.83 6.35 46.45 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.195 0.522 . . . . 0.0 110.552 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 560' ' ' GLY . . . . . . . . . . . . . . . -96.72 -39.58 4.09 Favored Glycine 0 N--CA 1.444 -0.769 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.685 179.502 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 561' ' ' ASP . . . . . 0.514 ' HB2' ' HG2' ' A' ' 564' ' ' GLU . 6.1 m-20 -103.81 119.89 39.85 Favored 'General case' 0 N--CA 1.445 -0.708 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 177.139 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 562' ' ' ALA . . . . . . . . . . . . . . . -65.74 -28.84 69.34 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.986 0.422 . . . . 0.0 111.153 -176.777 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 563' ' ' LYS . . . . . . . . . . . . . 4.2 mptp? -69.6 -36.84 76.57 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.1 179.02 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 564' ' ' GLU . . . . . 0.514 ' HG2' ' HB2' ' A' ' 561' ' ' ASP . 8.7 mm-40 -62.96 -40.4 97.57 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 179.384 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 565' ' ' LEU . . . . . 0.672 HD21 HD23 ' A' ' 559' ' ' LEU . 48.3 mt -57.07 -50.2 73.5 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.72 176.129 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 566' ' ' ALA . . . . . . . . . . . . . . . -60.48 -53.97 51.19 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.588 179.224 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 567' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -58.95 -49.96 75.88 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.811 -0.631 . . . . 0.0 112.207 -177.24 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 568' ' ' ILE . . . . . . . . . . . . . 40.7 mm -63.99 -40.4 88.93 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 CA-C-O 120.577 0.227 . . . . 0.0 111.557 -178.503 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 569' ' ' LEU . . . . . 0.464 ' HB3' ' O ' ' A' ' 565' ' ' LEU . 0.1 OUTLIER -72.58 -29.2 63.32 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 122.058 -0.401 . . . . 0.0 110.204 -177.344 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 570' ' ' LYS . . . . . . . . . . . . . 25.2 mtpp -62.19 -29.08 70.12 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.091 0.472 . . . . 0.0 110.684 174.086 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 571' ' ' TYR . . . . . 0.46 ' O ' HD21 ' A' ' 597' ' ' LEU . 55.2 t80 -75.46 -18.8 59.77 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.416 178.402 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 572' ' ' HIS . . . . . . . . . . . . . 64.7 m80 -87.64 -12.4 45.64 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.75 0.309 . . . . 0.0 111.331 -177.917 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 573' ' ' ILE . . . . . 0.667 HG23 HG22 ' A' ' 539' ' ' VAL . 28.7 mt -110.84 118.1 56.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 120.834 0.349 . . . . 0.0 111.18 -178.854 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 574' ' ' GLY . . . . . 0.449 ' HA2' ' HA ' ' A' ' 591' ' ' SER . . . -95.49 145.74 17.89 Favored Glycine 0 N--CA 1.446 -0.698 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 170.584 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 575' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -93.34 16.94 12.13 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 117.524 0.662 . . . . 0.0 111.119 -174.584 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 576' ' ' GLU . . . . . 0.518 ' HB2' HD21 ' A' ' 589' ' ' LEU . 48.8 mt-10 -137.55 124.08 20.88 Favored 'General case' 0 CA--C 1.512 -0.512 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 179.496 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 577' ' ' ILE . . . . . 0.74 ' HA ' ' OG1' ' A' ' 538' ' ' THR . 72.4 mt -67.43 117.74 9.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 O-C-N 123.612 0.57 . . . . 0.0 111.369 -173.879 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 578' ' ' LEU . . . . . 0.685 HD11 HG12 ' A' ' 583' ' ' ILE . 3.3 tm? -117.03 114.21 23.44 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.038 -0.983 . . . . 0.0 109.499 178.653 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 579' ' ' VAL . . . . . . . . . . . . . 29.4 m -108.59 163.4 6.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 177.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 580' ' ' SER . . . . . . . . . . . . . 23.6 t -59.39 -41.86 90.39 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.956 0.407 . . . . 0.0 110.857 -176.742 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 581' ' ' GLY . . . . . . . . . . . . . . . -77.57 19.79 3.79 Favored Glycine 0 CA--C 1.523 0.54 0 C-N-CA 120.777 -0.725 . . . . 0.0 113.152 -179.608 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . -142.35 16.54 2.5 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.473 178.547 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 583' ' ' ILE . . . . . 0.685 HG12 HD11 ' A' ' 578' ' ' LEU . 32.3 mt -85.33 -42.36 16.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.925 0.393 . . . . 0.0 110.95 179.601 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 584' ' ' GLY . . . . . . . . . . . . . . . 81.01 -87.71 1.36 Allowed Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.48 -0.867 . . . . 0.0 111.66 -178.171 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 585' ' ' ALA . . . . . . . . . . . . . . . -130.44 -66.7 0.76 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.003 0.43 . . . . 0.0 109.855 176.883 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 586' ' ' LEU . . . . . 0.8 ' HG ' ' HB2' ' A' ' 600' ' ' SER . 3.6 tt -142.21 134.56 27.83 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 174.871 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 587' ' ' VAL . . . . . . . . . . . . . 10.7 p -125.15 138.44 54.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-O 121.14 0.495 . . . . 0.0 110.955 -174.787 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 588' ' ' ARG . . . . . . . . . . . . . 95.2 mtt180 -99.35 101.75 13.14 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 178.564 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 589' ' ' LEU . . . . . 0.518 HD21 ' HB2' ' A' ' 576' ' ' GLU . 0.6 OUTLIER -109.05 127.04 53.77 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.008 -176.528 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 590' ' ' LYS . . . . . 0.435 ' HE3' ' OE2' ' A' ' 576' ' ' GLU . 22.5 pttp -86.21 145.0 27.16 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.107 0.479 . . . . 0.0 111.002 -176.67 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 591' ' ' SER . . . . . 0.449 ' HA ' ' HA2' ' A' ' 574' ' ' GLY . 79.4 p -95.79 177.84 5.64 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.296 -178.856 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 592' ' ' LEU . . . . . . . . . . . . . 49.1 mt -70.96 -13.87 62.16 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.906 0.384 . . . . 0.0 110.56 179.083 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 593' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -85.74 -29.55 23.8 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.046 -177.449 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 594' ' ' GLY . . . . . . . . . . . . . . . 121.0 -27.09 6.55 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.935 -0.65 . . . . 0.0 111.678 -177.34 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 595' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -73.78 166.04 24.04 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.013 0.435 . . . . 0.0 110.892 176.612 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 596' ' ' LYS . . . . . 0.508 ' O ' ' HD2' ' A' ' 596' ' ' LYS . 0.1 OUTLIER -105.32 141.75 36.29 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.045 -179.601 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 597' ' ' LEU . . . . . 0.46 HD21 ' O ' ' A' ' 571' ' ' TYR . 71.0 mt -92.24 120.27 32.64 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.448 -0.796 . . . . 0.0 108.935 172.966 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 598' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 -81.29 84.15 6.68 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.188 0.518 . . . . 0.0 109.799 -176.289 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 599' ' ' VAL . . . . . . . . . . . . . 42.1 t -98.07 133.77 38.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.086 -175.447 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 600' ' ' SER . . . . . 0.8 ' HB2' ' HG ' ' A' ' 586' ' ' LEU . 29.7 t -144.66 167.86 21.54 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 121.325 0.583 . . . . 0.0 110.569 -177.888 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 601' ' ' LEU . . . . . 0.464 HD13 HD12 ' A' ' 583' ' ' ILE . 31.3 tp -131.45 107.6 9.02 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 114.93 -1.032 . . . . 0.0 109.275 -178.345 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 602' ' ' LYS . . . . . . . . . . . . . 24.7 ttmm -119.0 113.76 21.48 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.217 -0.447 . . . . 0.0 109.85 -177.0 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 603' ' ' ASN . . . . . 0.451 ' O ' ' HB2' ' A' ' 604' ' ' ASN . 91.2 m-20 59.48 32.88 22.0 Favored 'General case' 0 N--CA 1.466 0.338 0 O-C-N 123.43 0.456 . . . . 0.0 110.435 -177.87 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 604' ' ' ASN . . . . . 0.451 ' HB2' ' O ' ' A' ' 603' ' ' ASN . 11.2 m120 73.15 10.59 5.19 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 115.205 -0.907 . . . . 0.0 111.939 -179.013 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 605' ' ' VAL . . . . . . . . . . . . . 61.1 t -97.97 119.98 46.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 174.08 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 606' ' ' VAL . . . . . . . . . . . . . 19.7 t -81.0 136.67 22.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.727 -178.506 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 607' ' ' SER . . . . . . . . . . . . . 8.2 p -142.25 147.92 37.26 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.481 178.62 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 608' ' ' VAL . . . . . . . . . . . . . 7.0 p -131.56 117.38 35.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.122 177.455 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 609' ' ' ASN . . . . . 0.487 ' O ' ' HB2' ' A' ' 610' ' ' LYS . 88.6 m-20 61.35 31.58 19.23 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.676 -178.61 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 610' ' ' LYS . . . . . 0.487 ' HB2' ' O ' ' A' ' 609' ' ' ASN . 11.7 mmmm 79.58 -2.47 2.12 Favored 'General case' 0 N--CA 1.472 0.664 0 O-C-N 124.283 0.989 . . . . 0.0 111.725 -178.133 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 611' ' ' GLU . . . . . 0.485 ' HA ' ' HD3' ' A' ' 612' ' ' PRO . 4.4 mm-40 -93.42 125.81 52.68 Favored Pre-proline 0 C--N 1.33 -0.241 0 N-CA-C 109.654 -0.498 . . . . 0.0 109.654 177.269 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 612' ' ' PRO . . . . . 0.485 ' HD3' ' HA ' ' A' ' 611' ' ' GLU . 8.4 Cg_exo -72.31 144.57 41.58 Favored 'Trans proline' 0 N--CA 1.463 -0.295 0 C-N-CA 122.985 2.457 . . . . 0.0 112.982 -176.252 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 613' ' ' VAL . . . . . . . . . . . . . 98.7 t -86.17 125.97 40.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.61 175.318 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 614' ' ' ALA . . . . . 0.559 ' HB2' HG23 ' A' ' 629' ' ' THR . . . -80.75 -28.48 36.48 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.69 -0.687 . . . . 0.0 111.721 -174.368 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 615' ' ' GLU . . . . . 0.54 ' HB3' ' CG2' ' A' ' 627' ' ' VAL . 10.1 tp10 -161.46 93.97 1.39 Allowed Pre-proline 0 C--N 1.328 -0.363 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 -179.019 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 616' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -89.33 161.04 5.58 Favored 'Trans proline' 0 N--CA 1.46 -0.494 0 C-N-CA 123.353 2.702 . . . . 0.0 113.81 -177.209 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 77.05 32.7 0.47 Allowed 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 121.962 0.887 . . . . 0.0 110.343 164.772 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 618' ' ' ILE . . . . . 0.474 ' CG2' ' HB ' ' A' ' 625' ' ' VAL . 13.2 mt -75.81 111.28 12.04 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.909 0 CA-C-N 114.498 -1.228 . . . . 0.0 109.694 175.342 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 619' ' ' MET . . . . . . . . . . . . . 9.5 mmt -74.86 122.65 23.7 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.809 -0.632 . . . . 0.0 112.114 -175.254 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 620' ' ' ALA . . . . . . . . . . . . . . . -122.47 161.05 24.29 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 172.432 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 621' ' ' THR . . . . . 0.626 HG22 ' HA ' ' A' ' 504' ' ' THR . 9.9 t -69.32 -30.13 68.11 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.587 -0.445 . . . . 0.0 111.823 -174.512 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 622' ' ' ASN . . . . . 0.641 ' HB3' ' HA ' ' A' ' 534' ' ' GLU . 29.3 p-10 -118.07 28.26 8.49 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 111.921 0.341 . . . . 0.0 111.921 -178.027 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 623' ' ' GLY . . . . . . . . . . . . . . . 155.68 -160.68 30.12 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.171 -1.014 . . . . 0.0 112.444 176.882 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 624' ' ' VAL . . . . . . . . . . . . . 8.8 p -128.66 157.44 41.3 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 N-CA-C 110.04 -0.356 . . . . 0.0 110.04 179.001 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 625' ' ' VAL . . . . . 0.661 HG22 HG23 ' A' ' 505' ' ' VAL . 42.8 t -125.02 136.18 61.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 116.246 -0.434 . . . . 0.0 109.932 -179.222 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 626' ' ' HIS . . . . . . . . . . . . . 95.6 m-70 -122.57 112.07 17.57 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-O 121.067 0.461 . . . . 0.0 109.982 175.558 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 627' ' ' VAL . . . . . 0.795 HG22 ' HZ ' ' A' ' 515' ' ' PHE . 67.7 t -67.45 129.01 31.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.061 179.402 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 628' ' ' ILE . . . . . 0.581 HG13 ' HA ' ' A' ' 542' ' ' PRO . 9.2 pt -126.02 146.11 32.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.158 0.504 . . . . 0.0 110.932 175.398 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 629' ' ' THR . . . . . 0.559 HG23 ' HB2' ' A' ' 614' ' ' ALA . 35.3 p -95.22 -1.55 51.4 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.042 179.764 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 630' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -125.29 163.07 23.34 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.846 -0.615 . . . . 0.0 109.691 -175.693 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 631' ' ' VAL . . . . . 0.621 HG23 ' HB1' ' A' ' 546' ' ' ALA . 58.5 t -99.3 123.23 51.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 177.548 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 632' ' ' LEU . . . . . . . . . . . . . 80.4 mt -80.88 116.3 20.79 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.144 0.497 . . . . 0.0 111.338 -177.4 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 633' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 -120.15 129.92 25.1 Favored Pre-proline 0 C--N 1.321 -0.651 0 CA-C-N 115.648 -0.706 . . . . 0.0 109.1 176.461 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 634' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo . . . . . 0 C--O 1.249 1.047 0 C-N-CA 123.296 2.664 . . . . 0.0 112.826 -179.543 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 500' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.022 0 N-CA-C 110.245 -0.28 . . . . 0.0 110.245 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 501' ' ' GLY . . . . . . . . . . . . . . . 166.79 114.91 0.31 Allowed Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 120.596 -0.811 . . . . 0.0 112.314 -179.524 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 502' ' ' MET . . . . . . . . . . . . . 49.6 mtm 68.78 155.22 0.12 Allowed 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 123.288 0.635 . . . . 0.0 111.428 179.664 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . -130.71 130.1 6.02 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.865 -0.684 . . . . 0.0 112.029 177.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 504' ' ' THR . . . . . 0.469 ' HA ' HG22 ' A' ' 621' ' ' THR . 41.1 p -78.92 170.46 16.65 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 110.446 -0.205 . . . . 0.0 110.446 178.589 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 505' ' ' VAL . . . . . 0.726 ' O ' ' HG ' ' A' ' 509' ' ' LEU . 10.7 m -60.54 -34.09 56.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 175.061 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 506' ' ' MET . . . . . . . . . . . . . 93.5 mmm -65.03 -34.78 79.25 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-O 120.809 0.338 . . . . 0.0 110.357 177.354 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 507' ' ' ASP . . . . . 0.537 ' HA ' ' HE3' ' A' ' 510' ' ' LYS . 29.9 t70 -70.29 -44.06 69.14 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.183 178.298 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 508' ' ' VAL . . . . . 0.448 HG23 ' O ' ' A' ' 504' ' ' THR . 67.7 t -59.24 -42.94 88.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.886 177.595 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 509' ' ' LEU . . . . . 0.726 ' HG ' ' O ' ' A' ' 505' ' ' VAL . 71.7 mt -68.51 -32.0 71.65 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.512 -178.199 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 510' ' ' LYS . . . . . 0.537 ' HE3' ' HA ' ' A' ' 507' ' ' ASP . 22.9 pttp -88.11 -13.54 41.08 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.184 0.516 . . . . 0.0 110.048 -178.309 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 511' ' ' GLY . . . . . . . . . . . . . . . -84.51 -8.65 82.85 Favored Glycine 0 N--CA 1.442 -0.912 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.562 174.31 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 512' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -116.24 135.72 53.65 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.604 0.24 . . . . 0.0 110.477 178.216 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 42.2 t30 -64.39 -36.89 85.63 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.844 -176.052 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 514' ' ' ARG . . . . . 0.698 ' HD3' HG22 ' A' ' 543' ' ' THR . 74.8 mtt180 -73.45 -46.94 45.32 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.305 0.574 . . . . 0.0 110.245 -176.731 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 515' ' ' PHE . . . . . 0.975 ' HZ ' HG22 ' A' ' 627' ' ' VAL . 13.9 m-30 -67.42 -18.11 64.98 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.99 -178.546 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 66.2 m -57.43 -36.86 71.9 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.362 -0.381 . . . . 0.0 112.018 -177.593 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 517' ' ' MET . . . . . 0.545 ' HE1' ' HA ' ' A' ' 544' ' ' ASN . 44.7 mtm -72.32 -33.25 67.21 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.752 -0.379 . . . . 0.0 110.177 -179.454 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 518' ' ' LEU . . . . . 0.41 HD22 ' HA ' ' A' ' 541' ' ' ALA . 66.1 tp -64.06 -38.72 92.11 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.088 -0.505 . . . . 0.0 109.908 173.94 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 519' ' ' VAL . . . . . 0.433 HG23 ' O ' ' A' ' 515' ' ' PHE . 56.7 t -57.33 -36.12 51.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 121.156 0.503 . . . . 0.0 109.875 174.399 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 520' ' ' ALA . . . . . . . . . . . . . . . -70.29 -38.84 75.1 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.326 179.549 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 521' ' ' ALA . . . . . . . . . . . . . . . -65.79 -48.87 70.32 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.508 176.754 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 522' ' ' ILE . . . . . . . . . . . . . 94.7 mt -57.06 -41.42 77.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.828 -0.623 . . . . 0.0 110.872 176.5 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 523' ' ' GLN . . . . . . . . . . . . . 33.8 tt0 -64.95 -43.48 92.58 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.2 177.915 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 20.3 t -70.74 -31.36 68.16 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.538 -176.642 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 525' ' ' ALA . . . . . 0.549 ' HB2' ' HB3' ' A' ' 565' ' ' LEU . . . -88.94 -27.1 21.16 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.726 0.298 . . . . 0.0 111.473 -179.242 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 526' ' ' GLY . . . . . . . . . . . . . . . 87.13 49.65 3.93 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.867 -0.683 . . . . 0.0 112.391 178.78 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 527' ' ' LEU . . . . . 0.411 ' HA ' HD13 ' A' ' 527' ' ' LEU . 4.3 mm? -111.5 8.78 21.2 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.151 0.5 . . . . 0.0 110.691 178.042 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 528' ' ' THR . . . . . . . . . . . . . 5.9 m -60.42 -33.93 73.22 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.464 -177.612 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 529' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -61.29 -33.64 73.89 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.114 -178.633 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 530' ' ' THR . . . . . . . . . . . . . 30.4 m -70.29 -48.32 57.23 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.998 -0.547 . . . . 0.0 111.279 -176.315 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 531' ' ' LEU . . . . . 0.539 ' HB3' ' CG2' ' A' ' 505' ' ' VAL . 31.4 mt -85.96 6.21 29.68 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.323 0.582 . . . . 0.0 111.403 -175.674 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 532' ' ' ASN . . . . . . . . . . . . . 53.0 t30 -83.95 -37.76 21.88 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.091 179.356 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 533' ' ' ARG . . . . . . . . . . . . . 76.6 mtm180 -79.44 131.54 36.11 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.862 -178.475 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 534' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -75.03 127.54 33.46 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.524 179.671 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 535' ' ' GLY . . . . . . . . . . . . . . . -174.26 -132.22 1.52 Allowed Glycine 0 CA--C 1.502 -0.721 0 N-CA-C 110.265 -1.134 . . . . 0.0 110.265 -179.574 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 536' ' ' VAL . . . . . . . . . . . . . 33.9 m -124.36 129.25 74.0 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-O 121.261 0.553 . . . . 0.0 110.719 177.584 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 537' ' ' TYR . . . . . . . . . . . . . 80.4 m-85 -154.86 150.35 27.38 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.161 179.266 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 538' ' ' THR . . . . . 0.723 ' OG1' ' HA ' ' A' ' 577' ' ' ILE . 34.1 m -120.26 102.2 8.33 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 173.723 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 539' ' ' VAL . . . . . 0.502 HG22 HG23 ' A' ' 573' ' ' ILE . 44.2 t -105.11 123.87 59.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.498 -173.035 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 540' ' ' PHE . . . . . 0.607 ' HB3' HD13 ' A' ' 628' ' ' ILE . 93.7 m-85 -95.94 112.86 24.47 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 174.341 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 541' ' ' ALA . . . . . 0.41 ' HA ' HD22 ' A' ' 518' ' ' LEU . . . -101.72 110.66 62.56 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-O 120.935 0.398 . . . . 0.0 110.809 -176.751 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 542' ' ' PRO . . . . . 0.624 ' HA ' HG13 ' A' ' 628' ' ' ILE . 16.9 Cg_exo -69.24 138.98 40.84 Favored 'Trans proline' 0 N--CA 1.461 -0.393 0 C-N-CA 123.11 2.54 . . . . 0.0 112.118 178.332 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 543' ' ' THR . . . . . 0.698 HG22 ' HD3' ' A' ' 514' ' ' ARG . 36.8 p -82.53 179.9 7.64 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.239 -178.912 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 544' ' ' ASN . . . . . 0.545 ' HA ' ' HE1' ' A' ' 517' ' ' MET . 14.9 m120 -56.65 -34.84 67.72 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.885 0.374 . . . . 0.0 111.181 179.522 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 545' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -73.07 -23.38 60.54 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.759 -174.906 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -69.16 -51.32 39.34 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-O 121.283 0.563 . . . . 0.0 110.709 179.826 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 547' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -71.65 -20.86 61.9 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.601 -179.369 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 548' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.62 -29.06 62.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.989 -0.551 . . . . 0.0 109.677 176.353 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 549' ' ' ALA . . . . . . . . . . . . . . . -89.32 2.91 53.71 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.368 -175.815 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 550' ' ' LEU . . . . . 0.458 ' HA ' ' HD3' ' A' ' 551' ' ' PRO . 75.3 mt -72.83 137.24 79.84 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.561 178.641 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 551' ' ' PRO . . . . . 0.593 ' HD2' ' HB2' ' A' ' 554' ' ' GLU . 17.5 Cg_exo -66.55 150.63 83.94 Favored 'Trans proline' 0 N--CA 1.461 -0.392 0 C-N-CA 122.819 2.346 . . . . 0.0 112.108 -177.364 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 552' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 551' ' ' PRO . 60.0 Cg_exo -53.4 -28.28 43.35 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 123.247 2.632 . . . . 0.0 112.98 -179.236 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 553' ' ' ARG . . . . . . . . . . . . . 23.0 mmt180 -81.11 -54.29 5.66 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.061 0.458 . . . . 0.0 110.041 -179.691 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 554' ' ' GLU . . . . . 0.593 ' HB2' ' HD2' ' A' ' 551' ' ' PRO . 3.3 mp0 -62.88 -37.64 87.7 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.52 -0.764 . . . . 0.0 112.201 -177.017 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 555' ' ' ARG . . . . . . . . . . . . . 36.5 ptt180 -63.79 -35.11 79.52 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.793 -0.363 . . . . 0.0 110.611 178.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 34.7 m -73.88 -32.05 63.43 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.224 0.535 . . . . 0.0 110.197 179.345 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 557' ' ' ARG . . . . . . . . . . . . . 63.5 mtp180 -68.05 -58.63 4.18 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.624 175.862 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 558' ' ' LEU . . . . . 0.598 ' O ' ' HG ' ' A' ' 565' ' ' LEU . 27.3 tp -62.39 -42.47 99.45 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.285 -172.729 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 559' ' ' LEU . . . . . . . . . . . . . 80.5 mt -88.21 13.0 12.34 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.972 0.415 . . . . 0.0 111.105 -178.152 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 560' ' ' GLY . . . . . . . . . . . . . . . -122.35 -41.2 0.48 Allowed Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.911 -0.662 . . . . 0.0 112.188 178.283 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 561' ' ' ASP . . . . . 0.4 ' OD1' ' HB3' ' A' ' 563' ' ' LYS . 16.9 t70 -99.52 116.75 32.37 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.924 0.392 . . . . 0.0 110.428 -179.395 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 562' ' ' ALA . . . . . . . . . . . . . . . -68.45 -21.55 64.64 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.788 -175.893 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 563' ' ' LYS . . . . . 0.4 ' HB3' ' OD1' ' A' ' 561' ' ' ASP . 59.6 tttm -78.78 -48.33 15.04 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 110.22 -0.289 . . . . 0.0 110.22 -178.599 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 564' ' ' GLU . . . . . 0.519 ' O ' HG12 ' A' ' 568' ' ' ILE . 40.7 mt-10 -57.65 -38.1 74.47 Favored 'General case' 0 C--N 1.332 -0.169 0 O-C-N 123.248 0.343 . . . . 0.0 110.107 177.233 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 565' ' ' LEU . . . . . 0.598 ' HG ' ' O ' ' A' ' 558' ' ' LEU . 3.7 mt -55.06 -54.16 46.64 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.63 174.512 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 566' ' ' ALA . . . . . . . . . . . . . . . -62.94 -37.76 88.34 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.475 -178.515 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 567' ' ' ASN . . . . . . . . . . . . . 12.1 m120 -67.41 -41.69 84.47 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.171 -178.76 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 568' ' ' ILE . . . . . 0.519 HG12 ' O ' ' A' ' 564' ' ' GLU . 48.8 mm -69.29 -34.3 62.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.903 0.382 . . . . 0.0 110.736 178.596 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 569' ' ' LEU . . . . . 0.558 ' HG ' ' O ' ' A' ' 565' ' ' LEU . 77.1 mt -64.72 -36.7 85.14 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.814 0.34 . . . . 0.0 110.881 177.037 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 570' ' ' LYS . . . . . 0.797 ' HE3' ' HA ' ' A' ' 593' ' ' GLN . 26.5 mtpp -63.93 -13.62 47.13 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.017 177.451 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 571' ' ' TYR . . . . . 0.419 ' O ' HD21 ' A' ' 597' ' ' LEU . 7.5 t80 -97.38 -16.0 20.43 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.069 -177.462 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 572' ' ' HIS . . . . . . . . . . . . . 59.6 m80 -95.31 -12.25 26.46 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.958 0.409 . . . . 0.0 111.274 -178.488 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 573' ' ' ILE . . . . . 0.521 HD13 HD21 ' A' ' 531' ' ' LEU . 21.3 mt -108.65 123.01 64.07 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.204 178.96 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 574' ' ' GLY . . . . . 0.547 ' HA2' ' HA ' ' A' ' 591' ' ' SER . . . -92.92 151.2 20.34 Favored Glycine 0 N--CA 1.447 -0.591 0 N-CA-C 111.505 -0.638 . . . . 0.0 111.505 175.137 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 575' ' ' ASP . . . . . 0.483 ' HB3' ' HE3' ' A' ' 590' ' ' LYS . 19.3 t70 -70.35 -21.18 62.91 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 112.879 0.696 . . . . 0.0 112.879 -171.07 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 576' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -149.67 153.06 36.4 Favored 'General case' 0 N--CA 1.439 -1.025 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 -174.69 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 577' ' ' ILE . . . . . 0.723 ' HA ' ' OG1' ' A' ' 538' ' ' THR . 77.3 mt -72.95 126.44 33.61 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 O-C-N 124.028 0.83 . . . . 0.0 112.14 -171.399 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 578' ' ' LEU . . . . . 0.572 HD21 ' HB ' ' A' ' 587' ' ' VAL . 41.9 tp -126.84 105.26 8.53 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 114.998 -1.001 . . . . 0.0 109.146 173.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 579' ' ' VAL . . . . . 0.525 ' CG1' ' H ' ' A' ' 581' ' ' GLY . 1.0 OUTLIER -102.08 167.57 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.106 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.11 -177.441 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 580' ' ' SER . . . . . 0.415 ' N ' HG13 ' A' ' 579' ' ' VAL . 20.2 m -57.82 -25.93 61.3 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.364 -0.835 . . . . 0.0 111.67 -175.164 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 581' ' ' GLY . . . . . 0.525 ' H ' ' CG1' ' A' ' 579' ' ' VAL . . . -87.29 -2.84 82.59 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.523 -176.799 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . -110.69 -18.59 8.34 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.37 -179.195 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 583' ' ' ILE . . . . . 0.412 HG13 ' O ' ' A' ' 579' ' ' VAL . 51.2 mt -70.96 -63.38 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.726 0.298 . . . . 0.0 111.2 -177.512 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 584' ' ' GLY . . . . . . . . . . . . . . . 81.53 -63.23 4.38 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.283 -178.175 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 585' ' ' ALA . . . . . . . . . . . . . . . -134.71 -71.01 0.49 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.781 0.324 . . . . 0.0 110.286 178.143 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 586' ' ' LEU . . . . . 0.54 HD13 ' HB3' ' A' ' 600' ' ' SER . 45.5 tp -147.27 132.68 18.59 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.44 -179.448 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 587' ' ' VAL . . . . . 0.572 ' HB ' HD21 ' A' ' 578' ' ' LEU . 57.5 t -137.93 129.17 38.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 116.022 -0.536 . . . . 0.0 109.661 176.655 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 588' ' ' ARG . . . . . 0.402 ' HG2' ' OE2' ' A' ' 598' ' ' GLU . 55.2 mtm180 -85.74 109.84 18.92 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.05 -179.251 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 589' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -95.79 124.88 40.0 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.812 -174.992 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 590' ' ' LYS . . . . . 0.483 ' HE3' ' HB3' ' A' ' 575' ' ' ASP . 47.4 pttt -77.96 138.93 39.12 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.11 0.481 . . . . 0.0 110.125 177.365 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 591' ' ' SER . . . . . 0.547 ' HA ' ' HA2' ' A' ' 574' ' ' GLY . 80.2 p -104.27 166.24 10.53 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.338 -177.953 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 592' ' ' LEU . . . . . . . . . . . . . 10.1 mp -68.73 -7.81 37.06 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.246 0.461 . . . . 0.0 112.246 178.173 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 593' ' ' GLN . . . . . 0.797 ' HA ' ' HE3' ' A' ' 570' ' ' LYS . 29.1 tt0 -80.61 -29.03 36.89 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.206 0.527 . . . . 0.0 109.661 173.455 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 594' ' ' GLY . . . . . . . . . . . . . . . 106.55 -13.56 42.86 Favored Glycine 0 N--CA 1.441 -0.993 0 N-CA-C 110.717 -0.953 . . . . 0.0 110.717 -172.327 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 595' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -81.36 -174.43 4.92 Favored 'General case' 0 C--O 1.237 0.396 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 179.304 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 596' ' ' LYS . . . . . . . . . . . . . 59.0 pttt -115.33 135.18 54.41 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.175 0.512 . . . . 0.0 111.422 -171.521 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 597' ' ' LEU . . . . . 0.419 HD21 ' O ' ' A' ' 571' ' ' TYR . 57.6 mt -106.04 114.46 28.61 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 168.771 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 598' ' ' GLU . . . . . 0.43 ' HG3' HD11 ' A' ' 586' ' ' LEU . 1.0 OUTLIER -83.4 92.07 7.48 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 -179.929 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 599' ' ' VAL . . . . . 0.525 ' HA ' ' O ' ' A' ' 607' ' ' SER . 43.2 t -98.4 118.78 45.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 121.245 0.545 . . . . 0.0 110.411 -177.175 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 600' ' ' SER . . . . . 0.54 ' HB3' HD13 ' A' ' 586' ' ' LEU . 2.7 p -129.43 151.77 49.7 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.059 -178.097 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 601' ' ' LEU . . . . . . . . . . . . . 47.6 tp -113.04 108.03 16.77 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.374 179.418 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 602' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -131.12 127.27 37.74 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.361 -177.336 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 603' ' ' ASN . . . . . . . . . . . . . 66.2 t30 62.49 27.45 16.28 Favored 'General case' 0 N--CA 1.464 0.273 0 O-C-N 123.652 0.595 . . . . 0.0 109.946 -178.603 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 604' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 69.19 12.72 8.53 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 115.137 -0.938 . . . . 0.0 111.513 -177.57 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 605' ' ' VAL . . . . . . . . . . . . . 48.6 t -110.85 123.33 66.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 176.828 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 606' ' ' VAL . . . . . 0.441 ' HB ' ' HB ' ' A' ' 613' ' ' VAL . 42.0 t -72.52 148.33 9.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.25 -179.8 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 607' ' ' SER . . . . . 0.525 ' O ' ' HA ' ' A' ' 599' ' ' VAL . 4.5 p -141.52 140.62 33.5 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.221 -0.445 . . . . 0.0 109.983 179.789 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 608' ' ' VAL . . . . . . . . . . . . . 3.8 p -126.13 110.36 23.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-O 121.059 0.456 . . . . 0.0 110.315 179.025 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 609' ' ' ASN . . . . . 0.473 ' O ' ' HB3' ' A' ' 610' ' ' LYS . 92.9 m-20 55.48 54.07 8.97 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.87 -179.64 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 610' ' ' LYS . . . . . 0.473 ' HB3' ' O ' ' A' ' 609' ' ' ASN . 61.8 tttp 77.59 -27.32 0.17 Allowed 'General case' 0 N--CA 1.469 0.475 0 CA-C-N 115.525 -0.762 . . . . 0.0 111.721 178.77 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 611' ' ' GLU . . . . . 0.533 ' HB3' ' ND2' ' A' ' 630' ' ' ASN . 6.0 mm-40 -80.35 123.42 83.05 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 120.646 0.26 . . . . 0.0 110.978 -178.482 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 612' ' ' PRO . . . . . 0.494 ' HD3' ' HA ' ' A' ' 611' ' ' GLU . 7.9 Cg_exo -72.75 145.05 40.39 Favored 'Trans proline' 0 CA--C 1.531 0.367 0 C-N-CA 123.0 2.467 . . . . 0.0 113.11 -178.73 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 613' ' ' VAL . . . . . 0.441 ' HB ' ' HB ' ' A' ' 606' ' ' VAL . 70.7 t -91.44 139.23 18.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.951 176.631 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 614' ' ' ALA . . . . . 0.569 ' HB2' HG23 ' A' ' 629' ' ' THR . . . -86.13 -36.21 19.71 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.125 -0.489 . . . . 0.0 112.063 -175.787 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 615' ' ' GLU . . . . . . . . . . . . . 20.4 tp10 -157.78 99.74 1.84 Allowed Pre-proline 0 C--N 1.327 -0.401 0 CA-C-O 121.046 0.45 . . . . 0.0 110.306 -176.593 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 616' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -90.13 168.87 4.36 Favored 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 123.326 2.684 . . . . 0.0 113.844 -178.318 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 77.29 32.74 0.44 Allowed 'General case' 0 CA--C 1.508 -0.657 0 CA-C-O 122.073 0.94 . . . . 0.0 111.025 163.611 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 618' ' ' ILE . . . . . 0.529 ' HB ' ' O ' ' A' ' 625' ' ' VAL . 18.1 mt -83.3 98.98 5.55 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.147 0 CA-C-N 114.149 -1.387 . . . . 0.0 109.29 174.198 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 619' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.96 130.08 36.1 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.777 -174.965 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 620' ' ' ALA . . . . . . . . . . . . . . . -130.76 177.04 7.71 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.524 173.599 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 621' ' ' THR . . . . . 0.469 HG22 ' HA ' ' A' ' 504' ' ' THR . 10.7 t -81.07 -14.58 57.68 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.44 -0.504 . . . . 0.0 111.59 -177.937 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 622' ' ' ASN . . . . . 0.504 ' HB2' HG13 ' A' ' 505' ' ' VAL . 7.5 m120 -102.69 -0.34 31.89 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.697 0.284 . . . . 0.0 110.643 179.311 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 623' ' ' GLY . . . . . 0.68 ' HA2' HD11 ' A' ' 577' ' ' ILE . . . 145.62 -140.12 8.75 Favored Glycine 0 N--CA 1.445 -0.76 0 C-N-CA 120.379 -0.915 . . . . 0.0 112.596 180.0 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 624' ' ' VAL . . . . . . . . . . . . . 4.8 p -126.45 156.02 36.97 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-O 120.898 0.38 . . . . 0.0 109.981 179.817 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 625' ' ' VAL . . . . . 0.529 ' O ' ' HB ' ' A' ' 618' ' ' ILE . 61.4 t -125.55 136.98 59.14 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.534 179.803 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 626' ' ' HIS . . . . . . . . . . . . . 94.3 m-70 -119.2 115.9 25.18 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-O 120.866 0.365 . . . . 0.0 110.052 177.242 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 627' ' ' VAL . . . . . 0.975 HG22 ' HZ ' ' A' ' 515' ' ' PHE . 38.6 t -70.18 124.95 27.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.334 177.865 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 628' ' ' ILE . . . . . 0.624 HG13 ' HA ' ' A' ' 542' ' ' PRO . 3.8 pt -123.97 145.03 31.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-O 121.368 0.604 . . . . 0.0 111.3 178.358 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 629' ' ' THR . . . . . 0.569 HG23 ' HB2' ' A' ' 614' ' ' ALA . 22.7 p -94.11 7.48 45.03 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.788 0.804 . . . . 0.0 109.836 179.782 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 630' ' ' ASN . . . . . 0.533 ' ND2' ' HB3' ' A' ' 611' ' ' GLU . 6.1 p30 -141.19 166.05 25.84 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 114.33 -1.305 . . . . 0.0 109.52 -177.164 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 631' ' ' VAL . . . . . 0.445 HG11 HD21 ' A' ' 550' ' ' LEU . 2.7 p -125.91 123.53 64.34 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.982 0 N-CA-C 110.26 -0.274 . . . . 0.0 110.26 -179.643 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 632' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -63.19 120.27 11.18 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-O 121.085 0.469 . . . . 0.0 111.092 -177.024 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 633' ' ' GLN . . . . . . . . . . . . . 57.1 tp60 -126.96 110.45 21.94 Favored Pre-proline 0 C--N 1.319 -0.743 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 178.188 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 634' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo . . . . . 0 C--O 1.249 1.05 0 C-N-CA 123.013 2.475 . . . . 0.0 111.872 -178.7 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 500' ' ' ALA . . . . . 0.677 ' HB2' ' HA3' ' A' ' 511' ' ' GLY . . . . . . . . 0 N--CA 1.479 0.995 0 CA-C-O 120.899 0.38 . . . . 0.0 110.469 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 501' ' ' GLY . . . . . . . . . . . . . . . 98.8 13.27 40.94 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.667 -0.778 . . . . 0.0 111.484 -177.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 502' ' ' MET . . . . . . . . . . . . . 2.4 mpt? -106.4 -23.85 12.4 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.856 0.36 . . . . 0.0 110.094 179.004 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . -129.38 -126.91 2.89 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.381 -0.914 . . . . 0.0 112.933 -178.165 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 65.6 p -87.52 -176.04 5.44 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.728 0.299 . . . . 0.0 111.165 -176.205 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 505' ' ' VAL . . . . . 0.617 ' O ' ' HG ' ' A' ' 509' ' ' LEU . 21.4 t -54.16 -41.63 52.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.388 175.997 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 506' ' ' MET . . . . . . . . . . . . . 4.1 mmt -55.11 -43.07 73.7 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.538 179.013 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 507' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -61.68 -39.68 92.27 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.996 0.427 . . . . 0.0 111.022 179.395 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 508' ' ' VAL . . . . . . . . . . . . . 43.2 t -65.53 -46.38 89.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.512 179.074 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 509' ' ' LEU . . . . . 0.617 ' HG ' ' O ' ' A' ' 505' ' ' VAL . 39.0 mt -68.92 -20.8 64.24 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.482 -175.537 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -89.35 -15.99 32.06 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.329 -178.067 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 511' ' ' GLY . . . . . 0.677 ' HA3' ' HB2' ' A' ' 500' ' ' ALA . . . -82.07 -9.75 84.8 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.751 -0.738 . . . . 0.0 111.445 177.365 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 512' ' ' ASP . . . . . 0.5 ' O ' ' HB2' ' A' ' 516' ' ' SER . 28.1 t70 -120.3 146.99 45.57 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.521 -0.34 . . . . 0.0 110.872 179.359 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -75.52 -32.97 60.69 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.831 0.348 . . . . 0.0 111.434 -178.36 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 514' ' ' ARG . . . . . 0.48 ' HD3' ' HB ' ' A' ' 543' ' ' THR . 78.7 mtt180 -74.78 -49.39 21.03 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.128 0.49 . . . . 0.0 109.711 -176.749 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 515' ' ' PHE . . . . . 0.404 ' HZ ' HG22 ' A' ' 627' ' ' VAL . 15.2 m-30 -65.67 -26.0 67.59 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.809 178.684 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 516' ' ' SER . . . . . 0.5 ' HB2' ' O ' ' A' ' 512' ' ' ASP . 15.9 t -65.34 -26.53 68.07 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.111 -179.219 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 517' ' ' MET . . . . . 0.482 ' HE2' ' HB2' ' A' ' 517' ' ' MET . 33.9 mtm -72.02 -35.21 69.34 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 176.018 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 518' ' ' LEU . . . . . . . . . . . . . 61.4 tp -64.68 -39.13 93.14 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.716 173.837 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 519' ' ' VAL . . . . . . . . . . . . . 86.0 t -55.06 -36.85 40.43 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.147 0 CA-C-O 121.163 0.506 . . . . 0.0 110.277 174.506 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 520' ' ' ALA . . . . . . . . . . . . . . . -70.99 -42.82 69.17 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.77 -179.423 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 521' ' ' ALA . . . . . . . . . . . . . . . -64.49 -48.65 74.42 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.623 177.581 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 522' ' ' ILE . . . . . 0.626 HG23 ' HB2' ' A' ' 527' ' ' LEU . 88.6 mt -59.48 -38.85 77.31 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.923 178.694 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 523' ' ' GLN . . . . . . . . . . . . . 22.0 tm0? -64.71 -44.22 90.94 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.343 177.417 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 13.6 t -68.69 -35.87 77.76 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.749 -178.506 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 525' ' ' ALA . . . . . 0.452 ' HB1' ' HB2' ' A' ' 566' ' ' ALA . . . -73.85 -28.05 61.4 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.849 0.357 . . . . 0.0 111.354 179.344 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 526' ' ' GLY . . . . . . . . . . . . . . . 90.18 48.54 3.52 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.385 179.129 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 527' ' ' LEU . . . . . 0.626 ' HB2' HG23 ' A' ' 522' ' ' ILE . 93.1 mt -124.32 26.35 7.41 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.06 0.457 . . . . 0.0 110.233 178.578 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 528' ' ' THR . . . . . . . . . . . . . 24.5 m -74.86 -36.47 62.32 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.206 -175.37 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 529' ' ' GLU . . . . . 0.464 ' CD ' ' H ' ' A' ' 529' ' ' GLU . 1.9 mp0 -57.82 -36.25 71.99 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.685 -179.511 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 530' ' ' THR . . . . . . . . . . . . . 4.0 m -58.95 -43.13 91.2 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.653 -176.439 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 531' ' ' LEU . . . . . . . . . . . . . 59.1 mt -94.77 14.03 22.65 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.342 -175.582 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 532' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -90.98 -49.47 6.4 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.788 -178.028 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 533' ' ' ARG . . . . . 0.561 ' HG2' ' OE1' ' A' ' 534' ' ' GLU . 18.6 ttp180 -89.87 172.55 8.81 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 -178.662 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 534' ' ' GLU . . . . . 0.584 ' HA ' ' CB ' ' A' ' 622' ' ' ASN . 1.6 pm0 -90.56 -179.18 5.5 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-O 121.446 0.641 . . . . 0.0 111.634 -179.684 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 535' ' ' GLY . . . . . . . . . . . . . . . 142.66 -145.17 15.02 Favored Glycine 0 N--CA 1.446 -0.665 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -172.806 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 536' ' ' VAL . . . . . 0.466 ' HB ' HG13 ' A' ' 577' ' ' ILE . 29.1 m -127.63 130.64 70.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 117.774 0.787 . . . . 0.0 110.487 174.074 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 537' ' ' TYR . . . . . . . . . . . . . 93.2 m-85 -148.47 148.31 30.11 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.84 -179.765 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 538' ' ' THR . . . . . 0.775 ' OG1' ' HA ' ' A' ' 577' ' ' ILE . 37.0 m -127.6 102.01 6.65 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 174.182 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 539' ' ' VAL . . . . . 0.525 HG22 HG23 ' A' ' 573' ' ' ILE . 40.3 t -108.93 131.13 60.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.203 -173.449 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 540' ' ' PHE . . . . . 0.52 ' HB3' HD13 ' A' ' 628' ' ' ILE . 92.9 m-85 -101.48 109.98 21.9 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.376 174.685 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -96.02 115.48 65.59 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.498 -178.662 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 542' ' ' PRO . . . . . 0.524 ' HA ' HG13 ' A' ' 628' ' ' ILE . 6.7 Cg_exo -73.79 135.18 21.15 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 122.872 2.382 . . . . 0.0 111.619 178.176 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 543' ' ' THR . . . . . 0.48 ' HB ' ' HD3' ' A' ' 514' ' ' ARG . 34.4 p -75.98 -178.16 4.23 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.06 -179.092 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 544' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -67.27 -32.88 74.18 Favored 'General case' 0 CA--C 1.517 -0.308 0 N-CA-C 110.351 -0.24 . . . . 0.0 110.351 -177.574 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 545' ' ' GLU . . . . . 0.518 ' CD ' ' H ' ' A' ' 545' ' ' GLU . 1.6 mp0 -59.77 -35.43 74.6 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.246 178.205 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 546' ' ' ALA . . . . . 0.625 ' HB1' HG22 ' A' ' 631' ' ' VAL . . . -62.06 -47.51 84.35 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-O 121.275 0.56 . . . . 0.0 110.724 179.347 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 547' ' ' PHE . . . . . 0.651 ' HA ' HD23 ' A' ' 550' ' ' LEU . 94.2 m-85 -78.28 -21.95 49.02 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.797 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 548' ' ' ARG . . . . . . . . . . . . . 20.6 tpp180 -72.61 -35.04 67.76 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.963 177.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 549' ' ' ALA . . . . . . . . . . . . . . . -74.24 -16.08 60.97 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.278 -179.563 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 550' ' ' LEU . . . . . 0.806 HD11 ' HB3' ' A' ' 555' ' ' ARG . 0.2 OUTLIER -98.55 130.5 27.88 Favored Pre-proline 0 N--CA 1.445 -0.712 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 -179.298 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 551' ' ' PRO . . . . . 0.59 ' HD2' ' HB2' ' A' ' 554' ' ' GLU . 5.0 Cg_exo -77.26 160.52 32.67 Favored 'Trans proline' 0 CA--C 1.528 0.212 0 C-N-CA 123.705 2.937 . . . . 0.0 113.488 -169.145 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 552' ' ' PRO . . . . . 0.778 ' HA ' ' HG2' ' A' ' 555' ' ' ARG . 15.0 Cg_endo -58.88 -35.64 98.26 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 123.088 2.525 . . . . 0.0 112.21 176.453 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 553' ' ' ARG . . . . . . . . . . . . . 25.2 tpp180 -61.56 -47.39 85.73 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.383 179.591 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 554' ' ' GLU . . . . . 0.59 ' HB2' ' HD2' ' A' ' 551' ' ' PRO . 18.9 mm-40 -73.76 -44.96 54.66 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.314 -178.752 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 555' ' ' ARG . . . . . 0.806 ' HB3' HD11 ' A' ' 550' ' ' LEU . 14.4 ptp180 -59.06 -41.31 87.64 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 120.711 -0.396 . . . . 0.0 110.798 -179.173 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 13.1 t -65.02 -36.61 84.96 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.903 0.382 . . . . 0.0 110.457 -178.248 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 557' ' ' ARG . . . . . . . . . . . . . 16.3 mmm180 -61.34 -46.26 90.96 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.883 176.143 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 558' ' ' LEU . . . . . . . . . . . . . 51.7 tp -70.85 -56.35 6.49 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.188 -0.914 . . . . 0.0 111.586 -177.29 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 559' ' ' LEU . . . . . 0.715 ' HG ' ' O ' ' A' ' 555' ' ' ARG . 3.9 pp -73.77 -8.6 56.65 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 120.951 -0.3 . . . . 0.0 111.452 -174.662 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 560' ' ' GLY . . . . . . . . . . . . . . . -66.87 -34.46 87.24 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.958 -0.639 . . . . 0.0 111.605 175.283 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 561' ' ' ASP . . . . . 0.471 ' OD2' ' HB3' ' A' ' 563' ' ' LYS . 14.7 t70 -111.59 121.56 45.47 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.829 0.347 . . . . 0.0 110.673 -179.55 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 562' ' ' ALA . . . . . . . . . . . . . . . -65.45 -28.87 69.54 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.161 -178.631 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 563' ' ' LYS . . . . . 0.471 ' HB3' ' OD2' ' A' ' 561' ' ' ASP . 14.5 ttpp -66.09 -52.16 51.34 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.267 -178.604 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 564' ' ' GLU . . . . . 0.512 ' HA ' ' HB3' ' A' ' 567' ' ' ASN . 8.9 mt-10 -71.76 -24.43 61.77 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.584 -179.487 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 565' ' ' LEU . . . . . 0.489 HD23 ' HA ' ' A' ' 565' ' ' LEU . 9.9 mt -59.39 -55.16 38.22 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 109.368 -0.605 . . . . 0.0 109.368 169.606 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 566' ' ' ALA . . . . . 0.452 ' HB2' ' HB1' ' A' ' 525' ' ' ALA . . . -64.4 -34.75 78.91 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.343 179.274 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 567' ' ' ASN . . . . . 0.512 ' HB3' ' HA ' ' A' ' 564' ' ' GLU . 39.9 t30 -56.43 -54.47 45.33 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.154 -179.854 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 568' ' ' ILE . . . . . . . . . . . . . 48.9 mm -70.93 -37.32 67.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.746 0.308 . . . . 0.0 111.068 -177.739 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 569' ' ' LEU . . . . . 0.419 ' HG ' ' O ' ' A' ' 565' ' ' LEU . 95.5 mt -65.2 -33.45 76.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.041 0.448 . . . . 0.0 110.946 178.289 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 570' ' ' LYS . . . . . 0.565 ' HE2' ' HA ' ' A' ' 593' ' ' GLN . 80.0 tttt -67.2 -16.73 64.48 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.559 -178.946 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 571' ' ' TYR . . . . . . . . . . . . . 45.5 t80 -89.98 -17.76 27.27 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.04 177.595 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 572' ' ' HIS . . . . . . . . . . . . . 53.2 m80 -86.07 -10.3 55.18 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.722 0.296 . . . . 0.0 111.158 -177.549 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 573' ' ' ILE . . . . . 0.525 HG23 HG22 ' A' ' 539' ' ' VAL . 31.2 mt -109.79 120.84 61.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.808 -179.137 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 574' ' ' GLY . . . . . 0.586 ' HA2' ' HA ' ' A' ' 591' ' ' SER . . . -98.62 148.26 18.79 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.909 -0.663 . . . . 0.0 111.663 175.052 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 575' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -93.4 9.07 37.97 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 111.936 0.347 . . . . 0.0 111.936 -173.693 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 576' ' ' GLU . . . . . 0.441 ' O ' HD21 ' A' ' 589' ' ' LEU . 12.2 pt-20 -144.92 133.32 21.84 Favored 'General case' 0 CA--C 1.508 -0.652 0 N-CA-C 109.765 -0.458 . . . . 0.0 109.765 178.616 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 577' ' ' ILE . . . . . 0.775 ' HA ' ' OG1' ' A' ' 538' ' ' THR . 76.3 mt -75.32 117.2 19.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.435 -175.513 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 578' ' ' LEU . . . . . 0.45 ' HB2' HD23 ' A' ' 589' ' ' LEU . 48.7 tp -118.41 108.65 15.31 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.318 -0.856 . . . . 0.0 109.858 176.841 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 579' ' ' VAL . . . . . . . . . . . . . 29.0 m -91.26 160.67 2.68 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.135 177.688 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 580' ' ' SER . . . . . . . . . . . . . 6.1 p -58.18 -42.81 86.89 Favored 'General case' 0 C--N 1.328 -0.355 0 O-C-N 123.292 0.37 . . . . 0.0 111.436 -176.613 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 581' ' ' GLY . . . . . . . . . . . . . . . -71.78 -11.86 73.9 Favored Glycine 0 CA--C 1.521 0.412 0 C-N-CA 120.964 -0.636 . . . . 0.0 113.087 -178.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . -96.71 -9.96 55.85 Favored Glycine 0 N--CA 1.454 -0.135 0 C-N-CA 121.043 -0.599 . . . . 0.0 112.508 -179.179 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 583' ' ' ILE . . . . . . . . . . . . . 58.7 mt -70.38 -60.21 2.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 121.06 0.457 . . . . 0.0 110.926 -178.295 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 584' ' ' GLY . . . . . . . . . . . . . . . 82.15 -89.04 1.44 Allowed Glycine 0 N--CA 1.444 -0.775 0 C-N-CA 120.55 -0.833 . . . . 0.0 111.383 -176.604 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 585' ' ' ALA . . . . . . . . . . . . . . . -102.71 -75.12 0.61 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.087 0.47 . . . . 0.0 110.351 178.184 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 586' ' ' LEU . . . . . 0.882 ' HG ' ' HB2' ' A' ' 600' ' ' SER . 5.7 tt -155.23 134.05 12.08 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 179.227 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 587' ' ' VAL . . . . . 0.442 ' N ' HD23 ' A' ' 586' ' ' LEU . 61.9 t -132.22 137.11 55.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 N-CA-C 110.199 -0.297 . . . . 0.0 110.199 -178.111 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 588' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -84.98 112.57 20.71 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 177.519 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 589' ' ' LEU . . . . . 0.672 ' HB3' ' HB2' ' A' ' 597' ' ' LEU . 1.9 tm? -89.9 121.09 31.69 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 -177.916 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 590' ' ' LYS . . . . . . . . . . . . . 33.8 mttp -87.86 131.16 34.65 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 121.303 0.573 . . . . 0.0 111.239 -172.315 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 591' ' ' SER . . . . . 0.586 ' HA ' ' HA2' ' A' ' 574' ' ' GLY . 84.0 p -97.41 159.78 14.72 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 114.973 -1.012 . . . . 0.0 110.718 -177.038 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 592' ' ' LEU . . . . . . . . . . . . . 9.9 mp -63.45 -21.18 66.16 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.491 177.631 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 593' ' ' GLN . . . . . 0.565 ' HA ' ' HE2' ' A' ' 570' ' ' LYS . 55.7 tt0 -73.0 -29.12 62.8 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.068 0.461 . . . . 0.0 110.291 175.895 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 594' ' ' GLY . . . . . . . . . . . . . . . 112.75 -14.21 24.54 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.172 -179.26 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 595' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -79.65 169.0 18.62 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-O 121.127 0.489 . . . . 0.0 111.106 179.268 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 596' ' ' LYS . . . . . . . . . . . . . 20.0 pttp -106.89 123.42 48.14 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.579 -174.25 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 597' ' ' LEU . . . . . 0.672 ' HB2' ' HB3' ' A' ' 589' ' ' LEU . 40.1 mt -87.73 122.14 31.03 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.947 173.526 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 598' ' ' GLU . . . . . 0.761 ' O ' ' HA ' ' A' ' 608' ' ' VAL . 18.2 tt0 -75.89 94.05 3.3 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.234 177.702 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 599' ' ' VAL . . . . . . . . . . . . . 41.5 t -107.84 121.71 61.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-O 121.317 0.58 . . . . 0.0 110.32 178.32 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 600' ' ' SER . . . . . 0.882 ' HB2' ' HG ' ' A' ' 586' ' ' LEU . 34.9 t -141.8 168.71 19.1 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.703 -177.13 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 601' ' ' LEU . . . . . . . . . . . . . 42.4 tp -135.95 107.78 7.07 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.111 -0.95 . . . . 0.0 108.738 -178.479 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 602' ' ' LYS . . . . . 0.606 ' O ' HG12 ' A' ' 605' ' ' VAL . 57.0 mtpt -131.02 114.33 15.06 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.076 -172.832 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 603' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 57.83 47.16 15.78 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.704 177.663 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 604' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 71.97 9.32 6.09 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 114.855 -1.066 . . . . 0.0 112.967 174.683 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 605' ' ' VAL . . . . . 0.606 HG12 ' O ' ' A' ' 602' ' ' LYS . 7.6 p -118.2 134.26 62.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 C-N-CA 120.146 -0.621 . . . . 0.0 110.326 173.829 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 606' ' ' VAL . . . . . 0.812 HG13 ' HB ' ' A' ' 613' ' ' VAL . 3.9 p -101.64 136.93 31.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.043 178.318 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 607' ' ' SER . . . . . . . . . . . . . 45.0 m -136.93 151.03 48.58 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.759 -177.585 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 608' ' ' VAL . . . . . 0.761 ' HA ' ' O ' ' A' ' 598' ' ' GLU . 4.3 p -128.62 108.41 17.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.411 0.624 . . . . 0.0 110.059 176.956 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 609' ' ' ASN . . . . . 0.407 ' O ' ' HB2' ' A' ' 610' ' ' LYS . 25.0 m120 60.34 47.98 8.41 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.638 -176.415 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 610' ' ' LYS . . . . . 0.407 ' HB2' ' O ' ' A' ' 609' ' ' ASN . 56.0 mtpt 73.17 -19.02 0.34 Allowed 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 115.534 -0.757 . . . . 0.0 112.097 -178.533 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 611' ' ' GLU . . . . . 0.428 ' HA ' ' HD3' ' A' ' 612' ' ' PRO . 5.2 mm-40 -79.16 123.74 84.71 Favored Pre-proline 0 C--N 1.331 -0.213 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 -179.359 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 612' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 611' ' ' GLU . 7.3 Cg_exo -73.12 136.12 24.07 Favored 'Trans proline' 0 C--O 1.236 0.382 0 C-N-CA 123.235 2.623 . . . . 0.0 112.939 -176.193 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 613' ' ' VAL . . . . . 0.812 ' HB ' HG13 ' A' ' 606' ' ' VAL . 93.7 t -81.83 130.5 35.7 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.92 175.712 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 614' ' ' ALA . . . . . . . . . . . . . . . -78.44 -33.39 48.55 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.503 -176.239 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 615' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -165.47 107.53 0.77 Allowed Pre-proline 0 C--O 1.233 0.197 0 CA-C-O 120.835 0.35 . . . . 0.0 110.576 -179.673 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 616' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_endo -89.32 156.37 5.52 Favored 'Trans proline' 0 N--CA 1.459 -0.524 0 C-N-CA 123.29 2.66 . . . . 0.0 114.008 -178.065 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 35.3 t70 77.95 61.94 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 122.687 1.232 . . . . 0.0 110.463 166.524 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 618' ' ' ILE . . . . . 0.435 ' HB ' ' O ' ' A' ' 625' ' ' VAL . 7.9 mt -104.73 112.83 39.95 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.301 0 CA-C-N 113.757 -1.565 . . . . 0.0 108.438 174.695 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 619' ' ' MET . . . . . 0.467 ' HA ' ' CE ' ' A' ' 619' ' ' MET . 4.9 mmt -77.83 131.36 37.53 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 -170.588 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 620' ' ' ALA . . . . . . . . . . . . . . . -130.23 162.6 28.57 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 114.995 -1.002 . . . . 0.0 108.466 170.318 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 621' ' ' THR . . . . . . . . . . . . . 5.7 t -73.86 -20.37 60.44 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 120.502 -0.479 . . . . 0.0 111.351 -175.753 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 622' ' ' ASN . . . . . 0.584 ' CB ' ' HA ' ' A' ' 534' ' ' GLU . 28.2 p-10 -116.84 15.54 15.28 Favored 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 120.642 -0.423 . . . . 0.0 111.986 -177.362 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 623' ' ' GLY . . . . . 0.635 ' HA2' HD11 ' A' ' 577' ' ' ILE . . . 157.07 -156.22 27.03 Favored Glycine 0 N--CA 1.443 -0.872 0 C-N-CA 119.97 -1.109 . . . . 0.0 112.762 179.437 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 624' ' ' VAL . . . . . . . . . . . . . 6.3 p -131.22 156.11 42.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-O 121.033 0.444 . . . . 0.0 110.115 -178.201 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 625' ' ' VAL . . . . . 0.541 HG22 HG13 ' A' ' 505' ' ' VAL . 42.6 t -123.74 132.93 70.56 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.645 179.416 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 626' ' ' HIS . . . . . . . . . . . . . 96.2 m-70 -119.16 115.35 24.05 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 174.883 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 627' ' ' VAL . . . . . 0.404 HG22 ' HZ ' ' A' ' 515' ' ' PHE . 40.4 t -69.87 123.74 24.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.719 -179.8 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 628' ' ' ILE . . . . . 0.524 HG13 ' HA ' ' A' ' 542' ' ' PRO . 8.1 pt -117.51 143.28 28.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 121.192 0.52 . . . . 0.0 111.063 176.436 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 629' ' ' THR . . . . . . . . . . . . . 8.4 t -94.85 5.77 50.93 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.369 -178.857 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 630' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -135.96 165.83 24.76 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.052 -179.437 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 631' ' ' VAL . . . . . 0.625 HG22 ' HB1' ' A' ' 546' ' ' ALA . 0.7 OUTLIER -98.17 130.14 47.38 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.886 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.755 175.91 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 632' ' ' LEU . . . . . 0.662 HD21 HG13 ' A' ' 608' ' ' VAL . 96.1 mt -77.32 115.93 17.51 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.242 0.544 . . . . 0.0 110.922 -177.355 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 633' ' ' GLN . . . . . . . . . . . . . 7.1 tp60 -118.51 117.18 34.63 Favored Pre-proline 0 C--N 1.322 -0.599 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.937 -178.221 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 634' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo . . . . . 0 C--O 1.251 1.133 0 C-N-CA 122.65 2.233 . . . . 0.0 111.944 177.42 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 500' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.064 0 CA-C-O 120.843 0.354 . . . . 0.0 110.869 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 501' ' ' GLY . . . . . . . . . . . . . . . -152.44 -174.01 22.54 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.923 -0.656 . . . . 0.0 111.652 178.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 502' ' ' MET . . . . . . . . . . . . . 21.1 ptp -63.06 121.87 14.67 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.036 0.446 . . . . 0.0 110.444 177.846 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . -163.72 -178.45 37.36 Favored Glycine 0 N--CA 1.445 -0.703 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.697 179.68 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 78.9 p -86.14 173.11 10.06 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.912 0.356 . . . . 0.0 110.536 -179.359 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 505' ' ' VAL . . . . . 0.538 ' O ' ' HG ' ' A' ' 509' ' ' LEU . 24.2 t -53.57 -40.6 42.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 121.224 0.535 . . . . 0.0 110.009 175.098 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 506' ' ' MET . . . . . . . . . . . . . 7.4 mmt -56.5 -40.65 75.32 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.021 -0.991 . . . . 0.0 112.296 179.809 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 507' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -67.63 -40.91 84.6 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 121.035 0.445 . . . . 0.0 110.564 -179.821 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 508' ' ' VAL . . . . . . . . . . . . . 62.1 t -60.66 -41.38 87.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.416 178.601 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 509' ' ' LEU . . . . . 0.538 ' HG ' ' O ' ' A' ' 505' ' ' VAL . 53.9 mt -75.33 -23.26 57.24 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.693 -179.853 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 510' ' ' LYS . . . . . 0.567 ' HB3' ' NZ ' ' A' ' 510' ' ' LYS . 1.6 mmmp? -85.8 -33.36 21.38 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.084 -176.688 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 511' ' ' GLY . . . . . . . . . . . . . . . -73.4 -10.75 79.45 Favored Glycine 0 N--CA 1.445 -0.741 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.928 178.702 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 512' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -110.23 148.61 31.53 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.24 0.543 . . . . 0.0 111.278 -178.2 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -75.19 -33.0 61.37 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.617 -177.73 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 514' ' ' ARG . . . . . 0.682 ' H ' ' HD2' ' A' ' 514' ' ' ARG . 0.3 OUTLIER -88.46 -45.06 10.26 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.059 0.457 . . . . 0.0 110.039 -171.906 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 515' ' ' PHE . . . . . 0.708 ' HZ ' HG22 ' A' ' 627' ' ' VAL . 14.8 m-30 -63.9 -24.69 67.84 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.155 177.523 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 26.5 t -60.76 -36.4 78.85 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.887 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 517' ' ' MET . . . . . . . . . . . . . 59.3 mtm -65.39 -34.5 78.44 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-O 121.003 0.43 . . . . 0.0 110.093 177.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 518' ' ' LEU . . . . . . . . . . . . . 56.1 tp -66.96 -39.8 87.33 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.436 174.661 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 519' ' ' VAL . . . . . . . . . . . . . 58.1 t -54.84 -37.66 41.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-O 121.093 0.473 . . . . 0.0 109.808 174.823 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 520' ' ' ALA . . . . . . . . . . . . . . . -65.02 -39.98 94.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.627 -179.268 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 521' ' ' ALA . . . . . . . . . . . . . . . -69.08 -43.58 74.27 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.465 176.438 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 522' ' ' ILE . . . . . . . . . . . . . 89.3 mt -58.01 -41.81 81.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.224 177.05 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 523' ' ' GLN . . . . . . . . . . . . . 17.6 mm-40 -65.22 -23.96 67.22 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-O 121.011 0.434 . . . . 0.0 111.405 178.774 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 30.0 t -79.66 -41.11 27.6 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.535 177.501 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 525' ' ' ALA . . . . . . . . . . . . . . . -82.29 -29.0 31.4 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.118 0.414 . . . . 0.0 112.118 -176.625 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 526' ' ' GLY . . . . . . . . . . . . . . . 95.08 25.45 14.39 Favored Glycine 0 CA--C 1.519 0.327 0 C-N-CA 120.546 -0.835 . . . . 0.0 113.332 176.883 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 527' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -91.58 8.39 36.88 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 121.173 0.511 . . . . 0.0 110.171 178.342 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 528' ' ' THR . . . . . . . . . . . . . 16.9 m -57.87 -44.05 86.4 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.439 -0.8 . . . . 0.0 111.238 -178.282 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 529' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -65.48 -31.31 72.31 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.026 -0.533 . . . . 0.0 111.352 -176.732 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 530' ' ' THR . . . . . . . . . . . . . 12.4 m -63.21 -46.57 86.4 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.108 -179.238 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 531' ' ' LEU . . . . . . . . . . . . . 42.4 mt -90.44 8.28 34.5 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 120.978 0.418 . . . . 0.0 111.236 -177.156 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 532' ' ' ASN . . . . . . . . . . . . . 63.1 t30 -95.01 -25.15 16.61 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.019 -177.195 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 533' ' ' ARG . . . . . . . . . . . . . 69.1 mtm180 -92.39 157.69 16.47 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.345 -177.819 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 534' ' ' GLU . . . . . 0.583 ' HA ' ' HB3' ' A' ' 622' ' ' ASN . 12.7 pt-20 -78.75 162.76 25.92 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.758 178.567 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 535' ' ' GLY . . . . . . . . . . . . . . . 139.05 -138.63 9.5 Favored Glycine 0 N--CA 1.446 -0.67 0 N-CA-C 110.302 -1.119 . . . . 0.0 110.302 -176.113 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 536' ' ' VAL . . . . . 0.556 ' HB ' HG13 ' A' ' 577' ' ' ILE . 35.3 m -127.07 129.06 71.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 121.229 0.538 . . . . 0.0 111.043 176.417 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 537' ' ' TYR . . . . . 0.436 ' O ' ' HA3' ' A' ' 623' ' ' GLY . 69.2 m-85 -153.07 130.89 11.66 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.595 -0.729 . . . . 0.0 109.695 179.003 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 538' ' ' THR . . . . . 0.707 ' OG1' ' HA ' ' A' ' 577' ' ' ILE . 28.3 m -114.62 106.3 14.08 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.961 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 539' ' ' VAL . . . . . . . . . . . . . 40.0 t -112.15 130.86 65.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-O 121.021 0.439 . . . . 0.0 111.35 -174.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 540' ' ' PHE . . . . . 0.474 ' HB3' HD13 ' A' ' 628' ' ' ILE . 87.5 m-85 -97.68 111.2 23.58 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 174.056 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 541' ' ' ALA . . . . . 0.404 ' HA ' ' HD3' ' A' ' 542' ' ' PRO . . . -101.73 118.38 59.7 Favored Pre-proline 0 C--N 1.325 -0.471 0 CA-C-O 120.669 0.271 . . . . 0.0 110.887 -177.029 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 542' ' ' PRO . . . . . 0.539 ' HA ' HG13 ' A' ' 628' ' ' ILE . 7.4 Cg_exo -74.08 141.52 29.71 Favored 'Trans proline' 0 N--CA 1.461 -0.401 0 C-N-CA 123.155 2.57 . . . . 0.0 112.149 178.339 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 61.0 p -81.66 -176.61 6.15 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.683 -179.124 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 544' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -61.13 -32.7 72.39 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 121.352 0.596 . . . . 0.0 110.162 179.067 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 545' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -59.5 -40.48 87.22 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.037 -0.983 . . . . 0.0 110.939 -179.517 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 546' ' ' ALA . . . . . 0.693 ' HB1' HG23 ' A' ' 631' ' ' VAL . . . -61.54 -50.18 73.7 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.559 -177.993 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 547' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -69.51 -20.86 63.7 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.136 -177.884 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 548' ' ' ARG . . . . . . . . . . . . . 30.5 tpt180 -83.37 -33.89 25.71 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.056 0.455 . . . . 0.0 110.236 177.527 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 549' ' ' ALA . . . . . . . . . . . . . . . -75.5 -21.38 58.06 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.375 -0.83 . . . . 0.0 111.441 -179.69 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 550' ' ' LEU . . . . . 0.617 HD11 HG21 ' A' ' 631' ' ' VAL . 73.5 mt -69.85 129.1 91.38 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-O 120.772 0.32 . . . . 0.0 111.058 178.385 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 551' ' ' PRO . . . . . 0.487 ' HD3' ' HA ' ' A' ' 550' ' ' LEU . 5.1 Cg_exo -77.78 148.29 25.32 Favored 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 123.061 2.508 . . . . 0.0 111.209 -179.207 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 552' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 551' ' ' PRO . 50.1 Cg_exo -53.85 -34.42 75.6 Favored 'Trans proline' 0 N--CA 1.471 0.194 0 C-N-CA 122.915 2.41 . . . . 0.0 112.435 -178.768 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 553' ' ' ARG . . . . . . . . . . . . . 34.8 mtp180 -62.24 -42.78 99.62 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.539 179.77 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -83.78 -35.01 24.65 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.808 0.337 . . . . 0.0 110.84 179.589 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 555' ' ' ARG . . . . . . . . . . . . . 14.4 mtp180 -58.05 -42.56 85.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.137 176.108 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 28.5 t -59.93 -28.55 67.71 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.863 -178.561 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 557' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -67.14 -62.91 1.2 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.357 0.599 . . . . 0.0 110.193 176.377 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 558' ' ' LEU . . . . . 0.573 ' O ' ' HG ' ' A' ' 565' ' ' LEU . 53.2 tp -68.88 -52.66 27.25 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.26 -0.882 . . . . 0.0 112.107 -172.422 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 559' ' ' LEU . . . . . . . . . . . . . 72.5 mt -80.33 4.74 16.87 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.802 -170.739 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 560' ' ' GLY . . . . . . . . . . . . . . . -123.66 3.97 9.33 Favored Glycine 0 N--CA 1.446 -0.7 0 C-N-CA 120.381 -0.914 . . . . 0.0 112.619 -179.794 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 561' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -135.82 128.67 31.16 Favored 'General case' 0 C--N 1.326 -0.431 0 O-C-N 122.538 -0.389 . . . . 0.0 111.051 -178.676 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 562' ' ' ALA . . . . . . . . . . . . . . . -70.32 -38.54 74.95 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.677 -176.132 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 563' ' ' LYS . . . . . 0.48 ' HG2' ' OE1' ' A' ' 564' ' ' GLU . 31.4 tttm -66.65 -47.87 71.18 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.036 -178.394 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 564' ' ' GLU . . . . . 0.48 ' OE1' ' HG2' ' A' ' 563' ' ' LYS . 5.7 mm-40 -67.33 -36.0 80.54 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.602 -0.272 . . . . 0.0 110.786 -179.436 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 565' ' ' LEU . . . . . 0.573 ' HG ' ' O ' ' A' ' 558' ' ' LEU . 6.6 mt -56.62 -52.52 64.56 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-O 120.893 0.377 . . . . 0.0 110.331 174.812 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 566' ' ' ALA . . . . . 0.5 ' O ' ' HG3' ' A' ' 570' ' ' LYS . . . -61.16 -48.71 80.34 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.34 -179.038 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 567' ' ' ASN . . . . . . . . . . . . . 9.8 t30 -59.84 -48.08 83.15 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.822 -177.861 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 568' ' ' ILE . . . . . . . . . . . . . 43.4 mm -69.47 -35.27 65.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.706 0.289 . . . . 0.0 111.459 -178.698 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 569' ' ' LEU . . . . . 0.49 ' HG ' ' O ' ' A' ' 565' ' ' LEU . 61.2 mt -66.23 -36.95 84.35 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.813 -0.355 . . . . 0.0 110.59 177.128 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 570' ' ' LYS . . . . . 0.5 ' HG3' ' O ' ' A' ' 566' ' ' ALA . 53.2 mtpt -69.33 -9.84 55.16 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.682 0.277 . . . . 0.0 111.061 177.355 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 571' ' ' TYR . . . . . 0.408 ' O ' HD21 ' A' ' 597' ' ' LEU . 33.9 t80 -92.78 -18.93 22.29 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.87 0.367 . . . . 0.0 110.525 179.065 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 572' ' ' HIS . . . . . . . . . . . . . 67.2 m80 -92.93 -7.08 47.06 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.17 0.509 . . . . 0.0 110.581 179.75 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 573' ' ' ILE . . . . . . . . . . . . . 54.0 mt -113.75 124.12 70.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.885 179.018 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 574' ' ' GLY . . . . . 0.502 ' HA3' ' CD2' ' A' ' 589' ' ' LEU . . . -113.95 149.7 18.67 Favored Glycine 0 N--CA 1.445 -0.74 0 N-CA-C 110.575 -1.01 . . . . 0.0 110.575 171.48 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 575' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -100.35 24.51 8.73 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 117.553 0.677 . . . . 0.0 110.879 -177.0 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 576' ' ' GLU . . . . . 0.421 ' HG3' ' HG ' ' A' ' 589' ' ' LEU . 14.8 pt-20 -136.21 125.88 25.46 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 175.426 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 577' ' ' ILE . . . . . 0.707 ' HA ' ' OG1' ' A' ' 538' ' ' THR . 61.2 mt -77.57 115.07 18.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.147 -175.423 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 578' ' ' LEU . . . . . 0.562 HD11 ' HA ' ' A' ' 583' ' ' ILE . 48.7 tp -121.67 103.44 8.89 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.267 -0.879 . . . . 0.0 109.791 177.85 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 579' ' ' VAL . . . . . 0.497 ' O ' HG13 ' A' ' 583' ' ' ILE . 30.4 m -95.36 162.41 2.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.964 178.035 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 580' ' ' SER . . . . . . . . . . . . . 15.3 m -56.6 -45.93 81.14 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 123.354 0.409 . . . . 0.0 111.914 -175.722 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 581' ' ' GLY . . . . . . . . . . . . . . . -70.43 -21.17 77.42 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.52 -0.848 . . . . 0.0 112.619 -179.104 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . -99.43 2.64 57.6 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.876 -0.678 . . . . 0.0 113.296 -175.222 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 583' ' ' ILE . . . . . 0.562 ' HA ' HD11 ' A' ' 578' ' ' LEU . 62.7 mt -67.75 -65.21 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 117.183 0.491 . . . . 0.0 111.1 179.142 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 584' ' ' GLY . . . . . . . . . . . . . . . 78.83 78.32 0.84 Allowed Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.241 -0.981 . . . . 0.0 111.556 -175.388 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 585' ' ' ALA . . . . . . . . . . . . . . . 70.68 -80.12 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 123.303 0.641 . . . . 0.0 111.88 -178.884 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 586' ' ' LEU . . . . . 0.96 ' HG ' ' HB3' ' A' ' 600' ' ' SER . 6.4 tt -151.32 129.02 11.54 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.7 0.286 . . . . 0.0 110.654 -175.458 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 587' ' ' VAL . . . . . . . . . . . . . 68.3 t -148.02 119.65 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.848 -0.614 . . . . 0.0 109.62 179.107 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 588' ' ' ARG . . . . . 0.551 ' HG2' ' HA ' ' A' ' 598' ' ' GLU . 92.3 mtt180 -85.36 123.06 30.39 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.125 0.488 . . . . 0.0 110.875 -179.131 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 589' ' ' LEU . . . . . 0.527 HD12 ' HB3' ' A' ' 578' ' ' LEU . 6.2 tt -90.56 125.63 35.68 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 114.749 -1.114 . . . . 0.0 109.77 -172.775 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 590' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -76.72 132.31 39.24 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.169 0.509 . . . . 0.0 110.774 -179.157 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 591' ' ' SER . . . . . . . . . . . . . 78.3 p -99.76 159.85 14.75 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.744 -176.885 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 592' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -58.01 -25.64 61.37 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 116.187 -0.46 . . . . 0.0 112.053 179.177 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 593' ' ' GLN . . . . . . . . . . . . . 19.3 tt0 -68.39 -27.09 65.91 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.175 0.512 . . . . 0.0 110.664 178.763 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 594' ' ' GLY . . . . . . . . . . . . . . . 107.17 -4.95 35.72 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.744 -0.741 . . . . 0.0 111.369 -174.663 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 595' ' ' ASP . . . . . 0.401 ' HB3' ' CE1' ' A' ' 571' ' ' TYR . 2.2 t70 -88.81 -176.78 5.34 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 179.22 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 596' ' ' LYS . . . . . 0.679 ' N ' ' HD3' ' A' ' 596' ' ' LYS . 0.0 OUTLIER -125.56 129.74 50.29 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.078 0.466 . . . . 0.0 110.875 -172.283 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 597' ' ' LEU . . . . . 0.408 HD21 ' O ' ' A' ' 571' ' ' TYR . 59.7 mt -93.46 119.53 32.65 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.63 177.453 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 598' ' ' GLU . . . . . 0.551 ' HA ' ' HG2' ' A' ' 588' ' ' ARG . 10.7 tp10 -75.76 86.55 2.77 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.356 -179.74 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 599' ' ' VAL . . . . . . . . . . . . . 49.3 t -105.86 125.43 61.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 121.198 0.523 . . . . 0.0 110.395 -179.415 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 600' ' ' SER . . . . . 0.96 ' HB3' ' HG ' ' A' ' 586' ' ' LEU . 3.0 p -142.72 157.43 44.66 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.107 -179.114 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 601' ' ' LEU . . . . . 0.494 ' HB2' HD12 ' A' ' 583' ' ' ILE . 33.9 tp -123.06 122.92 39.66 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.096 -177.525 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 602' ' ' LYS . . . . . . . . . . . . . 34.9 ttmt -139.42 109.26 6.32 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.712 0.292 . . . . 0.0 110.515 -177.482 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 603' ' ' ASN . . . . . . . . . . . . . 18.7 m120 61.75 46.77 6.74 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.61 178.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 604' ' ' ASN . . . . . . . . . . . . . 15.9 t-20 76.64 -8.77 1.61 Allowed 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 115.307 -0.86 . . . . 0.0 111.777 177.277 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 605' ' ' VAL . . . . . . . . . . . . . 49.0 t -94.14 126.43 46.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-O 120.75 0.309 . . . . 0.0 110.198 -179.789 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 606' ' ' VAL . . . . . 0.553 HG13 ' HB ' ' A' ' 613' ' ' VAL . 6.7 p -108.76 131.11 60.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.625 -179.665 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 607' ' ' SER . . . . . . . . . . . . . 45.2 p -131.92 144.4 50.81 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.2 -179.203 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 608' ' ' VAL . . . . . 0.473 ' HA ' ' O ' ' A' ' 598' ' ' GLU . 4.4 p -118.83 115.04 46.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.81 176.205 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 609' ' ' ASN . . . . . . . . . . . . . 95.7 m-20 61.79 32.33 18.2 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.093 -176.378 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 610' ' ' LYS . . . . . 0.533 ' NZ ' ' HB2' ' A' ' 610' ' ' LYS . 0.0 OUTLIER 81.48 -6.18 1.54 Allowed 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 114.792 -1.094 . . . . 0.0 111.134 -179.176 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 611' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -87.11 111.34 40.13 Favored Pre-proline 0 C--N 1.326 -0.42 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 177.438 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 612' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -65.41 135.23 41.83 Favored 'Trans proline' 0 N--CA 1.462 -0.361 0 C-N-CA 122.634 2.223 . . . . 0.0 112.185 -178.901 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 613' ' ' VAL . . . . . 0.553 ' HB ' HG13 ' A' ' 606' ' ' VAL . 89.8 t -73.84 125.01 32.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.068 177.823 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 614' ' ' ALA . . . . . 0.69 ' HB2' HG23 ' A' ' 629' ' ' THR . . . -64.65 -45.34 87.18 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.748 -177.82 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 615' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -154.46 99.04 2.48 Favored Pre-proline 0 N--CA 1.466 0.374 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.782 -177.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 616' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -88.87 162.29 6.09 Favored 'Trans proline' 0 N--CA 1.459 -0.51 0 C-N-CA 123.026 2.484 . . . . 0.0 114.195 -176.836 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 37.5 t0 77.33 46.93 0.06 Allowed 'General case' 0 C--O 1.234 0.272 0 CA-C-O 122.735 1.255 . . . . 0.0 110.114 165.238 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 618' ' ' ILE . . . . . 0.474 ' HB ' ' O ' ' A' ' 625' ' ' VAL . 11.6 mt -90.63 113.5 26.62 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.812 0 CA-C-N 113.503 -1.681 . . . . 0.0 109.674 174.302 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 619' ' ' MET . . . . . . . . . . . . . 7.7 mmt -77.2 133.48 38.9 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 -170.207 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 620' ' ' ALA . . . . . . . . . . . . . . . -130.31 170.92 13.5 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 115.113 -0.949 . . . . 0.0 108.802 170.097 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 621' ' ' THR . . . . . . . . . . . . . 5.0 t -81.32 -23.99 37.47 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.775 -0.37 . . . . 0.0 111.056 -178.53 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 622' ' ' ASN . . . . . 0.583 ' HB3' ' HA ' ' A' ' 534' ' ' GLU . 29.7 p-10 -117.11 22.64 12.4 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.844 0.354 . . . . 0.0 111.066 -176.953 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 623' ' ' GLY . . . . . 0.47 ' HA2' HD11 ' A' ' 577' ' ' ILE . . . 152.52 -147.11 16.38 Favored Glycine 0 N--CA 1.444 -0.796 0 C-N-CA 120.231 -0.985 . . . . 0.0 112.68 177.469 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 624' ' ' VAL . . . . . . . . . . . . . 9.5 p -144.46 158.51 14.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 -177.37 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 625' ' ' VAL . . . . . 0.474 ' O ' ' HB ' ' A' ' 618' ' ' ILE . 60.9 t -125.85 135.4 64.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 -179.828 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 626' ' ' HIS . . . . . . . . . . . . . 95.5 m-70 -119.33 116.15 25.61 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.23 -0.441 . . . . 0.0 109.946 175.748 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 627' ' ' VAL . . . . . 0.708 HG22 ' HZ ' ' A' ' 515' ' ' PHE . 48.3 t -70.24 125.67 28.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.281 179.75 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 628' ' ' ILE . . . . . 0.539 HG13 ' HA ' ' A' ' 542' ' ' PRO . 7.9 pt -121.28 145.88 27.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 121.32 0.581 . . . . 0.0 111.018 176.679 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 629' ' ' THR . . . . . 0.69 HG23 ' HB2' ' A' ' 614' ' ' ALA . 16.9 p -90.35 -3.33 57.81 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.493 -0.776 . . . . 0.0 112.197 -176.737 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 630' ' ' ASN . . . . . . . . . . . . . 64.1 t30 -141.91 175.05 10.03 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.503 -0.555 . . . . 0.0 109.503 -179.405 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 631' ' ' VAL . . . . . 0.693 HG23 ' HB1' ' A' ' 546' ' ' ALA . 51.2 t -106.21 123.79 61.13 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 N-CA-C 109.484 -0.562 . . . . 0.0 109.484 -178.729 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 632' ' ' LEU . . . . . 0.4 HD21 HG13 ' A' ' 608' ' ' VAL . 88.4 mt -68.24 126.08 28.44 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.042 0.449 . . . . 0.0 111.46 -173.069 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 633' ' ' GLN . . . . . . . . . . . . . 82.9 mm-40 -118.44 119.77 32.64 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.058 -178.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 634' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo . . . . . 0 C--O 1.251 1.139 0 C-N-CA 122.685 2.257 . . . . 0.0 112.171 177.59 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.619 0 N-CA-C 112.132 -0.387 . . . . 0.0 112.132 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 504' ' ' THR . . . . . 0.602 ' HA ' HG22 ' A' ' 621' ' ' THR . 33.7 p -78.85 172.35 13.88 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.539 0.209 . . . . 0.0 110.582 179.29 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 505' ' ' VAL . . . . . 0.713 ' O ' ' HG ' ' A' ' 509' ' ' LEU . 13.0 m -57.85 -34.96 49.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.696 -0.229 . . . . 0.0 110.929 176.125 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 506' ' ' MET . . . . . . . . . . . . . 95.0 mmm -61.5 -35.93 79.07 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-O 120.77 0.319 . . . . 0.0 110.928 178.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 507' ' ' ASP . . . . . 0.748 ' HA ' ' HE3' ' A' ' 510' ' ' LYS . 23.0 t70 -67.49 -35.85 79.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.279 -178.686 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 508' ' ' VAL . . . . . . . . . . . . . 45.8 t -71.92 -41.37 69.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 115.63 -0.713 . . . . 0.0 110.58 178.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 509' ' ' LEU . . . . . 0.713 ' HG ' ' O ' ' A' ' 505' ' ' VAL . 77.4 mt -62.73 -31.74 72.73 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.745 -176.672 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 510' ' ' LYS . . . . . 0.748 ' HE3' ' HA ' ' A' ' 507' ' ' ASP . 22.8 pttp -88.62 -13.71 39.25 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.061 0.458 . . . . 0.0 110.618 -177.741 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 511' ' ' GLY . . . . . . . . . . . . . . . -85.21 -11.57 75.48 Favored Glycine 0 N--CA 1.442 -0.947 0 C-N-CA 120.463 -0.875 . . . . 0.0 110.976 175.34 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 512' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -108.84 134.58 51.34 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.894 0.378 . . . . 0.0 110.194 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -72.88 -22.52 60.75 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.537 -176.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 514' ' ' ARG . . . . . 0.582 ' HG2' HD21 ' A' ' 544' ' ' ASN . 63.9 mtm180 -84.16 -33.85 24.14 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 120.987 0.422 . . . . 0.0 110.352 -176.799 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 515' ' ' PHE . . . . . 0.995 ' HZ ' HG22 ' A' ' 627' ' ' VAL . 11.5 m-30 -81.1 -7.73 59.62 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.408 -179.788 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 23.2 t -58.93 -43.32 91.14 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.872 -174.186 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 517' ' ' MET . . . . . . . . . . . . . 4.3 mpp? -67.18 -30.35 70.28 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-O 120.879 0.371 . . . . 0.0 110.504 179.346 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 518' ' ' LEU . . . . . 0.484 HD22 ' HA ' ' A' ' 541' ' ' ALA . 61.8 tp -68.68 -41.28 79.44 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.66 -0.416 . . . . 0.0 109.903 177.1 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 519' ' ' VAL . . . . . 0.426 ' O ' ' HG3' ' A' ' 523' ' ' GLN . 61.3 t -56.94 -36.42 50.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.086 0.47 . . . . 0.0 109.955 175.067 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 520' ' ' ALA . . . . . . . . . . . . . . . -69.67 -39.46 77.01 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.436 -179.451 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 521' ' ' ALA . . . . . . . . . . . . . . . -67.26 -46.65 73.07 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.299 176.091 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 522' ' ' ILE . . . . . 0.416 HG13 ' O ' ' A' ' 518' ' ' LEU . 71.5 mt -55.07 -45.46 76.98 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.072 177.248 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 523' ' ' GLN . . . . . 0.426 ' HG3' ' O ' ' A' ' 519' ' ' VAL . 26.3 mt-30 -65.46 -44.73 86.28 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.314 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 24.2 t -69.71 -32.46 71.04 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.567 -176.648 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 525' ' ' ALA . . . . . 0.521 ' HB1' ' HB2' ' A' ' 566' ' ' ALA . . . -86.32 -25.48 25.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.725 0.298 . . . . 0.0 111.265 -179.37 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 526' ' ' GLY . . . . . . . . . . . . . . . 90.76 31.71 9.87 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 121.009 -0.615 . . . . 0.0 112.564 177.424 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 527' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -92.16 -4.7 53.86 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.549 0.214 . . . . 0.0 111.303 -179.114 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 528' ' ' THR . . . . . . . . . . . . . 8.1 m -54.24 -37.85 65.12 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.824 -176.428 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 529' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -62.84 -19.51 64.18 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 112.219 0.452 . . . . 0.0 112.219 -176.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 530' ' ' THR . . . . . . . . . . . . . 84.8 m -75.06 -54.7 6.71 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.94 0.4 . . . . 0.0 110.18 177.266 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 531' ' ' LEU . . . . . 0.666 ' H ' HD22 ' A' ' 531' ' ' LEU . 1.4 mm? -75.53 -5.33 44.69 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.26 179.457 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 532' ' ' ASN . . . . . . . . . . . . . 61.3 t30 -81.44 -5.8 58.28 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.196 178.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 533' ' ' ARG . . . . . . . . . . . . . 29.6 mmm180 -110.12 146.9 34.67 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.283 178.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 534' ' ' GLU . . . . . 0.673 ' HA ' ' CB ' ' A' ' 622' ' ' ASN . 35.7 mt-10 -90.74 155.25 18.94 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.893 0.378 . . . . 0.0 110.253 177.572 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 535' ' ' GLY . . . . . . . . . . . . . . . 151.83 -132.74 3.9 Favored Glycine 0 N--CA 1.447 -0.62 0 N-CA-C 110.834 -0.907 . . . . 0.0 110.834 -174.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 536' ' ' VAL . . . . . 0.442 ' HA ' HD11 ' A' ' 577' ' ' ILE . 33.8 m -123.17 128.41 74.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 120.965 0.412 . . . . 0.0 110.851 177.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 537' ' ' TYR . . . . . . . . . . . . . 82.2 m-85 -155.16 152.94 30.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.057 179.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 538' ' ' THR . . . . . 0.663 ' OG1' ' HA ' ' A' ' 577' ' ' ILE . 94.6 m -130.42 102.8 6.33 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.213 -0.449 . . . . 0.0 109.994 174.825 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 539' ' ' VAL . . . . . . . . . . . . . 26.6 t -100.89 125.75 54.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 120.937 0.399 . . . . 0.0 111.411 -172.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 540' ' ' PHE . . . . . 0.608 ' HB3' HD13 ' A' ' 628' ' ' ILE . 97.3 m-85 -98.47 111.57 23.88 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 173.362 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 541' ' ' ALA . . . . . 0.484 ' HA ' HD22 ' A' ' 518' ' ' LEU . . . -102.08 115.41 64.69 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 116.651 -0.25 . . . . 0.0 111.263 -176.799 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 542' ' ' PRO . . . . . 0.47 ' HA ' HG13 ' A' ' 628' ' ' ILE . 13.4 Cg_exo -71.02 141.02 39.17 Favored 'Trans proline' 0 N--CA 1.463 -0.279 0 C-N-CA 123.146 2.564 . . . . 0.0 112.195 177.376 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 41.7 p -85.85 -177.03 6.25 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.058 178.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 544' ' ' ASN . . . . . 0.582 HD21 ' HG2' ' A' ' 514' ' ' ARG . 0.5 OUTLIER -59.72 -40.36 87.71 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 121.387 0.613 . . . . 0.0 109.958 -179.057 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 545' ' ' GLU . . . . . 0.511 ' H ' ' CD ' ' A' ' 545' ' ' GLU . 3.3 mp0 -58.15 -39.11 77.97 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 114.736 -1.12 . . . . 0.0 110.812 -178.148 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 546' ' ' ALA . . . . . 0.621 ' HB1' HG13 ' A' ' 631' ' ' VAL . . . -63.96 -43.51 95.59 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.027 0.441 . . . . 0.0 111.232 -178.4 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 547' ' ' PHE . . . . . . . . . . . . . 75.1 m-85 -72.87 -27.75 62.1 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.151 -179.007 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 548' ' ' ARG . . . . . 0.443 ' O ' ' HD2' ' A' ' 548' ' ' ARG . 5.5 tmm_? -80.33 -29.07 38.04 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.219 0.533 . . . . 0.0 109.912 179.161 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 549' ' ' ALA . . . . . . . . . . . . . . . -76.09 -17.68 59.51 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.232 179.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 550' ' ' LEU . . . . . 0.715 ' HB3' ' HB3' ' A' ' 555' ' ' ARG . 20.0 mt -58.31 134.3 84.94 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.089 178.116 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 551' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 550' ' ' LEU . 28.0 Cg_exo -62.84 143.9 92.55 Favored 'Trans proline' 0 C--O 1.234 0.308 0 C-N-CA 122.909 2.406 . . . . 0.0 111.766 -179.582 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 552' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -53.67 -38.0 84.16 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 123.261 2.64 . . . . 0.0 112.249 -177.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 553' ' ' ARG . . . . . . . . . . . . . 22.4 mmm180 -69.05 -52.92 23.56 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.851 -178.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 18.2 mt-10 -66.69 -51.22 58.53 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.712 -0.676 . . . . 0.0 112.42 -175.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 555' ' ' ARG . . . . . 0.715 ' HB3' ' HB3' ' A' ' 550' ' ' LEU . 18.6 ptt180 -67.4 -27.64 67.26 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 120.445 -0.502 . . . . 0.0 111.396 -175.063 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 47.1 t -71.21 -31.55 67.75 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.733 0.301 . . . . 0.0 110.701 177.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 557' ' ' ARG . . . . . 0.427 HH11 ' HD3' ' A' ' 557' ' ' ARG . 8.7 tpt180 -83.28 -53.03 6.06 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.487 -179.411 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 558' ' ' LEU . . . . . 0.55 HD22 ' HB3' ' A' ' 564' ' ' GLU . 0.3 OUTLIER -57.48 -47.36 82.11 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.23 -0.896 . . . . 0.0 111.429 -174.602 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 559' ' ' LEU . . . . . 0.676 HD23 HD21 ' A' ' 565' ' ' LEU . 93.5 mt -77.81 0.7 22.78 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.563 -175.161 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 560' ' ' GLY . . . . . . . . . . . . . . . -97.2 -11.51 52.05 Favored Glycine 0 N--CA 1.445 -0.746 0 C-N-CA 120.444 -0.884 . . . . 0.0 112.585 -178.287 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 561' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -132.23 127.91 36.78 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.923 0.392 . . . . 0.0 111.205 -177.282 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 562' ' ' ALA . . . . . . . . . . . . . . . -64.31 -29.24 70.33 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.909 -0.587 . . . . 0.0 112.227 -176.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 563' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -78.71 -39.85 35.34 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 -177.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 564' ' ' GLU . . . . . 0.55 ' HB3' HD22 ' A' ' 558' ' ' LEU . 44.5 mt-10 -64.25 -34.52 78.3 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.164 -0.471 . . . . 0.0 109.937 175.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 565' ' ' LEU . . . . . 0.676 HD21 HD23 ' A' ' 559' ' ' LEU . 58.1 mt -64.34 -52.42 58.49 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.986 175.031 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 566' ' ' ALA . . . . . 0.521 ' HB2' ' HB1' ' A' ' 525' ' ' ALA . . . -56.4 -40.71 75.09 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.821 -176.548 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 567' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -60.97 -47.91 84.27 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.757 -177.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 568' ' ' ILE . . . . . . . . . . . . . 50.6 mm -69.87 -33.42 55.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.389 -177.583 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 569' ' ' LEU . . . . . 0.436 ' HG ' ' O ' ' A' ' 565' ' ' LEU . 78.7 mt -65.98 -33.47 75.89 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.541 -0.3 . . . . 0.0 111.517 -179.15 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 570' ' ' LYS . . . . . 0.53 ' HE3' ' HA ' ' A' ' 593' ' ' GLN . 28.0 mtpp -66.94 -18.7 65.5 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.135 179.807 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 571' ' ' TYR . . . . . . . . . . . . . 20.5 t80 -87.12 -18.26 30.88 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.223 178.366 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 572' ' ' HIS . . . . . . . . . . . . . 62.5 m80 -89.09 -12.14 42.02 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.883 0.373 . . . . 0.0 111.403 -178.487 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 573' ' ' ILE . . . . . 0.406 ' O ' HD23 ' A' ' 592' ' ' LEU . 38.5 mt -108.64 119.69 58.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.359 179.105 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 574' ' ' GLY . . . . . 0.572 ' HA2' ' HA ' ' A' ' 591' ' ' SER . . . -91.97 151.24 20.68 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.99 -0.624 . . . . 0.0 111.941 177.179 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 575' ' ' ASP . . . . . 0.414 ' HB3' ' HG3' ' A' ' 590' ' ' LYS . 6.4 t70 -93.99 9.3 38.11 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.087 0.47 . . . . 0.0 110.703 -173.782 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 576' ' ' GLU . . . . . 0.572 ' OE1' ' HG2' ' A' ' 590' ' ' LYS . 42.8 mt-10 -142.08 126.12 17.3 Favored 'General case' 0 CA--C 1.511 -0.521 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.951 -176.063 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 577' ' ' ILE . . . . . 0.663 ' HA ' ' OG1' ' A' ' 538' ' ' THR . 58.5 mt -76.06 105.11 4.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 121.218 0.532 . . . . 0.0 111.235 -177.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 578' ' ' LEU . . . . . 0.438 ' HG ' HG11 ' A' ' 587' ' ' VAL . 3.9 mm? -119.7 100.79 7.47 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.153 176.644 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 579' ' ' VAL . . . . . 0.544 ' O ' HG13 ' A' ' 583' ' ' ILE . 34.0 m -86.82 166.89 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 109.614 -0.514 . . . . 0.0 109.614 175.079 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 580' ' ' SER . . . . . . . . . . . . . 20.8 m -57.12 -40.13 76.5 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.893 0.377 . . . . 0.0 111.226 -176.084 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 581' ' ' GLY . . . . . . . . . . . . . . . -76.26 -8.7 85.61 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.783 -179.412 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . -103.24 -27.12 6.65 Favored Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.918 -177.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 583' ' ' ILE . . . . . 0.544 HG13 ' O ' ' A' ' 579' ' ' VAL . 77.1 mt -60.27 -59.02 4.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 120.893 0.377 . . . . 0.0 111.548 -178.158 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 584' ' ' GLY . . . . . . . . . . . . . . . 94.23 -81.29 0.96 Allowed Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.236 -178.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 585' ' ' ALA . . . . . . . . . . . . . . . -128.07 -62.26 1.06 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.753 0.311 . . . . 0.0 110.929 179.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 586' ' ' LEU . . . . . 0.958 ' HG ' ' HB3' ' A' ' 600' ' ' SER . 3.9 tt -155.3 140.2 17.25 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 178.344 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 587' ' ' VAL . . . . . 0.521 ' N ' HD23 ' A' ' 586' ' ' LEU . 9.3 p -142.18 136.92 29.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-O 121.102 0.477 . . . . 0.0 111.086 -178.515 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 588' ' ' ARG . . . . . . . . . . . . . 8.2 ttt180 -85.03 101.49 12.44 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.625 174.182 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 589' ' ' LEU . . . . . . . . . . . . . 2.7 tt -97.53 128.77 44.54 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.45 -0.796 . . . . 0.0 109.456 -175.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 590' ' ' LYS . . . . . 0.572 ' HG2' ' OE1' ' A' ' 576' ' ' GLU . 27.8 pttt -82.03 143.65 31.41 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 120.691 -0.404 . . . . 0.0 110.795 178.706 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 591' ' ' SER . . . . . 0.572 ' HA ' ' HA2' ' A' ' 574' ' ' GLY . 80.3 p -105.1 165.15 11.29 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.597 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 592' ' ' LEU . . . . . 0.406 HD23 ' O ' ' A' ' 573' ' ' ILE . 3.5 mm? -66.88 -9.17 35.08 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 178.572 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 593' ' ' GLN . . . . . 0.53 ' HA ' ' HE3' ' A' ' 570' ' ' LYS . 7.9 tt0 -86.01 -29.46 23.46 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.103 0.477 . . . . 0.0 110.359 176.283 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 594' ' ' GLY . . . . . . . . . . . . . . . 117.94 -21.21 10.42 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.559 -0.829 . . . . 0.0 111.784 -176.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 595' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -78.37 179.28 7.08 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 109.271 -0.641 . . . . 0.0 109.271 177.271 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 596' ' ' LYS . . . . . 0.803 ' HD3' ' H ' ' A' ' 596' ' ' LYS . 0.0 OUTLIER -115.8 140.29 49.36 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-O 121.027 0.442 . . . . 0.0 110.316 -175.741 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 597' ' ' LEU . . . . . . . . . . . . . 71.0 mt -101.39 117.17 34.41 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.934 -0.575 . . . . 0.0 109.601 173.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 598' ' ' GLU . . . . . 0.498 ' OE1' ' HG2' ' A' ' 596' ' ' LYS . 1.6 mp0 -80.89 84.86 6.3 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.204 0.525 . . . . 0.0 110.006 178.225 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 599' ' ' VAL . . . . . . . . . . . . . 26.1 t -93.29 126.53 45.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.586 -0.733 . . . . 0.0 109.738 -179.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 600' ' ' SER . . . . . 0.958 ' HB3' ' HG ' ' A' ' 586' ' ' LEU . 23.9 p -135.01 159.33 41.84 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.251 0.548 . . . . 0.0 111.692 -178.32 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 601' ' ' LEU . . . . . . . . . . . . . 27.5 tp -130.45 108.77 10.21 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.014 -0.994 . . . . 0.0 109.0 179.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 602' ' ' LYS . . . . . . . . . . . . . 8.6 ptpp? -137.07 131.68 33.09 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 110.113 -0.329 . . . . 0.0 110.113 -179.037 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 603' ' ' ASN . . . . . . . . . . . . . 14.1 m120 65.06 25.54 12.58 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.743 -176.466 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 604' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 71.59 10.3 6.43 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 114.952 -1.022 . . . . 0.0 110.164 -177.286 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 605' ' ' VAL . . . . . . . . . . . . . 62.1 t -101.11 119.23 48.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.936 177.004 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 606' ' ' VAL . . . . . 0.686 HG13 ' HB ' ' A' ' 613' ' ' VAL . 5.6 p -91.11 137.31 22.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 121.104 0.478 . . . . 0.0 110.635 178.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 607' ' ' SER . . . . . . . . . . . . . 18.5 m -143.34 140.02 30.35 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.862 -179.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 608' ' ' VAL . . . . . . . . . . . . . 3.8 p -113.63 114.3 46.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.637 176.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 609' ' ' ASN . . . . . . . . . . . . . 84.4 m-20 57.04 44.55 22.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.244 -175.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 610' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 76.9 -19.67 0.41 Allowed 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.141 0.977 . . . . 0.0 112.443 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 611' ' ' GLU . . . . . 0.477 ' HA ' ' HD3' ' A' ' 612' ' ' PRO . 46.7 mm-40 -79.28 121.27 82.79 Favored Pre-proline 0 C--N 1.332 -0.172 0 CA-C-O 120.831 0.348 . . . . 0.0 110.386 179.085 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 612' ' ' PRO . . . . . 0.477 ' HD3' ' HA ' ' A' ' 611' ' ' GLU . 11.7 Cg_exo -70.39 146.56 56.67 Favored 'Trans proline' 0 CA--C 1.529 0.255 0 C-N-CA 123.038 2.492 . . . . 0.0 112.935 -178.422 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 613' ' ' VAL . . . . . 0.686 ' HB ' HG13 ' A' ' 606' ' ' VAL . 85.4 t -87.85 135.63 25.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.979 177.604 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 614' ' ' ALA . . . . . . . . . . . . . . . -84.5 -31.91 24.22 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.553 -175.349 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 615' ' ' GLU . . . . . 0.499 ' HB3' ' CG2' ' A' ' 627' ' ' VAL . 8.7 tp10 -161.92 92.32 1.37 Allowed Pre-proline 0 C--N 1.327 -0.407 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 -177.597 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 616' ' ' PRO . . . . . 0.408 ' HB3' HG11 ' A' ' 613' ' ' VAL . 60.8 Cg_endo -89.77 165.67 5.02 Favored 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 123.078 2.519 . . . . 0.0 114.035 -176.315 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 617' ' ' ASP . . . . . 0.447 ' OD2' ' HB ' ' A' ' 579' ' ' VAL . 0.9 OUTLIER 76.81 34.54 0.43 Allowed 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 122.33 1.062 . . . . 0.0 110.514 165.78 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 618' ' ' ILE . . . . . 0.513 ' HB ' ' O ' ' A' ' 625' ' ' VAL . 13.6 mt -78.02 109.59 12.8 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.969 0 CA-C-N 113.92 -1.491 . . . . 0.0 109.327 172.254 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 619' ' ' MET . . . . . . . . . . . . . 8.0 mmt -80.08 131.34 35.74 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.87 -0.604 . . . . 0.0 112.034 -174.13 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 620' ' ' ALA . . . . . . . . . . . . . . . -130.6 173.07 11.24 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.262 173.358 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 621' ' ' THR . . . . . 0.602 HG22 ' HA ' ' A' ' 504' ' ' THR . 6.3 t -72.14 -29.4 64.01 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.887 0.375 . . . . 0.0 111.239 -176.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 622' ' ' ASN . . . . . 0.673 ' CB ' ' HA ' ' A' ' 534' ' ' GLU . 28.7 p-10 -117.34 22.7 12.29 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 112.168 0.433 . . . . 0.0 112.168 -173.745 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 623' ' ' GLY . . . . . . . . . . . . . . . 151.05 -154.85 25.82 Favored Glycine 0 N--CA 1.442 -0.919 0 C-N-CA 119.631 -1.271 . . . . 0.0 113.056 176.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 624' ' ' VAL . . . . . 0.503 HG21 HG12 ' A' ' 579' ' ' VAL . 9.7 p -129.65 159.0 42.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 N-CA-C 109.932 -0.395 . . . . 0.0 109.932 -179.707 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 625' ' ' VAL . . . . . 0.513 ' O ' ' HB ' ' A' ' 618' ' ' ILE . 67.9 t -128.04 132.3 68.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.819 178.606 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 626' ' ' HIS . . . . . . . . . . . . . 69.6 m-70 -118.46 112.3 19.77 Favored 'General case' 0 N--CA 1.445 -0.68 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 177.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 627' ' ' VAL . . . . . 0.995 HG22 ' HZ ' ' A' ' 515' ' ' PHE . 38.5 t -64.38 126.11 22.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.146 178.757 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 628' ' ' ILE . . . . . 0.608 HD13 ' HB3' ' A' ' 540' ' ' PHE . 5.4 pt -121.06 142.52 36.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.064 0.459 . . . . 0.0 110.701 176.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 629' ' ' THR . . . . . . . . . . . . . 9.5 t -97.31 2.87 51.2 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.778 0.799 . . . . 0.0 109.851 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 630' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -132.77 157.56 44.64 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.086 -0.961 . . . . 0.0 108.833 178.1 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 631' ' ' VAL . . . . . 0.621 HG13 ' HB1' ' A' ' 546' ' ' ALA . 23.8 m -92.79 156.28 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.015 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 176.363 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 632' ' ' LEU . . . . . . . . . . . . . 92.2 mt -106.1 110.89 23.3 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-O 121.281 0.562 . . . . 0.0 110.521 -178.446 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 633' ' ' GLN . . . . . 0.481 ' HA ' ' HD3' ' A' ' 634' ' ' PRO . 53.8 mt-30 -117.44 130.76 24.44 Favored Pre-proline 0 C--N 1.319 -0.735 0 CA-C-N 115.122 -0.944 . . . . 0.0 109.936 -177.675 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 634' ' ' PRO . . . . . 0.481 ' HD3' ' HA ' ' A' ' 633' ' ' GLN . 14.2 Cg_exo . . . . . 0 C--O 1.25 1.113 0 C-N-CA 122.814 2.343 . . . . 0.0 111.722 177.528 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.545 0 N-CA-C 111.77 -0.532 . . . . 0.0 111.77 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 31.5 p -90.01 -179.28 5.66 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.366 0.127 . . . . 0.0 110.875 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 505' ' ' VAL . . . . . 0.672 ' O ' ' HG ' ' A' ' 509' ' ' LEU . 22.2 t -50.43 -47.61 26.49 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.275 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.223 179.826 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 506' ' ' MET . . . . . 0.473 ' HG2' ' HB2' ' A' ' 531' ' ' LEU . 90.8 mmm -57.37 -34.81 69.22 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.993 -176.135 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 507' ' ' ASP . . . . . 0.468 ' HA ' ' NZ ' ' A' ' 510' ' ' LYS . 12.1 t70 -76.13 -35.64 59.16 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.799 0.333 . . . . 0.0 110.133 -178.675 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 508' ' ' VAL . . . . . . . . . . . . . 64.3 t -66.0 -39.61 85.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.473 178.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 509' ' ' LEU . . . . . 0.672 ' HG ' ' O ' ' A' ' 505' ' ' VAL . 22.8 mt -65.61 -19.92 66.11 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.048 -178.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 510' ' ' LYS . . . . . 0.468 ' NZ ' ' HA ' ' A' ' 507' ' ' ASP . 30.2 mtmm -81.62 -24.96 36.08 Favored 'General case' 0 CA--C 1.514 -0.432 0 CA-C-O 121.223 0.535 . . . . 0.0 110.024 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 511' ' ' GLY . . . . . . . . . . . . . . . -80.38 -8.17 87.83 Favored Glycine 0 N--CA 1.443 -0.872 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.806 179.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 512' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -118.9 152.99 35.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.341 0.591 . . . . 0.0 111.769 -178.423 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 43.2 t-20 -76.82 -39.41 51.41 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.408 -0.815 . . . . 0.0 111.095 -178.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 514' ' ' ARG . . . . . . . . . . . . . 3.0 mpp_? -80.58 -34.31 35.39 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.105 0.479 . . . . 0.0 110.808 -171.565 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 515' ' ' PHE . . . . . 0.544 ' CZ ' HG22 ' A' ' 627' ' ' VAL . 14.5 m-30 -75.99 -8.25 56.51 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.827 178.798 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 16.8 t -59.05 -38.55 79.62 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.673 -176.071 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 517' ' ' MET . . . . . 0.546 ' HE3' ' HA ' ' A' ' 544' ' ' ASN . 3.4 mpp? -68.61 -26.56 65.42 Favored 'General case' 0 CA--C 1.519 -0.219 0 C-N-CA 120.787 -0.365 . . . . 0.0 111.025 -179.821 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 518' ' ' LEU . . . . . 0.557 HD13 HD11 ' A' ' 522' ' ' ILE . 3.3 mt -65.49 -43.29 90.64 Favored 'General case' 0 CA--C 1.517 -0.312 0 C-N-CA 120.261 -0.575 . . . . 0.0 109.554 174.201 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 519' ' ' VAL . . . . . 0.692 ' O ' ' HB2' ' A' ' 523' ' ' GLN . 30.1 t -55.09 -31.68 26.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.129 0.49 . . . . 0.0 110.41 178.455 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 520' ' ' ALA . . . . . . . . . . . . . . . -84.29 -46.71 11.51 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.46 178.497 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 521' ' ' ALA . . . . . . . . . . . . . . . -64.73 -52.52 56.64 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.872 0.368 . . . . 0.0 110.934 -178.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 522' ' ' ILE . . . . . 0.557 HD11 HD13 ' A' ' 518' ' ' LEU . 41.2 mt -59.67 -26.93 36.45 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.306 177.75 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 523' ' ' GLN . . . . . 0.692 ' HB2' ' O ' ' A' ' 519' ' ' VAL . 7.5 tp-100 -69.49 -51.98 30.8 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.398 179.297 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 38.7 t -71.53 -23.37 61.76 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.587 -176.03 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 525' ' ' ALA . . . . . . . . . . . . . . . -81.87 -17.81 46.03 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 120.972 -0.291 . . . . 0.0 111.266 178.49 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 526' ' ' GLY . . . . . . . . . . . . . . . 82.86 22.68 57.42 Favored Glycine 0 N--CA 1.453 -0.193 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.852 179.276 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 527' ' ' LEU . . . . . 0.409 HD13 ' HA ' ' A' ' 527' ' ' LEU . 4.2 mm? -98.01 4.74 49.3 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.873 0.368 . . . . 0.0 110.776 -179.709 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 528' ' ' THR . . . . . 0.419 ' OG1' ' HA ' ' A' ' 523' ' ' GLN . 15.5 m -59.99 -37.0 78.38 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.422 -177.109 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 529' ' ' GLU . . . . . 0.436 ' H ' ' HG2' ' A' ' 529' ' ' GLU . 7.1 pt-20 -64.79 -28.73 69.77 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.732 -178.068 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 530' ' ' THR . . . . . 0.535 ' HB ' HD22 ' A' ' 531' ' ' LEU . 26.4 m -64.29 -59.27 4.59 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.98 -179.415 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 531' ' ' LEU . . . . . 0.577 ' H ' HD22 ' A' ' 531' ' ' LEU . 1.7 mm? -76.57 5.83 6.8 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-O 120.869 0.366 . . . . 0.0 111.524 -179.189 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 532' ' ' ASN . . . . . . . . . . . . . 64.7 t30 -86.26 -27.14 24.61 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.37 0.605 . . . . 0.0 109.716 177.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 533' ' ' ARG . . . . . . . . . . . . . 12.7 mmm180 -92.13 160.34 15.24 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.672 178.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 534' ' ' GLU . . . . . 0.798 ' HA ' ' HB3' ' A' ' 622' ' ' ASN . 40.9 mt-10 -87.71 179.35 6.52 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 120.76 -0.376 . . . . 0.0 110.25 177.232 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 535' ' ' GLY . . . . . . . . . . . . . . . 134.86 -145.3 17.41 Favored Glycine 0 N--CA 1.445 -0.764 0 N-CA-C 110.675 -0.97 . . . . 0.0 110.675 -175.108 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 536' ' ' VAL . . . . . 0.407 ' HB ' HG13 ' A' ' 577' ' ' ILE . 34.5 m -123.07 130.37 74.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-O 121.07 0.462 . . . . 0.0 110.057 176.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 537' ' ' TYR . . . . . . . . . . . . . 71.2 m-85 -152.46 153.73 34.11 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.057 -178.611 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 538' ' ' THR . . . . . 0.764 ' OG1' ' HA ' ' A' ' 577' ' ' ILE . 50.4 m -132.1 103.71 6.41 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 174.673 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 539' ' ' VAL . . . . . . . . . . . . . 47.9 t -105.71 124.65 60.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.926 -173.228 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 540' ' ' PHE . . . . . 0.567 ' HB3' HD13 ' A' ' 628' ' ' ILE . 99.0 m-85 -95.85 111.08 23.15 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 173.328 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -97.82 112.97 62.98 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.712 -176.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 542' ' ' PRO . . . . . 0.471 ' HA ' HG13 ' A' ' 628' ' ' ILE . 7.9 Cg_exo -73.12 135.75 23.46 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 122.702 2.268 . . . . 0.0 110.708 174.302 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 40.4 p -76.96 179.31 6.28 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.529 -177.216 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 544' ' ' ASN . . . . . 0.546 ' HA ' ' HE3' ' A' ' 517' ' ' MET . 25.0 t-20 -62.41 -33.73 75.37 Favored 'General case' 0 CA--C 1.52 -0.185 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 178.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 545' ' ' GLU . . . . . 0.428 ' H ' ' CD ' ' A' ' 545' ' ' GLU . 1.6 mp0 -54.28 -45.09 72.41 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.19 -0.913 . . . . 0.0 110.759 178.152 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 546' ' ' ALA . . . . . 0.455 ' O ' HD23 ' A' ' 550' ' ' LEU . . . -67.06 -49.12 66.17 Favored 'General case' 0 CA--C 1.514 -0.431 0 CA-C-O 121.018 0.437 . . . . 0.0 111.283 -179.18 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 547' ' ' PHE . . . . . . . . . . . . . 29.9 m-85 -64.24 -25.61 68.14 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.705 -0.68 . . . . 0.0 111.315 -177.32 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 548' ' ' ARG . . . . . . . . . . . . . 23.8 ttm180 -86.7 -28.02 23.36 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.273 0.559 . . . . 0.0 110.179 178.526 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 549' ' ' ALA . . . . . . . . . . . . . . . -79.63 -10.51 59.8 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.242 -0.89 . . . . 0.0 112.103 -176.235 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 550' ' ' LEU . . . . . 0.511 ' HB2' ' HG3' ' A' ' 555' ' ' ARG . 0.1 OUTLIER -54.23 143.47 44.55 Favored Pre-proline 0 N--CA 1.454 -0.23 0 CA-C-O 120.759 0.314 . . . . 0.0 110.671 174.503 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 551' ' ' PRO . . . . . 0.637 ' HD2' ' HB2' ' A' ' 554' ' ' GLU . 2.6 Cg_endo -80.02 142.04 15.24 Favored 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 123.125 2.55 . . . . 0.0 110.547 -172.567 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 552' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_exo -43.47 -39.87 9.73 Favored 'Trans proline' 0 CA--C 1.533 0.458 0 C-N-CA 123.139 2.56 . . . . 0.0 113.348 -176.637 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 553' ' ' ARG . . . . . . . . . . . . . 44.7 mtp180 -68.3 -52.14 37.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.862 0.363 . . . . 0.0 111.721 177.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 554' ' ' GLU . . . . . 0.637 ' HB2' ' HD2' ' A' ' 551' ' ' PRO . 5.1 mm-40 -83.15 -42.72 17.0 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.911 -171.843 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 555' ' ' ARG . . . . . 0.511 ' HG3' ' HB2' ' A' ' 550' ' ' LEU . 26.1 ttt180 -46.87 -55.76 7.45 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 122.697 0.399 . . . . 0.0 111.429 173.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 14.8 m -62.45 -31.98 72.78 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.123 -178.159 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 557' ' ' ARG . . . . . . . . . . . . . 24.4 ttt180 -69.42 -59.24 3.12 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.587 176.703 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 558' ' ' LEU . . . . . 0.859 HD22 ' HB3' ' A' ' 564' ' ' GLU . 0.7 OUTLIER -60.2 -50.47 73.54 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.507 -175.406 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 559' ' ' LEU . . . . . . . . . . . . . 74.6 mt -87.95 19.53 3.53 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.632 -177.368 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 560' ' ' GLY . . . . . . . . . . . . . . . -125.4 4.11 8.21 Favored Glycine 0 N--CA 1.445 -0.706 0 CA-C-N 115.949 -0.568 . . . . 0.0 111.928 179.459 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 561' ' ' ASP . . . . . 0.495 ' OD2' ' HB3' ' A' ' 563' ' ' LYS . 18.0 t70 -142.59 142.24 32.11 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.653 0.264 . . . . 0.0 110.666 179.443 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 562' ' ' ALA . . . . . . . . . . . . . . . -76.51 -32.26 58.19 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.856 -177.657 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 563' ' ' LYS . . . . . 0.495 ' HB3' ' OD2' ' A' ' 561' ' ' ASP . 13.1 ttpt -69.0 -49.51 57.16 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.136 179.772 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 564' ' ' GLU . . . . . 0.859 ' HB3' HD22 ' A' ' 558' ' ' LEU . 59.7 mm-40 -52.07 -48.83 64.47 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.729 176.387 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 565' ' ' LEU . . . . . . . . . . . . . 39.5 mt -56.02 -55.2 35.71 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.416 177.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 566' ' ' ALA . . . . . . . . . . . . . . . -57.13 -48.06 79.6 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.55 -175.38 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 567' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -61.25 -45.62 93.78 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.637 -176.205 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 568' ' ' ILE . . . . . 0.714 HG13 HD21 ' A' ' 558' ' ' LEU . 47.7 mm -74.17 -34.9 39.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.828 -176.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 569' ' ' LEU . . . . . . . . . . . . . 66.4 mt -68.04 -33.31 74.33 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.962 -0.295 . . . . 0.0 111.01 179.632 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 570' ' ' LYS . . . . . 0.766 ' HE3' ' HA ' ' A' ' 593' ' ' GLN . 26.9 mtpp -62.97 -18.5 63.29 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.939 0.4 . . . . 0.0 111.012 175.61 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 571' ' ' TYR . . . . . 0.506 ' O ' HD21 ' A' ' 597' ' ' LEU . 25.9 t80 -91.75 -17.85 24.78 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.895 -177.136 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 572' ' ' HIS . . . . . . . . . . . . . 61.5 m80 -90.72 -14.72 31.59 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.866 0.365 . . . . 0.0 111.053 -179.287 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 573' ' ' ILE . . . . . . . . . . . . . 42.9 mt -103.83 116.4 47.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.318 178.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 574' ' ' GLY . . . . . 0.545 ' HA2' ' HA ' ' A' ' 591' ' ' SER . . . -97.95 153.86 20.14 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 121.013 -0.613 . . . . 0.0 111.723 176.043 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 575' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -90.96 -6.46 54.03 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.252 0.549 . . . . 0.0 111.062 -176.196 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 576' ' ' GLU . . . . . 0.449 ' HB2' HD21 ' A' ' 589' ' ' LEU . 24.9 mt-10 -129.11 122.75 30.54 Favored 'General case' 0 CA--C 1.508 -0.663 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 -170.245 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 577' ' ' ILE . . . . . 0.764 ' HA ' ' OG1' ' A' ' 538' ' ' THR . 61.5 mt -73.05 116.55 15.42 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.943 -175.233 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 578' ' ' LEU . . . . . 0.574 HD11 ' HA ' ' A' ' 583' ' ' ILE . 23.5 tp -127.03 113.41 16.43 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.442 179.057 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 579' ' ' VAL . . . . . 0.488 ' O ' HG13 ' A' ' 583' ' ' ILE . 35.8 m -104.96 163.1 4.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.177 178.086 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 580' ' ' SER . . . . . . . . . . . . . 32.8 t -56.48 -47.74 78.6 Favored 'General case' 0 C--N 1.331 -0.228 0 O-C-N 123.32 0.388 . . . . 0.0 110.887 -176.282 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 581' ' ' GLY . . . . . . . . . . . . . . . -74.73 8.27 15.76 Favored Glycine 0 CA--C 1.521 0.411 0 C-N-CA 120.941 -0.647 . . . . 0.0 113.327 -178.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . -131.77 9.87 5.48 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.511 -0.852 . . . . 0.0 113.109 179.245 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 583' ' ' ILE . . . . . 0.574 ' HA ' HD11 ' A' ' 578' ' ' LEU . 47.0 mt -78.02 -77.54 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.956 0.378 . . . . 0.0 110.877 178.779 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 584' ' ' GLY . . . . . . . . . . . . . . . 84.72 81.69 1.05 Allowed Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.495 -0.859 . . . . 0.0 112.069 -175.314 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 585' ' ' ALA . . . . . . . . . . . . . . . 71.73 -74.69 0.08 Allowed 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 123.578 0.751 . . . . 0.0 112.084 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 586' ' ' LEU . . . . . 0.61 ' HG ' ' HB2' ' A' ' 600' ' ' SER . 2.3 tt -164.71 142.2 6.37 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.571 0.225 . . . . 0.0 110.422 -176.755 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 587' ' ' VAL . . . . . 0.522 ' N ' HD23 ' A' ' 586' ' ' LEU . 91.2 t -140.14 139.75 36.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.23 -178.697 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 588' ' ' ARG . . . . . 0.406 ' HD3' ' HA ' ' A' ' 588' ' ' ARG . 34.0 mmt180 -85.57 105.51 16.21 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.927 0.394 . . . . 0.0 110.138 177.122 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 589' ' ' LEU . . . . . 0.449 HD21 ' HB2' ' A' ' 576' ' ' GLU . 0.3 OUTLIER -99.86 124.62 45.36 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.374 -177.189 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 590' ' ' LYS . . . . . . . . . . . . . 47.4 mtpt -90.48 140.1 30.06 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.466 0.65 . . . . 0.0 111.563 -177.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 591' ' ' SER . . . . . 0.545 ' HA ' ' HA2' ' A' ' 574' ' ' GLY . 78.0 p -102.15 166.47 10.58 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.367 -177.542 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 592' ' ' LEU . . . . . . . . . . . . . 9.9 mp -67.44 -7.21 23.56 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 112.527 0.566 . . . . 0.0 112.527 178.235 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 593' ' ' GLN . . . . . 0.766 ' HA ' ' HE3' ' A' ' 570' ' ' LYS . 4.6 tt0 -76.74 -29.2 56.05 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 171.708 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 594' ' ' GLY . . . . . . . . . . . . . . . 113.41 -20.36 18.61 Favored Glycine 0 N--CA 1.444 -0.791 0 CA-C-N 115.203 -0.908 . . . . 0.0 111.62 -177.15 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 595' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -84.08 -178.57 7.0 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 120.984 0.421 . . . . 0.0 109.867 -179.594 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 596' ' ' LYS . . . . . 0.788 ' HD3' ' H ' ' A' ' 596' ' ' LYS . 0.0 OUTLIER -118.72 136.96 53.66 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.796 -172.272 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 597' ' ' LEU . . . . . 0.506 HD21 ' O ' ' A' ' 571' ' ' TYR . 56.6 mt -90.51 142.55 27.63 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.648 179.609 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 598' ' ' GLU . . . . . 0.559 ' O ' ' HA ' ' A' ' 608' ' ' VAL . 13.7 tp10 -86.01 82.2 8.2 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 178.497 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 599' ' ' VAL . . . . . 0.439 HG11 HD23 ' A' ' 578' ' ' LEU . 25.8 t -104.58 121.88 56.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 121.128 0.489 . . . . 0.0 110.081 -176.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 600' ' ' SER . . . . . 0.61 ' HB2' ' HG ' ' A' ' 586' ' ' LEU . 37.4 t -141.23 168.39 19.89 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.499 0.666 . . . . 0.0 110.96 -172.626 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 601' ' ' LEU . . . . . 0.516 ' HB2' HD12 ' A' ' 583' ' ' ILE . 52.7 tp -140.45 108.27 5.67 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 114.535 -1.211 . . . . 0.0 108.955 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 602' ' ' LYS . . . . . . . . . . . . . 65.1 mttp -120.79 107.12 12.35 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.903 -177.239 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 603' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 63.42 42.86 6.41 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.613 177.503 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 604' ' ' ASN . . . . . . . . . . . . . 66.6 t30 72.95 14.65 4.75 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.608 178.067 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 605' ' ' VAL . . . . . . . . . . . . . 56.6 t -110.51 114.01 45.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.997 175.495 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 606' ' ' VAL . . . . . 0.738 HG13 ' HB ' ' A' ' 613' ' ' VAL . 6.6 p -84.97 140.16 16.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.2 0.524 . . . . 0.0 110.935 -179.01 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 607' ' ' SER . . . . . . . . . . . . . 7.4 p -142.19 154.58 44.94 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.835 -178.197 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 608' ' ' VAL . . . . . 0.559 ' HA ' ' O ' ' A' ' 598' ' ' GLU . 7.5 p -142.65 119.89 6.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.147 178.006 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 609' ' ' ASN . . . . . 0.832 ' HB2' HD22 ' A' ' 632' ' ' LEU . 4.0 m-20 59.88 50.04 7.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.131 173.715 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 610' ' ' LYS . . . . . 0.495 ' HB2' ' HE3' ' A' ' 610' ' ' LYS . 35.6 mtmt 77.15 -21.91 0.31 Allowed 'General case' 0 N--CA 1.476 0.826 0 O-C-N 123.66 0.6 . . . . 0.0 111.378 179.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 611' ' ' GLU . . . . . . . . . . . . . 48.6 mm-40 -90.96 140.91 26.19 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.732 -176.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 612' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -81.26 141.58 12.89 Favored 'Trans proline' 0 N--CA 1.458 -0.603 0 C-N-CA 122.134 1.889 . . . . 0.0 111.459 173.589 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 613' ' ' VAL . . . . . 0.738 ' HB ' HG13 ' A' ' 606' ' ' VAL . 99.5 t -74.34 120.59 23.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 176.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 614' ' ' ALA . . . . . 0.527 ' HB2' HG23 ' A' ' 629' ' ' THR . . . -76.5 -26.22 55.05 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.868 -172.815 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 615' ' ' GLU . . . . . 0.604 ' HB3' ' HB ' ' A' ' 627' ' ' VAL . 17.4 tt0 -165.49 89.25 0.94 Allowed Pre-proline 0 C--N 1.325 -0.49 0 CA-C-O 121.189 0.519 . . . . 0.0 109.832 -174.417 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 616' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -88.82 163.57 6.14 Favored 'Trans proline' 0 N--CA 1.456 -0.732 0 C-N-CA 123.059 2.506 . . . . 0.0 113.708 -175.669 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 26.6 t0 78.43 64.61 0.03 OUTLIER 'General case' 0 CA--C 1.51 -0.567 0 CA-C-O 123.024 1.392 . . . . 0.0 110.594 169.38 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 618' ' ' ILE . . . . . 0.498 ' HB ' ' O ' ' A' ' 625' ' ' VAL . 24.4 mt -115.86 102.21 13.38 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.278 0 CA-C-N 112.795 -2.002 . . . . 0.0 108.573 176.058 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 619' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.73 135.7 37.21 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.707 -0.679 . . . . 0.0 112.812 -169.313 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 620' ' ' ALA . . . . . . . . . . . . . . . -129.1 176.72 7.68 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.329 -0.851 . . . . 0.0 108.795 171.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 621' ' ' THR . . . . . . . . . . . . . 4.5 t -82.75 -21.71 34.6 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.603 -0.439 . . . . 0.0 110.874 -179.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 622' ' ' ASN . . . . . 0.798 ' HB3' ' HA ' ' A' ' 534' ' ' GLU . 27.4 p-10 -116.24 22.11 13.13 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.719 0.295 . . . . 0.0 111.441 -176.692 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 623' ' ' GLY . . . . . . . . . . . . . . . 147.47 -150.88 23.18 Favored Glycine 0 N--CA 1.443 -0.859 0 C-N-CA 120.332 -0.937 . . . . 0.0 112.626 177.229 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 624' ' ' VAL . . . . . . . . . . . . . 6.3 p -135.79 158.46 39.41 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 -179.164 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 625' ' ' VAL . . . . . 0.498 ' O ' ' HB ' ' A' ' 618' ' ' ILE . 46.8 t -123.93 136.87 58.87 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.675 178.764 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 626' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 -122.79 121.13 35.55 Favored 'General case' 0 N--CA 1.445 -0.681 0 N-CA-C 109.908 -0.405 . . . . 0.0 109.908 175.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 627' ' ' VAL . . . . . 0.604 ' HB ' ' HB3' ' A' ' 615' ' ' GLU . 60.8 t -70.21 130.67 34.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.56 179.025 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 628' ' ' ILE . . . . . 0.567 HD13 ' HB3' ' A' ' 540' ' ' PHE . 7.2 pt -127.34 150.19 33.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.819 176.199 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 629' ' ' THR . . . . . 0.527 HG23 ' HB2' ' A' ' 614' ' ' ALA . 16.6 p -94.91 2.83 55.45 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.91 -176.283 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 630' ' ' ASN . . . . . . . . . . . . . 66.1 m-20 -144.08 168.76 19.24 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.409 -177.39 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 631' ' ' VAL . . . . . . . . . . . . . 97.2 t -95.91 125.74 48.65 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 115.426 -0.807 . . . . 0.0 109.206 176.518 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 632' ' ' LEU . . . . . 0.832 HD22 ' HB2' ' A' ' 609' ' ' ASN . 89.6 mt -70.87 114.41 8.91 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-O 121.33 0.586 . . . . 0.0 110.893 -174.602 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 633' ' ' GLN . . . . . 0.512 ' HA ' ' HD3' ' A' ' 634' ' ' PRO . 85.7 mm-40 -102.47 131.17 22.74 Favored Pre-proline 0 C--N 1.317 -0.835 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.947 -177.095 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 634' ' ' PRO . . . . . 0.512 ' HD3' ' HA ' ' A' ' 633' ' ' GLN . 4.9 Cg_exo . . . . . 0 C--O 1.253 1.25 0 C-N-CA 123.051 2.501 . . . . 0.0 111.569 176.25 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.57 0 N-CA-C 111.311 -0.715 . . . . 0.0 111.311 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 504' ' ' THR . . . . . 0.48 ' O ' HG23 ' A' ' 508' ' ' VAL . 38.8 p -81.47 156.95 25.07 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 120.83 -0.348 . . . . 0.0 110.307 179.118 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 7.1 p -49.55 -39.2 13.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.892 -0.595 . . . . 0.0 112.359 -176.099 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 506' ' ' MET . . . . . 0.517 ' HG2' ' HB2' ' A' ' 531' ' ' LEU . 2.9 ppp? -83.82 -21.86 31.96 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.806 0.336 . . . . 0.0 111.524 -177.109 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 507' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -86.22 -28.89 23.58 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.042 0.448 . . . . 0.0 110.645 -178.238 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 508' ' ' VAL . . . . . 0.48 HG23 ' O ' ' A' ' 504' ' ' THR . 87.5 t -61.89 -27.58 42.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.297 175.394 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 509' ' ' LEU . . . . . . . . . . . . . 25.3 mt -65.05 -19.54 66.04 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.536 -179.099 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 510' ' ' LYS . . . . . 0.433 ' HE3' HG13 ' A' ' 519' ' ' VAL . 5.3 mptt -76.25 -24.15 54.53 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.022 0.439 . . . . 0.0 110.481 -179.068 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 511' ' ' GLY . . . . . . . . . . . . . . . -80.56 -10.11 85.63 Favored Glycine 0 N--CA 1.444 -0.773 0 C-N-CA 120.407 -0.902 . . . . 0.0 111.179 177.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 512' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -114.86 137.62 51.75 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.26 0.552 . . . . 0.0 111.714 -176.253 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 9.9 p30 -77.34 -19.76 55.85 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 115.526 -0.761 . . . . 0.0 112.459 -177.214 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 514' ' ' ARG . . . . . . . . . . . . . 5.3 tpp180 -89.04 -28.54 20.08 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 120.687 0.279 . . . . 0.0 110.988 -170.765 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 515' ' ' PHE . . . . . 0.607 ' CZ ' HG22 ' A' ' 627' ' ' VAL . 9.5 m-85 -92.83 8.62 38.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.682 178.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 13.0 p -55.37 -44.8 76.36 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.066 -0.515 . . . . 0.0 112.376 -176.145 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 517' ' ' MET . . . . . . . . . . . . . 2.8 mpp? -63.36 -31.29 72.4 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.502 0.191 . . . . 0.0 111.09 179.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 518' ' ' LEU . . . . . 0.409 HD22 ' HA ' ' A' ' 541' ' ' ALA . 44.2 tp -70.63 -36.38 73.41 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 120.502 -0.479 . . . . 0.0 110.207 -179.408 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 519' ' ' VAL . . . . . 0.433 HG13 ' HE3' ' A' ' 510' ' ' LYS . 59.1 t -58.94 -37.7 68.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.257 0.551 . . . . 0.0 109.559 174.834 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 520' ' ' ALA . . . . . . . . . . . . . . . -71.61 -40.98 69.46 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.644 -178.225 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 521' ' ' ALA . . . . . . . . . . . . . . . -63.96 -50.41 68.72 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.927 178.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 522' ' ' ILE . . . . . . . . . . . . . 72.9 mt -60.88 -40.43 85.25 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.894 179.115 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 523' ' ' GLN . . . . . . . . . . . . . 59.2 tt0 -61.78 -46.28 90.22 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.864 178.543 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 27.5 m -67.68 -47.52 69.22 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.495 -177.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 525' ' ' ALA . . . . . 0.413 ' HB1' ' HB2' ' A' ' 566' ' ' ALA . . . -70.77 -28.46 64.69 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.642 0.258 . . . . 0.0 111.504 -179.044 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 526' ' ' GLY . . . . . . . . . . . . . . . 85.54 41.49 7.31 Favored Glycine 0 C--O 1.227 -0.323 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.61 178.119 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 527' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -102.06 13.0 35.95 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.909 0.385 . . . . 0.0 110.863 -178.548 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 528' ' ' THR . . . . . . . . . . . . . 18.7 m -65.17 -33.99 77.31 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.117 -178.163 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 529' ' ' GLU . . . . . . . . . . . . . 28.9 mm-40 -55.44 -43.69 75.64 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.814 -176.681 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 530' ' ' THR . . . . . . . . . . . . . 22.1 m -66.27 -43.08 87.45 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.293 -176.124 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 531' ' ' LEU . . . . . 0.517 ' HB2' ' HG2' ' A' ' 506' ' ' MET . 68.8 mt -87.67 14.09 9.16 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.027 0.441 . . . . 0.0 111.314 -174.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 532' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -89.56 -29.5 18.86 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.756 178.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 533' ' ' ARG . . . . . 0.449 HH11 ' HD2' ' A' ' 533' ' ' ARG . 4.2 tpp180 -86.09 143.84 27.85 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.415 -0.812 . . . . 0.0 110.245 179.069 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 534' ' ' GLU . . . . . 0.673 ' HA ' ' CB ' ' A' ' 622' ' ' ASN . 42.8 tt0 -79.93 147.66 31.55 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.078 0.466 . . . . 0.0 110.515 176.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 535' ' ' GLY . . . . . . . . . . . . . . . 169.0 -136.33 4.01 Favored Glycine 0 N--CA 1.445 -0.75 0 N-CA-C 110.4 -1.08 . . . . 0.0 110.4 -177.51 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 536' ' ' VAL . . . . . 0.534 ' HB ' HG13 ' A' ' 577' ' ' ILE . 34.0 m -124.22 129.79 73.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 117.297 0.549 . . . . 0.0 110.411 177.518 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 537' ' ' TYR . . . . . . . . . . . . . 82.4 m-85 -154.19 146.55 23.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.934 -0.575 . . . . 0.0 109.926 -179.033 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 538' ' ' THR . . . . . 0.766 ' OG1' ' HA ' ' A' ' 577' ' ' ILE . 55.7 m -136.76 100.36 4.3 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 120.813 0.339 . . . . 0.0 110.117 175.235 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 539' ' ' VAL . . . . . 0.632 ' HA ' ' O ' ' A' ' 572' ' ' HIS . 1.3 p -115.17 132.09 65.48 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-O 121.392 0.615 . . . . 0.0 111.242 -177.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 540' ' ' PHE . . . . . . . . . . . . . 68.4 m-85 -89.1 117.16 27.9 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.003 -0.999 . . . . 0.0 109.693 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 541' ' ' ALA . . . . . 0.427 ' HA ' ' HD3' ' A' ' 542' ' ' PRO . . . -93.67 114.42 62.96 Favored Pre-proline 0 C--N 1.326 -0.435 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.575 -179.34 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 542' ' ' PRO . . . . . 0.595 ' HA ' HG13 ' A' ' 628' ' ' ILE . 7.9 Cg_exo -72.88 131.47 17.03 Favored 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 122.88 2.387 . . . . 0.0 111.516 177.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 75.2 p -71.87 175.48 5.77 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.574 179.364 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 544' ' ' ASN . . . . . . . . . . . . . 10.7 p30 -72.67 -21.21 61.11 Favored 'General case' 0 CA--C 1.519 -0.221 0 C-N-CA 120.094 -0.643 . . . . 0.0 109.449 179.05 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 545' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -62.18 -35.7 79.63 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.74 174.319 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 546' ' ' ALA . . . . . 0.558 ' HB1' HG23 ' A' ' 631' ' ' VAL . . . -70.13 -48.31 58.03 Favored 'General case' 0 CA--C 1.513 -0.474 0 CA-C-O 121.19 0.519 . . . . 0.0 110.772 178.838 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 547' ' ' PHE . . . . . . . . . . . . . 64.2 m-85 -68.14 -23.72 64.91 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.331 -177.575 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 548' ' ' ARG . . . . . 0.405 ' HD2' HH11 ' A' ' 548' ' ' ARG . 43.7 mtm180 -86.78 -21.9 26.23 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-O 120.706 0.289 . . . . 0.0 110.863 175.746 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 549' ' ' ALA . . . . . . . . . . . . . . . -85.66 -5.59 59.25 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.969 0.414 . . . . 0.0 110.682 177.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 550' ' ' LEU . . . . . 0.538 HD11 HG21 ' A' ' 631' ' ' VAL . 93.5 mt -75.74 134.27 72.43 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.264 176.172 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 551' ' ' PRO . . . . . 0.498 ' HD3' ' HA ' ' A' ' 550' ' ' LEU . 12.4 Cg_exo -69.99 148.02 62.68 Favored 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 122.7 2.267 . . . . 0.0 110.568 179.034 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 552' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_exo -50.83 -41.73 53.98 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.576 2.184 . . . . 0.0 112.072 -178.5 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 553' ' ' ARG . . . . . . . . . . . . . 22.8 tpt180 -57.25 -52.16 66.46 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.287 178.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -65.88 -55.29 17.73 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 111.824 0.305 . . . . 0.0 111.824 -176.328 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 555' ' ' ARG . . . . . 0.458 ' HG2' ' O ' ' A' ' 551' ' ' PRO . 30.8 ptt180 -63.96 -32.65 74.26 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 -175.699 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 32.1 m -74.94 -31.69 61.57 Favored 'General case' 0 N--CA 1.464 0.262 0 O-C-N 122.083 -0.385 . . . . 0.0 110.936 179.588 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 557' ' ' ARG . . . . . . . . . . . . . 73.7 ttt180 -69.65 -47.79 62.14 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.976 0.417 . . . . 0.0 109.964 176.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 558' ' ' LEU . . . . . 0.563 ' HG ' HD23 ' A' ' 565' ' ' LEU . 40.1 tp -60.56 -44.83 95.72 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.493 -178.131 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 559' ' ' LEU . . . . . 0.629 HD23 HD21 ' A' ' 565' ' ' LEU . 96.7 mt -81.98 4.55 22.29 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.065 0.459 . . . . 0.0 110.898 -179.452 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 560' ' ' GLY . . . . . . . . . . . . . . . -85.0 -22.61 52.14 Favored Glycine 0 N--CA 1.439 -1.114 0 C-N-CA 120.663 -0.78 . . . . 0.0 112.012 179.158 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 561' ' ' ASP . . . . . 0.695 ' HB3' ' HG2' ' A' ' 564' ' ' GLU . 11.9 t70 -139.38 142.7 37.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.939 0.399 . . . . 0.0 110.691 -178.037 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 562' ' ' ALA . . . . . . . . . . . . . . . -77.58 -29.04 51.86 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.821 -175.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 563' ' ' LYS . . . . . . . . . . . . . 27.2 ttpp -73.16 -39.03 65.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.815 0.341 . . . . 0.0 110.203 -178.231 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 564' ' ' GLU . . . . . 0.695 ' HG2' ' HB3' ' A' ' 561' ' ' ASP . 3.3 mm-40 -62.89 -42.5 99.8 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.436 178.728 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 565' ' ' LEU . . . . . 0.629 HD21 HD23 ' A' ' 559' ' ' LEU . 69.3 mt -55.81 -51.35 67.77 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.489 174.5 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 566' ' ' ALA . . . . . 0.413 ' HB2' ' HB1' ' A' ' 525' ' ' ALA . . . -58.07 -44.01 87.28 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.535 -178.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 567' ' ' ASN . . . . . . . . . . . . . 4.9 t30 -67.65 -32.86 73.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.189 -177.294 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 568' ' ' ILE . . . . . 0.522 HG12 ' O ' ' A' ' 564' ' ' GLU . 47.9 mm -72.94 -40.25 59.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 120.86 0.362 . . . . 0.0 110.386 176.73 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 569' ' ' LEU . . . . . 0.51 ' HG ' ' O ' ' A' ' 565' ' ' LEU . 96.0 mt -63.01 -42.92 99.96 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.301 179.673 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 570' ' ' LYS . . . . . 0.682 ' HE2' ' HA ' ' A' ' 593' ' ' GLN . 17.5 ptmt -70.86 -8.05 49.94 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.113 -178.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 571' ' ' TYR . . . . . 0.5 ' HB2' HE21 ' A' ' 593' ' ' GLN . 62.3 t80 -93.81 -18.76 21.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.962 0.41 . . . . 0.0 110.392 174.609 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 572' ' ' HIS . . . . . 0.632 ' O ' ' HA ' ' A' ' 539' ' ' VAL . 47.4 m80 -91.07 -20.18 22.34 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.748 179.643 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 573' ' ' ILE . . . . . 0.425 HG13 ' O ' ' A' ' 569' ' ' LEU . 27.2 mt -96.07 116.62 38.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.526 177.469 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 574' ' ' GLY . . . . . 0.592 ' HA2' ' HA ' ' A' ' 591' ' ' SER . . . -88.61 156.01 26.32 Favored Glycine 0 N--CA 1.449 -0.473 0 N-CA-C 111.78 -0.528 . . . . 0.0 111.78 176.297 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 575' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -82.75 -3.19 56.2 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 112.219 0.451 . . . . 0.0 112.219 -172.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 576' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -152.7 157.72 41.31 Favored 'General case' 0 N--CA 1.44 -0.967 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 -174.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 577' ' ' ILE . . . . . 0.766 ' HA ' ' OG1' ' A' ' 538' ' ' THR . 68.7 mt -92.56 117.59 36.27 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-N 115.76 -0.655 . . . . 0.0 112.055 -172.709 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 578' ' ' LEU . . . . . 0.579 HD23 HD13 ' A' ' 589' ' ' LEU . 3.4 mm? -123.99 102.3 7.69 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.389 175.544 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 579' ' ' VAL . . . . . 0.508 ' O ' HG13 ' A' ' 583' ' ' ILE . 30.9 m -97.28 172.11 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.07 179.36 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 580' ' ' SER . . . . . 0.532 ' HA ' HD11 ' A' ' 601' ' ' LEU . 27.6 m -54.72 -36.49 64.78 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.5 179.549 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 581' ' ' GLY . . . . . . . . . . . . . . . -80.81 -1.02 89.23 Favored Glycine 0 CA--C 1.521 0.425 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.982 -179.13 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . -114.4 -38.92 1.06 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.526 -0.845 . . . . 0.0 113.001 -177.554 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 583' ' ' ILE . . . . . 0.56 ' HB ' HD12 ' A' ' 601' ' ' LEU . 63.8 mt -60.03 -57.69 10.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 120.692 0.282 . . . . 0.0 111.555 -176.292 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 584' ' ' GLY . . . . . . . . . . . . . . . 78.9 -66.47 3.37 Favored Glycine 0 CA--C 1.52 0.356 0 C-N-CA 120.924 -0.655 . . . . 0.0 113.327 176.523 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 585' ' ' ALA . . . . . . . . . . . . . . . -130.02 -68.61 0.7 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.532 0.206 . . . . 0.0 111.549 -176.382 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 586' ' ' LEU . . . . . 0.579 HD13 ' HB3' ' A' ' 600' ' ' SER . 41.2 tp -153.57 128.62 9.64 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.773 0.32 . . . . 0.0 110.569 -179.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 587' ' ' VAL . . . . . . . . . . . . . 57.9 t -137.03 127.47 39.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.627 178.421 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 588' ' ' ARG . . . . . 0.442 ' HG2' ' HG2' ' A' ' 598' ' ' GLU . 72.8 mtt180 -85.54 109.02 18.22 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.485 0.659 . . . . 0.0 109.909 176.662 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 589' ' ' LEU . . . . . 0.579 HD13 HD23 ' A' ' 578' ' ' LEU . 34.7 tp -91.22 113.78 26.13 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 114.806 -1.088 . . . . 0.0 110.214 -175.53 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 590' ' ' LYS . . . . . . . . . . . . . 25.6 pttm -76.46 134.82 39.43 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.635 -0.505 . . . . 0.0 109.635 177.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 591' ' ' SER . . . . . 0.592 ' HA ' ' HA2' ' A' ' 574' ' ' GLY . 79.7 p -99.08 166.88 11.04 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.128 -177.442 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 592' ' ' LEU . . . . . . . . . . . . . 10.3 mp -63.86 -12.9 40.5 Favored 'General case' 0 C--N 1.333 -0.123 0 N-CA-C 112.211 0.449 . . . . 0.0 112.211 178.244 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 593' ' ' GLN . . . . . 0.682 ' HA ' ' HE2' ' A' ' 570' ' ' LYS . 5.0 tt0 -77.55 -29.32 52.2 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.391 0.615 . . . . 0.0 109.854 174.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 594' ' ' GLY . . . . . . . . . . . . . . . 111.48 -16.53 26.61 Favored Glycine 0 N--CA 1.447 -0.588 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.423 -174.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 595' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -79.0 178.6 7.9 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 179.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 596' ' ' LYS . . . . . . . . . . . . . 56.6 mttp -124.43 121.4 34.8 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.281 0.562 . . . . 0.0 111.983 -169.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 597' ' ' LEU . . . . . . . . . . . . . 67.5 mt -90.38 116.54 28.4 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.235 -0.893 . . . . 0.0 109.306 173.527 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 598' ' ' GLU . . . . . 0.442 ' HG2' ' HG2' ' A' ' 588' ' ' ARG . 46.9 mt-10 -89.13 92.75 9.32 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 121.456 0.646 . . . . 0.0 110.092 -177.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 599' ' ' VAL . . . . . . . . . . . . . 23.4 t -96.53 125.64 49.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.051 -0.977 . . . . 0.0 110.146 -176.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 600' ' ' SER . . . . . 0.579 ' HB3' HD13 ' A' ' 586' ' ' LEU . 18.2 p -125.78 156.87 38.79 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.445 -179.383 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 601' ' ' LEU . . . . . 0.56 HD12 ' HB ' ' A' ' 583' ' ' ILE . 0.3 OUTLIER -127.75 109.9 12.1 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.261 -179.626 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 602' ' ' LYS . . . . . 0.4 ' HE2' ' HB2' ' A' ' 602' ' ' LYS . 25.8 mtmm -128.87 123.0 31.58 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.25 -0.887 . . . . 0.0 109.806 -171.73 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 603' ' ' ASN . . . . . 0.448 ' O ' ' HB2' ' A' ' 604' ' ' ASN . 13.3 m120 64.38 25.93 13.49 Favored 'General case' 0 N--CA 1.466 0.34 0 O-C-N 123.571 0.544 . . . . 0.0 109.778 178.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 604' ' ' ASN . . . . . 0.448 ' HB2' ' O ' ' A' ' 603' ' ' ASN . 88.5 m-20 71.84 14.26 5.97 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.324 -175.633 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 605' ' ' VAL . . . . . . . . . . . . . 44.8 t -107.98 119.84 58.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.129 -0.487 . . . . 0.0 109.809 173.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 606' ' ' VAL . . . . . 0.806 HG13 ' HB ' ' A' ' 613' ' ' VAL . 5.2 p -86.67 139.8 16.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 121.026 0.441 . . . . 0.0 110.887 -178.6 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 607' ' ' SER . . . . . . . . . . . . . 2.9 m -140.71 135.19 31.33 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.474 -178.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 608' ' ' VAL . . . . . 0.413 HG13 HD21 ' A' ' 632' ' ' LEU . 3.7 p -111.48 119.95 60.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 177.64 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 609' ' ' ASN . . . . . 0.52 ' O ' ' HB2' ' A' ' 610' ' ' LYS . 5.3 m-20 59.22 37.18 23.9 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.485 177.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 610' ' ' LYS . . . . . 0.52 ' HB2' ' O ' ' A' ' 609' ' ' ASN . 34.4 mmtp 81.34 -15.44 0.72 Allowed 'General case' 0 N--CA 1.475 0.797 0 O-C-N 124.171 0.919 . . . . 0.0 112.326 -178.716 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 611' ' ' GLU . . . . . 0.425 ' HA ' ' HD3' ' A' ' 612' ' ' PRO . 18.1 mm-40 -84.8 138.55 37.63 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 120.8 0.333 . . . . 0.0 111.072 -178.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 612' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 611' ' ' GLU . 1.9 Cg_endo -82.02 134.02 8.03 Favored 'Trans proline' 0 N--CA 1.46 -0.468 0 C-N-CA 123.387 2.724 . . . . 0.0 113.274 -176.471 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 613' ' ' VAL . . . . . 0.806 ' HB ' HG13 ' A' ' 606' ' ' VAL . 50.3 t -81.57 130.89 35.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.053 175.773 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 614' ' ' ALA . . . . . . . . . . . . . . . -71.21 -42.72 68.58 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.173 -176.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 615' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -162.82 103.82 1.04 Allowed Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.27 0.557 . . . . 0.0 110.576 -178.656 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 616' ' ' PRO . . . . . 0.404 ' O ' ' HB2' ' A' ' 617' ' ' ASP . 65.0 Cg_endo -89.85 171.2 4.13 Favored 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 123.539 2.826 . . . . 0.0 113.411 -177.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 617' ' ' ASP . . . . . 0.404 ' HB2' ' O ' ' A' ' 616' ' ' PRO . 1.1 m-20 79.0 28.28 0.4 Allowed 'General case' 0 CA--C 1.508 -0.664 0 CA-C-N 115.123 -0.944 . . . . 0.0 111.373 164.721 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 618' ' ' ILE . . . . . 0.48 ' HB ' ' O ' ' A' ' 625' ' ' VAL . 18.5 mt -74.87 103.42 2.73 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 CA-C-N 114.591 -1.186 . . . . 0.0 109.085 171.505 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 619' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.77 132.96 38.32 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.841 -0.618 . . . . 0.0 112.391 -171.094 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 620' ' ' ALA . . . . . . . . . . . . . . . -127.92 173.61 9.87 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 170.408 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 621' ' ' THR . . . . . . . . . . . . . 4.7 t -75.56 -31.72 60.13 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 120.385 -0.526 . . . . 0.0 111.217 -174.374 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 622' ' ' ASN . . . . . 0.673 ' CB ' ' HA ' ' A' ' 534' ' ' GLU . 31.8 p-10 -117.39 21.76 12.87 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 111.946 0.35 . . . . 0.0 111.946 -176.325 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 623' ' ' GLY . . . . . . . . . . . . . . . 165.36 -167.71 39.03 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.159 -1.019 . . . . 0.0 112.87 178.526 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 624' ' ' VAL . . . . . 0.436 HG21 HG12 ' A' ' 579' ' ' VAL . 5.8 p -133.09 155.43 41.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 178.671 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 625' ' ' VAL . . . . . 0.48 ' O ' ' HB ' ' A' ' 618' ' ' ILE . 49.6 t -120.2 127.84 75.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.188 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 626' ' ' HIS . . . . . . . . . . . . . 46.9 m-70 -113.76 110.27 19.89 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.155 -0.475 . . . . 0.0 109.774 175.409 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 627' ' ' VAL . . . . . 0.607 HG22 ' CZ ' ' A' ' 515' ' ' PHE . 22.9 t -65.56 124.85 21.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.044 -179.741 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 628' ' ' ILE . . . . . 0.595 HG13 ' HA ' ' A' ' 542' ' ' PRO . 8.2 pt -116.86 143.77 26.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-O 121.353 0.596 . . . . 0.0 110.732 175.276 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 629' ' ' THR . . . . . . . . . . . . . 10.3 t -95.59 12.33 30.01 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-O 122.216 1.008 . . . . 0.0 109.318 -179.322 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 630' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 -139.19 176.66 8.51 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 114.381 -1.281 . . . . 0.0 109.359 -176.32 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 631' ' ' VAL . . . . . 0.558 HG23 ' HB1' ' A' ' 546' ' ' ALA . 61.6 t -116.64 144.26 24.78 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 172.366 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 632' ' ' LEU . . . . . 0.413 HD21 HG13 ' A' ' 608' ' ' VAL . 87.8 mt -96.58 118.26 32.69 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.018 0.437 . . . . 0.0 110.735 -177.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 633' ' ' GLN . . . . . . . . . . . . . 27.0 mp0 -96.64 116.79 66.27 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.089 -177.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 634' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo . . . . . 0 N--CA 1.452 -0.951 0 C-N-CA 122.902 2.401 . . . . 0.0 111.113 173.403 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.728 0 N-CA-C 110.987 -0.845 . . . . 0.0 110.987 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 504' ' ' THR . . . . . 0.491 ' HA ' HG22 ' A' ' 621' ' ' THR . 46.7 p -75.88 165.75 24.54 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 117.165 0.483 . . . . 0.0 110.118 178.495 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 505' ' ' VAL . . . . . 0.66 ' O ' ' HG ' ' A' ' 509' ' ' LEU . 14.7 p -60.0 -31.66 48.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 120.991 0.424 . . . . 0.0 110.307 179.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 506' ' ' MET . . . . . 0.487 ' O ' ' HG2' ' A' ' 510' ' ' LYS . 5.7 tpp -69.31 -43.17 74.31 Favored 'General case' 0 N--CA 1.437 -1.112 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.688 178.198 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 507' ' ' ASP . . . . . 0.566 ' HA ' ' CG ' ' A' ' 510' ' ' LYS . 31.5 t70 -67.29 -32.5 73.53 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.882 0.373 . . . . 0.0 110.557 -178.435 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 508' ' ' VAL . . . . . 0.479 HG23 ' O ' ' A' ' 504' ' ' THR . 90.0 t -62.27 -35.72 70.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.519 176.087 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 509' ' ' LEU . . . . . 0.66 ' HG ' ' O ' ' A' ' 505' ' ' VAL . 61.3 mt -74.44 -37.44 63.28 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.164 -178.602 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 510' ' ' LYS . . . . . 0.566 ' CG ' ' HA ' ' A' ' 507' ' ' ASP . 10.8 ptmm? -84.27 -13.13 53.38 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.284 -178.303 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 511' ' ' GLY . . . . . . . . . . . . . . . -85.7 -11.92 73.16 Favored Glycine 0 N--CA 1.441 -0.987 0 N-CA-C 111.169 -0.772 . . . . 0.0 111.169 173.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 512' ' ' ASP . . . . . 0.57 ' O ' ' HB2' ' A' ' 516' ' ' SER . 26.6 t70 -104.22 152.54 22.05 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.826 0.346 . . . . 0.0 111.122 179.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 42.4 m-80 -76.28 -33.32 59.1 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.864 -176.243 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 514' ' ' ARG . . . . . 0.415 ' HB3' ' HA ' ' A' ' 543' ' ' THR . 26.2 mmt180 -82.88 -49.95 9.13 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.908 0.385 . . . . 0.0 110.086 -176.039 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 515' ' ' PHE . . . . . 1.012 ' HZ ' HG22 ' A' ' 627' ' ' VAL . 4.2 m-30 -66.97 -17.83 65.1 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.505 -177.458 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 516' ' ' SER . . . . . 0.57 ' HB2' ' O ' ' A' ' 512' ' ' ASP . 16.3 t -57.54 -41.9 81.84 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.665 -176.476 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 517' ' ' MET . . . . . . . . . . . . . 3.4 ppp? -76.49 -24.96 53.8 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.881 0.372 . . . . 0.0 110.643 -178.426 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 518' ' ' LEU . . . . . 0.628 HD22 ' HD2' ' A' ' 542' ' ' PRO . 39.4 tp -66.8 -37.86 85.37 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 170.01 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 519' ' ' VAL . . . . . 0.468 ' O ' ' HG2' ' A' ' 523' ' ' GLN . 85.4 t -58.21 -34.46 49.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 174.498 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 520' ' ' ALA . . . . . . . . . . . . . . . -63.76 -38.26 90.43 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.937 0.399 . . . . 0.0 110.17 177.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 521' ' ' ALA . . . . . 0.419 ' HA ' HD23 ' A' ' 565' ' ' LEU . . . -66.61 -43.11 85.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.267 174.392 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 522' ' ' ILE . . . . . 0.567 HG23 ' HB2' ' A' ' 527' ' ' LEU . 76.6 mt -59.73 -39.49 79.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.269 177.381 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 523' ' ' GLN . . . . . 0.468 ' HG2' ' O ' ' A' ' 519' ' ' VAL . 16.1 mm100 -62.82 -33.93 76.25 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-O 121.087 0.47 . . . . 0.0 111.152 177.727 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 8.3 t -81.67 -36.2 29.05 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.321 -179.399 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 525' ' ' ALA . . . . . 0.406 ' HB1' ' HA ' ' A' ' 566' ' ' ALA . . . -78.18 -29.84 48.73 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.922 -178.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 526' ' ' GLY . . . . . . . . . . . . . . . 85.14 50.53 4.06 Favored Glycine 0 CA--C 1.52 0.355 0 C-N-CA 121.025 -0.607 . . . . 0.0 112.801 179.319 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 527' ' ' LEU . . . . . 0.567 ' HB2' HG23 ' A' ' 522' ' ' ILE . 4.0 mm? -113.12 5.91 17.31 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.875 0.369 . . . . 0.0 110.518 177.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 528' ' ' THR . . . . . . . . . . . . . 4.4 m -62.29 -48.1 81.37 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.528 -175.404 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 529' ' ' GLU . . . . . 0.539 ' O ' ' HG3' ' A' ' 533' ' ' ARG . 29.9 mp0 -57.95 -40.89 81.64 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.883 0.373 . . . . 0.0 110.581 178.553 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 530' ' ' THR . . . . . . . . . . . . . 40.4 m -62.14 -45.98 91.02 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.558 -177.316 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 531' ' ' LEU . . . . . 0.518 HD21 HD13 ' A' ' 573' ' ' ILE . 61.5 mt -82.59 -4.91 58.39 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -175.378 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 532' ' ' ASN . . . . . . . . . . . . . 67.1 t30 -89.09 -18.24 27.65 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.273 0.558 . . . . 0.0 110.043 178.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 533' ' ' ARG . . . . . 0.539 ' HG3' ' O ' ' A' ' 529' ' ' GLU . 32.9 mtp85 -83.08 136.69 34.39 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.205 -179.215 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 534' ' ' GLU . . . . . 0.574 ' HA ' ' HB3' ' A' ' 622' ' ' ASN . 11.5 pt-20 -71.56 156.13 39.76 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.868 178.257 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 535' ' ' GLY . . . . . . . . . . . . . . . 147.05 -136.59 6.21 Favored Glycine 0 N--CA 1.445 -0.759 0 N-CA-C 110.43 -1.068 . . . . 0.0 110.43 -176.064 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 536' ' ' VAL . . . . . 0.455 ' HB ' HG13 ' A' ' 577' ' ' ILE . 34.3 m -124.08 130.08 73.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-O 121.142 0.496 . . . . 0.0 110.813 179.005 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 537' ' ' TYR . . . . . . . . . . . . . 84.4 m-85 -152.87 146.98 25.47 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.385 178.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 538' ' ' THR . . . . . 0.685 ' OG1' ' HA ' ' A' ' 577' ' ' ILE . 67.2 m -132.98 102.6 5.68 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 175.413 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 539' ' ' VAL . . . . . 0.448 HG22 HG23 ' A' ' 573' ' ' ILE . 48.5 t -107.31 122.88 62.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.085 0.469 . . . . 0.0 111.44 -172.788 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 540' ' ' PHE . . . . . 0.479 ' HB3' HD13 ' A' ' 628' ' ' ILE . 84.8 m-85 -91.77 107.15 19.0 Favored 'General case' 0 N--CA 1.447 -0.613 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 172.759 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 541' ' ' ALA . . . . . 0.442 ' HA ' ' HD3' ' A' ' 542' ' ' PRO . . . -97.2 113.71 63.59 Favored Pre-proline 0 C--N 1.323 -0.577 0 CA-C-O 120.713 0.292 . . . . 0.0 110.924 -176.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 542' ' ' PRO . . . . . 0.628 ' HD2' HD22 ' A' ' 518' ' ' LEU . 7.9 Cg_exo -72.44 138.16 29.36 Favored 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 123.04 2.494 . . . . 0.0 111.427 177.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 543' ' ' THR . . . . . 0.415 ' HA ' ' HB3' ' A' ' 514' ' ' ARG . 60.8 p -74.22 -179.11 3.7 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.526 178.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 544' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -62.35 -33.64 75.1 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.172 0.511 . . . . 0.0 109.742 179.603 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 545' ' ' GLU . . . . . 0.414 ' HA ' ' HB3' ' A' ' 548' ' ' ARG . 14.1 mp0 -63.85 -27.44 69.17 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 114.798 -1.092 . . . . 0.0 111.499 -178.004 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 546' ' ' ALA . . . . . 0.605 ' HB1' HG22 ' A' ' 631' ' ' VAL . . . -64.24 -55.61 20.32 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.354 0.597 . . . . 0.0 110.514 179.142 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 547' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -70.63 -21.48 62.63 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.644 179.127 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 548' ' ' ARG . . . . . 0.414 ' HB3' ' HA ' ' A' ' 545' ' ' GLU . 75.2 ttt180 -74.81 -36.82 62.45 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.117 177.611 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 549' ' ' ALA . . . . . . . . . . . . . . . -62.03 -34.38 76.11 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.456 176.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 550' ' ' LEU . . . . . 0.51 ' HA ' ' HD3' ' A' ' 551' ' ' PRO . 81.2 mt -65.53 132.24 95.01 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.392 175.82 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 551' ' ' PRO . . . . . 0.51 ' HD3' ' HA ' ' A' ' 550' ' ' LEU . 21.3 Cg_exo -64.58 147.9 90.3 Favored 'Trans proline' 0 N--CA 1.463 -0.29 0 C-N-CA 122.98 2.453 . . . . 0.0 111.856 -173.723 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 552' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 551' ' ' PRO . 86.7 Cg_exo -48.89 -35.51 31.54 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 123.177 2.584 . . . . 0.0 113.351 -177.722 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 553' ' ' ARG . . . . . . . . . . . . . 56.2 ttp180 -73.57 -45.52 52.81 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.771 0.32 . . . . 0.0 110.842 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 554' ' ' GLU . . . . . 0.474 ' HB2' ' HD2' ' A' ' 551' ' ' PRO . 20.5 mm-40 -74.09 -41.66 61.34 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.454 -175.061 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 555' ' ' ARG . . . . . . . . . . . . . 5.5 ptp180 -61.75 -33.6 74.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.877 0.37 . . . . 0.0 110.024 177.451 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 7.9 t -71.5 -36.94 71.27 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.2 -0.455 . . . . 0.0 109.808 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 557' ' ' ARG . . . . . . . . . . . . . 79.8 mtt180 -61.22 -49.5 76.91 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.378 176.236 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 558' ' ' LEU . . . . . 0.506 HD21 HG13 ' A' ' 568' ' ' ILE . 2.1 tm? -57.95 -52.33 65.94 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.057 -0.974 . . . . 0.0 110.457 -178.54 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 559' ' ' LEU . . . . . 0.766 ' HA ' HD11 ' A' ' 565' ' ' LEU . 86.4 mt -76.78 -3.75 39.9 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.378 -175.352 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 560' ' ' GLY . . . . . . . . . . . . . . . -72.57 -22.54 78.93 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 121.168 -0.539 . . . . 0.0 112.534 -179.316 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 561' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -141.63 126.17 17.82 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 122.53 -0.394 . . . . 0.0 110.674 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 562' ' ' ALA . . . . . 0.434 ' HA ' HD13 ' A' ' 565' ' ' LEU . . . -59.46 -22.81 62.07 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.764 -0.653 . . . . 0.0 112.384 -176.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 563' ' ' LYS . . . . . . . . . . . . . 57.9 tttp -63.69 -40.3 96.47 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.358 0.599 . . . . 0.0 110.395 179.275 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 564' ' ' GLU . . . . . 0.458 ' HB3' HD22 ' A' ' 558' ' ' LEU . 7.7 mm-40 -68.55 -40.47 80.64 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.987 -178.011 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 565' ' ' LEU . . . . . 0.766 HD11 ' HA ' ' A' ' 559' ' ' LEU . 8.2 mp -57.19 -47.29 81.62 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.115 174.6 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 566' ' ' ALA . . . . . 0.64 ' O ' ' HB2' ' A' ' 570' ' ' LYS . . . -60.2 -40.18 89.17 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.245 -0.889 . . . . 0.0 111.666 -177.744 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 567' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -75.53 -47.12 28.27 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 120.916 -0.314 . . . . 0.0 111.318 -176.013 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 568' ' ' ILE . . . . . 0.506 HG13 HD21 ' A' ' 558' ' ' LEU . 28.5 mm -65.29 -48.85 81.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 112.465 0.543 . . . . 0.0 112.465 -177.728 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 569' ' ' LEU . . . . . 0.401 HD12 ' C ' ' A' ' 569' ' ' LEU . 0.6 OUTLIER -71.33 -21.84 61.99 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.736 -0.385 . . . . 0.0 110.433 -175.879 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 570' ' ' LYS . . . . . 0.64 ' HB2' ' O ' ' A' ' 566' ' ' ALA . 78.3 tttt -67.56 -22.17 65.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.214 0.531 . . . . 0.0 110.434 178.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 571' ' ' TYR . . . . . 0.456 ' CE1' ' HB3' ' A' ' 595' ' ' ASP . 15.3 t80 -77.89 -18.05 56.62 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.711 177.268 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 572' ' ' HIS . . . . . . . . . . . . . 74.4 m80 -88.56 -12.44 42.74 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.658 -176.706 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 573' ' ' ILE . . . . . 0.518 HD13 HD21 ' A' ' 531' ' ' LEU . 47.7 mt -104.42 114.28 43.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.627 179.615 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 574' ' ' GLY . . . . . 0.68 ' HA2' ' HA ' ' A' ' 591' ' ' SER . . . -99.4 152.99 19.61 Favored Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 121.06 -0.59 . . . . 0.0 111.777 176.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 575' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -96.79 16.13 20.04 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.064 0.459 . . . . 0.0 111.31 -175.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 576' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -139.27 122.17 16.62 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.139 -177.409 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 577' ' ' ILE . . . . . 0.685 ' HA ' ' OG1' ' A' ' 538' ' ' THR . 63.3 mt -79.95 101.27 4.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.272 0.558 . . . . 0.0 110.681 -179.024 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 578' ' ' LEU . . . . . . . . . . . . . 96.7 mt -118.91 102.48 8.82 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.393 -0.821 . . . . 0.0 109.879 178.045 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 579' ' ' VAL . . . . . . . . . . . . . 27.1 m -90.82 178.43 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.361 178.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 580' ' ' SER . . . . . . . . . . . . . 13.0 m -53.57 -38.77 64.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.26 -179.039 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 581' ' ' GLY . . . . . . . . . . . . . . . -86.53 23.66 9.77 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 121.13 -0.557 . . . . 0.0 112.824 -178.553 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . -138.63 6.82 3.28 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.595 177.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 583' ' ' ILE . . . . . . . . . . . . . 37.4 mt -83.95 -47.75 17.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.968 0.414 . . . . 0.0 110.977 -178.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 584' ' ' GLY . . . . . . . . . . . . . . . 79.39 -69.18 3.03 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.929 -0.653 . . . . 0.0 112.07 -178.024 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 585' ' ' ALA . . . . . . . . . . . . . . . -143.18 -69.87 0.33 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.862 0.363 . . . . 0.0 110.321 179.53 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 586' ' ' LEU . . . . . 0.8 ' HG ' ' HB2' ' A' ' 600' ' ' SER . 3.9 tt -151.33 131.15 13.24 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 176.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 587' ' ' VAL . . . . . 0.413 ' N ' HD23 ' A' ' 586' ' ' LEU . 7.8 p -143.99 137.23 23.93 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.173 -175.137 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 588' ' ' ARG . . . . . . . . . . . . . 35.0 ptt180 -88.04 108.52 19.27 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.414 0.626 . . . . 0.0 110.561 178.278 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 589' ' ' LEU . . . . . . . . . . . . . 3.8 tt -91.04 114.47 27.0 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 -178.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 590' ' ' LYS . . . . . 0.606 ' NZ ' ' HB2' ' A' ' 590' ' ' LYS . 9.6 mtmp? -72.43 148.69 44.93 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 121.273 0.559 . . . . 0.0 111.411 -174.062 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 591' ' ' SER . . . . . 0.68 ' HA ' ' HA2' ' A' ' 574' ' ' GLY . 68.7 p -112.09 158.63 19.37 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.823 -179.104 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 592' ' ' LEU . . . . . 0.493 ' O ' ' HE2' ' A' ' 570' ' ' LYS . 10.0 mp -62.26 -19.82 63.62 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.933 178.355 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 593' ' ' GLN . . . . . 0.414 HE21 ' HB3' ' A' ' 593' ' ' GLN . 6.4 tt0 -69.5 -29.69 67.38 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.806 -0.358 . . . . 0.0 110.537 176.477 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 594' ' ' GLY . . . . . . . . . . . . . . . 115.97 -4.85 20.46 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.674 -0.775 . . . . 0.0 112.745 -178.324 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 595' ' ' ASP . . . . . 0.456 ' HB3' ' CE1' ' A' ' 571' ' ' TYR . 11.2 t70 -101.29 -168.94 1.62 Allowed 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 175.768 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 596' ' ' LYS . . . . . 0.549 ' HD3' ' N ' ' A' ' 596' ' ' LYS . 0.0 OUTLIER -135.05 131.83 37.48 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.007 0.432 . . . . 0.0 111.3 -172.881 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 597' ' ' LEU . . . . . 0.677 ' HB3' HG23 ' A' ' 608' ' ' VAL . 2.7 mm? -82.32 115.89 21.58 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 169.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 598' ' ' GLU . . . . . . . . . . . . . 57.8 mt-10 -84.42 92.43 8.05 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-O 121.626 0.727 . . . . 0.0 109.775 179.039 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 599' ' ' VAL . . . . . 0.46 ' HA ' ' O ' ' A' ' 607' ' ' SER . 61.1 t -93.64 132.41 37.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 114.619 -1.173 . . . . 0.0 110.118 -176.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 600' ' ' SER . . . . . 0.8 ' HB2' ' HG ' ' A' ' 586' ' ' LEU . 29.6 t -131.95 165.43 23.95 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-O 121.215 0.531 . . . . 0.0 110.286 179.69 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 601' ' ' LEU . . . . . . . . . . . . . 33.3 tp -136.89 108.07 6.79 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 114.929 -1.032 . . . . 0.0 109.609 -177.055 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 602' ' ' LYS . . . . . . . . . . . . . 11.3 ptmm? -134.77 118.19 16.78 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.899 -178.31 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 603' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 63.0 28.87 16.39 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 121.542 0.686 . . . . 0.0 109.539 -174.492 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 604' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 69.16 5.98 5.4 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 115.053 -0.976 . . . . 0.0 111.903 -177.368 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 605' ' ' VAL . . . . . . . . . . . . . 46.3 t -86.86 108.13 17.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 109.419 -0.585 . . . . 0.0 109.419 175.278 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 606' ' ' VAL . . . . . 0.726 HG13 ' HB ' ' A' ' 613' ' ' VAL . 6.1 p -84.33 134.41 27.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.934 -178.21 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 607' ' ' SER . . . . . 0.46 ' O ' ' HA ' ' A' ' 599' ' ' VAL . 3.3 p -139.03 142.58 38.25 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.72 -178.709 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 608' ' ' VAL . . . . . 0.677 HG23 ' HB3' ' A' ' 597' ' ' LEU . 3.0 p -122.07 112.78 36.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 116.238 -0.437 . . . . 0.0 109.962 179.159 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 609' ' ' ASN . . . . . 0.43 ' O ' ' HB3' ' A' ' 610' ' ' LYS . 87.7 m-20 56.57 44.76 23.48 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.763 -178.82 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 610' ' ' LYS . . . . . 0.43 ' HB3' ' O ' ' A' ' 609' ' ' ASN . 48.8 tttp 81.19 -26.19 0.15 Allowed 'General case' 0 N--CA 1.472 0.642 0 O-C-N 124.097 0.873 . . . . 0.0 111.701 179.096 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 611' ' ' GLU . . . . . 0.492 ' HA ' ' HD3' ' A' ' 612' ' ' PRO . 5.6 mm-40 -78.6 135.09 60.67 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 120.647 0.26 . . . . 0.0 110.393 -177.22 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 612' ' ' PRO . . . . . 0.492 ' HD3' ' HA ' ' A' ' 611' ' ' GLU . 4.9 Cg_exo -79.38 138.86 14.22 Favored 'Trans proline' 0 N--CA 1.462 -0.381 0 C-N-CA 123.038 2.492 . . . . 0.0 112.988 -176.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 613' ' ' VAL . . . . . 0.726 ' HB ' HG13 ' A' ' 606' ' ' VAL . 94.7 t -84.34 124.39 39.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.581 175.177 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 614' ' ' ALA . . . . . 0.547 ' HB2' HG23 ' A' ' 629' ' ' THR . . . -76.14 -31.41 58.58 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.573 -174.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 615' ' ' GLU . . . . . 0.402 ' HB3' ' CG2' ' A' ' 627' ' ' VAL . 28.1 tt0 -162.61 93.85 1.22 Allowed Pre-proline 0 C--N 1.325 -0.485 0 CA-C-O 121.184 0.516 . . . . 0.0 110.275 -176.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 616' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -89.32 165.24 5.5 Favored 'Trans proline' 0 N--CA 1.456 -0.708 0 C-N-CA 123.113 2.542 . . . . 0.0 113.422 -178.206 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 26.4 t0 77.36 40.63 0.16 Allowed 'General case' 0 CA--C 1.516 -0.345 0 CA-C-O 122.708 1.242 . . . . 0.0 110.092 165.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 618' ' ' ILE . . . . . 0.428 ' HB ' ' O ' ' A' ' 625' ' ' VAL . 17.8 mt -89.04 109.29 20.04 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.999 0 CA-C-N 113.776 -1.556 . . . . 0.0 109.266 173.226 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 619' ' ' MET . . . . . . . . . . . . . 6.8 mmt -73.41 133.12 43.66 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.686 -0.688 . . . . 0.0 112.355 -173.086 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 620' ' ' ALA . . . . . . . . . . . . . . . -131.06 166.33 21.27 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 108.96 -0.755 . . . . 0.0 108.96 172.051 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 621' ' ' THR . . . . . 0.491 HG22 ' HA ' ' A' ' 504' ' ' THR . 1.2 t -72.82 -33.45 66.21 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.455 -0.498 . . . . 0.0 111.361 -174.167 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 622' ' ' ASN . . . . . 0.574 ' HB3' ' HA ' ' A' ' 534' ' ' GLU . 28.5 p-10 -117.83 24.02 11.31 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.656 0.265 . . . . 0.0 111.556 -176.016 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 623' ' ' GLY . . . . . 0.42 ' HA2' ' CD1' ' A' ' 577' ' ' ILE . . . 162.55 -160.13 32.42 Favored Glycine 0 N--CA 1.442 -0.922 0 C-N-CA 120.187 -1.006 . . . . 0.0 112.816 178.386 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 624' ' ' VAL . . . . . . . . . . . . . 8.5 p -134.83 157.29 40.9 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 179.448 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 625' ' ' VAL . . . . . 0.428 ' O ' ' HB ' ' A' ' 618' ' ' ILE . 59.4 t -122.77 134.13 66.87 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.163 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 626' ' ' HIS . . . . . . . . . . . . . 95.7 m-70 -121.47 112.95 19.16 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 175.033 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 627' ' ' VAL . . . . . 1.012 HG22 ' HZ ' ' A' ' 515' ' ' PHE . 37.1 t -68.22 128.89 32.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.844 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 628' ' ' ILE . . . . . 0.574 HG13 ' HA ' ' A' ' 542' ' ' PRO . 6.4 pt -126.71 147.35 31.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 121.22 0.533 . . . . 0.0 111.043 175.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 629' ' ' THR . . . . . 0.547 HG23 ' HB2' ' A' ' 614' ' ' ALA . 30.1 p -96.43 -1.47 47.42 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.401 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 630' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -126.17 158.95 34.27 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.64 -174.273 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 631' ' ' VAL . . . . . 0.605 HG22 ' HB1' ' A' ' 546' ' ' ALA . 2.3 t -96.06 122.42 47.54 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.7 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 177.116 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 632' ' ' LEU . . . . . 0.457 HD21 HG13 ' A' ' 608' ' ' VAL . 96.2 mt -71.83 110.67 6.51 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.485 0.66 . . . . 0.0 110.401 -177.362 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 633' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -120.92 120.76 29.2 Favored Pre-proline 0 C--N 1.318 -0.802 0 CA-C-N 114.907 -1.042 . . . . 0.0 109.649 -175.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 634' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_exo . . . . . 0 C--O 1.249 1.07 0 C-N-CA 122.752 2.301 . . . . 0.0 111.754 -179.867 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.714 0 N-CA-C 111.252 -0.739 . . . . 0.0 111.252 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 39.1 p -71.9 175.63 5.66 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 177.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 505' ' ' VAL . . . . . 0.648 ' O ' ' HG ' ' A' ' 509' ' ' LEU . 8.5 t -54.63 -38.71 43.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 121.146 0.498 . . . . 0.0 110.261 178.07 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 506' ' ' MET . . . . . . . . . . . . . 16.5 mmt -63.55 -35.1 79.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.787 -178.628 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 507' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -62.91 -28.84 70.33 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.267 0.556 . . . . 0.0 110.27 -178.091 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 508' ' ' VAL . . . . . . . . . . . . . 47.3 t -87.41 -43.11 15.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.797 179.147 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 509' ' ' LEU . . . . . 0.648 ' HG ' ' O ' ' A' ' 505' ' ' VAL . 69.7 mt -64.73 -24.22 67.5 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 121.097 0.475 . . . . 0.0 111.907 -176.01 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -85.71 -21.57 28.24 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.402 -176.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 511' ' ' GLY . . . . . . . . . . . . . . . -81.27 -9.54 85.86 Favored Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 120.665 -0.778 . . . . 0.0 111.53 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 512' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -109.84 148.18 31.99 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.16 0.505 . . . . 0.0 111.607 -178.406 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -76.51 -21.4 55.81 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.757 -0.656 . . . . 0.0 112.521 -176.488 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 514' ' ' ARG . . . . . 0.692 ' HB3' ' HA ' ' A' ' 543' ' ' THR . 9.8 mmt180 -89.97 -51.38 5.51 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.495 0.664 . . . . 0.0 109.496 -177.716 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 515' ' ' PHE . . . . . 0.967 ' HZ ' HG22 ' A' ' 627' ' ' VAL . 9.1 m-30 -62.31 -29.38 70.4 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 114.664 -1.153 . . . . 0.0 111.25 -175.583 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 2.7 p -62.82 -25.7 68.39 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 -175.055 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 517' ' ' MET . . . . . . . . . . . . . 48.4 ttp -80.91 -37.78 29.07 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 175.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 518' ' ' LEU . . . . . 0.462 HD22 ' HD2' ' A' ' 542' ' ' PRO . 66.5 tp -57.81 -39.11 76.81 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.234 171.39 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 519' ' ' VAL . . . . . 0.505 HG23 ' O ' ' A' ' 515' ' ' PHE . 86.6 t -53.76 -37.52 32.62 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 CA-C-O 121.058 0.456 . . . . 0.0 110.582 175.111 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 520' ' ' ALA . . . . . . . . . . . . . . . -71.64 -35.24 70.32 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.441 -178.132 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 521' ' ' ALA . . . . . . . . . . . . . . . -68.59 -48.14 64.93 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.491 176.439 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 522' ' ' ILE . . . . . 0.432 HG23 ' HB2' ' A' ' 527' ' ' LEU . 69.2 mt -59.55 -37.01 68.13 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.886 177.402 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 523' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -61.98 -52.93 62.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.015 177.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 40.8 m -62.0 -34.25 75.83 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.735 -178.386 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 525' ' ' ALA . . . . . . . . . . . . . . . -77.69 -12.01 59.93 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.479 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 526' ' ' GLY . . . . . . . . . . . . . . . 72.73 34.6 59.41 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 121.061 -0.59 . . . . 0.0 112.958 178.093 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 527' ' ' LEU . . . . . 0.432 ' HB2' HG23 ' A' ' 522' ' ' ILE . 95.2 mt -109.13 10.31 26.0 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.901 0.381 . . . . 0.0 110.49 -179.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 528' ' ' THR . . . . . . . . . . . . . 8.1 m -57.08 -43.18 81.92 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 -173.003 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 529' ' ' GLU . . . . . 0.499 ' O ' ' HG2' ' A' ' 533' ' ' ARG . 11.5 pt-20 -70.34 -17.01 63.05 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 111.826 0.306 . . . . 0.0 111.826 -174.091 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 530' ' ' THR . . . . . . . . . . . . . 78.0 m -62.77 -49.17 76.05 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.83 0.348 . . . . 0.0 110.613 178.531 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 531' ' ' LEU . . . . . 0.592 ' H ' HD22 ' A' ' 531' ' ' LEU . 1.9 mm? -75.49 -14.51 60.43 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.19 178.25 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 532' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -78.47 -32.94 48.57 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.603 179.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 533' ' ' ARG . . . . . 0.499 ' HG2' ' O ' ' A' ' 529' ' ' GLU . 30.7 mmm180 -66.91 123.18 19.45 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.334 178.128 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 534' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -71.69 94.79 1.39 Allowed 'General case' 0 N--CA 1.443 -0.82 0 CA-C-O 122.627 1.203 . . . . 0.0 110.697 176.129 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 535' ' ' GLY . . . . . . . . . . . . . . . -161.85 175.06 38.41 Favored Glycine 0 N--CA 1.441 -1.001 0 N-CA-C 108.092 -2.003 . . . . 0.0 108.092 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 536' ' ' VAL . . . . . 0.647 ' HB ' HG13 ' A' ' 577' ' ' ILE . 33.9 m -87.32 131.42 35.2 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 118.405 1.103 . . . . 0.0 111.87 -167.489 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 537' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -150.48 144.31 25.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.051 -0.977 . . . . 0.0 109.964 179.406 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 538' ' ' THR . . . . . . . . . . . . . 22.6 m -108.32 102.91 11.99 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 173.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 539' ' ' VAL . . . . . 0.55 HG21 HG11 ' A' ' 505' ' ' VAL . 47.2 t -100.88 123.24 53.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 120.864 0.364 . . . . 0.0 111.641 -173.231 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 540' ' ' PHE . . . . . 0.549 ' HB3' HD13 ' A' ' 628' ' ' ILE . 97.6 m-85 -102.34 110.0 21.83 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 173.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -103.21 112.61 65.85 Favored Pre-proline 0 C--N 1.324 -0.537 0 CA-C-O 120.748 0.308 . . . . 0.0 110.863 -175.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 542' ' ' PRO . . . . . 0.542 ' HA ' HG13 ' A' ' 628' ' ' ILE . 11.8 Cg_exo -71.5 142.26 40.13 Favored 'Trans proline' 0 N--CA 1.461 -0.4 0 C-N-CA 123.028 2.485 . . . . 0.0 112.146 178.554 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 543' ' ' THR . . . . . 0.692 ' HA ' ' HB3' ' A' ' 514' ' ' ARG . 44.9 p -78.13 175.42 10.16 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.736 178.241 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 544' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -73.72 -24.17 59.87 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.821 -0.352 . . . . 0.0 110.478 -176.56 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 545' ' ' GLU . . . . . 0.436 ' OE2' ' HB ' ' A' ' 543' ' ' THR . 1.9 mp0 -64.35 -33.17 75.22 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 110.043 -0.355 . . . . 0.0 110.043 177.492 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 546' ' ' ALA . . . . . 0.673 ' HB1' HG23 ' A' ' 631' ' ' VAL . . . -59.76 -49.62 77.02 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.592 177.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 547' ' ' PHE . . . . . 0.402 ' HA ' ' HG ' ' A' ' 550' ' ' LEU . 88.9 m-85 -68.98 -21.81 64.13 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.79 -179.634 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 548' ' ' ARG . . . . . . . . . . . . . 30.5 ttm180 -79.12 -28.17 42.92 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.868 179.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 549' ' ' ALA . . . . . . . . . . . . . . . -96.41 1.07 51.37 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.452 -176.379 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 550' ' ' LEU . . . . . 0.439 ' HG ' ' O ' ' A' ' 546' ' ' ALA . 75.0 mt -67.35 137.72 93.88 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.564 179.71 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 551' ' ' PRO . . . . . 0.533 ' HD2' ' HB2' ' A' ' 554' ' ' GLU . 16.0 Cg_exo -68.1 155.81 68.13 Favored 'Trans proline' 0 C--O 1.235 0.368 0 C-N-CA 123.036 2.491 . . . . 0.0 111.437 179.593 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 552' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -43.93 -55.29 3.17 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 123.861 3.041 . . . . 0.0 113.598 -176.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 553' ' ' ARG . . . . . . . . . . . . . 8.6 ptm180 -63.5 -38.76 92.35 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 -177.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 554' ' ' GLU . . . . . 0.533 ' HB2' ' HD2' ' A' ' 551' ' ' PRO . 4.5 mm-40 -73.22 -49.48 27.67 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.827 0.346 . . . . 0.0 111.04 -174.301 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 555' ' ' ARG . . . . . 0.438 ' HB3' ' HB2' ' A' ' 550' ' ' LEU . 20.6 ptt180 -66.53 -28.39 68.51 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.11 -179.285 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 47.6 t -73.37 -29.99 63.0 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.712 0.291 . . . . 0.0 110.757 179.522 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 557' ' ' ARG . . . . . . . . . . . . . 22.2 mtp180 -83.04 -53.63 5.67 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.023 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 558' ' ' LEU . . . . . 0.587 ' O ' ' HG ' ' A' ' 565' ' ' LEU . 47.2 tp -63.91 -40.43 96.49 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.655 0.264 . . . . 0.0 111.564 -174.297 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 559' ' ' LEU . . . . . . . . . . . . . 63.7 mt -94.11 13.23 23.77 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.052 0.453 . . . . 0.0 110.98 -178.144 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 560' ' ' GLY . . . . . . . . . . . . . . . -126.12 -48.66 0.19 Allowed Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.609 -0.805 . . . . 0.0 112.469 -178.584 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 561' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -86.24 116.15 24.24 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.97 0.414 . . . . 0.0 110.548 -176.44 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 562' ' ' ALA . . . . . . . . . . . . . . . -68.71 -21.9 64.37 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.537 -176.386 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 563' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -81.33 -45.74 15.73 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 -178.761 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 564' ' ' GLU . . . . . 0.445 ' O ' HG12 ' A' ' 568' ' ' ILE . 29.2 mt-10 -69.69 -25.18 63.76 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.481 177.8 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 565' ' ' LEU . . . . . 0.587 ' HG ' ' O ' ' A' ' 558' ' ' LEU . 4.0 mt -58.77 -55.85 29.72 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.957 0.408 . . . . 0.0 109.946 170.797 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 566' ' ' ALA . . . . . 0.567 ' O ' ' HG3' ' A' ' 570' ' ' LYS . . . -62.51 -26.97 68.82 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.843 178.444 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 567' ' ' ASN . . . . . 0.457 ' C ' HD22 ' A' ' 567' ' ' ASN . 0.2 OUTLIER -73.18 -55.24 6.73 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.985 179.362 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 568' ' ' ILE . . . . . 0.445 HG12 ' O ' ' A' ' 564' ' ' GLU . 50.8 mm -68.81 -34.65 65.7 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 CA-C-O 120.701 0.286 . . . . 0.0 111.738 -175.113 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 569' ' ' LEU . . . . . 0.444 ' HG ' ' O ' ' A' ' 565' ' ' LEU . 87.1 mt -63.12 -25.63 68.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.799 0.333 . . . . 0.0 111.227 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 570' ' ' LYS . . . . . 0.567 ' HG3' ' O ' ' A' ' 566' ' ' ALA . 62.5 mttp -69.5 -13.93 62.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.893 0.378 . . . . 0.0 111.099 178.018 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 571' ' ' TYR . . . . . . . . . . . . . 15.6 t80 -94.72 -7.86 39.38 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.149 0.5 . . . . 0.0 110.506 -177.21 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 572' ' ' HIS . . . . . . . . . . . . . 75.8 m80 -101.03 -9.21 21.64 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.71 -179.227 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 573' ' ' ILE . . . . . 0.408 ' O ' HD23 ' A' ' 592' ' ' LEU . 29.3 mt -111.9 123.13 67.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.418 178.233 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 574' ' ' GLY . . . . . 0.495 ' HA2' ' HA ' ' A' ' 591' ' ' SER . . . -98.87 167.39 21.85 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.21 176.388 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 575' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -92.24 -4.8 53.56 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 113.112 0.782 . . . . 0.0 113.112 -168.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 576' ' ' GLU . . . . . 0.735 ' HB2' HD21 ' A' ' 589' ' ' LEU . 70.0 mm-40 -128.77 -167.08 1.72 Allowed 'General case' 0 CA--C 1.504 -0.812 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 179.783 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 577' ' ' ILE . . . . . 0.647 HG13 ' HB ' ' A' ' 536' ' ' VAL . 82.0 mt -112.42 105.32 18.56 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 N-CA-C 110.051 -0.352 . . . . 0.0 110.051 167.773 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 578' ' ' LEU . . . . . 0.657 HD21 HG11 ' A' ' 587' ' ' VAL . 0.3 OUTLIER -100.86 115.27 29.97 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 178.644 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 579' ' ' VAL . . . . . . . . . . . . . 30.6 m -113.69 163.73 10.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.496 179.384 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 580' ' ' SER . . . . . . . . . . . . . 49.6 p -62.33 -33.8 75.39 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-O 120.868 0.366 . . . . 0.0 111.03 -178.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 581' ' ' GLY . . . . . . . . . . . . . . . -77.32 22.9 2.41 Favored Glycine 0 CA--C 1.519 0.287 0 C-N-CA 121.207 -0.52 . . . . 0.0 112.543 179.529 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . -140.58 23.64 2.66 Favored Glycine 0 N--CA 1.445 -0.757 0 N-CA-C 111.543 -0.623 . . . . 0.0 111.543 176.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 583' ' ' ILE . . . . . . . . . . . . . 2.5 mt -122.3 98.94 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 CA-C-O 121.152 0.501 . . . . 0.0 110.38 179.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 584' ' ' GLY . . . . . . . . . . . . . . . -82.15 -20.59 62.48 Favored Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 120.63 -0.795 . . . . 0.0 111.781 176.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 585' ' ' ALA . . . . . . . . . . . . . . . -163.19 -79.77 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.921 0.391 . . . . 0.0 110.328 178.028 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 586' ' ' LEU . . . . . 0.789 HD11 ' HB3' ' A' ' 598' ' ' GLU . 53.4 tp -135.92 132.6 36.68 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.173 179.681 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 587' ' ' VAL . . . . . 0.657 HG11 HD21 ' A' ' 578' ' ' LEU . 42.8 t -127.21 116.52 44.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.185 177.343 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 588' ' ' ARG . . . . . 0.871 ' HG2' ' HG2' ' A' ' 598' ' ' GLU . 96.7 mtt180 -85.43 103.59 14.46 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.142 0.496 . . . . 0.0 109.966 176.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 589' ' ' LEU . . . . . 0.735 HD21 ' HB2' ' A' ' 576' ' ' GLU . 0.7 OUTLIER -101.18 125.15 47.78 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.312 -0.858 . . . . 0.0 108.772 -177.309 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 590' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -65.05 149.97 48.92 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.088 0.47 . . . . 0.0 111.552 -177.751 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 591' ' ' SER . . . . . 0.495 ' HA ' ' HA2' ' A' ' 574' ' ' GLY . 54.4 p -111.17 158.3 19.07 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.493 174.414 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 592' ' ' LEU . . . . . 0.408 HD23 ' O ' ' A' ' 573' ' ' ILE . 3.3 mm? -60.74 -18.23 53.37 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 112.068 0.395 . . . . 0.0 112.068 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 593' ' ' GLN . . . . . 0.461 ' N ' ' HB3' ' A' ' 570' ' ' LYS . 4.8 tt0 -71.51 -29.04 64.34 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.027 0.441 . . . . 0.0 110.352 176.649 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 594' ' ' GLY . . . . . . . . . . . . . . . 109.3 -6.72 32.18 Favored Glycine 0 N--CA 1.443 -0.891 0 C-N-CA 120.72 -0.753 . . . . 0.0 111.683 -173.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 595' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -89.93 -174.59 4.31 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 176.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 596' ' ' LYS . . . . . 0.598 ' HD3' ' H ' ' A' ' 596' ' ' LYS . 0.0 OUTLIER -121.66 132.76 54.83 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.206 0.527 . . . . 0.0 111.287 -172.509 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 597' ' ' LEU . . . . . 0.668 ' HA ' HD21 ' A' ' 609' ' ' ASN . 42.6 mt -101.17 115.28 30.12 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 172.17 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 598' ' ' GLU . . . . . 0.871 ' HG2' ' HG2' ' A' ' 588' ' ' ARG . 46.3 mt-10 -89.42 91.78 8.86 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-O 121.203 0.525 . . . . 0.0 109.863 -179.135 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 599' ' ' VAL . . . . . . . . . . . . . 20.3 t -86.6 121.2 37.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 115.267 -0.879 . . . . 0.0 108.871 179.506 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 600' ' ' SER . . . . . . . . . . . . . 3.5 p -130.59 156.32 45.05 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.56 -174.008 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 601' ' ' LEU . . . . . . . . . . . . . 21.3 tp -126.35 107.3 10.17 Favored 'General case' 0 N--CA 1.445 -0.724 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 175.368 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 602' ' ' LYS . . . . . 0.542 ' HG2' ' OD1' ' A' ' 603' ' ' ASN . 36.1 ttpt -127.7 118.91 24.7 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.965 -175.71 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 603' ' ' ASN . . . . . 0.542 ' OD1' ' HG2' ' A' ' 602' ' ' LYS . 18.1 m120 61.47 35.93 17.38 Favored 'General case' 0 C--N 1.331 -0.217 0 O-C-N 123.346 0.404 . . . . 0.0 109.946 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 604' ' ' ASN . . . . . . . . . . . . . 14.2 m120 72.45 4.77 5.1 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 115.144 -0.935 . . . . 0.0 111.669 179.673 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 605' ' ' VAL . . . . . . . . . . . . . 58.6 t -103.56 123.54 57.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 110.273 -0.269 . . . . 0.0 110.273 178.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 606' ' ' VAL . . . . . 0.603 HG13 ' HB ' ' A' ' 613' ' ' VAL . 7.1 p -88.41 129.33 39.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 121.175 0.512 . . . . 0.0 110.8 -179.352 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 607' ' ' SER . . . . . 0.455 ' HA ' ' HA ' ' A' ' 612' ' ' PRO . 2.8 p -133.16 152.49 51.94 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.984 -179.76 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 608' ' ' VAL . . . . . . . . . . . . . 2.6 p -133.91 104.73 6.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.863 179.676 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 609' ' ' ASN . . . . . 0.668 HD21 ' HA ' ' A' ' 597' ' ' LEU . 89.2 m-20 55.8 66.43 1.21 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.84 -178.43 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 610' ' ' LYS . . . . . 0.526 ' HB3' ' O ' ' A' ' 609' ' ' ASN . 58.9 tptt 78.56 -42.81 0.34 Allowed 'General case' 0 N--CA 1.47 0.575 0 CA-C-N 115.724 -0.671 . . . . 0.0 112.715 178.365 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 611' ' ' GLU . . . . . 0.48 ' HA ' ' HD3' ' A' ' 612' ' ' PRO . 4.5 mm-40 -88.99 137.66 29.57 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-O 120.79 0.329 . . . . 0.0 111.463 -172.599 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 612' ' ' PRO . . . . . 0.48 ' HD3' ' HA ' ' A' ' 611' ' ' GLU . 5.8 Cg_exo -77.65 153.91 30.46 Favored 'Trans proline' 0 N--CA 1.459 -0.501 0 C-N-CA 122.917 2.412 . . . . 0.0 112.445 179.236 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 613' ' ' VAL . . . . . 0.603 ' HB ' HG13 ' A' ' 606' ' ' VAL . 24.7 t -94.52 134.11 33.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.341 177.319 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 614' ' ' ALA . . . . . 0.503 ' HB2' HG23 ' A' ' 629' ' ' THR . . . -74.18 -47.1 37.88 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.533 -175.746 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 615' ' ' GLU . . . . . 0.457 ' HB3' ' CG2' ' A' ' 627' ' ' VAL . 36.7 tt0 -147.76 101.64 3.69 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-O 120.969 0.414 . . . . 0.0 110.332 -177.423 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 616' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -90.01 162.57 4.9 Favored 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 123.228 2.619 . . . . 0.0 113.866 -178.414 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 26.8 m-20 77.64 28.79 0.55 Allowed 'General case' 0 CA--C 1.508 -0.635 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.77 163.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 618' ' ' ILE . . . . . 0.557 ' HB ' ' O ' ' A' ' 625' ' ' VAL . 20.2 mt -71.92 108.73 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.081 0 CA-C-N 114.505 -1.225 . . . . 0.0 109.03 173.38 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 619' ' ' MET . . . . . . . . . . . . . 5.7 mmt -79.04 129.29 34.29 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.769 -0.65 . . . . 0.0 112.547 -171.422 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 620' ' ' ALA . . . . . . . . . . . . . . . -118.71 174.91 6.0 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 169.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 621' ' ' THR . . . . . . . . . . . . . 6.0 t -75.19 -25.46 58.27 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.319 -0.552 . . . . 0.0 110.939 -178.115 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 622' ' ' ASN . . . . . 0.464 ' O ' ' HA ' ' A' ' 536' ' ' VAL . 22.9 p-10 -116.88 -9.2 11.22 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 112.481 0.548 . . . . 0.0 112.481 -175.359 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 623' ' ' GLY . . . . . . . . . . . . . . . -169.66 -160.7 18.55 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 119.369 -1.396 . . . . 0.0 113.202 -175.635 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 624' ' ' VAL . . . . . . . . . . . . . 5.6 p -130.13 155.27 41.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 -178.541 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 625' ' ' VAL . . . . . 0.557 ' O ' ' HB ' ' A' ' 618' ' ' ILE . 61.5 t -126.05 135.39 64.0 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.935 179.199 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 626' ' ' HIS . . . . . . . . . . . . . 82.4 m-70 -120.92 114.43 21.54 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.687 177.081 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 627' ' ' VAL . . . . . 0.967 HG22 ' HZ ' ' A' ' 515' ' ' PHE . 29.9 t -67.09 124.11 21.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.418 177.544 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 628' ' ' ILE . . . . . 0.549 HD13 ' HB3' ' A' ' 540' ' ' PHE . 4.4 pt -121.43 142.36 37.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-O 121.124 0.488 . . . . 0.0 110.565 175.273 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 629' ' ' THR . . . . . 0.503 HG23 ' HB2' ' A' ' 614' ' ' ALA . 37.8 p -89.12 -7.44 55.74 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.194 -178.151 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 630' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -129.05 160.43 32.8 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.649 -175.316 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 631' ' ' VAL . . . . . 0.673 HG23 ' HB1' ' A' ' 546' ' ' ALA . 81.1 t -95.11 128.98 45.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 179.479 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 632' ' ' LEU . . . . . . . . . . . . . 96.3 mt -80.92 111.51 17.46 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.313 0.578 . . . . 0.0 110.619 -178.403 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 633' ' ' GLN . . . . . 0.449 ' HA ' ' HD3' ' A' ' 634' ' ' PRO . 51.3 mt-30 -110.84 131.48 22.1 Favored Pre-proline 0 C--N 1.318 -0.761 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.619 -179.397 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 634' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 633' ' ' GLN . 5.6 Cg_exo . . . . . 0 C--O 1.248 0.998 0 C-N-CA 122.971 2.447 . . . . 0.0 111.179 175.307 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.904 0 N-CA-C 111.574 -0.61 . . . . 0.0 111.574 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 26.5 p -69.7 176.23 3.72 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 177.59 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 505' ' ' VAL . . . . . 0.712 ' O ' ' HG ' ' A' ' 509' ' ' LEU . 15.8 m -58.0 -32.04 42.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 C-N-CA 120.775 -0.37 . . . . 0.0 110.387 175.512 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 506' ' ' MET . . . . . . . . . . . . . 11.0 mmt -62.41 -43.74 98.1 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.271 176.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 507' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -61.39 -44.75 96.62 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 120.869 0.366 . . . . 0.0 110.84 179.454 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 508' ' ' VAL . . . . . . . . . . . . . 60.9 t -60.92 -45.51 98.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.745 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 509' ' ' LEU . . . . . 0.712 ' HG ' ' O ' ' A' ' 505' ' ' VAL . 77.5 mt -68.48 -36.23 78.65 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.218 -177.752 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 510' ' ' LYS . . . . . 0.41 ' HE2' HG11 ' A' ' 519' ' ' VAL . 54.4 mttm -77.28 -26.73 52.64 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.272 0.558 . . . . 0.0 110.011 -178.341 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 511' ' ' GLY . . . . . . . . . . . . . . . -71.48 -15.21 75.12 Favored Glycine 0 N--CA 1.445 -0.758 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.678 176.593 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 512' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -106.64 145.77 31.55 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.983 0.42 . . . . 0.0 111.04 179.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 -75.55 -25.23 56.97 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.207 -175.002 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 514' ' ' ARG . . . . . 0.431 ' HB3' ' HA ' ' A' ' 543' ' ' THR . 3.0 mpt_? -86.32 -50.0 7.25 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.305 0.574 . . . . 0.0 109.833 -178.189 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 515' ' ' PHE . . . . . 0.542 ' CZ ' HG22 ' A' ' 627' ' ' VAL . 11.5 m-30 -66.49 -27.0 67.44 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.635 -175.461 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 5.1 p -63.38 -30.21 71.38 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.657 0.265 . . . . 0.0 111.71 -178.52 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 517' ' ' MET . . . . . . . . . . . . . 54.7 mtm -69.78 -34.37 73.66 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 176.474 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 518' ' ' LEU . . . . . 0.545 HD22 ' HD2' ' A' ' 542' ' ' PRO . 51.9 tp -67.58 -40.04 84.84 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.372 173.362 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 519' ' ' VAL . . . . . 0.41 HG11 ' HE2' ' A' ' 510' ' ' LYS . 86.7 t -55.74 -37.09 45.44 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.371 0 CA-C-N 116.223 -0.444 . . . . 0.0 109.925 174.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 520' ' ' ALA . . . . . . . . . . . . . . . -63.74 -38.61 91.77 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.402 -179.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 521' ' ' ALA . . . . . . . . . . . . . . . -67.86 -51.39 48.78 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.825 0.345 . . . . 0.0 110.327 176.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 522' ' ' ILE . . . . . 0.527 ' HA ' ' HG ' ' A' ' 569' ' ' LEU . 62.1 mt -57.74 -40.83 77.71 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 CA-C-O 121.216 0.531 . . . . 0.0 111.164 178.136 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 523' ' ' GLN . . . . . 0.474 ' HA ' ' OG1' ' A' ' 528' ' ' THR . 21.5 tt0 -70.06 -39.21 75.79 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.408 -0.815 . . . . 0.0 110.762 -175.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 43.6 m -72.83 -31.16 64.6 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.93 0.395 . . . . 0.0 110.715 178.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 525' ' ' ALA . . . . . 0.652 ' HB1' ' HA ' ' A' ' 566' ' ' ALA . . . -74.86 -19.92 59.96 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.226 0.536 . . . . 0.0 110.524 176.817 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 526' ' ' GLY . . . . . . . . . . . . . . . 84.46 37.52 10.73 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.774 -0.726 . . . . 0.0 113.153 176.119 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 527' ' ' LEU . . . . . . . . . . . . . 9.1 mp -112.35 15.24 20.38 Favored 'General case' 0 C--N 1.326 -0.416 0 O-C-N 122.599 -0.353 . . . . 0.0 110.957 177.117 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 528' ' ' THR . . . . . 0.474 ' OG1' ' HA ' ' A' ' 523' ' ' GLN . 14.6 m -62.08 -33.74 74.99 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.579 -178.233 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 529' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -69.4 -24.85 63.91 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.551 -177.39 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 530' ' ' THR . . . . . 0.615 ' HB ' HD22 ' A' ' 531' ' ' LEU . 11.0 m -63.14 -53.36 54.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.062 0.458 . . . . 0.0 110.58 179.524 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 531' ' ' LEU . . . . . 0.615 HD22 ' HB ' ' A' ' 530' ' ' THR . 1.8 mm? -79.43 6.11 11.04 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.907 -178.808 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 532' ' ' ASN . . . . . . . . . . . . . 37.5 t-20 -87.83 -28.06 21.87 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.35 0.595 . . . . 0.0 109.428 179.441 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 533' ' ' ARG . . . . . . . . . . . . . 9.5 ttp180 -79.22 137.17 37.3 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.608 -0.723 . . . . 0.0 110.492 178.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 534' ' ' GLU . . . . . 0.645 ' HA ' ' HB3' ' A' ' 622' ' ' ASN . 48.5 mt-10 -77.04 133.91 38.95 Favored 'General case' 0 C--O 1.233 0.191 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 175.188 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 535' ' ' GLY . . . . . . . . . . . . . . . 173.7 -137.64 4.16 Favored Glycine 0 CA--C 1.501 -0.826 0 N-CA-C 110.675 -0.97 . . . . 0.0 110.675 -178.579 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 536' ' ' VAL . . . . . 0.459 ' HB ' HG13 ' A' ' 577' ' ' ILE . 33.8 m -119.52 130.27 74.27 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-O 121.077 0.465 . . . . 0.0 110.963 178.555 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 537' ' ' TYR . . . . . . . . . . . . . 75.8 m-85 -151.25 146.42 26.05 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.636 178.22 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 538' ' ' THR . . . . . 0.73 ' OG1' ' HA ' ' A' ' 577' ' ' ILE . 30.9 m -120.02 101.56 7.93 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 171.3 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 539' ' ' VAL . . . . . . . . . . . . . 51.8 t -103.46 127.34 57.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.115 -174.276 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 540' ' ' PHE . . . . . 0.57 ' HB3' HD13 ' A' ' 628' ' ' ILE . 94.8 m-85 -100.09 112.67 24.97 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 175.675 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 541' ' ' ALA . . . . . 0.465 ' HA ' HD22 ' A' ' 518' ' ' LEU . . . -105.93 113.0 64.2 Favored Pre-proline 0 C--N 1.325 -0.487 0 CA-C-O 120.705 0.288 . . . . 0.0 111.423 -176.788 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 542' ' ' PRO . . . . . 0.545 ' HD2' HD22 ' A' ' 518' ' ' LEU . 13.2 Cg_exo -71.02 142.24 41.94 Favored 'Trans proline' 0 N--CA 1.463 -0.29 0 C-N-CA 123.068 2.512 . . . . 0.0 112.079 176.693 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 543' ' ' THR . . . . . 0.431 ' HA ' ' HB3' ' A' ' 514' ' ' ARG . 40.9 p -80.4 179.56 7.64 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.017 178.732 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 544' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -61.78 -34.37 75.74 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.639 -179.168 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 545' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -62.82 -30.11 71.23 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.107 -176.131 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 546' ' ' ALA . . . . . 0.566 ' HB1' HG23 ' A' ' 631' ' ' VAL . . . -64.95 -49.73 69.2 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.301 0.572 . . . . 0.0 110.634 179.145 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 547' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -69.76 -22.04 63.39 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.784 -178.342 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 548' ' ' ARG . . . . . 0.514 ' O ' ' HD2' ' A' ' 548' ' ' ARG . 5.0 tmm_? -84.48 -35.71 22.78 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.859 -179.107 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 549' ' ' ALA . . . . . . . . . . . . . . . -69.36 -29.97 67.88 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.335 176.42 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 550' ' ' LEU . . . . . 0.472 ' HA ' ' HD3' ' A' ' 551' ' ' PRO . 70.8 mt -64.6 131.49 95.13 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.546 175.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 551' ' ' PRO . . . . . 0.477 ' HD2' ' HB2' ' A' ' 554' ' ' GLU . 6.9 Cg_exo -72.56 145.71 42.59 Favored 'Trans proline' 0 N--CA 1.459 -0.548 0 C-N-CA 122.828 2.352 . . . . 0.0 111.609 -177.309 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 552' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 551' ' ' PRO . 50.0 Cg_exo -53.86 -30.45 57.84 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 123.074 2.516 . . . . 0.0 112.082 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 553' ' ' ARG . . . . . . . . . . . . . 58.7 ttp180 -66.68 -54.71 20.2 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.806 177.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 554' ' ' GLU . . . . . 0.477 ' HB2' ' HD2' ' A' ' 551' ' ' PRO . 0.9 OUTLIER -65.15 -48.9 71.9 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.909 -175.939 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 555' ' ' ARG . . . . . 0.405 ' HG2' ' O ' ' A' ' 551' ' ' PRO . 14.3 ptm180 -60.18 -39.23 85.73 Favored 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 121.12 -0.232 . . . . 0.0 111.464 -176.101 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 50.0 m -71.52 -27.5 63.24 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 111.683 0.253 . . . . 0.0 111.683 -175.611 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 557' ' ' ARG . . . . . . . . . . . . . 33.0 ttm180 -75.96 -43.28 45.39 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.053 0.454 . . . . 0.0 109.781 177.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 558' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -66.71 -42.88 85.67 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.218 -179.383 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 559' ' ' LEU . . . . . 0.77 HD23 HD21 ' A' ' 565' ' ' LEU . 63.7 mt -83.13 0.13 46.6 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.047 -178.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 560' ' ' GLY . . . . . . . . . . . . . . . -88.13 -9.63 70.12 Favored Glycine 0 N--CA 1.453 -0.196 0 CA-C-N 116.039 -0.528 . . . . 0.0 112.612 -178.25 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 561' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -127.86 129.92 47.73 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 178.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 562' ' ' ALA . . . . . . . . . . . . . . . -76.9 -28.23 55.26 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 111.927 0.343 . . . . 0.0 111.927 -175.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 563' ' ' LYS . . . . . 0.476 ' HD2' ' N ' ' A' ' 563' ' ' LYS . 0.5 OUTLIER -80.36 -35.28 35.68 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 -177.125 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 564' ' ' GLU . . . . . . . . . . . . . 21.4 mm-40 -61.14 -43.96 98.06 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 171.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 565' ' ' LEU . . . . . 0.77 HD21 HD23 ' A' ' 559' ' ' LEU . 60.3 mt -57.5 -53.36 59.03 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.74 175.261 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 566' ' ' ALA . . . . . 0.652 ' HA ' ' HB1' ' A' ' 525' ' ' ALA . . . -55.75 -26.18 44.38 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.218 -178.825 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 567' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -86.59 -35.12 19.64 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.808 -179.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 568' ' ' ILE . . . . . . . . . . . . . 22.3 mm -69.71 -52.19 34.1 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 CA-C-N 116.075 -0.511 . . . . 0.0 112.331 -179.127 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 569' ' ' LEU . . . . . 0.527 ' HG ' ' HA ' ' A' ' 522' ' ' ILE . 2.7 mm? -64.22 -23.46 67.32 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-O 121.1 0.476 . . . . 0.0 110.968 177.619 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 570' ' ' LYS . . . . . . . . . . . . . 16.3 ttmm -70.96 -12.4 61.51 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.646 177.073 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 571' ' ' TYR . . . . . 0.47 ' HB2' HE21 ' A' ' 593' ' ' GLN . 59.9 t80 -102.77 -18.07 15.31 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.872 -0.603 . . . . 0.0 111.222 -177.644 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 572' ' ' HIS . . . . . . . . . . . . . 55.4 m80 -86.43 -3.75 59.06 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.118 0.485 . . . . 0.0 110.89 -177.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 573' ' ' ILE . . . . . 0.513 HD13 HD11 ' A' ' 531' ' ' LEU . 27.0 mt -118.19 127.24 75.37 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.134 179.806 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 574' ' ' GLY . . . . . 0.571 ' HA2' ' HA ' ' A' ' 591' ' ' SER . . . -89.12 153.46 23.6 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.934 -0.65 . . . . 0.0 111.58 175.667 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 575' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -74.81 -8.7 57.23 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 120.978 0.418 . . . . 0.0 111.989 -171.482 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 576' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -160.47 162.99 33.3 Favored 'General case' 0 N--CA 1.438 -1.058 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 177.553 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 577' ' ' ILE . . . . . 0.73 ' HA ' ' OG1' ' A' ' 538' ' ' THR . 70.0 mt -78.6 124.1 36.47 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 O-C-N 124.005 0.816 . . . . 0.0 112.386 -170.695 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 578' ' ' LEU . . . . . 0.517 HD11 ' HA ' ' A' ' 583' ' ' ILE . 42.3 tp -122.9 102.09 7.81 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.1 -0.955 . . . . 0.0 109.082 173.428 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 579' ' ' VAL . . . . . . . . . . . . . 30.1 m -96.54 157.39 3.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.84 -177.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 580' ' ' SER . . . . . . . . . . . . . 31.8 t -58.44 -38.96 78.56 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.351 -179.534 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 581' ' ' GLY . . . . . . . . . . . . . . . -74.48 9.96 9.37 Favored Glycine 0 N--CA 1.449 -0.486 0 CA-C-N 115.74 -0.663 . . . . 0.0 113.717 -179.477 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . -162.77 42.59 0.35 Allowed Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.814 -0.707 . . . . 0.0 112.87 178.441 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 583' ' ' ILE . . . . . 0.777 HD12 ' HB2' ' A' ' 601' ' ' LEU . 30.6 mt -80.18 -65.46 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.828 0.347 . . . . 0.0 110.614 176.769 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 584' ' ' GLY . . . . . . . . . . . . . . . 99.82 63.11 0.82 Allowed Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.605 -0.807 . . . . 0.0 111.856 -177.063 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 585' ' ' ALA . . . . . . . . . . . . . . . 67.63 -75.57 0.06 Allowed 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 123.389 0.676 . . . . 0.0 111.96 -179.611 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 586' ' ' LEU . . . . . 0.998 ' HG ' ' HB3' ' A' ' 600' ' ' SER . 6.5 tt -151.32 129.85 12.2 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.904 0.383 . . . . 0.0 110.237 -178.268 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 587' ' ' VAL . . . . . . . . . . . . . 94.5 t -133.59 133.6 57.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.752 -178.042 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 588' ' ' ARG . . . . . . . . . . . . . 71.8 mtt180 -84.26 102.78 12.92 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 173.044 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 589' ' ' LEU . . . . . . . . . . . . . 60.3 tp -90.51 111.98 23.47 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.584 0.707 . . . . 0.0 110.788 -173.401 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 590' ' ' LYS . . . . . . . . . . . . . 46.5 pttt -60.3 137.35 58.14 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 114.93 -1.032 . . . . 0.0 110.634 176.516 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 591' ' ' SER . . . . . 0.571 ' HA ' ' HA2' ' A' ' 574' ' ' GLY . 44.9 p -99.24 172.59 7.26 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.161 175.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 592' ' ' LEU . . . . . 0.423 HD23 ' O ' ' A' ' 573' ' ' ILE . 2.9 mm? -58.76 -22.54 58.22 Favored 'General case' 0 CA--C 1.529 0.173 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 179.593 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 593' ' ' GLN . . . . . 0.749 ' HG3' ' H ' ' A' ' 595' ' ' ASP . 5.8 pt20 -85.34 -29.9 24.12 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.63 -0.428 . . . . 0.0 111.145 178.345 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 594' ' ' GLY . . . . . 0.433 ' N ' ' HG3' ' A' ' 593' ' ' GLN . . . 122.06 -18.76 8.39 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.611 -0.804 . . . . 0.0 113.136 -177.313 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 595' ' ' ASP . . . . . 0.749 ' H ' ' HG3' ' A' ' 593' ' ' GLN . 18.1 t70 -68.46 165.0 19.83 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-N 117.708 0.754 . . . . 0.0 110.189 178.421 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 596' ' ' LYS . . . . . . . . . . . . . 44.9 mttm -109.45 113.37 26.11 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.189 -170.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 597' ' ' LEU . . . . . . . . . . . . . 58.3 mt -79.55 125.76 30.01 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.042 175.233 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 598' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -78.85 84.64 4.88 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 120.612 -0.435 . . . . 0.0 110.163 176.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 599' ' ' VAL . . . . . . . . . . . . . 38.1 t -97.92 121.4 48.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 121.217 0.532 . . . . 0.0 109.588 178.528 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 600' ' ' SER . . . . . 0.998 ' HB3' ' HG ' ' A' ' 586' ' ' LEU . 8.2 p -139.64 160.13 40.57 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-O 120.872 0.367 . . . . 0.0 111.377 -175.429 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 601' ' ' LEU . . . . . 0.777 ' HB2' HD12 ' A' ' 583' ' ' ILE . 39.4 tp -118.45 109.92 16.81 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.852 -179.388 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 602' ' ' LYS . . . . . . . . . . . . . 43.6 mmtm -121.53 114.96 21.96 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.132 -0.485 . . . . 0.0 109.826 178.173 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 603' ' ' ASN . . . . . . . . . . . . . 16.7 m120 58.92 38.52 24.39 Favored 'General case' 0 N--CA 1.465 0.31 0 O-C-N 123.316 0.385 . . . . 0.0 110.526 178.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 604' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 66.34 17.25 10.66 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.236 -179.455 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 605' ' ' VAL . . . . . . . . . . . . . 61.2 t -110.05 121.86 63.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 175.032 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 606' ' ' VAL . . . . . . . . . . . . . 25.1 t -85.83 131.35 34.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.395 -178.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 607' ' ' SER . . . . . . . . . . . . . 42.1 m -131.24 131.43 43.91 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.356 176.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 608' ' ' VAL . . . . . 0.462 HG13 HD21 ' A' ' 632' ' ' LEU . 3.6 p -115.2 111.82 37.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.86 178.609 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 609' ' ' ASN . . . . . 0.506 ' O ' ' HB3' ' A' ' 610' ' ' LYS . 91.6 m-20 60.89 35.47 19.23 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.921 -175.04 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 610' ' ' LYS . . . . . 0.506 ' HB3' ' O ' ' A' ' 609' ' ' ASN . 83.9 tttt 82.28 -24.99 0.16 Allowed 'General case' 0 N--CA 1.47 0.547 0 O-C-N 124.544 1.152 . . . . 0.0 111.795 -177.634 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 611' ' ' GLU . . . . . 0.429 ' HA ' ' HD3' ' A' ' 612' ' ' PRO . 11.0 mm-40 -67.81 127.47 93.36 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.064 0.459 . . . . 0.0 110.602 -179.208 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 612' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 611' ' ' GLU . 3.1 Cg_exo -74.76 130.74 13.83 Favored 'Trans proline' 0 N--CA 1.459 -0.526 0 C-N-CA 123.099 2.533 . . . . 0.0 112.701 -175.034 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 613' ' ' VAL . . . . . . . . . . . . . 96.7 t -79.71 125.9 38.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.568 175.295 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 614' ' ' ALA . . . . . 0.649 ' HB2' HG23 ' A' ' 629' ' ' THR . . . -78.94 -36.79 41.15 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.789 -176.463 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 615' ' ' GLU . . . . . 0.425 ' HB2' ' HB ' ' A' ' 627' ' ' VAL . 9.8 mm-40 -152.48 94.65 3.18 Favored Pre-proline 0 N--CA 1.467 0.393 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.848 -177.114 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 616' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -90.48 162.88 4.41 Favored 'Trans proline' 0 N--CA 1.46 -0.46 0 C-N-CA 123.139 2.56 . . . . 0.0 113.562 179.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 617' ' ' ASP . . . . . 0.434 ' H ' ' CE1' ' A' ' 626' ' ' HIS . 5.0 m-20 76.07 33.22 0.59 Allowed 'General case' 0 CA--C 1.506 -0.743 0 CA-C-O 122.103 0.954 . . . . 0.0 110.261 165.264 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 618' ' ' ILE . . . . . 0.506 ' HB ' ' O ' ' A' ' 625' ' ' VAL . 22.7 mt -82.19 97.72 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.36 0 CA-C-N 113.936 -1.484 . . . . 0.0 109.449 178.569 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 619' ' ' MET . . . . . 0.41 ' HA ' ' CE ' ' A' ' 619' ' ' MET . 2.8 mmt -62.39 111.28 1.95 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 114.948 -1.024 . . . . 0.0 111.939 -177.196 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 620' ' ' ALA . . . . . . . . . . . . . . . -110.73 -179.49 3.76 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 171.639 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 621' ' ' THR . . . . . . . . . . . . . 35.2 m -69.66 -46.86 65.18 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-O 120.886 0.374 . . . . 0.0 111.633 -177.566 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 622' ' ' ASN . . . . . 0.645 ' HB3' ' HA ' ' A' ' 534' ' ' GLU . 24.0 p-10 -116.72 32.81 5.93 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.827 -174.045 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 623' ' ' GLY . . . . . 0.611 ' HA2' HD11 ' A' ' 577' ' ' ILE . . . 150.67 -159.65 28.24 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.527 -0.844 . . . . 0.0 112.46 176.77 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 624' ' ' VAL . . . . . . . . . . . . . 9.8 m -123.4 165.95 19.04 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.753 0 CA-C-O 121.909 0.861 . . . . 0.0 111.352 176.111 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 625' ' ' VAL . . . . . 0.506 ' O ' ' HB ' ' A' ' 618' ' ' ILE . 89.8 t -128.51 107.33 15.75 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.193 0 CA-C-N 113.584 -1.644 . . . . 0.0 109.43 177.742 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 626' ' ' HIS . . . . . 0.434 ' CE1' ' H ' ' A' ' 617' ' ' ASP . 28.4 m-70 -95.41 103.31 15.17 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 177.192 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 627' ' ' VAL . . . . . 0.542 HG22 ' CZ ' ' A' ' 515' ' ' PHE . 41.8 t -62.75 130.85 27.81 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.0 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 628' ' ' ILE . . . . . 0.57 HD13 ' HB3' ' A' ' 540' ' ' PHE . 3.9 pt -124.85 143.64 37.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 121.193 0.52 . . . . 0.0 111.145 178.647 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 629' ' ' THR . . . . . 0.649 HG23 ' HB2' ' A' ' 614' ' ' ALA . 24.5 p -88.31 7.46 32.19 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.965 -0.561 . . . . 0.0 112.329 -178.485 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 630' ' ' ASN . . . . . . . . . . . . . 65.7 t30 -150.05 174.08 13.14 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 176.703 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 631' ' ' VAL . . . . . 0.566 HG23 ' HB1' ' A' ' 546' ' ' ALA . 48.9 t -101.19 133.81 43.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.036 -178.102 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 632' ' ' LEU . . . . . 0.462 HD21 HG13 ' A' ' 608' ' ' VAL . 95.9 mt -79.23 116.78 19.7 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-O 121.312 0.577 . . . . 0.0 111.149 -175.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 633' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -122.98 116.67 28.74 Favored Pre-proline 0 C--N 1.317 -0.814 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.083 179.464 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 634' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo . . . . . 0 C--O 1.249 1.057 0 C-N-CA 122.349 2.032 . . . . 0.0 112.266 -179.421 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.67 0 N-CA-C 111.11 -0.796 . . . . 0.0 111.11 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 504' ' ' THR . . . . . 0.626 ' HA ' HG22 ' A' ' 621' ' ' THR . 47.7 p -81.25 172.36 13.72 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 117.065 0.432 . . . . 0.0 110.292 177.884 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 505' ' ' VAL . . . . . 0.661 HG23 HG22 ' A' ' 625' ' ' VAL . 5.0 p -54.66 -47.96 72.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.682 -179.179 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 506' ' ' MET . . . . . 0.601 ' HA ' HD13 ' A' ' 509' ' ' LEU . 2.8 ppp? -81.79 -17.09 48.78 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.519 -0.473 . . . . 0.0 111.077 -178.66 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 507' ' ' ASP . . . . . 0.497 ' HA ' ' HB2' ' A' ' 510' ' ' LYS . 27.6 t70 -68.13 -29.89 68.9 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 173.19 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 508' ' ' VAL . . . . . . . . . . . . . 84.9 t -61.79 -49.33 84.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.824 -0.626 . . . . 0.0 109.578 171.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 509' ' ' LEU . . . . . 1.055 ' HG ' ' HB3' ' A' ' 515' ' ' PHE . 9.6 mp -53.78 -42.36 68.21 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 121.617 0.722 . . . . 0.0 111.25 171.701 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 510' ' ' LYS . . . . . 0.507 ' HD3' ' SD ' ' A' ' 506' ' ' MET . 0.7 OUTLIER -68.59 -20.43 64.51 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 114.769 -1.105 . . . . 0.0 111.467 -177.937 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 511' ' ' GLY . . . . . . . . . . . . . . . -96.82 -0.91 60.2 Favored Glycine 0 N--CA 1.437 -1.252 0 C-N-CA 120.8 -0.714 . . . . 0.0 111.617 177.208 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 512' ' ' ASP . . . . . 0.421 ' O ' ' HB2' ' A' ' 516' ' ' SER . 27.0 t70 -117.98 148.84 41.82 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.513 0.673 . . . . 0.0 112.39 -176.527 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -75.56 -34.96 60.75 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.428 -179.513 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 514' ' ' ARG . . . . . . . . . . . . . 35.6 mtt180 -79.0 -53.25 7.22 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.085 -174.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 515' ' ' PHE . . . . . 1.055 ' HB3' ' HG ' ' A' ' 509' ' ' LEU . 14.4 m-30 -64.27 -17.12 63.31 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.066 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 516' ' ' SER . . . . . 0.421 ' HB2' ' O ' ' A' ' 512' ' ' ASP . 39.6 t -58.03 -31.06 66.63 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.304 -178.247 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 517' ' ' MET . . . . . 0.489 ' HB2' ' HE3' ' A' ' 517' ' ' MET . 47.7 mtm -72.39 -30.7 64.9 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.742 0.306 . . . . 0.0 110.441 178.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 518' ' ' LEU . . . . . 0.608 HD23 HD21 ' A' ' 509' ' ' LEU . 47.7 tp -70.23 -34.07 72.42 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 173.46 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 519' ' ' VAL . . . . . 0.419 ' CG2' ' HB3' ' A' ' 509' ' ' LEU . 56.7 t -61.41 -33.04 55.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 121.096 0.474 . . . . 0.0 109.774 174.162 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 520' ' ' ALA . . . . . . . . . . . . . . . -67.0 -40.59 87.38 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.325 177.739 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 521' ' ' ALA . . . . . . . . . . . . . . . -66.69 -47.75 71.44 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.151 176.236 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 522' ' ' ILE . . . . . 0.434 HG13 ' O ' ' A' ' 518' ' ' LEU . 87.9 mt -56.34 -43.01 76.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.752 176.575 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 523' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -62.69 -47.91 81.6 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.125 178.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 40.1 m -66.61 -36.42 82.55 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.062 -176.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 525' ' ' ALA . . . . . . . . . . . . . . . -78.58 -28.3 45.83 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.484 -0.326 . . . . 0.0 110.968 177.289 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 526' ' ' GLY . . . . . . . . . . . . . . . 82.02 38.04 14.37 Favored Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 121.286 -0.483 . . . . 0.0 112.931 177.277 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 527' ' ' LEU . . . . . . . . . . . . . 97.5 mt -111.07 20.41 17.46 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.765 0.317 . . . . 0.0 111.209 -177.568 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 528' ' ' THR . . . . . . . . . . . . . 8.8 m -62.08 -37.08 83.68 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.724 -177.535 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 529' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -63.44 -31.62 72.83 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 121.025 0.44 . . . . 0.0 110.681 -178.045 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 530' ' ' THR . . . . . . . . . . . . . 27.0 m -59.84 -46.63 88.66 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.078 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 531' ' ' LEU . . . . . 0.524 HD21 HD13 ' A' ' 573' ' ' ILE . 67.1 mt -93.05 11.44 27.57 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.161 0.505 . . . . 0.0 111.268 -178.094 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 532' ' ' ASN . . . . . . . . . . . . . 58.2 t30 -91.47 -51.01 5.48 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.55 -178.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 533' ' ' ARG . . . . . . . . . . . . . 1.7 tpt180 -68.43 146.1 53.5 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.733 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 534' ' ' GLU . . . . . 0.641 ' HA ' ' HB3' ' A' ' 622' ' ' ASN . 23.2 pm0 -76.6 143.74 40.03 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 121.322 0.582 . . . . 0.0 110.537 -179.345 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 535' ' ' GLY . . . . . 0.414 ' H ' ' HB2' ' A' ' 622' ' ' ASN . . . 177.2 -139.57 4.44 Favored Glycine 0 N--CA 1.446 -0.655 0 N-CA-C 110.117 -1.193 . . . . 0.0 110.117 -176.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 536' ' ' VAL . . . . . . . . . . . . . 33.0 m -124.48 130.31 73.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 117.31 0.555 . . . . 0.0 110.612 176.277 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 537' ' ' TYR . . . . . . . . . . . . . 76.0 m-85 -153.07 152.42 31.31 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.635 -178.488 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 538' ' ' THR . . . . . 0.74 ' OG1' ' HA ' ' A' ' 577' ' ' ILE . 30.7 m -134.89 102.38 5.22 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.403 174.031 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 539' ' ' VAL . . . . . 0.667 HG22 HG23 ' A' ' 573' ' ' ILE . 39.2 t -109.92 127.0 67.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 120.976 0.417 . . . . 0.0 111.694 -172.66 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 540' ' ' PHE . . . . . 0.529 ' HB3' HD13 ' A' ' 628' ' ' ILE . 87.9 m-85 -95.38 109.01 21.23 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 172.264 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 541' ' ' ALA . . . . . 0.473 ' HA ' HD22 ' A' ' 518' ' ' LEU . . . -96.01 111.23 55.53 Favored Pre-proline 0 C--N 1.322 -0.618 0 CA-C-N 116.628 -0.26 . . . . 0.0 111.193 -176.418 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 542' ' ' PRO . . . . . 0.581 ' HA ' HG13 ' A' ' 628' ' ' ILE . 18.5 Cg_endo -66.91 130.05 22.21 Favored 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 122.141 1.894 . . . . 0.0 110.967 175.251 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 17.4 p -96.4 -174.78 3.15 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.509 -0.769 . . . . 0.0 112.55 -171.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 544' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -49.76 -37.15 28.48 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 114.746 -1.115 . . . . 0.0 111.715 178.056 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 545' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -65.0 -28.62 69.63 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.976 -175.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 546' ' ' ALA . . . . . 0.621 ' HB1' HG23 ' A' ' 631' ' ' VAL . . . -79.08 -58.46 3.22 Favored 'General case' 0 CA--C 1.516 -0.348 0 CA-C-O 121.082 0.468 . . . . 0.0 111.616 -176.149 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 547' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -64.62 -29.85 70.86 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.727 -0.669 . . . . 0.0 111.548 -175.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 548' ' ' ARG . . . . . . . . . . . . . 47.3 ttp180 -66.66 -30.68 71.0 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.923 0.392 . . . . 0.0 110.46 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 549' ' ' ALA . . . . . . . . . . . . . . . -86.89 -10.57 53.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.461 -176.016 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 550' ' ' LEU . . . . . 0.491 HD11 HG21 ' A' ' 631' ' ' VAL . 88.2 mt -70.79 122.78 87.79 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 120.922 0.392 . . . . 0.0 110.978 -178.112 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 551' ' ' PRO . . . . . 0.477 ' HD3' ' HA ' ' A' ' 550' ' ' LEU . 16.5 Cg_exo -68.89 157.72 60.75 Favored 'Trans proline' 0 C--O 1.236 0.375 0 C-N-CA 123.327 2.685 . . . . 0.0 111.853 -178.294 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 552' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -44.17 -53.01 5.11 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 123.831 3.021 . . . . 0.0 113.225 -177.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 553' ' ' ARG . . . . . . . . . . . . . 23.2 mtm180 -63.2 -48.35 78.67 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 120.715 0.293 . . . . 0.0 111.513 -175.575 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -63.74 -52.77 58.99 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.736 -174.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 555' ' ' ARG . . . . . . . . . . . . . 19.6 ptt180 -66.34 -29.16 69.3 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.274 -177.474 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 29.2 t -75.6 -24.06 56.5 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.615 0.245 . . . . 0.0 110.834 -178.256 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 557' ' ' ARG . . . . . . . . . . . . . 12.3 tpp180 -82.94 -46.52 12.83 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.53 -0.304 . . . . 0.0 110.265 178.281 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 558' ' ' LEU . . . . . . . . . . . . . 51.2 tp -61.17 -41.56 97.01 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.768 179.223 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 559' ' ' LEU . . . . . 0.672 HD23 HD21 ' A' ' 565' ' ' LEU . 80.5 mt -91.83 6.35 46.45 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.195 0.522 . . . . 0.0 110.552 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 560' ' ' GLY . . . . . . . . . . . . . . . -96.72 -39.58 4.09 Favored Glycine 0 N--CA 1.444 -0.769 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.685 179.502 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 561' ' ' ASP . . . . . 0.514 ' HB2' ' HG2' ' A' ' 564' ' ' GLU . 6.1 m-20 -103.81 119.89 39.85 Favored 'General case' 0 N--CA 1.445 -0.708 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 177.139 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 562' ' ' ALA . . . . . . . . . . . . . . . -65.74 -28.84 69.34 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.986 0.422 . . . . 0.0 111.153 -176.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 563' ' ' LYS . . . . . . . . . . . . . 4.2 mptp? -69.6 -36.84 76.57 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.1 179.02 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 564' ' ' GLU . . . . . 0.514 ' HG2' ' HB2' ' A' ' 561' ' ' ASP . 8.7 mm-40 -62.96 -40.4 97.57 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 179.384 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 565' ' ' LEU . . . . . 0.672 HD21 HD23 ' A' ' 559' ' ' LEU . 48.3 mt -57.07 -50.2 73.5 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.72 176.129 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 566' ' ' ALA . . . . . . . . . . . . . . . -60.48 -53.97 51.19 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.588 179.224 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 567' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -58.95 -49.96 75.88 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.811 -0.631 . . . . 0.0 112.207 -177.24 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 568' ' ' ILE . . . . . . . . . . . . . 40.7 mm -63.99 -40.4 88.93 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 CA-C-O 120.577 0.227 . . . . 0.0 111.557 -178.503 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 569' ' ' LEU . . . . . 0.464 ' HB3' ' O ' ' A' ' 565' ' ' LEU . 0.1 OUTLIER -72.58 -29.2 63.32 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 122.058 -0.401 . . . . 0.0 110.204 -177.344 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 570' ' ' LYS . . . . . . . . . . . . . 25.2 mtpp -62.19 -29.08 70.12 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.091 0.472 . . . . 0.0 110.684 174.086 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 571' ' ' TYR . . . . . 0.518 ' HB2' ' NE2' ' A' ' 593' ' ' GLN . 55.2 t80 -75.46 -18.8 59.77 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.416 178.402 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 572' ' ' HIS . . . . . . . . . . . . . 64.7 m80 -87.64 -12.4 45.64 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.75 0.309 . . . . 0.0 111.331 -177.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 573' ' ' ILE . . . . . 0.667 HG23 HG22 ' A' ' 539' ' ' VAL . 28.7 mt -110.84 118.1 56.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 120.834 0.349 . . . . 0.0 111.18 -178.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 574' ' ' GLY . . . . . 0.449 ' HA2' ' HA ' ' A' ' 591' ' ' SER . . . -95.49 145.74 17.89 Favored Glycine 0 N--CA 1.446 -0.698 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 170.584 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 575' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -93.34 16.94 12.13 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 117.524 0.662 . . . . 0.0 111.119 -174.584 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 576' ' ' GLU . . . . . 0.518 ' HB2' HD21 ' A' ' 589' ' ' LEU . 48.8 mt-10 -137.55 124.08 20.88 Favored 'General case' 0 CA--C 1.512 -0.512 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 179.496 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 577' ' ' ILE . . . . . 0.74 ' HA ' ' OG1' ' A' ' 538' ' ' THR . 72.4 mt -67.43 117.74 9.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 O-C-N 123.612 0.57 . . . . 0.0 111.369 -173.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 578' ' ' LEU . . . . . 0.685 HD11 HG12 ' A' ' 583' ' ' ILE . 3.3 tm? -117.03 114.21 23.44 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.038 -0.983 . . . . 0.0 109.499 178.653 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 579' ' ' VAL . . . . . . . . . . . . . 29.4 m -108.59 163.4 6.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 177.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 580' ' ' SER . . . . . . . . . . . . . 23.6 t -59.39 -41.86 90.39 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.956 0.407 . . . . 0.0 110.857 -176.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 581' ' ' GLY . . . . . . . . . . . . . . . -77.57 19.79 3.79 Favored Glycine 0 CA--C 1.523 0.54 0 C-N-CA 120.777 -0.725 . . . . 0.0 113.152 -179.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . -142.35 16.54 2.5 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.473 178.547 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 583' ' ' ILE . . . . . 0.685 HG12 HD11 ' A' ' 578' ' ' LEU . 32.3 mt -85.33 -42.36 16.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.925 0.393 . . . . 0.0 110.95 179.601 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 584' ' ' GLY . . . . . . . . . . . . . . . 81.01 -87.71 1.36 Allowed Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.48 -0.867 . . . . 0.0 111.66 -178.171 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 585' ' ' ALA . . . . . . . . . . . . . . . -130.44 -66.7 0.76 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.003 0.43 . . . . 0.0 109.855 176.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 586' ' ' LEU . . . . . 0.8 ' HG ' ' HB2' ' A' ' 600' ' ' SER . 3.6 tt -142.21 134.56 27.83 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 174.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 587' ' ' VAL . . . . . . . . . . . . . 10.7 p -125.15 138.44 54.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-O 121.14 0.495 . . . . 0.0 110.955 -174.787 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 588' ' ' ARG . . . . . . . . . . . . . 95.2 mtt180 -99.35 101.75 13.14 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 178.564 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 589' ' ' LEU . . . . . 0.518 HD21 ' HB2' ' A' ' 576' ' ' GLU . 0.6 OUTLIER -109.05 127.04 53.77 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.008 -176.528 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 590' ' ' LYS . . . . . 0.435 ' HE3' ' OE2' ' A' ' 576' ' ' GLU . 22.5 pttp -86.21 145.0 27.16 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.107 0.479 . . . . 0.0 111.002 -176.67 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 591' ' ' SER . . . . . 0.449 ' HA ' ' HA2' ' A' ' 574' ' ' GLY . 79.4 p -95.79 177.84 5.64 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.296 -178.856 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 592' ' ' LEU . . . . . . . . . . . . . 49.1 mt -70.96 -13.87 62.16 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.906 0.384 . . . . 0.0 110.56 179.083 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 593' ' ' GLN . . . . . 0.518 ' NE2' ' HB2' ' A' ' 571' ' ' TYR . 9.4 tt0 -85.74 -29.55 23.8 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.046 -177.449 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 594' ' ' GLY . . . . . . . . . . . . . . . 121.0 -27.09 6.55 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.935 -0.65 . . . . 0.0 111.678 -177.34 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 595' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -73.78 166.04 24.04 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.013 0.435 . . . . 0.0 110.892 176.612 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 596' ' ' LYS . . . . . 0.508 ' HD2' ' O ' ' A' ' 596' ' ' LYS . 0.1 OUTLIER -105.32 141.75 36.29 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.045 -179.601 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 597' ' ' LEU . . . . . 0.46 HD21 ' O ' ' A' ' 571' ' ' TYR . 71.0 mt -92.24 120.27 32.64 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.448 -0.796 . . . . 0.0 108.935 172.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 598' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 -81.29 84.15 6.68 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.188 0.518 . . . . 0.0 109.799 -176.289 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 599' ' ' VAL . . . . . . . . . . . . . 42.1 t -98.07 133.77 38.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.086 -175.447 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 600' ' ' SER . . . . . 0.8 ' HB2' ' HG ' ' A' ' 586' ' ' LEU . 29.7 t -144.66 167.86 21.54 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 121.325 0.583 . . . . 0.0 110.569 -177.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 601' ' ' LEU . . . . . 0.464 HD13 HD12 ' A' ' 583' ' ' ILE . 31.3 tp -131.45 107.6 9.02 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 114.93 -1.032 . . . . 0.0 109.275 -178.345 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 602' ' ' LYS . . . . . . . . . . . . . 24.7 ttmm -119.0 113.76 21.48 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.217 -0.447 . . . . 0.0 109.85 -177.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 603' ' ' ASN . . . . . 0.451 ' O ' ' HB2' ' A' ' 604' ' ' ASN . 14.2 m120 59.48 32.88 22.0 Favored 'General case' 0 N--CA 1.466 0.338 0 O-C-N 123.43 0.456 . . . . 0.0 110.435 -177.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 604' ' ' ASN . . . . . 0.451 ' HB2' ' O ' ' A' ' 603' ' ' ASN . 11.2 m120 73.15 10.59 5.19 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 115.205 -0.907 . . . . 0.0 111.939 -179.013 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 605' ' ' VAL . . . . . . . . . . . . . 61.1 t -97.97 119.98 46.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 174.08 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 606' ' ' VAL . . . . . . . . . . . . . 19.7 t -81.0 136.67 22.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.727 -178.506 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 607' ' ' SER . . . . . . . . . . . . . 8.2 p -142.25 147.92 37.26 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.481 178.62 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 608' ' ' VAL . . . . . . . . . . . . . 7.0 p -131.56 117.38 35.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.122 177.455 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 609' ' ' ASN . . . . . 0.487 ' O ' ' HB2' ' A' ' 610' ' ' LYS . 88.6 m-20 61.35 31.58 19.23 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.676 -178.61 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 610' ' ' LYS . . . . . 0.487 ' HB2' ' O ' ' A' ' 609' ' ' ASN . 11.7 mmmm 79.58 -2.47 2.12 Favored 'General case' 0 N--CA 1.472 0.664 0 O-C-N 124.283 0.989 . . . . 0.0 111.725 -178.133 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 611' ' ' GLU . . . . . 0.485 ' HA ' ' HD3' ' A' ' 612' ' ' PRO . 4.4 mm-40 -93.42 125.81 52.68 Favored Pre-proline 0 C--N 1.33 -0.241 0 N-CA-C 109.654 -0.498 . . . . 0.0 109.654 177.269 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 612' ' ' PRO . . . . . 0.485 ' HD3' ' HA ' ' A' ' 611' ' ' GLU . 8.4 Cg_exo -72.31 144.57 41.58 Favored 'Trans proline' 0 N--CA 1.463 -0.295 0 C-N-CA 122.985 2.457 . . . . 0.0 112.982 -176.252 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 613' ' ' VAL . . . . . . . . . . . . . 98.7 t -86.17 125.97 40.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.61 175.318 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 614' ' ' ALA . . . . . 0.559 ' HB2' HG23 ' A' ' 629' ' ' THR . . . -80.75 -28.48 36.48 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.69 -0.687 . . . . 0.0 111.721 -174.368 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 615' ' ' GLU . . . . . 0.54 ' HB3' ' CG2' ' A' ' 627' ' ' VAL . 10.1 tp10 -161.46 93.97 1.39 Allowed Pre-proline 0 C--N 1.328 -0.363 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 -179.019 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 616' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -89.33 161.04 5.58 Favored 'Trans proline' 0 N--CA 1.46 -0.494 0 C-N-CA 123.353 2.702 . . . . 0.0 113.81 -177.209 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 77.05 32.7 0.47 Allowed 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 121.962 0.887 . . . . 0.0 110.343 164.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 618' ' ' ILE . . . . . 0.474 ' CG2' ' HB ' ' A' ' 625' ' ' VAL . 13.2 mt -75.81 111.28 12.04 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.909 0 CA-C-N 114.498 -1.228 . . . . 0.0 109.694 175.342 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 619' ' ' MET . . . . . . . . . . . . . 9.5 mmt -74.86 122.65 23.7 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.809 -0.632 . . . . 0.0 112.114 -175.254 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 620' ' ' ALA . . . . . . . . . . . . . . . -122.47 161.05 24.29 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 172.432 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 621' ' ' THR . . . . . 0.626 HG22 ' HA ' ' A' ' 504' ' ' THR . 9.9 t -69.32 -30.13 68.11 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.587 -0.445 . . . . 0.0 111.823 -174.512 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 622' ' ' ASN . . . . . 0.641 ' HB3' ' HA ' ' A' ' 534' ' ' GLU . 29.3 p-10 -118.07 28.26 8.49 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 111.921 0.341 . . . . 0.0 111.921 -178.027 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 623' ' ' GLY . . . . . . . . . . . . . . . 155.68 -160.68 30.12 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.171 -1.014 . . . . 0.0 112.444 176.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 624' ' ' VAL . . . . . . . . . . . . . 8.8 p -128.66 157.44 41.3 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 N-CA-C 110.04 -0.356 . . . . 0.0 110.04 179.001 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 625' ' ' VAL . . . . . 0.661 HG22 HG23 ' A' ' 505' ' ' VAL . 42.8 t -125.02 136.18 61.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 116.246 -0.434 . . . . 0.0 109.932 -179.222 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 626' ' ' HIS . . . . . . . . . . . . . 95.6 m-70 -122.57 112.07 17.57 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-O 121.067 0.461 . . . . 0.0 109.982 175.558 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 627' ' ' VAL . . . . . 0.795 HG22 ' HZ ' ' A' ' 515' ' ' PHE . 67.7 t -67.45 129.01 31.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.061 179.402 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 628' ' ' ILE . . . . . 0.581 HG13 ' HA ' ' A' ' 542' ' ' PRO . 9.2 pt -126.02 146.11 32.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.158 0.504 . . . . 0.0 110.932 175.398 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 629' ' ' THR . . . . . 0.559 HG23 ' HB2' ' A' ' 614' ' ' ALA . 35.3 p -95.22 -1.55 51.4 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.042 179.764 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 630' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -125.29 163.07 23.34 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.846 -0.615 . . . . 0.0 109.691 -175.693 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 631' ' ' VAL . . . . . 0.621 HG23 ' HB1' ' A' ' 546' ' ' ALA . 58.5 t -99.3 123.23 51.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 177.548 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 632' ' ' LEU . . . . . . . . . . . . . 80.4 mt -80.88 116.3 20.79 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.144 0.497 . . . . 0.0 111.338 -177.4 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 633' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 -120.15 129.92 25.1 Favored Pre-proline 0 C--N 1.321 -0.651 0 CA-C-N 115.648 -0.706 . . . . 0.0 109.1 176.461 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 634' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo . . . . . 0 C--O 1.249 1.047 0 C-N-CA 123.296 2.664 . . . . 0.0 112.826 -179.543 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.634 0 N-CA-C 112.029 -0.428 . . . . 0.0 112.029 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 504' ' ' THR . . . . . 0.469 ' HA ' HG22 ' A' ' 621' ' ' THR . 41.1 p -78.92 170.46 16.65 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 110.446 -0.205 . . . . 0.0 110.446 178.589 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 505' ' ' VAL . . . . . 0.726 ' O ' ' HG ' ' A' ' 509' ' ' LEU . 10.7 m -60.54 -34.09 56.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 175.061 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 506' ' ' MET . . . . . . . . . . . . . 93.5 mmm -65.03 -34.78 79.25 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-O 120.809 0.338 . . . . 0.0 110.357 177.354 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 507' ' ' ASP . . . . . 0.537 ' HA ' ' HE3' ' A' ' 510' ' ' LYS . 29.9 t70 -70.29 -44.06 69.14 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.183 178.298 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 508' ' ' VAL . . . . . 0.448 HG23 ' O ' ' A' ' 504' ' ' THR . 67.7 t -59.24 -42.94 88.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.886 177.595 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 509' ' ' LEU . . . . . 0.726 ' HG ' ' O ' ' A' ' 505' ' ' VAL . 71.7 mt -68.51 -32.0 71.65 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.512 -178.199 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 510' ' ' LYS . . . . . 0.537 ' HE3' ' HA ' ' A' ' 507' ' ' ASP . 22.9 pttp -88.11 -13.54 41.08 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.184 0.516 . . . . 0.0 110.048 -178.309 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 511' ' ' GLY . . . . . . . . . . . . . . . -84.51 -8.65 82.85 Favored Glycine 0 N--CA 1.442 -0.912 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.562 174.31 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 512' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -116.24 135.72 53.65 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.604 0.24 . . . . 0.0 110.477 178.216 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -64.39 -36.89 85.63 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.844 -176.052 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 514' ' ' ARG . . . . . 0.698 ' HD3' HG22 ' A' ' 543' ' ' THR . 74.8 mtt180 -73.45 -46.94 45.32 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.305 0.574 . . . . 0.0 110.245 -176.731 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 515' ' ' PHE . . . . . 0.975 ' HZ ' HG22 ' A' ' 627' ' ' VAL . 13.9 m-30 -67.42 -18.11 64.98 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.99 -178.546 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 66.2 m -57.43 -36.86 71.9 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.362 -0.381 . . . . 0.0 112.018 -177.593 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 517' ' ' MET . . . . . 0.545 ' HE1' ' HA ' ' A' ' 544' ' ' ASN . 44.7 mtm -72.32 -33.25 67.21 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.752 -0.379 . . . . 0.0 110.177 -179.454 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 518' ' ' LEU . . . . . 0.41 HD22 ' HA ' ' A' ' 541' ' ' ALA . 66.1 tp -64.06 -38.72 92.11 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.088 -0.505 . . . . 0.0 109.908 173.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 519' ' ' VAL . . . . . 0.433 HG23 ' O ' ' A' ' 515' ' ' PHE . 56.7 t -57.33 -36.12 51.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 121.156 0.503 . . . . 0.0 109.875 174.399 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 520' ' ' ALA . . . . . . . . . . . . . . . -70.29 -38.84 75.1 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.326 179.549 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 521' ' ' ALA . . . . . . . . . . . . . . . -65.79 -48.87 70.32 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.508 176.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 522' ' ' ILE . . . . . . . . . . . . . 94.7 mt -57.06 -41.42 77.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.828 -0.623 . . . . 0.0 110.872 176.5 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 523' ' ' GLN . . . . . . . . . . . . . 33.8 tt0 -64.95 -43.48 92.58 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.2 177.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 20.3 t -70.74 -31.36 68.16 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.538 -176.642 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 525' ' ' ALA . . . . . 0.549 ' HB2' ' HB3' ' A' ' 565' ' ' LEU . . . -88.94 -27.1 21.16 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.726 0.298 . . . . 0.0 111.473 -179.242 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 526' ' ' GLY . . . . . . . . . . . . . . . 87.13 49.65 3.93 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.867 -0.683 . . . . 0.0 112.391 178.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 527' ' ' LEU . . . . . 0.411 ' HA ' HD13 ' A' ' 527' ' ' LEU . 4.3 mm? -111.5 8.78 21.2 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.151 0.5 . . . . 0.0 110.691 178.042 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 528' ' ' THR . . . . . . . . . . . . . 5.9 m -60.42 -33.93 73.22 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.464 -177.612 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 529' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -61.29 -33.64 73.89 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.114 -178.633 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 530' ' ' THR . . . . . . . . . . . . . 30.4 m -70.29 -48.32 57.23 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.998 -0.547 . . . . 0.0 111.279 -176.315 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 531' ' ' LEU . . . . . 0.539 ' HB3' ' CG2' ' A' ' 505' ' ' VAL . 31.4 mt -85.96 6.21 29.68 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.323 0.582 . . . . 0.0 111.403 -175.674 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 532' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -83.95 -37.76 21.88 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.091 179.356 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 533' ' ' ARG . . . . . . . . . . . . . 76.6 mtm180 -79.44 131.54 36.11 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.862 -178.475 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 534' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -75.03 127.54 33.46 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.524 179.671 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 535' ' ' GLY . . . . . . . . . . . . . . . -174.26 -132.22 1.52 Allowed Glycine 0 CA--C 1.502 -0.721 0 N-CA-C 110.265 -1.134 . . . . 0.0 110.265 -179.574 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 536' ' ' VAL . . . . . . . . . . . . . 33.9 m -124.36 129.25 74.0 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-O 121.261 0.553 . . . . 0.0 110.719 177.584 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 537' ' ' TYR . . . . . . . . . . . . . 80.4 m-85 -154.86 150.35 27.38 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.161 179.266 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 538' ' ' THR . . . . . 0.723 ' OG1' ' HA ' ' A' ' 577' ' ' ILE . 34.1 m -120.26 102.2 8.33 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 173.723 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 539' ' ' VAL . . . . . 0.502 HG22 HG23 ' A' ' 573' ' ' ILE . 44.2 t -105.11 123.87 59.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.498 -173.035 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 540' ' ' PHE . . . . . 0.607 ' HB3' HD13 ' A' ' 628' ' ' ILE . 93.7 m-85 -95.94 112.86 24.47 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 174.341 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 541' ' ' ALA . . . . . 0.41 ' HA ' HD22 ' A' ' 518' ' ' LEU . . . -101.72 110.66 62.56 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-O 120.935 0.398 . . . . 0.0 110.809 -176.751 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 542' ' ' PRO . . . . . 0.624 ' HA ' HG13 ' A' ' 628' ' ' ILE . 16.9 Cg_exo -69.24 138.98 40.84 Favored 'Trans proline' 0 N--CA 1.461 -0.393 0 C-N-CA 123.11 2.54 . . . . 0.0 112.118 178.332 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 543' ' ' THR . . . . . 0.698 HG22 ' HD3' ' A' ' 514' ' ' ARG . 36.8 p -82.53 179.9 7.64 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.239 -178.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 544' ' ' ASN . . . . . 0.545 ' HA ' ' HE1' ' A' ' 517' ' ' MET . 14.9 m120 -56.65 -34.84 67.72 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.885 0.374 . . . . 0.0 111.181 179.522 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 545' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -73.07 -23.38 60.54 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.759 -174.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -69.16 -51.32 39.34 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-O 121.283 0.563 . . . . 0.0 110.709 179.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 547' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -71.65 -20.86 61.9 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.601 -179.369 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 548' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.62 -29.06 62.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.989 -0.551 . . . . 0.0 109.677 176.353 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 549' ' ' ALA . . . . . . . . . . . . . . . -89.32 2.91 53.71 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.368 -175.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 550' ' ' LEU . . . . . 0.458 ' HA ' ' HD3' ' A' ' 551' ' ' PRO . 75.3 mt -72.83 137.24 79.84 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.561 178.641 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 551' ' ' PRO . . . . . 0.593 ' HD2' ' HB2' ' A' ' 554' ' ' GLU . 17.5 Cg_exo -66.55 150.63 83.94 Favored 'Trans proline' 0 N--CA 1.461 -0.392 0 C-N-CA 122.819 2.346 . . . . 0.0 112.108 -177.364 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 552' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 551' ' ' PRO . 60.0 Cg_exo -53.4 -28.28 43.35 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 123.247 2.632 . . . . 0.0 112.98 -179.236 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 553' ' ' ARG . . . . . . . . . . . . . 23.0 mmt180 -81.11 -54.29 5.66 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.061 0.458 . . . . 0.0 110.041 -179.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 554' ' ' GLU . . . . . 0.593 ' HB2' ' HD2' ' A' ' 551' ' ' PRO . 3.3 mp0 -62.88 -37.64 87.7 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.52 -0.764 . . . . 0.0 112.201 -177.017 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 555' ' ' ARG . . . . . . . . . . . . . 36.5 ptt180 -63.79 -35.11 79.52 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.793 -0.363 . . . . 0.0 110.611 178.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 34.7 m -73.88 -32.05 63.43 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.224 0.535 . . . . 0.0 110.197 179.345 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 557' ' ' ARG . . . . . . . . . . . . . 63.5 mtp180 -68.05 -58.63 4.18 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.624 175.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 558' ' ' LEU . . . . . 0.598 ' O ' ' HG ' ' A' ' 565' ' ' LEU . 27.3 tp -62.39 -42.47 99.45 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.285 -172.729 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 559' ' ' LEU . . . . . . . . . . . . . 80.5 mt -88.21 13.0 12.34 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.972 0.415 . . . . 0.0 111.105 -178.152 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 560' ' ' GLY . . . . . . . . . . . . . . . -122.35 -41.2 0.48 Allowed Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.911 -0.662 . . . . 0.0 112.188 178.283 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 561' ' ' ASP . . . . . 0.4 ' OD1' ' HB3' ' A' ' 563' ' ' LYS . 16.9 t70 -99.52 116.75 32.37 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.924 0.392 . . . . 0.0 110.428 -179.395 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 562' ' ' ALA . . . . . . . . . . . . . . . -68.45 -21.55 64.64 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.788 -175.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 563' ' ' LYS . . . . . 0.4 ' HB3' ' OD1' ' A' ' 561' ' ' ASP . 59.6 tttm -78.78 -48.33 15.04 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 110.22 -0.289 . . . . 0.0 110.22 -178.599 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 564' ' ' GLU . . . . . 0.519 ' O ' HG12 ' A' ' 568' ' ' ILE . 40.7 mt-10 -57.65 -38.1 74.47 Favored 'General case' 0 C--N 1.332 -0.169 0 O-C-N 123.248 0.343 . . . . 0.0 110.107 177.233 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 565' ' ' LEU . . . . . 0.598 ' HG ' ' O ' ' A' ' 558' ' ' LEU . 3.7 mt -55.06 -54.16 46.64 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.63 174.512 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 566' ' ' ALA . . . . . . . . . . . . . . . -62.94 -37.76 88.34 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.475 -178.515 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 567' ' ' ASN . . . . . . . . . . . . . 12.1 m120 -67.41 -41.69 84.47 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.171 -178.76 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 568' ' ' ILE . . . . . 0.519 HG12 ' O ' ' A' ' 564' ' ' GLU . 48.8 mm -69.29 -34.3 62.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.903 0.382 . . . . 0.0 110.736 178.596 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 569' ' ' LEU . . . . . 0.558 ' HG ' ' O ' ' A' ' 565' ' ' LEU . 77.1 mt -64.72 -36.7 85.14 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.814 0.34 . . . . 0.0 110.881 177.037 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 570' ' ' LYS . . . . . 0.797 ' HE3' ' HA ' ' A' ' 593' ' ' GLN . 26.5 mtpp -63.93 -13.62 47.13 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.017 177.451 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 571' ' ' TYR . . . . . 0.419 ' O ' HD21 ' A' ' 597' ' ' LEU . 7.5 t80 -97.38 -16.0 20.43 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.069 -177.462 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 572' ' ' HIS . . . . . . . . . . . . . 59.6 m80 -95.31 -12.25 26.46 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.958 0.409 . . . . 0.0 111.274 -178.488 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 573' ' ' ILE . . . . . 0.521 HD13 HD21 ' A' ' 531' ' ' LEU . 21.3 mt -108.65 123.01 64.07 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.204 178.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 574' ' ' GLY . . . . . 0.547 ' HA2' ' HA ' ' A' ' 591' ' ' SER . . . -92.92 151.2 20.34 Favored Glycine 0 N--CA 1.447 -0.591 0 N-CA-C 111.505 -0.638 . . . . 0.0 111.505 175.137 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 575' ' ' ASP . . . . . 0.483 ' HB3' ' HE3' ' A' ' 590' ' ' LYS . 19.3 t70 -70.35 -21.18 62.91 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 112.879 0.696 . . . . 0.0 112.879 -171.07 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 576' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -149.67 153.06 36.4 Favored 'General case' 0 N--CA 1.439 -1.025 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 -174.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 577' ' ' ILE . . . . . 0.723 ' HA ' ' OG1' ' A' ' 538' ' ' THR . 77.3 mt -72.95 126.44 33.61 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 O-C-N 124.028 0.83 . . . . 0.0 112.14 -171.399 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 578' ' ' LEU . . . . . 0.572 HD21 ' HB ' ' A' ' 587' ' ' VAL . 41.9 tp -126.84 105.26 8.53 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 114.998 -1.001 . . . . 0.0 109.146 173.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 579' ' ' VAL . . . . . 0.525 ' CG1' ' H ' ' A' ' 581' ' ' GLY . 1.0 OUTLIER -102.08 167.57 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.106 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.11 -177.441 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 580' ' ' SER . . . . . 0.415 ' N ' HG13 ' A' ' 579' ' ' VAL . 20.2 m -57.82 -25.93 61.3 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.364 -0.835 . . . . 0.0 111.67 -175.164 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 581' ' ' GLY . . . . . 0.525 ' H ' ' CG1' ' A' ' 579' ' ' VAL . . . -87.29 -2.84 82.59 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.523 -176.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . -110.69 -18.59 8.34 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.37 -179.195 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 583' ' ' ILE . . . . . 0.412 HG13 ' O ' ' A' ' 579' ' ' VAL . 51.2 mt -70.96 -63.38 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.726 0.298 . . . . 0.0 111.2 -177.512 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 584' ' ' GLY . . . . . . . . . . . . . . . 81.53 -63.23 4.38 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.283 -178.175 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 585' ' ' ALA . . . . . . . . . . . . . . . -134.71 -71.01 0.49 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.781 0.324 . . . . 0.0 110.286 178.143 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 586' ' ' LEU . . . . . 0.54 HD13 ' HB3' ' A' ' 600' ' ' SER . 45.5 tp -147.27 132.68 18.59 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.44 -179.448 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 587' ' ' VAL . . . . . 0.572 ' HB ' HD21 ' A' ' 578' ' ' LEU . 57.5 t -137.93 129.17 38.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 116.022 -0.536 . . . . 0.0 109.661 176.655 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 588' ' ' ARG . . . . . 0.402 ' HG2' ' OE2' ' A' ' 598' ' ' GLU . 55.2 mtm180 -85.74 109.84 18.92 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.05 -179.251 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 589' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -95.79 124.88 40.0 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.812 -174.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 590' ' ' LYS . . . . . 0.483 ' HE3' ' HB3' ' A' ' 575' ' ' ASP . 47.4 pttt -77.96 138.93 39.12 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.11 0.481 . . . . 0.0 110.125 177.365 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 591' ' ' SER . . . . . 0.547 ' HA ' ' HA2' ' A' ' 574' ' ' GLY . 80.2 p -104.27 166.24 10.53 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.338 -177.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 592' ' ' LEU . . . . . . . . . . . . . 10.1 mp -68.73 -7.81 37.06 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.246 0.461 . . . . 0.0 112.246 178.173 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 593' ' ' GLN . . . . . 0.797 ' HA ' ' HE3' ' A' ' 570' ' ' LYS . 5.4 tt0 -80.61 -29.03 36.89 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.206 0.527 . . . . 0.0 109.661 173.455 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 594' ' ' GLY . . . . . . . . . . . . . . . 106.55 -13.56 42.86 Favored Glycine 0 N--CA 1.441 -0.993 0 N-CA-C 110.717 -0.953 . . . . 0.0 110.717 -172.327 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 595' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -81.36 -174.43 4.92 Favored 'General case' 0 C--O 1.237 0.396 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 179.304 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 596' ' ' LYS . . . . . . . . . . . . . 59.0 pttt -115.33 135.18 54.41 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.175 0.512 . . . . 0.0 111.422 -171.521 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 597' ' ' LEU . . . . . 0.419 HD21 ' O ' ' A' ' 571' ' ' TYR . 57.6 mt -106.04 114.46 28.61 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 168.771 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 598' ' ' GLU . . . . . 0.43 ' HG3' HD11 ' A' ' 586' ' ' LEU . 1.0 OUTLIER -83.4 92.07 7.48 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 -179.929 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 599' ' ' VAL . . . . . 0.525 ' HA ' ' O ' ' A' ' 607' ' ' SER . 43.2 t -98.4 118.78 45.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 121.245 0.545 . . . . 0.0 110.411 -177.175 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 600' ' ' SER . . . . . 0.54 ' HB3' HD13 ' A' ' 586' ' ' LEU . 2.7 p -129.43 151.77 49.7 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.059 -178.097 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 601' ' ' LEU . . . . . . . . . . . . . 47.6 tp -113.04 108.03 16.77 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.374 179.418 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 602' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -131.12 127.27 37.74 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.361 -177.336 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 603' ' ' ASN . . . . . . . . . . . . . 66.2 t30 62.49 27.45 16.28 Favored 'General case' 0 N--CA 1.464 0.273 0 O-C-N 123.652 0.595 . . . . 0.0 109.946 -178.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 604' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 69.19 12.72 8.53 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 115.137 -0.938 . . . . 0.0 111.513 -177.57 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 605' ' ' VAL . . . . . . . . . . . . . 48.6 t -110.85 123.33 66.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 176.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 606' ' ' VAL . . . . . 0.441 ' HB ' ' HB ' ' A' ' 613' ' ' VAL . 42.0 t -72.52 148.33 9.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.25 -179.8 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 607' ' ' SER . . . . . 0.525 ' O ' ' HA ' ' A' ' 599' ' ' VAL . 4.5 p -141.52 140.62 33.5 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.221 -0.445 . . . . 0.0 109.983 179.789 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 608' ' ' VAL . . . . . . . . . . . . . 3.8 p -126.13 110.36 23.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-O 121.059 0.456 . . . . 0.0 110.315 179.025 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 609' ' ' ASN . . . . . 0.473 ' O ' ' HB3' ' A' ' 610' ' ' LYS . 92.9 m-20 55.48 54.07 8.97 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.87 -179.64 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 610' ' ' LYS . . . . . 0.473 ' HB3' ' O ' ' A' ' 609' ' ' ASN . 61.8 tttp 77.59 -27.32 0.17 Allowed 'General case' 0 N--CA 1.469 0.475 0 CA-C-N 115.525 -0.762 . . . . 0.0 111.721 178.77 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 611' ' ' GLU . . . . . 0.533 ' HB3' ' ND2' ' A' ' 630' ' ' ASN . 6.0 mm-40 -80.35 123.42 83.05 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 120.646 0.26 . . . . 0.0 110.978 -178.482 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 612' ' ' PRO . . . . . 0.494 ' HD3' ' HA ' ' A' ' 611' ' ' GLU . 7.9 Cg_exo -72.75 145.05 40.39 Favored 'Trans proline' 0 CA--C 1.531 0.367 0 C-N-CA 123.0 2.467 . . . . 0.0 113.11 -178.73 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 613' ' ' VAL . . . . . 0.441 ' HB ' ' HB ' ' A' ' 606' ' ' VAL . 70.7 t -91.44 139.23 18.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.951 176.631 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 614' ' ' ALA . . . . . 0.569 ' HB2' HG23 ' A' ' 629' ' ' THR . . . -86.13 -36.21 19.71 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.125 -0.489 . . . . 0.0 112.063 -175.787 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 615' ' ' GLU . . . . . . . . . . . . . 20.4 tp10 -157.78 99.74 1.84 Allowed Pre-proline 0 C--N 1.327 -0.401 0 CA-C-O 121.046 0.45 . . . . 0.0 110.306 -176.593 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 616' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -90.13 168.87 4.36 Favored 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 123.326 2.684 . . . . 0.0 113.844 -178.318 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 77.29 32.74 0.44 Allowed 'General case' 0 CA--C 1.508 -0.657 0 CA-C-O 122.073 0.94 . . . . 0.0 111.025 163.611 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 618' ' ' ILE . . . . . 0.529 ' HB ' ' O ' ' A' ' 625' ' ' VAL . 18.1 mt -83.3 98.98 5.55 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.147 0 CA-C-N 114.149 -1.387 . . . . 0.0 109.29 174.198 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 619' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.96 130.08 36.1 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.777 -174.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 620' ' ' ALA . . . . . . . . . . . . . . . -130.76 177.04 7.71 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.524 173.599 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 621' ' ' THR . . . . . 0.469 HG22 ' HA ' ' A' ' 504' ' ' THR . 10.7 t -81.07 -14.58 57.68 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.44 -0.504 . . . . 0.0 111.59 -177.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 622' ' ' ASN . . . . . 0.504 ' HB2' HG13 ' A' ' 505' ' ' VAL . 7.5 m120 -102.69 -0.34 31.89 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.697 0.284 . . . . 0.0 110.643 179.311 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 623' ' ' GLY . . . . . 0.68 ' HA2' HD11 ' A' ' 577' ' ' ILE . . . 145.62 -140.12 8.75 Favored Glycine 0 N--CA 1.445 -0.76 0 C-N-CA 120.379 -0.915 . . . . 0.0 112.596 180.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 624' ' ' VAL . . . . . . . . . . . . . 4.8 p -126.45 156.02 36.97 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-O 120.898 0.38 . . . . 0.0 109.981 179.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 625' ' ' VAL . . . . . 0.529 ' O ' ' HB ' ' A' ' 618' ' ' ILE . 61.4 t -125.55 136.98 59.14 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.534 179.803 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 626' ' ' HIS . . . . . . . . . . . . . 94.3 m-70 -119.2 115.9 25.18 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-O 120.866 0.365 . . . . 0.0 110.052 177.242 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 627' ' ' VAL . . . . . 0.975 HG22 ' HZ ' ' A' ' 515' ' ' PHE . 38.6 t -70.18 124.95 27.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.334 177.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 628' ' ' ILE . . . . . 0.624 HG13 ' HA ' ' A' ' 542' ' ' PRO . 3.8 pt -123.97 145.03 31.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-O 121.368 0.604 . . . . 0.0 111.3 178.358 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 629' ' ' THR . . . . . 0.569 HG23 ' HB2' ' A' ' 614' ' ' ALA . 22.7 p -94.11 7.48 45.03 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.788 0.804 . . . . 0.0 109.836 179.782 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 630' ' ' ASN . . . . . 0.533 ' ND2' ' HB3' ' A' ' 611' ' ' GLU . 6.1 p30 -141.19 166.05 25.84 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 114.33 -1.305 . . . . 0.0 109.52 -177.164 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 631' ' ' VAL . . . . . 0.445 HG11 HD21 ' A' ' 550' ' ' LEU . 2.7 p -125.91 123.53 64.34 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.982 0 N-CA-C 110.26 -0.274 . . . . 0.0 110.26 -179.643 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 632' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -63.19 120.27 11.18 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-O 121.085 0.469 . . . . 0.0 111.092 -177.024 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 633' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -126.96 110.45 21.94 Favored Pre-proline 0 C--N 1.319 -0.743 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 178.188 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 634' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo . . . . . 0 C--O 1.249 1.05 0 C-N-CA 123.013 2.475 . . . . 0.0 111.872 -178.7 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.595 0 CA-C-O 121.068 0.26 . . . . 0.0 112.933 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 65.6 p -87.52 -176.04 5.44 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.728 0.299 . . . . 0.0 111.165 -176.205 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 505' ' ' VAL . . . . . 0.617 ' O ' ' HG ' ' A' ' 509' ' ' LEU . 21.4 t -54.16 -41.63 52.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.388 175.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 506' ' ' MET . . . . . . . . . . . . . 4.1 mmt -55.11 -43.07 73.7 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.538 179.013 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 507' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -61.68 -39.68 92.27 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.996 0.427 . . . . 0.0 111.022 179.395 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 508' ' ' VAL . . . . . . . . . . . . . 43.2 t -65.53 -46.38 89.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.512 179.074 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 509' ' ' LEU . . . . . 0.617 ' HG ' ' O ' ' A' ' 505' ' ' VAL . 39.0 mt -68.92 -20.8 64.24 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.482 -175.537 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -89.35 -15.99 32.06 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.329 -178.067 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 511' ' ' GLY . . . . . . . . . . . . . . . -82.07 -9.75 84.8 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.751 -0.738 . . . . 0.0 111.445 177.365 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 512' ' ' ASP . . . . . 0.5 ' O ' ' HB2' ' A' ' 516' ' ' SER . 28.1 t70 -120.3 146.99 45.57 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.521 -0.34 . . . . 0.0 110.872 179.359 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -75.52 -32.97 60.69 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.831 0.348 . . . . 0.0 111.434 -178.36 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 514' ' ' ARG . . . . . 0.48 ' HD3' ' HB ' ' A' ' 543' ' ' THR . 78.7 mtt180 -74.78 -49.39 21.03 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.128 0.49 . . . . 0.0 109.711 -176.749 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 515' ' ' PHE . . . . . 0.404 ' HZ ' HG22 ' A' ' 627' ' ' VAL . 15.2 m-30 -65.67 -26.0 67.59 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.809 178.684 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 516' ' ' SER . . . . . 0.5 ' HB2' ' O ' ' A' ' 512' ' ' ASP . 15.9 t -65.34 -26.53 68.07 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.111 -179.219 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 517' ' ' MET . . . . . 0.482 ' HB2' ' HE2' ' A' ' 517' ' ' MET . 33.9 mtm -72.02 -35.21 69.34 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 176.018 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 518' ' ' LEU . . . . . . . . . . . . . 61.4 tp -64.68 -39.13 93.14 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.716 173.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 519' ' ' VAL . . . . . . . . . . . . . 86.0 t -55.06 -36.85 40.43 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.147 0 CA-C-O 121.163 0.506 . . . . 0.0 110.277 174.506 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 520' ' ' ALA . . . . . . . . . . . . . . . -70.99 -42.82 69.17 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.77 -179.423 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 521' ' ' ALA . . . . . . . . . . . . . . . -64.49 -48.65 74.42 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.623 177.581 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 522' ' ' ILE . . . . . 0.626 HG23 ' HB2' ' A' ' 527' ' ' LEU . 88.6 mt -59.48 -38.85 77.31 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.923 178.694 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 523' ' ' GLN . . . . . 0.403 HE21 ' HB3' ' A' ' 523' ' ' GLN . 0.9 OUTLIER -64.71 -44.22 90.94 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.343 177.417 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 13.6 t -68.69 -35.87 77.76 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.749 -178.506 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 525' ' ' ALA . . . . . 0.452 ' HB1' ' HB2' ' A' ' 566' ' ' ALA . . . -73.85 -28.05 61.4 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.849 0.357 . . . . 0.0 111.354 179.344 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 526' ' ' GLY . . . . . . . . . . . . . . . 90.18 48.54 3.52 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.385 179.129 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 527' ' ' LEU . . . . . 0.626 ' HB2' HG23 ' A' ' 522' ' ' ILE . 93.1 mt -124.32 26.35 7.41 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.06 0.457 . . . . 0.0 110.233 178.578 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 528' ' ' THR . . . . . . . . . . . . . 24.5 m -74.86 -36.47 62.32 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.206 -175.37 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 529' ' ' GLU . . . . . 0.464 ' CD ' ' H ' ' A' ' 529' ' ' GLU . 1.9 mp0 -57.82 -36.25 71.99 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.685 -179.511 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 530' ' ' THR . . . . . . . . . . . . . 4.0 m -58.95 -43.13 91.2 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.653 -176.439 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 531' ' ' LEU . . . . . . . . . . . . . 59.1 mt -94.77 14.03 22.65 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.342 -175.582 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 532' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -90.98 -49.47 6.4 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.788 -178.028 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 533' ' ' ARG . . . . . 0.561 ' HG2' ' OE1' ' A' ' 534' ' ' GLU . 18.6 ttp180 -89.87 172.55 8.81 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 -178.662 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 534' ' ' GLU . . . . . 0.584 ' HA ' ' CB ' ' A' ' 622' ' ' ASN . 1.6 pm0 -90.56 -179.18 5.5 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-O 121.446 0.641 . . . . 0.0 111.634 -179.684 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 535' ' ' GLY . . . . . . . . . . . . . . . 142.66 -145.17 15.02 Favored Glycine 0 N--CA 1.446 -0.665 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -172.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 536' ' ' VAL . . . . . 0.466 ' HB ' HG13 ' A' ' 577' ' ' ILE . 29.1 m -127.63 130.64 70.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 117.774 0.787 . . . . 0.0 110.487 174.074 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 537' ' ' TYR . . . . . . . . . . . . . 93.2 m-85 -148.47 148.31 30.11 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.84 -179.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 538' ' ' THR . . . . . 0.775 ' OG1' ' HA ' ' A' ' 577' ' ' ILE . 37.0 m -127.6 102.01 6.65 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 174.182 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 539' ' ' VAL . . . . . 0.525 HG22 HG23 ' A' ' 573' ' ' ILE . 40.3 t -108.93 131.13 60.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.203 -173.449 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 540' ' ' PHE . . . . . 0.52 ' HB3' HD13 ' A' ' 628' ' ' ILE . 92.9 m-85 -101.48 109.98 21.9 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.376 174.685 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -96.02 115.48 65.59 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.498 -178.662 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 542' ' ' PRO . . . . . 0.524 ' HA ' HG13 ' A' ' 628' ' ' ILE . 6.7 Cg_exo -73.79 135.18 21.15 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 122.872 2.382 . . . . 0.0 111.619 178.176 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 543' ' ' THR . . . . . 0.48 ' HB ' ' HD3' ' A' ' 514' ' ' ARG . 34.4 p -75.98 -178.16 4.23 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.06 -179.092 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 544' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -67.27 -32.88 74.18 Favored 'General case' 0 CA--C 1.517 -0.308 0 N-CA-C 110.351 -0.24 . . . . 0.0 110.351 -177.574 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 545' ' ' GLU . . . . . 0.518 ' H ' ' CD ' ' A' ' 545' ' ' GLU . 1.6 mp0 -59.77 -35.43 74.6 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.246 178.205 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 546' ' ' ALA . . . . . 0.625 ' HB1' HG22 ' A' ' 631' ' ' VAL . . . -62.06 -47.51 84.35 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-O 121.275 0.56 . . . . 0.0 110.724 179.347 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 547' ' ' PHE . . . . . 0.651 ' HA ' HD23 ' A' ' 550' ' ' LEU . 94.2 m-85 -78.28 -21.95 49.02 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.797 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 548' ' ' ARG . . . . . . . . . . . . . 20.6 tpp180 -72.61 -35.04 67.76 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.963 177.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 549' ' ' ALA . . . . . . . . . . . . . . . -74.24 -16.08 60.97 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.278 -179.563 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 550' ' ' LEU . . . . . 0.806 HD11 ' HB3' ' A' ' 555' ' ' ARG . 0.2 OUTLIER -98.55 130.5 27.88 Favored Pre-proline 0 N--CA 1.445 -0.712 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 -179.298 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 551' ' ' PRO . . . . . 0.59 ' HD2' ' HB2' ' A' ' 554' ' ' GLU . 5.0 Cg_exo -77.26 160.52 32.67 Favored 'Trans proline' 0 CA--C 1.528 0.212 0 C-N-CA 123.705 2.937 . . . . 0.0 113.488 -169.145 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 552' ' ' PRO . . . . . 0.778 ' HA ' ' HG2' ' A' ' 555' ' ' ARG . 15.0 Cg_endo -58.88 -35.64 98.26 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 123.088 2.525 . . . . 0.0 112.21 176.453 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 553' ' ' ARG . . . . . . . . . . . . . 25.2 tpp180 -61.56 -47.39 85.73 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.383 179.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 554' ' ' GLU . . . . . 0.59 ' HB2' ' HD2' ' A' ' 551' ' ' PRO . 18.9 mm-40 -73.76 -44.96 54.66 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.314 -178.752 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 555' ' ' ARG . . . . . 0.806 ' HB3' HD11 ' A' ' 550' ' ' LEU . 14.4 ptp180 -59.06 -41.31 87.64 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 120.711 -0.396 . . . . 0.0 110.798 -179.173 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 13.1 t -65.02 -36.61 84.96 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.903 0.382 . . . . 0.0 110.457 -178.248 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 557' ' ' ARG . . . . . . . . . . . . . 16.3 mmm180 -61.34 -46.26 90.96 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.883 176.143 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 558' ' ' LEU . . . . . . . . . . . . . 51.7 tp -70.85 -56.35 6.49 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.188 -0.914 . . . . 0.0 111.586 -177.29 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 559' ' ' LEU . . . . . 0.715 ' HG ' ' O ' ' A' ' 555' ' ' ARG . 3.9 pp -73.77 -8.6 56.65 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 120.951 -0.3 . . . . 0.0 111.452 -174.662 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 560' ' ' GLY . . . . . . . . . . . . . . . -66.87 -34.46 87.24 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.958 -0.639 . . . . 0.0 111.605 175.283 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 561' ' ' ASP . . . . . 0.471 ' OD2' ' HB3' ' A' ' 563' ' ' LYS . 14.7 t70 -111.59 121.56 45.47 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.829 0.347 . . . . 0.0 110.673 -179.55 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 562' ' ' ALA . . . . . . . . . . . . . . . -65.45 -28.87 69.54 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.161 -178.631 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 563' ' ' LYS . . . . . 0.471 ' HB3' ' OD2' ' A' ' 561' ' ' ASP . 14.5 ttpp -66.09 -52.16 51.34 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.267 -178.604 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 564' ' ' GLU . . . . . 0.512 ' HA ' ' HB3' ' A' ' 567' ' ' ASN . 8.9 mt-10 -71.76 -24.43 61.77 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.584 -179.487 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 565' ' ' LEU . . . . . 0.489 HD23 ' HA ' ' A' ' 565' ' ' LEU . 9.9 mt -59.39 -55.16 38.22 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 109.368 -0.605 . . . . 0.0 109.368 169.606 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 566' ' ' ALA . . . . . 0.452 ' HB2' ' HB1' ' A' ' 525' ' ' ALA . . . -64.4 -34.75 78.91 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.343 179.274 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 567' ' ' ASN . . . . . 0.512 ' HB3' ' HA ' ' A' ' 564' ' ' GLU . 3.4 t-20 -56.43 -54.47 45.33 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.154 -179.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 568' ' ' ILE . . . . . . . . . . . . . 48.9 mm -70.93 -37.32 67.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.746 0.308 . . . . 0.0 111.068 -177.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 569' ' ' LEU . . . . . 0.419 ' HG ' ' O ' ' A' ' 565' ' ' LEU . 95.5 mt -65.2 -33.45 76.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.041 0.448 . . . . 0.0 110.946 178.289 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 570' ' ' LYS . . . . . 0.565 ' HE2' ' HA ' ' A' ' 593' ' ' GLN . 80.0 tttt -67.2 -16.73 64.48 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.559 -178.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 571' ' ' TYR . . . . . 0.458 ' HB2' ' NE2' ' A' ' 593' ' ' GLN . 45.5 t80 -89.98 -17.76 27.27 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.04 177.595 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 572' ' ' HIS . . . . . . . . . . . . . 53.2 m80 -86.07 -10.3 55.18 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.722 0.296 . . . . 0.0 111.158 -177.549 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 573' ' ' ILE . . . . . 0.525 HG23 HG22 ' A' ' 539' ' ' VAL . 31.2 mt -109.79 120.84 61.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.808 -179.137 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 574' ' ' GLY . . . . . 0.586 ' HA2' ' HA ' ' A' ' 591' ' ' SER . . . -98.62 148.26 18.79 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.909 -0.663 . . . . 0.0 111.663 175.052 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 575' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -93.4 9.07 37.97 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 111.936 0.347 . . . . 0.0 111.936 -173.693 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 576' ' ' GLU . . . . . 0.441 ' O ' HD21 ' A' ' 589' ' ' LEU . 12.2 pt-20 -144.92 133.32 21.84 Favored 'General case' 0 CA--C 1.508 -0.652 0 N-CA-C 109.765 -0.458 . . . . 0.0 109.765 178.616 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 577' ' ' ILE . . . . . 0.775 ' HA ' ' OG1' ' A' ' 538' ' ' THR . 76.3 mt -75.32 117.2 19.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.435 -175.513 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 578' ' ' LEU . . . . . 0.45 ' HB2' HD23 ' A' ' 589' ' ' LEU . 48.7 tp -118.41 108.65 15.31 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.318 -0.856 . . . . 0.0 109.858 176.841 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 579' ' ' VAL . . . . . . . . . . . . . 29.0 m -91.26 160.67 2.68 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.135 177.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 580' ' ' SER . . . . . . . . . . . . . 6.1 p -58.18 -42.81 86.89 Favored 'General case' 0 C--N 1.328 -0.355 0 O-C-N 123.292 0.37 . . . . 0.0 111.436 -176.613 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 581' ' ' GLY . . . . . . . . . . . . . . . -71.78 -11.86 73.9 Favored Glycine 0 CA--C 1.521 0.412 0 C-N-CA 120.964 -0.636 . . . . 0.0 113.087 -178.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . -96.71 -9.96 55.85 Favored Glycine 0 N--CA 1.454 -0.135 0 C-N-CA 121.043 -0.599 . . . . 0.0 112.508 -179.179 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 583' ' ' ILE . . . . . . . . . . . . . 58.7 mt -70.38 -60.21 2.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 121.06 0.457 . . . . 0.0 110.926 -178.295 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 584' ' ' GLY . . . . . . . . . . . . . . . 82.15 -89.04 1.44 Allowed Glycine 0 N--CA 1.444 -0.775 0 C-N-CA 120.55 -0.833 . . . . 0.0 111.383 -176.604 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 585' ' ' ALA . . . . . . . . . . . . . . . -102.71 -75.12 0.61 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.087 0.47 . . . . 0.0 110.351 178.184 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 586' ' ' LEU . . . . . 0.882 ' HG ' ' HB2' ' A' ' 600' ' ' SER . 5.7 tt -155.23 134.05 12.08 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 179.227 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 587' ' ' VAL . . . . . 0.442 ' N ' HD23 ' A' ' 586' ' ' LEU . 61.9 t -132.22 137.11 55.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 N-CA-C 110.199 -0.297 . . . . 0.0 110.199 -178.111 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 588' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -84.98 112.57 20.71 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 177.519 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 589' ' ' LEU . . . . . 0.672 ' HB3' ' HB2' ' A' ' 597' ' ' LEU . 1.9 tm? -89.9 121.09 31.69 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 -177.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 590' ' ' LYS . . . . . . . . . . . . . 33.8 mttp -87.86 131.16 34.65 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 121.303 0.573 . . . . 0.0 111.239 -172.315 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 591' ' ' SER . . . . . 0.586 ' HA ' ' HA2' ' A' ' 574' ' ' GLY . 84.0 p -97.41 159.78 14.72 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 114.973 -1.012 . . . . 0.0 110.718 -177.038 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 592' ' ' LEU . . . . . . . . . . . . . 9.9 mp -63.45 -21.18 66.16 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.491 177.631 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 593' ' ' GLN . . . . . 0.565 ' HA ' ' HE2' ' A' ' 570' ' ' LYS . 7.6 tt0 -73.0 -29.12 62.8 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.068 0.461 . . . . 0.0 110.291 175.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 594' ' ' GLY . . . . . . . . . . . . . . . 112.75 -14.21 24.54 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.172 -179.26 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 595' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -79.65 169.0 18.62 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-O 121.127 0.489 . . . . 0.0 111.106 179.268 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 596' ' ' LYS . . . . . . . . . . . . . 20.0 pttp -106.89 123.42 48.14 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.579 -174.25 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 597' ' ' LEU . . . . . 0.672 ' HB2' ' HB3' ' A' ' 589' ' ' LEU . 40.1 mt -87.73 122.14 31.03 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.947 173.526 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 598' ' ' GLU . . . . . 0.761 ' O ' ' HA ' ' A' ' 608' ' ' VAL . 18.2 tt0 -75.89 94.05 3.3 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.234 177.702 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 599' ' ' VAL . . . . . . . . . . . . . 41.5 t -107.84 121.71 61.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-O 121.317 0.58 . . . . 0.0 110.32 178.32 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 600' ' ' SER . . . . . 0.882 ' HB2' ' HG ' ' A' ' 586' ' ' LEU . 34.9 t -141.8 168.71 19.1 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.703 -177.13 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 601' ' ' LEU . . . . . . . . . . . . . 42.4 tp -135.95 107.78 7.07 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.111 -0.95 . . . . 0.0 108.738 -178.479 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 602' ' ' LYS . . . . . 0.606 ' O ' HG12 ' A' ' 605' ' ' VAL . 57.0 mtpt -131.02 114.33 15.06 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.076 -172.832 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 603' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 57.83 47.16 15.78 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.704 177.663 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 604' ' ' ASN . . . . . . . . . . . . . 13.9 m120 71.97 9.32 6.09 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 114.855 -1.066 . . . . 0.0 112.967 174.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 605' ' ' VAL . . . . . 0.606 HG12 ' O ' ' A' ' 602' ' ' LYS . 7.6 p -118.2 134.26 62.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 C-N-CA 120.146 -0.621 . . . . 0.0 110.326 173.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 606' ' ' VAL . . . . . 0.812 HG13 ' HB ' ' A' ' 613' ' ' VAL . 3.9 p -101.64 136.93 31.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.043 178.318 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 607' ' ' SER . . . . . . . . . . . . . 45.0 m -136.93 151.03 48.58 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.759 -177.585 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 608' ' ' VAL . . . . . 0.761 ' HA ' ' O ' ' A' ' 598' ' ' GLU . 4.3 p -128.62 108.41 17.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.411 0.624 . . . . 0.0 110.059 176.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 609' ' ' ASN . . . . . 0.465 HD21 ' HA ' ' A' ' 597' ' ' LEU . 64.0 m-80 60.34 47.98 8.41 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.638 -176.415 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 610' ' ' LYS . . . . . 0.407 ' HB2' ' O ' ' A' ' 609' ' ' ASN . 56.0 mtpt 73.17 -19.02 0.34 Allowed 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 115.534 -0.757 . . . . 0.0 112.097 -178.533 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 611' ' ' GLU . . . . . 0.428 ' HA ' ' HD3' ' A' ' 612' ' ' PRO . 5.2 mm-40 -79.16 123.74 84.71 Favored Pre-proline 0 C--N 1.331 -0.213 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 -179.359 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 612' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 611' ' ' GLU . 7.3 Cg_exo -73.12 136.12 24.07 Favored 'Trans proline' 0 C--O 1.236 0.382 0 C-N-CA 123.235 2.623 . . . . 0.0 112.939 -176.193 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 613' ' ' VAL . . . . . 0.812 ' HB ' HG13 ' A' ' 606' ' ' VAL . 93.7 t -81.83 130.5 35.7 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.92 175.712 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 614' ' ' ALA . . . . . . . . . . . . . . . -78.44 -33.39 48.55 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.503 -176.239 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 615' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -165.47 107.53 0.77 Allowed Pre-proline 0 C--O 1.233 0.197 0 CA-C-O 120.835 0.35 . . . . 0.0 110.576 -179.673 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 616' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_endo -89.32 156.37 5.52 Favored 'Trans proline' 0 N--CA 1.459 -0.524 0 C-N-CA 123.29 2.66 . . . . 0.0 114.008 -178.065 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 35.3 t70 77.95 61.94 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 122.687 1.232 . . . . 0.0 110.463 166.524 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 618' ' ' ILE . . . . . 0.435 ' HB ' ' O ' ' A' ' 625' ' ' VAL . 7.9 mt -104.73 112.83 39.95 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.301 0 CA-C-N 113.757 -1.565 . . . . 0.0 108.438 174.695 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 619' ' ' MET . . . . . 0.467 ' HA ' ' CE ' ' A' ' 619' ' ' MET . 4.9 mmt -77.83 131.36 37.53 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 -170.588 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 620' ' ' ALA . . . . . . . . . . . . . . . -130.23 162.6 28.57 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 114.995 -1.002 . . . . 0.0 108.466 170.318 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 621' ' ' THR . . . . . . . . . . . . . 5.7 t -73.86 -20.37 60.44 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 120.502 -0.479 . . . . 0.0 111.351 -175.753 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 622' ' ' ASN . . . . . 0.584 ' CB ' ' HA ' ' A' ' 534' ' ' GLU . 28.2 p-10 -116.84 15.54 15.28 Favored 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 120.642 -0.423 . . . . 0.0 111.986 -177.362 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 623' ' ' GLY . . . . . 0.635 ' HA2' HD11 ' A' ' 577' ' ' ILE . . . 157.07 -156.22 27.03 Favored Glycine 0 N--CA 1.443 -0.872 0 C-N-CA 119.97 -1.109 . . . . 0.0 112.762 179.437 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 624' ' ' VAL . . . . . . . . . . . . . 6.3 p -131.22 156.11 42.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-O 121.033 0.444 . . . . 0.0 110.115 -178.201 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 625' ' ' VAL . . . . . 0.541 HG22 HG13 ' A' ' 505' ' ' VAL . 42.6 t -123.74 132.93 70.56 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.645 179.416 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 626' ' ' HIS . . . . . . . . . . . . . 96.2 m-70 -119.16 115.35 24.05 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 174.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 627' ' ' VAL . . . . . 0.404 HG22 ' HZ ' ' A' ' 515' ' ' PHE . 40.4 t -69.87 123.74 24.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.719 -179.8 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 628' ' ' ILE . . . . . 0.524 HG13 ' HA ' ' A' ' 542' ' ' PRO . 8.1 pt -117.51 143.28 28.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 121.192 0.52 . . . . 0.0 111.063 176.436 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 629' ' ' THR . . . . . . . . . . . . . 8.4 t -94.85 5.77 50.93 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.369 -178.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 630' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -135.96 165.83 24.76 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.052 -179.437 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 631' ' ' VAL . . . . . 0.625 HG22 ' HB1' ' A' ' 546' ' ' ALA . 0.7 OUTLIER -98.17 130.14 47.38 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.886 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.755 175.91 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 632' ' ' LEU . . . . . 0.662 HD21 HG13 ' A' ' 608' ' ' VAL . 96.1 mt -77.32 115.93 17.51 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.242 0.544 . . . . 0.0 110.922 -177.355 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 633' ' ' GLN . . . . . 0.542 ' HA ' HE21 ' A' ' 633' ' ' GLN . 0.1 OUTLIER -118.51 117.18 34.63 Favored Pre-proline 0 C--N 1.322 -0.599 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.937 -178.221 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 634' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo . . . . . 0 C--O 1.251 1.133 0 C-N-CA 122.65 2.233 . . . . 0.0 111.944 177.42 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.703 0 N-CA-C 111.697 -0.561 . . . . 0.0 111.697 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 78.9 p -86.14 173.11 10.06 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.912 0.356 . . . . 0.0 110.536 -179.359 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 505' ' ' VAL . . . . . 0.538 ' O ' ' HG ' ' A' ' 509' ' ' LEU . 24.2 t -53.57 -40.6 42.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 121.224 0.535 . . . . 0.0 110.009 175.098 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 506' ' ' MET . . . . . . . . . . . . . 7.4 mmt -56.5 -40.65 75.32 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.021 -0.991 . . . . 0.0 112.296 179.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 507' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -67.63 -40.91 84.6 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 121.035 0.445 . . . . 0.0 110.564 -179.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 508' ' ' VAL . . . . . . . . . . . . . 62.1 t -60.66 -41.38 87.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.416 178.601 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 509' ' ' LEU . . . . . 0.538 ' HG ' ' O ' ' A' ' 505' ' ' VAL . 53.9 mt -75.33 -23.26 57.24 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.693 -179.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 510' ' ' LYS . . . . . 0.567 ' HB3' ' NZ ' ' A' ' 510' ' ' LYS . 1.6 mmmp? -85.8 -33.36 21.38 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.084 -176.688 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 511' ' ' GLY . . . . . . . . . . . . . . . -73.4 -10.75 79.45 Favored Glycine 0 N--CA 1.445 -0.741 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.928 178.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 512' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -110.23 148.61 31.53 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.24 0.543 . . . . 0.0 111.278 -178.2 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -75.19 -33.0 61.37 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.617 -177.73 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 514' ' ' ARG . . . . . 0.682 ' HD2' ' H ' ' A' ' 514' ' ' ARG . 0.3 OUTLIER -88.46 -45.06 10.26 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.059 0.457 . . . . 0.0 110.039 -171.906 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 515' ' ' PHE . . . . . 0.708 ' HZ ' HG22 ' A' ' 627' ' ' VAL . 14.8 m-30 -63.9 -24.69 67.84 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.155 177.523 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 26.5 t -60.76 -36.4 78.85 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.887 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 517' ' ' MET . . . . . . . . . . . . . 59.3 mtm -65.39 -34.5 78.44 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-O 121.003 0.43 . . . . 0.0 110.093 177.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 518' ' ' LEU . . . . . . . . . . . . . 56.1 tp -66.96 -39.8 87.33 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.436 174.661 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 519' ' ' VAL . . . . . . . . . . . . . 58.1 t -54.84 -37.66 41.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-O 121.093 0.473 . . . . 0.0 109.808 174.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 520' ' ' ALA . . . . . . . . . . . . . . . -65.02 -39.98 94.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.627 -179.268 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 521' ' ' ALA . . . . . . . . . . . . . . . -69.08 -43.58 74.27 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.465 176.438 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 522' ' ' ILE . . . . . . . . . . . . . 89.3 mt -58.01 -41.81 81.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.224 177.05 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 523' ' ' GLN . . . . . 0.726 HE21 ' HA ' ' A' ' 523' ' ' GLN . 0.0 OUTLIER -65.22 -23.96 67.22 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-O 121.011 0.434 . . . . 0.0 111.405 178.774 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 30.0 t -79.66 -41.11 27.6 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.535 177.501 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 525' ' ' ALA . . . . . . . . . . . . . . . -82.29 -29.0 31.4 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.118 0.414 . . . . 0.0 112.118 -176.625 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 526' ' ' GLY . . . . . . . . . . . . . . . 95.08 25.45 14.39 Favored Glycine 0 CA--C 1.519 0.327 0 C-N-CA 120.546 -0.835 . . . . 0.0 113.332 176.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 527' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -91.58 8.39 36.88 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 121.173 0.511 . . . . 0.0 110.171 178.342 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 528' ' ' THR . . . . . . . . . . . . . 16.9 m -57.87 -44.05 86.4 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.439 -0.8 . . . . 0.0 111.238 -178.282 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 529' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -65.48 -31.31 72.31 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.026 -0.533 . . . . 0.0 111.352 -176.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 530' ' ' THR . . . . . . . . . . . . . 12.4 m -63.21 -46.57 86.4 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.108 -179.238 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 531' ' ' LEU . . . . . . . . . . . . . 42.4 mt -90.44 8.28 34.5 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 120.978 0.418 . . . . 0.0 111.236 -177.156 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 532' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -95.01 -25.15 16.61 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.019 -177.195 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 533' ' ' ARG . . . . . . . . . . . . . 69.1 mtm180 -92.39 157.69 16.47 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.345 -177.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 534' ' ' GLU . . . . . 0.583 ' HA ' ' HB3' ' A' ' 622' ' ' ASN . 12.7 pt-20 -78.75 162.76 25.92 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.758 178.567 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 535' ' ' GLY . . . . . . . . . . . . . . . 139.05 -138.63 9.5 Favored Glycine 0 N--CA 1.446 -0.67 0 N-CA-C 110.302 -1.119 . . . . 0.0 110.302 -176.113 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 536' ' ' VAL . . . . . 0.556 ' HB ' HG13 ' A' ' 577' ' ' ILE . 35.3 m -127.07 129.06 71.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 121.229 0.538 . . . . 0.0 111.043 176.417 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 537' ' ' TYR . . . . . 0.436 ' O ' ' HA3' ' A' ' 623' ' ' GLY . 69.2 m-85 -153.07 130.89 11.66 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.595 -0.729 . . . . 0.0 109.695 179.003 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 538' ' ' THR . . . . . 0.707 ' OG1' ' HA ' ' A' ' 577' ' ' ILE . 28.3 m -114.62 106.3 14.08 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.961 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 539' ' ' VAL . . . . . . . . . . . . . 40.0 t -112.15 130.86 65.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-O 121.021 0.439 . . . . 0.0 111.35 -174.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 540' ' ' PHE . . . . . 0.474 ' HB3' HD13 ' A' ' 628' ' ' ILE . 87.5 m-85 -97.68 111.2 23.58 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 174.056 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 541' ' ' ALA . . . . . 0.404 ' HA ' ' HD3' ' A' ' 542' ' ' PRO . . . -101.73 118.38 59.7 Favored Pre-proline 0 C--N 1.325 -0.471 0 CA-C-O 120.669 0.271 . . . . 0.0 110.887 -177.029 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 542' ' ' PRO . . . . . 0.539 ' HA ' HG13 ' A' ' 628' ' ' ILE . 7.4 Cg_exo -74.08 141.52 29.71 Favored 'Trans proline' 0 N--CA 1.461 -0.401 0 C-N-CA 123.155 2.57 . . . . 0.0 112.149 178.339 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 61.0 p -81.66 -176.61 6.15 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.683 -179.124 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 544' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -61.13 -32.7 72.39 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 121.352 0.596 . . . . 0.0 110.162 179.067 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 545' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -59.5 -40.48 87.22 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.037 -0.983 . . . . 0.0 110.939 -179.517 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 546' ' ' ALA . . . . . 0.693 ' HB1' HG23 ' A' ' 631' ' ' VAL . . . -61.54 -50.18 73.7 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.559 -177.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 547' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -69.51 -20.86 63.7 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.136 -177.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 548' ' ' ARG . . . . . . . . . . . . . 30.5 tpt180 -83.37 -33.89 25.71 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.056 0.455 . . . . 0.0 110.236 177.527 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 549' ' ' ALA . . . . . . . . . . . . . . . -75.5 -21.38 58.06 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.375 -0.83 . . . . 0.0 111.441 -179.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 550' ' ' LEU . . . . . 0.617 HD11 HG21 ' A' ' 631' ' ' VAL . 73.5 mt -69.85 129.1 91.38 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-O 120.772 0.32 . . . . 0.0 111.058 178.385 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 551' ' ' PRO . . . . . 0.487 ' HD3' ' HA ' ' A' ' 550' ' ' LEU . 5.1 Cg_exo -77.78 148.29 25.32 Favored 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 123.061 2.508 . . . . 0.0 111.209 -179.207 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 552' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 551' ' ' PRO . 50.1 Cg_exo -53.85 -34.42 75.6 Favored 'Trans proline' 0 N--CA 1.471 0.194 0 C-N-CA 122.915 2.41 . . . . 0.0 112.435 -178.768 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 553' ' ' ARG . . . . . . . . . . . . . 34.8 mtp180 -62.24 -42.78 99.62 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.539 179.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -83.78 -35.01 24.65 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.808 0.337 . . . . 0.0 110.84 179.589 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 555' ' ' ARG . . . . . . . . . . . . . 14.4 mtp180 -58.05 -42.56 85.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.137 176.108 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 28.5 t -59.93 -28.55 67.71 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.863 -178.561 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 557' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -67.14 -62.91 1.2 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.357 0.599 . . . . 0.0 110.193 176.377 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 558' ' ' LEU . . . . . 0.573 ' O ' ' HG ' ' A' ' 565' ' ' LEU . 53.2 tp -68.88 -52.66 27.25 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.26 -0.882 . . . . 0.0 112.107 -172.422 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 559' ' ' LEU . . . . . . . . . . . . . 72.5 mt -80.33 4.74 16.87 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.802 -170.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 560' ' ' GLY . . . . . . . . . . . . . . . -123.66 3.97 9.33 Favored Glycine 0 N--CA 1.446 -0.7 0 C-N-CA 120.381 -0.914 . . . . 0.0 112.619 -179.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 561' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -135.82 128.67 31.16 Favored 'General case' 0 C--N 1.326 -0.431 0 O-C-N 122.538 -0.389 . . . . 0.0 111.051 -178.676 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 562' ' ' ALA . . . . . . . . . . . . . . . -70.32 -38.54 74.95 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.677 -176.132 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 563' ' ' LYS . . . . . 0.48 ' HG2' ' OE1' ' A' ' 564' ' ' GLU . 31.4 tttm -66.65 -47.87 71.18 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.036 -178.394 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 564' ' ' GLU . . . . . 0.48 ' OE1' ' HG2' ' A' ' 563' ' ' LYS . 5.7 mm-40 -67.33 -36.0 80.54 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.602 -0.272 . . . . 0.0 110.786 -179.436 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 565' ' ' LEU . . . . . 0.573 ' HG ' ' O ' ' A' ' 558' ' ' LEU . 6.6 mt -56.62 -52.52 64.56 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-O 120.893 0.377 . . . . 0.0 110.331 174.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 566' ' ' ALA . . . . . 0.5 ' O ' ' HG3' ' A' ' 570' ' ' LYS . . . -61.16 -48.71 80.34 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.34 -179.038 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 567' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -59.84 -48.08 83.15 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.822 -177.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 568' ' ' ILE . . . . . . . . . . . . . 43.4 mm -69.47 -35.27 65.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.706 0.289 . . . . 0.0 111.459 -178.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 569' ' ' LEU . . . . . 0.49 ' HG ' ' O ' ' A' ' 565' ' ' LEU . 61.2 mt -66.23 -36.95 84.35 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.813 -0.355 . . . . 0.0 110.59 177.128 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 570' ' ' LYS . . . . . 0.5 ' HG3' ' O ' ' A' ' 566' ' ' ALA . 53.2 mtpt -69.33 -9.84 55.16 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.682 0.277 . . . . 0.0 111.061 177.355 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 571' ' ' TYR . . . . . 0.506 ' HB2' HE21 ' A' ' 593' ' ' GLN . 33.9 t80 -92.78 -18.93 22.29 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.87 0.367 . . . . 0.0 110.525 179.065 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 572' ' ' HIS . . . . . . . . . . . . . 67.2 m80 -92.93 -7.08 47.06 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.17 0.509 . . . . 0.0 110.581 179.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 573' ' ' ILE . . . . . . . . . . . . . 54.0 mt -113.75 124.12 70.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.885 179.018 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 574' ' ' GLY . . . . . 0.502 ' HA3' ' CD2' ' A' ' 589' ' ' LEU . . . -113.95 149.7 18.67 Favored Glycine 0 N--CA 1.445 -0.74 0 N-CA-C 110.575 -1.01 . . . . 0.0 110.575 171.48 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 575' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -100.35 24.51 8.73 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 117.553 0.677 . . . . 0.0 110.879 -177.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 576' ' ' GLU . . . . . 0.421 ' HG3' ' HG ' ' A' ' 589' ' ' LEU . 14.8 pt-20 -136.21 125.88 25.46 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 175.426 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 577' ' ' ILE . . . . . 0.707 ' HA ' ' OG1' ' A' ' 538' ' ' THR . 61.2 mt -77.57 115.07 18.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.147 -175.423 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 578' ' ' LEU . . . . . 0.562 HD11 ' HA ' ' A' ' 583' ' ' ILE . 48.7 tp -121.67 103.44 8.89 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.267 -0.879 . . . . 0.0 109.791 177.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 579' ' ' VAL . . . . . 0.497 ' O ' HG13 ' A' ' 583' ' ' ILE . 30.4 m -95.36 162.41 2.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.964 178.035 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 580' ' ' SER . . . . . . . . . . . . . 15.3 m -56.6 -45.93 81.14 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 123.354 0.409 . . . . 0.0 111.914 -175.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 581' ' ' GLY . . . . . . . . . . . . . . . -70.43 -21.17 77.42 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.52 -0.848 . . . . 0.0 112.619 -179.104 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . -99.43 2.64 57.6 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.876 -0.678 . . . . 0.0 113.296 -175.222 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 583' ' ' ILE . . . . . 0.562 ' HA ' HD11 ' A' ' 578' ' ' LEU . 62.7 mt -67.75 -65.21 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 117.183 0.491 . . . . 0.0 111.1 179.142 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 584' ' ' GLY . . . . . . . . . . . . . . . 78.83 78.32 0.84 Allowed Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.241 -0.981 . . . . 0.0 111.556 -175.388 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 585' ' ' ALA . . . . . . . . . . . . . . . 70.68 -80.12 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 123.303 0.641 . . . . 0.0 111.88 -178.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 586' ' ' LEU . . . . . 0.96 ' HG ' ' HB3' ' A' ' 600' ' ' SER . 6.4 tt -151.32 129.02 11.54 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.7 0.286 . . . . 0.0 110.654 -175.458 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 587' ' ' VAL . . . . . . . . . . . . . 68.3 t -148.02 119.65 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.848 -0.614 . . . . 0.0 109.62 179.107 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 588' ' ' ARG . . . . . 0.551 ' HG2' ' HA ' ' A' ' 598' ' ' GLU . 92.3 mtt180 -85.36 123.06 30.39 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.125 0.488 . . . . 0.0 110.875 -179.131 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 589' ' ' LEU . . . . . 0.527 HD12 ' HB3' ' A' ' 578' ' ' LEU . 6.2 tt -90.56 125.63 35.68 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 114.749 -1.114 . . . . 0.0 109.77 -172.775 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 590' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -76.72 132.31 39.24 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.169 0.509 . . . . 0.0 110.774 -179.157 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 591' ' ' SER . . . . . . . . . . . . . 78.3 p -99.76 159.85 14.75 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.744 -176.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 592' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -58.01 -25.64 61.37 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 116.187 -0.46 . . . . 0.0 112.053 179.177 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 593' ' ' GLN . . . . . 0.506 HE21 ' HB2' ' A' ' 571' ' ' TYR . 4.0 tt0 -68.39 -27.09 65.91 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.175 0.512 . . . . 0.0 110.664 178.763 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 594' ' ' GLY . . . . . . . . . . . . . . . 107.17 -4.95 35.72 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.744 -0.741 . . . . 0.0 111.369 -174.663 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 595' ' ' ASP . . . . . 0.401 ' HB3' ' CE1' ' A' ' 571' ' ' TYR . 2.2 t70 -88.81 -176.78 5.34 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 179.22 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 596' ' ' LYS . . . . . 0.679 ' HD3' ' N ' ' A' ' 596' ' ' LYS . 0.0 OUTLIER -125.56 129.74 50.29 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.078 0.466 . . . . 0.0 110.875 -172.283 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 597' ' ' LEU . . . . . 0.408 HD21 ' O ' ' A' ' 571' ' ' TYR . 59.7 mt -93.46 119.53 32.65 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.63 177.453 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 598' ' ' GLU . . . . . 0.551 ' HA ' ' HG2' ' A' ' 588' ' ' ARG . 10.7 tp10 -75.76 86.55 2.77 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.356 -179.74 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 599' ' ' VAL . . . . . . . . . . . . . 49.3 t -105.86 125.43 61.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 121.198 0.523 . . . . 0.0 110.395 -179.415 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 600' ' ' SER . . . . . 0.96 ' HB3' ' HG ' ' A' ' 586' ' ' LEU . 3.0 p -142.72 157.43 44.66 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.107 -179.114 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 601' ' ' LEU . . . . . 0.494 ' HB2' HD12 ' A' ' 583' ' ' ILE . 33.9 tp -123.06 122.92 39.66 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.096 -177.525 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 602' ' ' LYS . . . . . . . . . . . . . 34.9 ttmt -139.42 109.26 6.32 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.712 0.292 . . . . 0.0 110.515 -177.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 603' ' ' ASN . . . . . . . . . . . . . 18.7 m120 61.75 46.77 6.74 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.61 178.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 604' ' ' ASN . . . . . . . . . . . . . 15.9 t-20 76.64 -8.77 1.61 Allowed 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 115.307 -0.86 . . . . 0.0 111.777 177.277 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 605' ' ' VAL . . . . . . . . . . . . . 49.0 t -94.14 126.43 46.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-O 120.75 0.309 . . . . 0.0 110.198 -179.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 606' ' ' VAL . . . . . 0.553 HG13 ' HB ' ' A' ' 613' ' ' VAL . 6.7 p -108.76 131.11 60.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.625 -179.665 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 607' ' ' SER . . . . . . . . . . . . . 45.2 p -131.92 144.4 50.81 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.2 -179.203 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 608' ' ' VAL . . . . . 0.473 ' HA ' ' O ' ' A' ' 598' ' ' GLU . 4.4 p -118.83 115.04 46.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.81 176.205 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 609' ' ' ASN . . . . . . . . . . . . . 95.7 m-20 61.79 32.33 18.2 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.093 -176.378 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 610' ' ' LYS . . . . . 0.533 ' NZ ' ' HB2' ' A' ' 610' ' ' LYS . 0.0 OUTLIER 81.48 -6.18 1.54 Allowed 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 114.792 -1.094 . . . . 0.0 111.134 -179.176 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 611' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -87.11 111.34 40.13 Favored Pre-proline 0 C--N 1.326 -0.42 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 177.438 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 612' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -65.41 135.23 41.83 Favored 'Trans proline' 0 N--CA 1.462 -0.361 0 C-N-CA 122.634 2.223 . . . . 0.0 112.185 -178.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 613' ' ' VAL . . . . . 0.553 ' HB ' HG13 ' A' ' 606' ' ' VAL . 89.8 t -73.84 125.01 32.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.068 177.823 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 614' ' ' ALA . . . . . 0.69 ' HB2' HG23 ' A' ' 629' ' ' THR . . . -64.65 -45.34 87.18 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.748 -177.82 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 615' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -154.46 99.04 2.48 Favored Pre-proline 0 N--CA 1.466 0.374 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.782 -177.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 616' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -88.87 162.29 6.09 Favored 'Trans proline' 0 N--CA 1.459 -0.51 0 C-N-CA 123.026 2.484 . . . . 0.0 114.195 -176.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 37.5 t0 77.33 46.93 0.06 Allowed 'General case' 0 C--O 1.234 0.272 0 CA-C-O 122.735 1.255 . . . . 0.0 110.114 165.238 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 618' ' ' ILE . . . . . 0.474 ' HB ' ' O ' ' A' ' 625' ' ' VAL . 11.6 mt -90.63 113.5 26.62 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.812 0 CA-C-N 113.503 -1.681 . . . . 0.0 109.674 174.302 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 619' ' ' MET . . . . . . . . . . . . . 7.7 mmt -77.2 133.48 38.9 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 -170.207 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 620' ' ' ALA . . . . . . . . . . . . . . . -130.31 170.92 13.5 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 115.113 -0.949 . . . . 0.0 108.802 170.097 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 621' ' ' THR . . . . . . . . . . . . . 5.0 t -81.32 -23.99 37.47 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.775 -0.37 . . . . 0.0 111.056 -178.53 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 622' ' ' ASN . . . . . 0.583 ' HB3' ' HA ' ' A' ' 534' ' ' GLU . 29.7 p-10 -117.11 22.64 12.4 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.844 0.354 . . . . 0.0 111.066 -176.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 623' ' ' GLY . . . . . 0.47 ' HA2' HD11 ' A' ' 577' ' ' ILE . . . 152.52 -147.11 16.38 Favored Glycine 0 N--CA 1.444 -0.796 0 C-N-CA 120.231 -0.985 . . . . 0.0 112.68 177.469 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 624' ' ' VAL . . . . . . . . . . . . . 9.5 p -144.46 158.51 14.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 -177.37 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 625' ' ' VAL . . . . . 0.474 ' O ' ' HB ' ' A' ' 618' ' ' ILE . 60.9 t -125.85 135.4 64.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 -179.828 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 626' ' ' HIS . . . . . . . . . . . . . 95.5 m-70 -119.33 116.15 25.61 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.23 -0.441 . . . . 0.0 109.946 175.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 627' ' ' VAL . . . . . 0.708 HG22 ' HZ ' ' A' ' 515' ' ' PHE . 48.3 t -70.24 125.67 28.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.281 179.75 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 628' ' ' ILE . . . . . 0.539 HG13 ' HA ' ' A' ' 542' ' ' PRO . 7.9 pt -121.28 145.88 27.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 121.32 0.581 . . . . 0.0 111.018 176.679 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 629' ' ' THR . . . . . 0.69 HG23 ' HB2' ' A' ' 614' ' ' ALA . 16.9 p -90.35 -3.33 57.81 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.493 -0.776 . . . . 0.0 112.197 -176.737 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 630' ' ' ASN . . . . . . . . . . . . . 64.1 t30 -141.91 175.05 10.03 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.503 -0.555 . . . . 0.0 109.503 -179.405 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 631' ' ' VAL . . . . . 0.693 HG23 ' HB1' ' A' ' 546' ' ' ALA . 51.2 t -106.21 123.79 61.13 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 N-CA-C 109.484 -0.562 . . . . 0.0 109.484 -178.729 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 632' ' ' LEU . . . . . 0.4 HD21 HG13 ' A' ' 608' ' ' VAL . 88.4 mt -68.24 126.08 28.44 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.042 0.449 . . . . 0.0 111.46 -173.069 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 633' ' ' GLN . . . . . . . . . . . . . 82.9 mm-40 -118.44 119.77 32.64 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.058 -178.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 634' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo . . . . . 0 C--O 1.251 1.139 0 C-N-CA 122.685 2.257 . . . . 0.0 112.171 177.59 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 500' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.058 0 CA-C-O 120.768 0.318 . . . . 0.0 110.875 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 501' ' ' GLY . . . . . . . . . . . . . . . 97.16 164.56 32.31 Favored Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 120.938 -0.649 . . . . 0.0 111.695 -177.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 502' ' ' MET . . . . . . . . . . . . . 4.7 mpp? -108.29 -65.65 1.11 Allowed 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.868 0.366 . . . . 0.0 110.112 178.456 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . -158.87 -128.59 1.0 Allowed Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.132 177.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 504' ' ' THR . . . . . 0.602 ' HA ' HG22 ' A' ' 621' ' ' THR . 33.7 p -78.85 172.35 13.88 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.539 0.209 . . . . 0.0 110.582 179.29 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 505' ' ' VAL . . . . . 0.713 ' O ' ' HG ' ' A' ' 509' ' ' LEU . 13.0 m -57.85 -34.96 49.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.696 -0.229 . . . . 0.0 110.929 176.125 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 506' ' ' MET . . . . . . . . . . . . . 95.0 mmm -61.5 -35.93 79.07 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-O 120.77 0.319 . . . . 0.0 110.928 178.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 507' ' ' ASP . . . . . 0.748 ' HA ' ' HE3' ' A' ' 510' ' ' LYS . 23.0 t70 -67.49 -35.85 79.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.279 -178.686 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 508' ' ' VAL . . . . . . . . . . . . . 45.8 t -71.92 -41.37 69.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 115.63 -0.713 . . . . 0.0 110.58 178.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 509' ' ' LEU . . . . . 0.713 ' HG ' ' O ' ' A' ' 505' ' ' VAL . 77.4 mt -62.73 -31.74 72.73 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.745 -176.672 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 510' ' ' LYS . . . . . 0.748 ' HE3' ' HA ' ' A' ' 507' ' ' ASP . 22.8 pttp -88.62 -13.71 39.25 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.061 0.458 . . . . 0.0 110.618 -177.741 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 511' ' ' GLY . . . . . . . . . . . . . . . -85.21 -11.57 75.48 Favored Glycine 0 N--CA 1.442 -0.947 0 C-N-CA 120.463 -0.875 . . . . 0.0 110.976 175.34 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 512' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -108.84 134.58 51.34 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.894 0.378 . . . . 0.0 110.194 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -72.88 -22.52 60.75 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.537 -176.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 514' ' ' ARG . . . . . 0.582 ' HG2' HD21 ' A' ' 544' ' ' ASN . 63.9 mtm180 -84.16 -33.85 24.14 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 120.987 0.422 . . . . 0.0 110.352 -176.799 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 515' ' ' PHE . . . . . 0.995 ' HZ ' HG22 ' A' ' 627' ' ' VAL . 11.5 m-30 -81.1 -7.73 59.62 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.408 -179.788 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 23.2 t -58.93 -43.32 91.14 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.872 -174.186 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 517' ' ' MET . . . . . . . . . . . . . 4.3 mpp? -67.18 -30.35 70.28 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-O 120.879 0.371 . . . . 0.0 110.504 179.346 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 518' ' ' LEU . . . . . 0.484 HD22 ' HA ' ' A' ' 541' ' ' ALA . 61.8 tp -68.68 -41.28 79.44 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.66 -0.416 . . . . 0.0 109.903 177.1 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 519' ' ' VAL . . . . . 0.426 ' O ' ' HG3' ' A' ' 523' ' ' GLN . 61.3 t -56.94 -36.42 50.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.086 0.47 . . . . 0.0 109.955 175.067 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 520' ' ' ALA . . . . . . . . . . . . . . . -69.67 -39.46 77.01 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.436 -179.451 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 521' ' ' ALA . . . . . . . . . . . . . . . -67.26 -46.65 73.07 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.299 176.091 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 522' ' ' ILE . . . . . 0.416 HG13 ' O ' ' A' ' 518' ' ' LEU . 71.5 mt -55.07 -45.46 76.98 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.072 177.248 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 523' ' ' GLN . . . . . 0.426 ' HG3' ' O ' ' A' ' 519' ' ' VAL . 26.3 mt-30 -65.46 -44.73 86.28 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.314 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 24.2 t -69.71 -32.46 71.04 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.567 -176.648 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 525' ' ' ALA . . . . . 0.521 ' HB1' ' HB2' ' A' ' 566' ' ' ALA . . . -86.32 -25.48 25.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.725 0.298 . . . . 0.0 111.265 -179.37 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 526' ' ' GLY . . . . . . . . . . . . . . . 90.76 31.71 9.87 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 121.009 -0.615 . . . . 0.0 112.564 177.424 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 527' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -92.16 -4.7 53.86 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.549 0.214 . . . . 0.0 111.303 -179.114 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 528' ' ' THR . . . . . . . . . . . . . 8.1 m -54.24 -37.85 65.12 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.824 -176.428 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 529' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -62.84 -19.51 64.18 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 112.219 0.452 . . . . 0.0 112.219 -176.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 530' ' ' THR . . . . . . . . . . . . . 84.8 m -75.06 -54.7 6.71 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.94 0.4 . . . . 0.0 110.18 177.266 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 531' ' ' LEU . . . . . 0.666 ' H ' HD22 ' A' ' 531' ' ' LEU . 1.4 mm? -75.53 -5.33 44.69 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.26 179.457 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 532' ' ' ASN . . . . . . . . . . . . . 61.3 t30 -81.44 -5.8 58.28 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.196 178.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 533' ' ' ARG . . . . . . . . . . . . . 29.6 mmm180 -110.12 146.9 34.67 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.283 178.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 534' ' ' GLU . . . . . 0.673 ' HA ' ' CB ' ' A' ' 622' ' ' ASN . 35.7 mt-10 -90.74 155.25 18.94 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.893 0.378 . . . . 0.0 110.253 177.572 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 535' ' ' GLY . . . . . . . . . . . . . . . 151.83 -132.74 3.9 Favored Glycine 0 N--CA 1.447 -0.62 0 N-CA-C 110.834 -0.907 . . . . 0.0 110.834 -174.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 536' ' ' VAL . . . . . 0.442 ' HA ' HD11 ' A' ' 577' ' ' ILE . 33.8 m -123.17 128.41 74.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 120.965 0.412 . . . . 0.0 110.851 177.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 537' ' ' TYR . . . . . . . . . . . . . 82.2 m-85 -155.16 152.94 30.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.057 179.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 538' ' ' THR . . . . . 0.663 ' OG1' ' HA ' ' A' ' 577' ' ' ILE . 94.6 m -130.42 102.8 6.33 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.213 -0.449 . . . . 0.0 109.994 174.825 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 539' ' ' VAL . . . . . . . . . . . . . 26.6 t -100.89 125.75 54.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 120.937 0.399 . . . . 0.0 111.411 -172.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 540' ' ' PHE . . . . . 0.608 ' HB3' HD13 ' A' ' 628' ' ' ILE . 97.3 m-85 -98.47 111.57 23.88 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 173.362 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 541' ' ' ALA . . . . . 0.484 ' HA ' HD22 ' A' ' 518' ' ' LEU . . . -102.08 115.41 64.69 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 116.651 -0.25 . . . . 0.0 111.263 -176.799 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 542' ' ' PRO . . . . . 0.47 ' HA ' HG13 ' A' ' 628' ' ' ILE . 13.4 Cg_exo -71.02 141.02 39.17 Favored 'Trans proline' 0 N--CA 1.463 -0.279 0 C-N-CA 123.146 2.564 . . . . 0.0 112.195 177.376 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 41.7 p -85.85 -177.03 6.25 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.058 178.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 544' ' ' ASN . . . . . 0.582 HD21 ' HG2' ' A' ' 514' ' ' ARG . 0.5 OUTLIER -59.72 -40.36 87.71 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 121.387 0.613 . . . . 0.0 109.958 -179.057 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 545' ' ' GLU . . . . . 0.511 ' H ' ' CD ' ' A' ' 545' ' ' GLU . 3.3 mp0 -58.15 -39.11 77.97 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 114.736 -1.12 . . . . 0.0 110.812 -178.148 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 546' ' ' ALA . . . . . 0.621 ' HB1' HG13 ' A' ' 631' ' ' VAL . . . -63.96 -43.51 95.59 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.027 0.441 . . . . 0.0 111.232 -178.4 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 547' ' ' PHE . . . . . . . . . . . . . 75.1 m-85 -72.87 -27.75 62.1 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.151 -179.007 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 548' ' ' ARG . . . . . 0.443 ' O ' ' HD2' ' A' ' 548' ' ' ARG . 5.5 tmm_? -80.33 -29.07 38.04 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.219 0.533 . . . . 0.0 109.912 179.161 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 549' ' ' ALA . . . . . . . . . . . . . . . -76.09 -17.68 59.51 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.232 179.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 550' ' ' LEU . . . . . 0.715 ' HB3' ' HB3' ' A' ' 555' ' ' ARG . 20.0 mt -58.31 134.3 84.94 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.089 178.116 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 551' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 550' ' ' LEU . 28.0 Cg_exo -62.84 143.9 92.55 Favored 'Trans proline' 0 C--O 1.234 0.308 0 C-N-CA 122.909 2.406 . . . . 0.0 111.766 -179.582 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 552' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -53.67 -38.0 84.16 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 123.261 2.64 . . . . 0.0 112.249 -177.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 553' ' ' ARG . . . . . . . . . . . . . 22.4 mmm180 -69.05 -52.92 23.56 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.851 -178.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 18.2 mt-10 -66.69 -51.22 58.53 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.712 -0.676 . . . . 0.0 112.42 -175.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 555' ' ' ARG . . . . . 0.715 ' HB3' ' HB3' ' A' ' 550' ' ' LEU . 18.6 ptt180 -67.4 -27.64 67.26 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 120.445 -0.502 . . . . 0.0 111.396 -175.063 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 47.1 t -71.21 -31.55 67.75 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.733 0.301 . . . . 0.0 110.701 177.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 557' ' ' ARG . . . . . 0.427 HH11 ' HD3' ' A' ' 557' ' ' ARG . 8.7 tpt180 -83.28 -53.03 6.06 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.487 -179.411 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 558' ' ' LEU . . . . . 0.55 HD22 ' HB3' ' A' ' 564' ' ' GLU . 0.3 OUTLIER -57.48 -47.36 82.11 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.23 -0.896 . . . . 0.0 111.429 -174.602 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 559' ' ' LEU . . . . . 0.676 HD23 HD21 ' A' ' 565' ' ' LEU . 93.5 mt -77.81 0.7 22.78 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.563 -175.161 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 560' ' ' GLY . . . . . . . . . . . . . . . -97.2 -11.51 52.05 Favored Glycine 0 N--CA 1.445 -0.746 0 C-N-CA 120.444 -0.884 . . . . 0.0 112.585 -178.287 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 561' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -132.23 127.91 36.78 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.923 0.392 . . . . 0.0 111.205 -177.282 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 562' ' ' ALA . . . . . . . . . . . . . . . -64.31 -29.24 70.33 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.909 -0.587 . . . . 0.0 112.227 -176.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 563' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -78.71 -39.85 35.34 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 -177.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 564' ' ' GLU . . . . . 0.55 ' HB3' HD22 ' A' ' 558' ' ' LEU . 44.5 mt-10 -64.25 -34.52 78.3 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.164 -0.471 . . . . 0.0 109.937 175.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 565' ' ' LEU . . . . . 0.676 HD21 HD23 ' A' ' 559' ' ' LEU . 58.1 mt -64.34 -52.42 58.49 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.986 175.031 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 566' ' ' ALA . . . . . 0.521 ' HB2' ' HB1' ' A' ' 525' ' ' ALA . . . -56.4 -40.71 75.09 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.821 -176.548 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 567' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -60.97 -47.91 84.27 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.757 -177.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 568' ' ' ILE . . . . . . . . . . . . . 50.6 mm -69.87 -33.42 55.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.389 -177.583 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 569' ' ' LEU . . . . . 0.436 ' HG ' ' O ' ' A' ' 565' ' ' LEU . 78.7 mt -65.98 -33.47 75.89 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.541 -0.3 . . . . 0.0 111.517 -179.15 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 570' ' ' LYS . . . . . 0.53 ' HE3' ' HA ' ' A' ' 593' ' ' GLN . 28.0 mtpp -66.94 -18.7 65.5 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.135 179.807 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 571' ' ' TYR . . . . . . . . . . . . . 20.5 t80 -87.12 -18.26 30.88 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.223 178.366 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 572' ' ' HIS . . . . . . . . . . . . . 62.5 m80 -89.09 -12.14 42.02 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.883 0.373 . . . . 0.0 111.403 -178.487 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 573' ' ' ILE . . . . . 0.406 ' O ' HD23 ' A' ' 592' ' ' LEU . 38.5 mt -108.64 119.69 58.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.359 179.105 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 574' ' ' GLY . . . . . 0.572 ' HA2' ' HA ' ' A' ' 591' ' ' SER . . . -91.97 151.24 20.68 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.99 -0.624 . . . . 0.0 111.941 177.179 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 575' ' ' ASP . . . . . 0.414 ' HB3' ' HG3' ' A' ' 590' ' ' LYS . 6.4 t70 -93.99 9.3 38.11 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.087 0.47 . . . . 0.0 110.703 -173.782 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 576' ' ' GLU . . . . . 0.572 ' OE1' ' HG2' ' A' ' 590' ' ' LYS . 42.8 mt-10 -142.08 126.12 17.3 Favored 'General case' 0 CA--C 1.511 -0.521 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.951 -176.063 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 577' ' ' ILE . . . . . 0.663 ' HA ' ' OG1' ' A' ' 538' ' ' THR . 58.5 mt -76.06 105.11 4.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 121.218 0.532 . . . . 0.0 111.235 -177.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 578' ' ' LEU . . . . . 0.438 ' HG ' HG11 ' A' ' 587' ' ' VAL . 3.9 mm? -119.7 100.79 7.47 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.153 176.644 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 579' ' ' VAL . . . . . 0.544 ' O ' HG13 ' A' ' 583' ' ' ILE . 34.0 m -86.82 166.89 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 109.614 -0.514 . . . . 0.0 109.614 175.079 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 580' ' ' SER . . . . . . . . . . . . . 20.8 m -57.12 -40.13 76.5 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.893 0.377 . . . . 0.0 111.226 -176.084 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 581' ' ' GLY . . . . . . . . . . . . . . . -76.26 -8.7 85.61 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.783 -179.412 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . -103.24 -27.12 6.65 Favored Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.918 -177.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 583' ' ' ILE . . . . . 0.544 HG13 ' O ' ' A' ' 579' ' ' VAL . 77.1 mt -60.27 -59.02 4.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 120.893 0.377 . . . . 0.0 111.548 -178.158 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 584' ' ' GLY . . . . . . . . . . . . . . . 94.23 -81.29 0.96 Allowed Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.236 -178.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 585' ' ' ALA . . . . . . . . . . . . . . . -128.07 -62.26 1.06 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.753 0.311 . . . . 0.0 110.929 179.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 586' ' ' LEU . . . . . 0.958 ' HG ' ' HB3' ' A' ' 600' ' ' SER . 3.9 tt -155.3 140.2 17.25 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 178.344 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 587' ' ' VAL . . . . . 0.521 ' N ' HD23 ' A' ' 586' ' ' LEU . 9.3 p -142.18 136.92 29.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-O 121.102 0.477 . . . . 0.0 111.086 -178.515 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 588' ' ' ARG . . . . . . . . . . . . . 8.2 ttt180 -85.03 101.49 12.44 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.625 174.182 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 589' ' ' LEU . . . . . . . . . . . . . 2.7 tt -97.53 128.77 44.54 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.45 -0.796 . . . . 0.0 109.456 -175.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 590' ' ' LYS . . . . . 0.572 ' HG2' ' OE1' ' A' ' 576' ' ' GLU . 27.8 pttt -82.03 143.65 31.41 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 120.691 -0.404 . . . . 0.0 110.795 178.706 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 591' ' ' SER . . . . . 0.572 ' HA ' ' HA2' ' A' ' 574' ' ' GLY . 80.3 p -105.1 165.15 11.29 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.597 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 592' ' ' LEU . . . . . 0.406 HD23 ' O ' ' A' ' 573' ' ' ILE . 3.5 mm? -66.88 -9.17 35.08 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 178.572 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 593' ' ' GLN . . . . . 0.53 ' HA ' ' HE3' ' A' ' 570' ' ' LYS . 7.9 tt0 -86.01 -29.46 23.46 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.103 0.477 . . . . 0.0 110.359 176.283 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 594' ' ' GLY . . . . . . . . . . . . . . . 117.94 -21.21 10.42 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.559 -0.829 . . . . 0.0 111.784 -176.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 595' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -78.37 179.28 7.08 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 109.271 -0.641 . . . . 0.0 109.271 177.271 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 596' ' ' LYS . . . . . 0.803 ' HD3' ' H ' ' A' ' 596' ' ' LYS . 0.0 OUTLIER -115.8 140.29 49.36 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-O 121.027 0.442 . . . . 0.0 110.316 -175.741 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 597' ' ' LEU . . . . . . . . . . . . . 71.0 mt -101.39 117.17 34.41 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.934 -0.575 . . . . 0.0 109.601 173.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 598' ' ' GLU . . . . . 0.498 ' OE1' ' HG2' ' A' ' 596' ' ' LYS . 1.6 mp0 -80.89 84.86 6.3 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.204 0.525 . . . . 0.0 110.006 178.225 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 599' ' ' VAL . . . . . . . . . . . . . 26.1 t -93.29 126.53 45.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.586 -0.733 . . . . 0.0 109.738 -179.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 600' ' ' SER . . . . . 0.958 ' HB3' ' HG ' ' A' ' 586' ' ' LEU . 23.9 p -135.01 159.33 41.84 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.251 0.548 . . . . 0.0 111.692 -178.32 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 601' ' ' LEU . . . . . . . . . . . . . 27.5 tp -130.45 108.77 10.21 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.014 -0.994 . . . . 0.0 109.0 179.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 602' ' ' LYS . . . . . . . . . . . . . 8.6 ptpp? -137.07 131.68 33.09 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 110.113 -0.329 . . . . 0.0 110.113 -179.037 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 603' ' ' ASN . . . . . . . . . . . . . 14.1 m120 65.06 25.54 12.58 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.743 -176.466 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 604' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 71.59 10.3 6.43 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 114.952 -1.022 . . . . 0.0 110.164 -177.286 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 605' ' ' VAL . . . . . . . . . . . . . 62.1 t -101.11 119.23 48.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.936 177.004 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 606' ' ' VAL . . . . . 0.686 HG13 ' HB ' ' A' ' 613' ' ' VAL . 5.6 p -91.11 137.31 22.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 121.104 0.478 . . . . 0.0 110.635 178.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 607' ' ' SER . . . . . . . . . . . . . 18.5 m -143.34 140.02 30.35 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.862 -179.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 608' ' ' VAL . . . . . . . . . . . . . 3.8 p -113.63 114.3 46.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.637 176.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 609' ' ' ASN . . . . . . . . . . . . . 84.4 m-20 57.04 44.55 22.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.244 -175.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 610' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 76.9 -19.67 0.41 Allowed 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.141 0.977 . . . . 0.0 112.443 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 611' ' ' GLU . . . . . 0.477 ' HA ' ' HD3' ' A' ' 612' ' ' PRO . 46.7 mm-40 -79.28 121.27 82.79 Favored Pre-proline 0 C--N 1.332 -0.172 0 CA-C-O 120.831 0.348 . . . . 0.0 110.386 179.085 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 612' ' ' PRO . . . . . 0.477 ' HD3' ' HA ' ' A' ' 611' ' ' GLU . 11.7 Cg_exo -70.39 146.56 56.67 Favored 'Trans proline' 0 CA--C 1.529 0.255 0 C-N-CA 123.038 2.492 . . . . 0.0 112.935 -178.422 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 613' ' ' VAL . . . . . 0.686 ' HB ' HG13 ' A' ' 606' ' ' VAL . 85.4 t -87.85 135.63 25.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.979 177.604 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 614' ' ' ALA . . . . . . . . . . . . . . . -84.5 -31.91 24.22 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.553 -175.349 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 615' ' ' GLU . . . . . 0.499 ' HB3' ' CG2' ' A' ' 627' ' ' VAL . 8.7 tp10 -161.92 92.32 1.37 Allowed Pre-proline 0 C--N 1.327 -0.407 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 -177.597 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 616' ' ' PRO . . . . . 0.408 ' HB3' HG11 ' A' ' 613' ' ' VAL . 60.8 Cg_endo -89.77 165.67 5.02 Favored 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 123.078 2.519 . . . . 0.0 114.035 -176.315 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 617' ' ' ASP . . . . . 0.447 ' OD2' ' HB ' ' A' ' 579' ' ' VAL . 0.9 OUTLIER 76.81 34.54 0.43 Allowed 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 122.33 1.062 . . . . 0.0 110.514 165.78 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 618' ' ' ILE . . . . . 0.513 ' HB ' ' O ' ' A' ' 625' ' ' VAL . 13.6 mt -78.02 109.59 12.8 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.969 0 CA-C-N 113.92 -1.491 . . . . 0.0 109.327 172.254 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 619' ' ' MET . . . . . . . . . . . . . 8.0 mmt -80.08 131.34 35.74 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.87 -0.604 . . . . 0.0 112.034 -174.13 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 620' ' ' ALA . . . . . . . . . . . . . . . -130.6 173.07 11.24 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.262 173.358 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 621' ' ' THR . . . . . 0.602 HG22 ' HA ' ' A' ' 504' ' ' THR . 6.3 t -72.14 -29.4 64.01 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.887 0.375 . . . . 0.0 111.239 -176.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 622' ' ' ASN . . . . . 0.673 ' CB ' ' HA ' ' A' ' 534' ' ' GLU . 28.7 p-10 -117.34 22.7 12.29 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 112.168 0.433 . . . . 0.0 112.168 -173.745 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 623' ' ' GLY . . . . . . . . . . . . . . . 151.05 -154.85 25.82 Favored Glycine 0 N--CA 1.442 -0.919 0 C-N-CA 119.631 -1.271 . . . . 0.0 113.056 176.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 624' ' ' VAL . . . . . 0.503 HG21 HG12 ' A' ' 579' ' ' VAL . 9.7 p -129.65 159.0 42.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 N-CA-C 109.932 -0.395 . . . . 0.0 109.932 -179.707 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 625' ' ' VAL . . . . . 0.513 ' O ' ' HB ' ' A' ' 618' ' ' ILE . 67.9 t -128.04 132.3 68.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.819 178.606 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 626' ' ' HIS . . . . . . . . . . . . . 69.6 m-70 -118.46 112.3 19.77 Favored 'General case' 0 N--CA 1.445 -0.68 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 177.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 627' ' ' VAL . . . . . 0.995 HG22 ' HZ ' ' A' ' 515' ' ' PHE . 38.5 t -64.38 126.11 22.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.146 178.757 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 628' ' ' ILE . . . . . 0.608 HD13 ' HB3' ' A' ' 540' ' ' PHE . 5.4 pt -121.06 142.52 36.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.064 0.459 . . . . 0.0 110.701 176.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 629' ' ' THR . . . . . . . . . . . . . 9.5 t -97.31 2.87 51.2 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.778 0.799 . . . . 0.0 109.851 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 630' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -132.77 157.56 44.64 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.086 -0.961 . . . . 0.0 108.833 178.1 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 631' ' ' VAL . . . . . 0.621 HG13 ' HB1' ' A' ' 546' ' ' ALA . 23.8 m -92.79 156.28 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.015 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 176.363 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 632' ' ' LEU . . . . . . . . . . . . . 92.2 mt -106.1 110.89 23.3 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-O 121.281 0.562 . . . . 0.0 110.521 -178.446 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 633' ' ' GLN . . . . . 0.481 ' HA ' ' HD3' ' A' ' 634' ' ' PRO . 53.8 mt-30 -117.44 130.76 24.44 Favored Pre-proline 0 C--N 1.319 -0.735 0 CA-C-N 115.122 -0.944 . . . . 0.0 109.936 -177.675 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 634' ' ' PRO . . . . . 0.481 ' HD3' ' HA ' ' A' ' 633' ' ' GLN . 14.2 Cg_exo . . . . . 0 C--O 1.25 1.113 0 C-N-CA 122.814 2.343 . . . . 0.0 111.722 177.528 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 500' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 0.995 0 CA-C-O 120.755 0.312 . . . . 0.0 110.506 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 501' ' ' GLY . . . . . . . . . . . . . . . 103.03 -132.71 11.12 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.786 -0.721 . . . . 0.0 111.89 178.558 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 502' ' ' MET . . . . . . . . . . . . . 48.7 ttm -75.79 94.92 3.37 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.959 0.409 . . . . 0.0 110.19 179.053 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . -153.41 -175.77 25.14 Favored Glycine 0 N--CA 1.448 -0.545 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.77 179.668 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 31.5 p -90.01 -179.28 5.66 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.366 0.127 . . . . 0.0 110.875 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 505' ' ' VAL . . . . . 0.672 ' O ' ' HG ' ' A' ' 509' ' ' LEU . 22.2 t -50.43 -47.61 26.49 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.275 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.223 179.826 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 506' ' ' MET . . . . . 0.473 ' HG2' ' HB2' ' A' ' 531' ' ' LEU . 90.8 mmm -57.37 -34.81 69.22 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.993 -176.135 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 507' ' ' ASP . . . . . 0.468 ' HA ' ' NZ ' ' A' ' 510' ' ' LYS . 12.1 t70 -76.13 -35.64 59.16 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.799 0.333 . . . . 0.0 110.133 -178.675 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 508' ' ' VAL . . . . . . . . . . . . . 64.3 t -66.0 -39.61 85.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.473 178.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 509' ' ' LEU . . . . . 0.672 ' HG ' ' O ' ' A' ' 505' ' ' VAL . 22.8 mt -65.61 -19.92 66.11 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.048 -178.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 510' ' ' LYS . . . . . 0.468 ' NZ ' ' HA ' ' A' ' 507' ' ' ASP . 30.2 mtmm -81.62 -24.96 36.08 Favored 'General case' 0 CA--C 1.514 -0.432 0 CA-C-O 121.223 0.535 . . . . 0.0 110.024 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 511' ' ' GLY . . . . . . . . . . . . . . . -80.38 -8.17 87.83 Favored Glycine 0 N--CA 1.443 -0.872 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.806 179.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 512' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -118.9 152.99 35.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.341 0.591 . . . . 0.0 111.769 -178.423 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 43.2 t-20 -76.82 -39.41 51.41 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.408 -0.815 . . . . 0.0 111.095 -178.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 514' ' ' ARG . . . . . . . . . . . . . 3.0 mpp_? -80.58 -34.31 35.39 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.105 0.479 . . . . 0.0 110.808 -171.565 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 515' ' ' PHE . . . . . 0.544 ' CZ ' HG22 ' A' ' 627' ' ' VAL . 14.5 m-30 -75.99 -8.25 56.51 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.827 178.798 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 16.8 t -59.05 -38.55 79.62 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.673 -176.071 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 517' ' ' MET . . . . . 0.546 ' HE3' ' HA ' ' A' ' 544' ' ' ASN . 3.4 mpp? -68.61 -26.56 65.42 Favored 'General case' 0 CA--C 1.519 -0.219 0 C-N-CA 120.787 -0.365 . . . . 0.0 111.025 -179.821 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 518' ' ' LEU . . . . . 0.557 HD13 HD11 ' A' ' 522' ' ' ILE . 3.3 mt -65.49 -43.29 90.64 Favored 'General case' 0 CA--C 1.517 -0.312 0 C-N-CA 120.261 -0.575 . . . . 0.0 109.554 174.201 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 519' ' ' VAL . . . . . 0.692 ' O ' ' HB2' ' A' ' 523' ' ' GLN . 30.1 t -55.09 -31.68 26.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.129 0.49 . . . . 0.0 110.41 178.455 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 520' ' ' ALA . . . . . . . . . . . . . . . -84.29 -46.71 11.51 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.46 178.497 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 521' ' ' ALA . . . . . . . . . . . . . . . -64.73 -52.52 56.64 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.872 0.368 . . . . 0.0 110.934 -178.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 522' ' ' ILE . . . . . 0.557 HD11 HD13 ' A' ' 518' ' ' LEU . 41.2 mt -59.67 -26.93 36.45 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.306 177.75 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 523' ' ' GLN . . . . . 0.692 ' HB2' ' O ' ' A' ' 519' ' ' VAL . 7.5 tp-100 -69.49 -51.98 30.8 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.398 179.297 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 38.7 t -71.53 -23.37 61.76 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.587 -176.03 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 525' ' ' ALA . . . . . . . . . . . . . . . -81.87 -17.81 46.03 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 120.972 -0.291 . . . . 0.0 111.266 178.49 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 526' ' ' GLY . . . . . . . . . . . . . . . 82.86 22.68 57.42 Favored Glycine 0 N--CA 1.453 -0.193 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.852 179.276 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 527' ' ' LEU . . . . . 0.409 HD13 ' HA ' ' A' ' 527' ' ' LEU . 4.2 mm? -98.01 4.74 49.3 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.873 0.368 . . . . 0.0 110.776 -179.709 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 528' ' ' THR . . . . . 0.419 ' OG1' ' HA ' ' A' ' 523' ' ' GLN . 15.5 m -59.99 -37.0 78.38 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.422 -177.109 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 529' ' ' GLU . . . . . 0.436 ' H ' ' HG2' ' A' ' 529' ' ' GLU . 7.1 pt-20 -64.79 -28.73 69.77 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.732 -178.068 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 530' ' ' THR . . . . . 0.535 ' HB ' HD22 ' A' ' 531' ' ' LEU . 26.4 m -64.29 -59.27 4.59 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.98 -179.415 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 531' ' ' LEU . . . . . 0.577 ' H ' HD22 ' A' ' 531' ' ' LEU . 1.7 mm? -76.57 5.83 6.8 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-O 120.869 0.366 . . . . 0.0 111.524 -179.189 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 532' ' ' ASN . . . . . . . . . . . . . 64.7 t30 -86.26 -27.14 24.61 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.37 0.605 . . . . 0.0 109.716 177.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 533' ' ' ARG . . . . . . . . . . . . . 12.7 mmm180 -92.13 160.34 15.24 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.672 178.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 534' ' ' GLU . . . . . 0.798 ' HA ' ' HB3' ' A' ' 622' ' ' ASN . 40.9 mt-10 -87.71 179.35 6.52 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 120.76 -0.376 . . . . 0.0 110.25 177.232 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 535' ' ' GLY . . . . . . . . . . . . . . . 134.86 -145.3 17.41 Favored Glycine 0 N--CA 1.445 -0.764 0 N-CA-C 110.675 -0.97 . . . . 0.0 110.675 -175.108 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 536' ' ' VAL . . . . . 0.407 ' HB ' HG13 ' A' ' 577' ' ' ILE . 34.5 m -123.07 130.37 74.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-O 121.07 0.462 . . . . 0.0 110.057 176.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 537' ' ' TYR . . . . . . . . . . . . . 71.2 m-85 -152.46 153.73 34.11 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.057 -178.611 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 538' ' ' THR . . . . . 0.764 ' OG1' ' HA ' ' A' ' 577' ' ' ILE . 50.4 m -132.1 103.71 6.41 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 174.673 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 539' ' ' VAL . . . . . . . . . . . . . 47.9 t -105.71 124.65 60.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.926 -173.228 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 540' ' ' PHE . . . . . 0.567 ' HB3' HD13 ' A' ' 628' ' ' ILE . 99.0 m-85 -95.85 111.08 23.15 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 173.328 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -97.82 112.97 62.98 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.712 -176.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 542' ' ' PRO . . . . . 0.471 ' HA ' HG13 ' A' ' 628' ' ' ILE . 7.9 Cg_exo -73.12 135.75 23.46 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 122.702 2.268 . . . . 0.0 110.708 174.302 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 40.4 p -76.96 179.31 6.28 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.529 -177.216 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 544' ' ' ASN . . . . . 0.546 ' HA ' ' HE3' ' A' ' 517' ' ' MET . 25.0 t-20 -62.41 -33.73 75.37 Favored 'General case' 0 CA--C 1.52 -0.185 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 178.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 545' ' ' GLU . . . . . 0.428 ' H ' ' CD ' ' A' ' 545' ' ' GLU . 1.6 mp0 -54.28 -45.09 72.41 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.19 -0.913 . . . . 0.0 110.759 178.152 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 546' ' ' ALA . . . . . 0.455 ' O ' HD23 ' A' ' 550' ' ' LEU . . . -67.06 -49.12 66.17 Favored 'General case' 0 CA--C 1.514 -0.431 0 CA-C-O 121.018 0.437 . . . . 0.0 111.283 -179.18 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 547' ' ' PHE . . . . . . . . . . . . . 29.9 m-85 -64.24 -25.61 68.14 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.705 -0.68 . . . . 0.0 111.315 -177.32 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 548' ' ' ARG . . . . . . . . . . . . . 23.8 ttm180 -86.7 -28.02 23.36 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.273 0.559 . . . . 0.0 110.179 178.526 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 549' ' ' ALA . . . . . . . . . . . . . . . -79.63 -10.51 59.8 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.242 -0.89 . . . . 0.0 112.103 -176.235 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 550' ' ' LEU . . . . . 0.511 ' HB2' ' HG3' ' A' ' 555' ' ' ARG . 0.1 OUTLIER -54.23 143.47 44.55 Favored Pre-proline 0 N--CA 1.454 -0.23 0 CA-C-O 120.759 0.314 . . . . 0.0 110.671 174.503 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 551' ' ' PRO . . . . . 0.637 ' HD2' ' HB2' ' A' ' 554' ' ' GLU . 2.6 Cg_endo -80.02 142.04 15.24 Favored 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 123.125 2.55 . . . . 0.0 110.547 -172.567 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 552' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_exo -43.47 -39.87 9.73 Favored 'Trans proline' 0 CA--C 1.533 0.458 0 C-N-CA 123.139 2.56 . . . . 0.0 113.348 -176.637 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 553' ' ' ARG . . . . . . . . . . . . . 44.7 mtp180 -68.3 -52.14 37.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.862 0.363 . . . . 0.0 111.721 177.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 554' ' ' GLU . . . . . 0.637 ' HB2' ' HD2' ' A' ' 551' ' ' PRO . 5.1 mm-40 -83.15 -42.72 17.0 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.911 -171.843 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 555' ' ' ARG . . . . . 0.511 ' HG3' ' HB2' ' A' ' 550' ' ' LEU . 26.1 ttt180 -46.87 -55.76 7.45 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 122.697 0.399 . . . . 0.0 111.429 173.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 14.8 m -62.45 -31.98 72.78 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.123 -178.159 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 557' ' ' ARG . . . . . . . . . . . . . 24.4 ttt180 -69.42 -59.24 3.12 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.587 176.703 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 558' ' ' LEU . . . . . 0.859 HD22 ' HB3' ' A' ' 564' ' ' GLU . 0.7 OUTLIER -60.2 -50.47 73.54 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.507 -175.406 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 559' ' ' LEU . . . . . . . . . . . . . 74.6 mt -87.95 19.53 3.53 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.632 -177.368 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 560' ' ' GLY . . . . . . . . . . . . . . . -125.4 4.11 8.21 Favored Glycine 0 N--CA 1.445 -0.706 0 CA-C-N 115.949 -0.568 . . . . 0.0 111.928 179.459 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 561' ' ' ASP . . . . . 0.495 ' OD2' ' HB3' ' A' ' 563' ' ' LYS . 18.0 t70 -142.59 142.24 32.11 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.653 0.264 . . . . 0.0 110.666 179.443 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 562' ' ' ALA . . . . . . . . . . . . . . . -76.51 -32.26 58.19 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.856 -177.657 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 563' ' ' LYS . . . . . 0.495 ' HB3' ' OD2' ' A' ' 561' ' ' ASP . 13.1 ttpt -69.0 -49.51 57.16 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.136 179.772 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 564' ' ' GLU . . . . . 0.859 ' HB3' HD22 ' A' ' 558' ' ' LEU . 59.7 mm-40 -52.07 -48.83 64.47 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.729 176.387 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 565' ' ' LEU . . . . . . . . . . . . . 39.5 mt -56.02 -55.2 35.71 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.416 177.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 566' ' ' ALA . . . . . . . . . . . . . . . -57.13 -48.06 79.6 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.55 -175.38 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 567' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -61.25 -45.62 93.78 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.637 -176.205 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 568' ' ' ILE . . . . . 0.714 HG13 HD21 ' A' ' 558' ' ' LEU . 47.7 mm -74.17 -34.9 39.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.828 -176.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 569' ' ' LEU . . . . . . . . . . . . . 66.4 mt -68.04 -33.31 74.33 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.962 -0.295 . . . . 0.0 111.01 179.632 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 570' ' ' LYS . . . . . 0.766 ' HE3' ' HA ' ' A' ' 593' ' ' GLN . 26.9 mtpp -62.97 -18.5 63.29 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.939 0.4 . . . . 0.0 111.012 175.61 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 571' ' ' TYR . . . . . 0.506 ' O ' HD21 ' A' ' 597' ' ' LEU . 25.9 t80 -91.75 -17.85 24.78 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.895 -177.136 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 572' ' ' HIS . . . . . . . . . . . . . 61.5 m80 -90.72 -14.72 31.59 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.866 0.365 . . . . 0.0 111.053 -179.287 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 573' ' ' ILE . . . . . . . . . . . . . 42.9 mt -103.83 116.4 47.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.318 178.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 574' ' ' GLY . . . . . 0.545 ' HA2' ' HA ' ' A' ' 591' ' ' SER . . . -97.95 153.86 20.14 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 121.013 -0.613 . . . . 0.0 111.723 176.043 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 575' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -90.96 -6.46 54.03 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.252 0.549 . . . . 0.0 111.062 -176.196 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 576' ' ' GLU . . . . . 0.449 ' HB2' HD21 ' A' ' 589' ' ' LEU . 24.9 mt-10 -129.11 122.75 30.54 Favored 'General case' 0 CA--C 1.508 -0.663 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 -170.245 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 577' ' ' ILE . . . . . 0.764 ' HA ' ' OG1' ' A' ' 538' ' ' THR . 61.5 mt -73.05 116.55 15.42 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.943 -175.233 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 578' ' ' LEU . . . . . 0.574 HD11 ' HA ' ' A' ' 583' ' ' ILE . 23.5 tp -127.03 113.41 16.43 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.442 179.057 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 579' ' ' VAL . . . . . 0.488 ' O ' HG13 ' A' ' 583' ' ' ILE . 35.8 m -104.96 163.1 4.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.177 178.086 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 580' ' ' SER . . . . . . . . . . . . . 32.8 t -56.48 -47.74 78.6 Favored 'General case' 0 C--N 1.331 -0.228 0 O-C-N 123.32 0.388 . . . . 0.0 110.887 -176.282 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 581' ' ' GLY . . . . . . . . . . . . . . . -74.73 8.27 15.76 Favored Glycine 0 CA--C 1.521 0.411 0 C-N-CA 120.941 -0.647 . . . . 0.0 113.327 -178.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . -131.77 9.87 5.48 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.511 -0.852 . . . . 0.0 113.109 179.245 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 583' ' ' ILE . . . . . 0.574 ' HA ' HD11 ' A' ' 578' ' ' LEU . 47.0 mt -78.02 -77.54 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.956 0.378 . . . . 0.0 110.877 178.779 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 584' ' ' GLY . . . . . . . . . . . . . . . 84.72 81.69 1.05 Allowed Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.495 -0.859 . . . . 0.0 112.069 -175.314 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 585' ' ' ALA . . . . . . . . . . . . . . . 71.73 -74.69 0.08 Allowed 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 123.578 0.751 . . . . 0.0 112.084 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 586' ' ' LEU . . . . . 0.61 ' HG ' ' HB2' ' A' ' 600' ' ' SER . 2.3 tt -164.71 142.2 6.37 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.571 0.225 . . . . 0.0 110.422 -176.755 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 587' ' ' VAL . . . . . 0.522 ' N ' HD23 ' A' ' 586' ' ' LEU . 91.2 t -140.14 139.75 36.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.23 -178.697 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 588' ' ' ARG . . . . . 0.406 ' HD3' ' HA ' ' A' ' 588' ' ' ARG . 34.0 mmt180 -85.57 105.51 16.21 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.927 0.394 . . . . 0.0 110.138 177.122 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 589' ' ' LEU . . . . . 0.449 HD21 ' HB2' ' A' ' 576' ' ' GLU . 0.3 OUTLIER -99.86 124.62 45.36 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.374 -177.189 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 590' ' ' LYS . . . . . . . . . . . . . 47.4 mtpt -90.48 140.1 30.06 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.466 0.65 . . . . 0.0 111.563 -177.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 591' ' ' SER . . . . . 0.545 ' HA ' ' HA2' ' A' ' 574' ' ' GLY . 78.0 p -102.15 166.47 10.58 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.367 -177.542 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 592' ' ' LEU . . . . . . . . . . . . . 9.9 mp -67.44 -7.21 23.56 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 112.527 0.566 . . . . 0.0 112.527 178.235 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 593' ' ' GLN . . . . . 0.766 ' HA ' ' HE3' ' A' ' 570' ' ' LYS . 4.6 tt0 -76.74 -29.2 56.05 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 171.708 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 594' ' ' GLY . . . . . . . . . . . . . . . 113.41 -20.36 18.61 Favored Glycine 0 N--CA 1.444 -0.791 0 CA-C-N 115.203 -0.908 . . . . 0.0 111.62 -177.15 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 595' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -84.08 -178.57 7.0 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 120.984 0.421 . . . . 0.0 109.867 -179.594 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 596' ' ' LYS . . . . . 0.788 ' HD3' ' H ' ' A' ' 596' ' ' LYS . 0.0 OUTLIER -118.72 136.96 53.66 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.796 -172.272 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 597' ' ' LEU . . . . . 0.506 HD21 ' O ' ' A' ' 571' ' ' TYR . 56.6 mt -90.51 142.55 27.63 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.648 179.609 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 598' ' ' GLU . . . . . 0.559 ' O ' ' HA ' ' A' ' 608' ' ' VAL . 13.7 tp10 -86.01 82.2 8.2 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 178.497 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 599' ' ' VAL . . . . . 0.439 HG11 HD23 ' A' ' 578' ' ' LEU . 25.8 t -104.58 121.88 56.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 121.128 0.489 . . . . 0.0 110.081 -176.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 600' ' ' SER . . . . . 0.61 ' HB2' ' HG ' ' A' ' 586' ' ' LEU . 37.4 t -141.23 168.39 19.89 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.499 0.666 . . . . 0.0 110.96 -172.626 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 601' ' ' LEU . . . . . 0.516 ' HB2' HD12 ' A' ' 583' ' ' ILE . 52.7 tp -140.45 108.27 5.67 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 114.535 -1.211 . . . . 0.0 108.955 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 602' ' ' LYS . . . . . . . . . . . . . 65.1 mttp -120.79 107.12 12.35 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.903 -177.239 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 603' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 63.42 42.86 6.41 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.613 177.503 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 604' ' ' ASN . . . . . . . . . . . . . 66.6 t30 72.95 14.65 4.75 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.608 178.067 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 605' ' ' VAL . . . . . . . . . . . . . 56.6 t -110.51 114.01 45.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.997 175.495 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 606' ' ' VAL . . . . . 0.738 HG13 ' HB ' ' A' ' 613' ' ' VAL . 6.6 p -84.97 140.16 16.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.2 0.524 . . . . 0.0 110.935 -179.01 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 607' ' ' SER . . . . . . . . . . . . . 7.4 p -142.19 154.58 44.94 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.835 -178.197 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 608' ' ' VAL . . . . . 0.559 ' HA ' ' O ' ' A' ' 598' ' ' GLU . 7.5 p -142.65 119.89 6.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.147 178.006 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 609' ' ' ASN . . . . . 0.832 ' HB2' HD22 ' A' ' 632' ' ' LEU . 4.0 m-20 59.88 50.04 7.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.131 173.715 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 610' ' ' LYS . . . . . 0.495 ' HB2' ' HE3' ' A' ' 610' ' ' LYS . 35.6 mtmt 77.15 -21.91 0.31 Allowed 'General case' 0 N--CA 1.476 0.826 0 O-C-N 123.66 0.6 . . . . 0.0 111.378 179.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 611' ' ' GLU . . . . . . . . . . . . . 48.6 mm-40 -90.96 140.91 26.19 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.732 -176.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 612' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -81.26 141.58 12.89 Favored 'Trans proline' 0 N--CA 1.458 -0.603 0 C-N-CA 122.134 1.889 . . . . 0.0 111.459 173.589 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 613' ' ' VAL . . . . . 0.738 ' HB ' HG13 ' A' ' 606' ' ' VAL . 99.5 t -74.34 120.59 23.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 176.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 614' ' ' ALA . . . . . 0.527 ' HB2' HG23 ' A' ' 629' ' ' THR . . . -76.5 -26.22 55.05 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.868 -172.815 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 615' ' ' GLU . . . . . 0.604 ' HB3' ' HB ' ' A' ' 627' ' ' VAL . 17.4 tt0 -165.49 89.25 0.94 Allowed Pre-proline 0 C--N 1.325 -0.49 0 CA-C-O 121.189 0.519 . . . . 0.0 109.832 -174.417 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 616' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -88.82 163.57 6.14 Favored 'Trans proline' 0 N--CA 1.456 -0.732 0 C-N-CA 123.059 2.506 . . . . 0.0 113.708 -175.669 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 26.6 t0 78.43 64.61 0.03 OUTLIER 'General case' 0 CA--C 1.51 -0.567 0 CA-C-O 123.024 1.392 . . . . 0.0 110.594 169.38 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 618' ' ' ILE . . . . . 0.498 ' HB ' ' O ' ' A' ' 625' ' ' VAL . 24.4 mt -115.86 102.21 13.38 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.278 0 CA-C-N 112.795 -2.002 . . . . 0.0 108.573 176.058 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 619' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.73 135.7 37.21 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.707 -0.679 . . . . 0.0 112.812 -169.313 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 620' ' ' ALA . . . . . . . . . . . . . . . -129.1 176.72 7.68 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.329 -0.851 . . . . 0.0 108.795 171.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 621' ' ' THR . . . . . . . . . . . . . 4.5 t -82.75 -21.71 34.6 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.603 -0.439 . . . . 0.0 110.874 -179.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 622' ' ' ASN . . . . . 0.798 ' HB3' ' HA ' ' A' ' 534' ' ' GLU . 27.4 p-10 -116.24 22.11 13.13 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.719 0.295 . . . . 0.0 111.441 -176.692 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 623' ' ' GLY . . . . . . . . . . . . . . . 147.47 -150.88 23.18 Favored Glycine 0 N--CA 1.443 -0.859 0 C-N-CA 120.332 -0.937 . . . . 0.0 112.626 177.229 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 624' ' ' VAL . . . . . . . . . . . . . 6.3 p -135.79 158.46 39.41 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 -179.164 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 625' ' ' VAL . . . . . 0.498 ' O ' ' HB ' ' A' ' 618' ' ' ILE . 46.8 t -123.93 136.87 58.87 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.675 178.764 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 626' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 -122.79 121.13 35.55 Favored 'General case' 0 N--CA 1.445 -0.681 0 N-CA-C 109.908 -0.405 . . . . 0.0 109.908 175.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 627' ' ' VAL . . . . . 0.604 ' HB ' ' HB3' ' A' ' 615' ' ' GLU . 60.8 t -70.21 130.67 34.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.56 179.025 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 628' ' ' ILE . . . . . 0.567 HD13 ' HB3' ' A' ' 540' ' ' PHE . 7.2 pt -127.34 150.19 33.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.819 176.199 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 629' ' ' THR . . . . . 0.527 HG23 ' HB2' ' A' ' 614' ' ' ALA . 16.6 p -94.91 2.83 55.45 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.91 -176.283 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 630' ' ' ASN . . . . . . . . . . . . . 66.1 m-20 -144.08 168.76 19.24 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.409 -177.39 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 631' ' ' VAL . . . . . . . . . . . . . 97.2 t -95.91 125.74 48.65 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 115.426 -0.807 . . . . 0.0 109.206 176.518 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 632' ' ' LEU . . . . . 0.832 HD22 ' HB2' ' A' ' 609' ' ' ASN . 89.6 mt -70.87 114.41 8.91 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-O 121.33 0.586 . . . . 0.0 110.893 -174.602 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 633' ' ' GLN . . . . . 0.512 ' HA ' ' HD3' ' A' ' 634' ' ' PRO . 85.7 mm-40 -102.47 131.17 22.74 Favored Pre-proline 0 C--N 1.317 -0.835 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.947 -177.095 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 634' ' ' PRO . . . . . 0.512 ' HD3' ' HA ' ' A' ' 633' ' ' GLN . 4.9 Cg_exo . . . . . 0 C--O 1.253 1.25 0 C-N-CA 123.051 2.501 . . . . 0.0 111.569 176.25 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 500' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.053 0 N-CA-C 110.189 -0.3 . . . . 0.0 110.189 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 501' ' ' GLY . . . . . . . . . . . . . . . 148.72 2.59 0.37 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.495 -178.308 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 502' ' ' MET . . . . . . . . . . . . . 24.7 mmt 67.88 -174.45 0.19 Allowed 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 121.012 0.434 . . . . 0.0 111.511 178.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 99.04 164.77 29.99 Favored Glycine 0 N--CA 1.447 -0.57 0 N-CA-C 111.311 -0.715 . . . . 0.0 111.311 -176.423 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 504' ' ' THR . . . . . 0.48 ' O ' HG23 ' A' ' 508' ' ' VAL . 38.8 p -81.47 156.95 25.07 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 120.83 -0.348 . . . . 0.0 110.307 179.118 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 505' ' ' VAL . . . . . . . . . . . . . 7.1 p -49.55 -39.2 13.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.892 -0.595 . . . . 0.0 112.359 -176.099 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 506' ' ' MET . . . . . 0.517 ' HG2' ' HB2' ' A' ' 531' ' ' LEU . 2.9 ppp? -83.82 -21.86 31.96 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.806 0.336 . . . . 0.0 111.524 -177.109 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 507' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -86.22 -28.89 23.58 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.042 0.448 . . . . 0.0 110.645 -178.238 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 508' ' ' VAL . . . . . 0.48 HG23 ' O ' ' A' ' 504' ' ' THR . 87.5 t -61.89 -27.58 42.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.297 175.394 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 509' ' ' LEU . . . . . . . . . . . . . 25.3 mt -65.05 -19.54 66.04 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.536 -179.099 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 510' ' ' LYS . . . . . 0.433 ' HE3' HG13 ' A' ' 519' ' ' VAL . 5.3 mptt -76.25 -24.15 54.53 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.022 0.439 . . . . 0.0 110.481 -179.068 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 511' ' ' GLY . . . . . . . . . . . . . . . -80.56 -10.11 85.63 Favored Glycine 0 N--CA 1.444 -0.773 0 C-N-CA 120.407 -0.902 . . . . 0.0 111.179 177.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 512' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -114.86 137.62 51.75 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.26 0.552 . . . . 0.0 111.714 -176.253 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 9.9 p30 -77.34 -19.76 55.85 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 115.526 -0.761 . . . . 0.0 112.459 -177.214 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 514' ' ' ARG . . . . . . . . . . . . . 5.3 tpp180 -89.04 -28.54 20.08 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 120.687 0.279 . . . . 0.0 110.988 -170.765 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 515' ' ' PHE . . . . . 0.607 ' CZ ' HG22 ' A' ' 627' ' ' VAL . 9.5 m-85 -92.83 8.62 38.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.682 178.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 13.0 p -55.37 -44.8 76.36 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.066 -0.515 . . . . 0.0 112.376 -176.145 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 517' ' ' MET . . . . . . . . . . . . . 2.8 mpp? -63.36 -31.29 72.4 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.502 0.191 . . . . 0.0 111.09 179.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 518' ' ' LEU . . . . . 0.409 HD22 ' HA ' ' A' ' 541' ' ' ALA . 44.2 tp -70.63 -36.38 73.41 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 120.502 -0.479 . . . . 0.0 110.207 -179.408 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 519' ' ' VAL . . . . . 0.433 HG13 ' HE3' ' A' ' 510' ' ' LYS . 59.1 t -58.94 -37.7 68.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.257 0.551 . . . . 0.0 109.559 174.834 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 520' ' ' ALA . . . . . . . . . . . . . . . -71.61 -40.98 69.46 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.644 -178.225 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 521' ' ' ALA . . . . . . . . . . . . . . . -63.96 -50.41 68.72 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.927 178.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 522' ' ' ILE . . . . . . . . . . . . . 72.9 mt -60.88 -40.43 85.25 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.894 179.115 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 523' ' ' GLN . . . . . . . . . . . . . 59.2 tt0 -61.78 -46.28 90.22 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.864 178.543 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 27.5 m -67.68 -47.52 69.22 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.495 -177.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 525' ' ' ALA . . . . . 0.413 ' HB1' ' HB2' ' A' ' 566' ' ' ALA . . . -70.77 -28.46 64.69 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.642 0.258 . . . . 0.0 111.504 -179.044 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 526' ' ' GLY . . . . . . . . . . . . . . . 85.54 41.49 7.31 Favored Glycine 0 C--O 1.227 -0.323 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.61 178.119 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 527' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -102.06 13.0 35.95 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.909 0.385 . . . . 0.0 110.863 -178.548 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 528' ' ' THR . . . . . . . . . . . . . 18.7 m -65.17 -33.99 77.31 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.117 -178.163 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 529' ' ' GLU . . . . . . . . . . . . . 28.9 mm-40 -55.44 -43.69 75.64 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.814 -176.681 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 530' ' ' THR . . . . . . . . . . . . . 22.1 m -66.27 -43.08 87.45 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.293 -176.124 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 531' ' ' LEU . . . . . 0.517 ' HB2' ' HG2' ' A' ' 506' ' ' MET . 68.8 mt -87.67 14.09 9.16 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.027 0.441 . . . . 0.0 111.314 -174.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 532' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -89.56 -29.5 18.86 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.756 178.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 533' ' ' ARG . . . . . 0.449 HH11 ' HD2' ' A' ' 533' ' ' ARG . 4.2 tpp180 -86.09 143.84 27.85 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.415 -0.812 . . . . 0.0 110.245 179.069 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 534' ' ' GLU . . . . . 0.673 ' HA ' ' CB ' ' A' ' 622' ' ' ASN . 42.8 tt0 -79.93 147.66 31.55 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.078 0.466 . . . . 0.0 110.515 176.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 535' ' ' GLY . . . . . . . . . . . . . . . 169.0 -136.33 4.01 Favored Glycine 0 N--CA 1.445 -0.75 0 N-CA-C 110.4 -1.08 . . . . 0.0 110.4 -177.51 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 536' ' ' VAL . . . . . 0.534 ' HB ' HG13 ' A' ' 577' ' ' ILE . 34.0 m -124.22 129.79 73.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 117.297 0.549 . . . . 0.0 110.411 177.518 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 537' ' ' TYR . . . . . . . . . . . . . 82.4 m-85 -154.19 146.55 23.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.934 -0.575 . . . . 0.0 109.926 -179.033 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 538' ' ' THR . . . . . 0.766 ' OG1' ' HA ' ' A' ' 577' ' ' ILE . 55.7 m -136.76 100.36 4.3 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 120.813 0.339 . . . . 0.0 110.117 175.235 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 539' ' ' VAL . . . . . 0.632 ' HA ' ' O ' ' A' ' 572' ' ' HIS . 1.3 p -115.17 132.09 65.48 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-O 121.392 0.615 . . . . 0.0 111.242 -177.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 540' ' ' PHE . . . . . . . . . . . . . 68.4 m-85 -89.1 117.16 27.9 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.003 -0.999 . . . . 0.0 109.693 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 541' ' ' ALA . . . . . 0.427 ' HA ' ' HD3' ' A' ' 542' ' ' PRO . . . -93.67 114.42 62.96 Favored Pre-proline 0 C--N 1.326 -0.435 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.575 -179.34 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 542' ' ' PRO . . . . . 0.595 ' HA ' HG13 ' A' ' 628' ' ' ILE . 7.9 Cg_exo -72.88 131.47 17.03 Favored 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 122.88 2.387 . . . . 0.0 111.516 177.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 75.2 p -71.87 175.48 5.77 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.574 179.364 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 544' ' ' ASN . . . . . . . . . . . . . 10.7 p30 -72.67 -21.21 61.11 Favored 'General case' 0 CA--C 1.519 -0.221 0 C-N-CA 120.094 -0.643 . . . . 0.0 109.449 179.05 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 545' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -62.18 -35.7 79.63 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.74 174.319 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 546' ' ' ALA . . . . . 0.558 ' HB1' HG23 ' A' ' 631' ' ' VAL . . . -70.13 -48.31 58.03 Favored 'General case' 0 CA--C 1.513 -0.474 0 CA-C-O 121.19 0.519 . . . . 0.0 110.772 178.838 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 547' ' ' PHE . . . . . . . . . . . . . 64.2 m-85 -68.14 -23.72 64.91 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.331 -177.575 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 548' ' ' ARG . . . . . 0.405 ' HD2' HH11 ' A' ' 548' ' ' ARG . 43.7 mtm180 -86.78 -21.9 26.23 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-O 120.706 0.289 . . . . 0.0 110.863 175.746 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 549' ' ' ALA . . . . . . . . . . . . . . . -85.66 -5.59 59.25 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.969 0.414 . . . . 0.0 110.682 177.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 550' ' ' LEU . . . . . 0.538 HD11 HG21 ' A' ' 631' ' ' VAL . 93.5 mt -75.74 134.27 72.43 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.264 176.172 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 551' ' ' PRO . . . . . 0.498 ' HD3' ' HA ' ' A' ' 550' ' ' LEU . 12.4 Cg_exo -69.99 148.02 62.68 Favored 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 122.7 2.267 . . . . 0.0 110.568 179.034 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 552' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_exo -50.83 -41.73 53.98 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.576 2.184 . . . . 0.0 112.072 -178.5 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 553' ' ' ARG . . . . . . . . . . . . . 22.8 tpt180 -57.25 -52.16 66.46 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.287 178.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -65.88 -55.29 17.73 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 111.824 0.305 . . . . 0.0 111.824 -176.328 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 555' ' ' ARG . . . . . 0.458 ' HG2' ' O ' ' A' ' 551' ' ' PRO . 30.8 ptt180 -63.96 -32.65 74.26 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 -175.699 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 32.1 m -74.94 -31.69 61.57 Favored 'General case' 0 N--CA 1.464 0.262 0 O-C-N 122.083 -0.385 . . . . 0.0 110.936 179.588 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 557' ' ' ARG . . . . . . . . . . . . . 73.7 ttt180 -69.65 -47.79 62.14 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.976 0.417 . . . . 0.0 109.964 176.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 558' ' ' LEU . . . . . 0.563 ' HG ' HD23 ' A' ' 565' ' ' LEU . 40.1 tp -60.56 -44.83 95.72 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.493 -178.131 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 559' ' ' LEU . . . . . 0.629 HD23 HD21 ' A' ' 565' ' ' LEU . 96.7 mt -81.98 4.55 22.29 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.065 0.459 . . . . 0.0 110.898 -179.452 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 560' ' ' GLY . . . . . . . . . . . . . . . -85.0 -22.61 52.14 Favored Glycine 0 N--CA 1.439 -1.114 0 C-N-CA 120.663 -0.78 . . . . 0.0 112.012 179.158 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 561' ' ' ASP . . . . . 0.695 ' HB3' ' HG2' ' A' ' 564' ' ' GLU . 11.9 t70 -139.38 142.7 37.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.939 0.399 . . . . 0.0 110.691 -178.037 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 562' ' ' ALA . . . . . . . . . . . . . . . -77.58 -29.04 51.86 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.821 -175.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 563' ' ' LYS . . . . . . . . . . . . . 27.2 ttpp -73.16 -39.03 65.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.815 0.341 . . . . 0.0 110.203 -178.231 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 564' ' ' GLU . . . . . 0.695 ' HG2' ' HB3' ' A' ' 561' ' ' ASP . 3.3 mm-40 -62.89 -42.5 99.8 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.436 178.728 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 565' ' ' LEU . . . . . 0.629 HD21 HD23 ' A' ' 559' ' ' LEU . 69.3 mt -55.81 -51.35 67.77 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.489 174.5 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 566' ' ' ALA . . . . . 0.413 ' HB2' ' HB1' ' A' ' 525' ' ' ALA . . . -58.07 -44.01 87.28 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.535 -178.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 567' ' ' ASN . . . . . . . . . . . . . 4.9 t30 -67.65 -32.86 73.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.189 -177.294 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 568' ' ' ILE . . . . . 0.522 HG12 ' O ' ' A' ' 564' ' ' GLU . 47.9 mm -72.94 -40.25 59.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 120.86 0.362 . . . . 0.0 110.386 176.73 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 569' ' ' LEU . . . . . 0.51 ' HG ' ' O ' ' A' ' 565' ' ' LEU . 96.0 mt -63.01 -42.92 99.96 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.301 179.673 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 570' ' ' LYS . . . . . 0.682 ' HE2' ' HA ' ' A' ' 593' ' ' GLN . 17.5 ptmt -70.86 -8.05 49.94 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.113 -178.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 571' ' ' TYR . . . . . 0.5 ' HB2' HE21 ' A' ' 593' ' ' GLN . 62.3 t80 -93.81 -18.76 21.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.962 0.41 . . . . 0.0 110.392 174.609 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 572' ' ' HIS . . . . . 0.632 ' O ' ' HA ' ' A' ' 539' ' ' VAL . 47.4 m80 -91.07 -20.18 22.34 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.748 179.643 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 573' ' ' ILE . . . . . 0.425 HG13 ' O ' ' A' ' 569' ' ' LEU . 27.2 mt -96.07 116.62 38.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.526 177.469 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 574' ' ' GLY . . . . . 0.592 ' HA2' ' HA ' ' A' ' 591' ' ' SER . . . -88.61 156.01 26.32 Favored Glycine 0 N--CA 1.449 -0.473 0 N-CA-C 111.78 -0.528 . . . . 0.0 111.78 176.297 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 575' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -82.75 -3.19 56.2 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 112.219 0.451 . . . . 0.0 112.219 -172.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 576' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -152.7 157.72 41.31 Favored 'General case' 0 N--CA 1.44 -0.967 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 -174.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 577' ' ' ILE . . . . . 0.766 ' HA ' ' OG1' ' A' ' 538' ' ' THR . 68.7 mt -92.56 117.59 36.27 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-N 115.76 -0.655 . . . . 0.0 112.055 -172.709 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 578' ' ' LEU . . . . . 0.579 HD23 HD13 ' A' ' 589' ' ' LEU . 3.4 mm? -123.99 102.3 7.69 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.389 175.544 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 579' ' ' VAL . . . . . 0.508 ' O ' HG13 ' A' ' 583' ' ' ILE . 30.9 m -97.28 172.11 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.07 179.36 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 580' ' ' SER . . . . . 0.532 ' HA ' HD11 ' A' ' 601' ' ' LEU . 27.6 m -54.72 -36.49 64.78 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.5 179.549 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 581' ' ' GLY . . . . . . . . . . . . . . . -80.81 -1.02 89.23 Favored Glycine 0 CA--C 1.521 0.425 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.982 -179.13 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . -114.4 -38.92 1.06 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.526 -0.845 . . . . 0.0 113.001 -177.554 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 583' ' ' ILE . . . . . 0.56 ' HB ' HD12 ' A' ' 601' ' ' LEU . 63.8 mt -60.03 -57.69 10.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 120.692 0.282 . . . . 0.0 111.555 -176.292 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 584' ' ' GLY . . . . . . . . . . . . . . . 78.9 -66.47 3.37 Favored Glycine 0 CA--C 1.52 0.356 0 C-N-CA 120.924 -0.655 . . . . 0.0 113.327 176.523 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 585' ' ' ALA . . . . . . . . . . . . . . . -130.02 -68.61 0.7 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.532 0.206 . . . . 0.0 111.549 -176.382 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 586' ' ' LEU . . . . . 0.579 HD13 ' HB3' ' A' ' 600' ' ' SER . 41.2 tp -153.57 128.62 9.64 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.773 0.32 . . . . 0.0 110.569 -179.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 587' ' ' VAL . . . . . . . . . . . . . 57.9 t -137.03 127.47 39.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.627 178.421 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 588' ' ' ARG . . . . . 0.442 ' HG2' ' HG2' ' A' ' 598' ' ' GLU . 72.8 mtt180 -85.54 109.02 18.22 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.485 0.659 . . . . 0.0 109.909 176.662 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 589' ' ' LEU . . . . . 0.579 HD13 HD23 ' A' ' 578' ' ' LEU . 34.7 tp -91.22 113.78 26.13 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 114.806 -1.088 . . . . 0.0 110.214 -175.53 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 590' ' ' LYS . . . . . . . . . . . . . 25.6 pttm -76.46 134.82 39.43 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.635 -0.505 . . . . 0.0 109.635 177.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 591' ' ' SER . . . . . 0.592 ' HA ' ' HA2' ' A' ' 574' ' ' GLY . 79.7 p -99.08 166.88 11.04 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.128 -177.442 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 592' ' ' LEU . . . . . . . . . . . . . 10.3 mp -63.86 -12.9 40.5 Favored 'General case' 0 C--N 1.333 -0.123 0 N-CA-C 112.211 0.449 . . . . 0.0 112.211 178.244 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 593' ' ' GLN . . . . . 0.682 ' HA ' ' HE2' ' A' ' 570' ' ' LYS . 5.0 tt0 -77.55 -29.32 52.2 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.391 0.615 . . . . 0.0 109.854 174.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 594' ' ' GLY . . . . . . . . . . . . . . . 111.48 -16.53 26.61 Favored Glycine 0 N--CA 1.447 -0.588 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.423 -174.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 595' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -79.0 178.6 7.9 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 179.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 596' ' ' LYS . . . . . . . . . . . . . 56.6 mttp -124.43 121.4 34.8 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.281 0.562 . . . . 0.0 111.983 -169.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 597' ' ' LEU . . . . . . . . . . . . . 67.5 mt -90.38 116.54 28.4 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.235 -0.893 . . . . 0.0 109.306 173.527 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 598' ' ' GLU . . . . . 0.442 ' HG2' ' HG2' ' A' ' 588' ' ' ARG . 46.9 mt-10 -89.13 92.75 9.32 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 121.456 0.646 . . . . 0.0 110.092 -177.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 599' ' ' VAL . . . . . . . . . . . . . 23.4 t -96.53 125.64 49.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.051 -0.977 . . . . 0.0 110.146 -176.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 600' ' ' SER . . . . . 0.579 ' HB3' HD13 ' A' ' 586' ' ' LEU . 18.2 p -125.78 156.87 38.79 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.445 -179.383 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 601' ' ' LEU . . . . . 0.56 HD12 ' HB ' ' A' ' 583' ' ' ILE . 0.3 OUTLIER -127.75 109.9 12.1 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.261 -179.626 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 602' ' ' LYS . . . . . 0.4 ' HE2' ' HB2' ' A' ' 602' ' ' LYS . 25.8 mtmm -128.87 123.0 31.58 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.25 -0.887 . . . . 0.0 109.806 -171.73 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 603' ' ' ASN . . . . . 0.448 ' O ' ' HB2' ' A' ' 604' ' ' ASN . 13.3 m120 64.38 25.93 13.49 Favored 'General case' 0 N--CA 1.466 0.34 0 O-C-N 123.571 0.544 . . . . 0.0 109.778 178.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 604' ' ' ASN . . . . . 0.448 ' HB2' ' O ' ' A' ' 603' ' ' ASN . 88.5 m-20 71.84 14.26 5.97 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.324 -175.633 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 605' ' ' VAL . . . . . . . . . . . . . 44.8 t -107.98 119.84 58.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.129 -0.487 . . . . 0.0 109.809 173.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 606' ' ' VAL . . . . . 0.806 HG13 ' HB ' ' A' ' 613' ' ' VAL . 5.2 p -86.67 139.8 16.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 121.026 0.441 . . . . 0.0 110.887 -178.6 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 607' ' ' SER . . . . . . . . . . . . . 2.9 m -140.71 135.19 31.33 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.474 -178.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 608' ' ' VAL . . . . . 0.413 HG13 HD21 ' A' ' 632' ' ' LEU . 3.7 p -111.48 119.95 60.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 177.64 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 609' ' ' ASN . . . . . 0.52 ' O ' ' HB2' ' A' ' 610' ' ' LYS . 5.3 m-20 59.22 37.18 23.9 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.485 177.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 610' ' ' LYS . . . . . 0.52 ' HB2' ' O ' ' A' ' 609' ' ' ASN . 34.4 mmtp 81.34 -15.44 0.72 Allowed 'General case' 0 N--CA 1.475 0.797 0 O-C-N 124.171 0.919 . . . . 0.0 112.326 -178.716 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 611' ' ' GLU . . . . . 0.425 ' HA ' ' HD3' ' A' ' 612' ' ' PRO . 18.1 mm-40 -84.8 138.55 37.63 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 120.8 0.333 . . . . 0.0 111.072 -178.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 612' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 611' ' ' GLU . 1.9 Cg_endo -82.02 134.02 8.03 Favored 'Trans proline' 0 N--CA 1.46 -0.468 0 C-N-CA 123.387 2.724 . . . . 0.0 113.274 -176.471 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 613' ' ' VAL . . . . . 0.806 ' HB ' HG13 ' A' ' 606' ' ' VAL . 50.3 t -81.57 130.89 35.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.053 175.773 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 614' ' ' ALA . . . . . . . . . . . . . . . -71.21 -42.72 68.58 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.173 -176.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 615' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -162.82 103.82 1.04 Allowed Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.27 0.557 . . . . 0.0 110.576 -178.656 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 616' ' ' PRO . . . . . 0.404 ' O ' ' HB2' ' A' ' 617' ' ' ASP . 65.0 Cg_endo -89.85 171.2 4.13 Favored 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 123.539 2.826 . . . . 0.0 113.411 -177.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 617' ' ' ASP . . . . . 0.404 ' HB2' ' O ' ' A' ' 616' ' ' PRO . 1.1 m-20 79.0 28.28 0.4 Allowed 'General case' 0 CA--C 1.508 -0.664 0 CA-C-N 115.123 -0.944 . . . . 0.0 111.373 164.721 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 618' ' ' ILE . . . . . 0.48 ' HB ' ' O ' ' A' ' 625' ' ' VAL . 18.5 mt -74.87 103.42 2.73 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 CA-C-N 114.591 -1.186 . . . . 0.0 109.085 171.505 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 619' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.77 132.96 38.32 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.841 -0.618 . . . . 0.0 112.391 -171.094 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 620' ' ' ALA . . . . . . . . . . . . . . . -127.92 173.61 9.87 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 170.408 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 621' ' ' THR . . . . . . . . . . . . . 4.7 t -75.56 -31.72 60.13 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 120.385 -0.526 . . . . 0.0 111.217 -174.374 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 622' ' ' ASN . . . . . 0.673 ' CB ' ' HA ' ' A' ' 534' ' ' GLU . 31.8 p-10 -117.39 21.76 12.87 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 111.946 0.35 . . . . 0.0 111.946 -176.325 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 623' ' ' GLY . . . . . . . . . . . . . . . 165.36 -167.71 39.03 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.159 -1.019 . . . . 0.0 112.87 178.526 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 624' ' ' VAL . . . . . 0.436 HG21 HG12 ' A' ' 579' ' ' VAL . 5.8 p -133.09 155.43 41.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 178.671 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 625' ' ' VAL . . . . . 0.48 ' O ' ' HB ' ' A' ' 618' ' ' ILE . 49.6 t -120.2 127.84 75.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.188 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 626' ' ' HIS . . . . . . . . . . . . . 46.9 m-70 -113.76 110.27 19.89 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.155 -0.475 . . . . 0.0 109.774 175.409 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 627' ' ' VAL . . . . . 0.607 HG22 ' CZ ' ' A' ' 515' ' ' PHE . 22.9 t -65.56 124.85 21.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.044 -179.741 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 628' ' ' ILE . . . . . 0.595 HG13 ' HA ' ' A' ' 542' ' ' PRO . 8.2 pt -116.86 143.77 26.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-O 121.353 0.596 . . . . 0.0 110.732 175.276 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 629' ' ' THR . . . . . . . . . . . . . 10.3 t -95.59 12.33 30.01 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-O 122.216 1.008 . . . . 0.0 109.318 -179.322 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 630' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 -139.19 176.66 8.51 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 114.381 -1.281 . . . . 0.0 109.359 -176.32 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 631' ' ' VAL . . . . . 0.558 HG23 ' HB1' ' A' ' 546' ' ' ALA . 61.6 t -116.64 144.26 24.78 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 172.366 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 632' ' ' LEU . . . . . 0.413 HD21 HG13 ' A' ' 608' ' ' VAL . 87.8 mt -96.58 118.26 32.69 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.018 0.437 . . . . 0.0 110.735 -177.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 633' ' ' GLN . . . . . . . . . . . . . 27.0 mp0 -96.64 116.79 66.27 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.089 -177.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 634' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo . . . . . 0 N--CA 1.452 -0.951 0 C-N-CA 122.902 2.401 . . . . 0.0 111.113 173.403 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 500' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.155 0 CA-C-O 120.672 0.272 . . . . 0.0 110.33 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 501' ' ' GLY . . . . . . . . . . . . . . . 152.6 -117.81 0.84 Allowed Glycine 0 N--CA 1.444 -0.819 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.114 178.076 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 502' ' ' MET . . . . . . . . . . . . . 50.9 ttm -178.51 -40.79 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 -178.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 138.88 149.01 5.37 Favored Glycine 0 N--CA 1.445 -0.728 0 CA-C-N 114.999 -1.0 . . . . 0.0 110.987 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 504' ' ' THR . . . . . 0.491 ' HA ' HG22 ' A' ' 621' ' ' THR . 46.7 p -75.88 165.75 24.54 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 117.165 0.483 . . . . 0.0 110.118 178.495 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 505' ' ' VAL . . . . . 0.66 ' O ' ' HG ' ' A' ' 509' ' ' LEU . 14.7 p -60.0 -31.66 48.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 120.991 0.424 . . . . 0.0 110.307 179.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 506' ' ' MET . . . . . 0.487 ' O ' ' HG2' ' A' ' 510' ' ' LYS . 5.7 tpp -69.31 -43.17 74.31 Favored 'General case' 0 N--CA 1.437 -1.112 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.688 178.198 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 507' ' ' ASP . . . . . 0.566 ' HA ' ' CG ' ' A' ' 510' ' ' LYS . 31.5 t70 -67.29 -32.5 73.53 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.882 0.373 . . . . 0.0 110.557 -178.435 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 508' ' ' VAL . . . . . 0.479 HG23 ' O ' ' A' ' 504' ' ' THR . 90.0 t -62.27 -35.72 70.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.519 176.087 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 509' ' ' LEU . . . . . 0.66 ' HG ' ' O ' ' A' ' 505' ' ' VAL . 61.3 mt -74.44 -37.44 63.28 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.164 -178.602 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 510' ' ' LYS . . . . . 0.566 ' CG ' ' HA ' ' A' ' 507' ' ' ASP . 10.8 ptmm? -84.27 -13.13 53.38 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.284 -178.303 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 511' ' ' GLY . . . . . . . . . . . . . . . -85.7 -11.92 73.16 Favored Glycine 0 N--CA 1.441 -0.987 0 N-CA-C 111.169 -0.772 . . . . 0.0 111.169 173.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 512' ' ' ASP . . . . . 0.57 ' O ' ' HB2' ' A' ' 516' ' ' SER . 26.6 t70 -104.22 152.54 22.05 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.826 0.346 . . . . 0.0 111.122 179.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 42.4 m-80 -76.28 -33.32 59.1 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.864 -176.243 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 514' ' ' ARG . . . . . 0.415 ' HB3' ' HA ' ' A' ' 543' ' ' THR . 26.2 mmt180 -82.88 -49.95 9.13 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.908 0.385 . . . . 0.0 110.086 -176.039 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 515' ' ' PHE . . . . . 1.012 ' HZ ' HG22 ' A' ' 627' ' ' VAL . 4.2 m-30 -66.97 -17.83 65.1 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.505 -177.458 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 516' ' ' SER . . . . . 0.57 ' HB2' ' O ' ' A' ' 512' ' ' ASP . 16.3 t -57.54 -41.9 81.84 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.665 -176.476 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 517' ' ' MET . . . . . . . . . . . . . 3.4 ppp? -76.49 -24.96 53.8 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.881 0.372 . . . . 0.0 110.643 -178.426 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 518' ' ' LEU . . . . . 0.628 HD22 ' HD2' ' A' ' 542' ' ' PRO . 39.4 tp -66.8 -37.86 85.37 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 170.01 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 519' ' ' VAL . . . . . 0.468 ' O ' ' HG2' ' A' ' 523' ' ' GLN . 85.4 t -58.21 -34.46 49.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 174.498 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 520' ' ' ALA . . . . . . . . . . . . . . . -63.76 -38.26 90.43 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.937 0.399 . . . . 0.0 110.17 177.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 521' ' ' ALA . . . . . 0.419 ' HA ' HD23 ' A' ' 565' ' ' LEU . . . -66.61 -43.11 85.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.267 174.392 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 522' ' ' ILE . . . . . 0.567 HG23 ' HB2' ' A' ' 527' ' ' LEU . 76.6 mt -59.73 -39.49 79.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.269 177.381 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 523' ' ' GLN . . . . . 0.468 ' HG2' ' O ' ' A' ' 519' ' ' VAL . 16.1 mm100 -62.82 -33.93 76.25 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-O 121.087 0.47 . . . . 0.0 111.152 177.727 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 8.3 t -81.67 -36.2 29.05 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.321 -179.399 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 525' ' ' ALA . . . . . 0.406 ' HB1' ' HA ' ' A' ' 566' ' ' ALA . . . -78.18 -29.84 48.73 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.922 -178.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 526' ' ' GLY . . . . . . . . . . . . . . . 85.14 50.53 4.06 Favored Glycine 0 CA--C 1.52 0.355 0 C-N-CA 121.025 -0.607 . . . . 0.0 112.801 179.319 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 527' ' ' LEU . . . . . 0.567 ' HB2' HG23 ' A' ' 522' ' ' ILE . 4.0 mm? -113.12 5.91 17.31 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.875 0.369 . . . . 0.0 110.518 177.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 528' ' ' THR . . . . . . . . . . . . . 4.4 m -62.29 -48.1 81.37 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.528 -175.404 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 529' ' ' GLU . . . . . 0.539 ' O ' ' HG3' ' A' ' 533' ' ' ARG . 29.9 mp0 -57.95 -40.89 81.64 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.883 0.373 . . . . 0.0 110.581 178.553 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 530' ' ' THR . . . . . . . . . . . . . 40.4 m -62.14 -45.98 91.02 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.558 -177.316 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 531' ' ' LEU . . . . . 0.518 HD21 HD13 ' A' ' 573' ' ' ILE . 61.5 mt -82.59 -4.91 58.39 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -175.378 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 532' ' ' ASN . . . . . . . . . . . . . 67.1 t30 -89.09 -18.24 27.65 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.273 0.558 . . . . 0.0 110.043 178.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 533' ' ' ARG . . . . . 0.539 ' HG3' ' O ' ' A' ' 529' ' ' GLU . 32.9 mtp85 -83.08 136.69 34.39 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.205 -179.215 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 534' ' ' GLU . . . . . 0.574 ' HA ' ' HB3' ' A' ' 622' ' ' ASN . 11.5 pt-20 -71.56 156.13 39.76 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.868 178.257 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 535' ' ' GLY . . . . . . . . . . . . . . . 147.05 -136.59 6.21 Favored Glycine 0 N--CA 1.445 -0.759 0 N-CA-C 110.43 -1.068 . . . . 0.0 110.43 -176.064 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 536' ' ' VAL . . . . . 0.455 ' HB ' HG13 ' A' ' 577' ' ' ILE . 34.3 m -124.08 130.08 73.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-O 121.142 0.496 . . . . 0.0 110.813 179.005 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 537' ' ' TYR . . . . . . . . . . . . . 84.4 m-85 -152.87 146.98 25.47 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.385 178.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 538' ' ' THR . . . . . 0.685 ' OG1' ' HA ' ' A' ' 577' ' ' ILE . 67.2 m -132.98 102.6 5.68 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 175.413 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 539' ' ' VAL . . . . . 0.448 HG22 HG23 ' A' ' 573' ' ' ILE . 48.5 t -107.31 122.88 62.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.085 0.469 . . . . 0.0 111.44 -172.788 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 540' ' ' PHE . . . . . 0.479 ' HB3' HD13 ' A' ' 628' ' ' ILE . 84.8 m-85 -91.77 107.15 19.0 Favored 'General case' 0 N--CA 1.447 -0.613 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 172.759 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 541' ' ' ALA . . . . . 0.442 ' HA ' ' HD3' ' A' ' 542' ' ' PRO . . . -97.2 113.71 63.59 Favored Pre-proline 0 C--N 1.323 -0.577 0 CA-C-O 120.713 0.292 . . . . 0.0 110.924 -176.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 542' ' ' PRO . . . . . 0.628 ' HD2' HD22 ' A' ' 518' ' ' LEU . 7.9 Cg_exo -72.44 138.16 29.36 Favored 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 123.04 2.494 . . . . 0.0 111.427 177.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 543' ' ' THR . . . . . 0.415 ' HA ' ' HB3' ' A' ' 514' ' ' ARG . 60.8 p -74.22 -179.11 3.7 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.526 178.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 544' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -62.35 -33.64 75.1 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.172 0.511 . . . . 0.0 109.742 179.603 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 545' ' ' GLU . . . . . 0.414 ' HA ' ' HB3' ' A' ' 548' ' ' ARG . 14.1 mp0 -63.85 -27.44 69.17 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 114.798 -1.092 . . . . 0.0 111.499 -178.004 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 546' ' ' ALA . . . . . 0.605 ' HB1' HG22 ' A' ' 631' ' ' VAL . . . -64.24 -55.61 20.32 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.354 0.597 . . . . 0.0 110.514 179.142 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 547' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -70.63 -21.48 62.63 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.644 179.127 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 548' ' ' ARG . . . . . 0.414 ' HB3' ' HA ' ' A' ' 545' ' ' GLU . 75.2 ttt180 -74.81 -36.82 62.45 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.117 177.611 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 549' ' ' ALA . . . . . . . . . . . . . . . -62.03 -34.38 76.11 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.456 176.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 550' ' ' LEU . . . . . 0.51 ' HA ' ' HD3' ' A' ' 551' ' ' PRO . 81.2 mt -65.53 132.24 95.01 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.392 175.82 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 551' ' ' PRO . . . . . 0.51 ' HD3' ' HA ' ' A' ' 550' ' ' LEU . 21.3 Cg_exo -64.58 147.9 90.3 Favored 'Trans proline' 0 N--CA 1.463 -0.29 0 C-N-CA 122.98 2.453 . . . . 0.0 111.856 -173.723 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 552' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 551' ' ' PRO . 86.7 Cg_exo -48.89 -35.51 31.54 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 123.177 2.584 . . . . 0.0 113.351 -177.722 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 553' ' ' ARG . . . . . . . . . . . . . 56.2 ttp180 -73.57 -45.52 52.81 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.771 0.32 . . . . 0.0 110.842 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 554' ' ' GLU . . . . . 0.474 ' HB2' ' HD2' ' A' ' 551' ' ' PRO . 20.5 mm-40 -74.09 -41.66 61.34 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.454 -175.061 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 555' ' ' ARG . . . . . . . . . . . . . 5.5 ptp180 -61.75 -33.6 74.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.877 0.37 . . . . 0.0 110.024 177.451 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 7.9 t -71.5 -36.94 71.27 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.2 -0.455 . . . . 0.0 109.808 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 557' ' ' ARG . . . . . . . . . . . . . 79.8 mtt180 -61.22 -49.5 76.91 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.378 176.236 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 558' ' ' LEU . . . . . 0.506 HD21 HG13 ' A' ' 568' ' ' ILE . 2.1 tm? -57.95 -52.33 65.94 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.057 -0.974 . . . . 0.0 110.457 -178.54 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 559' ' ' LEU . . . . . 0.766 ' HA ' HD11 ' A' ' 565' ' ' LEU . 86.4 mt -76.78 -3.75 39.9 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.378 -175.352 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 560' ' ' GLY . . . . . . . . . . . . . . . -72.57 -22.54 78.93 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 121.168 -0.539 . . . . 0.0 112.534 -179.316 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 561' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -141.63 126.17 17.82 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 122.53 -0.394 . . . . 0.0 110.674 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 562' ' ' ALA . . . . . 0.434 ' HA ' HD13 ' A' ' 565' ' ' LEU . . . -59.46 -22.81 62.07 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.764 -0.653 . . . . 0.0 112.384 -176.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 563' ' ' LYS . . . . . . . . . . . . . 57.9 tttp -63.69 -40.3 96.47 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.358 0.599 . . . . 0.0 110.395 179.275 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 564' ' ' GLU . . . . . 0.458 ' HB3' HD22 ' A' ' 558' ' ' LEU . 7.7 mm-40 -68.55 -40.47 80.64 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.987 -178.011 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 565' ' ' LEU . . . . . 0.766 HD11 ' HA ' ' A' ' 559' ' ' LEU . 8.2 mp -57.19 -47.29 81.62 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.115 174.6 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 566' ' ' ALA . . . . . 0.64 ' O ' ' HB2' ' A' ' 570' ' ' LYS . . . -60.2 -40.18 89.17 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.245 -0.889 . . . . 0.0 111.666 -177.744 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 567' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -75.53 -47.12 28.27 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 120.916 -0.314 . . . . 0.0 111.318 -176.013 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 568' ' ' ILE . . . . . 0.506 HG13 HD21 ' A' ' 558' ' ' LEU . 28.5 mm -65.29 -48.85 81.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 112.465 0.543 . . . . 0.0 112.465 -177.728 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 569' ' ' LEU . . . . . 0.401 HD12 ' C ' ' A' ' 569' ' ' LEU . 0.6 OUTLIER -71.33 -21.84 61.99 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.736 -0.385 . . . . 0.0 110.433 -175.879 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 570' ' ' LYS . . . . . 0.64 ' HB2' ' O ' ' A' ' 566' ' ' ALA . 78.3 tttt -67.56 -22.17 65.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.214 0.531 . . . . 0.0 110.434 178.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 571' ' ' TYR . . . . . 0.456 ' CE1' ' HB3' ' A' ' 595' ' ' ASP . 15.3 t80 -77.89 -18.05 56.62 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.711 177.268 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 572' ' ' HIS . . . . . . . . . . . . . 74.4 m80 -88.56 -12.44 42.74 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.658 -176.706 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 573' ' ' ILE . . . . . 0.518 HD13 HD21 ' A' ' 531' ' ' LEU . 47.7 mt -104.42 114.28 43.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.627 179.615 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 574' ' ' GLY . . . . . 0.68 ' HA2' ' HA ' ' A' ' 591' ' ' SER . . . -99.4 152.99 19.61 Favored Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 121.06 -0.59 . . . . 0.0 111.777 176.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 575' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -96.79 16.13 20.04 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.064 0.459 . . . . 0.0 111.31 -175.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 576' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -139.27 122.17 16.62 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.139 -177.409 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 577' ' ' ILE . . . . . 0.685 ' HA ' ' OG1' ' A' ' 538' ' ' THR . 63.3 mt -79.95 101.27 4.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.272 0.558 . . . . 0.0 110.681 -179.024 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 578' ' ' LEU . . . . . . . . . . . . . 96.7 mt -118.91 102.48 8.82 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.393 -0.821 . . . . 0.0 109.879 178.045 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 579' ' ' VAL . . . . . . . . . . . . . 27.1 m -90.82 178.43 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.361 178.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 580' ' ' SER . . . . . . . . . . . . . 13.0 m -53.57 -38.77 64.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.26 -179.039 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 581' ' ' GLY . . . . . . . . . . . . . . . -86.53 23.66 9.77 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 121.13 -0.557 . . . . 0.0 112.824 -178.553 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . -138.63 6.82 3.28 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.595 177.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 583' ' ' ILE . . . . . . . . . . . . . 37.4 mt -83.95 -47.75 17.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.968 0.414 . . . . 0.0 110.977 -178.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 584' ' ' GLY . . . . . . . . . . . . . . . 79.39 -69.18 3.03 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.929 -0.653 . . . . 0.0 112.07 -178.024 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 585' ' ' ALA . . . . . . . . . . . . . . . -143.18 -69.87 0.33 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.862 0.363 . . . . 0.0 110.321 179.53 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 586' ' ' LEU . . . . . 0.8 ' HG ' ' HB2' ' A' ' 600' ' ' SER . 3.9 tt -151.33 131.15 13.24 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 176.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 587' ' ' VAL . . . . . 0.413 ' N ' HD23 ' A' ' 586' ' ' LEU . 7.8 p -143.99 137.23 23.93 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.173 -175.137 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 588' ' ' ARG . . . . . . . . . . . . . 35.0 ptt180 -88.04 108.52 19.27 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.414 0.626 . . . . 0.0 110.561 178.278 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 589' ' ' LEU . . . . . . . . . . . . . 3.8 tt -91.04 114.47 27.0 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 -178.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 590' ' ' LYS . . . . . 0.606 ' NZ ' ' HB2' ' A' ' 590' ' ' LYS . 9.6 mtmp? -72.43 148.69 44.93 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 121.273 0.559 . . . . 0.0 111.411 -174.062 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 591' ' ' SER . . . . . 0.68 ' HA ' ' HA2' ' A' ' 574' ' ' GLY . 68.7 p -112.09 158.63 19.37 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.823 -179.104 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 592' ' ' LEU . . . . . 0.493 ' O ' ' HE2' ' A' ' 570' ' ' LYS . 10.0 mp -62.26 -19.82 63.62 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.933 178.355 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 593' ' ' GLN . . . . . 0.414 HE21 ' HB3' ' A' ' 593' ' ' GLN . 6.4 tt0 -69.5 -29.69 67.38 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.806 -0.358 . . . . 0.0 110.537 176.477 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 594' ' ' GLY . . . . . . . . . . . . . . . 115.97 -4.85 20.46 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.674 -0.775 . . . . 0.0 112.745 -178.324 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 595' ' ' ASP . . . . . 0.456 ' HB3' ' CE1' ' A' ' 571' ' ' TYR . 11.2 t70 -101.29 -168.94 1.62 Allowed 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 175.768 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 596' ' ' LYS . . . . . 0.549 ' HD3' ' N ' ' A' ' 596' ' ' LYS . 0.0 OUTLIER -135.05 131.83 37.48 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.007 0.432 . . . . 0.0 111.3 -172.881 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 597' ' ' LEU . . . . . 0.677 ' HB3' HG23 ' A' ' 608' ' ' VAL . 2.7 mm? -82.32 115.89 21.58 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 169.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 598' ' ' GLU . . . . . . . . . . . . . 57.8 mt-10 -84.42 92.43 8.05 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-O 121.626 0.727 . . . . 0.0 109.775 179.039 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 599' ' ' VAL . . . . . 0.46 ' HA ' ' O ' ' A' ' 607' ' ' SER . 61.1 t -93.64 132.41 37.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 114.619 -1.173 . . . . 0.0 110.118 -176.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 600' ' ' SER . . . . . 0.8 ' HB2' ' HG ' ' A' ' 586' ' ' LEU . 29.6 t -131.95 165.43 23.95 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-O 121.215 0.531 . . . . 0.0 110.286 179.69 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 601' ' ' LEU . . . . . . . . . . . . . 33.3 tp -136.89 108.07 6.79 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 114.929 -1.032 . . . . 0.0 109.609 -177.055 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 602' ' ' LYS . . . . . . . . . . . . . 11.3 ptmm? -134.77 118.19 16.78 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.899 -178.31 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 603' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 63.0 28.87 16.39 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 121.542 0.686 . . . . 0.0 109.539 -174.492 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 604' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 69.16 5.98 5.4 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 115.053 -0.976 . . . . 0.0 111.903 -177.368 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 605' ' ' VAL . . . . . . . . . . . . . 46.3 t -86.86 108.13 17.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 109.419 -0.585 . . . . 0.0 109.419 175.278 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 606' ' ' VAL . . . . . 0.726 HG13 ' HB ' ' A' ' 613' ' ' VAL . 6.1 p -84.33 134.41 27.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.934 -178.21 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 607' ' ' SER . . . . . 0.46 ' O ' ' HA ' ' A' ' 599' ' ' VAL . 3.3 p -139.03 142.58 38.25 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.72 -178.709 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 608' ' ' VAL . . . . . 0.677 HG23 ' HB3' ' A' ' 597' ' ' LEU . 3.0 p -122.07 112.78 36.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 116.238 -0.437 . . . . 0.0 109.962 179.159 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 609' ' ' ASN . . . . . 0.43 ' O ' ' HB3' ' A' ' 610' ' ' LYS . 87.7 m-20 56.57 44.76 23.48 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.763 -178.82 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 610' ' ' LYS . . . . . 0.43 ' HB3' ' O ' ' A' ' 609' ' ' ASN . 48.8 tttp 81.19 -26.19 0.15 Allowed 'General case' 0 N--CA 1.472 0.642 0 O-C-N 124.097 0.873 . . . . 0.0 111.701 179.096 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 611' ' ' GLU . . . . . 0.492 ' HA ' ' HD3' ' A' ' 612' ' ' PRO . 5.6 mm-40 -78.6 135.09 60.67 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 120.647 0.26 . . . . 0.0 110.393 -177.22 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 612' ' ' PRO . . . . . 0.492 ' HD3' ' HA ' ' A' ' 611' ' ' GLU . 4.9 Cg_exo -79.38 138.86 14.22 Favored 'Trans proline' 0 N--CA 1.462 -0.381 0 C-N-CA 123.038 2.492 . . . . 0.0 112.988 -176.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 613' ' ' VAL . . . . . 0.726 ' HB ' HG13 ' A' ' 606' ' ' VAL . 94.7 t -84.34 124.39 39.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.581 175.177 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 614' ' ' ALA . . . . . 0.547 ' HB2' HG23 ' A' ' 629' ' ' THR . . . -76.14 -31.41 58.58 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.573 -174.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 615' ' ' GLU . . . . . 0.402 ' HB3' ' CG2' ' A' ' 627' ' ' VAL . 28.1 tt0 -162.61 93.85 1.22 Allowed Pre-proline 0 C--N 1.325 -0.485 0 CA-C-O 121.184 0.516 . . . . 0.0 110.275 -176.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 616' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -89.32 165.24 5.5 Favored 'Trans proline' 0 N--CA 1.456 -0.708 0 C-N-CA 123.113 2.542 . . . . 0.0 113.422 -178.206 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 26.4 t0 77.36 40.63 0.16 Allowed 'General case' 0 CA--C 1.516 -0.345 0 CA-C-O 122.708 1.242 . . . . 0.0 110.092 165.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 618' ' ' ILE . . . . . 0.428 ' HB ' ' O ' ' A' ' 625' ' ' VAL . 17.8 mt -89.04 109.29 20.04 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.999 0 CA-C-N 113.776 -1.556 . . . . 0.0 109.266 173.226 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 619' ' ' MET . . . . . . . . . . . . . 6.8 mmt -73.41 133.12 43.66 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.686 -0.688 . . . . 0.0 112.355 -173.086 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 620' ' ' ALA . . . . . . . . . . . . . . . -131.06 166.33 21.27 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 108.96 -0.755 . . . . 0.0 108.96 172.051 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 621' ' ' THR . . . . . 0.491 HG22 ' HA ' ' A' ' 504' ' ' THR . 1.2 t -72.82 -33.45 66.21 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.455 -0.498 . . . . 0.0 111.361 -174.167 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 622' ' ' ASN . . . . . 0.574 ' HB3' ' HA ' ' A' ' 534' ' ' GLU . 28.5 p-10 -117.83 24.02 11.31 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.656 0.265 . . . . 0.0 111.556 -176.016 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 623' ' ' GLY . . . . . 0.42 ' HA2' ' CD1' ' A' ' 577' ' ' ILE . . . 162.55 -160.13 32.42 Favored Glycine 0 N--CA 1.442 -0.922 0 C-N-CA 120.187 -1.006 . . . . 0.0 112.816 178.386 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 624' ' ' VAL . . . . . . . . . . . . . 8.5 p -134.83 157.29 40.9 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 179.448 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 625' ' ' VAL . . . . . 0.428 ' O ' ' HB ' ' A' ' 618' ' ' ILE . 59.4 t -122.77 134.13 66.87 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.163 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 626' ' ' HIS . . . . . . . . . . . . . 95.7 m-70 -121.47 112.95 19.16 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 175.033 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 627' ' ' VAL . . . . . 1.012 HG22 ' HZ ' ' A' ' 515' ' ' PHE . 37.1 t -68.22 128.89 32.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.844 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 628' ' ' ILE . . . . . 0.574 HG13 ' HA ' ' A' ' 542' ' ' PRO . 6.4 pt -126.71 147.35 31.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 121.22 0.533 . . . . 0.0 111.043 175.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 629' ' ' THR . . . . . 0.547 HG23 ' HB2' ' A' ' 614' ' ' ALA . 30.1 p -96.43 -1.47 47.42 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.401 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 630' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -126.17 158.95 34.27 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.64 -174.273 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 631' ' ' VAL . . . . . 0.605 HG22 ' HB1' ' A' ' 546' ' ' ALA . 2.3 t -96.06 122.42 47.54 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.7 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 177.116 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 632' ' ' LEU . . . . . 0.457 HD21 HG13 ' A' ' 608' ' ' VAL . 96.2 mt -71.83 110.67 6.51 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.485 0.66 . . . . 0.0 110.401 -177.362 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 633' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -120.92 120.76 29.2 Favored Pre-proline 0 C--N 1.318 -0.802 0 CA-C-N 114.907 -1.042 . . . . 0.0 109.649 -175.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 634' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_exo . . . . . 0 C--O 1.249 1.07 0 C-N-CA 122.752 2.301 . . . . 0.0 111.754 -179.867 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 500' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.934 0 CA-C-O 121.118 0.485 . . . . 0.0 110.264 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 501' ' ' GLY . . . . . . . . . . . . . . . 161.22 -79.59 0.15 Allowed Glycine 0 N--CA 1.448 -0.545 0 N-CA-C 111.279 -0.728 . . . . 0.0 111.279 -179.312 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 502' ' ' MET . . . . . . . . . . . . . 93.9 mmm -124.15 85.29 2.39 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.095 0.474 . . . . 0.0 110.392 178.308 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . -129.25 -154.84 8.33 Favored Glycine 0 N--CA 1.445 -0.714 0 N-CA-C 111.252 -0.739 . . . . 0.0 111.252 177.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 39.1 p -71.9 175.63 5.66 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 177.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 505' ' ' VAL . . . . . 0.648 ' O ' ' HG ' ' A' ' 509' ' ' LEU . 8.5 t -54.63 -38.71 43.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 121.146 0.498 . . . . 0.0 110.261 178.07 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 506' ' ' MET . . . . . . . . . . . . . 16.5 mmt -63.55 -35.1 79.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.787 -178.628 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 507' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -62.91 -28.84 70.33 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.267 0.556 . . . . 0.0 110.27 -178.091 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 508' ' ' VAL . . . . . . . . . . . . . 47.3 t -87.41 -43.11 15.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.797 179.147 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 509' ' ' LEU . . . . . 0.648 ' HG ' ' O ' ' A' ' 505' ' ' VAL . 69.7 mt -64.73 -24.22 67.5 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 121.097 0.475 . . . . 0.0 111.907 -176.01 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -85.71 -21.57 28.24 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.402 -176.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 511' ' ' GLY . . . . . . . . . . . . . . . -81.27 -9.54 85.86 Favored Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 120.665 -0.778 . . . . 0.0 111.53 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 512' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -109.84 148.18 31.99 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.16 0.505 . . . . 0.0 111.607 -178.406 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -76.51 -21.4 55.81 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.757 -0.656 . . . . 0.0 112.521 -176.488 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 514' ' ' ARG . . . . . 0.692 ' HB3' ' HA ' ' A' ' 543' ' ' THR . 9.8 mmt180 -89.97 -51.38 5.51 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.495 0.664 . . . . 0.0 109.496 -177.716 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 515' ' ' PHE . . . . . 0.967 ' HZ ' HG22 ' A' ' 627' ' ' VAL . 9.1 m-30 -62.31 -29.38 70.4 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 114.664 -1.153 . . . . 0.0 111.25 -175.583 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 2.7 p -62.82 -25.7 68.39 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 -175.055 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 517' ' ' MET . . . . . . . . . . . . . 48.4 ttp -80.91 -37.78 29.07 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 175.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 518' ' ' LEU . . . . . 0.462 HD22 ' HD2' ' A' ' 542' ' ' PRO . 66.5 tp -57.81 -39.11 76.81 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.234 171.39 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 519' ' ' VAL . . . . . 0.505 HG23 ' O ' ' A' ' 515' ' ' PHE . 86.6 t -53.76 -37.52 32.62 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 CA-C-O 121.058 0.456 . . . . 0.0 110.582 175.111 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 520' ' ' ALA . . . . . . . . . . . . . . . -71.64 -35.24 70.32 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.441 -178.132 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 521' ' ' ALA . . . . . . . . . . . . . . . -68.59 -48.14 64.93 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.491 176.439 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 522' ' ' ILE . . . . . 0.432 HG23 ' HB2' ' A' ' 527' ' ' LEU . 69.2 mt -59.55 -37.01 68.13 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.886 177.402 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 523' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -61.98 -52.93 62.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.015 177.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 40.8 m -62.0 -34.25 75.83 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.735 -178.386 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 525' ' ' ALA . . . . . . . . . . . . . . . -77.69 -12.01 59.93 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.479 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 526' ' ' GLY . . . . . . . . . . . . . . . 72.73 34.6 59.41 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 121.061 -0.59 . . . . 0.0 112.958 178.093 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 527' ' ' LEU . . . . . 0.432 ' HB2' HG23 ' A' ' 522' ' ' ILE . 95.2 mt -109.13 10.31 26.0 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.901 0.381 . . . . 0.0 110.49 -179.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 528' ' ' THR . . . . . . . . . . . . . 8.1 m -57.08 -43.18 81.92 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 -173.003 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 529' ' ' GLU . . . . . 0.499 ' O ' ' HG2' ' A' ' 533' ' ' ARG . 11.5 pt-20 -70.34 -17.01 63.05 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 111.826 0.306 . . . . 0.0 111.826 -174.091 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 530' ' ' THR . . . . . . . . . . . . . 78.0 m -62.77 -49.17 76.05 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.83 0.348 . . . . 0.0 110.613 178.531 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 531' ' ' LEU . . . . . 0.592 ' H ' HD22 ' A' ' 531' ' ' LEU . 1.9 mm? -75.49 -14.51 60.43 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.19 178.25 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 532' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -78.47 -32.94 48.57 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.603 179.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 533' ' ' ARG . . . . . 0.499 ' HG2' ' O ' ' A' ' 529' ' ' GLU . 30.7 mmm180 -66.91 123.18 19.45 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.334 178.128 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 534' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -71.69 94.79 1.39 Allowed 'General case' 0 N--CA 1.443 -0.82 0 CA-C-O 122.627 1.203 . . . . 0.0 110.697 176.129 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 535' ' ' GLY . . . . . . . . . . . . . . . -161.85 175.06 38.41 Favored Glycine 0 N--CA 1.441 -1.001 0 N-CA-C 108.092 -2.003 . . . . 0.0 108.092 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 536' ' ' VAL . . . . . 0.647 ' HB ' HG13 ' A' ' 577' ' ' ILE . 33.9 m -87.32 131.42 35.2 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 118.405 1.103 . . . . 0.0 111.87 -167.489 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 537' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -150.48 144.31 25.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.051 -0.977 . . . . 0.0 109.964 179.406 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 538' ' ' THR . . . . . . . . . . . . . 22.6 m -108.32 102.91 11.99 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 173.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 539' ' ' VAL . . . . . 0.55 HG21 HG11 ' A' ' 505' ' ' VAL . 47.2 t -100.88 123.24 53.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 120.864 0.364 . . . . 0.0 111.641 -173.231 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 540' ' ' PHE . . . . . 0.549 ' HB3' HD13 ' A' ' 628' ' ' ILE . 97.6 m-85 -102.34 110.0 21.83 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 173.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -103.21 112.61 65.85 Favored Pre-proline 0 C--N 1.324 -0.537 0 CA-C-O 120.748 0.308 . . . . 0.0 110.863 -175.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 542' ' ' PRO . . . . . 0.542 ' HA ' HG13 ' A' ' 628' ' ' ILE . 11.8 Cg_exo -71.5 142.26 40.13 Favored 'Trans proline' 0 N--CA 1.461 -0.4 0 C-N-CA 123.028 2.485 . . . . 0.0 112.146 178.554 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 543' ' ' THR . . . . . 0.692 ' HA ' ' HB3' ' A' ' 514' ' ' ARG . 44.9 p -78.13 175.42 10.16 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.736 178.241 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 544' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -73.72 -24.17 59.87 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.821 -0.352 . . . . 0.0 110.478 -176.56 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 545' ' ' GLU . . . . . 0.436 ' OE2' ' HB ' ' A' ' 543' ' ' THR . 1.9 mp0 -64.35 -33.17 75.22 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 110.043 -0.355 . . . . 0.0 110.043 177.492 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 546' ' ' ALA . . . . . 0.673 ' HB1' HG23 ' A' ' 631' ' ' VAL . . . -59.76 -49.62 77.02 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.592 177.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 547' ' ' PHE . . . . . 0.402 ' HA ' ' HG ' ' A' ' 550' ' ' LEU . 88.9 m-85 -68.98 -21.81 64.13 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.79 -179.634 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 548' ' ' ARG . . . . . . . . . . . . . 30.5 ttm180 -79.12 -28.17 42.92 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.868 179.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 549' ' ' ALA . . . . . . . . . . . . . . . -96.41 1.07 51.37 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.452 -176.379 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 550' ' ' LEU . . . . . 0.439 ' HG ' ' O ' ' A' ' 546' ' ' ALA . 75.0 mt -67.35 137.72 93.88 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.564 179.71 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 551' ' ' PRO . . . . . 0.533 ' HD2' ' HB2' ' A' ' 554' ' ' GLU . 16.0 Cg_exo -68.1 155.81 68.13 Favored 'Trans proline' 0 C--O 1.235 0.368 0 C-N-CA 123.036 2.491 . . . . 0.0 111.437 179.593 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 552' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -43.93 -55.29 3.17 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 123.861 3.041 . . . . 0.0 113.598 -176.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 553' ' ' ARG . . . . . . . . . . . . . 8.6 ptm180 -63.5 -38.76 92.35 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 -177.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 554' ' ' GLU . . . . . 0.533 ' HB2' ' HD2' ' A' ' 551' ' ' PRO . 4.5 mm-40 -73.22 -49.48 27.67 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.827 0.346 . . . . 0.0 111.04 -174.301 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 555' ' ' ARG . . . . . 0.438 ' HB3' ' HB2' ' A' ' 550' ' ' LEU . 20.6 ptt180 -66.53 -28.39 68.51 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.11 -179.285 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 47.6 t -73.37 -29.99 63.0 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.712 0.291 . . . . 0.0 110.757 179.522 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 557' ' ' ARG . . . . . . . . . . . . . 22.2 mtp180 -83.04 -53.63 5.67 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.023 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 558' ' ' LEU . . . . . 0.587 ' O ' ' HG ' ' A' ' 565' ' ' LEU . 47.2 tp -63.91 -40.43 96.49 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.655 0.264 . . . . 0.0 111.564 -174.297 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 559' ' ' LEU . . . . . . . . . . . . . 63.7 mt -94.11 13.23 23.77 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.052 0.453 . . . . 0.0 110.98 -178.144 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 560' ' ' GLY . . . . . . . . . . . . . . . -126.12 -48.66 0.19 Allowed Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.609 -0.805 . . . . 0.0 112.469 -178.584 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 561' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -86.24 116.15 24.24 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.97 0.414 . . . . 0.0 110.548 -176.44 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 562' ' ' ALA . . . . . . . . . . . . . . . -68.71 -21.9 64.37 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.537 -176.386 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 563' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -81.33 -45.74 15.73 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 -178.761 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 564' ' ' GLU . . . . . 0.445 ' O ' HG12 ' A' ' 568' ' ' ILE . 29.2 mt-10 -69.69 -25.18 63.76 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.481 177.8 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 565' ' ' LEU . . . . . 0.587 ' HG ' ' O ' ' A' ' 558' ' ' LEU . 4.0 mt -58.77 -55.85 29.72 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.957 0.408 . . . . 0.0 109.946 170.797 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 566' ' ' ALA . . . . . 0.567 ' O ' ' HG3' ' A' ' 570' ' ' LYS . . . -62.51 -26.97 68.82 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.843 178.444 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 567' ' ' ASN . . . . . 0.457 ' C ' HD22 ' A' ' 567' ' ' ASN . 0.2 OUTLIER -73.18 -55.24 6.73 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.985 179.362 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 568' ' ' ILE . . . . . 0.445 HG12 ' O ' ' A' ' 564' ' ' GLU . 50.8 mm -68.81 -34.65 65.7 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 CA-C-O 120.701 0.286 . . . . 0.0 111.738 -175.113 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 569' ' ' LEU . . . . . 0.444 ' HG ' ' O ' ' A' ' 565' ' ' LEU . 87.1 mt -63.12 -25.63 68.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.799 0.333 . . . . 0.0 111.227 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 570' ' ' LYS . . . . . 0.567 ' HG3' ' O ' ' A' ' 566' ' ' ALA . 62.5 mttp -69.5 -13.93 62.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.893 0.378 . . . . 0.0 111.099 178.018 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 571' ' ' TYR . . . . . . . . . . . . . 15.6 t80 -94.72 -7.86 39.38 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.149 0.5 . . . . 0.0 110.506 -177.21 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 572' ' ' HIS . . . . . . . . . . . . . 75.8 m80 -101.03 -9.21 21.64 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.71 -179.227 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 573' ' ' ILE . . . . . 0.408 ' O ' HD23 ' A' ' 592' ' ' LEU . 29.3 mt -111.9 123.13 67.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.418 178.233 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 574' ' ' GLY . . . . . 0.495 ' HA2' ' HA ' ' A' ' 591' ' ' SER . . . -98.87 167.39 21.85 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.21 176.388 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 575' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -92.24 -4.8 53.56 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 113.112 0.782 . . . . 0.0 113.112 -168.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 576' ' ' GLU . . . . . 0.735 ' HB2' HD21 ' A' ' 589' ' ' LEU . 70.0 mm-40 -128.77 -167.08 1.72 Allowed 'General case' 0 CA--C 1.504 -0.812 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 179.783 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 577' ' ' ILE . . . . . 0.647 HG13 ' HB ' ' A' ' 536' ' ' VAL . 82.0 mt -112.42 105.32 18.56 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 N-CA-C 110.051 -0.352 . . . . 0.0 110.051 167.773 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 578' ' ' LEU . . . . . 0.657 HD21 HG11 ' A' ' 587' ' ' VAL . 0.3 OUTLIER -100.86 115.27 29.97 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 178.644 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 579' ' ' VAL . . . . . . . . . . . . . 30.6 m -113.69 163.73 10.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.496 179.384 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 580' ' ' SER . . . . . . . . . . . . . 49.6 p -62.33 -33.8 75.39 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-O 120.868 0.366 . . . . 0.0 111.03 -178.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 581' ' ' GLY . . . . . . . . . . . . . . . -77.32 22.9 2.41 Favored Glycine 0 CA--C 1.519 0.287 0 C-N-CA 121.207 -0.52 . . . . 0.0 112.543 179.529 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . -140.58 23.64 2.66 Favored Glycine 0 N--CA 1.445 -0.757 0 N-CA-C 111.543 -0.623 . . . . 0.0 111.543 176.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 583' ' ' ILE . . . . . . . . . . . . . 2.5 mt -122.3 98.94 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 CA-C-O 121.152 0.501 . . . . 0.0 110.38 179.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 584' ' ' GLY . . . . . . . . . . . . . . . -82.15 -20.59 62.48 Favored Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 120.63 -0.795 . . . . 0.0 111.781 176.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 585' ' ' ALA . . . . . . . . . . . . . . . -163.19 -79.77 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.921 0.391 . . . . 0.0 110.328 178.028 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 586' ' ' LEU . . . . . 0.789 HD11 ' HB3' ' A' ' 598' ' ' GLU . 53.4 tp -135.92 132.6 36.68 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.173 179.681 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 587' ' ' VAL . . . . . 0.657 HG11 HD21 ' A' ' 578' ' ' LEU . 42.8 t -127.21 116.52 44.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.185 177.343 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 588' ' ' ARG . . . . . 0.871 ' HG2' ' HG2' ' A' ' 598' ' ' GLU . 96.7 mtt180 -85.43 103.59 14.46 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.142 0.496 . . . . 0.0 109.966 176.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 589' ' ' LEU . . . . . 0.735 HD21 ' HB2' ' A' ' 576' ' ' GLU . 0.7 OUTLIER -101.18 125.15 47.78 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.312 -0.858 . . . . 0.0 108.772 -177.309 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 590' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -65.05 149.97 48.92 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.088 0.47 . . . . 0.0 111.552 -177.751 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 591' ' ' SER . . . . . 0.495 ' HA ' ' HA2' ' A' ' 574' ' ' GLY . 54.4 p -111.17 158.3 19.07 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.493 174.414 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 592' ' ' LEU . . . . . 0.408 HD23 ' O ' ' A' ' 573' ' ' ILE . 3.3 mm? -60.74 -18.23 53.37 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 112.068 0.395 . . . . 0.0 112.068 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 593' ' ' GLN . . . . . 0.461 ' N ' ' HB3' ' A' ' 570' ' ' LYS . 4.8 tt0 -71.51 -29.04 64.34 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.027 0.441 . . . . 0.0 110.352 176.649 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 594' ' ' GLY . . . . . . . . . . . . . . . 109.3 -6.72 32.18 Favored Glycine 0 N--CA 1.443 -0.891 0 C-N-CA 120.72 -0.753 . . . . 0.0 111.683 -173.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 595' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -89.93 -174.59 4.31 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 176.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 596' ' ' LYS . . . . . 0.598 ' HD3' ' H ' ' A' ' 596' ' ' LYS . 0.0 OUTLIER -121.66 132.76 54.83 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.206 0.527 . . . . 0.0 111.287 -172.509 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 597' ' ' LEU . . . . . 0.668 ' HA ' HD21 ' A' ' 609' ' ' ASN . 42.6 mt -101.17 115.28 30.12 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 172.17 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 598' ' ' GLU . . . . . 0.871 ' HG2' ' HG2' ' A' ' 588' ' ' ARG . 46.3 mt-10 -89.42 91.78 8.86 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-O 121.203 0.525 . . . . 0.0 109.863 -179.135 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 599' ' ' VAL . . . . . . . . . . . . . 20.3 t -86.6 121.2 37.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 115.267 -0.879 . . . . 0.0 108.871 179.506 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 600' ' ' SER . . . . . . . . . . . . . 3.5 p -130.59 156.32 45.05 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.56 -174.008 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 601' ' ' LEU . . . . . . . . . . . . . 21.3 tp -126.35 107.3 10.17 Favored 'General case' 0 N--CA 1.445 -0.724 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 175.368 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 602' ' ' LYS . . . . . 0.542 ' HG2' ' OD1' ' A' ' 603' ' ' ASN . 36.1 ttpt -127.7 118.91 24.7 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.965 -175.71 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 603' ' ' ASN . . . . . 0.542 ' OD1' ' HG2' ' A' ' 602' ' ' LYS . 18.1 m120 61.47 35.93 17.38 Favored 'General case' 0 C--N 1.331 -0.217 0 O-C-N 123.346 0.404 . . . . 0.0 109.946 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 604' ' ' ASN . . . . . . . . . . . . . 14.2 m120 72.45 4.77 5.1 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 115.144 -0.935 . . . . 0.0 111.669 179.673 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 605' ' ' VAL . . . . . . . . . . . . . 58.6 t -103.56 123.54 57.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 110.273 -0.269 . . . . 0.0 110.273 178.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 606' ' ' VAL . . . . . 0.603 HG13 ' HB ' ' A' ' 613' ' ' VAL . 7.1 p -88.41 129.33 39.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 121.175 0.512 . . . . 0.0 110.8 -179.352 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 607' ' ' SER . . . . . 0.455 ' HA ' ' HA ' ' A' ' 612' ' ' PRO . 2.8 p -133.16 152.49 51.94 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.984 -179.76 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 608' ' ' VAL . . . . . . . . . . . . . 2.6 p -133.91 104.73 6.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.863 179.676 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 609' ' ' ASN . . . . . 0.668 HD21 ' HA ' ' A' ' 597' ' ' LEU . 89.2 m-20 55.8 66.43 1.21 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.84 -178.43 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 610' ' ' LYS . . . . . 0.526 ' HB3' ' O ' ' A' ' 609' ' ' ASN . 58.9 tptt 78.56 -42.81 0.34 Allowed 'General case' 0 N--CA 1.47 0.575 0 CA-C-N 115.724 -0.671 . . . . 0.0 112.715 178.365 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 611' ' ' GLU . . . . . 0.48 ' HA ' ' HD3' ' A' ' 612' ' ' PRO . 4.5 mm-40 -88.99 137.66 29.57 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-O 120.79 0.329 . . . . 0.0 111.463 -172.599 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 612' ' ' PRO . . . . . 0.48 ' HD3' ' HA ' ' A' ' 611' ' ' GLU . 5.8 Cg_exo -77.65 153.91 30.46 Favored 'Trans proline' 0 N--CA 1.459 -0.501 0 C-N-CA 122.917 2.412 . . . . 0.0 112.445 179.236 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 613' ' ' VAL . . . . . 0.603 ' HB ' HG13 ' A' ' 606' ' ' VAL . 24.7 t -94.52 134.11 33.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.341 177.319 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 614' ' ' ALA . . . . . 0.503 ' HB2' HG23 ' A' ' 629' ' ' THR . . . -74.18 -47.1 37.88 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.533 -175.746 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 615' ' ' GLU . . . . . 0.457 ' HB3' ' CG2' ' A' ' 627' ' ' VAL . 36.7 tt0 -147.76 101.64 3.69 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-O 120.969 0.414 . . . . 0.0 110.332 -177.423 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 616' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -90.01 162.57 4.9 Favored 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 123.228 2.619 . . . . 0.0 113.866 -178.414 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 26.8 m-20 77.64 28.79 0.55 Allowed 'General case' 0 CA--C 1.508 -0.635 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.77 163.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 618' ' ' ILE . . . . . 0.557 ' HB ' ' O ' ' A' ' 625' ' ' VAL . 20.2 mt -71.92 108.73 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.081 0 CA-C-N 114.505 -1.225 . . . . 0.0 109.03 173.38 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 619' ' ' MET . . . . . . . . . . . . . 5.7 mmt -79.04 129.29 34.29 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.769 -0.65 . . . . 0.0 112.547 -171.422 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 620' ' ' ALA . . . . . . . . . . . . . . . -118.71 174.91 6.0 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 169.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 621' ' ' THR . . . . . . . . . . . . . 6.0 t -75.19 -25.46 58.27 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.319 -0.552 . . . . 0.0 110.939 -178.115 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 622' ' ' ASN . . . . . 0.464 ' O ' ' HA ' ' A' ' 536' ' ' VAL . 22.9 p-10 -116.88 -9.2 11.22 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 112.481 0.548 . . . . 0.0 112.481 -175.359 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 623' ' ' GLY . . . . . . . . . . . . . . . -169.66 -160.7 18.55 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 119.369 -1.396 . . . . 0.0 113.202 -175.635 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 624' ' ' VAL . . . . . . . . . . . . . 5.6 p -130.13 155.27 41.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 -178.541 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 625' ' ' VAL . . . . . 0.557 ' O ' ' HB ' ' A' ' 618' ' ' ILE . 61.5 t -126.05 135.39 64.0 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.935 179.199 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 626' ' ' HIS . . . . . . . . . . . . . 82.4 m-70 -120.92 114.43 21.54 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.687 177.081 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 627' ' ' VAL . . . . . 0.967 HG22 ' HZ ' ' A' ' 515' ' ' PHE . 29.9 t -67.09 124.11 21.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.418 177.544 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 628' ' ' ILE . . . . . 0.549 HD13 ' HB3' ' A' ' 540' ' ' PHE . 4.4 pt -121.43 142.36 37.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-O 121.124 0.488 . . . . 0.0 110.565 175.273 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 629' ' ' THR . . . . . 0.503 HG23 ' HB2' ' A' ' 614' ' ' ALA . 37.8 p -89.12 -7.44 55.74 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.194 -178.151 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 630' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -129.05 160.43 32.8 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.649 -175.316 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 631' ' ' VAL . . . . . 0.673 HG23 ' HB1' ' A' ' 546' ' ' ALA . 81.1 t -95.11 128.98 45.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 179.479 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 632' ' ' LEU . . . . . . . . . . . . . 96.3 mt -80.92 111.51 17.46 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.313 0.578 . . . . 0.0 110.619 -178.403 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 633' ' ' GLN . . . . . 0.449 ' HA ' ' HD3' ' A' ' 634' ' ' PRO . 51.3 mt-30 -110.84 131.48 22.1 Favored Pre-proline 0 C--N 1.318 -0.761 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.619 -179.397 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 634' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 633' ' ' GLN . 5.6 Cg_exo . . . . . 0 C--O 1.248 0.998 0 C-N-CA 122.971 2.447 . . . . 0.0 111.179 175.307 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 500' ' ' ALA . . . . . 0.482 ' HA ' ' OE2' ' A' ' 534' ' ' GLU . . . . . . . . 0 N--CA 1.478 0.959 0 CA-C-O 121.201 0.524 . . . . 0.0 111.153 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 501' ' ' GLY . . . . . . . . . . . . . . . -161.03 -101.22 0.16 Allowed Glycine 0 N--CA 1.447 -0.568 0 N-CA-C 111.067 -0.813 . . . . 0.0 111.067 177.284 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 502' ' ' MET . . . . . . . . . . . . . 26.2 ttt -150.15 -74.59 0.16 Allowed 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 110.13 -0.322 . . . . 0.0 110.13 176.336 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . -104.51 130.85 10.39 Favored Glycine 0 N--CA 1.442 -0.904 0 C-N-CA 120.481 -0.866 . . . . 0.0 111.574 179.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 26.5 p -69.7 176.23 3.72 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 177.59 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 505' ' ' VAL . . . . . 0.712 ' O ' ' HG ' ' A' ' 509' ' ' LEU . 15.8 m -58.0 -32.04 42.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 C-N-CA 120.775 -0.37 . . . . 0.0 110.387 175.512 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 506' ' ' MET . . . . . . . . . . . . . 11.0 mmt -62.41 -43.74 98.1 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.271 176.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 507' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -61.39 -44.75 96.62 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 120.869 0.366 . . . . 0.0 110.84 179.454 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 508' ' ' VAL . . . . . . . . . . . . . 60.9 t -60.92 -45.51 98.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.745 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 509' ' ' LEU . . . . . 0.712 ' HG ' ' O ' ' A' ' 505' ' ' VAL . 77.5 mt -68.48 -36.23 78.65 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.218 -177.752 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 510' ' ' LYS . . . . . 0.41 ' HE2' HG11 ' A' ' 519' ' ' VAL . 54.4 mttm -77.28 -26.73 52.64 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.272 0.558 . . . . 0.0 110.011 -178.341 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 511' ' ' GLY . . . . . . . . . . . . . . . -71.48 -15.21 75.12 Favored Glycine 0 N--CA 1.445 -0.758 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.678 176.593 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 512' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -106.64 145.77 31.55 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.983 0.42 . . . . 0.0 111.04 179.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 -75.55 -25.23 56.97 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.207 -175.002 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 514' ' ' ARG . . . . . 0.431 ' HB3' ' HA ' ' A' ' 543' ' ' THR . 3.0 mpt_? -86.32 -50.0 7.25 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.305 0.574 . . . . 0.0 109.833 -178.189 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 515' ' ' PHE . . . . . 0.542 ' CZ ' HG22 ' A' ' 627' ' ' VAL . 11.5 m-30 -66.49 -27.0 67.44 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.635 -175.461 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 5.1 p -63.38 -30.21 71.38 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.657 0.265 . . . . 0.0 111.71 -178.52 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 517' ' ' MET . . . . . . . . . . . . . 54.7 mtm -69.78 -34.37 73.66 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 176.474 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 518' ' ' LEU . . . . . 0.545 HD22 ' HD2' ' A' ' 542' ' ' PRO . 51.9 tp -67.58 -40.04 84.84 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.372 173.362 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 519' ' ' VAL . . . . . 0.41 HG11 ' HE2' ' A' ' 510' ' ' LYS . 86.7 t -55.74 -37.09 45.44 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.371 0 CA-C-N 116.223 -0.444 . . . . 0.0 109.925 174.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 520' ' ' ALA . . . . . . . . . . . . . . . -63.74 -38.61 91.77 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.402 -179.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 521' ' ' ALA . . . . . . . . . . . . . . . -67.86 -51.39 48.78 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.825 0.345 . . . . 0.0 110.327 176.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 522' ' ' ILE . . . . . 0.527 ' HA ' ' HG ' ' A' ' 569' ' ' LEU . 62.1 mt -57.74 -40.83 77.71 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 CA-C-O 121.216 0.531 . . . . 0.0 111.164 178.136 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 523' ' ' GLN . . . . . 0.474 ' HA ' ' OG1' ' A' ' 528' ' ' THR . 21.5 tt0 -70.06 -39.21 75.79 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.408 -0.815 . . . . 0.0 110.762 -175.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 43.6 m -72.83 -31.16 64.6 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.93 0.395 . . . . 0.0 110.715 178.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 525' ' ' ALA . . . . . 0.652 ' HB1' ' HA ' ' A' ' 566' ' ' ALA . . . -74.86 -19.92 59.96 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.226 0.536 . . . . 0.0 110.524 176.817 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 526' ' ' GLY . . . . . . . . . . . . . . . 84.46 37.52 10.73 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.774 -0.726 . . . . 0.0 113.153 176.119 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 527' ' ' LEU . . . . . . . . . . . . . 9.1 mp -112.35 15.24 20.38 Favored 'General case' 0 C--N 1.326 -0.416 0 O-C-N 122.599 -0.353 . . . . 0.0 110.957 177.117 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 528' ' ' THR . . . . . 0.474 ' OG1' ' HA ' ' A' ' 523' ' ' GLN . 14.6 m -62.08 -33.74 74.99 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.579 -178.233 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 529' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -69.4 -24.85 63.91 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.551 -177.39 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 530' ' ' THR . . . . . 0.615 ' HB ' HD22 ' A' ' 531' ' ' LEU . 11.0 m -63.14 -53.36 54.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.062 0.458 . . . . 0.0 110.58 179.524 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 531' ' ' LEU . . . . . 0.615 HD22 ' HB ' ' A' ' 530' ' ' THR . 1.8 mm? -79.43 6.11 11.04 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.907 -178.808 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 532' ' ' ASN . . . . . . . . . . . . . 37.5 t-20 -87.83 -28.06 21.87 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.35 0.595 . . . . 0.0 109.428 179.441 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 533' ' ' ARG . . . . . . . . . . . . . 9.5 ttp180 -79.22 137.17 37.3 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.608 -0.723 . . . . 0.0 110.492 178.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 534' ' ' GLU . . . . . 0.645 ' HA ' ' HB3' ' A' ' 622' ' ' ASN . 48.5 mt-10 -77.04 133.91 38.95 Favored 'General case' 0 C--O 1.233 0.191 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 175.188 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 535' ' ' GLY . . . . . . . . . . . . . . . 173.7 -137.64 4.16 Favored Glycine 0 CA--C 1.501 -0.826 0 N-CA-C 110.675 -0.97 . . . . 0.0 110.675 -178.579 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 536' ' ' VAL . . . . . 0.459 ' HB ' HG13 ' A' ' 577' ' ' ILE . 33.8 m -119.52 130.27 74.27 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-O 121.077 0.465 . . . . 0.0 110.963 178.555 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 537' ' ' TYR . . . . . . . . . . . . . 75.8 m-85 -151.25 146.42 26.05 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.636 178.22 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 538' ' ' THR . . . . . 0.73 ' OG1' ' HA ' ' A' ' 577' ' ' ILE . 30.9 m -120.02 101.56 7.93 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 171.3 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 539' ' ' VAL . . . . . . . . . . . . . 51.8 t -103.46 127.34 57.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.115 -174.276 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 540' ' ' PHE . . . . . 0.57 ' HB3' HD13 ' A' ' 628' ' ' ILE . 94.8 m-85 -100.09 112.67 24.97 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 175.675 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 541' ' ' ALA . . . . . 0.465 ' HA ' HD22 ' A' ' 518' ' ' LEU . . . -105.93 113.0 64.2 Favored Pre-proline 0 C--N 1.325 -0.487 0 CA-C-O 120.705 0.288 . . . . 0.0 111.423 -176.788 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 542' ' ' PRO . . . . . 0.545 ' HD2' HD22 ' A' ' 518' ' ' LEU . 13.2 Cg_exo -71.02 142.24 41.94 Favored 'Trans proline' 0 N--CA 1.463 -0.29 0 C-N-CA 123.068 2.512 . . . . 0.0 112.079 176.693 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 543' ' ' THR . . . . . 0.431 ' HA ' ' HB3' ' A' ' 514' ' ' ARG . 40.9 p -80.4 179.56 7.64 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.017 178.732 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 544' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -61.78 -34.37 75.74 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.639 -179.168 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 545' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -62.82 -30.11 71.23 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.107 -176.131 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 546' ' ' ALA . . . . . 0.566 ' HB1' HG23 ' A' ' 631' ' ' VAL . . . -64.95 -49.73 69.2 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.301 0.572 . . . . 0.0 110.634 179.145 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 547' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -69.76 -22.04 63.39 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.784 -178.342 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 548' ' ' ARG . . . . . 0.514 ' O ' ' HD2' ' A' ' 548' ' ' ARG . 5.0 tmm_? -84.48 -35.71 22.78 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.859 -179.107 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 549' ' ' ALA . . . . . . . . . . . . . . . -69.36 -29.97 67.88 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.335 176.42 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 550' ' ' LEU . . . . . 0.472 ' HA ' ' HD3' ' A' ' 551' ' ' PRO . 70.8 mt -64.6 131.49 95.13 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.546 175.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 551' ' ' PRO . . . . . 0.477 ' HD2' ' HB2' ' A' ' 554' ' ' GLU . 6.9 Cg_exo -72.56 145.71 42.59 Favored 'Trans proline' 0 N--CA 1.459 -0.548 0 C-N-CA 122.828 2.352 . . . . 0.0 111.609 -177.309 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 552' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 551' ' ' PRO . 50.0 Cg_exo -53.86 -30.45 57.84 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 123.074 2.516 . . . . 0.0 112.082 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 553' ' ' ARG . . . . . . . . . . . . . 58.7 ttp180 -66.68 -54.71 20.2 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.806 177.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 554' ' ' GLU . . . . . 0.477 ' HB2' ' HD2' ' A' ' 551' ' ' PRO . 0.9 OUTLIER -65.15 -48.9 71.9 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.909 -175.939 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 555' ' ' ARG . . . . . 0.405 ' HG2' ' O ' ' A' ' 551' ' ' PRO . 14.3 ptm180 -60.18 -39.23 85.73 Favored 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 121.12 -0.232 . . . . 0.0 111.464 -176.101 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 50.0 m -71.52 -27.5 63.24 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 111.683 0.253 . . . . 0.0 111.683 -175.611 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 557' ' ' ARG . . . . . . . . . . . . . 33.0 ttm180 -75.96 -43.28 45.39 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.053 0.454 . . . . 0.0 109.781 177.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 558' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -66.71 -42.88 85.67 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.218 -179.383 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 559' ' ' LEU . . . . . 0.77 HD23 HD21 ' A' ' 565' ' ' LEU . 63.7 mt -83.13 0.13 46.6 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.047 -178.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 560' ' ' GLY . . . . . . . . . . . . . . . -88.13 -9.63 70.12 Favored Glycine 0 N--CA 1.453 -0.196 0 CA-C-N 116.039 -0.528 . . . . 0.0 112.612 -178.25 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 561' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -127.86 129.92 47.73 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 178.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 562' ' ' ALA . . . . . . . . . . . . . . . -76.9 -28.23 55.26 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 111.927 0.343 . . . . 0.0 111.927 -175.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 563' ' ' LYS . . . . . 0.476 ' HD2' ' N ' ' A' ' 563' ' ' LYS . 0.5 OUTLIER -80.36 -35.28 35.68 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 -177.125 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 564' ' ' GLU . . . . . . . . . . . . . 21.4 mm-40 -61.14 -43.96 98.06 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 171.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 565' ' ' LEU . . . . . 0.77 HD21 HD23 ' A' ' 559' ' ' LEU . 60.3 mt -57.5 -53.36 59.03 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.74 175.261 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 566' ' ' ALA . . . . . 0.652 ' HA ' ' HB1' ' A' ' 525' ' ' ALA . . . -55.75 -26.18 44.38 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.218 -178.825 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 567' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -86.59 -35.12 19.64 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.808 -179.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 568' ' ' ILE . . . . . . . . . . . . . 22.3 mm -69.71 -52.19 34.1 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 CA-C-N 116.075 -0.511 . . . . 0.0 112.331 -179.127 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 569' ' ' LEU . . . . . 0.527 ' HG ' ' HA ' ' A' ' 522' ' ' ILE . 2.7 mm? -64.22 -23.46 67.32 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-O 121.1 0.476 . . . . 0.0 110.968 177.619 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 570' ' ' LYS . . . . . . . . . . . . . 16.3 ttmm -70.96 -12.4 61.51 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.646 177.073 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 571' ' ' TYR . . . . . 0.47 ' HB2' HE21 ' A' ' 593' ' ' GLN . 59.9 t80 -102.77 -18.07 15.31 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.872 -0.603 . . . . 0.0 111.222 -177.644 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 572' ' ' HIS . . . . . . . . . . . . . 55.4 m80 -86.43 -3.75 59.06 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.118 0.485 . . . . 0.0 110.89 -177.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 573' ' ' ILE . . . . . 0.513 HD13 HD11 ' A' ' 531' ' ' LEU . 27.0 mt -118.19 127.24 75.37 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.134 179.806 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 574' ' ' GLY . . . . . 0.571 ' HA2' ' HA ' ' A' ' 591' ' ' SER . . . -89.12 153.46 23.6 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.934 -0.65 . . . . 0.0 111.58 175.667 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 575' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -74.81 -8.7 57.23 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 120.978 0.418 . . . . 0.0 111.989 -171.482 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 576' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -160.47 162.99 33.3 Favored 'General case' 0 N--CA 1.438 -1.058 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 177.553 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 577' ' ' ILE . . . . . 0.73 ' HA ' ' OG1' ' A' ' 538' ' ' THR . 70.0 mt -78.6 124.1 36.47 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 O-C-N 124.005 0.816 . . . . 0.0 112.386 -170.695 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 578' ' ' LEU . . . . . 0.517 HD11 ' HA ' ' A' ' 583' ' ' ILE . 42.3 tp -122.9 102.09 7.81 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.1 -0.955 . . . . 0.0 109.082 173.428 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 579' ' ' VAL . . . . . . . . . . . . . 30.1 m -96.54 157.39 3.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.84 -177.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 580' ' ' SER . . . . . . . . . . . . . 31.8 t -58.44 -38.96 78.56 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.351 -179.534 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 581' ' ' GLY . . . . . . . . . . . . . . . -74.48 9.96 9.37 Favored Glycine 0 N--CA 1.449 -0.486 0 CA-C-N 115.74 -0.663 . . . . 0.0 113.717 -179.477 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . -162.77 42.59 0.35 Allowed Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.814 -0.707 . . . . 0.0 112.87 178.441 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 583' ' ' ILE . . . . . 0.777 HD12 ' HB2' ' A' ' 601' ' ' LEU . 30.6 mt -80.18 -65.46 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.828 0.347 . . . . 0.0 110.614 176.769 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 584' ' ' GLY . . . . . . . . . . . . . . . 99.82 63.11 0.82 Allowed Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.605 -0.807 . . . . 0.0 111.856 -177.063 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 585' ' ' ALA . . . . . . . . . . . . . . . 67.63 -75.57 0.06 Allowed 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 123.389 0.676 . . . . 0.0 111.96 -179.611 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 586' ' ' LEU . . . . . 0.998 ' HG ' ' HB3' ' A' ' 600' ' ' SER . 6.5 tt -151.32 129.85 12.2 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.904 0.383 . . . . 0.0 110.237 -178.268 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 587' ' ' VAL . . . . . . . . . . . . . 94.5 t -133.59 133.6 57.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.752 -178.042 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 588' ' ' ARG . . . . . . . . . . . . . 71.8 mtt180 -84.26 102.78 12.92 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 173.044 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 589' ' ' LEU . . . . . . . . . . . . . 60.3 tp -90.51 111.98 23.47 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.584 0.707 . . . . 0.0 110.788 -173.401 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 590' ' ' LYS . . . . . . . . . . . . . 46.5 pttt -60.3 137.35 58.14 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 114.93 -1.032 . . . . 0.0 110.634 176.516 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 591' ' ' SER . . . . . 0.571 ' HA ' ' HA2' ' A' ' 574' ' ' GLY . 44.9 p -99.24 172.59 7.26 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.161 175.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 592' ' ' LEU . . . . . 0.423 HD23 ' O ' ' A' ' 573' ' ' ILE . 2.9 mm? -58.76 -22.54 58.22 Favored 'General case' 0 CA--C 1.529 0.173 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 179.593 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 593' ' ' GLN . . . . . 0.749 ' HG3' ' H ' ' A' ' 595' ' ' ASP . 5.8 pt20 -85.34 -29.9 24.12 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.63 -0.428 . . . . 0.0 111.145 178.345 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 594' ' ' GLY . . . . . 0.433 ' N ' ' HG3' ' A' ' 593' ' ' GLN . . . 122.06 -18.76 8.39 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.611 -0.804 . . . . 0.0 113.136 -177.313 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 595' ' ' ASP . . . . . 0.749 ' H ' ' HG3' ' A' ' 593' ' ' GLN . 18.1 t70 -68.46 165.0 19.83 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-N 117.708 0.754 . . . . 0.0 110.189 178.421 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 596' ' ' LYS . . . . . . . . . . . . . 44.9 mttm -109.45 113.37 26.11 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.189 -170.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 597' ' ' LEU . . . . . . . . . . . . . 58.3 mt -79.55 125.76 30.01 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.042 175.233 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 598' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -78.85 84.64 4.88 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 120.612 -0.435 . . . . 0.0 110.163 176.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 599' ' ' VAL . . . . . . . . . . . . . 38.1 t -97.92 121.4 48.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 121.217 0.532 . . . . 0.0 109.588 178.528 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 600' ' ' SER . . . . . 0.998 ' HB3' ' HG ' ' A' ' 586' ' ' LEU . 8.2 p -139.64 160.13 40.57 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-O 120.872 0.367 . . . . 0.0 111.377 -175.429 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 601' ' ' LEU . . . . . 0.777 ' HB2' HD12 ' A' ' 583' ' ' ILE . 39.4 tp -118.45 109.92 16.81 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.852 -179.388 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 602' ' ' LYS . . . . . . . . . . . . . 43.6 mmtm -121.53 114.96 21.96 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.132 -0.485 . . . . 0.0 109.826 178.173 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 603' ' ' ASN . . . . . . . . . . . . . 16.7 m120 58.92 38.52 24.39 Favored 'General case' 0 N--CA 1.465 0.31 0 O-C-N 123.316 0.385 . . . . 0.0 110.526 178.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 604' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 66.34 17.25 10.66 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.236 -179.455 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 605' ' ' VAL . . . . . . . . . . . . . 61.2 t -110.05 121.86 63.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 175.032 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 606' ' ' VAL . . . . . . . . . . . . . 25.1 t -85.83 131.35 34.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.395 -178.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 607' ' ' SER . . . . . . . . . . . . . 42.1 m -131.24 131.43 43.91 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.356 176.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 608' ' ' VAL . . . . . 0.462 HG13 HD21 ' A' ' 632' ' ' LEU . 3.6 p -115.2 111.82 37.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.86 178.609 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 609' ' ' ASN . . . . . 0.506 ' O ' ' HB3' ' A' ' 610' ' ' LYS . 91.6 m-20 60.89 35.47 19.23 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.921 -175.04 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 610' ' ' LYS . . . . . 0.506 ' HB3' ' O ' ' A' ' 609' ' ' ASN . 83.9 tttt 82.28 -24.99 0.16 Allowed 'General case' 0 N--CA 1.47 0.547 0 O-C-N 124.544 1.152 . . . . 0.0 111.795 -177.634 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 611' ' ' GLU . . . . . 0.429 ' HA ' ' HD3' ' A' ' 612' ' ' PRO . 11.0 mm-40 -67.81 127.47 93.36 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.064 0.459 . . . . 0.0 110.602 -179.208 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 612' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 611' ' ' GLU . 3.1 Cg_exo -74.76 130.74 13.83 Favored 'Trans proline' 0 N--CA 1.459 -0.526 0 C-N-CA 123.099 2.533 . . . . 0.0 112.701 -175.034 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 613' ' ' VAL . . . . . . . . . . . . . 96.7 t -79.71 125.9 38.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.568 175.295 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 614' ' ' ALA . . . . . 0.649 ' HB2' HG23 ' A' ' 629' ' ' THR . . . -78.94 -36.79 41.15 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.789 -176.463 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 615' ' ' GLU . . . . . 0.425 ' HB2' ' HB ' ' A' ' 627' ' ' VAL . 9.8 mm-40 -152.48 94.65 3.18 Favored Pre-proline 0 N--CA 1.467 0.393 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.848 -177.114 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 616' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -90.48 162.88 4.41 Favored 'Trans proline' 0 N--CA 1.46 -0.46 0 C-N-CA 123.139 2.56 . . . . 0.0 113.562 179.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 617' ' ' ASP . . . . . 0.434 ' H ' ' CE1' ' A' ' 626' ' ' HIS . 5.0 m-20 76.07 33.22 0.59 Allowed 'General case' 0 CA--C 1.506 -0.743 0 CA-C-O 122.103 0.954 . . . . 0.0 110.261 165.264 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 618' ' ' ILE . . . . . 0.506 ' HB ' ' O ' ' A' ' 625' ' ' VAL . 22.7 mt -82.19 97.72 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.36 0 CA-C-N 113.936 -1.484 . . . . 0.0 109.449 178.569 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 619' ' ' MET . . . . . 0.41 ' HA ' ' CE ' ' A' ' 619' ' ' MET . 2.8 mmt -62.39 111.28 1.95 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 114.948 -1.024 . . . . 0.0 111.939 -177.196 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 620' ' ' ALA . . . . . . . . . . . . . . . -110.73 -179.49 3.76 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 171.639 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 621' ' ' THR . . . . . . . . . . . . . 35.2 m -69.66 -46.86 65.18 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-O 120.886 0.374 . . . . 0.0 111.633 -177.566 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 622' ' ' ASN . . . . . 0.645 ' HB3' ' HA ' ' A' ' 534' ' ' GLU . 24.0 p-10 -116.72 32.81 5.93 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.827 -174.045 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 623' ' ' GLY . . . . . 0.611 ' HA2' HD11 ' A' ' 577' ' ' ILE . . . 150.67 -159.65 28.24 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.527 -0.844 . . . . 0.0 112.46 176.77 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 624' ' ' VAL . . . . . . . . . . . . . 9.8 m -123.4 165.95 19.04 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.753 0 CA-C-O 121.909 0.861 . . . . 0.0 111.352 176.111 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 625' ' ' VAL . . . . . 0.506 ' O ' ' HB ' ' A' ' 618' ' ' ILE . 89.8 t -128.51 107.33 15.75 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.193 0 CA-C-N 113.584 -1.644 . . . . 0.0 109.43 177.742 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 626' ' ' HIS . . . . . 0.434 ' CE1' ' H ' ' A' ' 617' ' ' ASP . 28.4 m-70 -95.41 103.31 15.17 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 177.192 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 627' ' ' VAL . . . . . 0.542 HG22 ' CZ ' ' A' ' 515' ' ' PHE . 41.8 t -62.75 130.85 27.81 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.0 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 628' ' ' ILE . . . . . 0.57 HD13 ' HB3' ' A' ' 540' ' ' PHE . 3.9 pt -124.85 143.64 37.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 121.193 0.52 . . . . 0.0 111.145 178.647 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 629' ' ' THR . . . . . 0.649 HG23 ' HB2' ' A' ' 614' ' ' ALA . 24.5 p -88.31 7.46 32.19 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.965 -0.561 . . . . 0.0 112.329 -178.485 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 630' ' ' ASN . . . . . . . . . . . . . 65.7 t30 -150.05 174.08 13.14 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 176.703 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 631' ' ' VAL . . . . . 0.566 HG23 ' HB1' ' A' ' 546' ' ' ALA . 48.9 t -101.19 133.81 43.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.036 -178.102 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 632' ' ' LEU . . . . . 0.462 HD21 HG13 ' A' ' 608' ' ' VAL . 95.9 mt -79.23 116.78 19.7 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-O 121.312 0.577 . . . . 0.0 111.149 -175.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 633' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -122.98 116.67 28.74 Favored Pre-proline 0 C--N 1.317 -0.814 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.083 179.464 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 634' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo . . . . . 0 C--O 1.249 1.057 0 C-N-CA 122.349 2.032 . . . . 0.0 112.266 -179.421 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 500' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.101 0 CA-C-O 120.677 0.275 . . . . 0.0 110.711 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 501' ' ' GLY . . . . . . . . . . . . . . . 111.68 114.07 3.39 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 121.044 -0.598 . . . . 0.0 111.709 179.696 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 502' ' ' MET . . . . . . . . . . . . . 61.4 mtm -117.91 8.29 12.55 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.149 0.5 . . . . 0.0 110.42 -179.123 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . -172.35 -176.29 41.01 Favored Glycine 0 N--CA 1.446 -0.67 0 N-CA-C 111.11 -0.796 . . . . 0.0 111.11 179.298 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 504' ' ' THR . . . . . 0.626 ' HA ' HG22 ' A' ' 621' ' ' THR . 47.7 p -81.25 172.36 13.72 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 117.065 0.432 . . . . 0.0 110.292 177.884 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 505' ' ' VAL . . . . . 0.661 HG23 HG22 ' A' ' 625' ' ' VAL . 5.0 p -54.66 -47.96 72.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.682 -179.179 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 506' ' ' MET . . . . . 0.601 ' HA ' HD13 ' A' ' 509' ' ' LEU . 2.8 ppp? -81.79 -17.09 48.78 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.519 -0.473 . . . . 0.0 111.077 -178.66 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 507' ' ' ASP . . . . . 0.497 ' HA ' ' HB2' ' A' ' 510' ' ' LYS . 27.6 t70 -68.13 -29.89 68.9 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 173.19 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 508' ' ' VAL . . . . . . . . . . . . . 84.9 t -61.79 -49.33 84.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.824 -0.626 . . . . 0.0 109.578 171.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 509' ' ' LEU . . . . . 1.055 ' HG ' ' HB3' ' A' ' 515' ' ' PHE . 9.6 mp -53.78 -42.36 68.21 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 121.617 0.722 . . . . 0.0 111.25 171.701 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 510' ' ' LYS . . . . . 0.507 ' HD3' ' SD ' ' A' ' 506' ' ' MET . 0.7 OUTLIER -68.59 -20.43 64.51 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 114.769 -1.105 . . . . 0.0 111.467 -177.937 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 511' ' ' GLY . . . . . . . . . . . . . . . -96.82 -0.91 60.2 Favored Glycine 0 N--CA 1.437 -1.252 0 C-N-CA 120.8 -0.714 . . . . 0.0 111.617 177.208 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 512' ' ' ASP . . . . . 0.421 ' O ' ' HB2' ' A' ' 516' ' ' SER . 27.0 t70 -117.98 148.84 41.82 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.513 0.673 . . . . 0.0 112.39 -176.527 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -75.56 -34.96 60.75 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.428 -179.513 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 514' ' ' ARG . . . . . . . . . . . . . 35.6 mtt180 -79.0 -53.25 7.22 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.085 -174.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 515' ' ' PHE . . . . . 1.055 ' HB3' ' HG ' ' A' ' 509' ' ' LEU . 14.4 m-30 -64.27 -17.12 63.31 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.066 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 516' ' ' SER . . . . . 0.421 ' HB2' ' O ' ' A' ' 512' ' ' ASP . 39.6 t -58.03 -31.06 66.63 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.304 -178.247 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 517' ' ' MET . . . . . 0.489 ' HB2' ' HE3' ' A' ' 517' ' ' MET . 47.7 mtm -72.39 -30.7 64.9 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.742 0.306 . . . . 0.0 110.441 178.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 518' ' ' LEU . . . . . 0.608 HD23 HD21 ' A' ' 509' ' ' LEU . 47.7 tp -70.23 -34.07 72.42 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 173.46 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 519' ' ' VAL . . . . . 0.419 ' CG2' ' HB3' ' A' ' 509' ' ' LEU . 56.7 t -61.41 -33.04 55.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 121.096 0.474 . . . . 0.0 109.774 174.162 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 520' ' ' ALA . . . . . . . . . . . . . . . -67.0 -40.59 87.38 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.325 177.739 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 521' ' ' ALA . . . . . . . . . . . . . . . -66.69 -47.75 71.44 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.151 176.236 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 522' ' ' ILE . . . . . 0.434 HG13 ' O ' ' A' ' 518' ' ' LEU . 87.9 mt -56.34 -43.01 76.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.752 176.575 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 523' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -62.69 -47.91 81.6 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.125 178.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 40.1 m -66.61 -36.42 82.55 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.062 -176.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 525' ' ' ALA . . . . . . . . . . . . . . . -78.58 -28.3 45.83 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.484 -0.326 . . . . 0.0 110.968 177.289 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 526' ' ' GLY . . . . . . . . . . . . . . . 82.02 38.04 14.37 Favored Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 121.286 -0.483 . . . . 0.0 112.931 177.277 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 527' ' ' LEU . . . . . . . . . . . . . 97.5 mt -111.07 20.41 17.46 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.765 0.317 . . . . 0.0 111.209 -177.568 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 528' ' ' THR . . . . . . . . . . . . . 8.8 m -62.08 -37.08 83.68 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.724 -177.535 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 529' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -63.44 -31.62 72.83 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 121.025 0.44 . . . . 0.0 110.681 -178.045 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 530' ' ' THR . . . . . . . . . . . . . 27.0 m -59.84 -46.63 88.66 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.078 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 531' ' ' LEU . . . . . 0.524 HD21 HD13 ' A' ' 573' ' ' ILE . 67.1 mt -93.05 11.44 27.57 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.161 0.505 . . . . 0.0 111.268 -178.094 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 532' ' ' ASN . . . . . . . . . . . . . 58.2 t30 -91.47 -51.01 5.48 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.55 -178.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 533' ' ' ARG . . . . . . . . . . . . . 1.7 tpt180 -68.43 146.1 53.5 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.733 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 534' ' ' GLU . . . . . 0.641 ' HA ' ' HB3' ' A' ' 622' ' ' ASN . 23.2 pm0 -76.6 143.74 40.03 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 121.322 0.582 . . . . 0.0 110.537 -179.345 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 535' ' ' GLY . . . . . 0.414 ' H ' ' HB2' ' A' ' 622' ' ' ASN . . . 177.2 -139.57 4.44 Favored Glycine 0 N--CA 1.446 -0.655 0 N-CA-C 110.117 -1.193 . . . . 0.0 110.117 -176.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 536' ' ' VAL . . . . . . . . . . . . . 33.0 m -124.48 130.31 73.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 117.31 0.555 . . . . 0.0 110.612 176.277 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 537' ' ' TYR . . . . . . . . . . . . . 76.0 m-85 -153.07 152.42 31.31 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.635 -178.488 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 538' ' ' THR . . . . . 0.74 ' OG1' ' HA ' ' A' ' 577' ' ' ILE . 30.7 m -134.89 102.38 5.22 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.403 174.031 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 539' ' ' VAL . . . . . 0.667 HG22 HG23 ' A' ' 573' ' ' ILE . 39.2 t -109.92 127.0 67.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 120.976 0.417 . . . . 0.0 111.694 -172.66 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 540' ' ' PHE . . . . . 0.529 ' HB3' HD13 ' A' ' 628' ' ' ILE . 87.9 m-85 -95.38 109.01 21.23 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 172.264 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 541' ' ' ALA . . . . . 0.473 ' HA ' HD22 ' A' ' 518' ' ' LEU . . . -96.01 111.23 55.53 Favored Pre-proline 0 C--N 1.322 -0.618 0 CA-C-N 116.628 -0.26 . . . . 0.0 111.193 -176.418 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 542' ' ' PRO . . . . . 0.581 ' HA ' HG13 ' A' ' 628' ' ' ILE . 18.5 Cg_endo -66.91 130.05 22.21 Favored 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 122.141 1.894 . . . . 0.0 110.967 175.251 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 17.4 p -96.4 -174.78 3.15 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.509 -0.769 . . . . 0.0 112.55 -171.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 544' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -49.76 -37.15 28.48 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 114.746 -1.115 . . . . 0.0 111.715 178.056 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 545' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -65.0 -28.62 69.63 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.976 -175.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 546' ' ' ALA . . . . . 0.621 ' HB1' HG23 ' A' ' 631' ' ' VAL . . . -79.08 -58.46 3.22 Favored 'General case' 0 CA--C 1.516 -0.348 0 CA-C-O 121.082 0.468 . . . . 0.0 111.616 -176.149 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 547' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -64.62 -29.85 70.86 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.727 -0.669 . . . . 0.0 111.548 -175.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 548' ' ' ARG . . . . . . . . . . . . . 47.3 ttp180 -66.66 -30.68 71.0 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.923 0.392 . . . . 0.0 110.46 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 549' ' ' ALA . . . . . . . . . . . . . . . -86.89 -10.57 53.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.461 -176.016 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 550' ' ' LEU . . . . . 0.491 HD11 HG21 ' A' ' 631' ' ' VAL . 88.2 mt -70.79 122.78 87.79 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 120.922 0.392 . . . . 0.0 110.978 -178.112 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 551' ' ' PRO . . . . . 0.477 ' HD3' ' HA ' ' A' ' 550' ' ' LEU . 16.5 Cg_exo -68.89 157.72 60.75 Favored 'Trans proline' 0 C--O 1.236 0.375 0 C-N-CA 123.327 2.685 . . . . 0.0 111.853 -178.294 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 552' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -44.17 -53.01 5.11 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 123.831 3.021 . . . . 0.0 113.225 -177.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 553' ' ' ARG . . . . . . . . . . . . . 23.2 mtm180 -63.2 -48.35 78.67 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 120.715 0.293 . . . . 0.0 111.513 -175.575 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -63.74 -52.77 58.99 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.736 -174.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 555' ' ' ARG . . . . . . . . . . . . . 19.6 ptt180 -66.34 -29.16 69.3 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.274 -177.474 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 29.2 t -75.6 -24.06 56.5 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.615 0.245 . . . . 0.0 110.834 -178.256 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 557' ' ' ARG . . . . . . . . . . . . . 12.3 tpp180 -82.94 -46.52 12.83 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.53 -0.304 . . . . 0.0 110.265 178.281 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 558' ' ' LEU . . . . . . . . . . . . . 51.2 tp -61.17 -41.56 97.01 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.768 179.223 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 559' ' ' LEU . . . . . 0.672 HD23 HD21 ' A' ' 565' ' ' LEU . 80.5 mt -91.83 6.35 46.45 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.195 0.522 . . . . 0.0 110.552 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 560' ' ' GLY . . . . . . . . . . . . . . . -96.72 -39.58 4.09 Favored Glycine 0 N--CA 1.444 -0.769 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.685 179.502 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 561' ' ' ASP . . . . . 0.514 ' HB2' ' HG2' ' A' ' 564' ' ' GLU . 6.1 m-20 -103.81 119.89 39.85 Favored 'General case' 0 N--CA 1.445 -0.708 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 177.139 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 562' ' ' ALA . . . . . . . . . . . . . . . -65.74 -28.84 69.34 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.986 0.422 . . . . 0.0 111.153 -176.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 563' ' ' LYS . . . . . . . . . . . . . 4.2 mptp? -69.6 -36.84 76.57 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.1 179.02 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 564' ' ' GLU . . . . . 0.514 ' HG2' ' HB2' ' A' ' 561' ' ' ASP . 8.7 mm-40 -62.96 -40.4 97.57 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 179.384 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 565' ' ' LEU . . . . . 0.672 HD21 HD23 ' A' ' 559' ' ' LEU . 48.3 mt -57.07 -50.2 73.5 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.72 176.129 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 566' ' ' ALA . . . . . . . . . . . . . . . -60.48 -53.97 51.19 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.588 179.224 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 567' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -58.95 -49.96 75.88 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.811 -0.631 . . . . 0.0 112.207 -177.24 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 568' ' ' ILE . . . . . . . . . . . . . 40.7 mm -63.99 -40.4 88.93 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 CA-C-O 120.577 0.227 . . . . 0.0 111.557 -178.503 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 569' ' ' LEU . . . . . 0.464 ' HB3' ' O ' ' A' ' 565' ' ' LEU . 0.1 OUTLIER -72.58 -29.2 63.32 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 122.058 -0.401 . . . . 0.0 110.204 -177.344 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 570' ' ' LYS . . . . . . . . . . . . . 25.2 mtpp -62.19 -29.08 70.12 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.091 0.472 . . . . 0.0 110.684 174.086 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 571' ' ' TYR . . . . . 0.518 ' HB2' ' NE2' ' A' ' 593' ' ' GLN . 55.2 t80 -75.46 -18.8 59.77 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.416 178.402 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 572' ' ' HIS . . . . . . . . . . . . . 64.7 m80 -87.64 -12.4 45.64 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.75 0.309 . . . . 0.0 111.331 -177.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 573' ' ' ILE . . . . . 0.667 HG23 HG22 ' A' ' 539' ' ' VAL . 28.7 mt -110.84 118.1 56.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 120.834 0.349 . . . . 0.0 111.18 -178.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 574' ' ' GLY . . . . . 0.449 ' HA2' ' HA ' ' A' ' 591' ' ' SER . . . -95.49 145.74 17.89 Favored Glycine 0 N--CA 1.446 -0.698 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 170.584 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 575' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -93.34 16.94 12.13 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 117.524 0.662 . . . . 0.0 111.119 -174.584 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 576' ' ' GLU . . . . . 0.518 ' HB2' HD21 ' A' ' 589' ' ' LEU . 48.8 mt-10 -137.55 124.08 20.88 Favored 'General case' 0 CA--C 1.512 -0.512 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 179.496 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 577' ' ' ILE . . . . . 0.74 ' HA ' ' OG1' ' A' ' 538' ' ' THR . 72.4 mt -67.43 117.74 9.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 O-C-N 123.612 0.57 . . . . 0.0 111.369 -173.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 578' ' ' LEU . . . . . 0.685 HD11 HG12 ' A' ' 583' ' ' ILE . 3.3 tm? -117.03 114.21 23.44 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.038 -0.983 . . . . 0.0 109.499 178.653 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 579' ' ' VAL . . . . . . . . . . . . . 29.4 m -108.59 163.4 6.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 177.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 580' ' ' SER . . . . . . . . . . . . . 23.6 t -59.39 -41.86 90.39 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.956 0.407 . . . . 0.0 110.857 -176.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 581' ' ' GLY . . . . . . . . . . . . . . . -77.57 19.79 3.79 Favored Glycine 0 CA--C 1.523 0.54 0 C-N-CA 120.777 -0.725 . . . . 0.0 113.152 -179.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . -142.35 16.54 2.5 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.473 178.547 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 583' ' ' ILE . . . . . 0.685 HG12 HD11 ' A' ' 578' ' ' LEU . 32.3 mt -85.33 -42.36 16.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.925 0.393 . . . . 0.0 110.95 179.601 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 584' ' ' GLY . . . . . . . . . . . . . . . 81.01 -87.71 1.36 Allowed Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.48 -0.867 . . . . 0.0 111.66 -178.171 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 585' ' ' ALA . . . . . . . . . . . . . . . -130.44 -66.7 0.76 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.003 0.43 . . . . 0.0 109.855 176.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 586' ' ' LEU . . . . . 0.8 ' HG ' ' HB2' ' A' ' 600' ' ' SER . 3.6 tt -142.21 134.56 27.83 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 174.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 587' ' ' VAL . . . . . . . . . . . . . 10.7 p -125.15 138.44 54.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-O 121.14 0.495 . . . . 0.0 110.955 -174.787 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 588' ' ' ARG . . . . . . . . . . . . . 95.2 mtt180 -99.35 101.75 13.14 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 178.564 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 589' ' ' LEU . . . . . 0.518 HD21 ' HB2' ' A' ' 576' ' ' GLU . 0.6 OUTLIER -109.05 127.04 53.77 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.008 -176.528 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 590' ' ' LYS . . . . . 0.435 ' HE3' ' OE2' ' A' ' 576' ' ' GLU . 22.5 pttp -86.21 145.0 27.16 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.107 0.479 . . . . 0.0 111.002 -176.67 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 591' ' ' SER . . . . . 0.449 ' HA ' ' HA2' ' A' ' 574' ' ' GLY . 79.4 p -95.79 177.84 5.64 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.296 -178.856 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 592' ' ' LEU . . . . . . . . . . . . . 49.1 mt -70.96 -13.87 62.16 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.906 0.384 . . . . 0.0 110.56 179.083 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 593' ' ' GLN . . . . . 0.518 ' NE2' ' HB2' ' A' ' 571' ' ' TYR . 9.4 tt0 -85.74 -29.55 23.8 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.046 -177.449 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 594' ' ' GLY . . . . . . . . . . . . . . . 121.0 -27.09 6.55 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.935 -0.65 . . . . 0.0 111.678 -177.34 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 595' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -73.78 166.04 24.04 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.013 0.435 . . . . 0.0 110.892 176.612 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 596' ' ' LYS . . . . . 0.508 ' HD2' ' O ' ' A' ' 596' ' ' LYS . 0.1 OUTLIER -105.32 141.75 36.29 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.045 -179.601 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 597' ' ' LEU . . . . . 0.46 HD21 ' O ' ' A' ' 571' ' ' TYR . 71.0 mt -92.24 120.27 32.64 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.448 -0.796 . . . . 0.0 108.935 172.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 598' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 -81.29 84.15 6.68 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.188 0.518 . . . . 0.0 109.799 -176.289 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 599' ' ' VAL . . . . . . . . . . . . . 42.1 t -98.07 133.77 38.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.086 -175.447 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 600' ' ' SER . . . . . 0.8 ' HB2' ' HG ' ' A' ' 586' ' ' LEU . 29.7 t -144.66 167.86 21.54 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 121.325 0.583 . . . . 0.0 110.569 -177.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 601' ' ' LEU . . . . . 0.464 HD13 HD12 ' A' ' 583' ' ' ILE . 31.3 tp -131.45 107.6 9.02 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 114.93 -1.032 . . . . 0.0 109.275 -178.345 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 602' ' ' LYS . . . . . . . . . . . . . 24.7 ttmm -119.0 113.76 21.48 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.217 -0.447 . . . . 0.0 109.85 -177.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 603' ' ' ASN . . . . . 0.451 ' O ' ' HB2' ' A' ' 604' ' ' ASN . 14.2 m120 59.48 32.88 22.0 Favored 'General case' 0 N--CA 1.466 0.338 0 O-C-N 123.43 0.456 . . . . 0.0 110.435 -177.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 604' ' ' ASN . . . . . 0.451 ' HB2' ' O ' ' A' ' 603' ' ' ASN . 11.2 m120 73.15 10.59 5.19 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 115.205 -0.907 . . . . 0.0 111.939 -179.013 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 605' ' ' VAL . . . . . . . . . . . . . 61.1 t -97.97 119.98 46.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 174.08 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 606' ' ' VAL . . . . . . . . . . . . . 19.7 t -81.0 136.67 22.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.727 -178.506 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 607' ' ' SER . . . . . . . . . . . . . 8.2 p -142.25 147.92 37.26 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.481 178.62 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 608' ' ' VAL . . . . . . . . . . . . . 7.0 p -131.56 117.38 35.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.122 177.455 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 609' ' ' ASN . . . . . 0.487 ' O ' ' HB2' ' A' ' 610' ' ' LYS . 88.6 m-20 61.35 31.58 19.23 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.676 -178.61 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 610' ' ' LYS . . . . . 0.487 ' HB2' ' O ' ' A' ' 609' ' ' ASN . 11.7 mmmm 79.58 -2.47 2.12 Favored 'General case' 0 N--CA 1.472 0.664 0 O-C-N 124.283 0.989 . . . . 0.0 111.725 -178.133 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 611' ' ' GLU . . . . . 0.485 ' HA ' ' HD3' ' A' ' 612' ' ' PRO . 4.4 mm-40 -93.42 125.81 52.68 Favored Pre-proline 0 C--N 1.33 -0.241 0 N-CA-C 109.654 -0.498 . . . . 0.0 109.654 177.269 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 612' ' ' PRO . . . . . 0.485 ' HD3' ' HA ' ' A' ' 611' ' ' GLU . 8.4 Cg_exo -72.31 144.57 41.58 Favored 'Trans proline' 0 N--CA 1.463 -0.295 0 C-N-CA 122.985 2.457 . . . . 0.0 112.982 -176.252 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 613' ' ' VAL . . . . . . . . . . . . . 98.7 t -86.17 125.97 40.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.61 175.318 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 614' ' ' ALA . . . . . 0.559 ' HB2' HG23 ' A' ' 629' ' ' THR . . . -80.75 -28.48 36.48 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.69 -0.687 . . . . 0.0 111.721 -174.368 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 615' ' ' GLU . . . . . 0.54 ' HB3' ' CG2' ' A' ' 627' ' ' VAL . 10.1 tp10 -161.46 93.97 1.39 Allowed Pre-proline 0 C--N 1.328 -0.363 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 -179.019 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 616' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -89.33 161.04 5.58 Favored 'Trans proline' 0 N--CA 1.46 -0.494 0 C-N-CA 123.353 2.702 . . . . 0.0 113.81 -177.209 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 77.05 32.7 0.47 Allowed 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 121.962 0.887 . . . . 0.0 110.343 164.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 618' ' ' ILE . . . . . 0.474 ' CG2' ' HB ' ' A' ' 625' ' ' VAL . 13.2 mt -75.81 111.28 12.04 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.909 0 CA-C-N 114.498 -1.228 . . . . 0.0 109.694 175.342 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 619' ' ' MET . . . . . . . . . . . . . 9.5 mmt -74.86 122.65 23.7 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.809 -0.632 . . . . 0.0 112.114 -175.254 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 620' ' ' ALA . . . . . . . . . . . . . . . -122.47 161.05 24.29 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 172.432 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 621' ' ' THR . . . . . 0.626 HG22 ' HA ' ' A' ' 504' ' ' THR . 9.9 t -69.32 -30.13 68.11 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.587 -0.445 . . . . 0.0 111.823 -174.512 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 622' ' ' ASN . . . . . 0.641 ' HB3' ' HA ' ' A' ' 534' ' ' GLU . 29.3 p-10 -118.07 28.26 8.49 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 111.921 0.341 . . . . 0.0 111.921 -178.027 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 623' ' ' GLY . . . . . . . . . . . . . . . 155.68 -160.68 30.12 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.171 -1.014 . . . . 0.0 112.444 176.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 624' ' ' VAL . . . . . . . . . . . . . 8.8 p -128.66 157.44 41.3 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 N-CA-C 110.04 -0.356 . . . . 0.0 110.04 179.001 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 625' ' ' VAL . . . . . 0.661 HG22 HG23 ' A' ' 505' ' ' VAL . 42.8 t -125.02 136.18 61.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 116.246 -0.434 . . . . 0.0 109.932 -179.222 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 626' ' ' HIS . . . . . . . . . . . . . 95.6 m-70 -122.57 112.07 17.57 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-O 121.067 0.461 . . . . 0.0 109.982 175.558 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 627' ' ' VAL . . . . . 0.795 HG22 ' HZ ' ' A' ' 515' ' ' PHE . 67.7 t -67.45 129.01 31.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.061 179.402 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 628' ' ' ILE . . . . . 0.581 HG13 ' HA ' ' A' ' 542' ' ' PRO . 9.2 pt -126.02 146.11 32.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.158 0.504 . . . . 0.0 110.932 175.398 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 629' ' ' THR . . . . . 0.559 HG23 ' HB2' ' A' ' 614' ' ' ALA . 35.3 p -95.22 -1.55 51.4 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.042 179.764 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 630' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -125.29 163.07 23.34 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.846 -0.615 . . . . 0.0 109.691 -175.693 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 631' ' ' VAL . . . . . 0.621 HG23 ' HB1' ' A' ' 546' ' ' ALA . 58.5 t -99.3 123.23 51.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 177.548 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 632' ' ' LEU . . . . . . . . . . . . . 80.4 mt -80.88 116.3 20.79 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.144 0.497 . . . . 0.0 111.338 -177.4 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 633' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 -120.15 129.92 25.1 Favored Pre-proline 0 C--N 1.321 -0.651 0 CA-C-N 115.648 -0.706 . . . . 0.0 109.1 176.461 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 634' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo . . . . . 0 C--O 1.249 1.047 0 C-N-CA 123.296 2.664 . . . . 0.0 112.826 -179.543 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 500' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.022 0 N-CA-C 110.245 -0.28 . . . . 0.0 110.245 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 501' ' ' GLY . . . . . . . . . . . . . . . 166.79 114.91 0.31 Allowed Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 120.596 -0.811 . . . . 0.0 112.314 -179.524 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 502' ' ' MET . . . . . . . . . . . . . 49.6 mtm 68.78 155.22 0.12 Allowed 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 123.288 0.635 . . . . 0.0 111.428 179.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . -130.71 130.1 6.02 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.865 -0.684 . . . . 0.0 112.029 177.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 504' ' ' THR . . . . . 0.469 ' HA ' HG22 ' A' ' 621' ' ' THR . 41.1 p -78.92 170.46 16.65 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 110.446 -0.205 . . . . 0.0 110.446 178.589 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 505' ' ' VAL . . . . . 0.726 ' O ' ' HG ' ' A' ' 509' ' ' LEU . 10.7 m -60.54 -34.09 56.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 175.061 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 506' ' ' MET . . . . . . . . . . . . . 93.5 mmm -65.03 -34.78 79.25 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-O 120.809 0.338 . . . . 0.0 110.357 177.354 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 507' ' ' ASP . . . . . 0.537 ' HA ' ' HE3' ' A' ' 510' ' ' LYS . 29.9 t70 -70.29 -44.06 69.14 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.183 178.298 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 508' ' ' VAL . . . . . 0.448 HG23 ' O ' ' A' ' 504' ' ' THR . 67.7 t -59.24 -42.94 88.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.886 177.595 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 509' ' ' LEU . . . . . 0.726 ' HG ' ' O ' ' A' ' 505' ' ' VAL . 71.7 mt -68.51 -32.0 71.65 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.512 -178.199 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 510' ' ' LYS . . . . . 0.537 ' HE3' ' HA ' ' A' ' 507' ' ' ASP . 22.9 pttp -88.11 -13.54 41.08 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.184 0.516 . . . . 0.0 110.048 -178.309 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 511' ' ' GLY . . . . . . . . . . . . . . . -84.51 -8.65 82.85 Favored Glycine 0 N--CA 1.442 -0.912 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.562 174.31 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 512' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -116.24 135.72 53.65 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.604 0.24 . . . . 0.0 110.477 178.216 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -64.39 -36.89 85.63 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.844 -176.052 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 514' ' ' ARG . . . . . 0.698 ' HD3' HG22 ' A' ' 543' ' ' THR . 74.8 mtt180 -73.45 -46.94 45.32 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.305 0.574 . . . . 0.0 110.245 -176.731 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 515' ' ' PHE . . . . . 0.975 ' HZ ' HG22 ' A' ' 627' ' ' VAL . 13.9 m-30 -67.42 -18.11 64.98 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.99 -178.546 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 66.2 m -57.43 -36.86 71.9 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.362 -0.381 . . . . 0.0 112.018 -177.593 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 517' ' ' MET . . . . . 0.545 ' HE1' ' HA ' ' A' ' 544' ' ' ASN . 44.7 mtm -72.32 -33.25 67.21 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.752 -0.379 . . . . 0.0 110.177 -179.454 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 518' ' ' LEU . . . . . 0.41 HD22 ' HA ' ' A' ' 541' ' ' ALA . 66.1 tp -64.06 -38.72 92.11 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.088 -0.505 . . . . 0.0 109.908 173.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 519' ' ' VAL . . . . . 0.433 HG23 ' O ' ' A' ' 515' ' ' PHE . 56.7 t -57.33 -36.12 51.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 121.156 0.503 . . . . 0.0 109.875 174.399 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 520' ' ' ALA . . . . . . . . . . . . . . . -70.29 -38.84 75.1 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.326 179.549 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 521' ' ' ALA . . . . . . . . . . . . . . . -65.79 -48.87 70.32 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.508 176.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 522' ' ' ILE . . . . . . . . . . . . . 94.7 mt -57.06 -41.42 77.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.828 -0.623 . . . . 0.0 110.872 176.5 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 523' ' ' GLN . . . . . . . . . . . . . 33.8 tt0 -64.95 -43.48 92.58 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.2 177.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 20.3 t -70.74 -31.36 68.16 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.538 -176.642 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 525' ' ' ALA . . . . . 0.549 ' HB2' ' HB3' ' A' ' 565' ' ' LEU . . . -88.94 -27.1 21.16 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.726 0.298 . . . . 0.0 111.473 -179.242 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 526' ' ' GLY . . . . . . . . . . . . . . . 87.13 49.65 3.93 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.867 -0.683 . . . . 0.0 112.391 178.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 527' ' ' LEU . . . . . 0.411 ' HA ' HD13 ' A' ' 527' ' ' LEU . 4.3 mm? -111.5 8.78 21.2 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.151 0.5 . . . . 0.0 110.691 178.042 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 528' ' ' THR . . . . . . . . . . . . . 5.9 m -60.42 -33.93 73.22 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.464 -177.612 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 529' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -61.29 -33.64 73.89 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.114 -178.633 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 530' ' ' THR . . . . . . . . . . . . . 30.4 m -70.29 -48.32 57.23 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.998 -0.547 . . . . 0.0 111.279 -176.315 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 531' ' ' LEU . . . . . 0.539 ' HB3' ' CG2' ' A' ' 505' ' ' VAL . 31.4 mt -85.96 6.21 29.68 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.323 0.582 . . . . 0.0 111.403 -175.674 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 532' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -83.95 -37.76 21.88 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.091 179.356 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 533' ' ' ARG . . . . . . . . . . . . . 76.6 mtm180 -79.44 131.54 36.11 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.862 -178.475 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 534' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -75.03 127.54 33.46 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.524 179.671 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 535' ' ' GLY . . . . . . . . . . . . . . . -174.26 -132.22 1.52 Allowed Glycine 0 CA--C 1.502 -0.721 0 N-CA-C 110.265 -1.134 . . . . 0.0 110.265 -179.574 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 536' ' ' VAL . . . . . . . . . . . . . 33.9 m -124.36 129.25 74.0 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-O 121.261 0.553 . . . . 0.0 110.719 177.584 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 537' ' ' TYR . . . . . . . . . . . . . 80.4 m-85 -154.86 150.35 27.38 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.161 179.266 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 538' ' ' THR . . . . . 0.723 ' OG1' ' HA ' ' A' ' 577' ' ' ILE . 34.1 m -120.26 102.2 8.33 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 173.723 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 539' ' ' VAL . . . . . 0.502 HG22 HG23 ' A' ' 573' ' ' ILE . 44.2 t -105.11 123.87 59.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.498 -173.035 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 540' ' ' PHE . . . . . 0.607 ' HB3' HD13 ' A' ' 628' ' ' ILE . 93.7 m-85 -95.94 112.86 24.47 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 174.341 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 541' ' ' ALA . . . . . 0.41 ' HA ' HD22 ' A' ' 518' ' ' LEU . . . -101.72 110.66 62.56 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-O 120.935 0.398 . . . . 0.0 110.809 -176.751 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 542' ' ' PRO . . . . . 0.624 ' HA ' HG13 ' A' ' 628' ' ' ILE . 16.9 Cg_exo -69.24 138.98 40.84 Favored 'Trans proline' 0 N--CA 1.461 -0.393 0 C-N-CA 123.11 2.54 . . . . 0.0 112.118 178.332 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 543' ' ' THR . . . . . 0.698 HG22 ' HD3' ' A' ' 514' ' ' ARG . 36.8 p -82.53 179.9 7.64 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.239 -178.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 544' ' ' ASN . . . . . 0.545 ' HA ' ' HE1' ' A' ' 517' ' ' MET . 14.9 m120 -56.65 -34.84 67.72 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.885 0.374 . . . . 0.0 111.181 179.522 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 545' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -73.07 -23.38 60.54 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.759 -174.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 546' ' ' ALA . . . . . . . . . . . . . . . -69.16 -51.32 39.34 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-O 121.283 0.563 . . . . 0.0 110.709 179.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 547' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -71.65 -20.86 61.9 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.601 -179.369 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 548' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.62 -29.06 62.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.989 -0.551 . . . . 0.0 109.677 176.353 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 549' ' ' ALA . . . . . . . . . . . . . . . -89.32 2.91 53.71 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.368 -175.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 550' ' ' LEU . . . . . 0.458 ' HA ' ' HD3' ' A' ' 551' ' ' PRO . 75.3 mt -72.83 137.24 79.84 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.561 178.641 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 551' ' ' PRO . . . . . 0.593 ' HD2' ' HB2' ' A' ' 554' ' ' GLU . 17.5 Cg_exo -66.55 150.63 83.94 Favored 'Trans proline' 0 N--CA 1.461 -0.392 0 C-N-CA 122.819 2.346 . . . . 0.0 112.108 -177.364 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 552' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 551' ' ' PRO . 60.0 Cg_exo -53.4 -28.28 43.35 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 123.247 2.632 . . . . 0.0 112.98 -179.236 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 553' ' ' ARG . . . . . . . . . . . . . 23.0 mmt180 -81.11 -54.29 5.66 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.061 0.458 . . . . 0.0 110.041 -179.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 554' ' ' GLU . . . . . 0.593 ' HB2' ' HD2' ' A' ' 551' ' ' PRO . 3.3 mp0 -62.88 -37.64 87.7 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.52 -0.764 . . . . 0.0 112.201 -177.017 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 555' ' ' ARG . . . . . . . . . . . . . 36.5 ptt180 -63.79 -35.11 79.52 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.793 -0.363 . . . . 0.0 110.611 178.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 34.7 m -73.88 -32.05 63.43 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.224 0.535 . . . . 0.0 110.197 179.345 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 557' ' ' ARG . . . . . . . . . . . . . 63.5 mtp180 -68.05 -58.63 4.18 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.624 175.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 558' ' ' LEU . . . . . 0.598 ' O ' ' HG ' ' A' ' 565' ' ' LEU . 27.3 tp -62.39 -42.47 99.45 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.285 -172.729 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 559' ' ' LEU . . . . . . . . . . . . . 80.5 mt -88.21 13.0 12.34 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.972 0.415 . . . . 0.0 111.105 -178.152 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 560' ' ' GLY . . . . . . . . . . . . . . . -122.35 -41.2 0.48 Allowed Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.911 -0.662 . . . . 0.0 112.188 178.283 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 561' ' ' ASP . . . . . 0.4 ' OD1' ' HB3' ' A' ' 563' ' ' LYS . 16.9 t70 -99.52 116.75 32.37 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.924 0.392 . . . . 0.0 110.428 -179.395 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 562' ' ' ALA . . . . . . . . . . . . . . . -68.45 -21.55 64.64 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.788 -175.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 563' ' ' LYS . . . . . 0.4 ' HB3' ' OD1' ' A' ' 561' ' ' ASP . 59.6 tttm -78.78 -48.33 15.04 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 110.22 -0.289 . . . . 0.0 110.22 -178.599 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 564' ' ' GLU . . . . . 0.519 ' O ' HG12 ' A' ' 568' ' ' ILE . 40.7 mt-10 -57.65 -38.1 74.47 Favored 'General case' 0 C--N 1.332 -0.169 0 O-C-N 123.248 0.343 . . . . 0.0 110.107 177.233 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 565' ' ' LEU . . . . . 0.598 ' HG ' ' O ' ' A' ' 558' ' ' LEU . 3.7 mt -55.06 -54.16 46.64 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.63 174.512 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 566' ' ' ALA . . . . . . . . . . . . . . . -62.94 -37.76 88.34 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.475 -178.515 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 567' ' ' ASN . . . . . . . . . . . . . 12.1 m120 -67.41 -41.69 84.47 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.171 -178.76 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 568' ' ' ILE . . . . . 0.519 HG12 ' O ' ' A' ' 564' ' ' GLU . 48.8 mm -69.29 -34.3 62.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.903 0.382 . . . . 0.0 110.736 178.596 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 569' ' ' LEU . . . . . 0.558 ' HG ' ' O ' ' A' ' 565' ' ' LEU . 77.1 mt -64.72 -36.7 85.14 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.814 0.34 . . . . 0.0 110.881 177.037 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 570' ' ' LYS . . . . . 0.797 ' HE3' ' HA ' ' A' ' 593' ' ' GLN . 26.5 mtpp -63.93 -13.62 47.13 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.017 177.451 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 571' ' ' TYR . . . . . 0.419 ' O ' HD21 ' A' ' 597' ' ' LEU . 7.5 t80 -97.38 -16.0 20.43 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.069 -177.462 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 572' ' ' HIS . . . . . . . . . . . . . 59.6 m80 -95.31 -12.25 26.46 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.958 0.409 . . . . 0.0 111.274 -178.488 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 573' ' ' ILE . . . . . 0.521 HD13 HD21 ' A' ' 531' ' ' LEU . 21.3 mt -108.65 123.01 64.07 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.204 178.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 574' ' ' GLY . . . . . 0.547 ' HA2' ' HA ' ' A' ' 591' ' ' SER . . . -92.92 151.2 20.34 Favored Glycine 0 N--CA 1.447 -0.591 0 N-CA-C 111.505 -0.638 . . . . 0.0 111.505 175.137 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 575' ' ' ASP . . . . . 0.483 ' HB3' ' HE3' ' A' ' 590' ' ' LYS . 19.3 t70 -70.35 -21.18 62.91 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 112.879 0.696 . . . . 0.0 112.879 -171.07 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 576' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -149.67 153.06 36.4 Favored 'General case' 0 N--CA 1.439 -1.025 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 -174.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 577' ' ' ILE . . . . . 0.723 ' HA ' ' OG1' ' A' ' 538' ' ' THR . 77.3 mt -72.95 126.44 33.61 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 O-C-N 124.028 0.83 . . . . 0.0 112.14 -171.399 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 578' ' ' LEU . . . . . 0.572 HD21 ' HB ' ' A' ' 587' ' ' VAL . 41.9 tp -126.84 105.26 8.53 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 114.998 -1.001 . . . . 0.0 109.146 173.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 579' ' ' VAL . . . . . 0.525 ' CG1' ' H ' ' A' ' 581' ' ' GLY . 1.0 OUTLIER -102.08 167.57 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.106 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.11 -177.441 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 580' ' ' SER . . . . . 0.415 ' N ' HG13 ' A' ' 579' ' ' VAL . 20.2 m -57.82 -25.93 61.3 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.364 -0.835 . . . . 0.0 111.67 -175.164 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 581' ' ' GLY . . . . . 0.525 ' H ' ' CG1' ' A' ' 579' ' ' VAL . . . -87.29 -2.84 82.59 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.523 -176.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . -110.69 -18.59 8.34 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.37 -179.195 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 583' ' ' ILE . . . . . 0.412 HG13 ' O ' ' A' ' 579' ' ' VAL . 51.2 mt -70.96 -63.38 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.726 0.298 . . . . 0.0 111.2 -177.512 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 584' ' ' GLY . . . . . . . . . . . . . . . 81.53 -63.23 4.38 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.283 -178.175 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 585' ' ' ALA . . . . . . . . . . . . . . . -134.71 -71.01 0.49 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.781 0.324 . . . . 0.0 110.286 178.143 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 586' ' ' LEU . . . . . 0.54 HD13 ' HB3' ' A' ' 600' ' ' SER . 45.5 tp -147.27 132.68 18.59 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.44 -179.448 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 587' ' ' VAL . . . . . 0.572 ' HB ' HD21 ' A' ' 578' ' ' LEU . 57.5 t -137.93 129.17 38.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 116.022 -0.536 . . . . 0.0 109.661 176.655 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 588' ' ' ARG . . . . . 0.402 ' HG2' ' OE2' ' A' ' 598' ' ' GLU . 55.2 mtm180 -85.74 109.84 18.92 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.05 -179.251 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 589' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -95.79 124.88 40.0 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.812 -174.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 590' ' ' LYS . . . . . 0.483 ' HE3' ' HB3' ' A' ' 575' ' ' ASP . 47.4 pttt -77.96 138.93 39.12 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.11 0.481 . . . . 0.0 110.125 177.365 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 591' ' ' SER . . . . . 0.547 ' HA ' ' HA2' ' A' ' 574' ' ' GLY . 80.2 p -104.27 166.24 10.53 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.338 -177.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 592' ' ' LEU . . . . . . . . . . . . . 10.1 mp -68.73 -7.81 37.06 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.246 0.461 . . . . 0.0 112.246 178.173 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 593' ' ' GLN . . . . . 0.797 ' HA ' ' HE3' ' A' ' 570' ' ' LYS . 5.4 tt0 -80.61 -29.03 36.89 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.206 0.527 . . . . 0.0 109.661 173.455 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 594' ' ' GLY . . . . . . . . . . . . . . . 106.55 -13.56 42.86 Favored Glycine 0 N--CA 1.441 -0.993 0 N-CA-C 110.717 -0.953 . . . . 0.0 110.717 -172.327 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 595' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -81.36 -174.43 4.92 Favored 'General case' 0 C--O 1.237 0.396 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 179.304 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 596' ' ' LYS . . . . . . . . . . . . . 59.0 pttt -115.33 135.18 54.41 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.175 0.512 . . . . 0.0 111.422 -171.521 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 597' ' ' LEU . . . . . 0.419 HD21 ' O ' ' A' ' 571' ' ' TYR . 57.6 mt -106.04 114.46 28.61 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 168.771 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 598' ' ' GLU . . . . . 0.43 ' HG3' HD11 ' A' ' 586' ' ' LEU . 1.0 OUTLIER -83.4 92.07 7.48 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 -179.929 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 599' ' ' VAL . . . . . 0.525 ' HA ' ' O ' ' A' ' 607' ' ' SER . 43.2 t -98.4 118.78 45.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 121.245 0.545 . . . . 0.0 110.411 -177.175 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 600' ' ' SER . . . . . 0.54 ' HB3' HD13 ' A' ' 586' ' ' LEU . 2.7 p -129.43 151.77 49.7 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.059 -178.097 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 601' ' ' LEU . . . . . . . . . . . . . 47.6 tp -113.04 108.03 16.77 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.374 179.418 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 602' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -131.12 127.27 37.74 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.361 -177.336 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 603' ' ' ASN . . . . . . . . . . . . . 66.2 t30 62.49 27.45 16.28 Favored 'General case' 0 N--CA 1.464 0.273 0 O-C-N 123.652 0.595 . . . . 0.0 109.946 -178.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 604' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 69.19 12.72 8.53 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 115.137 -0.938 . . . . 0.0 111.513 -177.57 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 605' ' ' VAL . . . . . . . . . . . . . 48.6 t -110.85 123.33 66.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 176.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 606' ' ' VAL . . . . . 0.441 ' HB ' ' HB ' ' A' ' 613' ' ' VAL . 42.0 t -72.52 148.33 9.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.25 -179.8 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 607' ' ' SER . . . . . 0.525 ' O ' ' HA ' ' A' ' 599' ' ' VAL . 4.5 p -141.52 140.62 33.5 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.221 -0.445 . . . . 0.0 109.983 179.789 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 608' ' ' VAL . . . . . . . . . . . . . 3.8 p -126.13 110.36 23.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-O 121.059 0.456 . . . . 0.0 110.315 179.025 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 609' ' ' ASN . . . . . 0.473 ' O ' ' HB3' ' A' ' 610' ' ' LYS . 92.9 m-20 55.48 54.07 8.97 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.87 -179.64 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 610' ' ' LYS . . . . . 0.473 ' HB3' ' O ' ' A' ' 609' ' ' ASN . 61.8 tttp 77.59 -27.32 0.17 Allowed 'General case' 0 N--CA 1.469 0.475 0 CA-C-N 115.525 -0.762 . . . . 0.0 111.721 178.77 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 611' ' ' GLU . . . . . 0.533 ' HB3' ' ND2' ' A' ' 630' ' ' ASN . 6.0 mm-40 -80.35 123.42 83.05 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 120.646 0.26 . . . . 0.0 110.978 -178.482 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 612' ' ' PRO . . . . . 0.494 ' HD3' ' HA ' ' A' ' 611' ' ' GLU . 7.9 Cg_exo -72.75 145.05 40.39 Favored 'Trans proline' 0 CA--C 1.531 0.367 0 C-N-CA 123.0 2.467 . . . . 0.0 113.11 -178.73 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 613' ' ' VAL . . . . . 0.441 ' HB ' ' HB ' ' A' ' 606' ' ' VAL . 70.7 t -91.44 139.23 18.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.951 176.631 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 614' ' ' ALA . . . . . 0.569 ' HB2' HG23 ' A' ' 629' ' ' THR . . . -86.13 -36.21 19.71 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.125 -0.489 . . . . 0.0 112.063 -175.787 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 615' ' ' GLU . . . . . . . . . . . . . 20.4 tp10 -157.78 99.74 1.84 Allowed Pre-proline 0 C--N 1.327 -0.401 0 CA-C-O 121.046 0.45 . . . . 0.0 110.306 -176.593 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 616' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -90.13 168.87 4.36 Favored 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 123.326 2.684 . . . . 0.0 113.844 -178.318 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 77.29 32.74 0.44 Allowed 'General case' 0 CA--C 1.508 -0.657 0 CA-C-O 122.073 0.94 . . . . 0.0 111.025 163.611 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 618' ' ' ILE . . . . . 0.529 ' HB ' ' O ' ' A' ' 625' ' ' VAL . 18.1 mt -83.3 98.98 5.55 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.147 0 CA-C-N 114.149 -1.387 . . . . 0.0 109.29 174.198 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 619' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.96 130.08 36.1 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.777 -174.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 620' ' ' ALA . . . . . . . . . . . . . . . -130.76 177.04 7.71 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.524 173.599 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 621' ' ' THR . . . . . 0.469 HG22 ' HA ' ' A' ' 504' ' ' THR . 10.7 t -81.07 -14.58 57.68 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.44 -0.504 . . . . 0.0 111.59 -177.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 622' ' ' ASN . . . . . 0.504 ' HB2' HG13 ' A' ' 505' ' ' VAL . 7.5 m120 -102.69 -0.34 31.89 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.697 0.284 . . . . 0.0 110.643 179.311 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 623' ' ' GLY . . . . . 0.68 ' HA2' HD11 ' A' ' 577' ' ' ILE . . . 145.62 -140.12 8.75 Favored Glycine 0 N--CA 1.445 -0.76 0 C-N-CA 120.379 -0.915 . . . . 0.0 112.596 180.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 624' ' ' VAL . . . . . . . . . . . . . 4.8 p -126.45 156.02 36.97 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-O 120.898 0.38 . . . . 0.0 109.981 179.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 625' ' ' VAL . . . . . 0.529 ' O ' ' HB ' ' A' ' 618' ' ' ILE . 61.4 t -125.55 136.98 59.14 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.534 179.803 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 626' ' ' HIS . . . . . . . . . . . . . 94.3 m-70 -119.2 115.9 25.18 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-O 120.866 0.365 . . . . 0.0 110.052 177.242 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 627' ' ' VAL . . . . . 0.975 HG22 ' HZ ' ' A' ' 515' ' ' PHE . 38.6 t -70.18 124.95 27.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.334 177.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 628' ' ' ILE . . . . . 0.624 HG13 ' HA ' ' A' ' 542' ' ' PRO . 3.8 pt -123.97 145.03 31.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-O 121.368 0.604 . . . . 0.0 111.3 178.358 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 629' ' ' THR . . . . . 0.569 HG23 ' HB2' ' A' ' 614' ' ' ALA . 22.7 p -94.11 7.48 45.03 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.788 0.804 . . . . 0.0 109.836 179.782 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 630' ' ' ASN . . . . . 0.533 ' ND2' ' HB3' ' A' ' 611' ' ' GLU . 6.1 p30 -141.19 166.05 25.84 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 114.33 -1.305 . . . . 0.0 109.52 -177.164 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 631' ' ' VAL . . . . . 0.445 HG11 HD21 ' A' ' 550' ' ' LEU . 2.7 p -125.91 123.53 64.34 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.982 0 N-CA-C 110.26 -0.274 . . . . 0.0 110.26 -179.643 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 632' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -63.19 120.27 11.18 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-O 121.085 0.469 . . . . 0.0 111.092 -177.024 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 633' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -126.96 110.45 21.94 Favored Pre-proline 0 C--N 1.319 -0.743 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 178.188 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 634' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo . . . . . 0 C--O 1.249 1.05 0 C-N-CA 123.013 2.475 . . . . 0.0 111.872 -178.7 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 500' ' ' ALA . . . . . 0.677 ' HB2' ' HA3' ' A' ' 511' ' ' GLY . . . . . . . . 0 N--CA 1.479 0.995 0 CA-C-O 120.899 0.38 . . . . 0.0 110.469 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 501' ' ' GLY . . . . . . . . . . . . . . . 98.8 13.27 40.94 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.667 -0.778 . . . . 0.0 111.484 -177.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 502' ' ' MET . . . . . . . . . . . . . 2.4 mpt? -106.4 -23.85 12.4 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.856 0.36 . . . . 0.0 110.094 179.004 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . -129.38 -126.91 2.89 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.381 -0.914 . . . . 0.0 112.933 -178.165 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 65.6 p -87.52 -176.04 5.44 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.728 0.299 . . . . 0.0 111.165 -176.205 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 505' ' ' VAL . . . . . 0.617 ' O ' ' HG ' ' A' ' 509' ' ' LEU . 21.4 t -54.16 -41.63 52.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.388 175.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 506' ' ' MET . . . . . . . . . . . . . 4.1 mmt -55.11 -43.07 73.7 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.538 179.013 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 507' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -61.68 -39.68 92.27 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.996 0.427 . . . . 0.0 111.022 179.395 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 508' ' ' VAL . . . . . . . . . . . . . 43.2 t -65.53 -46.38 89.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.512 179.074 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 509' ' ' LEU . . . . . 0.617 ' HG ' ' O ' ' A' ' 505' ' ' VAL . 39.0 mt -68.92 -20.8 64.24 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.482 -175.537 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 510' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -89.35 -15.99 32.06 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.329 -178.067 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 511' ' ' GLY . . . . . 0.677 ' HA3' ' HB2' ' A' ' 500' ' ' ALA . . . -82.07 -9.75 84.8 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.751 -0.738 . . . . 0.0 111.445 177.365 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 512' ' ' ASP . . . . . 0.5 ' O ' ' HB2' ' A' ' 516' ' ' SER . 28.1 t70 -120.3 146.99 45.57 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.521 -0.34 . . . . 0.0 110.872 179.359 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -75.52 -32.97 60.69 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.831 0.348 . . . . 0.0 111.434 -178.36 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 514' ' ' ARG . . . . . 0.48 ' HD3' ' HB ' ' A' ' 543' ' ' THR . 78.7 mtt180 -74.78 -49.39 21.03 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.128 0.49 . . . . 0.0 109.711 -176.749 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 515' ' ' PHE . . . . . 0.404 ' HZ ' HG22 ' A' ' 627' ' ' VAL . 15.2 m-30 -65.67 -26.0 67.59 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.809 178.684 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 516' ' ' SER . . . . . 0.5 ' HB2' ' O ' ' A' ' 512' ' ' ASP . 15.9 t -65.34 -26.53 68.07 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.111 -179.219 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 517' ' ' MET . . . . . 0.482 ' HB2' ' HE2' ' A' ' 517' ' ' MET . 33.9 mtm -72.02 -35.21 69.34 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 176.018 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 518' ' ' LEU . . . . . . . . . . . . . 61.4 tp -64.68 -39.13 93.14 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.716 173.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 519' ' ' VAL . . . . . . . . . . . . . 86.0 t -55.06 -36.85 40.43 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.147 0 CA-C-O 121.163 0.506 . . . . 0.0 110.277 174.506 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 520' ' ' ALA . . . . . . . . . . . . . . . -70.99 -42.82 69.17 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.77 -179.423 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 521' ' ' ALA . . . . . . . . . . . . . . . -64.49 -48.65 74.42 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.623 177.581 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 522' ' ' ILE . . . . . 0.626 HG23 ' HB2' ' A' ' 527' ' ' LEU . 88.6 mt -59.48 -38.85 77.31 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.923 178.694 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 523' ' ' GLN . . . . . 0.403 HE21 ' HB3' ' A' ' 523' ' ' GLN . 0.9 OUTLIER -64.71 -44.22 90.94 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.343 177.417 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 13.6 t -68.69 -35.87 77.76 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.749 -178.506 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 525' ' ' ALA . . . . . 0.452 ' HB1' ' HB2' ' A' ' 566' ' ' ALA . . . -73.85 -28.05 61.4 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.849 0.357 . . . . 0.0 111.354 179.344 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 526' ' ' GLY . . . . . . . . . . . . . . . 90.18 48.54 3.52 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.385 179.129 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 527' ' ' LEU . . . . . 0.626 ' HB2' HG23 ' A' ' 522' ' ' ILE . 93.1 mt -124.32 26.35 7.41 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.06 0.457 . . . . 0.0 110.233 178.578 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 528' ' ' THR . . . . . . . . . . . . . 24.5 m -74.86 -36.47 62.32 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.206 -175.37 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 529' ' ' GLU . . . . . 0.464 ' CD ' ' H ' ' A' ' 529' ' ' GLU . 1.9 mp0 -57.82 -36.25 71.99 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.685 -179.511 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 530' ' ' THR . . . . . . . . . . . . . 4.0 m -58.95 -43.13 91.2 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.653 -176.439 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 531' ' ' LEU . . . . . . . . . . . . . 59.1 mt -94.77 14.03 22.65 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.342 -175.582 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 532' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -90.98 -49.47 6.4 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.788 -178.028 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 533' ' ' ARG . . . . . 0.561 ' HG2' ' OE1' ' A' ' 534' ' ' GLU . 18.6 ttp180 -89.87 172.55 8.81 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 -178.662 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 534' ' ' GLU . . . . . 0.584 ' HA ' ' CB ' ' A' ' 622' ' ' ASN . 1.6 pm0 -90.56 -179.18 5.5 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-O 121.446 0.641 . . . . 0.0 111.634 -179.684 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 535' ' ' GLY . . . . . . . . . . . . . . . 142.66 -145.17 15.02 Favored Glycine 0 N--CA 1.446 -0.665 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -172.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 536' ' ' VAL . . . . . 0.466 ' HB ' HG13 ' A' ' 577' ' ' ILE . 29.1 m -127.63 130.64 70.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 117.774 0.787 . . . . 0.0 110.487 174.074 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 537' ' ' TYR . . . . . . . . . . . . . 93.2 m-85 -148.47 148.31 30.11 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.84 -179.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 538' ' ' THR . . . . . 0.775 ' OG1' ' HA ' ' A' ' 577' ' ' ILE . 37.0 m -127.6 102.01 6.65 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 174.182 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 539' ' ' VAL . . . . . 0.525 HG22 HG23 ' A' ' 573' ' ' ILE . 40.3 t -108.93 131.13 60.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.203 -173.449 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 540' ' ' PHE . . . . . 0.52 ' HB3' HD13 ' A' ' 628' ' ' ILE . 92.9 m-85 -101.48 109.98 21.9 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.376 174.685 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 541' ' ' ALA . . . . . . . . . . . . . . . -96.02 115.48 65.59 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.498 -178.662 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 542' ' ' PRO . . . . . 0.524 ' HA ' HG13 ' A' ' 628' ' ' ILE . 6.7 Cg_exo -73.79 135.18 21.15 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 122.872 2.382 . . . . 0.0 111.619 178.176 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 543' ' ' THR . . . . . 0.48 ' HB ' ' HD3' ' A' ' 514' ' ' ARG . 34.4 p -75.98 -178.16 4.23 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.06 -179.092 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 544' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -67.27 -32.88 74.18 Favored 'General case' 0 CA--C 1.517 -0.308 0 N-CA-C 110.351 -0.24 . . . . 0.0 110.351 -177.574 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 545' ' ' GLU . . . . . 0.518 ' H ' ' CD ' ' A' ' 545' ' ' GLU . 1.6 mp0 -59.77 -35.43 74.6 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.246 178.205 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 546' ' ' ALA . . . . . 0.625 ' HB1' HG22 ' A' ' 631' ' ' VAL . . . -62.06 -47.51 84.35 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-O 121.275 0.56 . . . . 0.0 110.724 179.347 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 547' ' ' PHE . . . . . 0.651 ' HA ' HD23 ' A' ' 550' ' ' LEU . 94.2 m-85 -78.28 -21.95 49.02 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.797 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 548' ' ' ARG . . . . . . . . . . . . . 20.6 tpp180 -72.61 -35.04 67.76 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.963 177.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 549' ' ' ALA . . . . . . . . . . . . . . . -74.24 -16.08 60.97 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.278 -179.563 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 550' ' ' LEU . . . . . 0.806 HD11 ' HB3' ' A' ' 555' ' ' ARG . 0.2 OUTLIER -98.55 130.5 27.88 Favored Pre-proline 0 N--CA 1.445 -0.712 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 -179.298 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 551' ' ' PRO . . . . . 0.59 ' HD2' ' HB2' ' A' ' 554' ' ' GLU . 5.0 Cg_exo -77.26 160.52 32.67 Favored 'Trans proline' 0 CA--C 1.528 0.212 0 C-N-CA 123.705 2.937 . . . . 0.0 113.488 -169.145 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 552' ' ' PRO . . . . . 0.778 ' HA ' ' HG2' ' A' ' 555' ' ' ARG . 15.0 Cg_endo -58.88 -35.64 98.26 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 123.088 2.525 . . . . 0.0 112.21 176.453 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 553' ' ' ARG . . . . . . . . . . . . . 25.2 tpp180 -61.56 -47.39 85.73 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.383 179.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 554' ' ' GLU . . . . . 0.59 ' HB2' ' HD2' ' A' ' 551' ' ' PRO . 18.9 mm-40 -73.76 -44.96 54.66 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.314 -178.752 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 555' ' ' ARG . . . . . 0.806 ' HB3' HD11 ' A' ' 550' ' ' LEU . 14.4 ptp180 -59.06 -41.31 87.64 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 120.711 -0.396 . . . . 0.0 110.798 -179.173 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 13.1 t -65.02 -36.61 84.96 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.903 0.382 . . . . 0.0 110.457 -178.248 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 557' ' ' ARG . . . . . . . . . . . . . 16.3 mmm180 -61.34 -46.26 90.96 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.883 176.143 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 558' ' ' LEU . . . . . . . . . . . . . 51.7 tp -70.85 -56.35 6.49 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.188 -0.914 . . . . 0.0 111.586 -177.29 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 559' ' ' LEU . . . . . 0.715 ' HG ' ' O ' ' A' ' 555' ' ' ARG . 3.9 pp -73.77 -8.6 56.65 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 120.951 -0.3 . . . . 0.0 111.452 -174.662 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 560' ' ' GLY . . . . . . . . . . . . . . . -66.87 -34.46 87.24 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.958 -0.639 . . . . 0.0 111.605 175.283 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 561' ' ' ASP . . . . . 0.471 ' OD2' ' HB3' ' A' ' 563' ' ' LYS . 14.7 t70 -111.59 121.56 45.47 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.829 0.347 . . . . 0.0 110.673 -179.55 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 562' ' ' ALA . . . . . . . . . . . . . . . -65.45 -28.87 69.54 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.161 -178.631 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 563' ' ' LYS . . . . . 0.471 ' HB3' ' OD2' ' A' ' 561' ' ' ASP . 14.5 ttpp -66.09 -52.16 51.34 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.267 -178.604 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 564' ' ' GLU . . . . . 0.512 ' HA ' ' HB3' ' A' ' 567' ' ' ASN . 8.9 mt-10 -71.76 -24.43 61.77 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.584 -179.487 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 565' ' ' LEU . . . . . 0.489 HD23 ' HA ' ' A' ' 565' ' ' LEU . 9.9 mt -59.39 -55.16 38.22 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 109.368 -0.605 . . . . 0.0 109.368 169.606 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 566' ' ' ALA . . . . . 0.452 ' HB2' ' HB1' ' A' ' 525' ' ' ALA . . . -64.4 -34.75 78.91 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.343 179.274 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 567' ' ' ASN . . . . . 0.512 ' HB3' ' HA ' ' A' ' 564' ' ' GLU . 3.4 t-20 -56.43 -54.47 45.33 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.154 -179.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 568' ' ' ILE . . . . . . . . . . . . . 48.9 mm -70.93 -37.32 67.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.746 0.308 . . . . 0.0 111.068 -177.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 569' ' ' LEU . . . . . 0.419 ' HG ' ' O ' ' A' ' 565' ' ' LEU . 95.5 mt -65.2 -33.45 76.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.041 0.448 . . . . 0.0 110.946 178.289 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 570' ' ' LYS . . . . . 0.565 ' HE2' ' HA ' ' A' ' 593' ' ' GLN . 80.0 tttt -67.2 -16.73 64.48 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.559 -178.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 571' ' ' TYR . . . . . 0.458 ' HB2' ' NE2' ' A' ' 593' ' ' GLN . 45.5 t80 -89.98 -17.76 27.27 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.04 177.595 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 572' ' ' HIS . . . . . . . . . . . . . 53.2 m80 -86.07 -10.3 55.18 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.722 0.296 . . . . 0.0 111.158 -177.549 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 573' ' ' ILE . . . . . 0.525 HG23 HG22 ' A' ' 539' ' ' VAL . 31.2 mt -109.79 120.84 61.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.808 -179.137 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 574' ' ' GLY . . . . . 0.586 ' HA2' ' HA ' ' A' ' 591' ' ' SER . . . -98.62 148.26 18.79 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.909 -0.663 . . . . 0.0 111.663 175.052 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 575' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -93.4 9.07 37.97 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 111.936 0.347 . . . . 0.0 111.936 -173.693 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 576' ' ' GLU . . . . . 0.441 ' O ' HD21 ' A' ' 589' ' ' LEU . 12.2 pt-20 -144.92 133.32 21.84 Favored 'General case' 0 CA--C 1.508 -0.652 0 N-CA-C 109.765 -0.458 . . . . 0.0 109.765 178.616 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 577' ' ' ILE . . . . . 0.775 ' HA ' ' OG1' ' A' ' 538' ' ' THR . 76.3 mt -75.32 117.2 19.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.435 -175.513 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 578' ' ' LEU . . . . . 0.45 ' HB2' HD23 ' A' ' 589' ' ' LEU . 48.7 tp -118.41 108.65 15.31 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.318 -0.856 . . . . 0.0 109.858 176.841 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 579' ' ' VAL . . . . . . . . . . . . . 29.0 m -91.26 160.67 2.68 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.135 177.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 580' ' ' SER . . . . . . . . . . . . . 6.1 p -58.18 -42.81 86.89 Favored 'General case' 0 C--N 1.328 -0.355 0 O-C-N 123.292 0.37 . . . . 0.0 111.436 -176.613 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 581' ' ' GLY . . . . . . . . . . . . . . . -71.78 -11.86 73.9 Favored Glycine 0 CA--C 1.521 0.412 0 C-N-CA 120.964 -0.636 . . . . 0.0 113.087 -178.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . -96.71 -9.96 55.85 Favored Glycine 0 N--CA 1.454 -0.135 0 C-N-CA 121.043 -0.599 . . . . 0.0 112.508 -179.179 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 583' ' ' ILE . . . . . . . . . . . . . 58.7 mt -70.38 -60.21 2.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 121.06 0.457 . . . . 0.0 110.926 -178.295 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 584' ' ' GLY . . . . . . . . . . . . . . . 82.15 -89.04 1.44 Allowed Glycine 0 N--CA 1.444 -0.775 0 C-N-CA 120.55 -0.833 . . . . 0.0 111.383 -176.604 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 585' ' ' ALA . . . . . . . . . . . . . . . -102.71 -75.12 0.61 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.087 0.47 . . . . 0.0 110.351 178.184 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 586' ' ' LEU . . . . . 0.882 ' HG ' ' HB2' ' A' ' 600' ' ' SER . 5.7 tt -155.23 134.05 12.08 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 179.227 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 587' ' ' VAL . . . . . 0.442 ' N ' HD23 ' A' ' 586' ' ' LEU . 61.9 t -132.22 137.11 55.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 N-CA-C 110.199 -0.297 . . . . 0.0 110.199 -178.111 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 588' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -84.98 112.57 20.71 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 177.519 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 589' ' ' LEU . . . . . 0.672 ' HB3' ' HB2' ' A' ' 597' ' ' LEU . 1.9 tm? -89.9 121.09 31.69 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 -177.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 590' ' ' LYS . . . . . . . . . . . . . 33.8 mttp -87.86 131.16 34.65 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 121.303 0.573 . . . . 0.0 111.239 -172.315 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 591' ' ' SER . . . . . 0.586 ' HA ' ' HA2' ' A' ' 574' ' ' GLY . 84.0 p -97.41 159.78 14.72 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 114.973 -1.012 . . . . 0.0 110.718 -177.038 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 592' ' ' LEU . . . . . . . . . . . . . 9.9 mp -63.45 -21.18 66.16 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.491 177.631 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 593' ' ' GLN . . . . . 0.565 ' HA ' ' HE2' ' A' ' 570' ' ' LYS . 7.6 tt0 -73.0 -29.12 62.8 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.068 0.461 . . . . 0.0 110.291 175.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 594' ' ' GLY . . . . . . . . . . . . . . . 112.75 -14.21 24.54 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.172 -179.26 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 595' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -79.65 169.0 18.62 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-O 121.127 0.489 . . . . 0.0 111.106 179.268 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 596' ' ' LYS . . . . . . . . . . . . . 20.0 pttp -106.89 123.42 48.14 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.579 -174.25 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 597' ' ' LEU . . . . . 0.672 ' HB2' ' HB3' ' A' ' 589' ' ' LEU . 40.1 mt -87.73 122.14 31.03 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.947 173.526 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 598' ' ' GLU . . . . . 0.761 ' O ' ' HA ' ' A' ' 608' ' ' VAL . 18.2 tt0 -75.89 94.05 3.3 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.234 177.702 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 599' ' ' VAL . . . . . . . . . . . . . 41.5 t -107.84 121.71 61.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-O 121.317 0.58 . . . . 0.0 110.32 178.32 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 600' ' ' SER . . . . . 0.882 ' HB2' ' HG ' ' A' ' 586' ' ' LEU . 34.9 t -141.8 168.71 19.1 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.703 -177.13 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 601' ' ' LEU . . . . . . . . . . . . . 42.4 tp -135.95 107.78 7.07 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.111 -0.95 . . . . 0.0 108.738 -178.479 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 602' ' ' LYS . . . . . 0.606 ' O ' HG12 ' A' ' 605' ' ' VAL . 57.0 mtpt -131.02 114.33 15.06 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.076 -172.832 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 603' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 57.83 47.16 15.78 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.704 177.663 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 604' ' ' ASN . . . . . . . . . . . . . 13.9 m120 71.97 9.32 6.09 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 114.855 -1.066 . . . . 0.0 112.967 174.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 605' ' ' VAL . . . . . 0.606 HG12 ' O ' ' A' ' 602' ' ' LYS . 7.6 p -118.2 134.26 62.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 C-N-CA 120.146 -0.621 . . . . 0.0 110.326 173.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 606' ' ' VAL . . . . . 0.812 HG13 ' HB ' ' A' ' 613' ' ' VAL . 3.9 p -101.64 136.93 31.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.043 178.318 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 607' ' ' SER . . . . . . . . . . . . . 45.0 m -136.93 151.03 48.58 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.759 -177.585 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 608' ' ' VAL . . . . . 0.761 ' HA ' ' O ' ' A' ' 598' ' ' GLU . 4.3 p -128.62 108.41 17.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.411 0.624 . . . . 0.0 110.059 176.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 609' ' ' ASN . . . . . 0.465 HD21 ' HA ' ' A' ' 597' ' ' LEU . 64.0 m-80 60.34 47.98 8.41 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.638 -176.415 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 610' ' ' LYS . . . . . 0.407 ' HB2' ' O ' ' A' ' 609' ' ' ASN . 56.0 mtpt 73.17 -19.02 0.34 Allowed 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 115.534 -0.757 . . . . 0.0 112.097 -178.533 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 611' ' ' GLU . . . . . 0.428 ' HA ' ' HD3' ' A' ' 612' ' ' PRO . 5.2 mm-40 -79.16 123.74 84.71 Favored Pre-proline 0 C--N 1.331 -0.213 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 -179.359 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 612' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 611' ' ' GLU . 7.3 Cg_exo -73.12 136.12 24.07 Favored 'Trans proline' 0 C--O 1.236 0.382 0 C-N-CA 123.235 2.623 . . . . 0.0 112.939 -176.193 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 613' ' ' VAL . . . . . 0.812 ' HB ' HG13 ' A' ' 606' ' ' VAL . 93.7 t -81.83 130.5 35.7 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.92 175.712 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 614' ' ' ALA . . . . . . . . . . . . . . . -78.44 -33.39 48.55 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.503 -176.239 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 615' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -165.47 107.53 0.77 Allowed Pre-proline 0 C--O 1.233 0.197 0 CA-C-O 120.835 0.35 . . . . 0.0 110.576 -179.673 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 616' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_endo -89.32 156.37 5.52 Favored 'Trans proline' 0 N--CA 1.459 -0.524 0 C-N-CA 123.29 2.66 . . . . 0.0 114.008 -178.065 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 35.3 t70 77.95 61.94 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 122.687 1.232 . . . . 0.0 110.463 166.524 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 618' ' ' ILE . . . . . 0.435 ' HB ' ' O ' ' A' ' 625' ' ' VAL . 7.9 mt -104.73 112.83 39.95 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.301 0 CA-C-N 113.757 -1.565 . . . . 0.0 108.438 174.695 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 619' ' ' MET . . . . . 0.467 ' HA ' ' CE ' ' A' ' 619' ' ' MET . 4.9 mmt -77.83 131.36 37.53 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 -170.588 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 620' ' ' ALA . . . . . . . . . . . . . . . -130.23 162.6 28.57 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 114.995 -1.002 . . . . 0.0 108.466 170.318 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 621' ' ' THR . . . . . . . . . . . . . 5.7 t -73.86 -20.37 60.44 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 120.502 -0.479 . . . . 0.0 111.351 -175.753 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 622' ' ' ASN . . . . . 0.584 ' CB ' ' HA ' ' A' ' 534' ' ' GLU . 28.2 p-10 -116.84 15.54 15.28 Favored 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 120.642 -0.423 . . . . 0.0 111.986 -177.362 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 623' ' ' GLY . . . . . 0.635 ' HA2' HD11 ' A' ' 577' ' ' ILE . . . 157.07 -156.22 27.03 Favored Glycine 0 N--CA 1.443 -0.872 0 C-N-CA 119.97 -1.109 . . . . 0.0 112.762 179.437 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 624' ' ' VAL . . . . . . . . . . . . . 6.3 p -131.22 156.11 42.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-O 121.033 0.444 . . . . 0.0 110.115 -178.201 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 625' ' ' VAL . . . . . 0.541 HG22 HG13 ' A' ' 505' ' ' VAL . 42.6 t -123.74 132.93 70.56 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.645 179.416 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 626' ' ' HIS . . . . . . . . . . . . . 96.2 m-70 -119.16 115.35 24.05 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 174.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 627' ' ' VAL . . . . . 0.404 HG22 ' HZ ' ' A' ' 515' ' ' PHE . 40.4 t -69.87 123.74 24.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.719 -179.8 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 628' ' ' ILE . . . . . 0.524 HG13 ' HA ' ' A' ' 542' ' ' PRO . 8.1 pt -117.51 143.28 28.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 121.192 0.52 . . . . 0.0 111.063 176.436 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 629' ' ' THR . . . . . . . . . . . . . 8.4 t -94.85 5.77 50.93 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.369 -178.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 630' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -135.96 165.83 24.76 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.052 -179.437 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 631' ' ' VAL . . . . . 0.625 HG22 ' HB1' ' A' ' 546' ' ' ALA . 0.7 OUTLIER -98.17 130.14 47.38 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.886 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.755 175.91 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 632' ' ' LEU . . . . . 0.662 HD21 HG13 ' A' ' 608' ' ' VAL . 96.1 mt -77.32 115.93 17.51 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.242 0.544 . . . . 0.0 110.922 -177.355 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 633' ' ' GLN . . . . . 0.542 ' HA ' HE21 ' A' ' 633' ' ' GLN . 0.1 OUTLIER -118.51 117.18 34.63 Favored Pre-proline 0 C--N 1.322 -0.599 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.937 -178.221 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 634' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo . . . . . 0 C--O 1.251 1.133 0 C-N-CA 122.65 2.233 . . . . 0.0 111.944 177.42 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 500' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.064 0 CA-C-O 120.843 0.354 . . . . 0.0 110.869 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 501' ' ' GLY . . . . . . . . . . . . . . . -152.44 -174.01 22.54 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.923 -0.656 . . . . 0.0 111.652 178.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 502' ' ' MET . . . . . . . . . . . . . 21.1 ptp -63.06 121.87 14.67 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.036 0.446 . . . . 0.0 110.444 177.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . -163.72 -178.45 37.36 Favored Glycine 0 N--CA 1.445 -0.703 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.697 179.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 78.9 p -86.14 173.11 10.06 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.912 0.356 . . . . 0.0 110.536 -179.359 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 505' ' ' VAL . . . . . 0.538 ' O ' ' HG ' ' A' ' 509' ' ' LEU . 24.2 t -53.57 -40.6 42.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 121.224 0.535 . . . . 0.0 110.009 175.098 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 506' ' ' MET . . . . . . . . . . . . . 7.4 mmt -56.5 -40.65 75.32 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.021 -0.991 . . . . 0.0 112.296 179.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 507' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -67.63 -40.91 84.6 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 121.035 0.445 . . . . 0.0 110.564 -179.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 508' ' ' VAL . . . . . . . . . . . . . 62.1 t -60.66 -41.38 87.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.416 178.601 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 509' ' ' LEU . . . . . 0.538 ' HG ' ' O ' ' A' ' 505' ' ' VAL . 53.9 mt -75.33 -23.26 57.24 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.693 -179.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 510' ' ' LYS . . . . . 0.567 ' HB3' ' NZ ' ' A' ' 510' ' ' LYS . 1.6 mmmp? -85.8 -33.36 21.38 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.084 -176.688 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 511' ' ' GLY . . . . . . . . . . . . . . . -73.4 -10.75 79.45 Favored Glycine 0 N--CA 1.445 -0.741 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.928 178.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 512' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -110.23 148.61 31.53 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.24 0.543 . . . . 0.0 111.278 -178.2 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 513' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -75.19 -33.0 61.37 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.617 -177.73 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 514' ' ' ARG . . . . . 0.682 ' HD2' ' H ' ' A' ' 514' ' ' ARG . 0.3 OUTLIER -88.46 -45.06 10.26 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.059 0.457 . . . . 0.0 110.039 -171.906 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 515' ' ' PHE . . . . . 0.708 ' HZ ' HG22 ' A' ' 627' ' ' VAL . 14.8 m-30 -63.9 -24.69 67.84 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.155 177.523 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 516' ' ' SER . . . . . . . . . . . . . 26.5 t -60.76 -36.4 78.85 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.887 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 517' ' ' MET . . . . . . . . . . . . . 59.3 mtm -65.39 -34.5 78.44 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-O 121.003 0.43 . . . . 0.0 110.093 177.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 518' ' ' LEU . . . . . . . . . . . . . 56.1 tp -66.96 -39.8 87.33 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.436 174.661 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 519' ' ' VAL . . . . . . . . . . . . . 58.1 t -54.84 -37.66 41.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-O 121.093 0.473 . . . . 0.0 109.808 174.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 520' ' ' ALA . . . . . . . . . . . . . . . -65.02 -39.98 94.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.627 -179.268 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 521' ' ' ALA . . . . . . . . . . . . . . . -69.08 -43.58 74.27 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.465 176.438 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 522' ' ' ILE . . . . . . . . . . . . . 89.3 mt -58.01 -41.81 81.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.224 177.05 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 523' ' ' GLN . . . . . 0.726 HE21 ' HA ' ' A' ' 523' ' ' GLN . 0.0 OUTLIER -65.22 -23.96 67.22 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-O 121.011 0.434 . . . . 0.0 111.405 178.774 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 524' ' ' SER . . . . . . . . . . . . . 30.0 t -79.66 -41.11 27.6 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.535 177.501 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 525' ' ' ALA . . . . . . . . . . . . . . . -82.29 -29.0 31.4 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.118 0.414 . . . . 0.0 112.118 -176.625 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 526' ' ' GLY . . . . . . . . . . . . . . . 95.08 25.45 14.39 Favored Glycine 0 CA--C 1.519 0.327 0 C-N-CA 120.546 -0.835 . . . . 0.0 113.332 176.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 527' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -91.58 8.39 36.88 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 121.173 0.511 . . . . 0.0 110.171 178.342 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 528' ' ' THR . . . . . . . . . . . . . 16.9 m -57.87 -44.05 86.4 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.439 -0.8 . . . . 0.0 111.238 -178.282 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 529' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -65.48 -31.31 72.31 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.026 -0.533 . . . . 0.0 111.352 -176.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 530' ' ' THR . . . . . . . . . . . . . 12.4 m -63.21 -46.57 86.4 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.108 -179.238 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 531' ' ' LEU . . . . . . . . . . . . . 42.4 mt -90.44 8.28 34.5 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 120.978 0.418 . . . . 0.0 111.236 -177.156 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 532' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -95.01 -25.15 16.61 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.019 -177.195 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 533' ' ' ARG . . . . . . . . . . . . . 69.1 mtm180 -92.39 157.69 16.47 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.345 -177.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 534' ' ' GLU . . . . . 0.583 ' HA ' ' HB3' ' A' ' 622' ' ' ASN . 12.7 pt-20 -78.75 162.76 25.92 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.758 178.567 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 535' ' ' GLY . . . . . . . . . . . . . . . 139.05 -138.63 9.5 Favored Glycine 0 N--CA 1.446 -0.67 0 N-CA-C 110.302 -1.119 . . . . 0.0 110.302 -176.113 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 536' ' ' VAL . . . . . 0.556 ' HB ' HG13 ' A' ' 577' ' ' ILE . 35.3 m -127.07 129.06 71.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 121.229 0.538 . . . . 0.0 111.043 176.417 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 537' ' ' TYR . . . . . 0.436 ' O ' ' HA3' ' A' ' 623' ' ' GLY . 69.2 m-85 -153.07 130.89 11.66 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.595 -0.729 . . . . 0.0 109.695 179.003 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 538' ' ' THR . . . . . 0.707 ' OG1' ' HA ' ' A' ' 577' ' ' ILE . 28.3 m -114.62 106.3 14.08 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.961 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 539' ' ' VAL . . . . . . . . . . . . . 40.0 t -112.15 130.86 65.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-O 121.021 0.439 . . . . 0.0 111.35 -174.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 540' ' ' PHE . . . . . 0.474 ' HB3' HD13 ' A' ' 628' ' ' ILE . 87.5 m-85 -97.68 111.2 23.58 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 174.056 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 541' ' ' ALA . . . . . 0.404 ' HA ' ' HD3' ' A' ' 542' ' ' PRO . . . -101.73 118.38 59.7 Favored Pre-proline 0 C--N 1.325 -0.471 0 CA-C-O 120.669 0.271 . . . . 0.0 110.887 -177.029 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 542' ' ' PRO . . . . . 0.539 ' HA ' HG13 ' A' ' 628' ' ' ILE . 7.4 Cg_exo -74.08 141.52 29.71 Favored 'Trans proline' 0 N--CA 1.461 -0.401 0 C-N-CA 123.155 2.57 . . . . 0.0 112.149 178.339 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 61.0 p -81.66 -176.61 6.15 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.683 -179.124 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 544' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -61.13 -32.7 72.39 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 121.352 0.596 . . . . 0.0 110.162 179.067 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 545' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -59.5 -40.48 87.22 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.037 -0.983 . . . . 0.0 110.939 -179.517 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 546' ' ' ALA . . . . . 0.693 ' HB1' HG23 ' A' ' 631' ' ' VAL . . . -61.54 -50.18 73.7 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.559 -177.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 547' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -69.51 -20.86 63.7 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.136 -177.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 548' ' ' ARG . . . . . . . . . . . . . 30.5 tpt180 -83.37 -33.89 25.71 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.056 0.455 . . . . 0.0 110.236 177.527 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 549' ' ' ALA . . . . . . . . . . . . . . . -75.5 -21.38 58.06 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.375 -0.83 . . . . 0.0 111.441 -179.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 550' ' ' LEU . . . . . 0.617 HD11 HG21 ' A' ' 631' ' ' VAL . 73.5 mt -69.85 129.1 91.38 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-O 120.772 0.32 . . . . 0.0 111.058 178.385 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 551' ' ' PRO . . . . . 0.487 ' HD3' ' HA ' ' A' ' 550' ' ' LEU . 5.1 Cg_exo -77.78 148.29 25.32 Favored 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 123.061 2.508 . . . . 0.0 111.209 -179.207 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 552' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 551' ' ' PRO . 50.1 Cg_exo -53.85 -34.42 75.6 Favored 'Trans proline' 0 N--CA 1.471 0.194 0 C-N-CA 122.915 2.41 . . . . 0.0 112.435 -178.768 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 553' ' ' ARG . . . . . . . . . . . . . 34.8 mtp180 -62.24 -42.78 99.62 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.539 179.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 554' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -83.78 -35.01 24.65 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.808 0.337 . . . . 0.0 110.84 179.589 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 555' ' ' ARG . . . . . . . . . . . . . 14.4 mtp180 -58.05 -42.56 85.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.137 176.108 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 28.5 t -59.93 -28.55 67.71 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.863 -178.561 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 557' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -67.14 -62.91 1.2 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.357 0.599 . . . . 0.0 110.193 176.377 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 558' ' ' LEU . . . . . 0.573 ' O ' ' HG ' ' A' ' 565' ' ' LEU . 53.2 tp -68.88 -52.66 27.25 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.26 -0.882 . . . . 0.0 112.107 -172.422 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 559' ' ' LEU . . . . . . . . . . . . . 72.5 mt -80.33 4.74 16.87 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.802 -170.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 560' ' ' GLY . . . . . . . . . . . . . . . -123.66 3.97 9.33 Favored Glycine 0 N--CA 1.446 -0.7 0 C-N-CA 120.381 -0.914 . . . . 0.0 112.619 -179.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 561' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -135.82 128.67 31.16 Favored 'General case' 0 C--N 1.326 -0.431 0 O-C-N 122.538 -0.389 . . . . 0.0 111.051 -178.676 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 562' ' ' ALA . . . . . . . . . . . . . . . -70.32 -38.54 74.95 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.677 -176.132 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 563' ' ' LYS . . . . . 0.48 ' HG2' ' OE1' ' A' ' 564' ' ' GLU . 31.4 tttm -66.65 -47.87 71.18 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.036 -178.394 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 564' ' ' GLU . . . . . 0.48 ' OE1' ' HG2' ' A' ' 563' ' ' LYS . 5.7 mm-40 -67.33 -36.0 80.54 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.602 -0.272 . . . . 0.0 110.786 -179.436 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 565' ' ' LEU . . . . . 0.573 ' HG ' ' O ' ' A' ' 558' ' ' LEU . 6.6 mt -56.62 -52.52 64.56 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-O 120.893 0.377 . . . . 0.0 110.331 174.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 566' ' ' ALA . . . . . 0.5 ' O ' ' HG3' ' A' ' 570' ' ' LYS . . . -61.16 -48.71 80.34 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.34 -179.038 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 567' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -59.84 -48.08 83.15 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.822 -177.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 568' ' ' ILE . . . . . . . . . . . . . 43.4 mm -69.47 -35.27 65.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.706 0.289 . . . . 0.0 111.459 -178.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 569' ' ' LEU . . . . . 0.49 ' HG ' ' O ' ' A' ' 565' ' ' LEU . 61.2 mt -66.23 -36.95 84.35 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.813 -0.355 . . . . 0.0 110.59 177.128 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 570' ' ' LYS . . . . . 0.5 ' HG3' ' O ' ' A' ' 566' ' ' ALA . 53.2 mtpt -69.33 -9.84 55.16 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.682 0.277 . . . . 0.0 111.061 177.355 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 571' ' ' TYR . . . . . 0.506 ' HB2' HE21 ' A' ' 593' ' ' GLN . 33.9 t80 -92.78 -18.93 22.29 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.87 0.367 . . . . 0.0 110.525 179.065 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 572' ' ' HIS . . . . . . . . . . . . . 67.2 m80 -92.93 -7.08 47.06 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.17 0.509 . . . . 0.0 110.581 179.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 573' ' ' ILE . . . . . . . . . . . . . 54.0 mt -113.75 124.12 70.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.885 179.018 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 574' ' ' GLY . . . . . 0.502 ' HA3' ' CD2' ' A' ' 589' ' ' LEU . . . -113.95 149.7 18.67 Favored Glycine 0 N--CA 1.445 -0.74 0 N-CA-C 110.575 -1.01 . . . . 0.0 110.575 171.48 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 575' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -100.35 24.51 8.73 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 117.553 0.677 . . . . 0.0 110.879 -177.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 576' ' ' GLU . . . . . 0.421 ' HG3' ' HG ' ' A' ' 589' ' ' LEU . 14.8 pt-20 -136.21 125.88 25.46 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 175.426 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 577' ' ' ILE . . . . . 0.707 ' HA ' ' OG1' ' A' ' 538' ' ' THR . 61.2 mt -77.57 115.07 18.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.147 -175.423 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 578' ' ' LEU . . . . . 0.562 HD11 ' HA ' ' A' ' 583' ' ' ILE . 48.7 tp -121.67 103.44 8.89 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.267 -0.879 . . . . 0.0 109.791 177.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 579' ' ' VAL . . . . . 0.497 ' O ' HG13 ' A' ' 583' ' ' ILE . 30.4 m -95.36 162.41 2.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.964 178.035 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 580' ' ' SER . . . . . . . . . . . . . 15.3 m -56.6 -45.93 81.14 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 123.354 0.409 . . . . 0.0 111.914 -175.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 581' ' ' GLY . . . . . . . . . . . . . . . -70.43 -21.17 77.42 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.52 -0.848 . . . . 0.0 112.619 -179.104 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 582' ' ' GLY . . . . . . . . . . . . . . . -99.43 2.64 57.6 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.876 -0.678 . . . . 0.0 113.296 -175.222 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 583' ' ' ILE . . . . . 0.562 ' HA ' HD11 ' A' ' 578' ' ' LEU . 62.7 mt -67.75 -65.21 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 117.183 0.491 . . . . 0.0 111.1 179.142 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 584' ' ' GLY . . . . . . . . . . . . . . . 78.83 78.32 0.84 Allowed Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.241 -0.981 . . . . 0.0 111.556 -175.388 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 585' ' ' ALA . . . . . . . . . . . . . . . 70.68 -80.12 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 123.303 0.641 . . . . 0.0 111.88 -178.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 586' ' ' LEU . . . . . 0.96 ' HG ' ' HB3' ' A' ' 600' ' ' SER . 6.4 tt -151.32 129.02 11.54 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.7 0.286 . . . . 0.0 110.654 -175.458 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 587' ' ' VAL . . . . . . . . . . . . . 68.3 t -148.02 119.65 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.848 -0.614 . . . . 0.0 109.62 179.107 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 588' ' ' ARG . . . . . 0.551 ' HG2' ' HA ' ' A' ' 598' ' ' GLU . 92.3 mtt180 -85.36 123.06 30.39 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.125 0.488 . . . . 0.0 110.875 -179.131 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 589' ' ' LEU . . . . . 0.527 HD12 ' HB3' ' A' ' 578' ' ' LEU . 6.2 tt -90.56 125.63 35.68 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 114.749 -1.114 . . . . 0.0 109.77 -172.775 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 590' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -76.72 132.31 39.24 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.169 0.509 . . . . 0.0 110.774 -179.157 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 591' ' ' SER . . . . . . . . . . . . . 78.3 p -99.76 159.85 14.75 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.744 -176.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 592' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -58.01 -25.64 61.37 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 116.187 -0.46 . . . . 0.0 112.053 179.177 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 593' ' ' GLN . . . . . 0.506 HE21 ' HB2' ' A' ' 571' ' ' TYR . 4.0 tt0 -68.39 -27.09 65.91 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.175 0.512 . . . . 0.0 110.664 178.763 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 594' ' ' GLY . . . . . . . . . . . . . . . 107.17 -4.95 35.72 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.744 -0.741 . . . . 0.0 111.369 -174.663 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 595' ' ' ASP . . . . . 0.401 ' HB3' ' CE1' ' A' ' 571' ' ' TYR . 2.2 t70 -88.81 -176.78 5.34 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 179.22 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 596' ' ' LYS . . . . . 0.679 ' HD3' ' N ' ' A' ' 596' ' ' LYS . 0.0 OUTLIER -125.56 129.74 50.29 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.078 0.466 . . . . 0.0 110.875 -172.283 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 597' ' ' LEU . . . . . 0.408 HD21 ' O ' ' A' ' 571' ' ' TYR . 59.7 mt -93.46 119.53 32.65 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.63 177.453 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 598' ' ' GLU . . . . . 0.551 ' HA ' ' HG2' ' A' ' 588' ' ' ARG . 10.7 tp10 -75.76 86.55 2.77 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.356 -179.74 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 599' ' ' VAL . . . . . . . . . . . . . 49.3 t -105.86 125.43 61.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 121.198 0.523 . . . . 0.0 110.395 -179.415 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 600' ' ' SER . . . . . 0.96 ' HB3' ' HG ' ' A' ' 586' ' ' LEU . 3.0 p -142.72 157.43 44.66 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.107 -179.114 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 601' ' ' LEU . . . . . 0.494 ' HB2' HD12 ' A' ' 583' ' ' ILE . 33.9 tp -123.06 122.92 39.66 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.096 -177.525 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 602' ' ' LYS . . . . . . . . . . . . . 34.9 ttmt -139.42 109.26 6.32 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.712 0.292 . . . . 0.0 110.515 -177.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 603' ' ' ASN . . . . . . . . . . . . . 18.7 m120 61.75 46.77 6.74 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.61 178.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 604' ' ' ASN . . . . . . . . . . . . . 15.9 t-20 76.64 -8.77 1.61 Allowed 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 115.307 -0.86 . . . . 0.0 111.777 177.277 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 605' ' ' VAL . . . . . . . . . . . . . 49.0 t -94.14 126.43 46.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-O 120.75 0.309 . . . . 0.0 110.198 -179.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 606' ' ' VAL . . . . . 0.553 HG13 ' HB ' ' A' ' 613' ' ' VAL . 6.7 p -108.76 131.11 60.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.625 -179.665 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 607' ' ' SER . . . . . . . . . . . . . 45.2 p -131.92 144.4 50.81 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.2 -179.203 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 608' ' ' VAL . . . . . 0.473 ' HA ' ' O ' ' A' ' 598' ' ' GLU . 4.4 p -118.83 115.04 46.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.81 176.205 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 609' ' ' ASN . . . . . . . . . . . . . 95.7 m-20 61.79 32.33 18.2 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.093 -176.378 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 610' ' ' LYS . . . . . 0.533 ' NZ ' ' HB2' ' A' ' 610' ' ' LYS . 0.0 OUTLIER 81.48 -6.18 1.54 Allowed 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 114.792 -1.094 . . . . 0.0 111.134 -179.176 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 611' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -87.11 111.34 40.13 Favored Pre-proline 0 C--N 1.326 -0.42 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 177.438 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 612' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -65.41 135.23 41.83 Favored 'Trans proline' 0 N--CA 1.462 -0.361 0 C-N-CA 122.634 2.223 . . . . 0.0 112.185 -178.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 613' ' ' VAL . . . . . 0.553 ' HB ' HG13 ' A' ' 606' ' ' VAL . 89.8 t -73.84 125.01 32.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.068 177.823 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 614' ' ' ALA . . . . . 0.69 ' HB2' HG23 ' A' ' 629' ' ' THR . . . -64.65 -45.34 87.18 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.748 -177.82 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 615' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -154.46 99.04 2.48 Favored Pre-proline 0 N--CA 1.466 0.374 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.782 -177.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 616' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -88.87 162.29 6.09 Favored 'Trans proline' 0 N--CA 1.459 -0.51 0 C-N-CA 123.026 2.484 . . . . 0.0 114.195 -176.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 617' ' ' ASP . . . . . . . . . . . . . 37.5 t0 77.33 46.93 0.06 Allowed 'General case' 0 C--O 1.234 0.272 0 CA-C-O 122.735 1.255 . . . . 0.0 110.114 165.238 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 618' ' ' ILE . . . . . 0.474 ' HB ' ' O ' ' A' ' 625' ' ' VAL . 11.6 mt -90.63 113.5 26.62 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.812 0 CA-C-N 113.503 -1.681 . . . . 0.0 109.674 174.302 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 619' ' ' MET . . . . . . . . . . . . . 7.7 mmt -77.2 133.48 38.9 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 -170.207 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 620' ' ' ALA . . . . . . . . . . . . . . . -130.31 170.92 13.5 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 115.113 -0.949 . . . . 0.0 108.802 170.097 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 621' ' ' THR . . . . . . . . . . . . . 5.0 t -81.32 -23.99 37.47 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.775 -0.37 . . . . 0.0 111.056 -178.53 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 622' ' ' ASN . . . . . 0.583 ' HB3' ' HA ' ' A' ' 534' ' ' GLU . 29.7 p-10 -117.11 22.64 12.4 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.844 0.354 . . . . 0.0 111.066 -176.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 623' ' ' GLY . . . . . 0.47 ' HA2' HD11 ' A' ' 577' ' ' ILE . . . 152.52 -147.11 16.38 Favored Glycine 0 N--CA 1.444 -0.796 0 C-N-CA 120.231 -0.985 . . . . 0.0 112.68 177.469 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 624' ' ' VAL . . . . . . . . . . . . . 9.5 p -144.46 158.51 14.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 -177.37 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 625' ' ' VAL . . . . . 0.474 ' O ' ' HB ' ' A' ' 618' ' ' ILE . 60.9 t -125.85 135.4 64.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 -179.828 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 626' ' ' HIS . . . . . . . . . . . . . 95.5 m-70 -119.33 116.15 25.61 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.23 -0.441 . . . . 0.0 109.946 175.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 627' ' ' VAL . . . . . 0.708 HG22 ' HZ ' ' A' ' 515' ' ' PHE . 48.3 t -70.24 125.67 28.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.281 179.75 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 628' ' ' ILE . . . . . 0.539 HG13 ' HA ' ' A' ' 542' ' ' PRO . 7.9 pt -121.28 145.88 27.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 121.32 0.581 . . . . 0.0 111.018 176.679 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 629' ' ' THR . . . . . 0.69 HG23 ' HB2' ' A' ' 614' ' ' ALA . 16.9 p -90.35 -3.33 57.81 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.493 -0.776 . . . . 0.0 112.197 -176.737 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 630' ' ' ASN . . . . . . . . . . . . . 64.1 t30 -141.91 175.05 10.03 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.503 -0.555 . . . . 0.0 109.503 -179.405 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 631' ' ' VAL . . . . . 0.693 HG23 ' HB1' ' A' ' 546' ' ' ALA . 51.2 t -106.21 123.79 61.13 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 N-CA-C 109.484 -0.562 . . . . 0.0 109.484 -178.729 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 632' ' ' LEU . . . . . 0.4 HD21 HG13 ' A' ' 608' ' ' VAL . 88.4 mt -68.24 126.08 28.44 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.042 0.449 . . . . 0.0 111.46 -173.069 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 633' ' ' GLN . . . . . . . . . . . . . 82.9 mm-40 -118.44 119.77 32.64 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.058 -178.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 634' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo . . . . . 0 C--O 1.251 1.139 0 C-N-CA 122.685 2.257 . . . . 0.0 112.171 177.59 . . . . . . . . 0 0 . 1 stop_ save_